data_2k5v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k5v _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 120.754 0.312 . . . . 75.099999999999994 110.365 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -87.16 152.41 22.36 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.484 0.659 . . . . 74.420000000000002 112.261 -174.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.468 ' HG2' ' OE1' ' A' ' 178' ' ' GLU . 27.5 mmtm -100.77 164.47 11.84 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.58 -0.896 . . . . 74.329999999999998 108.58 168.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 54.2 mt -58.31 -31.11 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 O-C-N 122.059 -0.401 . . . . 73.209999999999994 111.816 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.4 t -71.89 -24.14 61.61 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.147 0.425 . . . . 73.319999999999993 112.147 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.468 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 45.2 mt-10 -81.63 -5.95 58.54 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.126 -0.359 . . . . 70.430000000000007 111.824 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 247' ' ' VAL . 82.6 mt -75.86 125.58 29.36 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.293 0.568 . . . . 72.430000000000007 111.882 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.514 ' HG2' HD22 ' A' ' 183' ' ' LEU . 22.6 ptp -124.12 159.03 58.62 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 115.859 -0.61 . . . . 74.219999999999999 110.3 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 248' ' ' LYS . 14.8 Cg_endo -57.37 133.18 55.49 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.963 1.775 . . . . 75.019999999999996 112.904 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.428 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 76.4 m-20 69.57 29.89 4.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.397 0.679 . . . . 74.409999999999997 111.8 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.514 HD22 ' HG2' ' A' ' 180' ' ' MET . 27.0 tp -106.13 118.26 36.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.124 -0.489 . . . . 75.439999999999998 111.578 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.5 t -92.63 108.98 20.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.779 0.323 . . . . 73.420000000000002 110.201 173.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -153.29 172.56 32.19 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.585 -0.817 . . . . 73.140000000000001 113.911 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 244' ' ' SER . 34.8 m -114.17 129.77 56.62 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.78 0.324 . . . . 73.120000000000005 111.726 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.461 HD13 HD11 ' A' ' 179' ' ' LEU . 37.3 pt -122.16 163.68 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.301 0.572 . . . . 72.430000000000007 112.298 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -121.76 118.52 29.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.948 -0.569 . . . . 61.420000000000002 110.264 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -151.33 171.73 17.01 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.527 0.566 . . . . 73.049999999999997 112.527 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -96.01 141.66 29.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.066 -0.515 . . . . 64.230000000000004 111.589 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.9 t -78.95 103.49 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.972 0.415 . . . . 74.129999999999995 111.136 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' A' ' 216' ' ' LYS . 21.5 t -81.36 -28.61 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.0 0.429 . . . . 73.310000000000002 111.728 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -151.33 136.42 17.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.978 0.418 . . . . 71.329999999999998 111.572 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -124.05 114.36 19.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.885 -0.598 . . . . 71.099999999999994 110.818 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 212' ' ' SER . 94.9 m-85 -109.37 148.69 38.55 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 120.655 0.264 . . . . 75.129999999999995 111.632 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.41 156.65 16.79 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.984 2.456 . . . . 71.019999999999996 113.841 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -73.44 169.23 17.62 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.53 0.681 . . . . 72.340000000000003 111.989 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -138.65 149.47 45.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.455 -0.793 . . . . 72.239999999999995 109.361 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 209' ' ' GLN . 44.0 mt-10 -130.82 112.6 13.18 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.912 -0.492 . . . . 73.25 112.248 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.8 p90 . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 121.261 0.553 . . . . 73.540000000000006 111.421 -178.019 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.482 ' HG2' ' HG2' ' A' ' 199' ' ' GLU . 24.6 mt-30 . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 120.943 0.401 . . . . 73.400000000000006 111.591 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 32.8 tp -145.17 126.4 14.77 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.059 -0.519 . . . . 74.530000000000001 111.39 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 84.7 tttt -126.87 135.08 50.49 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.948 0.404 . . . . 75.409999999999997 111.194 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 5.0 m -98.24 128.37 44.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.016 -0.538 . . . . 61.399999999999999 111.81 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.407 HD13 HG11 ' A' ' 235' ' ' VAL . 93.8 mt -137.1 163.72 30.13 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.085 0.469 . . . . 64.310000000000002 112.115 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -135.15 129.91 34.57 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.257 -0.429 . . . . 70.230000000000004 110.367 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.7 mt -120.7 148.59 43.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.256 0.222 . . . . 74.030000000000001 111.376 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.404 ' HB3' HG21 ' A' ' 192' ' ' VAL . 21.4 pttm -136.86 151.97 49.71 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.401 0.62 . . . . 75.140000000000001 112.095 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -148.78 165.59 30.97 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.304 -0.862 . . . . 74.340000000000003 109.848 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -57.26 -30.65 64.83 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 111.942 0.349 . . . . 70.150000000000006 111.942 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 63.0 p -84.07 -11.49 56.62 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.584 0.587 . . . . 62.130000000000003 112.584 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 152.25 179.77 28.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.936 -0.65 . . . . 74.319999999999993 113.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.4 p -124.2 155.42 38.57 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 122.554 -0.38 . . . . 62.229999999999997 111.498 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -147.05 156.75 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.979 0.418 . . . . 75.340000000000003 111.716 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.501 ' HD2' ' N ' ' A' ' 223' ' ' ARG . 8.3 mpt_? -95.08 123.97 38.87 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.69 0.281 . . . . 75.239999999999995 110.733 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.43 152.85 20.53 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.26 -0.495 . . . . 74.310000000000002 113.617 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 70.2 m -144.4 115.45 7.89 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.091 0.404 . . . . 74.540000000000006 112.091 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 88.8 mt -98.6 137.48 37.18 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.453 -0.34 . . . . 73.450000000000003 111.307 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -114.62 151.02 34.2 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.14 0.495 . . . . 74.510000000000005 112.233 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 64.2 t30 52.93 -134.24 1.7 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.828 -0.624 . . . . 64.120000000000005 111.856 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.42 -26.15 52.57 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.595 0.591 . . . . 74.329999999999998 112.595 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.42 -27.19 69.13 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.036 0.446 . . . . 75.109999999999999 111.225 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 211' ' ' LYS . . . -67.38 -14.24 62.74 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.115 0.413 . . . . 73.230000000000004 112.115 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -92.03 -12.98 31.69 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.992 0.425 . . . . 70.549999999999997 110.974 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -61.87 134.32 56.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.988 0.423 . . . . 73.329999999999998 111.605 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.92 118.24 15.62 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.009 0.433 . . . . 75.430000000000007 111.436 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.407 HG11 HD13 ' A' ' 213' ' ' LEU . 4.2 p -139.07 117.51 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.137 0.494 . . . . 74.129999999999995 110.492 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -106.99 152.09 24.45 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.119 0.485 . . . . 75.430000000000007 111.885 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -70.15 117.85 12.24 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.187 -0.46 . . . . 72.409999999999997 111.478 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.57 -13.18 32.89 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.478 -0.391 . . . . 75.25 113.097 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.56 145.82 36.65 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.055 0.455 . . . . 72.219999999999999 111.93 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.558 HG22 HD13 ' A' ' 264' ' ' ILE . 38.9 mm -87.71 118.57 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.037 -0.529 . . . . 73.409999999999997 110.566 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -128.59 145.55 51.1 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.653 0.612 . . . . 71.209999999999994 112.653 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -103.92 110.42 22.56 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.916 -0.584 . . . . 64.109999999999999 109.927 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.6 t -108.62 115.29 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.733 0.642 . . . . 73.430000000000007 112.733 -171.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 186' ' ' THR . 35.8 t -95.72 122.41 38.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.039 -0.528 . . . . 73.439999999999998 110.124 173.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -158.5 167.11 34.51 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.235 -0.983 . . . . 62.439999999999998 114.529 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -92.89 104.54 16.77 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.128 0.571 . . . . 74.230000000000004 110.596 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.492 HG22 HD21 ' A' ' 179' ' ' LEU . 44.6 t -86.02 138.86 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.675 0.274 . . . . 73.140000000000001 111.438 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 181' ' ' PRO . 10.6 ptmm? -151.06 176.35 11.23 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.066 0.46 . . . . 73.430000000000007 111.821 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.482 ' HA ' HD21 ' A' ' 254' ' ' LEU . 23.5 tt0 . . . . . 0 CA--C 1.54 0.561 0 CA-C-N 115.947 -0.569 . . . . 70.450000000000003 111.144 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.482 HD21 ' HA ' ' A' ' 249' ' ' GLN . 92.3 mt . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 110.406 -0.22 . . . . 72.140000000000001 110.406 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -109.66 143.12 39.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.985 0.421 . . . . 75.129999999999995 111.482 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.6 tt -108.72 104.35 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.339 0.59 . . . . 73.450000000000003 111.202 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.9 t -77.44 98.92 5.45 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.123 -0.49 . . . . 53.119999999999997 110.409 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.86 131.26 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.929 0.714 . . . . 75.099999999999994 112.929 -171.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -99.64 -44.6 6.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.567 -0.742 . . . . 75.420000000000002 110.357 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 244' ' ' SER . 21.7 m-80 -135.93 137.13 41.05 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.344 -0.389 . . . . 73.299999999999997 110.536 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.4 tt -137.75 136.19 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.841 0.353 . . . . 74.0 111.571 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.06 140.52 7.93 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.197 -0.525 . . . . 64.129999999999995 113.163 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.2 mm -85.54 115.07 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.062 0.458 . . . . 75.519999999999996 110.853 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.558 HD13 HG22 ' A' ' 240' ' ' ILE . 63.0 mt -59.41 -35.95 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.476 0.547 . . . . 72.030000000000001 112.476 -174.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 113.396 0.888 . . . . 75.530000000000001 113.396 -174.662 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.027 0.441 . . . . 75.140000000000001 110.164 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -83.38 141.05 32.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.187 0.518 . . . . 75.040000000000006 111.942 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 175' ' ' LYS . 12.1 mptt -96.54 155.79 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.61 . . . . 75.049999999999997 109.545 173.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.417 HD13 HG23 ' A' ' 222' ' ' ILE . 55.9 mt -59.15 -33.09 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.064 0.394 . . . . 75.239999999999995 112.064 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 56.2 p -70.79 -15.45 62.67 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.073 0.398 . . . . 64.400000000000006 112.073 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -104.55 -5.97 21.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.975 0.417 . . . . 55.340000000000003 111.594 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.518 HD22 HG22 ' A' ' 247' ' ' VAL . 81.6 mt -71.49 148.36 46.87 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.184 0.516 . . . . 74.319999999999993 111.987 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.5 ptp -148.18 153.27 41.07 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.945 -0.571 . . . . 74.219999999999999 110.801 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.29 128.05 24.18 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.905 2.403 . . . . 74.010000000000005 114.358 -177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.42 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 2.1 m-20 66.04 50.77 1.4 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.594 0.711 . . . . 72.329999999999998 112.156 173.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.7 tt -131.46 134.03 45.77 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.514 -0.766 . . . . 74.439999999999998 110.355 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 89.8 p -100.5 148.13 25.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.129 0.49 . . . . 64.510000000000005 111.508 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.67 -169.77 41.39 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.088 -0.577 . . . . 75.349999999999994 113.152 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 94.6 m -118.41 124.77 48.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.843 0.354 . . . . 75.230000000000004 111.712 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 37.2 pt -109.02 154.17 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.068 -0.515 . . . . 75.239999999999995 110.285 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -135.4 108.51 7.69 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.042 -0.411 . . . . 75.040000000000006 110.872 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.29 172.15 13.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.065 0.46 . . . . 64.25 112.099 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.425 ' CD ' ' HZ3' ' A' ' 237' ' ' LYS . 4.0 tm-20 -93.61 139.04 31.24 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.911 -0.586 . . . . 72.099999999999994 110.635 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.467 ' HA ' HD22 ' A' ' 215' ' ' LEU . 38.2 t -79.16 100.98 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.308 0.484 . . . . 54.219999999999999 112.308 -174.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.458 ' CG2' ' HG2' ' A' ' 216' ' ' LYS . 48.6 t -59.62 -52.56 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.941 0.401 . . . . 74.310000000000002 111.723 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -132.71 124.66 28.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.189 -0.46 . . . . 71.420000000000002 111.27 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -106.16 102.82 12.21 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.925 0.393 . . . . 74.420000000000002 111.351 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -81.99 155.93 69.91 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.187 0.439 . . . . 75.340000000000003 112.187 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.96 175.84 10.79 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.61 2.207 . . . . 73.5 112.188 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.549 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 64.1 pttt -93.76 124.06 37.51 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.517 0.675 . . . . 71.420000000000002 112.754 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -87.42 146.13 25.99 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.307 -0.86 . . . . 74.439999999999998 110.818 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -99.16 136.79 38.61 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.87 0.367 . . . . 75.239999999999995 111.685 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.6 p90 . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.992 0.425 . . . . 71.439999999999998 111.153 175.442 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 . . . . . 0 CA--C 1.542 0.651 0 CA-C-O 120.703 0.287 . . . . 75.510000000000005 110.573 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 28.2 tp -121.64 125.35 46.47 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.441 0.296 . . . . 71.019999999999996 111.768 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -141.6 113.58 7.95 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.01 0.433 . . . . 73.230000000000004 111.625 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 64.4 m -93.93 139.48 30.86 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.114 0.483 . . . . 74.239999999999995 111.721 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.479 HD13 HG12 ' A' ' 235' ' ' VAL . 85.9 mt -123.4 126.34 46.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.476 -0.329 . . . . 74.200000000000003 110.603 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -92.12 115.95 28.52 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.988 -0.445 . . . . 73.400000000000006 110.759 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.488 HD11 HG22 ' A' ' 243' ' ' VAL . 58.6 mt -112.52 152.87 28.31 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.538 0.335 . . . . 74.349999999999994 111.288 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.458 ' HG2' ' CG2' ' A' ' 192' ' ' VAL . 12.9 ptmm? -162.14 150.3 14.72 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.206 0.526 . . . . 74.329999999999998 112.067 172.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -116.44 -164.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.714 -0.847 . . . . 73.420000000000002 108.714 167.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.53 -6.15 58.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.639 0.733 . . . . 75.349999999999994 109.606 166.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.5 p -81.51 -33.81 31.62 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.284 -0.871 . . . . 75.540000000000006 111.744 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 167.46 -178.69 41.37 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.396 -0.431 . . . . 72.319999999999993 112.811 -176.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 81.0 p -130.3 133.73 46.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 117.35 0.575 . . . . 63.219999999999999 112.25 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.417 HG23 HD13 ' A' ' 176' ' ' ILE . 11.6 tt -148.51 153.16 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.653 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -101.2 132.66 46.59 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.704 -0.623 . . . . 72.109999999999999 111.675 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -96.92 117.58 5.8 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.643 -0.583 . . . . 65.299999999999997 111.643 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 30.8 m -95.95 115.99 28.26 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.438 -0.448 . . . . 75.319999999999993 112.107 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.482 HD22 ' HB ' ' A' ' 258' ' ' VAL . 92.8 mt -91.64 128.39 37.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.07 -0.514 . . . . 71.439999999999998 111.17 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -113.47 153.85 28.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.231 0.539 . . . . 74.310000000000002 111.777 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.8 -134.27 0.69 Allowed 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 115.647 -0.706 . . . . 71.140000000000001 112.006 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -63.6 -18.34 63.79 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.097 0.777 . . . . 70.219999999999999 113.097 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.0 -14.93 63.38 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.755 0.312 . . . . 75.329999999999998 111.593 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -61.24 -43.69 98.47 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.214 0.45 . . . . 63.310000000000002 112.214 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.471 ' CG ' ' HZ3' ' A' ' 197' ' ' LYS . 12.9 m-20 -76.08 1.31 15.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.54 0.57 . . . . 74.519999999999996 112.54 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -67.25 123.07 19.29 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.167 -0.333 . . . . 74.230000000000004 110.53 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.84 92.98 0.37 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.205 0.526 . . . . 70.25 112.068 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.479 HG12 HD13 ' A' ' 213' ' ' LEU . 3.7 p -120.42 107.64 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.743 -0.662 . . . . 75.310000000000002 110.24 173.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -95.34 163.58 13.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.0 -0.545 . . . . 75.109999999999999 111.002 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.431 ' HD3' ' C ' ' A' ' 237' ' ' LYS . 8.1 tmtm? -71.12 113.12 7.84 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.481 -0.563 . . . . 74.310000000000002 109.481 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 121.95 -23.12 7.45 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 116.175 -0.466 . . . . 65.200000000000003 112.231 -172.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -65.5 125.58 25.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.137 0.494 . . . . 75.420000000000002 112.067 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 49.8 mm -77.85 97.97 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.514 -0.55 . . . . 71.430000000000007 109.514 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -97.04 129.96 44.41 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.179 0.807 . . . . 63.140000000000001 113.179 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.9 96.57 8.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.685 -0.689 . . . . 71.209999999999994 109.417 170.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.488 HG22 HD11 ' A' ' 215' ' ' LEU . 88.6 t -97.61 111.62 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.113 0.483 . . . . 72.209999999999994 111.471 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.7 t -118.35 135.51 54.28 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.757 0.313 . . . . 73.340000000000003 111.056 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 172.81 -152.91 17.36 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.448 -0.882 . . . . 64.5 113.803 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -111.59 115.18 28.72 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.753 0.311 . . . . 70.329999999999998 111.325 -175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.518 HG22 HD22 ' A' ' 179' ' ' LEU . 47.7 t -86.27 120.54 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.776 0.322 . . . . 71.349999999999994 111.092 178.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.42 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 19.4 ptpt -135.09 -179.82 5.86 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.817 0.341 . . . . 73.310000000000002 111.043 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 . . . . . 0 CA--C 1.536 0.438 0 CA-C-N 116.703 -0.226 . . . . 73.510000000000005 110.405 171.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 121.263 0.554 . . . . 62.149999999999999 109.87 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -119.19 137.07 53.88 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.982 -0.554 . . . . 75.530000000000001 111.724 -172.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.465 ' HB ' HG21 ' A' ' 247' ' ' VAL . 9.5 tt -104.79 121.05 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.294 0.569 . . . . 73.200000000000003 111.98 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 94.5 p -81.75 112.07 18.58 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.491 -0.559 . . . . 74.129999999999995 109.491 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.482 ' HB ' HD22 ' A' ' 226' ' ' LEU . 21.7 t -77.64 106.16 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.864 0.364 . . . . 64.209999999999994 111.963 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -84.07 -24.06 30.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.01 0.433 . . . . 73.120000000000005 111.299 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -146.4 125.78 13.14 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.926 -0.579 . . . . 75.439999999999998 111.101 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.441 ' HB ' HG11 ' A' ' 258' ' ' VAL . 13.1 tt -135.67 137.06 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.158 0.504 . . . . 72.340000000000003 111.769 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.43 140.27 7.71 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.892 -0.595 . . . . 63.43 111.826 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 40.5 mm -92.26 128.66 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 117.682 0.741 . . . . 71.209999999999994 111.705 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 27.1 mt -83.65 -45.88 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 121.368 0.604 . . . . 75.239999999999995 110.758 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.469 0.506 0 CA-C-N 116.052 -0.522 . . . . 73.349999999999994 111.35 -178.529 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 120.995 0.426 . . . . 73.209999999999994 111.477 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -94.96 151.36 19.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.292 0.568 . . . . 74.329999999999998 111.9 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -89.34 153.69 20.67 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.701 -0.851 . . . . 75.150000000000006 108.701 169.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 222' ' ' ILE . 36.0 mt -55.72 -36.25 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.328 0.492 . . . . 74.140000000000001 112.328 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.455 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 47.1 t -69.85 -24.09 63.39 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.138 0.421 . . . . 73.219999999999999 112.138 176.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.85 -5.78 59.14 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.288 0.477 . . . . 74.420000000000002 112.288 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.432 HD21 HG22 ' A' ' 247' ' ' VAL . 89.2 mt -70.84 155.71 40.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.504 0.669 . . . . 73.299999999999997 112.625 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.434 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.2 ptp -154.23 152.04 25.58 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.437 -0.801 . . . . 74.239999999999995 109.756 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.0 150.33 79.12 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 121.684 1.589 . . . . 72.120000000000005 112.492 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 246' ' ' TYR . 2.3 m-20 64.72 30.91 12.25 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.057 0.456 . . . . 53.409999999999997 111.445 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.434 HD22 ' HG2' ' A' ' 180' ' ' MET . 22.8 tp -114.58 115.88 27.88 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.353 -0.385 . . . . 72.129999999999995 111.372 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 90.2 p -103.83 109.52 21.28 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.66 0.267 . . . . 72.310000000000002 110.765 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.83 -161.56 11.44 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.778 -0.725 . . . . 60.210000000000001 113.508 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 25.1 m -122.81 142.98 50.16 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.65 -0.324 . . . . 74.040000000000006 111.418 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 34.8 pt -135.31 155.46 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.233 0.54 . . . . 74.109999999999999 112.431 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -111.19 124.48 52.28 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.15 -0.477 . . . . 71.25 110.531 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.8 164.94 38.09 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.339 0.59 . . . . 60.530000000000001 112.41 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -103.21 138.05 40.53 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.615 -0.721 . . . . 71.200000000000003 110.089 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.9 99.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.58 0.585 . . . . 72.450000000000003 112.58 -172.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.3 t -70.87 -44.75 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.074 0.464 . . . . 75.409999999999997 111.774 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -143.4 132.72 23.3 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.176 -0.465 . . . . 73.519999999999996 111.832 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -124.1 99.48 6.26 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.148 -0.478 . . . . 65.329999999999998 110.855 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -77.49 149.78 78.81 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.55 0.574 . . . . 71.349999999999994 112.55 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -62.19 172.62 3.95 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.299 2.666 . . . . 70.430000000000007 114.054 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.531 ' HB2' ' HZ3' ' A' ' 197' ' ' LYS . 0.2 OUTLIER -61.07 109.99 1.24 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.373 -0.83 . . . . 75.439999999999998 112.868 -176.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 210' ' ' LEU . 66.7 mttm -83.88 148.96 26.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.185 -0.461 . . . . 73.319999999999993 109.929 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -131.86 136.58 47.56 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.986 0.735 . . . . 73.239999999999995 112.986 -171.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.418 ' HE1' ' HB2' ' A' ' 210' ' ' LEU . 54.8 p90 . . . . . 0 CA--C 1.541 0.634 0 CA-C-N 115.587 -0.733 . . . . 73.150000000000006 110.456 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 197' ' ' LYS . 47.4 mt-30 . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.645 0.26 . . . . 75.049999999999997 111.016 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 198' ' ' LYS . 65.8 tp -144.81 149.38 35.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.992 0.425 . . . . 72.019999999999996 111.458 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 231' ' ' ALA . 45.6 tttp -149.85 121.1 7.82 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.937 0.399 . . . . 75.219999999999999 111.263 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 41.2 m -95.38 118.26 31.8 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.969 0.414 . . . . 73.409999999999997 111.663 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 74.4 mt -109.57 130.45 55.51 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.442 -0.345 . . . . 54.509999999999998 110.773 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -97.79 103.75 15.71 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.002 -0.436 . . . . 72.340000000000003 110.669 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.17 136.34 35.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.141 -0.481 . . . . 74.209999999999994 111.291 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.742 ' HB2' ' HZ2' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -122.62 147.72 46.09 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 112.718 0.636 . . . . 73.120000000000005 112.718 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -148.21 163.05 38.17 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.133 -0.94 . . . . 70.329999999999998 109.298 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -77.52 10.05 2.88 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.908 -0.495 . . . . 60.149999999999999 112.263 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 69.8 p -115.24 2.81 14.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.947 0.403 . . . . 72.129999999999995 111.072 169.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 147.1 170.08 15.11 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.332 -0.461 . . . . 73.140000000000001 113.25 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 80.3 p -128.64 126.5 40.32 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.442 -0.446 . . . . 72.540000000000006 111.061 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 176' ' ' ILE . 9.6 tp -129.76 151.75 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.946 0.403 . . . . 73.010000000000005 111.263 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.558 ' HD3' ' H ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -99.29 125.26 44.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.2 0.524 . . . . 74.230000000000004 111.441 178.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.539 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -91.83 138.31 14.19 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.705 -0.68 . . . . 71.030000000000001 112.489 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.427 HG23 HD12 ' A' ' 210' ' ' LEU . 28.4 m -106.43 105.5 15.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.903 0.334 . . . . 74.200000000000003 111.903 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 56.4 mt -90.42 138.71 31.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.831 0.348 . . . . 63.43 111.186 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -115.55 157.12 24.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.272 0.558 . . . . 74.099999999999994 112.101 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 55.4 t30 57.83 -141.68 0.74 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.559 -0.746 . . . . 71.400000000000006 112.468 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.42 -24.21 19.03 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.989 0.737 . . . . 74.010000000000005 112.989 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.57 -8.35 4.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.92 0.39 . . . . 75.049999999999997 112.006 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.597 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -66.06 -30.02 70.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.922 0.391 . . . . 64.540000000000006 111.82 175.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.4 5.84 50.18 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.336 -0.393 . . . . 62.130000000000003 111.847 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -59.77 126.46 27.66 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.944 0.402 . . . . 75.239999999999995 111.856 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -68.39 87.82 0.31 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.245 0.545 . . . . 50.43 111.796 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.5 p -116.89 128.78 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.112 -0.495 . . . . 74.219999999999999 110.735 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -93.28 150.86 20.17 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.3 0.572 . . . . 72.439999999999998 112.281 -175.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -80.16 117.23 20.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.898 -0.592 . . . . 75.120000000000005 110.068 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.58 23.6 13.72 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.938 -0.648 . . . . 74.239999999999995 112.659 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -113.72 162.77 15.87 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.702 0.287 . . . . 72.219999999999999 110.564 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 47.0 mm -98.94 114.12 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.738 0.304 . . . . 73.420000000000002 111.218 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -114.15 142.43 46.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.023 0.749 . . . . 75.019999999999996 113.023 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 264' ' ' ILE . 30.5 tt0 -112.05 108.73 18.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.971 -0.559 . . . . 73.299999999999997 109.655 172.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.1 t -107.04 133.86 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 112.676 0.621 . . . . 72.040000000000006 112.676 -170.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 42.8 t -111.94 112.1 23.5 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.356 -0.384 . . . . 73.400000000000006 110.375 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.49 -176.88 26.42 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.174 -1.012 . . . . 71.040000000000006 114.369 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.423 ' CZ ' ' HA ' ' A' ' 182' ' ' ASN . 86.2 t80 -112.92 105.98 14.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.134 0.574 . . . . 73.430000000000007 111.084 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 256' ' ' ILE . 24.9 t -74.04 142.35 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.477 -0.329 . . . . 73.140000000000001 110.718 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -156.5 178.25 10.54 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.46 0.648 . . . . 75.439999999999998 112.677 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 CA--C 1.541 0.599 0 CA-C-N 115.343 -0.844 . . . . 71.030000000000001 110.242 172.904 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 98.0 mt . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 109.846 -0.427 . . . . 74.310000000000002 109.846 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.92 172.57 7.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.066 0.46 . . . . 71.209999999999994 111.83 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.539 HG22 ' HA2' ' A' ' 224' ' ' GLY . 7.8 tt -127.55 112.84 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.339 0.59 . . . . 73.040000000000006 111.469 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 37.2 t -82.75 110.94 18.23 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.157 -0.474 . . . . 72.420000000000002 110.282 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.499 ' HB ' HD22 ' A' ' 226' ' ' LEU . 46.6 t -74.76 137.49 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.219 0.533 . . . . 75.140000000000001 111.936 -175.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -106.35 -43.86 4.67 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.993 -0.549 . . . . 62.310000000000002 110.583 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -139.41 145.2 38.61 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.093 -0.503 . . . . 75.239999999999995 110.479 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.1 tt -140.24 135.97 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.283 0.563 . . . . 74.140000000000001 111.983 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -140.68 121.82 2.01 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 116.081 -0.509 . . . . 64.540000000000006 112.385 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 14.0 mm -78.48 138.02 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 122.47 -0.429 . . . . 73.319999999999993 110.764 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.425 HD11 ' HB2' ' A' ' 242' ' ' GLU . 60.0 mt -84.58 -41.9 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 112.515 0.561 . . . . 71.209999999999994 112.515 -174.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 113.073 0.768 . . . . 74.329999999999998 113.073 -171.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 186' ' ' THR . 8.1 t30 . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.453 0.644 . . . . 74.120000000000005 112.725 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.425 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 57.6 m-85 -130.69 167.67 18.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.405 -0.816 . . . . 74.430000000000007 110.308 173.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.459 ' HB3' ' OG1' ' A' ' 219' ' ' THR . 22.7 mmtp -97.66 164.64 12.33 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.972 -0.381 . . . . 75.209999999999994 109.972 167.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 220' ' ' GLY . 56.8 mt -64.08 -30.34 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 111.946 0.35 . . . . 73.540000000000006 111.946 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.481 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 83.7 p -64.7 -24.86 67.71 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.046 0.451 . . . . 72.430000000000007 111.157 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 174' ' ' TYR . 26.3 mm-40 -86.79 -12.25 48.59 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.052 -0.522 . . . . 73.530000000000001 111.596 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.504 HD12 HD12 ' A' ' 187' ' ' ILE . 71.1 mt -70.16 141.75 52.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.384 0.611 . . . . 72.439999999999998 111.714 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.413 ' HG2' HD22 ' A' ' 183' ' ' LEU . 21.5 ptp -154.12 156.36 31.83 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.553 -0.748 . . . . 74.129999999999995 110.641 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.97 142.22 76.66 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.141 1.894 . . . . 72.230000000000004 112.484 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 66.16 26.21 10.61 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.903 0.382 . . . . 74.409999999999997 111.697 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.413 HD22 ' HG2' ' A' ' 180' ' ' MET . 46.5 tp -98.09 135.09 40.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.802 0.334 . . . . 64.200000000000003 111.55 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 72.0 p -114.08 118.92 35.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.522 -0.308 . . . . 74.200000000000003 110.869 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.76 -160.85 27.63 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 120.888 -0.672 . . . . 61.409999999999997 113.685 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 58.0 m -129.69 148.85 51.62 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.83 0.452 . . . . 73.530000000000001 111.0 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 179' ' ' LEU . 32.3 pt -131.95 144.61 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.244 0.545 . . . . 73.420000000000002 111.291 173.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -113.27 107.19 15.55 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.056 -0.52 . . . . 73.540000000000006 110.483 175.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.8 176.8 9.6 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.006 0.432 . . . . 63.219999999999999 111.819 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -94.0 145.17 24.85 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.149 0.499 . . . . 74.400000000000006 111.807 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.8 t -86.01 108.96 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.214 -0.448 . . . . 73.510000000000005 111.665 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.84 -35.67 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.161 -0.472 . . . . 71.439999999999998 111.449 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.09 124.26 5.74 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.313 -0.403 . . . . 63.32 111.607 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -108.17 100.93 10.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.221 -0.445 . . . . 62.030000000000001 110.749 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.499 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 99.0 m-85 -72.41 139.61 81.54 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 111.957 0.354 . . . . 63.409999999999997 111.957 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -53.8 148.99 34.9 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.666 2.244 . . . . 73.319999999999993 112.851 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -71.72 125.84 28.17 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.474 0.654 . . . . 75.129999999999995 112.375 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.02 166.47 11.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.78 -0.646 . . . . 73.0 110.731 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.44 112.17 18.63 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.681 0.277 . . . . 73.140000000000001 110.806 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 54.3 p90 . . . . . 0 CA--C 1.536 0.437 0 CA-C-O 121.317 0.579 . . . . 71.140000000000001 111.982 -177.096 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 120.825 0.345 . . . . 74.439999999999998 111.105 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 18.9 tp -127.65 111.13 13.37 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.225 0.454 . . . . 73.019999999999996 112.225 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 195' ' ' TYR . 81.5 tttt -122.21 109.6 14.68 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.191 -0.318 . . . . 65.230000000000004 111.282 175.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.9 t -86.07 145.94 26.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.927 0.394 . . . . 75.239999999999995 111.387 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.79 124.47 33.47 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.511 -0.313 . . . . 74.540000000000006 111.253 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -94.58 115.39 27.52 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 110.132 -0.321 . . . . 75.340000000000003 110.132 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.62 HD13 HG21 ' A' ' 243' ' ' VAL . 52.8 mt -112.54 150.75 30.87 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.556 0.217 . . . . 75.319999999999993 111.51 -176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -140.47 152.65 45.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.652 0.739 . . . . 74.129999999999995 111.934 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -148.19 166.09 28.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.802 -1.09 . . . . 71.239999999999995 108.739 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -56.69 -25.82 55.12 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.756 0.312 . . . . 64.430000000000007 111.772 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 71.6 p -89.88 1.95 55.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.826 0.676 . . . . 74.5 112.826 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.422 ' O ' HD11 ' A' ' 176' ' ' ILE . . . 137.41 -179.25 18.32 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.803 -0.713 . . . . 73.129999999999995 113.312 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 57.2 p -127.81 152.23 48.05 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 122.418 -0.46 . . . . 65.239999999999995 111.52 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.0 tp -151.77 160.06 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.72 -0.218 . . . . 75.109999999999999 111.291 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -107.36 128.08 54.14 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.193 0.52 . . . . 74.420000000000002 112.118 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -103.15 167.21 16.77 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.08 -0.509 . . . . 65.219999999999999 111.948 172.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 99.8 m -142.79 122.33 13.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.747 0.773 . . . . 75.540000000000006 112.379 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 91.4 mt -93.69 120.15 33.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.744 -0.662 . . . . 74.329999999999998 110.972 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -100.0 142.95 30.8 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.686 0.279 . . . . 71.120000000000005 111.713 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 60.8 t30 66.83 -138.03 0.14 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.099 0.559 . . . . 73.140000000000001 111.968 174.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -25.79 64.4 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.305 0.483 . . . . 74.510000000000005 112.305 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 91.0 mt -56.59 -21.81 29.36 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.799 0.333 . . . . 65.439999999999998 111.786 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.64 -20.15 66.11 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 111.978 0.362 . . . . 64.219999999999999 111.978 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -99.47 8.4 44.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.693 0.282 . . . . 75.140000000000001 111.703 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -65.58 143.7 57.45 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.093 0.473 . . . . 74.040000000000006 112.006 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -63.29 96.57 0.11 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.823 -0.626 . . . . 73.010000000000005 111.301 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 p -147.08 113.69 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.032 0.444 . . . . 74.310000000000002 111.008 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -105.58 160.45 15.17 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.438 0.637 . . . . 75.340000000000003 111.758 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.02 99.96 0.93 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.733 -0.667 . . . . 75.219999999999999 111.069 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 130.4 -10.61 5.84 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.187 -0.53 . . . . 65.200000000000003 114.036 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.78 157.07 20.34 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.782 0.66 . . . . 74.319999999999993 112.782 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 264' ' ' ILE . 40.9 mm -92.97 110.18 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.708 -0.678 . . . . 73.430000000000007 110.495 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -110.1 139.11 45.58 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.794 0.664 . . . . 53.240000000000002 112.794 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 31.9 tt0 -84.41 104.63 14.59 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.68 -0.691 . . . . 73.099999999999994 110.165 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.62 HG21 HD13 ' A' ' 215' ' ' LEU . 87.1 t -103.99 106.46 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.928 0.394 . . . . 75.430000000000007 111.505 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 39.1 p -116.53 130.49 56.78 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.461 -0.336 . . . . 70.209999999999994 111.439 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.97 -141.04 4.7 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.656 -0.783 . . . . 71.420000000000002 113.771 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -129.11 124.89 35.91 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.696 -0.296 . . . . 70.299999999999997 111.198 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.405 HG22 ' HB ' ' A' ' 256' ' ' ILE . 35.0 t -90.84 133.96 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.812 0.339 . . . . 75.109999999999999 111.821 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -126.39 -179.61 4.84 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.964 0.412 . . . . 74.140000000000001 111.204 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 N--CA 1.467 0.42 0 CA-C-N 116.421 -0.354 . . . . 75.420000000000002 111.516 178.401 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.913 0.387 . . . . 72.310000000000002 111.726 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.31 156.31 43.26 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.161 -0.472 . . . . 61.5 111.078 173.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.405 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.5 tt -122.99 119.38 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.292 0.567 . . . . 75.420000000000002 112.227 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.3 m -72.23 113.8 9.66 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.195 -0.457 . . . . 54.399999999999999 110.075 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.513 HG11 ' HB ' ' A' ' 261' ' ' ILE . 23.1 t -82.22 117.43 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.985 0.421 . . . . 75.420000000000002 111.731 -175.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -89.81 -26.93 20.3 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.174 0.512 . . . . 72.329999999999998 110.551 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -149.63 137.29 20.15 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.1 -0.5 . . . . 65.530000000000001 110.936 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.513 ' HB ' HG11 ' A' ' 258' ' ' VAL . 12.2 tt -143.58 135.82 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.026 0.441 . . . . 71.109999999999999 111.628 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -146.98 139.68 8.1 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.241 -0.504 . . . . 65.540000000000006 112.939 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 49.3 mm -75.41 115.76 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.278 -0.542 . . . . 74.129999999999995 110.821 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 240' ' ' ILE . 61.8 mt -59.94 -50.08 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 120.953 0.406 . . . . 72.299999999999997 111.806 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.468 0.445 0 CA-C-N 116.474 -0.33 . . . . 63.109999999999999 110.972 177.416 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.086 0.469 . . . . 71.230000000000004 110.449 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.42 ' CE2' ' HA3' ' A' ' 185' ' ' GLY . 96.5 m-85 -83.3 141.0 32.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.38 0.61 . . . . 72.099999999999994 112.411 -172.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.577 ' HD2' ' HG1' ' A' ' 219' ' ' THR . 18.2 tppt? -81.54 137.76 35.52 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.473 -0.785 . . . . 72.400000000000006 109.956 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.439 HD13 HG22 ' A' ' 222' ' ' ILE . 36.7 mt -52.79 -36.7 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 112.705 0.632 . . . . 74.030000000000001 112.705 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.406 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 35.4 t -64.51 -27.12 68.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.849 0.357 . . . . 71.310000000000002 111.549 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -95.05 6.1 50.04 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.32 0.489 . . . . 62.329999999999998 112.32 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.64 131.05 44.56 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.133 0.492 . . . . 74.430000000000007 111.527 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.7 mtt -121.07 155.28 58.12 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.135 -0.484 . . . . 73.540000000000006 111.506 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.419 ' HG3' HD22 ' A' ' 254' ' ' LEU . 31.2 Cg_exo -61.03 133.29 46.41 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.31 2.007 . . . . 73.439999999999998 112.186 173.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 66.35 37.62 4.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.872 0.469 . . . . 72.430000000000007 111.568 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.8 119.47 39.22 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.452 -0.34 . . . . 63.140000000000001 111.4 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 86.9 p -99.18 126.29 44.94 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.949 0.404 . . . . 63.0 111.181 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.42 ' HA3' ' CE2' ' A' ' 174' ' ' TYR . . . -171.58 -160.55 20.37 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.613 -0.803 . . . . 73.430000000000007 113.88 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 28.7 m -135.89 136.93 40.92 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.749 -0.266 . . . . 74.420000000000002 111.299 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.39 147.15 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.842 0.353 . . . . 71.25 111.735 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -108.16 112.31 24.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.579 -0.282 . . . . 55.310000000000002 110.647 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -147.95 174.59 11.73 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.316 0.488 . . . . 74.409999999999997 112.316 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -103.72 144.89 30.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.31 -0.404 . . . . 71.329999999999998 111.108 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.445 ' HA ' HD21 ' A' ' 215' ' ' LEU . 43.0 t -77.32 105.26 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.12 0.486 . . . . 75.409999999999997 111.556 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.31 -36.31 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.887 -0.597 . . . . 71.349999999999994 111.391 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.51 158.74 37.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.845 -0.616 . . . . 73.299999999999997 111.369 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.72 122.55 14.42 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.35 -0.386 . . . . 64.239999999999995 111.342 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.42 148.41 35.15 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 120.629 0.252 . . . . 72.329999999999998 111.463 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.81 168.08 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.809 2.34 . . . . 63.229999999999997 113.045 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -74.36 147.72 41.91 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.376 0.607 . . . . 74.409999999999997 112.26 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -111.4 157.25 20.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.863 -0.608 . . . . 75.200000000000003 110.145 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -110.03 157.58 19.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.2 0.524 . . . . 73.120000000000005 110.969 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 33.0 p90 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.734 -0.667 . . . . 72.409999999999997 110.071 177.347 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.477 ' NE2' ' HB2' ' A' ' 231' ' ' ALA . 9.0 pt20 . . . . . 0 CA--C 1.541 0.596 0 CA-C-O 121.116 0.484 . . . . 64.409999999999997 111.717 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 22.0 tp -111.8 105.96 14.59 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.741 -0.663 . . . . 72.519999999999996 112.388 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.446 ' HE3' HD23 ' A' ' 213' ' ' LEU . 4.0 tmtm? -113.02 126.35 55.39 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.141 -0.349 . . . . 74.310000000000002 110.258 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 25.1 p -110.24 142.74 41.41 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.433 0.635 . . . . 73.530000000000001 112.665 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.446 HD23 ' HE3' ' A' ' 211' ' ' LYS . 85.0 mt -125.18 159.92 30.4 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.604 -0.725 . . . . 74.5 110.886 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -125.41 119.71 29.06 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.733 0.301 . . . . 73.409999999999997 110.944 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.533 HD11 HG21 ' A' ' 243' ' ' VAL . 75.7 mt -114.68 162.26 17.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.726 0.41 . . . . 74.239999999999995 111.025 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 216' ' ' LYS . 18.5 ptmt -151.76 168.64 24.42 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.677 0.751 . . . . 75.319999999999993 112.643 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -146.33 174.84 11.0 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.66 -1.155 . . . . 72.109999999999999 109.113 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.14 -14.37 60.38 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.832 -0.543 . . . . 73.549999999999997 112.231 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.577 ' HG1' ' HD2' ' A' ' 175' ' ' LYS . 68.8 p -102.25 -18.86 15.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.289 0.848 . . . . 62.219999999999999 113.289 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 167.7 -179.82 40.86 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.386 -0.912 . . . . 60.119999999999997 113.684 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 44.8 m -127.64 144.41 51.08 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.807 0.337 . . . . 73.510000000000005 111.789 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 176' ' ' ILE . 9.7 tp -150.65 150.17 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 116.508 -0.314 . . . . 73.450000000000003 110.849 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.4 ' HD3' ' H ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -107.75 142.66 37.42 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.944 -0.472 . . . . 75.129999999999995 111.699 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -110.57 155.67 15.98 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 116.063 -0.517 . . . . 72.439999999999998 113.271 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.4 m -116.39 114.01 23.68 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.408 0.522 . . . . 74.430000000000007 112.408 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.462 HD23 ' HB ' ' A' ' 258' ' ' VAL . 85.5 mt -96.71 133.95 40.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.815 0.446 . . . . 74.219999999999999 111.403 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -115.4 156.97 24.6 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.745 0.307 . . . . 75.340000000000003 111.52 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 58.87 -141.16 0.7 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 112.102 0.408 . . . . 71.450000000000003 112.102 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -48.26 -32.27 7.03 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.919 0.711 . . . . 73.439999999999998 112.919 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.411 ' HB3' HD21 ' A' ' 226' ' ' LEU . 85.8 mt -59.71 -19.45 49.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.745 0.307 . . . . 74.219999999999999 111.538 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.477 ' HB2' ' NE2' ' A' ' 209' ' ' GLN . . . -67.22 -32.3 73.26 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.181 0.438 . . . . 75.019999999999996 112.181 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -94.89 -6.62 42.21 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.023 0.379 . . . . 74.530000000000001 112.023 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -54.98 125.61 21.08 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.457 -0.338 . . . . 75.340000000000003 110.365 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -68.94 111.38 4.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.351 0.595 . . . . 73.140000000000001 111.652 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.437 HG12 HD13 ' A' ' 213' ' ' LEU . 7.3 p -144.42 135.27 20.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.559 -0.746 . . . . 74.439999999999998 109.678 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -139.51 165.92 25.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.525 0.679 . . . . 75.010000000000005 112.133 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -64.36 101.02 0.39 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.917 -0.583 . . . . 74.209999999999994 111.075 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 147.87 -31.37 1.34 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.615 -0.802 . . . . 63.140000000000001 114.583 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.09 154.41 25.6 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.769 0.785 . . . . 73.140000000000001 112.699 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 38.9 mm -94.57 106.05 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.485 -0.78 . . . . 75.349999999999994 110.833 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -100.04 131.12 46.19 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.985 0.735 . . . . 62.350000000000001 112.985 -174.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -97.04 97.63 9.39 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.364 -0.606 . . . . 72.140000000000001 109.364 171.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.533 HG21 HD11 ' A' ' 215' ' ' LEU . 99.3 t -99.01 124.16 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.973 0.731 . . . . 75.129999999999995 112.973 -169.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 37.0 t -98.59 116.55 31.08 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.826 -0.625 . . . . 74.129999999999995 110.348 172.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.03 174.58 33.93 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.317 -0.944 . . . . 71.099999999999994 114.484 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -108.71 109.29 20.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.292 0.637 . . . . 72.510000000000005 110.788 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 256' ' ' ILE . 40.5 t -78.29 116.04 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.58 0.229 . . . . 64.209999999999994 111.109 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -128.46 161.19 30.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.671 0.272 . . . . 74.200000000000003 111.326 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.798 0.332 . . . . 73.310000000000002 111.521 179.376 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.419 HD22 ' HG3' ' A' ' 181' ' ' PRO . 94.8 mt . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 120.845 0.355 . . . . 74.430000000000007 111.516 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -134.74 132.58 38.95 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.974 0.416 . . . . 74.420000000000002 110.505 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.477 HG22 ' HA2' ' A' ' 224' ' ' GLY . 7.4 tt -101.13 111.55 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.399 0.619 . . . . 73.25 112.195 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 50.9 m -78.89 111.57 15.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.998 -0.546 . . . . 64.120000000000005 110.462 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.462 ' HB ' HD23 ' A' ' 226' ' ' LEU . 43.1 t -75.74 127.97 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 112.425 0.528 . . . . 75.120000000000005 112.425 -173.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -97.99 -22.49 16.25 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.917 0.389 . . . . 64.209999999999994 111.291 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 47.9 t-20 -156.94 132.68 9.43 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 75.510000000000005 110.377 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.3 tt -126.64 122.23 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.075 0.464 . . . . 74.420000000000002 111.533 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -133.11 117.9 2.03 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.376 -0.44 . . . . 74.510000000000005 112.245 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 63.6 mt -85.4 127.21 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 122.53 -0.394 . . . . 64.219999999999999 111.258 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.1 -46.03 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.084 0.469 . . . . 75.549999999999997 111.282 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 CA--C 1.535 0.403 0 CA-C-N 115.86 -0.609 . . . . 72.129999999999995 110.612 176.464 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.426 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 13.2 t-20 . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 110.205 -0.294 . . . . 74.310000000000002 110.205 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -84.6 137.02 33.53 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.616 0.598 . . . . 74.319999999999993 112.616 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 173' ' ' ASN . 2.8 mppt? -100.86 158.68 15.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.812 -0.631 . . . . 72.439999999999998 110.22 171.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.533 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 89.1 mt -60.93 -32.25 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 113.018 0.747 . . . . 74.109999999999999 113.018 -173.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.495 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 34.1 t -58.2 -31.82 67.69 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 122.103 -0.373 . . . . 71.219999999999999 111.954 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.16 -12.52 54.79 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.503 0.557 . . . . 72.140000000000001 112.503 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.533 ' HG ' ' HA ' ' A' ' 176' ' ' ILE . 65.7 mt -64.66 116.05 5.85 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.526 0.679 . . . . 72.040000000000006 111.934 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.6 ptp -125.74 160.97 53.65 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 115.648 -0.705 . . . . 74.420000000000002 110.55 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.523 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 43.4 Cg_exo -54.99 133.42 57.99 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.331 2.021 . . . . 65.230000000000004 112.876 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 16.4 m120 68.75 20.29 8.17 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.389 0.515 . . . . 72.019999999999996 112.389 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.11 139.48 31.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.951 0.405 . . . . 75.200000000000003 111.498 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.8 p -110.25 127.42 54.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.495 -0.32 . . . . 72.329999999999998 110.342 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.15 -169.78 38.76 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.422 -0.894 . . . . 61.439999999999998 113.987 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 79.1 m -132.63 120.86 22.33 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.706 -0.291 . . . . 74.329999999999998 111.179 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 41.1 pt -108.09 140.61 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.981 0.42 . . . . 74.010000000000005 111.585 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -115.99 112.11 21.33 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.454 -0.339 . . . . 73.310000000000002 110.219 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -142.52 169.34 17.76 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.105 0.479 . . . . 71.019999999999996 112.099 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.82 139.27 30.75 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.05 -0.523 . . . . 74.219999999999999 110.952 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.8 t -82.89 116.84 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.127 0.489 . . . . 74.409999999999997 111.534 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 35.7 t -90.41 -64.77 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.189 0.518 . . . . 75.519999999999996 111.553 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -126.84 132.59 50.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.32 -0.4 . . . . 74.530000000000001 111.518 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -103.57 128.03 50.89 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.334 -0.394 . . . . 71.299999999999997 111.011 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -92.2 119.62 68.09 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.744 -0.207 . . . . 72.310000000000002 110.953 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.49 153.81 7.09 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.782 2.321 . . . . 71.109999999999999 113.094 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -64.36 130.49 44.0 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.084 0.772 . . . . 74.140000000000001 113.084 -173.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 3.0 mptp? -101.57 157.09 17.07 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.912 -0.586 . . . . 72.430000000000007 109.499 170.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -130.58 139.12 50.43 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.315 0.579 . . . . 73.409999999999997 111.91 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 26.2 p90 . . . . . 0 CA--C 1.536 0.412 0 CA-C-N 115.933 -0.576 . . . . 74.140000000000001 110.893 -178.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 120.788 0.328 . . . . 73.450000000000003 110.893 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 51.5 tp -135.37 142.84 45.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.448 0.299 . . . . 74.010000000000005 111.02 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.496 ' HE2' HD22 ' A' ' 213' ' ' LEU . 0.7 OUTLIER -162.05 119.45 2.15 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.867 0.365 . . . . 64.450000000000003 110.868 -179.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.0 t -104.26 161.65 13.87 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.162 0.506 . . . . 72.209999999999994 112.218 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.496 HD22 ' HE2' ' A' ' 211' ' ' LYS . 95.5 mt -138.16 138.98 39.15 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.023 -0.535 . . . . 73.340000000000003 111.764 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -97.2 106.23 18.52 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.906 0.384 . . . . 74.140000000000001 110.39 175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.422 HD11 HG22 ' A' ' 243' ' ' VAL . 80.0 mt -109.95 156.88 19.88 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.325 -0.398 . . . . 75.239999999999995 111.529 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -160.99 148.52 15.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.956 0.407 . . . . 75.120000000000005 112.062 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -132.21 -162.92 1.28 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.365 -0.606 . . . . 75.530000000000001 109.365 169.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -77.79 -1.7 32.71 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.778 0.659 . . . . 74.349999999999994 112.778 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 30.0 p -114.2 3.21 15.09 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.018 0.748 . . . . 75.319999999999993 113.018 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 149.22 -178.35 26.82 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.37 -0.919 . . . . 60.130000000000003 113.953 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 96.9 p -124.86 145.36 49.83 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.615 0.366 . . . . 72.540000000000006 111.021 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.9 tp -139.42 154.54 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-O 120.912 0.387 . . . . 74.319999999999993 111.263 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -108.02 112.45 25.02 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.891 0.377 . . . . 75.310000000000002 111.107 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -85.14 151.24 25.62 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.363 -0.38 . . . . 74.120000000000005 113.013 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 87.2 m -124.01 112.42 17.15 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.459 -0.436 . . . . 71.5 111.941 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.439 HD11 ' HD2' ' A' ' 211' ' ' LYS . 89.8 mt -94.97 121.95 37.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.342 -0.39 . . . . 73.319999999999993 110.717 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.52 157.0 17.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.027 0.441 . . . . 75.310000000000002 111.875 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 54.95 -134.29 1.56 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.795 -0.639 . . . . 75.530000000000001 112.437 170.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 229' ' ' GLU . 4.1 mp0 -48.13 -34.18 9.44 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.704 0.802 . . . . 73.230000000000004 112.625 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 70.5 mt -69.52 -6.62 31.93 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.398 0.518 . . . . 74.239999999999995 112.398 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 211' ' ' LYS . . . -63.86 -45.92 87.31 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.841 0.353 . . . . 73.019999999999996 111.776 177.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.47 6.34 23.88 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.324 0.49 . . . . 71.530000000000001 112.324 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -61.27 123.33 17.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.824 -0.171 . . . . 75.439999999999998 110.664 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -73.7 96.01 2.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.719 0.771 . . . . 75.439999999999998 112.564 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.7 134.97 63.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.258 -0.883 . . . . 64.439999999999998 108.934 168.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -119.71 172.37 7.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.164 0.983 . . . . 74.140000000000001 113.246 -168.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -72.56 99.67 2.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.257 -0.883 . . . . 75.129999999999995 111.58 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.09 20.98 6.09 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.119 0.808 . . . . 62.140000000000001 115.119 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -103.23 167.46 9.81 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.38 1.09 . . . . 71.120000000000005 111.169 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 47.8 mm -101.42 104.74 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.128 -0.487 . . . . 72.010000000000005 110.845 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -104.72 125.55 50.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.077 0.465 . . . . 70.349999999999994 112.204 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -84.71 102.43 12.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.084 0.468 . . . . 71.230000000000004 109.838 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.422 HG22 HD11 ' A' ' 215' ' ' LEU . 98.6 t -99.8 105.9 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.325 0.583 . . . . 73.310000000000002 111.935 -175.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 36.7 t -97.11 125.92 41.92 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.035 -0.529 . . . . 73.010000000000005 110.383 174.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.83 -169.08 34.22 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.022 -1.085 . . . . 73.340000000000003 114.4 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -109.39 121.09 44.43 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.784 0.433 . . . . 74.319999999999993 110.854 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 179' ' ' LEU . 38.6 t -83.79 139.19 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.275 -0.42 . . . . 73.439999999999998 111.847 -177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.635 ' HB3' ' HZ2' ' A' ' 248' ' ' LYS . 8.4 mtpm? -134.25 168.39 18.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.183 0.516 . . . . 73.5 111.443 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.523 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 25.8 tt0 . . . . . 0 N--CA 1.467 0.416 0 CA-C-N 116.09 -0.504 . . . . 64.209999999999994 110.305 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.131 0.491 . . . . 71.219999999999999 110.795 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . 0.63 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 8.6 pt-20 -128.56 169.26 14.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.882 -0.599 . . . . 73.0 110.787 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.464 HG22 ' HA2' ' A' ' 224' ' ' GLY . 11.2 tt -148.79 117.22 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.461 0.648 . . . . 73.409999999999997 111.98 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 77.8 p -85.12 119.69 25.79 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.079 -0.51 . . . . 71.310000000000002 110.318 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.417 ' HB ' HD22 ' A' ' 226' ' ' LEU . 41.8 t -77.02 132.42 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.685 0.624 . . . . 74.420000000000002 112.685 -173.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -95.73 -54.74 3.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.829 -0.623 . . . . 72.420000000000002 110.276 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -139.78 126.81 20.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.056 -0.52 . . . . 73.030000000000001 110.785 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.7 tt -116.38 127.43 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.043 0.449 . . . . 72.129999999999995 111.284 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -125.28 118.78 3.36 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.142 -0.551 . . . . 73.530000000000001 112.955 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.3 mm -76.45 111.37 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.931 0.396 . . . . 64.409999999999997 110.889 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.8 mt -69.2 -42.99 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.844 0.354 . . . . 75.120000000000005 111.587 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 . . . . . 0 N--CA 1.47 0.549 0 CA-C-N 116.558 -0.292 . . . . 74.209999999999994 111.309 179.121 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 186' ' ' THR . 5.8 m-20 . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 121.103 0.478 . . . . 63.310000000000002 111.045 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -85.67 168.06 14.74 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.477 0.656 . . . . 74.439999999999998 112.091 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -96.72 156.8 16.19 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.511 -0.768 . . . . 75.150000000000006 109.868 169.218 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 51.0 mt -61.43 -32.67 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.105 0.409 . . . . 74.329999999999998 112.105 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.1 t -63.82 -22.73 67.05 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.882 0.373 . . . . 73.430000000000007 111.468 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -87.91 -12.02 45.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.38 -0.373 . . . . 65.329999999999998 111.85 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.459 HD22 HG22 ' A' ' 187' ' ' ILE . 84.1 mt -71.54 103.07 2.87 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.389 0.614 . . . . 73.109999999999999 111.413 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.428 ' HG2' HD11 ' A' ' 183' ' ' LEU . 23.1 ptp -112.56 157.24 40.82 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.844 -0.616 . . . . 61.439999999999998 110.956 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.427 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 52.0 Cg_exo -53.05 135.27 58.64 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.487 2.125 . . . . 74.239999999999995 113.271 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 69.8 26.89 4.71 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.208 0.603 . . . . 70.400000000000006 112.28 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.428 HD11 ' HG2' ' A' ' 180' ' ' MET . 9.1 tt -115.85 144.72 43.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.767 0.318 . . . . 74.109999999999999 110.715 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' SER . . . . . 0.427 ' HB2' ' CD2' ' A' ' 246' ' ' TYR . 47.3 t -126.45 157.32 38.94 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.934 0.397 . . . . 74.109999999999999 111.79 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.2 -168.6 33.08 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.043 -0.599 . . . . 62.039999999999999 113.214 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 65.1 m -106.39 152.48 23.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.366 0.266 . . . . 74.209999999999994 110.534 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.459 HG22 HD22 ' A' ' 179' ' ' LEU . 37.4 pt -139.22 161.15 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.117 0.484 . . . . 70.439999999999998 111.584 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -118.38 110.94 18.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.087 -0.506 . . . . 62.450000000000003 110.137 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.67 157.89 44.51 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.346 0.593 . . . . 73.409999999999997 112.085 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -93.65 134.39 36.0 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.702 -0.681 . . . . 75.340000000000003 110.816 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.89 125.48 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.003 0.43 . . . . 73.540000000000006 111.978 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.28 -42.6 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.179 0.514 . . . . 72.219999999999999 111.146 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -146.11 130.55 17.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.992 -0.549 . . . . 71.209999999999994 111.205 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.91 104.55 8.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.019 0.438 . . . . 75.439999999999998 111.602 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.479 ' HB3' ' HD2' ' A' ' 196' ' ' PRO . 97.2 m-85 -86.0 163.33 43.64 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 116.542 -0.299 . . . . 74.140000000000001 111.721 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 195' ' ' TYR . 60.7 Cg_endo -70.28 -164.65 0.14 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.798 2.332 . . . . 72.420000000000002 113.155 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.658 ' HD3' ' HB2' ' A' ' 232' ' ' ASP . 22.1 pttp -100.05 111.49 23.78 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.608 0.718 . . . . 73.519999999999996 111.841 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -92.45 176.55 6.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 64.239999999999995 110.697 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.3 150.12 48.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.091 0.472 . . . . 75.420000000000002 111.334 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 43.5 p90 . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 121.113 0.483 . . . . 74.439999999999998 111.265 -179.514 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 121.107 0.479 . . . . 75.510000000000005 111.982 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.5 tp -129.63 123.5 31.41 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.611 -0.722 . . . . 74.109999999999999 111.634 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.51 ' HD3' HD13 ' A' ' 226' ' ' LEU . 44.6 tttp -122.52 108.6 13.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.786 0.327 . . . . 72.319999999999993 111.309 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.6 m -74.32 125.85 29.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.476 -0.329 . . . . 71.0 111.178 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 97.8 mt -132.51 150.56 52.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.092 0.472 . . . . 75.409999999999997 111.67 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -135.01 124.25 24.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.469 -0.332 . . . . 75.25 110.32 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 86.7 mt -118.05 150.0 40.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.713 0.292 . . . . 74.319999999999993 111.688 -174.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -132.8 129.09 38.1 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.778 0.799 . . . . 73.319999999999993 112.095 175.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -115.11 165.68 12.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.113 -0.949 . . . . 71.340000000000003 109.042 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.72 -25.87 66.74 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 111.874 0.324 . . . . 70.430000000000007 111.874 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 69.6 p -91.86 0.34 57.48 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.697 0.628 . . . . 73.439999999999998 112.697 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 146.25 177.09 20.64 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.936 -0.65 . . . . 51.119999999999997 113.469 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 54.0 p -118.31 160.08 22.27 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 122.405 -0.467 . . . . 71.310000000000002 111.596 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.1 tp -146.47 152.67 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.011 0.434 . . . . 74.329999999999998 111.894 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -90.82 121.82 33.01 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.214 -0.448 . . . . 73.439999999999998 110.902 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -120.62 165.9 13.86 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.207 -0.52 . . . . 71.329999999999998 113.313 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 98.8 m -152.82 137.08 16.55 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.268 -0.548 . . . . 72.25 112.395 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.51 HD13 ' HD3' ' A' ' 211' ' ' LYS . 65.9 mt -106.1 141.31 37.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.84 -0.618 . . . . 70.109999999999999 110.47 172.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -114.84 160.88 18.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.1 0.476 . . . . 72.319999999999993 111.601 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 56.08 -134.13 1.41 Allowed 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.925 -0.579 . . . . 71.019999999999996 111.705 172.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.95 -34.65 68.23 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.468 0.544 . . . . 74.400000000000006 112.468 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.41 -15.39 62.55 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.119 0.414 . . . . 74.430000000000007 112.119 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -61.55 -27.68 68.79 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 120.965 0.412 . . . . 63.109999999999999 111.779 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.658 ' HB2' ' HD3' ' A' ' 197' ' ' LYS . 36.8 t70 -95.18 9.01 41.25 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 120.823 0.344 . . . . 73.140000000000001 111.481 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -56.9 128.52 37.21 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.905 0.383 . . . . 74.010000000000005 111.725 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.4 115.63 16.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.066 0.46 . . . . 71.200000000000003 110.609 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.27 150.02 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.918 -0.583 . . . . 74.530000000000001 110.946 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.42 ' HB2' ' CG ' ' A' ' 239' ' ' ASP . 9.5 mmmm -117.66 146.91 43.37 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.087 0.47 . . . . 75.030000000000001 112.242 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.27 95.82 0.32 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.109 -0.496 . . . . 73.329999999999998 110.406 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 129.56 -16.78 5.61 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.916 -0.659 . . . . 63.439999999999998 113.348 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . 0.42 ' CG ' ' HB2' ' A' ' 236' ' ' LYS . 66.2 m-20 -68.37 132.14 46.54 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.051 0.453 . . . . 72.040000000000006 111.086 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.455 HG22 HD12 ' A' ' 264' ' ' ILE . 46.5 mm -77.79 107.99 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.912 0.387 . . . . 74.420000000000002 110.385 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -104.01 139.39 39.2 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.04 0.755 . . . . 61.409999999999997 113.04 -173.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -95.17 99.71 11.64 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.178 -0.675 . . . . 75.200000000000003 109.178 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.27 123.87 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.506 0.558 . . . . 74.200000000000003 112.506 -170.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 45.5 t -112.09 123.19 49.72 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.861 0.363 . . . . 73.0 111.211 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -164.6 -167.25 24.86 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.562 -0.827 . . . . 65.420000000000002 113.997 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' A' ' 184' ' ' SER . 39.3 t80 -121.89 129.34 52.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.736 0.303 . . . . 75.129999999999995 110.966 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 47.0 t -96.22 125.68 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.005 0.431 . . . . 72.420000000000002 112.129 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -122.18 166.21 14.94 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.015 0.436 . . . . 73.140000000000001 110.736 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.427 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 25.2 tt0 . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 120.712 0.292 . . . . 74.239999999999995 110.899 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 120.762 0.315 . . . . 73.519999999999996 110.861 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -113.96 126.13 54.8 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.82 0.343 . . . . 75.329999999999998 111.167 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.04 106.44 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.627 0.727 . . . . 55.340000000000003 111.47 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.2 t -83.62 114.38 21.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.905 -0.589 . . . . 75.230000000000004 110.456 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.492 ' HB ' HD22 ' A' ' 226' ' ' LEU . 39.0 t -91.06 121.28 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.186 0.439 . . . . 73.530000000000001 112.186 -173.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -101.99 -14.24 17.25 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.786 0.327 . . . . 72.400000000000006 111.668 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -149.49 127.37 11.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.684 0.278 . . . . 71.409999999999997 110.668 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.7 tt -137.13 135.36 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.206 0.527 . . . . 72.439999999999998 112.278 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -147.69 122.69 1.59 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 115.826 -0.625 . . . . 74.420000000000002 112.074 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 58.0 mt -82.74 136.88 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 O-C-N 121.992 -0.711 . . . . 71.049999999999997 112.015 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.455 HD12 HG22 ' A' ' 240' ' ' ILE . 66.5 mt -70.6 -45.62 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.932 -0.576 . . . . 73.239999999999995 111.583 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.876 0.369 . . . . 54.399999999999999 111.585 -178.391 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.427 ' H ' HD21 ' A' ' 173' ' ' ASN . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 109.755 -0.461 . . . . 71.430000000000007 109.755 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.444 ' HB2' HG23 ' A' ' 187' ' ' ILE . 95.1 m-85 -98.94 135.61 40.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.373 0.606 . . . . 75.420000000000002 112.338 -176.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -91.52 153.37 19.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.012 -0.54 . . . . 75.219999999999999 110.063 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 220' ' ' GLY . 64.2 mt -54.23 -36.65 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 113.492 0.923 . . . . 63.130000000000003 113.492 -172.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.7 t -75.48 -10.14 59.19 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.828 -0.545 . . . . 74.150000000000006 112.348 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.74 -7.57 52.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.678 0.275 . . . . 71.540000000000006 111.388 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.85 159.47 33.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.641 0.734 . . . . 71.120000000000005 112.655 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.534 ' HG2' HD22 ' A' ' 183' ' ' LEU . 25.4 ptp -157.41 155.07 26.9 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.418 -0.81 . . . . 52.539999999999999 110.154 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.42 ' HB3' ' CB ' ' A' ' 249' ' ' GLN . 12.3 Cg_endo -57.35 150.75 56.94 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.995 1.796 . . . . 72.219999999999999 112.38 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 63.8 t30 65.09 32.15 10.51 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.387 0.613 . . . . 73.209999999999994 111.021 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.534 HD22 ' HG2' ' A' ' 180' ' ' MET . 30.1 tp -119.85 128.48 53.72 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.412 -0.358 . . . . 72.140000000000001 111.75 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 88.8 p -111.48 114.79 28.14 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.115 -0.366 . . . . 73.030000000000001 110.325 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.46 176.22 36.26 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.441 -0.885 . . . . 71.439999999999998 114.181 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 88.6 m -108.76 119.74 40.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.932 0.396 . . . . 73.129999999999995 111.328 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.444 HG23 ' HB2' ' A' ' 174' ' ' TYR . 34.4 pt -110.54 155.79 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.127 0.489 . . . . 63.229999999999997 111.886 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -118.58 113.01 20.61 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.226 -0.443 . . . . 75.5 110.483 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -145.65 163.05 36.05 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.294 0.569 . . . . 73.219999999999999 111.935 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -94.89 139.2 31.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.936 -0.574 . . . . 74.010000000000005 111.594 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.9 t -77.19 106.82 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.884 0.374 . . . . 74.299999999999997 111.563 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.93 -45.93 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.228 0.537 . . . . 75.140000000000001 111.229 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -145.05 115.82 7.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.116 -0.493 . . . . 74.230000000000004 111.438 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -100.79 108.81 20.71 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.376 -0.375 . . . . 75.540000000000006 110.852 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -70.78 159.99 83.47 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.505 -0.316 . . . . 75.329999999999998 111.45 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.16 159.45 49.79 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.261 1.974 . . . . 75.310000000000002 112.864 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.412 ' HG3' ' O ' ' A' ' 197' ' ' LYS . 21.0 ptmt -75.39 102.29 5.08 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.475 0.655 . . . . 74.430000000000007 112.075 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -67.08 163.55 19.83 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.66 -0.7 . . . . 75.420000000000002 112.048 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.56 131.11 53.68 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.711 -0.677 . . . . 71.230000000000004 111.485 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 8.0 p90 . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 120.706 0.288 . . . . 75.420000000000002 110.969 175.545 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.564 0.221 . . . . 75.439999999999998 110.648 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 38.3 tp -141.5 117.99 10.89 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.089 0.403 . . . . 74.409999999999997 112.089 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -134.9 114.56 12.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.948 0.404 . . . . 72.219999999999999 111.412 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 47.2 t -93.8 149.41 21.26 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.931 0.396 . . . . 74.0 111.396 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.493 HD23 HG12 ' A' ' 235' ' ' VAL . 74.0 mt -128.66 125.36 37.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.601 -0.272 . . . . 71.540000000000006 111.229 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -89.9 111.91 23.11 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.792 0.329 . . . . 73.310000000000002 110.243 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 48.1 mt -109.92 156.77 20.0 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.388 -0.369 . . . . 74.030000000000001 111.006 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 221' ' ' SER . 18.1 ptmt -148.79 165.46 31.39 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.494 0.664 . . . . 70.109999999999999 112.155 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -147.5 170.11 18.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.066 -0.97 . . . . 50.299999999999997 109.877 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -48.78 -31.76 7.53 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.561 0.578 . . . . 74.209999999999994 112.561 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.1 t -102.48 -8.92 20.67 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.194 1.183 . . . . 73.349999999999994 114.194 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.407 ' O ' HD11 ' A' ' 176' ' ' ILE . . . 168.32 -179.55 41.32 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 119.82 -1.181 . . . . 70.219999999999999 114.453 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 216' ' ' LYS . 36.4 m -122.92 157.96 31.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.541 0.336 . . . . 73.420000000000002 111.325 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.6 tp -151.83 156.46 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.828 0.347 . . . . 72.140000000000001 111.32 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -113.37 112.07 23.04 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.277 0.561 . . . . 71.219999999999999 111.532 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.518 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -94.42 164.78 25.84 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.299 -0.41 . . . . 62.409999999999997 113.065 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 86.0 m -137.51 127.22 25.36 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.483 0.549 . . . . 71.109999999999999 112.483 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.439 HD22 ' HB ' ' A' ' 258' ' ' VAL . 96.1 mt -107.28 124.02 49.17 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.969 -0.56 . . . . 72.239999999999995 110.875 174.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -103.24 152.51 21.41 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.075 0.464 . . . . 73.310000000000002 111.995 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 51.01 -132.52 1.9 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.566 0.58 . . . . 75.420000000000002 112.566 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -42.72 -39.53 2.46 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.433 0.901 . . . . 73.129999999999995 113.433 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.2 -19.77 63.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.975 0.417 . . . . 75.109999999999999 112.049 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.66 -21.98 66.86 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.091 0.404 . . . . 70.409999999999997 112.091 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.57 3.38 55.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.222 0.453 . . . . 75.400000000000006 112.222 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -64.33 124.31 21.41 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 110.289 -0.263 . . . . 74.340000000000003 110.289 174.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.418 ' OE2' ' HE2' ' A' ' 236' ' ' LYS . 28.9 tt0 -66.86 99.4 0.62 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.17 0.509 . . . . 73.010000000000005 112.043 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.493 HG12 HD23 ' A' ' 213' ' ' LEU . 4.0 p -116.85 111.19 34.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.466 0.65 . . . . 65.340000000000003 110.699 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.418 ' HE2' ' OE2' ' A' ' 234' ' ' GLU . 66.8 mttm -98.36 147.73 24.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.08 0.466 . . . . 75.329999999999998 111.506 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -65.1 112.85 3.56 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 75.439999999999998 110.597 177.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.63 -16.66 23.74 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.463 -0.399 . . . . 37.030000000000001 113.172 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.51 141.54 51.93 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.011 0.434 . . . . 74.420000000000002 111.482 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 37.2 mm -89.09 117.91 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.476 -0.329 . . . . 73.140000000000001 110.522 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -109.01 127.1 53.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.11 0.782 . . . . 72.129999999999995 113.11 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.2 97.54 6.96 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.228 -0.656 . . . . 73.540000000000006 109.228 167.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.7 t -100.79 106.02 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.251 0.548 . . . . 74.540000000000006 112.24 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.9 m -96.65 109.19 21.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.937 -0.574 . . . . 72.409999999999997 110.055 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.67 -172.98 22.33 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.199 -1.0 . . . . 37.030000000000001 114.343 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -115.38 115.66 26.96 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.39 -0.405 . . . . 74.329999999999998 110.856 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.83 126.66 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.16 0.505 . . . . 75.450000000000003 111.717 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.4 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 52.4 mtpt -123.04 146.49 47.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.067 -0.515 . . . . 71.349999999999994 111.504 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.42 ' CB ' ' HB3' ' A' ' 181' ' ' PRO . 25.3 tt0 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 75.219999999999999 110.648 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 120.96 0.409 . . . . 74.310000000000002 111.385 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 10.5 pt-20 -144.24 174.03 11.25 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.154 -0.475 . . . . 70.329999999999998 111.007 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.518 HG22 ' HA2' ' A' ' 224' ' ' GLY . 8.5 tt -154.05 116.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.477 0.656 . . . . 75.420000000000002 111.976 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.8 t -87.49 124.37 33.38 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.951 -0.568 . . . . 74.430000000000007 110.098 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.449 HG11 ' HB ' ' A' ' 261' ' ' ILE . 33.3 t -84.08 132.84 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 112.366 0.506 . . . . 74.420000000000002 112.366 -173.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -95.36 -42.48 8.48 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.311 0.577 . . . . 72.230000000000004 110.723 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -145.42 135.41 23.71 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.917 -0.583 . . . . 74.129999999999995 110.702 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.449 ' HB ' HG11 ' A' ' 258' ' ' VAL . 12.6 tt -137.92 140.12 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.935 0.398 . . . . 72.230000000000004 111.596 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -149.98 136.42 5.69 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 116.24 -0.436 . . . . 73.230000000000004 112.159 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.6 mm -84.8 132.84 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.324 -0.515 . . . . 75.340000000000003 111.287 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 46.6 mt -77.1 -74.52 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 116.713 -0.221 . . . . 71.430000000000007 111.191 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 121.201 0.524 . . . . 75.420000000000002 110.443 170.182 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 186' ' ' THR . 78.0 m-20 . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.912 0.387 . . . . 74.519999999999996 110.868 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -83.92 171.45 13.02 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.518 0.675 . . . . 64.310000000000002 112.09 -174.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -93.39 156.68 16.64 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.568 -0.742 . . . . 70.530000000000001 109.683 167.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.497 HD13 HG22 ' A' ' 222' ' ' ILE . 40.0 mt -59.12 -31.87 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.114 0.412 . . . . 74.549999999999997 112.114 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 34.8 t -62.11 -29.26 70.2 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.93 0.395 . . . . 74.409999999999997 111.598 174.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -83.5 -18.22 39.24 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.405 -0.361 . . . . 72.310000000000002 111.695 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.652 HD11 HD13 ' A' ' 187' ' ' ILE . 87.6 mt -64.45 98.86 0.27 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.232 0.539 . . . . 73.030000000000001 110.998 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.441 ' HG2' HD23 ' A' ' 183' ' ' LEU . 23.9 ptp -96.64 152.2 38.4 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.099 -0.5 . . . . 73.310000000000002 111.163 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.18 138.34 78.92 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.169 1.913 . . . . 72.140000000000001 112.769 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 72.54 18.91 4.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.263 0.625 . . . . 71.200000000000003 111.794 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.441 HD23 ' HG2' ' A' ' 180' ' ' MET . 44.1 tp -94.7 154.82 17.13 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 74.120000000000005 111.599 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.4 t -131.31 123.17 27.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.53 -0.305 . . . . 51.200000000000003 110.67 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.54 -164.45 26.28 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.89 -0.671 . . . . 73.299999999999997 113.527 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 43.8 m -133.76 147.36 51.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.433 0.293 . . . . 74.120000000000005 111.177 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.652 HD13 HD11 ' A' ' 179' ' ' LEU . 39.9 pt -142.51 165.53 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.01 0.433 . . . . 65.400000000000006 111.577 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -122.29 118.31 28.21 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.692 -0.485 . . . . 73.549999999999997 109.692 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.29 170.75 16.14 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.532 0.567 . . . . 73.329999999999998 112.532 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 215' ' ' LEU . 40.1 mt-10 -84.86 134.2 34.29 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.802 -0.635 . . . . 74.450000000000003 111.514 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.26 95.75 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.039 0.447 . . . . 73.120000000000005 110.63 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.25 -29.94 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.127 0.489 . . . . 71.319999999999993 112.001 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.97 145.02 28.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 75.140000000000001 111.694 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -140.84 116.31 10.11 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.216 -0.447 . . . . 74.519999999999996 111.384 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.476 ' O ' ' HE2' ' A' ' 211' ' ' LYS . 97.0 m-85 -87.4 153.93 53.75 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-N 116.627 -0.26 . . . . 75.109999999999999 110.956 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.25 162.43 23.43 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.663 2.242 . . . . 65.109999999999999 112.942 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.465 ' HZ3' ' CG ' ' A' ' 232' ' ' ASP . 20.3 ptmt -72.48 115.3 11.58 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.618 0.723 . . . . 74.329999999999998 111.744 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -102.27 148.74 25.08 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.0 -0.546 . . . . 74.299999999999997 111.19 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.41 144.37 45.05 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.895 0.378 . . . . 74.310000000000002 111.243 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 12.4 p90 . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 121.012 0.434 . . . . 63.32 111.315 177.379 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 121.424 0.631 . . . . 73.219999999999999 112.695 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.4 tp -138.37 116.5 11.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.431 -0.804 . . . . 75.549999999999997 111.221 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.512 ' HZ1' HD21 ' A' ' 213' ' ' LEU . 59.5 tttm -145.79 107.31 4.24 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.035 -0.416 . . . . 74.120000000000005 111.264 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 225' ' ' THR . 57.9 m -86.49 142.36 28.41 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.525 0.678 . . . . 73.129999999999995 112.65 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.512 HD21 ' HZ1' ' A' ' 211' ' ' LYS . 59.8 mt -123.74 163.01 22.01 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.27 -0.877 . . . . 73.340000000000003 109.619 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -119.92 117.12 27.26 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.956 -0.465 . . . . 71.040000000000006 110.686 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 78.3 mt -107.7 133.98 51.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.726 0.298 . . . . 75.140000000000001 111.224 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -124.03 153.64 41.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.426 0.631 . . . . 75.329999999999998 111.877 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -151.15 160.43 43.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.964 -1.016 . . . . 74.109999999999999 109.302 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.31 -25.78 49.84 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.107 0.41 . . . . 72.299999999999997 112.107 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 48.6 p -89.23 -14.09 36.72 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.061 0.763 . . . . 74.140000000000001 113.061 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.02 -179.76 41.55 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.341 -0.933 . . . . 61.299999999999997 114.218 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.5 p -135.41 132.48 37.55 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.659 -0.318 . . . . 54.32 111.216 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.497 HG22 HD13 ' A' ' 176' ' ' ILE . 15.5 tt -144.81 145.74 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.058 0.456 . . . . 73.310000000000002 111.75 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.638 ' H ' ' HD2' ' A' ' 223' ' ' ARG . 0.5 OUTLIER -89.93 130.33 36.16 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.985 -0.447 . . . . 74.439999999999998 111.313 177.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -112.32 114.43 3.52 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.459 -0.401 . . . . 74.349999999999994 112.906 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 212' ' ' SER . 87.9 m -95.47 120.14 35.19 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.477 0.547 . . . . 72.409999999999997 112.477 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 258' ' ' VAL . 91.3 mt -78.74 123.84 27.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.948 -0.569 . . . . 74.099999999999994 110.857 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -107.74 172.72 6.67 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.988 0.423 . . . . 75.230000000000004 111.362 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 57.7 t30 55.72 -141.11 0.86 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 111.525 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.85 -5.73 45.18 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.57 -0.706 . . . . 70.430000000000007 112.465 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.464 ' HB3' HD23 ' A' ' 226' ' ' LEU . 83.2 mt -68.3 -12.77 61.59 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 122.137 -0.352 . . . . 63.340000000000003 111.656 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.79 67.11 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.153 0.502 . . . . 73.219999999999999 111.595 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.465 ' CG ' ' HZ3' ' A' ' 197' ' ' LYS . 4.1 m-20 -87.0 -3.07 59.06 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.012 0.375 . . . . 73.439999999999998 112.012 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -62.96 118.26 7.56 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.146 0.498 . . . . 74.420000000000002 110.999 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.26 99.42 4.04 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.402 0.62 . . . . 72.329999999999998 112.086 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.77 141.64 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 115.733 -0.667 . . . . 75.540000000000006 110.731 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -116.92 171.03 8.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.037 0.446 . . . . 73.219999999999999 110.835 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -72.99 119.24 16.97 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.852 0.358 . . . . 73.409999999999997 110.633 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 118.16 -24.13 8.9 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.157 -0.544 . . . . 44.25 113.751 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -64.78 134.32 53.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 117.159 0.479 . . . . 72.420000000000002 111.962 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 49.8 mm -84.03 102.33 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.005 0.431 . . . . 72.25 110.112 173.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -108.74 141.61 40.49 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.661 0.615 . . . . 71.239999999999995 112.661 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -89.35 108.45 19.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.802 -0.636 . . . . 73.310000000000002 109.728 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.442 HG12 HG12 ' A' ' 258' ' ' VAL . 75.8 t -111.51 130.24 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.158 0.429 . . . . 72.230000000000004 112.158 -172.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 28.5 t -123.9 137.3 54.66 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.294 -0.412 . . . . 64.040000000000006 110.701 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.98 -164.16 32.29 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.194 -1.003 . . . . 72.439999999999998 114.169 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -105.47 123.19 47.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.827 0.451 . . . . 74.120000000000005 111.189 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.9 t -89.93 134.44 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.229 0.538 . . . . 73.109999999999999 112.271 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.549 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 7.9 mtpm? -128.03 157.2 41.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.94 -0.573 . . . . 70.510000000000005 110.441 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.469 0.517 0 O-C-N 122.173 -0.329 . . . . 74.400000000000006 110.326 173.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 CA--C 1.54 0.596 0 CA-C-O 121.42 0.629 . . . . 54.119999999999997 112.649 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 8.0 pt-20 -143.62 125.85 15.56 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.563 -0.744 . . . . 73.109999999999999 110.038 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.409 HG22 ' HA2' ' A' ' 224' ' ' GLY . 12.2 tt -116.72 135.12 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.438 0.637 . . . . 72.400000000000006 112.443 -176.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 69.8 m -95.66 115.06 26.89 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.771 -0.649 . . . . 74.109999999999999 110.343 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.483 ' HB ' HD22 ' A' ' 226' ' ' LEU . 38.5 t -75.54 120.32 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.302 0.573 . . . . 73.310000000000002 112.158 -174.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.36 -36.41 11.39 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.941 -0.572 . . . . 75.230000000000004 110.654 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 15.7 t-20 -139.93 140.14 36.31 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.804 -0.634 . . . . 74.109999999999999 110.334 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 14.2 tt -148.35 135.2 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.345 0.593 . . . . 74.219999999999999 112.288 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -148.49 125.18 2.01 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.104 -0.498 . . . . 74.340000000000003 112.304 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 54.0 mt -79.85 131.9 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 122.217 -0.578 . . . . 72.140000000000001 111.773 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.1 mt -73.33 -52.75 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.122 0.487 . . . . 73.530000000000001 111.332 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 . . . . . 0 N--CA 1.469 0.511 0 CA-C-N 116.075 -0.511 . . . . 75.430000000000007 111.792 179.812 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.726 -0.472 . . . . 72.140000000000001 109.726 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.408 ' O ' HG22 ' A' ' 187' ' ' ILE . 88.8 m-85 -84.35 145.36 28.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.326 0.584 . . . . 74.209999999999994 112.463 -173.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.465 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 46.4 mmtm -79.42 154.34 29.03 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.047 -0.723 . . . . 74.140000000000001 109.047 167.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.428 HG21 ' HB ' ' A' ' 222' ' ' ILE . 58.7 mt -51.94 -36.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 112.591 0.589 . . . . 75.120000000000005 112.591 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.4 t -67.76 -29.14 68.28 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 122.057 -0.402 . . . . 75.329999999999998 111.845 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.465 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 12.3 mm-40 -76.26 -8.04 56.21 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.851 0.315 . . . . 74.519999999999996 111.851 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.411 HD22 HG22 ' A' ' 247' ' ' VAL . 88.1 mt -73.41 145.29 45.92 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.314 0.578 . . . . 74.409999999999997 111.901 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.458 ' HG2' HD21 ' A' ' 183' ' ' LEU . 24.2 ptp -143.97 159.16 54.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.029 -0.532 . . . . 75.209999999999994 110.7 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.22 132.38 38.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.451 2.101 . . . . 75.430000000000007 113.192 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 65.05 46.08 2.89 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.065 0.459 . . . . 70.329999999999998 111.589 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.458 HD21 ' HG2' ' A' ' 180' ' ' MET . 42.8 tp -119.19 120.88 38.37 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.304 -0.407 . . . . 72.439999999999998 111.73 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.5 t -99.14 120.46 39.53 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.556 0.217 . . . . 74.540000000000006 110.639 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.82 -176.17 38.79 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.52 -0.848 . . . . 70.329999999999998 114.402 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 90.6 m -114.57 136.58 52.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.0 0.52 . . . . 74.349999999999994 111.698 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 174' ' ' TYR . 34.6 pt -126.8 157.8 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 122.63 0.372 . . . . 72.200000000000003 110.741 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -129.96 103.15 6.61 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.177 -0.327 . . . . 73.329999999999998 110.174 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -139.31 172.32 12.99 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 113.373 0.879 . . . . 73.010000000000005 113.373 -171.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.92 140.8 29.07 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.052 -0.976 . . . . 75.430000000000007 111.425 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.33 95.05 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.069 0.461 . . . . 75.540000000000006 110.761 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 16.2 t -72.26 -42.6 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.223 -0.444 . . . . 74.140000000000001 111.936 -176.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -140.32 127.7 21.29 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.99 0.424 . . . . 74.150000000000006 111.63 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -104.18 104.41 14.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.342 -0.39 . . . . 54.020000000000003 111.542 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -79.67 150.07 72.25 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.543 -0.299 . . . . 74.349999999999994 111.775 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.6 168.38 16.73 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.981 2.454 . . . . 74.530000000000001 113.801 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.2 156.39 33.65 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.102 -0.499 . . . . 73.430000000000007 111.675 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -141.88 159.08 42.95 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.112 -0.495 . . . . 74.129999999999995 111.056 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -129.08 153.45 47.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.991 0.424 . . . . 61.299999999999997 111.47 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . 0.561 ' HE2' ' HB2' ' A' ' 210' ' ' LEU . 52.4 p90 . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 121.032 0.444 . . . . 72.340000000000003 111.08 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 120.965 0.412 . . . . 75.120000000000005 111.981 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.561 ' HB2' ' HE2' ' A' ' 200' ' ' PHE . 51.7 tp -135.12 141.01 45.9 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.95 0.5 . . . . 74.409999999999997 111.321 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 231' ' ' ALA . 7.6 tmtm? -167.38 115.2 0.78 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.796 0.332 . . . . 71.329999999999998 111.034 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 69.8 m -99.83 167.26 10.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.741 0.782 . . . . 62.25 113.025 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.41 HD12 HG11 ' A' ' 235' ' ' VAL . 75.9 mt -142.66 157.33 44.79 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.179 -0.919 . . . . 75.530000000000001 110.752 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -117.13 122.52 44.32 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.133 -0.354 . . . . 75.530000000000001 110.851 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.512 HD11 HG21 ' A' ' 243' ' ' VAL . 44.3 mt -118.4 154.63 32.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.655 0.382 . . . . 72.420000000000002 111.004 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -153.25 132.81 12.97 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.764 0.654 . . . . 63.439999999999998 112.764 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -99.81 -171.17 2.0 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.977 -0.556 . . . . 60.530000000000001 110.315 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.94 -15.15 62.58 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.195 0.522 . . . . 73.25 110.587 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 54.1 p -94.47 -20.52 19.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.819 0.674 . . . . 65.25 112.819 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 158.12 -179.53 33.76 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.755 -0.736 . . . . 72.129999999999995 113.361 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 83.9 p -123.67 146.78 47.98 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.056 0.455 . . . . 74.040000000000006 112.047 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.428 ' HB ' HG21 ' A' ' 176' ' ' ILE . 11.4 tp -144.1 157.22 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.251 -0.432 . . . . 73.5 110.966 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 223' ' ' ARG . 29.1 mtm-85 -102.54 117.61 35.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.695 0.284 . . . . 74.019999999999996 111.455 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.525 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -97.7 119.76 6.52 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.419 -0.42 . . . . 62.149999999999999 112.84 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.0 m -99.25 118.41 35.87 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.355 0.502 . . . . 75.439999999999998 112.355 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.538 HD22 ' HB ' ' A' ' 258' ' ' VAL . 91.4 mt -91.9 133.82 35.33 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.974 -0.557 . . . . 71.109999999999999 111.046 175.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -115.46 159.4 21.22 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.08 0.467 . . . . 74.540000000000006 111.886 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.48 -133.54 1.06 Allowed 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 115.921 -0.581 . . . . 73.420000000000002 111.676 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.76 -31.58 39.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.242 0.46 . . . . 72.319999999999993 112.242 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 90.3 mt -64.27 -14.91 58.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.983 0.364 . . . . 74.349999999999994 111.983 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 211' ' ' LYS . . . -73.98 -1.96 22.09 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.968 0.413 . . . . 73.129999999999995 112.063 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.03 14.22 9.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.895 0.478 . . . . 75.420000000000002 110.961 173.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -72.69 126.22 29.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.042 -0.526 . . . . 75.299999999999997 111.139 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -62.86 97.36 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.169 0.509 . . . . 74.120000000000005 111.828 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.41 HG11 HD12 ' A' ' 213' ' ' LEU . 4.0 p -135.72 114.38 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.934 -0.576 . . . . 70.120000000000005 110.541 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -100.35 157.94 16.25 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.169 0.509 . . . . 73.450000000000003 111.507 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -69.35 94.77 0.74 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.994 -0.548 . . . . 74.329999999999998 111.664 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 137.27 -19.35 3.42 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.171 -0.538 . . . . 71.140000000000001 113.793 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -70.0 146.13 51.28 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.139 0.495 . . . . 63.509999999999998 112.083 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.545 HG22 HD12 ' A' ' 264' ' ' ILE . 45.8 mm -86.93 129.31 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.191 -0.458 . . . . 73.430000000000007 110.22 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.558 ' HB1' HD11 ' A' ' 263' ' ' ILE . . . -140.91 152.35 44.96 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.028 0.751 . . . . 74.239999999999995 113.028 -175.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.28 125.52 38.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.787 -0.642 . . . . 74.519999999999996 110.221 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.512 HG21 HD11 ' A' ' 215' ' ' LEU . 92.9 t -122.11 117.58 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.133 0.492 . . . . 71.019999999999996 111.786 -175.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 260' ' ' ASN . 69.7 m -118.0 133.18 56.16 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.321 -0.4 . . . . 73.129999999999995 110.955 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.26 -156.12 13.23 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.438 -0.887 . . . . 44.25 113.84 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -122.75 115.32 21.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.966 0.412 . . . . 73.120000000000005 111.339 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.527 HG21 ' HB ' ' A' ' 256' ' ' ILE . 38.3 t -86.89 125.69 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.249 -0.432 . . . . 75.230000000000004 111.614 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -154.08 154.45 33.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.804 0.335 . . . . 73.430000000000007 111.365 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 CA--C 1.536 0.428 0 CA-C-N 116.677 -0.238 . . . . 75.340000000000003 110.472 176.311 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.017 0.437 . . . . 73.230000000000004 111.278 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -122.27 133.81 54.68 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.437 -0.347 . . . . 73.230000000000004 111.293 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.527 ' HB ' HG21 ' A' ' 247' ' ' VAL . 8.5 tt -103.86 109.09 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.329 0.585 . . . . 74.109999999999999 111.104 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.7 t -78.28 115.47 18.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.212 -0.449 . . . . 74.010000000000005 110.024 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.538 ' HB ' HD22 ' A' ' 226' ' ' LEU . 38.8 t -88.45 116.9 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 112.607 0.595 . . . . 73.239999999999995 112.607 -170.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.76 -24.15 17.92 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.327 -0.397 . . . . 75.319999999999993 111.6 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 244' ' ' SER . 27.3 t-20 -139.79 131.78 27.81 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.678 0.275 . . . . 64.109999999999999 111.163 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.1 tt -149.04 139.33 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.877 0.37 . . . . 72.140000000000001 111.163 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -149.47 129.11 2.92 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.15 -0.548 . . . . 65.049999999999997 112.826 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.558 HD11 ' HB1' ' A' ' 241' ' ' ALA . 46.4 mm -73.36 115.16 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 122.678 -0.307 . . . . 74.120000000000005 110.749 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.545 HD12 HG22 ' A' ' 240' ' ' ILE . 72.2 mt -66.01 -53.62 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.008 0.432 . . . . 71.540000000000006 111.469 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 . . . . . 0 N--CA 1.47 0.536 0 CA-C-N 116.297 -0.41 . . . . 64.340000000000003 111.027 178.627 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 109.622 -0.51 . . . . 64.0 109.622 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -96.8 155.24 16.86 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.154 0.798 . . . . 74.129999999999995 113.154 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -100.04 155.59 17.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.345 -0.843 . . . . 74.340000000000003 109.945 169.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 220' ' ' GLY . 44.2 mt -66.06 -30.09 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 112.551 0.574 . . . . 73.340000000000003 112.551 -172.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 219' ' ' THR . 93.5 p -71.09 -28.52 64.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.237 0.542 . . . . 64.510000000000005 110.664 173.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -77.99 -31.47 50.73 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.959 -0.564 . . . . 74.200000000000003 111.262 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 247' ' ' VAL . 78.0 mt -52.9 134.07 37.55 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.228 0.537 . . . . 73.430000000000007 111.475 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.445 ' HB2' ' HD2' ' A' ' 181' ' ' PRO . 22.9 ptp -140.57 164.65 35.32 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.925 -0.58 . . . . 72.120000000000005 111.077 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.483 ' HB3' ' HB3' ' A' ' 249' ' ' GLN . 9.4 Cg_endo -54.53 144.0 65.05 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.405 2.07 . . . . 75.329999999999998 112.879 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.1 t30 67.6 13.9 9.4 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.034 0.445 . . . . 75.510000000000005 111.909 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 40.2 tp -91.12 150.86 21.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.133 0.492 . . . . 72.150000000000006 111.993 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.8 t -131.78 133.67 45.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.339 -0.392 . . . . 73.329999999999998 110.492 173.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 173.82 -176.61 46.32 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.418 -0.896 . . . . 74.109999999999999 113.864 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 90.5 m -117.23 136.43 53.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.868 0.366 . . . . 71.430000000000007 111.325 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.411 HD12 HD11 ' A' ' 179' ' ' LEU . 33.8 pt -129.25 163.48 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 122.885 0.474 . . . . 75.239999999999995 111.485 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.58 114.25 17.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.47 -0.332 . . . . 75.219999999999999 110.503 175.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.28 168.58 19.44 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.848 0.356 . . . . 62.530000000000001 111.945 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 14.7 pt-20 -89.44 143.51 26.77 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.009 0.433 . . . . 64.450000000000003 111.353 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.439 ' HA ' HD21 ' A' ' 215' ' ' LEU . 39.8 t -79.49 105.01 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.226 0.536 . . . . 74.310000000000002 111.608 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.48 -37.63 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.207 0.527 . . . . 72.5 111.116 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.2 134.05 11.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.041 -0.527 . . . . 74.540000000000006 111.409 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -115.1 101.52 9.06 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.897 0.38 . . . . 72.140000000000001 111.246 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -72.11 143.96 86.82 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.483 -0.326 . . . . 75.25 111.27 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.63 168.75 2.87 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.955 2.437 . . . . 64.310000000000002 113.956 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -83.31 118.28 23.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.319 0.581 . . . . 73.010000000000005 111.785 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.643 ' HE2' ' HG ' ' A' ' 210' ' ' LEU . 2.6 mppt? -96.92 162.82 13.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.117 -0.492 . . . . 74.109999999999999 111.408 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -111.09 146.86 36.04 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.196 -0.457 . . . . 71.099999999999994 111.393 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 36.2 p90 . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 121.175 0.512 . . . . 75.120000000000005 111.125 173.174 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 . . . . . 0 CA--C 1.542 0.659 0 CA-C-O 120.654 0.264 . . . . 75.230000000000004 110.882 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.643 ' HG ' ' HE2' ' A' ' 198' ' ' LYS . 14.9 tp -137.33 116.72 12.76 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.391 0.515 . . . . 62.530000000000001 112.391 -175.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 59.8 tttp -122.15 147.79 45.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.762 0.315 . . . . 72.340000000000003 110.736 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.44 ' OG ' ' NZ ' ' A' ' 198' ' ' LYS . 49.0 m -123.74 147.15 47.75 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.022 0.439 . . . . 64.030000000000001 111.342 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.3 mt -135.14 157.45 46.88 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.217 -0.447 . . . . 72.219999999999999 110.92 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -127.87 115.89 19.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.905 -0.406 . . . . 64.409999999999997 109.905 173.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.439 HD21 ' HA ' ' A' ' 191' ' ' VAL . 64.9 mt -117.64 153.49 33.21 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.403 -0.362 . . . . 73.319999999999993 111.316 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 22.0 pttp -147.24 145.2 29.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.782 0.801 . . . . 65.040000000000006 112.35 174.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -122.15 170.94 9.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.657 -1.156 . . . . 74.329999999999998 108.635 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -49.93 -29.91 9.27 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.138 0.494 . . . . 74.109999999999999 111.364 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 177' ' ' SER . 77.2 p -88.17 -2.15 58.43 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.755 1.02 . . . . 73.519999999999996 113.755 -175.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.424 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 143.09 -178.95 21.0 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 120.412 -0.899 . . . . 74.129999999999995 113.801 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.9 p -120.33 155.37 33.48 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 120.911 0.386 . . . . 70.310000000000002 111.78 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 14.9 tt -148.84 157.43 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.937 0.399 . . . . 72.049999999999997 111.768 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 223' ' ' ARG . 7.6 mpt_? -92.37 128.64 38.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.295 -0.411 . . . . 65.420000000000002 110.903 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -107.97 140.56 15.5 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.343 -0.456 . . . . 44.140000000000001 112.781 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 32.9 m -125.44 116.33 21.68 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.209 -0.583 . . . . 75.299999999999997 112.176 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.542 HD22 ' HB ' ' A' ' 258' ' ' VAL . 74.8 mt -99.02 132.25 44.47 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.479 -0.328 . . . . 75.239999999999995 111.038 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -113.14 154.93 25.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.157 0.503 . . . . 75.430000000000007 112.122 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.1 t30 62.18 -152.25 0.36 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.751 -0.659 . . . . 52.109999999999999 111.201 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.62 -7.29 0.91 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.671 0.989 . . . . 73.049999999999997 113.671 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.68 -13.68 55.23 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.167 0.508 . . . . 73.519999999999996 110.85 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -64.99 -28.89 69.82 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.106 -0.497 . . . . 62.149999999999999 112.151 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.01 0.19 53.97 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.108 0.41 . . . . 71.209999999999994 112.108 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -66.45 101.77 0.8 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.045 0.45 . . . . 72.010000000000005 110.658 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.51 100.55 1.43 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.12 0.415 . . . . 74.340000000000003 112.12 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.6 150.42 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.098 -0.501 . . . . 73.109999999999999 110.216 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -113.44 163.15 15.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.453 0.645 . . . . 71.219999999999999 112.08 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -81.11 94.76 6.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.136 -0.484 . . . . 65.25 110.688 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 141.57 -11.74 2.7 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.448 -0.882 . . . . 72.120000000000005 114.868 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -88.48 172.82 9.07 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.209 1.005 . . . . 70.439999999999998 111.456 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 48.1 mm -105.04 113.81 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.073 -0.512 . . . . 74.010000000000005 110.94 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -100.04 122.94 43.7 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.809 0.67 . . . . 72.510000000000005 112.809 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -80.24 104.86 11.08 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.818 -0.628 . . . . 73.200000000000003 109.55 170.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.407 HG23 HD11 ' A' ' 215' ' ' LEU . 93.1 t -115.83 128.77 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.543 0.571 . . . . 73.340000000000003 112.543 -172.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 39.2 t -120.85 132.52 55.04 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.16 -0.473 . . . . 73.349999999999994 110.405 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.33 -163.27 29.03 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.274 -0.965 . . . . 74.409999999999997 114.436 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -117.95 115.73 25.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.769 0.428 . . . . 75.109999999999999 111.264 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.498 HG21 HD23 ' A' ' 179' ' ' LEU . 48.5 t -85.44 133.16 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.666 0.617 . . . . 74.340000000000003 112.666 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -128.39 138.51 52.38 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.208 -0.451 . . . . 74.510000000000005 111.207 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 181' ' ' PRO . 29.2 tt0 . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 120.715 0.293 . . . . 75.430000000000007 110.827 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 121.053 0.454 . . . . 74.439999999999998 111.97 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.75 167.18 11.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.14 -0.482 . . . . 64.129999999999995 110.386 175.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tt -136.04 103.86 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.556 0.693 . . . . 71.230000000000004 111.129 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.9 t -66.28 106.72 1.76 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.986 -0.552 . . . . 71.230000000000004 109.873 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.542 ' HB ' HD22 ' A' ' 226' ' ' LEU . 38.9 t -75.5 124.48 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.571 0.582 . . . . 52.350000000000001 112.571 -171.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -81.63 -40.94 22.17 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.85 -0.613 . . . . 75.129999999999995 110.675 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -153.49 148.78 27.01 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.132 -0.486 . . . . 63.420000000000002 111.127 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.8 tt -140.85 142.64 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.062 0.458 . . . . 73.310000000000002 111.567 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -150.51 145.02 12.58 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.171 -0.538 . . . . 74.400000000000006 112.823 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.0 mt -81.79 127.94 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 122.443 -0.445 . . . . 73.209999999999994 110.903 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 34.8 mm -56.41 -43.76 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.718 0.636 . . . . 65.219999999999999 112.718 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 121.353 0.597 . . . . 73.329999999999998 112.105 -179.742 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.9 m120 . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 111.896 0.332 . . . . 71.439999999999998 111.896 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . 0.486 ' HB2' HG22 ' A' ' 187' ' ' ILE . 95.5 m-85 -120.78 143.28 48.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.339 0.59 . . . . 73.140000000000001 112.152 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -99.69 159.86 14.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 70.299999999999997 109.798 169.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.469 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 68.6 mt -64.06 -34.88 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 112.609 0.596 . . . . 72.049999999999997 112.609 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.4 t -69.03 -20.56 64.13 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.069 0.461 . . . . 63.039999999999999 111.144 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -84.26 -11.08 57.06 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.026 -0.534 . . . . 73.329999999999998 111.379 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.502 HD21 HG22 ' A' ' 247' ' ' VAL . 77.5 mt -68.44 162.03 26.37 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.888 0.852 . . . . 73.109999999999999 113.248 -174.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.0 ptp -162.7 153.75 14.66 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 114.877 -1.056 . . . . 62.240000000000002 110.031 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.74 144.2 87.63 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.251 1.967 . . . . 74.519999999999996 112.756 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 67.88 24.44 8.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.848 0.459 . . . . 74.230000000000004 111.978 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 49.5 tp -95.83 121.27 37.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.118 0.414 . . . . 65.549999999999997 112.118 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 60.6 m -104.65 115.96 31.23 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.455 -0.339 . . . . 54.140000000000001 110.41 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.08 -168.49 36.38 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.266 -0.969 . . . . 65.040000000000006 114.111 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 52.8 m -119.89 119.25 32.97 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.71 0.29 . . . . 74.420000000000002 111.44 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.486 HG22 ' HB2' ' A' ' 174' ' ' TYR . 31.9 pt -101.36 154.3 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.232 0.539 . . . . 73.540000000000006 111.945 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -122.23 109.08 14.04 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.158 0.504 . . . . 72.409999999999997 110.834 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 216' ' ' LYS . . . -148.4 -177.59 5.85 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.925 -0.58 . . . . 71.400000000000006 111.452 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 10.7 pt-20 -107.89 148.43 29.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.229 0.538 . . . . 74.120000000000005 111.355 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.14 114.29 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.058 -0.519 . . . . 74.140000000000001 111.909 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.1 -49.42 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.205 0.526 . . . . 74.420000000000002 110.988 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -139.2 135.52 34.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 63.039999999999999 111.138 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -131.05 102.89 6.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.333 -0.394 . . . . 63.210000000000001 111.265 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.515 ' HB2' ' HB2' ' A' ' 212' ' ' SER . 74.7 m-85 -95.04 126.3 47.23 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.381 -0.372 . . . . 74.420000000000002 110.607 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 195' ' ' TYR . 48.6 Cg_exo -57.67 -174.83 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.335 2.69 . . . . 74.120000000000005 114.521 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.631 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 20.7 pttm -67.79 141.22 56.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.505 0.928 . . . . 72.010000000000005 113.505 -174.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.713 ' HE2' ' HG ' ' A' ' 210' ' ' LEU . 32.0 mtmm -120.31 157.37 29.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.083 -0.962 . . . . 72.129999999999995 110.368 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -102.82 137.33 41.17 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.139 0.495 . . . . 75.129999999999995 111.952 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 24.6 p90 . . . . . 0 N--CA 1.47 0.572 0 CA-C-N 115.985 -0.552 . . . . 74.25 110.325 174.025 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 120.783 0.325 . . . . 64.5 111.276 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.713 ' HG ' ' HE2' ' A' ' 198' ' ' LYS . 18.4 tp -112.52 108.78 18.01 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.292 0.478 . . . . 70.540000000000006 112.292 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 82.6 tttt -117.62 139.53 50.87 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.807 0.336 . . . . 72.400000000000006 110.957 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.515 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 15.0 m -109.93 134.25 52.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.066 0.395 . . . . 71.030000000000001 112.066 -172.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 72.1 mt -129.88 145.53 51.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.254 0.549 . . . . 73.450000000000003 112.005 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -126.7 118.83 25.53 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.982 -0.554 . . . . 73.299999999999997 109.68 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.71 154.86 28.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.345 -0.389 . . . . 72.310000000000002 111.476 -174.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 189' ' ' ALA . 19.6 ptmt -153.74 170.01 21.96 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.899 0.381 . . . . 75.420000000000002 111.091 174.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.89 -174.73 4.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.852 -0.425 . . . . 74.120000000000005 109.852 171.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.64 -16.03 59.85 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.248 0.462 . . . . 74.150000000000006 112.248 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.4 p -98.76 -21.86 16.16 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.169 0.803 . . . . 73.239999999999995 113.169 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.98 -178.35 42.89 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 120.514 -0.851 . . . . 71.310000000000002 113.825 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 60.9 m -129.59 136.12 49.4 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 120.983 0.42 . . . . 74.430000000000007 111.892 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.0 tp -133.06 153.78 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.098 0.475 . . . . 74.439999999999998 111.76 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -111.42 135.4 52.03 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.768 0.318 . . . . 74.420000000000002 110.885 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -138.43 178.5 19.26 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.831 -0.699 . . . . 74.430000000000007 114.05 -174.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 88.0 m -148.37 137.4 21.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.568 -0.372 . . . . 61.240000000000002 111.933 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 83.5 mt -101.92 134.57 44.92 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.143 -0.481 . . . . 73.310000000000002 110.864 175.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -113.48 152.83 29.64 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.901 0.381 . . . . 75.019999999999996 111.666 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 14.4 m120 64.08 -143.36 0.29 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.191 -0.459 . . . . 72.519999999999996 112.001 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -48.33 -29.82 4.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.99 0.737 . . . . 72.109999999999999 112.99 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 92.4 mt -55.9 -18.89 10.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.003 0.43 . . . . 74.430000000000007 111.596 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -63.19 -44.05 96.45 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.994 0.426 . . . . 64.129999999999995 111.56 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -87.31 -5.33 58.95 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.961 0.356 . . . . 74.129999999999995 111.961 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -63.1 116.98 5.87 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.903 -0.406 . . . . 75.150000000000006 109.903 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.43 126.08 26.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.511 0.672 . . . . 74.329999999999998 112.383 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.08 127.23 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.606 -0.725 . . . . 74.239999999999995 110.039 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -100.34 141.99 32.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.142 0.496 . . . . 74.109999999999999 111.896 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.473 ' HB3' ' HE3' ' A' ' 237' ' ' LYS . 1.1 tmmt? -73.0 125.89 28.67 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.873 -0.603 . . . . 75.140000000000001 110.74 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.37 14.25 51.47 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.234 -0.508 . . . . 55.229999999999997 113.175 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.59 158.65 18.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.96 0.41 . . . . 64.439999999999998 112.071 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 32.7 mm -92.33 127.71 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 116.275 -0.42 . . . . 72.510000000000005 110.898 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -130.25 143.22 50.65 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.088 0.773 . . . . 75.400000000000006 113.088 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.55 117.36 29.87 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.656 -0.702 . . . . 74.400000000000006 109.513 171.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.4 t -117.82 111.47 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.57 0.581 . . . . 75.400000000000006 112.57 -173.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 52.0 m -96.58 112.55 24.25 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.422 -0.353 . . . . 74.540000000000006 110.382 174.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.59 -167.79 17.0 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.418 -0.896 . . . . 63.219999999999999 114.132 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.486 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 93.4 t80 -122.8 113.95 19.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.683 0.393 . . . . 75.319999999999993 111.124 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 179' ' ' LEU . 45.5 t -86.11 120.07 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.408 -0.36 . . . . 73.129999999999995 111.13 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 61.0 pttt -134.59 164.3 27.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.265 0.555 . . . . 75.099999999999994 112.06 -176.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 . . . . . 0 C--O 1.237 0.404 0 CA-C-N 115.596 -0.729 . . . . 75.129999999999995 109.776 173.823 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 109.322 -0.621 . . . . 72.230000000000004 109.322 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -111.54 132.91 54.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.291 0.567 . . . . 72.430000000000007 111.897 -176.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.1 tt -101.78 106.13 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.607 0.718 . . . . 75.239999999999995 111.108 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 35.9 t -77.35 110.25 11.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 53.210000000000001 109.959 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.554 ' HB ' HD22 ' A' ' 226' ' ' LEU . 37.9 t -81.27 124.18 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.043 0.449 . . . . 71.530000000000001 112.107 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.85 -43.95 14.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.977 -0.556 . . . . 65.219999999999999 110.797 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -147.16 139.12 24.37 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.142 -0.481 . . . . 71.319999999999993 110.443 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.2 tt -133.36 146.63 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.799 0.333 . . . . 74.019999999999996 111.216 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -147.74 131.97 4.07 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.17 -0.538 . . . . 73.420000000000002 113.047 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -80.85 130.93 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 122.269 -0.548 . . . . 75.150000000000006 110.678 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 54.8 mt -63.26 -64.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.825 0.345 . . . . 73.099999999999994 111.233 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 121.339 0.59 . . . . 74.430000000000007 111.225 175.705 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 186' ' ' THR . 2.8 p-10 . . . . . 0 CA--C 1.539 0.552 0 CA-C-O 121.101 0.476 . . . . 70.420000000000002 110.819 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -104.23 155.84 18.4 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.346 0.593 . . . . 74.239999999999995 111.96 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -74.6 147.07 41.97 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.617 -0.883 . . . . 74.319999999999993 108.617 167.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.73 -32.79 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 112.785 0.661 . . . . 74.209999999999994 112.785 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.5 m -68.94 -7.94 39.79 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.261 0.467 . . . . 74.420000000000002 112.261 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -95.21 -6.19 42.14 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.664 0.385 . . . . 75.129999999999995 111.789 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.566 HD11 HG23 ' A' ' 187' ' ' ILE . 79.9 mt -73.39 106.75 5.33 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.559 0.695 . . . . 71.519999999999996 112.449 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.9 ptp -114.86 156.2 45.35 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.447 -0.797 . . . . 73.450000000000003 110.351 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.01 144.27 69.23 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.17 1.913 . . . . 74.219999999999999 112.757 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 70.45 15.34 7.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.158 0.583 . . . . 75.25 112.151 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.7 tp -93.12 135.96 33.83 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.808 0.337 . . . . 74.040000000000006 111.361 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.6 t -113.01 118.33 34.51 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.766 0.317 . . . . 72.510000000000005 111.081 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.02 -166.15 33.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.657 -0.782 . . . . 74.150000000000006 113.822 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 48.4 m -128.12 146.31 50.74 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.7 0.4 . . . . 75.439999999999998 110.815 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.566 HG23 HD11 ' A' ' 179' ' ' LEU . 30.4 pt -130.46 149.6 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.57 0.582 . . . . 64.209999999999994 112.57 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -108.61 127.34 53.87 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.73 -0.668 . . . . 54.130000000000003 110.089 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -159.66 175.56 13.04 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.319 0.581 . . . . 75.030000000000001 112.497 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -103.61 151.67 22.66 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.756 -0.656 . . . . 64.219999999999999 110.747 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.2 t -88.72 117.55 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.879 0.371 . . . . 71.329999999999998 111.798 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.9 t -95.44 -48.2 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.077 0.465 . . . . 65.239999999999995 111.99 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -139.45 138.87 36.81 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.972 0.415 . . . . 75.409999999999997 112.082 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.77 105.35 8.9 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.017 -0.538 . . . . 71.519999999999996 110.759 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -87.03 142.19 33.71 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 111.873 0.324 . . . . 70.230000000000004 111.873 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -44.79 147.09 1.99 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.056 2.504 . . . . 72.239999999999995 113.485 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.565 ' HB2' ' HB2' ' A' ' 231' ' ' ALA . 23.0 pttp -74.47 134.93 42.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.611 0.719 . . . . 71.25 112.865 -172.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 2.4 mptp? -90.69 144.21 25.96 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.4 -0.818 . . . . 75.400000000000006 110.038 174.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -130.03 115.86 17.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.963 0.411 . . . . 73.349999999999994 110.728 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 37.0 p90 . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 121.301 0.572 . . . . 75.329999999999998 111.872 -173.407 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 N--CA 1.47 0.525 0 CA-C-O 120.839 0.352 . . . . 74.010000000000005 111.017 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 226' ' ' LEU . 58.6 tp -153.72 144.18 22.38 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.176 -0.466 . . . . 74.430000000000007 111.782 -176.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 230' ' ' LEU . 8.3 ttpm? -144.3 124.38 13.63 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.053 0.454 . . . . 73.019999999999996 111.127 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.5 m -88.32 130.74 35.05 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.087 -0.506 . . . . 72.400000000000006 111.355 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 81.3 mt -122.25 150.84 41.74 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.054 0.454 . . . . 73.239999999999995 111.408 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -114.62 115.41 27.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.326 -0.397 . . . . 75.519999999999996 110.111 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.03 153.62 32.37 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.183 0.193 . . . . 72.230000000000004 111.076 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 221' ' ' SER . 0.0 OUTLIER -146.38 142.92 28.69 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.011 0.91 . . . . 73.140000000000001 112.863 176.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.87 -178.48 3.73 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.791 -1.188 . . . . 64.230000000000004 107.791 165.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.29 -20.13 59.29 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.705 -0.622 . . . . 73.200000000000003 111.08 172.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -82.13 -28.05 32.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.231 0.456 . . . . 73.420000000000002 112.231 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.68 179.53 41.49 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.009 -0.615 . . . . 62.25 113.619 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 216' ' ' LYS . 79.1 p -114.22 163.93 14.57 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.346 0.498 . . . . 72.109999999999999 112.346 -176.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.5 tp -151.33 152.4 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 116.285 -0.416 . . . . 65.140000000000001 111.263 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -95.5 122.3 38.09 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.869 0.366 . . . . 74.010000000000005 111.834 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -93.72 135.5 12.59 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.403 -0.427 . . . . 53.340000000000003 112.957 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 63.2 m -118.26 103.79 10.17 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.524 -0.398 . . . . 74.450000000000003 111.388 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 210' ' ' LEU . 75.4 mt -94.46 117.1 29.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 111.828 0.307 . . . . 74.540000000000006 111.828 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . 0.458 ' O ' ' HB2' ' A' ' 230' ' ' LEU . 84.4 m95 -98.86 166.06 11.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.977 0.418 . . . . 71.230000000000004 111.466 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 61.94 -150.97 0.37 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.527 -0.306 . . . . 72.430000000000007 111.666 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.59 -15.06 6.3 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.612 0.597 . . . . 74.200000000000003 112.612 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.459 ' O ' ' NZ ' ' A' ' 211' ' ' LYS . 96.5 mt -59.13 -16.15 18.23 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.015 0.436 . . . . 74.219999999999999 110.812 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.565 ' HB2' ' HB2' ' A' ' 197' ' ' LYS . . . -65.15 -47.13 78.12 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.315 -0.402 . . . . 70.450000000000003 110.733 170.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.96 -29.31 67.51 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.387 -0.37 . . . . 73.409999999999997 111.425 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -50.87 103.03 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.885 0.374 . . . . 73.019999999999996 110.502 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -81.63 120.89 25.66 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.192 0.52 . . . . 75.530000000000001 111.792 -174.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.3 p -116.07 143.93 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.828 -0.624 . . . . 74.299999999999997 110.623 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.477 ' HB3' ' HZ2' ' A' ' 236' ' ' LYS . 5.7 mtpm? -104.97 154.36 20.21 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.979 0.363 . . . . 75.0 111.979 -173.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -81.19 133.66 35.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.808 0.337 . . . . 72.109999999999999 111.277 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.73 -34.45 5.46 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.524 -0.37 . . . . 72.319999999999993 113.06 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.2 144.86 56.56 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.057 0.456 . . . . 74.510000000000005 111.615 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.535 ' HB ' ' HG2' ' A' ' 265' ' ' GLU . 41.4 mm -92.39 136.38 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.75 0.309 . . . . 62.100000000000001 111.027 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -141.05 157.87 44.72 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.139 0.495 . . . . 71.349999999999994 112.122 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.47 120.19 40.78 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.002 -0.545 . . . . 71.329999999999998 110.098 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 85.9 t -110.56 123.89 66.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 111.897 0.332 . . . . 70.040000000000006 111.897 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.9 t -113.67 128.68 56.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.848 0.356 . . . . 75.019999999999996 111.435 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.91 -150.37 7.56 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.477 -0.868 . . . . 63.100000000000001 113.856 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -129.13 117.25 20.5 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.642 0.377 . . . . 72.530000000000001 111.056 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.507 HG22 HD21 ' A' ' 179' ' ' LEU . 46.3 t -86.79 125.88 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.624 0.249 . . . . 63.32 111.325 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.94 164.82 33.43 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.212 0.53 . . . . 74.340000000000003 112.01 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 CA--C 1.538 0.517 0 CA-C-N 116.046 -0.525 . . . . 74.230000000000004 110.626 178.024 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 109.331 -0.618 . . . . 74.420000000000002 109.331 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.86 148.46 39.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.582 -0.736 . . . . 73.349999999999994 112.28 -168.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.442 ' HB ' HG21 ' A' ' 247' ' ' VAL . 7.8 tt -105.67 107.93 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.277 0.561 . . . . 74.310000000000002 110.881 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.4 t -70.46 104.84 2.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.976 0.417 . . . . 63.240000000000002 110.241 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.447 ' HB ' HD22 ' A' ' 226' ' ' LEU . 33.4 t -80.25 127.56 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.711 0.634 . . . . 75.129999999999995 112.711 -171.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -92.49 -49.16 6.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.89 -0.596 . . . . 74.120000000000005 110.405 174.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -139.23 132.74 30.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.002 -0.545 . . . . 72.519999999999996 110.586 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.1 tt -125.69 133.81 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.951 0.405 . . . . 73.109999999999999 111.222 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -130.6 131.34 6.47 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.21 -0.519 . . . . 70.329999999999998 112.992 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.6 mm -79.43 131.78 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 122.618 -0.342 . . . . 73.209999999999994 111.275 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 240' ' ' ILE . 66.2 mt -83.59 -48.88 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.25 0.548 . . . . 75.530000000000001 110.335 176.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.535 ' HG2' ' HB ' ' A' ' 240' ' ' ILE . 24.2 mm-40 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.168 0.509 . . . . 74.5 110.236 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 121.193 0.521 . . . . 72.349999999999994 111.917 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -85.25 169.27 13.95 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.547 0.689 . . . . 75.120000000000005 112.105 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -101.25 167.75 10.0 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.575 -0.739 . . . . 71.409999999999997 109.389 174.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 220' ' ' GLY . 25.9 mt -76.73 -41.27 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 121.866 -0.521 . . . . 75.25 111.055 175.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.8 t -68.55 -8.1 38.49 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.191 0.52 . . . . 74.430000000000007 111.113 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 175' ' ' LYS . 6.8 tp10 -82.6 -21.37 35.19 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 61.039999999999999 110.672 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.714 HD12 HD11 ' A' ' 187' ' ' ILE . 78.3 mt -73.44 117.67 15.48 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.451 0.643 . . . . 75.140000000000001 112.16 -174.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 22.5 ptp -130.15 157.07 78.23 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.708 -0.678 . . . . 72.420000000000002 110.262 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 182' ' ' ASN . 11.3 Cg_endo -54.4 138.37 73.4 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.06 1.84 . . . . 65.230000000000004 112.39 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 181' ' ' PRO . 2.5 m-20 74.63 11.05 3.97 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.29 0.636 . . . . 70.340000000000003 112.443 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.9 tp -90.94 149.11 22.01 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.305 -0.247 . . . . 75.420000000000002 110.855 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 73.3 p -135.8 118.31 15.85 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.184 -0.323 . . . . 70.200000000000003 110.76 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.75 -177.45 40.2 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.354 -0.927 . . . . 74.510000000000005 113.986 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 38.2 m -114.21 122.64 47.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.659 0.266 . . . . 74.519999999999996 111.535 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.714 HD11 HD12 ' A' ' 179' ' ' LEU . 47.7 pt -115.67 138.18 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.058 0.456 . . . . 73.219999999999999 111.41 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -108.73 103.16 12.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.98 -0.378 . . . . 74.019999999999996 109.98 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.78 176.11 8.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.132 0.492 . . . . 64.409999999999997 111.985 -173.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -96.75 130.76 43.94 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.895 -0.593 . . . . 74.329999999999998 111.669 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.96 102.25 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.918 0.39 . . . . 73.400000000000006 111.265 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.86 -48.32 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.096 0.474 . . . . 61.520000000000003 111.583 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -134.3 122.41 22.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.948 0.404 . . . . 72.420000000000002 112.081 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -97.14 103.16 15.07 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.138 -0.483 . . . . 75.430000000000007 110.863 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.414 ' HB3' ' HD2' ' A' ' 196' ' ' PRO . 88.9 m-85 -79.3 160.0 71.42 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 116.6 -0.273 . . . . 74.109999999999999 111.536 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 195' ' ' TYR . 48.4 Cg_endo -67.69 153.66 75.42 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.296 1.997 . . . . 72.109999999999999 113.017 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -85.72 134.79 33.94 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.436 0.636 . . . . 75.040000000000006 112.058 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -104.92 169.71 8.29 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.692 -0.685 . . . . 75.340000000000003 111.105 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.23 152.9 52.06 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.573 -0.285 . . . . 72.230000000000004 110.602 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 38.4 p90 . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 121.489 0.662 . . . . 75.219999999999999 112.205 179.61 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 120.875 0.369 . . . . 73.329999999999998 111.668 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.0 tp -155.23 110.89 3.09 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.168 0.432 . . . . 74.540000000000006 112.168 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.96 140.51 52.26 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.056 -0.403 . . . . 73.209999999999994 111.447 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 37.7 t -106.8 152.61 23.62 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.946 0.403 . . . . 71.450000000000003 111.449 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.3 mt -136.27 143.76 44.42 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.651 0.38 . . . . 74.319999999999993 110.677 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -97.95 112.67 24.51 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.068 -0.395 . . . . 72.420000000000002 110.835 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 79.6 mt -107.74 135.93 48.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.415 0.286 . . . . 75.430000000000007 111.166 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -132.44 154.81 49.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.604 0.716 . . . . 73.340000000000003 111.923 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -155.45 167.21 31.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.971 -1.013 . . . . 72.120000000000005 109.068 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -60.03 -18.41 46.15 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.069 -0.394 . . . . 64.120000000000005 111.821 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 80.5 p -98.23 18.57 15.98 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.332 0.494 . . . . 72.540000000000006 112.332 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 125.83 -179.0 16.43 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.746 -0.74 . . . . 64.409999999999997 113.764 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 47.8 p -136.85 131.63 33.49 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.535 -0.391 . . . . 72.430000000000007 111.196 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 15.3 tt -138.04 156.73 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.005 0.431 . . . . 74.430000000000007 111.22 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -101.03 116.32 32.57 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.968 0.413 . . . . 75.340000000000003 111.29 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.41 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -83.01 157.62 35.57 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.235 -0.439 . . . . 72.329999999999998 113.521 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.1 m -128.97 114.23 16.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.882 0.372 . . . . 73.140000000000001 111.985 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 258' ' ' VAL . 87.2 mt -99.21 112.13 24.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.235 -0.439 . . . . 75.120000000000005 111.217 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -91.6 157.07 17.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.893 0.378 . . . . 74.540000000000006 111.57 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 63.76 -155.39 0.32 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.325 -0.398 . . . . 75.120000000000005 111.791 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -53.44 -20.12 4.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.964 0.727 . . . . 71.010000000000005 112.964 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 95.6 mt -57.44 -23.5 49.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.29 0.567 . . . . 75.120000000000005 111.276 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.12 -27.97 69.3 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.888 0.375 . . . . 55.310000000000002 111.679 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.48 -0.22 54.85 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.976 0.417 . . . . 72.209999999999994 111.012 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -57.79 135.1 56.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.18 -0.464 . . . . 75.230000000000004 111.87 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.67 118.01 7.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.637 -0.711 . . . . 72.549999999999997 111.979 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.583 ' HA ' HD12 ' A' ' 263' ' ' ILE . 9.7 p -134.53 142.94 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.906 0.384 . . . . 75.450000000000003 111.18 176.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -118.42 151.45 37.76 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.394 -0.366 . . . . 73.239999999999995 111.384 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -75.97 142.21 42.01 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.931 0.396 . . . . 73.200000000000003 111.388 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.77 28.55 73.5 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.124 -0.489 . . . . 75.420000000000002 113.351 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.17 158.1 21.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.784 0.326 . . . . 75.340000000000003 110.958 -178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.518 HG22 HD12 ' A' ' 264' ' ' ILE . 48.0 mm -96.67 117.04 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.214 0.53 . . . . 75.219999999999999 111.209 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -118.38 135.63 54.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.432 0.53 . . . . 74.109999999999999 112.432 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -82.66 103.91 12.52 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.862 -0.608 . . . . 71.439999999999998 109.855 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 72.9 t -113.5 111.84 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 112.219 0.452 . . . . 74.349999999999994 112.219 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 21.3 t -113.33 129.48 56.52 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.349 -0.22 . . . . 63.329999999999998 110.958 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.0 -173.02 37.08 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.388 -0.91 . . . . 71.420000000000002 114.274 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -104.87 119.41 38.94 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.969 0.508 . . . . 74.209999999999994 110.591 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.455 HG22 HD21 ' A' ' 179' ' ' LEU . 30.6 t -85.83 135.46 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.258 0.551 . . . . 70.340000000000003 112.211 -176.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.47 163.93 29.91 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.98 -0.554 . . . . 75.549999999999997 110.794 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 CA--C 1.535 0.374 0 CA-C-O 120.833 0.349 . . . . 74.140000000000001 111.057 175.908 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 120.945 0.402 . . . . 73.409999999999997 111.423 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.5 125.5 49.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.217 -0.447 . . . . 73.230000000000004 111.321 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.41 HG22 ' HA2' ' A' ' 224' ' ' GLY . 7.9 tt -105.51 112.79 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.343 0.592 . . . . 75.439999999999998 111.545 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.5 t -77.49 105.29 8.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.198 -0.455 . . . . 71.5 110.591 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.519 ' HB ' HD22 ' A' ' 226' ' ' LEU . 40.3 t -78.51 135.49 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.245 0.545 . . . . 75.340000000000003 112.459 -172.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -106.79 -43.21 4.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.918 -0.583 . . . . 73.129999999999995 110.818 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.408 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 25.6 t-20 -124.13 132.56 53.65 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.967 -0.561 . . . . 73.200000000000003 110.541 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.6 tt -144.02 123.93 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.219 0.533 . . . . 74.129999999999995 111.436 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -139.15 124.84 2.9 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 121.095 -0.574 . . . . 72.219999999999999 113.165 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 235' ' ' VAL . 46.4 mt -69.24 123.13 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.845 0.355 . . . . 70.310000000000002 111.213 176.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.518 HD12 HG22 ' A' ' 240' ' ' ILE . 68.0 mt -76.43 -43.79 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.248 -0.433 . . . . 73.510000000000005 111.631 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.55 0.691 . . . . 73.239999999999995 111.424 179.786 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 109.851 -0.426 . . . . 73.430000000000007 109.851 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -94.26 146.14 24.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.311 0.577 . . . . 74.129999999999995 112.17 -175.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.89 160.08 16.03 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.904 -0.589 . . . . 75.209999999999994 110.573 169.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 63.6 mt -59.09 -31.86 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.914 0.709 . . . . 74.340000000000003 112.914 -171.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.459 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 70.6 p -62.67 -31.02 71.83 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.946 0.35 . . . . 72.319999999999993 111.946 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -88.33 -19.93 26.04 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 111.816 0.302 . . . . 75.140000000000001 111.816 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.518 HD21 HG22 ' A' ' 247' ' ' VAL . 78.4 mt -56.25 117.37 3.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.5 0.556 . . . . 71.209999999999994 112.5 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 24.1 ptp -114.44 157.42 42.67 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.741 -0.663 . . . . 71.219999999999999 110.465 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.83 142.64 99.14 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.054 1.836 . . . . 73.140000000000001 112.52 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 72.7 14.89 4.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.129 0.572 . . . . 64.209999999999994 112.029 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 40.9 tp -93.28 132.89 37.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.959 0.355 . . . . 72.209999999999994 111.959 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.0 p -110.83 125.56 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.374 -0.204 . . . . 74.010000000000005 111.104 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -178.69 -165.56 33.39 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.628 -0.796 . . . . 73.0 113.848 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.9 m -126.09 140.48 52.55 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.45 0.3 . . . . 54.409999999999997 111.581 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 33.7 pt -127.12 156.78 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.18 0.515 . . . . 70.219999999999999 111.992 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -118.69 112.04 19.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.046 -0.524 . . . . 73.209999999999994 110.648 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -150.87 163.43 38.68 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.445 0.535 . . . . 75.040000000000006 112.445 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -82.44 135.52 35.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 111.494 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.04 100.59 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.929 0.395 . . . . 72.540000000000006 110.743 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.8 -59.04 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.117 0.484 . . . . 73.129999999999995 111.473 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -130.28 143.99 51.11 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.986 -0.552 . . . . 74.230000000000004 111.411 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -126.63 107.01 9.81 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.933 -0.576 . . . . 73.120000000000005 110.849 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.556 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 92.2 m-85 -96.13 135.16 22.84 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.681 -0.236 . . . . 73.430000000000007 111.338 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.46 162.07 0.63 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.222 2.615 . . . . 74.120000000000005 113.899 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -73.4 119.56 17.8 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.059 0.763 . . . . 75.439999999999998 113.059 -173.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -67.81 151.19 47.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.33 -0.85 . . . . 75.340000000000003 111.276 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -115.61 129.61 56.57 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.323 -0.399 . . . . 73.230000000000004 110.693 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.9 p90 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 121.173 0.511 . . . . 74.25 111.654 -178.351 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 120.688 0.28 . . . . 72.519999999999996 110.72 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 225' ' ' THR . 17.6 tp -144.54 125.14 14.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.181 0.438 . . . . 73.420000000000002 112.181 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 195' ' ' TYR . 7.2 ttpm? -112.63 131.92 55.4 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.729 -0.607 . . . . 74.140000000000001 111.111 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 51.2 m -98.86 121.39 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.115 -0.493 . . . . 75.030000000000001 111.686 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 226' ' ' LEU . 80.9 mt -119.8 157.43 28.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.352 -0.385 . . . . 74.549999999999997 111.16 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -128.3 120.81 27.82 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.645 0.26 . . . . 74.530000000000001 110.395 173.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.534 HD13 HG22 ' A' ' 243' ' ' VAL . 66.6 mt -105.2 153.09 22.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.808 0.337 . . . . 74.340000000000003 111.616 -176.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -141.67 152.32 43.81 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.278 0.561 . . . . 73.310000000000002 111.753 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -155.1 168.38 27.22 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.601 -0.727 . . . . 72.319999999999993 109.781 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -61.28 -20.14 62.53 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.928 -0.483 . . . . 74.200000000000003 111.947 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 80.2 p -91.2 -6.22 53.76 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.782 0.66 . . . . 71.319999999999993 112.782 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 150.03 -178.43 27.52 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.669 -0.777 . . . . 75.430000000000007 113.624 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 61.5 p -127.28 143.12 51.3 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.671 -0.311 . . . . 60.439999999999998 111.102 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.1 164.48 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 122.318 -0.239 . . . . 73.310000000000002 111.031 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . 0.666 ' H ' ' HD2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -111.52 137.42 49.37 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.851 -0.53 . . . . 75.209999999999994 110.808 176.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -108.24 131.49 10.62 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.46 -0.4 . . . . 75.109999999999999 113.205 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.462 HG22 HD13 ' A' ' 210' ' ' LEU . 85.4 m -107.21 111.88 24.49 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.693 -0.298 . . . . 74.140000000000001 111.762 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.507 HD22 ' HB ' ' A' ' 258' ' ' VAL . 70.9 mt -99.04 109.48 22.22 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.035 0.383 . . . . 71.140000000000001 112.035 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -93.44 161.86 14.21 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.11 0.481 . . . . 75.099999999999994 112.104 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.443 ' CG ' ' H ' ' A' ' 229' ' ' GLU . 62.9 t30 57.69 -133.93 1.17 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.178 -0.465 . . . . 74.510000000000005 111.615 170.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.443 ' H ' ' CG ' ' A' ' 228' ' ' ASN . 11.4 pt-20 -60.06 -29.02 68.27 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.912 -0.493 . . . . 74.239999999999995 111.76 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.481 ' HB3' HD23 ' A' ' 226' ' ' LEU . 72.1 mt -61.06 -16.98 49.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.92 0.391 . . . . 75.099999999999994 111.231 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.58 88.11 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.663 0.268 . . . . 73.109999999999999 111.178 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -94.28 -15.62 24.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.842 0.353 . . . . 75.549999999999997 110.96 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -47.34 128.07 11.61 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.706 0.402 . . . . 74.329999999999998 111.524 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -70.23 120.23 15.6 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.658 0.614 . . . . 74.120000000000005 112.658 -175.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.25 134.23 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.698 -0.683 . . . . 73.519999999999996 110.053 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 239' ' ' ASP . 58.6 mttm -99.9 150.71 22.11 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.156 0.503 . . . . 74.140000000000001 112.241 -173.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -66.61 108.7 2.54 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.385 -0.37 . . . . 71.400000000000006 110.419 174.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.39 17.17 29.86 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.408 -0.425 . . . . 53.530000000000001 112.798 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 25.2 t0 -90.88 157.0 17.59 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.699 0.285 . . . . 64.099999999999994 111.181 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 42.3 mm -95.18 105.28 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.146 0.498 . . . . 73.439999999999998 110.805 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -113.8 127.07 55.86 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.821 0.675 . . . . 72.409999999999997 112.821 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -86.75 104.17 15.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.228 0.537 . . . . 72.219999999999999 109.827 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 215' ' ' LEU . 89.0 t -102.47 120.24 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.61 0.596 . . . . 70.319999999999993 112.61 -171.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.1 t -113.64 133.14 55.48 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.24 -0.436 . . . . 61.100000000000001 111.176 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.03 -155.78 17.93 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.205 -0.998 . . . . 73.400000000000006 113.983 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 85.8 t80 -116.31 112.12 21.09 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.779 0.432 . . . . 71.25 111.467 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.518 HG22 HD21 ' A' ' 179' ' ' LEU . 48.1 t -83.34 118.18 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 120.965 0.412 . . . . 61.340000000000003 111.177 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 58.8 pttt -135.42 157.17 47.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.228 0.537 . . . . 73.319999999999993 111.437 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 121.046 0.45 . . . . 72.0 111.289 178.65 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 110.252 -0.277 . . . . 73.120000000000005 110.252 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 160.84 25.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.021 0.439 . . . . 74.239999999999995 111.118 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 7.9 tt -120.36 104.43 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.631 0.729 . . . . 72.439999999999998 111.421 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.6 t -68.93 102.52 1.6 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.647 -0.706 . . . . 75.540000000000006 110.296 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.507 ' HB ' HD22 ' A' ' 226' ' ' LEU . 21.7 t -74.43 117.72 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.264 -0.425 . . . . 72.340000000000003 112.122 -173.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -94.97 -21.7 18.44 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.879 0.371 . . . . 71.230000000000004 111.1 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -156.61 120.76 4.4 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.798 0.332 . . . . 73.219999999999999 110.944 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.487 ' HB ' HG12 ' A' ' 258' ' ' VAL . 11.4 tt -125.3 135.37 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.034 0.445 . . . . 73.230000000000004 111.582 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -133.59 125.29 3.92 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.15 -0.548 . . . . 75.420000000000002 112.763 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 49.4 mm -76.02 139.9 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.942 0.401 . . . . 75.340000000000003 110.737 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.521 HG23 ' HG3' ' A' ' 265' ' ' GLU . 48.1 mm -70.37 -46.4 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.776 0.322 . . . . 73.420000000000002 111.717 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.521 ' HG3' HG23 ' A' ' 264' ' ' ILE . 41.1 mt-10 . . . . . 0 N--CA 1.472 0.662 0 CA-C-O 120.741 0.305 . . . . 75.5 111.317 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 121.131 0.491 . . . . 73.329999999999998 111.066 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -106.52 153.93 21.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.298 0.571 . . . . 64.109999999999999 111.603 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -93.21 155.68 17.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.318 -0.623 . . . . 73.239999999999995 109.318 167.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 49.4 mt -61.33 -24.59 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.076 0.465 . . . . 74.019999999999996 111.599 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.44 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 39.2 t -70.75 -12.9 61.83 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.131 0.419 . . . . 74.239999999999995 112.131 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -97.3 -1.94 43.61 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.603 0.594 . . . . 72.420000000000002 112.603 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.51 HD21 HG22 ' A' ' 247' ' ' VAL . 88.4 mt -68.08 150.68 48.11 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.176 0.806 . . . . 75.319999999999993 113.176 -172.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -162.23 156.4 18.51 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.289 -0.869 . . . . 75.120000000000005 110.213 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.62 138.16 83.74 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.307 2.004 . . . . 74.319999999999993 113.295 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.406 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 65.3 m-20 65.42 33.4 8.9 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.161 0.585 . . . . 72.209999999999994 111.562 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 52.8 tp -96.03 145.51 25.39 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.119 -0.491 . . . . 71.230000000000004 111.739 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 75.4 p -120.98 129.36 53.39 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.245 -0.434 . . . . 65.219999999999999 110.693 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.67 179.53 47.87 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.714 -0.755 . . . . 71.540000000000006 113.761 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 77.2 m -121.55 128.14 51.7 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.735 0.302 . . . . 71.450000000000003 111.343 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 34.7 pt -120.5 152.79 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.171 0.51 . . . . 73.439999999999998 111.888 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -114.55 105.88 13.61 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.127 -0.488 . . . . 72.299999999999997 110.243 176.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.07 164.97 25.07 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.862 0.69 . . . . 61.140000000000001 112.862 -173.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.2 136.84 40.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.606 -0.725 . . . . 72.230000000000004 111.44 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.14 102.52 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.912 0.386 . . . . 72.150000000000006 111.519 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.7 t -82.62 -34.1 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.004 0.43 . . . . 72.25 111.872 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -141.17 117.74 10.9 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.757 0.313 . . . . 61.030000000000001 111.31 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -95.35 98.96 10.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.973 0.416 . . . . 63.340000000000003 110.981 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -78.5 143.96 64.75 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.463 -0.335 . . . . 74.430000000000007 111.078 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.12 151.6 83.32 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.775 2.317 . . . . 74.340000000000003 112.863 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 231' ' ' ALA . 20.5 ptmt -67.74 125.24 25.6 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.579 0.585 . . . . 72.409999999999997 112.579 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -94.1 153.16 18.27 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.044 -0.525 . . . . 75.409999999999997 110.94 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.49 143.96 49.37 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.448 -0.342 . . . . 75.409999999999997 110.743 176.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 39.7 p90 . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 121.296 0.569 . . . . 75.109999999999999 111.695 179.513 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 228' ' ' ASN . 37.5 mt-30 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 110.301 -0.259 . . . . 73.230000000000004 110.301 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 48.3 tp -142.48 112.75 7.13 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.766 0.317 . . . . 73.439999999999998 111.64 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 49.3 tttm -126.62 108.09 10.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.704 0.288 . . . . 62.109999999999999 110.834 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 66.9 m -86.27 150.07 24.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.932 0.396 . . . . 63.340000000000003 111.566 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.417 HD22 ' HZ2' ' A' ' 211' ' ' LYS . 91.7 mt -137.24 134.94 36.75 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.422 -0.354 . . . . 75.400000000000006 110.915 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -89.59 106.46 18.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.73 0.3 . . . . 75.25 110.224 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.67 141.96 34.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.503 0.321 . . . . 74.450000000000003 110.999 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -127.96 155.06 44.85 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.593 0.711 . . . . 74.409999999999997 112.443 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -148.24 160.9 42.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.06 -0.973 . . . . 74.150000000000006 109.347 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.18 -21.08 64.79 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.992 0.425 . . . . 75.129999999999995 111.553 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 72.3 p -92.49 -1.27 57.09 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.212 0.449 . . . . 73.420000000000002 112.212 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 148.06 176.75 21.84 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.071 -0.585 . . . . 75.530000000000001 113.612 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.7 p -120.48 158.8 26.46 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.503 -0.41 . . . . 72.329999999999998 111.341 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -157.95 145.28 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.92 0.39 . . . . 74.409999999999997 111.265 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -96.71 112.08 23.98 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.918 0.39 . . . . 71.030000000000001 111.197 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.4 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -81.91 159.08 39.43 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 116.101 -0.5 . . . . 38.810000000000002 113.366 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 84.9 m -129.08 114.63 16.6 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.357 0.503 . . . . 63.100000000000001 112.357 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 92.3 mt -95.6 117.28 30.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.437 -0.347 . . . . 71.420000000000002 110.993 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -99.07 156.35 16.98 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.086 0.47 . . . . 74.310000000000002 111.754 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 209' ' ' GLN . 61.2 t30 61.51 -146.84 0.42 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.968 -0.56 . . . . 72.040000000000006 111.482 174.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.407 ' H ' ' CG ' ' A' ' 228' ' ' ASN . 12.3 pt-20 -64.43 -4.9 4.38 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.661 0.615 . . . . 72.510000000000005 112.661 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 93.1 mt -65.29 -15.63 62.72 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.101 0.477 . . . . 74.400000000000006 110.707 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 197' ' ' LYS . . . -65.88 -23.07 66.57 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.201 -0.454 . . . . 52.329999999999998 111.499 175.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.21 4.09 53.17 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.286 -0.415 . . . . 74.209999999999994 111.557 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -69.3 113.8 6.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.044 0.45 . . . . 74.109999999999999 110.488 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.85 90.61 0.43 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.38 0.61 . . . . 63.240000000000002 111.838 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.0 p -128.44 122.83 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.509 -0.769 . . . . 65.010000000000005 110.794 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -113.63 172.36 7.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.098 0.475 . . . . 74.25 111.428 -175.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -65.4 122.1 16.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.361 -0.381 . . . . 73.239999999999995 110.848 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.14 -26.58 9.71 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.157 -0.544 . . . . 74.420000000000002 113.596 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -65.87 130.81 44.54 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 117.188 0.494 . . . . 64.319999999999993 111.618 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 42.0 mm -77.71 108.36 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.078 -0.51 . . . . 72.219999999999999 110.08 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -113.78 130.12 56.49 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.318 0.58 . . . . 71.230000000000004 112.555 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . 0.53 ' HB2' HD12 ' A' ' 264' ' ' ILE . 40.3 tt0 -92.72 112.7 24.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.905 -0.589 . . . . 73.430000000000007 109.597 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.1 t -115.34 127.04 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.269 0.557 . . . . 74.219999999999999 112.423 -172.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.7 t -124.24 132.9 53.62 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.091 -0.504 . . . . 71.340000000000003 109.79 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.02 -164.9 29.83 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.121 -1.038 . . . . 71.230000000000004 114.196 -177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -106.95 115.36 30.05 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.077 0.465 . . . . 73.219999999999999 111.172 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.51 HG22 HD21 ' A' ' 179' ' ' LEU . 47.5 t -89.09 123.87 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.294 -0.412 . . . . 74.099999999999994 111.052 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.406 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 26.6 pttm -142.37 158.23 43.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.094 0.473 . . . . 75.319999999999993 112.005 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 CA--C 1.541 0.611 0 CA-C-N 116.176 -0.465 . . . . 71.5 111.317 -179.546 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 120.869 0.366 . . . . 74.349999999999994 110.827 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -120.93 161.24 21.91 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.078 0.466 . . . . 63.329999999999998 111.481 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.418 ' HB ' HG21 ' A' ' 247' ' ' VAL . 6.9 tt -128.17 105.14 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.419 0.628 . . . . 72.150000000000006 110.83 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 72.4 m -73.59 106.95 5.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.114 -0.494 . . . . 74.430000000000007 110.049 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.521 HG11 ' HB ' ' A' ' 261' ' ' ILE . 46.5 t -66.6 129.67 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 113.17 0.804 . . . . 62.32 113.17 -171.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.64 -47.18 6.32 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.695 -0.684 . . . . 73.299999999999997 110.267 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -135.74 128.2 30.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.975 -0.557 . . . . 72.519999999999996 110.452 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.521 ' HB ' HG11 ' A' ' 258' ' ' VAL . 10.7 tt -134.25 135.02 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.777 0.322 . . . . 75.310000000000002 111.217 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -144.59 136.89 6.92 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.844 -0.693 . . . . 70.219999999999999 113.362 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.84 106.75 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.87 0.367 . . . . 75.0 110.964 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 242' ' ' GLU . 63.4 mt -66.37 -61.4 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.079 0.466 . . . . 71.049999999999997 111.125 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 CA--C 1.536 0.44 0 CA-C-N 116.031 -0.531 . . . . 75.129999999999995 110.73 179.749 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 186' ' ' THR . 12.3 m120 . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 120.931 0.396 . . . . 72.450000000000003 110.53 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -99.19 156.66 16.85 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.157 0.503 . . . . 53.140000000000001 111.377 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -98.72 168.17 10.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.507 -0.553 . . . . 74.209999999999994 109.507 169.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' A' ' 222' ' ' ILE . 56.8 mt -64.49 -18.5 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.359 0.503 . . . . 74.439999999999998 112.359 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 40.9 t -71.55 -36.46 70.97 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.001 0.371 . . . . 75.450000000000003 112.001 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -79.05 -10.22 59.76 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.511 0.56 . . . . 71.340000000000003 112.511 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.54 HD22 HG22 ' A' ' 247' ' ' VAL . 69.1 mt -62.52 121.73 14.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.315 0.579 . . . . 75.099999999999994 111.998 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.0 ptp -140.88 160.82 57.0 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.69 -0.686 . . . . 71.040000000000006 110.348 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' A' ' 248' ' ' LYS . 18.4 Cg_endo -58.63 133.94 57.6 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.941 1.761 . . . . 74.040000000000006 112.367 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 71.68 29.78 2.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.979 0.512 . . . . 74.239999999999995 111.726 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.62 138.37 40.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.033 0.444 . . . . 75.439999999999998 111.402 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.2 p -116.51 128.37 55.38 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.574 -0.284 . . . . 54.439999999999998 110.537 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.5 178.0 45.93 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.083 -1.055 . . . . 61.530000000000001 114.164 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 61.8 m -113.12 121.84 45.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.393 0.277 . . . . 74.530000000000001 111.627 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.6 pt -102.87 152.77 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.073 0.463 . . . . 74.400000000000006 112.029 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.96 110.98 17.34 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 111.607 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -161.39 167.12 26.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.835 0.35 . . . . 73.150000000000006 111.668 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.471 ' HB3' HD12 ' A' ' 240' ' ' ILE . 12.5 pt-20 -95.63 149.55 21.33 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.052 0.453 . . . . 74.409999999999997 111.493 176.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 23.5 t -81.81 114.17 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.352 0.596 . . . . 75.120000000000005 111.939 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 25.4 t -82.23 -52.39 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.945 -0.57 . . . . 73.209999999999994 111.451 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -127.58 128.65 45.94 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.254 -0.43 . . . . 72.430000000000007 111.388 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -114.45 119.08 35.64 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.26 -0.427 . . . . 54.119999999999997 111.17 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.428 ' O ' ' HG2' ' A' ' 211' ' ' LYS . 25.7 m-85 -89.13 140.15 28.86 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.445 -0.343 . . . . 72.140000000000001 111.337 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.73 172.9 14.31 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.56 2.173 . . . . 70.530000000000001 113.186 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . 0.471 ' HZ1' ' HB3' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -53.85 134.98 42.61 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.482 0.919 . . . . 73.430000000000007 113.482 -177.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -111.4 134.83 52.69 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.165 -0.68 . . . . 74.239999999999995 109.165 166.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.94 134.6 44.9 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.976 0.732 . . . . 74.319999999999993 112.976 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.7 p90 . . . . . 0 CA--C 1.538 0.516 0 CA-C-N 116.111 -0.495 . . . . 73.230000000000004 110.843 172.848 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 121.154 0.502 . . . . 73.099999999999994 111.659 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.7 tp -125.16 145.31 50.02 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.558 -0.746 . . . . 74.239999999999995 110.957 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.43 ' HE2' HD23 ' A' ' 213' ' ' LEU . 1.6 tmtp? -146.97 136.16 22.57 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.174 -0.328 . . . . 75.439999999999998 110.979 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 51.5 m -111.89 153.97 25.88 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.293 0.479 . . . . 75.310000000000002 112.293 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.43 HD23 ' HE2' ' A' ' 211' ' ' LYS . 95.5 mt -136.68 161.82 34.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.919 -0.582 . . . . 74.129999999999995 110.921 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -128.23 120.04 26.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.621 0.248 . . . . 71.540000000000006 110.869 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.581 HD11 HG21 ' A' ' 243' ' ' VAL . 78.8 mt -114.74 142.93 45.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.554 0.342 . . . . 75.510000000000005 110.653 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -134.92 147.94 49.93 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.346 0.593 . . . . 74.439999999999998 111.994 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -152.32 168.58 24.96 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.55 -0.75 . . . . 73.120000000000005 109.864 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -62.33 -25.23 67.77 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.99 0.424 . . . . 71.329999999999998 111.465 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 80.6 p -79.93 -14.75 58.38 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.403 0.52 . . . . 73.129999999999995 112.403 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 154.54 -179.03 30.98 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.939 -0.648 . . . . 75.129999999999995 113.351 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 84.8 p -127.89 125.75 40.22 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.496 -0.414 . . . . 73.329999999999998 110.976 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.413 ' HB ' HG23 ' A' ' 176' ' ' ILE . 10.1 tp -126.82 148.13 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.122 0.487 . . . . 74.519999999999996 111.93 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 73.9 mtm-85 -100.16 138.7 36.87 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.056 0.455 . . . . 74.150000000000006 110.953 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -114.63 152.25 18.16 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.303 -0.475 . . . . 73.439999999999998 113.197 -176.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 59.5 m -124.45 125.55 44.44 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.151 0.426 . . . . 72.519999999999996 112.151 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.534 HD22 ' HB ' ' A' ' 258' ' ' VAL . 83.4 mt -109.92 134.56 51.95 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.017 0.527 . . . . 72.439999999999998 111.246 176.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -114.58 172.13 7.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.926 0.393 . . . . 74.200000000000003 111.094 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 54.1 t30 57.89 -153.6 0.37 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 116.148 -0.478 . . . . 64.010000000000005 111.207 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.98 -27.11 61.15 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.822 -0.549 . . . . 72.230000000000004 112.46 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 73.7 mt -60.59 -18.83 55.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.906 0.384 . . . . 75.310000000000002 111.633 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 211' ' ' LYS . . . -59.47 -44.05 93.12 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.847 0.356 . . . . 64.230000000000004 111.494 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -90.67 13.39 16.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.903 0.334 . . . . 74.200000000000003 111.903 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -55.35 130.02 40.84 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.37 0.268 . . . . 75.340000000000003 110.722 175.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -70.71 77.44 0.61 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.524 0.678 . . . . 74.540000000000006 112.222 -174.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.66 139.75 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.927 -0.579 . . . . 74.099999999999994 110.23 174.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.406 ' HB3' ' NZ ' ' A' ' 236' ' ' LYS . 0.1 OUTLIER -126.75 115.8 19.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.363 0.601 . . . . 73.519999999999996 111.784 -173.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.632 ' HB2' ' HZ1' ' A' ' 237' ' ' LYS . 4.8 ttmp? -42.99 109.24 0.13 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.533 -0.758 . . . . 75.310000000000002 112.894 -172.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.48 4.53 23.38 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.095 -0.502 . . . . 52.450000000000003 113.685 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -86.21 156.67 20.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.148 0.499 . . . . 64.319999999999993 111.872 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.471 HD12 ' HB3' ' A' ' 190' ' ' GLU . 38.1 mm -92.09 103.71 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.267 -0.424 . . . . 74.010000000000005 110.909 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -107.25 119.65 39.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.321 0.489 . . . . 74.430000000000007 112.321 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -87.15 103.49 15.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.24 0.543 . . . . 72.200000000000003 109.77 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.581 HG21 HD11 ' A' ' 215' ' ' LEU . 78.7 t -100.0 124.3 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 112.799 0.666 . . . . 75.519999999999996 112.799 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 42.4 t -118.02 123.53 45.92 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.32 -0.4 . . . . 62.420000000000002 110.781 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 258' ' ' VAL . . . -167.22 -161.48 16.61 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.415 -0.897 . . . . 73.120000000000005 114.202 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -112.9 114.36 26.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.465 0.306 . . . . 74.329999999999998 110.991 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.54 HG22 HD22 ' A' ' 179' ' ' LEU . 25.8 t -90.52 128.14 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.657 0.265 . . . . 71.209999999999994 110.977 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 181' ' ' PRO . 14.6 ptmm? -154.16 170.86 20.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.269 0.557 . . . . 71.219999999999999 112.016 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.882 -0.599 . . . . 74.209999999999994 110.83 178.775 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.54 0.577 0 CA-C-O 120.35 0.119 . . . . 71.25 111.196 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -136.43 170.27 16.31 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.12 0.486 . . . . 74.120000000000005 111.705 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.483 ' HB ' HG21 ' A' ' 247' ' ' VAL . 7.3 tt -116.65 121.7 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.471 0.545 . . . . 74.540000000000006 112.471 -176.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.5 t -85.72 103.79 14.83 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.009 0.433 . . . . 72.430000000000007 109.917 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.534 ' HB ' HD22 ' A' ' 226' ' ' LEU . 27.0 t -74.56 136.49 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 112.544 0.572 . . . . 74.340000000000003 112.544 -171.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -105.13 -39.95 6.04 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.314 -0.403 . . . . 65.349999999999994 110.612 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -134.61 138.68 44.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.156 -0.474 . . . . 64.030000000000001 110.952 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.7 tt -141.45 123.66 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.05 0.452 . . . . 73.439999999999998 111.242 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -128.33 131.51 6.98 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.029 -0.605 . . . . 62.439999999999998 113.375 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.77 116.1 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 O-C-N 122.681 -0.306 . . . . 61.100000000000001 110.369 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 50.6 mt -56.79 -43.29 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.716 0.293 . . . . 74.409999999999997 111.681 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 121.065 0.459 . . . . 74.299999999999997 111.203 175.855 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 120.88 0.372 . . . . 75.200000000000003 111.52 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -131.78 158.17 41.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.077 0.465 . . . . 75.219999999999999 111.299 176.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -90.75 155.6 18.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 110.267 169.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.49 -35.61 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 112.522 0.564 . . . . 72.439999999999998 112.522 -174.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' SER . . . . . 0.527 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 68.2 p -57.96 -41.23 82.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.233 0.457 . . . . 72.120000000000005 112.233 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -73.42 -22.18 60.28 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.274 0.472 . . . . 73.310000000000002 112.274 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.572 HD11 HG21 ' A' ' 187' ' ' ILE . 81.7 mt -55.74 111.7 0.98 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.282 0.563 . . . . 74.340000000000003 112.386 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' MET . . . . . 0.443 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.1 ptp -106.64 157.63 34.67 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.545 -0.752 . . . . 65.25 110.997 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.17 130.6 40.42 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.336 2.024 . . . . 71.549999999999997 113.196 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 70.52 33.68 2.36 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.357 0.663 . . . . 74.120000000000005 111.854 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.443 HD22 ' HG2' ' A' ' 180' ' ' MET . 46.9 tp -102.09 134.41 45.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.216 -0.447 . . . . 63.200000000000003 111.318 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 81.4 p -110.31 118.35 36.09 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.27 -0.269 . . . . 64.329999999999998 111.077 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -173.79 -172.21 38.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.862 -0.685 . . . . 65.5 113.681 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.1 m -114.08 136.7 52.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.712 0.264 . . . . 75.510000000000005 111.712 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.572 HG21 HD11 ' A' ' 179' ' ' LEU . 33.2 pt -125.57 141.31 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.941 0.401 . . . . 75.519999999999996 111.227 175.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -115.21 116.27 28.07 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 73.120000000000005 111.608 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -158.66 178.33 10.23 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.31 -0.405 . . . . 74.409999999999997 111.362 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . 0.51 ' HB3' HD11 ' A' ' 240' ' ' ILE . 12.3 pt-20 -99.79 146.24 26.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.052 0.453 . . . . 74.120000000000005 111.493 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.48 HG21 HG21 ' A' ' 235' ' ' VAL . 58.1 t -76.15 108.73 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.11 -0.496 . . . . 75.510000000000005 111.831 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 216' ' ' LYS . 14.6 t -76.18 -27.62 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.046 0.451 . . . . 74.400000000000006 111.902 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -155.14 130.97 10.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.135 0.493 . . . . 73.340000000000003 112.016 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -113.53 102.65 10.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 63.350000000000001 110.031 174.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -84.33 155.37 63.16 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 111.962 0.356 . . . . 73.319999999999993 111.962 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.21 140.38 94.03 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.662 2.241 . . . . 71.140000000000001 112.787 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -75.41 126.33 30.81 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.521 0.677 . . . . 75.140000000000001 112.654 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.455 ' N ' ' HD2' ' A' ' 198' ' ' LYS . 2.9 mptp? -86.31 169.49 12.92 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.529 -0.759 . . . . 71.420000000000002 111.331 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -138.21 143.81 40.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.111 -0.495 . . . . 75.439999999999998 110.935 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 53.2 p90 . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 121.349 0.595 . . . . 74.219999999999999 112.316 178.461 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 110.439 -0.208 . . . . 75.310000000000002 110.439 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 49.4 tp -153.69 113.72 3.91 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.17 0.433 . . . . 72.340000000000003 112.17 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.416 ' HB3' ' HZ3' ' A' ' 211' ' ' LYS . 6.4 ttpm? -127.04 118.23 24.03 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.669 -0.645 . . . . 72.25 111.734 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.6 p -84.06 147.75 27.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.976 0.417 . . . . 73.409999999999997 111.711 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.402 HD23 ' HE2' ' A' ' 211' ' ' LYS . 97.0 mt -132.41 178.17 7.04 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.05 -0.523 . . . . 72.209999999999994 110.44 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.444 ' CE2' ' HB3' ' A' ' 221' ' ' SER . 21.0 t80 -141.84 138.31 32.08 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.184 -0.323 . . . . 74.140000000000001 110.635 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.477 HD11 HG22 ' A' ' 243' ' ' VAL . 91.2 mt -126.49 151.79 47.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.503 0.321 . . . . 74.239999999999995 111.344 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . 0.742 ' HB2' ' HZ2' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -135.76 149.3 49.12 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.496 0.554 . . . . 74.420000000000002 112.496 -178.655 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -154.68 167.33 30.52 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.486 -0.779 . . . . 71.120000000000005 109.9 174.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.52 -18.57 62.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.209 0.528 . . . . 75.349999999999994 111.601 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 75.0 p -91.05 -0.22 57.68 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.572 0.582 . . . . 61.420000000000002 112.572 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.92 -178.97 19.03 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.866 -0.683 . . . . 75.400000000000006 113.261 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.444 ' HB3' ' CE2' ' A' ' 214' ' ' PHE . 67.9 m -130.83 138.9 50.09 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.583 -0.363 . . . . 74.519999999999996 111.16 177.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 13.4 tt -141.95 153.84 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 120.779 0.323 . . . . 73.120000000000005 111.612 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -92.6 147.39 22.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.08 0.467 . . . . 71.129999999999995 111.745 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -112.96 157.33 15.01 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.286 -0.416 . . . . 72.530000000000001 112.531 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 63.4 m -133.15 116.09 15.85 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.197 0.498 . . . . 64.200000000000003 111.988 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.537 HD22 ' HB ' ' A' ' 258' ' ' VAL . 74.2 mt -98.9 116.27 30.77 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.422 -0.354 . . . . 74.329999999999998 111.608 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -102.22 165.77 10.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.995 0.426 . . . . 75.120000000000005 111.764 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 62.5 t30 58.6 -141.88 0.68 Allowed 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.977 -0.556 . . . . 73.0 111.735 171.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.43 -34.61 75.68 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.912 -0.493 . . . . 75.409999999999997 112.27 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.98 -7.64 30.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.964 0.411 . . . . 74.409999999999997 111.911 -176.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.26 77.65 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 122.133 -0.354 . . . . 73.030000000000001 111.951 177.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -84.74 1.0 48.57 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.947 -0.471 . . . . 75.129999999999995 111.861 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -52.09 116.19 2.08 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.825 0.345 . . . . 75.340000000000003 111.052 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -81.7 121.7 26.71 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.909 -0.587 . . . . 74.219999999999999 111.62 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.48 HG21 HG21 ' A' ' 191' ' ' VAL . 13.1 p -136.12 159.69 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.379 -0.373 . . . . 73.120000000000005 111.339 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.448 ' HZ1' ' HB3' ' A' ' 236' ' ' LYS . 8.8 mtpm? -110.67 163.87 13.31 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.126 0.489 . . . . 72.319999999999993 111.403 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 237' ' ' LYS . 13.2 tmtt? -90.01 123.2 33.7 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.17 -0.468 . . . . 75.099999999999994 110.794 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.99 0.61 56.13 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.241 -0.436 . . . . 61.409999999999997 113.679 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.81 150.2 21.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.934 0.397 . . . . 74.319999999999993 111.772 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 190' ' ' GLU . 32.5 mm -85.31 119.74 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 116.288 -0.415 . . . . 73.439999999999998 111.737 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -130.36 144.92 51.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.725 0.639 . . . . 75.409999999999997 112.725 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -100.5 115.11 29.32 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.841 -0.618 . . . . 75.099999999999994 110.197 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 215' ' ' LEU . 57.5 t -111.02 123.32 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.441 0.534 . . . . 72.430000000000007 112.441 -172.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 67.4 m -107.9 122.21 46.34 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.57 -0.287 . . . . 72.549999999999997 110.821 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -165.9 -164.47 21.46 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.99 -1.1 . . . . 51.439999999999998 114.858 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.403 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 75.4 t80 -122.47 106.01 10.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.123 0.569 . . . . 73.120000000000005 110.938 -177.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.524 HG21 ' HB ' ' A' ' 256' ' ' ILE . 40.6 t -76.57 114.28 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.422 -0.353 . . . . 73.340000000000003 110.998 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 20.8 ptmt -129.63 153.29 48.25 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.473 0.654 . . . . 71.0 112.197 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 N--CA 1.469 0.494 0 CA-C-N 115.906 -0.588 . . . . 73.519999999999996 111.814 -177.113 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.766 0.317 . . . . 75.540000000000006 111.446 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -139.81 162.75 34.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.93 0.395 . . . . 73.239999999999995 111.029 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.524 ' HB ' HG21 ' A' ' 247' ' ' VAL . 9.3 tt -108.97 104.93 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 121.388 0.613 . . . . 75.150000000000006 111.735 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.4 t -64.77 93.81 0.12 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.978 -0.556 . . . . 73.040000000000006 110.154 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.537 ' HB ' HD22 ' A' ' 226' ' ' LEU . 39.9 t -66.77 125.36 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.053 0.454 . . . . 70.409999999999997 112.143 -174.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -96.11 -28.44 14.59 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.167 -0.469 . . . . 74.430000000000007 110.976 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -160.02 141.71 12.79 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.92 -0.582 . . . . 73.420000000000002 110.5 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.4 tt -138.1 138.65 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.246 0.461 . . . . 75.310000000000002 112.246 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -140.83 119.63 1.58 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.36 -0.448 . . . . 60.439999999999998 112.399 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 63.8 mt -74.13 126.79 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 122.467 -0.431 . . . . 74.400000000000006 111.318 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 240' ' ' ILE . 69.0 mt -69.91 -50.18 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.998 0.428 . . . . 75.329999999999998 111.138 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.276 0.56 . . . . 72.310000000000002 112.017 179.312 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 112.561 0.578 . . . . 63.25 112.561 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.17 153.64 50.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.182 -0.463 . . . . 74.519999999999996 111.002 177.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.553 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 32.2 mmtp -82.07 162.92 22.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.364 -0.606 . . . . 74.200000000000003 109.364 170.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 35.6 mm -52.7 -45.36 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.638 0.733 . . . . 71.120000000000005 110.441 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.2 t -57.12 -28.7 62.93 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.34 -0.846 . . . . 72.430000000000007 112.607 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.553 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 15.6 mm-40 -92.98 2.77 56.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.913 0.338 . . . . 73.120000000000005 111.913 -174.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.499 HD21 HG22 ' A' ' 247' ' ' VAL . 90.6 mt -81.93 139.0 34.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.992 0.425 . . . . 75.420000000000002 111.331 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 55.8 mtt -132.78 155.18 81.47 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.39 -0.368 . . . . 74.230000000000004 111.255 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.468 ' HG3' HD23 ' A' ' 254' ' ' LEU . 44.3 Cg_exo -58.08 130.69 39.27 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.33 2.02 . . . . 64.340000000000003 112.454 174.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 70.34 22.55 5.32 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.947 0.499 . . . . 64.129999999999995 111.738 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.9 tt -111.18 131.36 55.17 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.0 0.429 . . . . 74.430000000000007 111.263 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.4 m -93.85 136.61 33.95 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.526 -0.306 . . . . 65.319999999999993 110.964 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.71 -174.47 36.72 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.393 -0.908 . . . . 63.450000000000003 113.954 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 53.1 m -131.65 131.68 43.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.666 0.386 . . . . 75.310000000000002 110.777 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.444 HG21 HD11 ' A' ' 179' ' ' LEU . 33.6 pt -124.53 150.35 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.562 0.696 . . . . 75.439999999999998 112.554 -176.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -112.74 103.38 11.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.768 -0.651 . . . . 75.420000000000002 110.093 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -144.01 168.61 19.58 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.793 0.33 . . . . 63.409999999999997 111.648 -175.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.01 155.85 16.6 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.126 0.488 . . . . 62.5 111.29 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 237' ' ' LYS . 61.1 t -83.83 114.1 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 111.553 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.3 t -77.47 -36.68 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.015 0.436 . . . . 63.329999999999998 111.272 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -154.59 143.14 20.66 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.702 -0.681 . . . . 70.200000000000003 111.533 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -133.34 108.39 8.68 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.42 -0.355 . . . . 72.010000000000005 110.987 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -89.62 147.91 38.91 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.306 0.484 . . . . 72.439999999999998 112.306 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.38 159.85 15.09 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.925 2.416 . . . . 74.209999999999994 113.364 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -65.28 160.5 21.48 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.925 0.713 . . . . 74.109999999999999 112.925 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -141.38 173.28 11.64 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.601 -0.727 . . . . 74.409999999999997 111.73 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -130.34 138.73 50.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.715 -0.675 . . . . 73.430000000000007 110.021 172.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 11.7 p90 . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 121.399 0.619 . . . . 75.230000000000004 111.695 -177.932 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 121.036 0.446 . . . . 74.420000000000002 111.246 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 45.2 tp -142.17 140.24 32.33 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.331 -0.395 . . . . 75.310000000000002 111.464 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.512 ' HD3' HD11 ' A' ' 226' ' ' LEU . 60.8 tttp -140.67 128.67 22.02 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.752 0.31 . . . . 75.450000000000003 110.745 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.6 t -96.55 134.18 40.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.189 0.518 . . . . 74.25 111.94 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.453 HD13 HD12 ' A' ' 226' ' ' LEU . 95.0 mt -130.83 174.31 10.09 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.919 -0.582 . . . . 74.200000000000003 111.02 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -148.86 121.46 8.58 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.239 -0.437 . . . . 72.219999999999999 110.013 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.8 mt -113.81 161.64 17.31 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.354 0.262 . . . . 61.409999999999997 110.991 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -159.17 154.19 25.04 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.27 0.841 . . . . 72.430000000000007 113.27 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -125.51 -175.48 3.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.448 -1.251 . . . . 75.150000000000006 108.973 163.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.07 -18.06 61.96 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.16 0.505 . . . . 74.329999999999998 110.796 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 77.6 p -81.83 -18.74 42.87 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.045 -0.525 . . . . 75.120000000000005 112.275 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 159.0 178.75 33.3 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.888 -0.672 . . . . 64.129999999999995 113.282 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 50.0 m -115.91 161.87 18.17 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.887 0.375 . . . . 71.430000000000007 111.651 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.6 tp -150.53 149.09 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 120.974 0.416 . . . . 64.140000000000001 111.363 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -89.7 122.77 33.12 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.293 -0.254 . . . . 72.340000000000003 110.934 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.5 120.3 6.83 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.89 -0.671 . . . . 64.310000000000002 112.901 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 62.3 m -111.51 118.94 37.14 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 122.126 -0.632 . . . . 75.140000000000001 111.845 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.512 HD11 ' HD3' ' A' ' 211' ' ' LYS . 94.0 mt -98.09 124.78 42.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.812 0.339 . . . . 75.200000000000003 111.286 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -107.17 150.82 26.19 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.775 0.321 . . . . 73.400000000000006 111.745 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 59.9 t30 56.75 -132.57 1.47 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 116.428 -0.351 . . . . 74.319999999999993 111.824 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.23 -14.16 46.16 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.666 0.617 . . . . 74.299999999999997 112.666 -174.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.49 ' HB3' HD23 ' A' ' 226' ' ' LEU . 86.9 mt -70.8 -18.49 62.74 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.938 -0.476 . . . . 75.010000000000005 111.142 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.16 78.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.741 0.645 . . . . 74.319999999999993 112.741 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -78.15 -3.9 44.82 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.072 0.397 . . . . 74.430000000000007 112.072 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.09 113.94 10.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.928 0.394 . . . . 71.400000000000006 110.766 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -75.83 105.06 6.66 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.198 0.523 . . . . 74.200000000000003 111.827 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.9 p -129.03 126.81 65.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.499 -0.773 . . . . 71.5 110.252 174.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -131.04 172.22 12.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.137 0.494 . . . . 74.329999999999998 111.9 -174.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.526 ' HA ' ' HB ' ' A' ' 191' ' ' VAL . 55.4 tttp -61.81 128.31 35.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.084 0.469 . . . . 74.439999999999998 111.423 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.65 -17.22 30.78 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.252 -0.431 . . . . 65.5 113.016 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -88.73 112.71 23.48 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.968 0.414 . . . . 73.409999999999997 110.79 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 51.6 mm -77.29 103.73 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-O 120.995 0.426 . . . . 75.439999999999998 110.933 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.63 ' HB3' HD12 ' A' ' 263' ' ' ILE . . . -110.67 140.9 44.61 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.536 0.569 . . . . 73.340000000000003 112.536 -175.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.1 106.39 18.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.095 0.474 . . . . 75.319999999999993 109.872 171.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.49 HG21 HG13 ' A' ' 261' ' ' ILE . 59.2 t -106.94 117.73 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.371 0.508 . . . . 72.420000000000002 112.371 -171.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 260' ' ' ASN . 82.4 p -106.9 133.52 51.42 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.411 -0.359 . . . . 62.119999999999997 110.557 173.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.6 -171.46 35.99 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.382 -0.913 . . . . 40.210000000000001 113.966 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -103.16 110.11 21.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.64 0.376 . . . . 75.310000000000002 110.877 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 HD21 ' A' ' 179' ' ' LEU . 50.6 t -81.03 122.18 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.874 0.368 . . . . 64.319999999999993 110.819 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -135.28 169.6 17.21 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.975 0.417 . . . . 73.400000000000006 111.328 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 120.887 0.375 . . . . 75.340000000000003 110.791 176.556 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.468 HD23 ' HG3' ' A' ' 181' ' ' PRO . 90.5 mt . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.38 0.609 . . . . 75.430000000000007 112.381 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.63 159.8 41.4 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.634 -0.712 . . . . 74.209999999999994 110.146 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 9.7 tt -118.65 109.04 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.403 0.621 . . . . 63.020000000000003 111.265 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 74.8 m -76.21 106.56 7.89 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.68 -0.489 . . . . 71.450000000000003 109.68 175.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.403 HG11 ' HB ' ' A' ' 261' ' ' ILE . 55.1 t -68.23 137.08 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.048 0.759 . . . . 71.439999999999998 113.048 -170.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -104.73 -37.15 7.18 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.753 -0.658 . . . . 75.209999999999994 110.528 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . 0.417 ' HB3' ' OG ' ' A' ' 244' ' ' SER . 64.0 t30 -149.76 118.43 6.58 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.163 -0.471 . . . . 73.409999999999997 110.849 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.49 HG13 HG21 ' A' ' 243' ' ' VAL . 9.7 tt -123.22 121.23 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.511 0.672 . . . . 75.120000000000005 111.669 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -132.56 125.76 4.28 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.1 -0.571 . . . . 72.209999999999994 113.136 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.63 HD12 ' HB3' ' A' ' 241' ' ' ALA . 32.6 mm -70.06 113.71 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.595 -0.356 . . . . 70.400000000000006 110.535 176.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.04 -66.47 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.963 0.411 . . . . 71.329999999999998 111.366 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 120.849 0.357 . . . . 71.140000000000001 111.004 178.738 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 186' ' ' THR . 23.8 p-10 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 121.283 0.563 . . . . 55.420000000000002 111.702 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -108.11 161.97 14.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.105 0.479 . . . . 75.319999999999993 112.138 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -75.88 151.03 37.47 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.264 -0.643 . . . . 73.530000000000001 109.264 163.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ILE . . . . . 0.408 HD13 HG23 ' A' ' 222' ' ' ILE . 28.4 mt -58.26 -39.03 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 121.832 -0.543 . . . . 74.219999999999999 111.835 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.0 t -73.81 -20.03 60.58 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.069 0.461 . . . . 72.400000000000006 111.379 175.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -78.94 -19.53 51.51 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.206 0.527 . . . . 71.5 110.711 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 187' ' ' ILE . 95.1 mt -67.12 146.78 53.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.135 0.493 . . . . 74.329999999999998 111.608 177.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.7 ptp -146.67 152.75 45.77 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.205 -0.452 . . . . 70.319999999999993 110.949 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 51.3 Cg_exo -54.63 147.63 48.2 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.983 2.455 . . . . 74.010000000000005 113.655 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.46 29.1 13.47 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.018 -0.537 . . . . 74.329999999999998 112.352 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.9 tt -133.61 136.75 45.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.343 -0.39 . . . . 73.439999999999998 110.886 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.0 p -97.88 133.92 41.72 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.768 0.318 . . . . 72.150000000000006 111.291 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.2 174.55 34.75 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.659 -0.781 . . . . 73.329999999999998 113.743 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 44.2 m -122.56 138.48 54.56 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.508 0.323 . . . . 71.510000000000005 110.345 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 179' ' ' LEU . 32.9 pt -134.73 146.12 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.262 0.553 . . . . 73.409999999999997 111.909 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -109.87 103.76 12.59 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.821 -0.437 . . . . 73.120000000000005 109.821 171.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.6 168.19 18.7 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.302 0.573 . . . . 71.109999999999999 112.187 -173.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -82.75 126.73 32.72 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.552 -0.749 . . . . 73.319999999999993 111.024 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' VAL . . . . . 0.512 HG21 HG21 ' A' ' 235' ' ' VAL . 61.8 t -76.57 95.35 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.204 0.526 . . . . 71.549999999999997 110.195 174.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.477 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 13.7 t -75.76 -35.13 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.963 -0.562 . . . . 64.109999999999999 111.548 -176.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.06 113.4 5.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.743 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.85 103.97 15.61 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.207 -0.451 . . . . 71.340000000000003 110.479 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -79.31 147.55 68.92 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.23 -0.441 . . . . 75.239999999999995 111.776 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.83 155.01 40.19 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.596 2.197 . . . . 74.400000000000006 112.687 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -72.94 156.05 39.24 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.396 0.617 . . . . 75.239999999999995 112.563 -173.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 210' ' ' LEU . 68.6 mttm -122.92 159.13 28.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.721 -0.672 . . . . 74.420000000000002 109.866 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -141.7 132.16 25.27 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.097 0.475 . . . . 70.140000000000001 111.408 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.0 p90 . . . . . 0 CA--C 1.54 0.594 0 CA-C-N 116.089 -0.505 . . . . 73.099999999999994 111.372 -176.163 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLN . . . . . 0.406 ' HB2' ' HA ' ' A' ' 228' ' ' ASN . 47.8 mt-30 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 120.705 0.288 . . . . 74.230000000000004 110.655 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 198' ' ' LYS . 56.8 tp -125.78 145.91 50.01 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.662 0.385 . . . . 75.209999999999994 111.571 -174.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 22.3 tptm -150.59 121.92 7.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.45 -0.341 . . . . 75.030000000000001 110.939 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 47.2 t -101.45 144.03 30.74 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.993 0.425 . . . . 74.409999999999997 111.821 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 97.3 mt -136.34 134.58 38.05 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.153 -0.476 . . . . 74.209999999999994 111.119 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -103.83 109.93 21.85 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.141 -0.349 . . . . 74.230000000000004 110.731 174.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.517 HD11 HG21 ' A' ' 243' ' ' VAL . 67.0 mt -107.55 145.09 33.65 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.346 -0.388 . . . . 74.219999999999999 110.674 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -137.52 150.46 47.54 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.539 0.685 . . . . 71.430000000000007 112.04 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -139.28 170.59 15.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.85 -1.068 . . . . 73.439999999999998 109.69 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -52.48 -41.24 63.2 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.792 0.33 . . . . 73.25 111.846 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 81.5 p -83.83 -6.26 59.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.487 0.921 . . . . 73.209999999999994 113.487 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 148.97 -179.8 25.49 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.721 -0.752 . . . . 70.299999999999997 113.149 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 84.9 p -121.83 159.4 26.84 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 122.258 -0.554 . . . . 74.329999999999998 111.893 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . 0.408 HG23 HD13 ' A' ' 176' ' ' ILE . 14.6 tt -151.8 150.33 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.073 0.463 . . . . 72.329999999999998 110.861 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 32.0 mtm-85 -100.93 123.27 44.87 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.021 0.439 . . . . 75.540000000000006 111.855 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -97.26 161.7 21.58 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 116.033 -0.531 . . . . 70.340000000000003 113.233 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 94.5 m -136.5 121.76 19.22 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.269 0.47 . . . . 74.049999999999997 112.269 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 92.3 mt -105.49 137.19 43.73 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.958 -0.565 . . . . 74.409999999999997 110.905 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -115.79 150.35 37.07 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.759 0.314 . . . . 74.230000000000004 111.656 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ASN . . . . . 0.41 ' HB3' ' OE2' ' A' ' 229' ' ' GLU . 65.4 t30 53.0 -128.3 2.42 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.552 0.575 . . . . 75.310000000000002 112.552 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' GLU . . . . . 0.41 ' OE2' ' HB3' ' A' ' 228' ' ' ASN . 0.9 OUTLIER -55.83 -16.69 4.84 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.276 0.843 . . . . 75.530000000000001 113.276 -175.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.42 ' HB3' HD23 ' A' ' 226' ' ' LEU . 91.7 mt -88.16 -17.75 30.25 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.956 0.407 . . . . 71.530000000000001 111.653 176.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.07 98.16 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.67 0.618 . . . . 74.549999999999997 112.67 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -77.7 3.2 14.6 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.668 0.618 . . . . 73.019999999999996 112.668 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -52.65 121.21 6.73 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.838 0.351 . . . . 73.200000000000003 111.74 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.6 116.31 22.54 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.241 -0.436 . . . . 73.430000000000007 111.549 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.512 HG21 HG21 ' A' ' 191' ' ' VAL . 7.9 p -142.57 142.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 116.091 -0.504 . . . . 65.430000000000007 110.382 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -95.55 160.42 14.52 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.04 0.448 . . . . 75.0 111.334 -176.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 192' ' ' VAL . 40.4 ttmt -67.91 93.91 0.44 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.982 0.42 . . . . 73.319999999999993 110.939 174.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 136.11 -21.71 3.48 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.092 -0.575 . . . . 54.32 113.683 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -57.77 137.12 56.88 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.216 0.532 . . . . 74.040000000000006 111.941 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.523 HG22 HD12 ' A' ' 264' ' ' ILE . 32.7 mm -84.85 103.17 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.18 -0.464 . . . . 75.510000000000005 110.03 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -103.07 136.01 43.68 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.886 0.698 . . . . 74.439999999999998 112.886 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.8 98.8 7.2 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.582 -0.736 . . . . 75.219999999999999 110.088 171.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.517 HG21 HD11 ' A' ' 215' ' ' LEU . 57.9 t -105.69 115.97 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.054 0.454 . . . . 71.140000000000001 111.793 -177.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 84.0 p -116.43 136.08 53.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.013 -0.539 . . . . 63.240000000000002 110.418 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -178.91 -166.84 35.58 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.13 -1.033 . . . . 62.329999999999998 114.839 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -106.74 122.07 45.64 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.085 0.554 . . . . 72.439999999999998 110.917 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 56.7 t -86.0 125.79 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.364 0.602 . . . . 73.209999999999994 112.364 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -121.16 169.23 10.74 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.624 -0.716 . . . . 74.329999999999998 110.348 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLN . . . . . 0.518 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 24.8 tt0 . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 120.704 0.288 . . . . 71.409999999999997 110.731 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 112.644 0.609 . . . . 72.200000000000003 112.644 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.44 125.07 39.9 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.618 -0.719 . . . . 74.209999999999994 109.357 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ILE . . . . . 0.459 HG22 ' HA2' ' A' ' 224' ' ' GLY . 10.1 tt -113.83 121.21 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.488 0.661 . . . . 72.439999999999998 112.592 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 18.0 m -82.94 111.71 19.07 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.803 -0.635 . . . . 53.219999999999999 110.024 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . 0.526 ' HB ' HD22 ' A' ' 226' ' ' LEU . 44.7 t -76.99 128.72 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.366 0.603 . . . . 74.120000000000005 112.542 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.8 -44.52 14.28 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.597 -0.729 . . . . 73.040000000000006 110.537 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -152.07 143.18 23.19 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.287 -0.415 . . . . 74.140000000000001 111.21 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 6.2 tt -134.52 134.1 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.285 -0.416 . . . . 75.129999999999995 111.412 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.23 139.01 6.9 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.204 -0.522 . . . . 61.030000000000001 112.146 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.9 mt -69.16 131.96 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 117.333 0.566 . . . . 75.040000000000006 110.642 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 240' ' ' ILE . 60.9 mt -70.31 -46.32 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.287 0.477 . . . . 64.439999999999998 112.287 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.961 0.41 . . . . 74.519999999999996 111.205 -178.755 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 13.0 ptt? . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.151 0.5 . . . . 74.420000000000002 111.569 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -79.8 117.46 20.7 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.424 -0.353 . . . . 75.099999999999994 110.365 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -87.16 152.41 22.36 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.484 0.659 . . . . 74.420000000000002 112.261 -174.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.468 ' HG2' ' OE1' ' A' ' 178' ' ' GLU . 27.5 mmtm -100.77 164.47 11.84 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.58 -0.896 . . . . 74.329999999999998 108.58 168.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 54.2 mt -58.31 -31.11 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 O-C-N 122.059 -0.401 . . . . 73.209999999999994 111.816 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 48.4 t -71.89 -24.14 61.61 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.147 0.425 . . . . 73.319999999999993 112.147 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.468 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 45.2 mt-10 -81.63 -5.95 58.54 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.126 -0.359 . . . . 70.430000000000007 111.824 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.492 HD21 HG22 ' A' ' 247' ' ' VAL . 82.6 mt -75.86 125.58 29.36 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.293 0.568 . . . . 72.430000000000007 111.882 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.514 ' HG2' HD22 ' A' ' 183' ' ' LEU . 22.6 ptp -124.12 159.03 58.62 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 115.859 -0.61 . . . . 74.219999999999999 110.3 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 248' ' ' LYS . 14.8 Cg_endo -57.37 133.18 55.49 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.963 1.775 . . . . 75.019999999999996 112.904 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.428 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 76.4 m-20 69.57 29.89 4.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.397 0.679 . . . . 74.409999999999997 111.8 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.514 HD22 ' HG2' ' A' ' 180' ' ' MET . 27.0 tp -106.13 118.26 36.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.124 -0.489 . . . . 75.439999999999998 111.578 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.5 t -92.63 108.98 20.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.779 0.323 . . . . 73.420000000000002 110.201 173.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -153.29 172.56 32.19 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.585 -0.817 . . . . 73.140000000000001 113.911 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 244' ' ' SER . 34.8 m -114.17 129.77 56.62 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.78 0.324 . . . . 73.120000000000005 111.726 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.461 HD13 HD11 ' A' ' 179' ' ' LEU . 37.3 pt -122.16 163.68 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.301 0.572 . . . . 72.430000000000007 112.298 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -121.76 118.52 29.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.948 -0.569 . . . . 61.420000000000002 110.264 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -151.33 171.73 17.01 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.527 0.566 . . . . 73.049999999999997 112.527 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -96.01 141.66 29.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.066 -0.515 . . . . 64.230000000000004 111.589 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.9 t -78.95 103.49 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.972 0.415 . . . . 74.129999999999995 111.136 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' A' ' 216' ' ' LYS . 21.5 t -81.36 -28.61 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.0 0.429 . . . . 73.310000000000002 111.728 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -151.33 136.42 17.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.978 0.418 . . . . 71.329999999999998 111.572 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -124.05 114.36 19.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.885 -0.598 . . . . 71.099999999999994 110.818 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 212' ' ' SER . 94.9 m-85 -109.37 148.69 38.55 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 120.655 0.264 . . . . 75.129999999999995 111.632 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.41 156.65 16.79 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.984 2.456 . . . . 71.019999999999996 113.841 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -73.44 169.23 17.62 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.53 0.681 . . . . 72.340000000000003 111.989 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -138.65 149.47 45.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.455 -0.793 . . . . 72.239999999999995 109.361 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 209' ' ' GLN . 44.0 mt-10 -130.82 112.6 13.18 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.912 -0.492 . . . . 73.25 112.248 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -127.72 -178.73 4.6 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.261 0.553 . . . . 73.540000000000006 111.421 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 69.6 m -111.19 126.58 55.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.384 -0.371 . . . . 72.409999999999997 111.008 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.56 151.27 41.94 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.668 -0.242 . . . . 75.200000000000003 110.559 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -53.34 -29.56 34.62 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.174 0.511 . . . . 75.420000000000002 111.516 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.72 -4.85 48.34 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.99 -0.55 . . . . 61.149999999999999 112.281 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 107.63 -37.66 3.71 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.198 -0.525 . . . . 63.340000000000003 113.62 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 43.8 p -68.68 145.99 53.39 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.993 0.425 . . . . 75.510000000000005 111.992 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -71.92 145.67 48.32 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.173 0.511 . . . . 70.099999999999994 112.125 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -143.93 136.7 6.99 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 116.245 -0.434 . . . . 71.209999999999994 112.689 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.482 ' HG2' ' HG2' ' A' ' 199' ' ' GLU . 24.6 mt-30 -102.53 161.24 13.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.943 0.401 . . . . 73.400000000000006 111.591 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 32.8 tp -145.17 126.4 14.77 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.059 -0.519 . . . . 74.530000000000001 111.39 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 84.7 tttt -126.87 135.08 50.49 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.948 0.404 . . . . 75.409999999999997 111.194 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 5.0 m -98.24 128.37 44.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.016 -0.538 . . . . 61.399999999999999 111.81 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.407 HD13 HG11 ' A' ' 235' ' ' VAL . 93.8 mt -137.1 163.72 30.13 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.085 0.469 . . . . 64.310000000000002 112.115 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -135.15 129.91 34.57 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.257 -0.429 . . . . 70.230000000000004 110.367 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.7 mt -120.7 148.59 43.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.256 0.222 . . . . 74.030000000000001 111.376 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.404 ' HB3' HG21 ' A' ' 192' ' ' VAL . 21.4 pttm -136.86 151.97 49.71 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.401 0.62 . . . . 75.140000000000001 112.095 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -148.78 165.59 30.97 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.304 -0.862 . . . . 74.340000000000003 109.848 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -57.26 -30.65 64.83 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 111.942 0.349 . . . . 70.150000000000006 111.942 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 63.0 p -84.07 -11.49 56.62 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.584 0.587 . . . . 62.130000000000003 112.584 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 152.25 179.77 28.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.936 -0.65 . . . . 74.319999999999993 113.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.4 p -124.2 155.42 38.57 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 122.554 -0.38 . . . . 62.229999999999997 111.498 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -147.05 156.75 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.979 0.418 . . . . 75.340000000000003 111.716 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.501 ' HD2' ' N ' ' A' ' 223' ' ' ARG . 8.3 mpt_? -95.08 123.97 38.87 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.69 0.281 . . . . 75.239999999999995 110.733 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.43 152.85 20.53 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.26 -0.495 . . . . 74.310000000000002 113.617 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 70.2 m -144.4 115.45 7.89 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.091 0.404 . . . . 74.540000000000006 112.091 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 88.8 mt -98.6 137.48 37.18 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.453 -0.34 . . . . 73.450000000000003 111.307 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -114.62 151.02 34.2 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.14 0.495 . . . . 74.510000000000005 112.233 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 64.2 t30 52.93 -134.24 1.7 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.828 -0.624 . . . . 64.120000000000005 111.856 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.42 -26.15 52.57 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.595 0.591 . . . . 74.329999999999998 112.595 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.42 -27.19 69.13 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.036 0.446 . . . . 75.109999999999999 111.225 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 211' ' ' LYS . . . -67.38 -14.24 62.74 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.115 0.413 . . . . 73.230000000000004 112.115 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -92.03 -12.98 31.69 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.992 0.425 . . . . 70.549999999999997 110.974 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -61.87 134.32 56.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.988 0.423 . . . . 73.329999999999998 111.605 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.92 118.24 15.62 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.009 0.433 . . . . 75.430000000000007 111.436 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.407 HG11 HD13 ' A' ' 213' ' ' LEU . 4.2 p -139.07 117.51 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.137 0.494 . . . . 74.129999999999995 110.492 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -106.99 152.09 24.45 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.119 0.485 . . . . 75.430000000000007 111.885 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -70.15 117.85 12.24 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.187 -0.46 . . . . 72.409999999999997 111.478 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.57 -13.18 32.89 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.478 -0.391 . . . . 75.25 113.097 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.56 145.82 36.65 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.055 0.455 . . . . 72.219999999999999 111.93 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.558 HG22 HD13 ' A' ' 264' ' ' ILE . 38.9 mm -87.71 118.57 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.037 -0.529 . . . . 73.409999999999997 110.566 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -128.59 145.55 51.1 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.653 0.612 . . . . 71.209999999999994 112.653 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -103.92 110.42 22.56 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.916 -0.584 . . . . 64.109999999999999 109.927 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.6 t -108.62 115.29 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.733 0.642 . . . . 73.430000000000007 112.733 -171.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.545 ' HA ' ' HA ' ' A' ' 186' ' ' THR . 35.8 t -95.72 122.41 38.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.039 -0.528 . . . . 73.439999999999998 110.124 173.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -158.5 167.11 34.51 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.235 -0.983 . . . . 62.439999999999998 114.529 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -92.89 104.54 16.77 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.128 0.571 . . . . 74.230000000000004 110.596 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.492 HG22 HD21 ' A' ' 179' ' ' LEU . 44.6 t -86.02 138.86 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.675 0.274 . . . . 73.140000000000001 111.438 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 181' ' ' PRO . 10.6 ptmm? -151.06 176.35 11.23 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.066 0.46 . . . . 73.430000000000007 111.821 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.482 ' HA ' HD21 ' A' ' 254' ' ' LEU . 23.5 tt0 -100.36 129.73 46.37 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.947 -0.569 . . . . 70.450000000000003 111.144 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 163.29 -75.77 0.17 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.808 -0.711 . . . . 72.430000000000007 113.409 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.618 ' HB3' ' HB3' ' A' ' 255' ' ' GLU . 57.9 t80 -75.74 122.77 24.52 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.63 -0.335 . . . . 74.510000000000005 110.891 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.3 t 55.16 28.96 11.79 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.236 0.541 . . . . 63.310000000000002 111.511 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 91.72 -66.04 2.3 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.248 -0.501 . . . . 53.299999999999997 112.264 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.482 HD21 ' HA ' ' A' ' 249' ' ' GLN . 92.3 mt -134.36 116.5 15.29 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.873 0.469 . . . . 72.140000000000001 110.406 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.618 ' HB3' ' HB3' ' A' ' 251' ' ' TYR . 2.5 pm0 -109.66 143.12 39.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.985 0.421 . . . . 75.129999999999995 111.482 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.6 tt -108.72 104.35 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.339 0.59 . . . . 73.450000000000003 111.202 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.9 t -77.44 98.92 5.45 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.123 -0.49 . . . . 53.119999999999997 110.409 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.86 131.26 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.929 0.714 . . . . 75.099999999999994 112.929 -171.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -99.64 -44.6 6.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.567 -0.742 . . . . 75.420000000000002 110.357 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.47 ' HB2' ' HB3' ' A' ' 244' ' ' SER . 21.7 m-80 -135.93 137.13 41.05 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.344 -0.389 . . . . 73.299999999999997 110.536 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.4 tt -137.75 136.19 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.841 0.353 . . . . 74.0 111.571 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.06 140.52 7.93 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.197 -0.525 . . . . 64.129999999999995 113.163 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.604 ' HB ' ' HG2' ' A' ' 266' ' ' LYS . 47.2 mm -85.54 115.07 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.062 0.458 . . . . 75.519999999999996 110.853 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.558 HD13 HG22 ' A' ' 240' ' ' ILE . 63.0 mt -59.41 -35.95 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.476 0.547 . . . . 72.030000000000001 112.476 -174.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.13 0.18 22.6 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.396 0.888 . . . . 75.530000000000001 113.396 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.604 ' HG2' ' HB ' ' A' ' 263' ' ' ILE . 69.8 mmtt -69.26 157.02 37.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.0 0.741 . . . . 72.349999999999994 113.0 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 88.9 p -158.37 179.31 9.26 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.272 -0.876 . . . . 73.329999999999998 110.356 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 2.5 pp -153.09 -176.96 6.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.907 0.336 . . . . 73.340000000000003 111.907 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.536 -0.745 . . . . 72.219999999999999 111.826 179.255 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 11.9 tpt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.873 0.368 . . . . 75.230000000000004 111.665 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -82.3 121.87 27.22 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.027 0.441 . . . . 75.140000000000001 110.164 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -83.38 141.05 32.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.187 0.518 . . . . 75.040000000000006 111.942 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 175' ' ' LYS . 12.1 mptt -96.54 155.79 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.61 . . . . 75.049999999999997 109.545 173.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.417 HD13 HG23 ' A' ' 222' ' ' ILE . 55.9 mt -59.15 -33.09 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.064 0.394 . . . . 75.239999999999995 112.064 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 56.2 p -70.79 -15.45 62.67 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.073 0.398 . . . . 64.400000000000006 112.073 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -104.55 -5.97 21.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.975 0.417 . . . . 55.340000000000003 111.594 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.518 HD22 HG22 ' A' ' 247' ' ' VAL . 81.6 mt -71.49 148.36 46.87 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.184 0.516 . . . . 74.319999999999993 111.987 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.5 ptp -148.18 153.27 41.07 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.945 -0.571 . . . . 74.219999999999999 110.801 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.29 128.05 24.18 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.905 2.403 . . . . 74.010000000000005 114.358 -177.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.42 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 2.1 m-20 66.04 50.77 1.4 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.594 0.711 . . . . 72.329999999999998 112.156 173.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.7 tt -131.46 134.03 45.77 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.514 -0.766 . . . . 74.439999999999998 110.355 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 89.8 p -100.5 148.13 25.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.129 0.49 . . . . 64.510000000000005 111.508 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.67 -169.77 41.39 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.088 -0.577 . . . . 75.349999999999994 113.152 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 94.6 m -118.41 124.77 48.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.843 0.354 . . . . 75.230000000000004 111.712 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 37.2 pt -109.02 154.17 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.068 -0.515 . . . . 75.239999999999995 110.285 173.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -135.4 108.51 7.69 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.042 -0.411 . . . . 75.040000000000006 110.872 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.29 172.15 13.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.065 0.46 . . . . 64.25 112.099 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.425 ' CD ' ' HZ3' ' A' ' 237' ' ' LYS . 4.0 tm-20 -93.61 139.04 31.24 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.911 -0.586 . . . . 72.099999999999994 110.635 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.467 ' HA ' HD22 ' A' ' 215' ' ' LEU . 38.2 t -79.16 100.98 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.308 0.484 . . . . 54.219999999999999 112.308 -174.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.458 ' CG2' ' HG2' ' A' ' 216' ' ' LYS . 48.6 t -59.62 -52.56 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.941 0.401 . . . . 74.310000000000002 111.723 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -132.71 124.66 28.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.189 -0.46 . . . . 71.420000000000002 111.27 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -106.16 102.82 12.21 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.925 0.393 . . . . 74.420000000000002 111.351 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -81.99 155.93 69.91 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.187 0.439 . . . . 75.340000000000003 112.187 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.96 175.84 10.79 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.61 2.207 . . . . 73.5 112.188 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.549 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 64.1 pttt -93.76 124.06 37.51 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.517 0.675 . . . . 71.420000000000002 112.754 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -87.42 146.13 25.99 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.307 -0.86 . . . . 74.439999999999998 110.818 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -99.16 136.79 38.61 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.87 0.367 . . . . 75.239999999999995 111.685 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.26 177.21 11.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.992 0.425 . . . . 71.439999999999998 111.153 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 55.7 m -111.4 140.25 46.14 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.057 0.456 . . . . 72.109999999999999 111.67 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -83.79 148.09 27.22 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.878 -0.601 . . . . 75.319999999999993 111.862 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -60.61 -28.85 68.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.276 0.56 . . . . 74.019999999999996 110.412 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.71 -19.9 66.03 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.357 -0.838 . . . . 64.340000000000003 111.776 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 101.77 8.01 46.57 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.408 -0.425 . . . . 71.319999999999993 113.384 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 75.0 p -106.17 171.89 7.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.253 0.549 . . . . 72.019999999999996 112.152 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -72.22 144.25 48.54 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.059 -0.519 . . . . 63.149999999999999 111.044 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -130.81 134.4 7.74 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.773 -0.727 . . . . 73.140000000000001 113.361 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -118.76 137.31 53.46 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.703 0.287 . . . . 75.510000000000005 110.573 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 28.2 tp -121.64 125.35 46.47 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.441 0.296 . . . . 71.019999999999996 111.768 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -141.6 113.58 7.95 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.01 0.433 . . . . 73.230000000000004 111.625 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 64.4 m -93.93 139.48 30.86 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.114 0.483 . . . . 74.239999999999995 111.721 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.479 HD13 HG12 ' A' ' 235' ' ' VAL . 85.9 mt -123.4 126.34 46.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.476 -0.329 . . . . 74.200000000000003 110.603 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -92.12 115.95 28.52 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.988 -0.445 . . . . 73.400000000000006 110.759 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.488 HD11 HG22 ' A' ' 243' ' ' VAL . 58.6 mt -112.52 152.87 28.31 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.538 0.335 . . . . 74.349999999999994 111.288 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.458 ' HG2' ' CG2' ' A' ' 192' ' ' VAL . 12.9 ptmm? -162.14 150.3 14.72 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.206 0.526 . . . . 74.329999999999998 112.067 172.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -116.44 -164.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.714 -0.847 . . . . 73.420000000000002 108.714 167.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.53 -6.15 58.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.639 0.733 . . . . 75.349999999999994 109.606 166.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.5 p -81.51 -33.81 31.62 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.284 -0.871 . . . . 75.540000000000006 111.744 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 167.46 -178.69 41.37 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.396 -0.431 . . . . 72.319999999999993 112.811 -176.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 81.0 p -130.3 133.73 46.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 117.35 0.575 . . . . 63.219999999999999 112.25 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.417 HG23 HD13 ' A' ' 176' ' ' ILE . 11.6 tt -148.51 153.16 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 116.173 -0.467 . . . . 73.420000000000002 110.653 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -101.2 132.66 46.59 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.704 -0.623 . . . . 72.109999999999999 111.675 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -96.92 117.58 5.8 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.643 -0.583 . . . . 65.299999999999997 111.643 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 30.8 m -95.95 115.99 28.26 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.438 -0.448 . . . . 75.319999999999993 112.107 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.482 HD22 ' HB ' ' A' ' 258' ' ' VAL . 92.8 mt -91.64 128.39 37.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.07 -0.514 . . . . 71.439999999999998 111.17 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -113.47 153.85 28.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.231 0.539 . . . . 74.310000000000002 111.777 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.8 -134.27 0.69 Allowed 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 115.647 -0.706 . . . . 71.140000000000001 112.006 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -63.6 -18.34 63.79 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.097 0.777 . . . . 70.219999999999999 113.097 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.0 -14.93 63.38 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.755 0.312 . . . . 75.329999999999998 111.593 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -61.24 -43.69 98.47 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.214 0.45 . . . . 63.310000000000002 112.214 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.471 ' CG ' ' HZ3' ' A' ' 197' ' ' LYS . 12.9 m-20 -76.08 1.31 15.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.54 0.57 . . . . 74.519999999999996 112.54 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -67.25 123.07 19.29 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.167 -0.333 . . . . 74.230000000000004 110.53 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.84 92.98 0.37 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.205 0.526 . . . . 70.25 112.068 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.479 HG12 HD13 ' A' ' 213' ' ' LEU . 3.7 p -120.42 107.64 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.743 -0.662 . . . . 75.310000000000002 110.24 173.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -95.34 163.58 13.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.0 -0.545 . . . . 75.109999999999999 111.002 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.431 ' HD3' ' C ' ' A' ' 237' ' ' LYS . 8.1 tmtm? -71.12 113.12 7.84 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.481 -0.563 . . . . 74.310000000000002 109.481 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 121.95 -23.12 7.45 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 116.175 -0.466 . . . . 65.200000000000003 112.231 -172.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -65.5 125.58 25.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.137 0.494 . . . . 75.420000000000002 112.067 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 49.8 mm -77.85 97.97 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.514 -0.55 . . . . 71.430000000000007 109.514 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -97.04 129.96 44.41 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.179 0.807 . . . . 63.140000000000001 113.179 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.9 96.57 8.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.685 -0.689 . . . . 71.209999999999994 109.417 170.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.488 HG22 HD11 ' A' ' 215' ' ' LEU . 88.6 t -97.61 111.62 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.113 0.483 . . . . 72.209999999999994 111.471 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.7 t -118.35 135.51 54.28 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.757 0.313 . . . . 73.340000000000003 111.056 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 172.81 -152.91 17.36 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.448 -0.882 . . . . 64.5 113.803 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -111.59 115.18 28.72 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.753 0.311 . . . . 70.329999999999998 111.325 -175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.518 HG22 HD22 ' A' ' 179' ' ' LEU . 47.7 t -86.27 120.54 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.776 0.322 . . . . 71.349999999999994 111.092 178.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.42 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 19.4 ptpt -135.09 -179.82 5.86 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.817 0.341 . . . . 73.310000000000002 111.043 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -107.93 129.56 55.09 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.703 -0.226 . . . . 73.510000000000005 110.405 171.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -129.99 -132.91 3.51 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.917 -0.659 . . . . 61.210000000000001 113.624 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -88.98 -28.87 19.93 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.392 0.515 . . . . 74.329999999999998 112.392 -174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 37.8 t -89.54 -35.22 16.04 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.081 0.467 . . . . 74.219999999999999 111.033 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 155.76 -135.54 4.63 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.95 -0.568 . . . . 70.430000000000007 112.041 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 67.7 mt -79.2 102.71 8.67 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.263 0.554 . . . . 62.149999999999999 109.87 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -119.19 137.07 53.88 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.982 -0.554 . . . . 75.530000000000001 111.724 -172.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.465 ' HB ' HG21 ' A' ' 247' ' ' VAL . 9.5 tt -104.79 121.05 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.294 0.569 . . . . 73.200000000000003 111.98 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 94.5 p -81.75 112.07 18.58 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.491 -0.559 . . . . 74.129999999999995 109.491 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.482 ' HB ' HD22 ' A' ' 226' ' ' LEU . 21.7 t -77.64 106.16 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.864 0.364 . . . . 64.209999999999994 111.963 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -84.07 -24.06 30.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.01 0.433 . . . . 73.120000000000005 111.299 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -146.4 125.78 13.14 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.926 -0.579 . . . . 75.439999999999998 111.101 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.441 ' HB ' HG11 ' A' ' 258' ' ' VAL . 13.1 tt -135.67 137.06 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.158 0.504 . . . . 72.340000000000003 111.769 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.43 140.27 7.71 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.892 -0.595 . . . . 63.43 111.826 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.541 HG22 ' HE3' ' A' ' 266' ' ' LYS . 40.5 mm -92.26 128.66 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 117.682 0.741 . . . . 71.209999999999994 111.705 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 27.1 mt -83.65 -45.88 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 121.368 0.604 . . . . 75.239999999999995 110.758 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -124.79 126.45 45.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.052 -0.522 . . . . 73.349999999999994 111.35 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.541 ' HE3' HG22 ' A' ' 263' ' ' ILE . 6.8 mmpt? -90.26 145.0 25.33 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.591 0.589 . . . . 65.230000000000004 112.591 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 46.0 m -121.31 25.05 9.69 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.917 -0.583 . . . . 74.150000000000006 111.087 173.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.565 HD11 ' HG2' ' A' ' 269' ' ' GLU . 3.1 pp -66.55 -20.95 66.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.674 0.274 . . . . 71.439999999999998 111.391 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.565 ' HG2' HD11 ' A' ' 268' ' ' LEU . 13.2 pt-20 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.68 -0.676 . . . . 73.510000000000005 111.026 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.738 0.304 . . . . 74.439999999999998 111.32 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -92.46 107.2 19.04 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.995 0.426 . . . . 73.209999999999994 111.477 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -94.96 151.36 19.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.292 0.568 . . . . 74.329999999999998 111.9 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -89.34 153.69 20.67 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.701 -0.851 . . . . 75.150000000000006 108.701 169.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 222' ' ' ILE . 36.0 mt -55.72 -36.25 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.328 0.492 . . . . 74.140000000000001 112.328 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.455 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 47.1 t -69.85 -24.09 63.39 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.138 0.421 . . . . 73.219999999999999 112.138 176.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.85 -5.78 59.14 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.288 0.477 . . . . 74.420000000000002 112.288 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.432 HD21 HG22 ' A' ' 247' ' ' VAL . 89.2 mt -70.84 155.71 40.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.504 0.669 . . . . 73.299999999999997 112.625 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.434 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.2 ptp -154.23 152.04 25.58 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.437 -0.801 . . . . 74.239999999999995 109.756 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.0 150.33 79.12 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 121.684 1.589 . . . . 72.120000000000005 112.492 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.423 ' HA ' ' CZ ' ' A' ' 246' ' ' TYR . 2.3 m-20 64.72 30.91 12.25 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.057 0.456 . . . . 53.409999999999997 111.445 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.434 HD22 ' HG2' ' A' ' 180' ' ' MET . 22.8 tp -114.58 115.88 27.88 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.353 -0.385 . . . . 72.129999999999995 111.372 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 90.2 p -103.83 109.52 21.28 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.66 0.267 . . . . 72.310000000000002 110.765 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.83 -161.56 11.44 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.778 -0.725 . . . . 60.210000000000001 113.508 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 25.1 m -122.81 142.98 50.16 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.65 -0.324 . . . . 74.040000000000006 111.418 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 34.8 pt -135.31 155.46 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.233 0.54 . . . . 74.109999999999999 112.431 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -111.19 124.48 52.28 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.15 -0.477 . . . . 71.25 110.531 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.8 164.94 38.09 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.339 0.59 . . . . 60.530000000000001 112.41 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -103.21 138.05 40.53 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.615 -0.721 . . . . 71.200000000000003 110.089 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.9 99.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.58 0.585 . . . . 72.450000000000003 112.58 -172.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.3 t -70.87 -44.75 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.074 0.464 . . . . 75.409999999999997 111.774 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -143.4 132.72 23.3 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.176 -0.465 . . . . 73.519999999999996 111.832 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -124.1 99.48 6.26 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.148 -0.478 . . . . 65.329999999999998 110.855 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -77.49 149.78 78.81 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.55 0.574 . . . . 71.349999999999994 112.55 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -62.19 172.62 3.95 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.299 2.666 . . . . 70.430000000000007 114.054 -178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.531 ' HB2' ' HZ3' ' A' ' 197' ' ' LYS . 0.2 OUTLIER -61.07 109.99 1.24 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.373 -0.83 . . . . 75.439999999999998 112.868 -176.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.497 ' HB2' ' HB3' ' A' ' 210' ' ' LEU . 66.7 mttm -83.88 148.96 26.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.185 -0.461 . . . . 73.319999999999993 109.929 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -131.86 136.58 47.56 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.986 0.735 . . . . 73.239999999999995 112.986 -171.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.418 ' HE1' ' HB2' ' A' ' 210' ' ' LEU . 54.8 p90 -156.37 -175.34 5.38 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.587 -0.733 . . . . 73.150000000000006 110.456 173.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 70.6 p -122.24 143.94 49.28 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.208 -0.307 . . . . 72.519999999999996 110.705 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 -90.45 141.01 29.18 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.874 0.369 . . . . 75.450000000000003 111.294 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -49.85 -30.31 9.65 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.212 0.53 . . . . 70.530000000000001 111.496 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -54.39 -44.09 72.0 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.725 -0.67 . . . . 74.209999999999994 112.141 175.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 126.52 -20.81 6.1 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.156 -0.545 . . . . 70.430000000000007 112.422 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.0 p -85.26 176.53 8.27 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.03 0.443 . . . . 71.040000000000006 111.947 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -72.83 163.38 28.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.52 0.676 . . . . 74.420000000000002 112.534 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.05 110.84 0.46 Allowed Glycine 0 CA--C 1.523 0.547 0 CA-C-N 115.675 -0.693 . . . . 73.230000000000004 112.442 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 197' ' ' LYS . 47.4 mt-30 -110.78 168.02 9.79 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.383 -0.48 . . . . 75.049999999999997 111.016 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 198' ' ' LYS . 65.8 tp -144.81 149.38 35.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.992 0.425 . . . . 72.019999999999996 111.458 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.597 ' HB2' ' HA ' ' A' ' 231' ' ' ALA . 45.6 tttp -149.85 121.1 7.82 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.937 0.399 . . . . 75.219999999999999 111.263 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 41.2 m -95.38 118.26 31.8 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.969 0.414 . . . . 73.409999999999997 111.663 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 74.4 mt -109.57 130.45 55.51 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.442 -0.345 . . . . 54.509999999999998 110.773 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -97.79 103.75 15.71 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.002 -0.436 . . . . 72.340000000000003 110.669 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.17 136.34 35.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.141 -0.481 . . . . 74.209999999999994 111.291 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.742 ' HB2' ' HZ2' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -122.62 147.72 46.09 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 112.718 0.636 . . . . 73.120000000000005 112.718 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -148.21 163.05 38.17 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.133 -0.94 . . . . 70.329999999999998 109.298 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -77.52 10.05 2.88 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.908 -0.495 . . . . 60.149999999999999 112.263 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 69.8 p -115.24 2.81 14.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.947 0.403 . . . . 72.129999999999995 111.072 169.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 147.1 170.08 15.11 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.332 -0.461 . . . . 73.140000000000001 113.25 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 80.3 p -128.64 126.5 40.32 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.442 -0.446 . . . . 72.540000000000006 111.061 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 176' ' ' ILE . 9.6 tp -129.76 151.75 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.946 0.403 . . . . 73.010000000000005 111.263 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.558 ' HD3' ' H ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -99.29 125.26 44.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.2 0.524 . . . . 74.230000000000004 111.441 178.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.539 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -91.83 138.31 14.19 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.705 -0.68 . . . . 71.030000000000001 112.489 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.427 HG23 HD12 ' A' ' 210' ' ' LEU . 28.4 m -106.43 105.5 15.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.903 0.334 . . . . 74.200000000000003 111.903 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 56.4 mt -90.42 138.71 31.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.831 0.348 . . . . 63.43 111.186 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -115.55 157.12 24.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.272 0.558 . . . . 74.099999999999994 112.101 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 55.4 t30 57.83 -141.68 0.74 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.559 -0.746 . . . . 71.400000000000006 112.468 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.42 -24.21 19.03 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.989 0.737 . . . . 74.010000000000005 112.989 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.57 -8.35 4.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.92 0.39 . . . . 75.049999999999997 112.006 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.597 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -66.06 -30.02 70.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.922 0.391 . . . . 64.540000000000006 111.82 175.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.4 5.84 50.18 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.336 -0.393 . . . . 62.130000000000003 111.847 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -59.77 126.46 27.66 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.944 0.402 . . . . 75.239999999999995 111.856 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -68.39 87.82 0.31 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.245 0.545 . . . . 50.43 111.796 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.5 p -116.89 128.78 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.112 -0.495 . . . . 74.219999999999999 110.735 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -93.28 150.86 20.17 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.3 0.572 . . . . 72.439999999999998 112.281 -175.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -80.16 117.23 20.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.898 -0.592 . . . . 75.120000000000005 110.068 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.58 23.6 13.72 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.938 -0.648 . . . . 74.239999999999995 112.659 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -113.72 162.77 15.87 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.702 0.287 . . . . 72.219999999999999 110.564 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 47.0 mm -98.94 114.12 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.738 0.304 . . . . 73.420000000000002 111.218 -177.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -114.15 142.43 46.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.023 0.749 . . . . 75.019999999999996 113.023 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 264' ' ' ILE . 30.5 tt0 -112.05 108.73 18.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.971 -0.559 . . . . 73.299999999999997 109.655 172.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.1 t -107.04 133.86 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 112.676 0.621 . . . . 72.040000000000006 112.676 -170.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 42.8 t -111.94 112.1 23.5 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.356 -0.384 . . . . 73.400000000000006 110.375 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.49 -176.88 26.42 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.174 -1.012 . . . . 71.040000000000006 114.369 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.423 ' CZ ' ' HA ' ' A' ' 182' ' ' ASN . 86.2 t80 -112.92 105.98 14.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.134 0.574 . . . . 73.430000000000007 111.084 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 256' ' ' ILE . 24.9 t -74.04 142.35 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.477 -0.329 . . . . 73.140000000000001 110.718 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -156.5 178.25 10.54 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.46 0.648 . . . . 75.439999999999998 112.677 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -107.36 145.27 33.08 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.343 -0.844 . . . . 71.030000000000001 110.242 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 156.51 -129.53 2.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.186 -1.007 . . . . 73.299999999999997 114.902 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -71.5 74.29 0.76 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.161 0.584 . . . . 72.219999999999999 111.222 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.5 t 155.75 -17.65 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.843 0.857 . . . . 75.140000000000001 110.315 -172.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 98.5 -84.29 0.67 Allowed Glycine 0 CA--C 1.519 0.313 0 N-CA-C 110.482 -1.047 . . . . 70.409999999999997 110.482 -170.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 98.0 mt -129.99 104.54 7.41 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.791 0.437 . . . . 74.310000000000002 109.846 170.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.92 172.57 7.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.066 0.46 . . . . 71.209999999999994 111.83 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.539 HG22 ' HA2' ' A' ' 224' ' ' GLY . 7.8 tt -127.55 112.84 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.339 0.59 . . . . 73.040000000000006 111.469 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 37.2 t -82.75 110.94 18.23 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.157 -0.474 . . . . 72.420000000000002 110.282 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.499 ' HB ' HD22 ' A' ' 226' ' ' LEU . 46.6 t -74.76 137.49 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.219 0.533 . . . . 75.140000000000001 111.936 -175.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -106.35 -43.86 4.67 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.993 -0.549 . . . . 62.310000000000002 110.583 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -139.41 145.2 38.61 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.093 -0.503 . . . . 75.239999999999995 110.479 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.1 tt -140.24 135.97 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.283 0.563 . . . . 74.140000000000001 111.983 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -140.68 121.82 2.01 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 116.081 -0.509 . . . . 64.540000000000006 112.385 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.415 ' HB ' ' HG3' ' A' ' 266' ' ' LYS . 14.0 mm -78.48 138.02 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 122.47 -0.429 . . . . 73.319999999999993 110.764 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.425 HD11 ' HB2' ' A' ' 242' ' ' GLU . 60.0 mt -84.58 -41.9 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 112.515 0.561 . . . . 71.209999999999994 112.515 -174.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -126.45 68.55 1.23 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.073 0.768 . . . . 74.329999999999998 113.073 -171.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.768 ' HZ1' ' HB3' ' A' ' 266' ' ' LYS . 8.8 mtpm? -89.81 142.82 27.34 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.66 0.743 . . . . 74.120000000000005 112.909 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 43.4 t -128.52 144.75 51.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.102 -0.953 . . . . 64.540000000000006 109.831 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 92.8 mt -56.89 -26.49 59.04 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.176 0.512 . . . . 71.239999999999995 111.163 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.25 1.126 0 CA-C-N 115.722 -0.672 . . . . 75.530000000000001 111.347 178.935 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 20.8 ptp . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 120.651 0.262 . . . . 73.150000000000006 111.209 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 186' ' ' THR . 8.1 t30 -97.49 143.42 28.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.453 0.644 . . . . 74.120000000000005 112.725 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.425 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 57.6 m-85 -130.69 167.67 18.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.405 -0.816 . . . . 74.430000000000007 110.308 173.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.459 ' HB3' ' OG1' ' A' ' 219' ' ' THR . 22.7 mmtp -97.66 164.64 12.33 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.972 -0.381 . . . . 75.209999999999994 109.972 167.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.422 HD11 ' O ' ' A' ' 220' ' ' GLY . 56.8 mt -64.08 -30.34 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 111.946 0.35 . . . . 73.540000000000006 111.946 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.481 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 83.7 p -64.7 -24.86 67.71 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.046 0.451 . . . . 72.430000000000007 111.157 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 174' ' ' TYR . 26.3 mm-40 -86.79 -12.25 48.59 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.052 -0.522 . . . . 73.530000000000001 111.596 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.504 HD12 HD12 ' A' ' 187' ' ' ILE . 71.1 mt -70.16 141.75 52.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.384 0.611 . . . . 72.439999999999998 111.714 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.413 ' HG2' HD22 ' A' ' 183' ' ' LEU . 21.5 ptp -154.12 156.36 31.83 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.553 -0.748 . . . . 74.129999999999995 110.641 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.97 142.22 76.66 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.141 1.894 . . . . 72.230000000000004 112.484 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 66.16 26.21 10.61 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.903 0.382 . . . . 74.409999999999997 111.697 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.413 HD22 ' HG2' ' A' ' 180' ' ' MET . 46.5 tp -98.09 135.09 40.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.802 0.334 . . . . 64.200000000000003 111.55 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 72.0 p -114.08 118.92 35.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.522 -0.308 . . . . 74.200000000000003 110.869 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.76 -160.85 27.63 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 120.888 -0.672 . . . . 61.409999999999997 113.685 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 58.0 m -129.69 148.85 51.62 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.83 0.452 . . . . 73.530000000000001 111.0 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.504 HD12 HD12 ' A' ' 179' ' ' LEU . 32.3 pt -131.95 144.61 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.244 0.545 . . . . 73.420000000000002 111.291 173.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -113.27 107.19 15.55 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.056 -0.52 . . . . 73.540000000000006 110.483 175.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.8 176.8 9.6 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.006 0.432 . . . . 63.219999999999999 111.819 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -94.0 145.17 24.85 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.149 0.499 . . . . 74.400000000000006 111.807 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.8 t -86.01 108.96 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.214 -0.448 . . . . 73.510000000000005 111.665 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.84 -35.67 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.161 -0.472 . . . . 71.439999999999998 111.449 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.09 124.26 5.74 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.313 -0.403 . . . . 63.32 111.607 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -108.17 100.93 10.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.221 -0.445 . . . . 62.030000000000001 110.749 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.499 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 99.0 m-85 -72.41 139.61 81.54 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 111.957 0.354 . . . . 63.409999999999997 111.957 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -53.8 148.99 34.9 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.666 2.244 . . . . 73.319999999999993 112.851 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -71.72 125.84 28.17 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.474 0.654 . . . . 75.129999999999995 112.375 -175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.02 166.47 11.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.78 -0.646 . . . . 73.0 110.731 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.44 112.17 18.63 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.681 0.277 . . . . 73.140000000000001 110.806 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -106.92 151.28 25.47 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.317 0.579 . . . . 71.140000000000001 111.982 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.8 p -99.36 126.89 45.32 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.955 -0.566 . . . . 73.219999999999999 111.169 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -85.89 140.45 30.37 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.512 -0.313 . . . . 75.430000000000007 111.175 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -57.69 -26.28 61.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.769 0.795 . . . . 74.239999999999995 110.148 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.77 -36.28 69.64 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.896 -1.047 . . . . 72.409999999999997 111.933 173.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 125.49 -30.45 4.48 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.356 -0.384 . . . . 64.219999999999999 112.986 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.0 p -77.95 163.22 26.17 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.734 0.642 . . . . 74.340000000000003 112.734 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -92.83 -173.69 3.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.978 -0.555 . . . . 75.340000000000003 110.735 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.36 149.24 10.93 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.813 -0.708 . . . . 72.450000000000003 113.308 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -96.67 136.22 37.5 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.825 0.345 . . . . 74.439999999999998 111.105 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 18.9 tp -127.65 111.13 13.37 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.225 0.454 . . . . 73.019999999999996 112.225 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 195' ' ' TYR . 81.5 tttt -122.21 109.6 14.68 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.191 -0.318 . . . . 65.230000000000004 111.282 175.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.9 t -86.07 145.94 26.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.927 0.394 . . . . 75.239999999999995 111.387 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.79 124.47 33.47 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.511 -0.313 . . . . 74.540000000000006 111.253 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -94.58 115.39 27.52 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 110.132 -0.321 . . . . 75.340000000000003 110.132 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.62 HD13 HG21 ' A' ' 243' ' ' VAL . 52.8 mt -112.54 150.75 30.87 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.556 0.217 . . . . 75.319999999999993 111.51 -176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -140.47 152.65 45.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.652 0.739 . . . . 74.129999999999995 111.934 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -148.19 166.09 28.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.802 -1.09 . . . . 71.239999999999995 108.739 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -56.69 -25.82 55.12 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.756 0.312 . . . . 64.430000000000007 111.772 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 71.6 p -89.88 1.95 55.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.826 0.676 . . . . 74.5 112.826 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.422 ' O ' HD11 ' A' ' 176' ' ' ILE . . . 137.41 -179.25 18.32 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.803 -0.713 . . . . 73.129999999999995 113.312 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 57.2 p -127.81 152.23 48.05 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 122.418 -0.46 . . . . 65.239999999999995 111.52 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.0 tp -151.77 160.06 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.72 -0.218 . . . . 75.109999999999999 111.291 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -107.36 128.08 54.14 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.193 0.52 . . . . 74.420000000000002 112.118 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -103.15 167.21 16.77 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.08 -0.509 . . . . 65.219999999999999 111.948 172.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 99.8 m -142.79 122.33 13.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.747 0.773 . . . . 75.540000000000006 112.379 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 91.4 mt -93.69 120.15 33.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.744 -0.662 . . . . 74.329999999999998 110.972 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -100.0 142.95 30.8 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.686 0.279 . . . . 71.120000000000005 111.713 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 60.8 t30 66.83 -138.03 0.14 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.099 0.559 . . . . 73.140000000000001 111.968 174.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -25.79 64.4 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.305 0.483 . . . . 74.510000000000005 112.305 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 91.0 mt -56.59 -21.81 29.36 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.799 0.333 . . . . 65.439999999999998 111.786 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.64 -20.15 66.11 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 111.978 0.362 . . . . 64.219999999999999 111.978 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -99.47 8.4 44.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.693 0.282 . . . . 75.140000000000001 111.703 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -65.58 143.7 57.45 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.093 0.473 . . . . 74.040000000000006 112.006 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -63.29 96.57 0.11 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.823 -0.626 . . . . 73.010000000000005 111.301 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 p -147.08 113.69 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.032 0.444 . . . . 74.310000000000002 111.008 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -105.58 160.45 15.17 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.438 0.637 . . . . 75.340000000000003 111.758 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.02 99.96 0.93 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.733 -0.667 . . . . 75.219999999999999 111.069 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 130.4 -10.61 5.84 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.187 -0.53 . . . . 65.200000000000003 114.036 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.78 157.07 20.34 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.782 0.66 . . . . 74.319999999999993 112.782 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 264' ' ' ILE . 40.9 mm -92.97 110.18 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.708 -0.678 . . . . 73.430000000000007 110.495 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -110.1 139.11 45.58 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.794 0.664 . . . . 53.240000000000002 112.794 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 31.9 tt0 -84.41 104.63 14.59 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.68 -0.691 . . . . 73.099999999999994 110.165 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.62 HG21 HD13 ' A' ' 215' ' ' LEU . 87.1 t -103.99 106.46 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.928 0.394 . . . . 75.430000000000007 111.505 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 39.1 p -116.53 130.49 56.78 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.461 -0.336 . . . . 70.209999999999994 111.439 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.97 -141.04 4.7 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.656 -0.783 . . . . 71.420000000000002 113.771 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -129.11 124.89 35.91 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.696 -0.296 . . . . 70.299999999999997 111.198 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.405 HG22 ' HB ' ' A' ' 256' ' ' ILE . 35.0 t -90.84 133.96 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.812 0.339 . . . . 75.109999999999999 111.821 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -126.39 -179.61 4.84 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.964 0.412 . . . . 74.140000000000001 111.204 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -119.37 125.56 49.29 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.421 -0.354 . . . . 75.420000000000002 111.516 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -88.59 -131.09 3.79 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.201 -0.999 . . . . 72.409999999999997 111.545 168.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -109.67 110.12 21.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.215 0.507 . . . . 73.430000000000007 110.385 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 44.2 t 65.33 5.4 3.11 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.32 0.489 . . . . 75.530000000000001 112.32 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -146.41 161.9 28.39 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.55 -0.357 . . . . 74.430000000000007 112.797 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.33 152.4 37.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.913 0.387 . . . . 72.310000000000002 111.726 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.31 156.31 43.26 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.161 -0.472 . . . . 61.5 111.078 173.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.405 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.5 tt -122.99 119.38 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.292 0.567 . . . . 75.420000000000002 112.227 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.3 m -72.23 113.8 9.66 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.195 -0.457 . . . . 54.399999999999999 110.075 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.513 HG11 ' HB ' ' A' ' 261' ' ' ILE . 23.1 t -82.22 117.43 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.985 0.421 . . . . 75.420000000000002 111.731 -175.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -89.81 -26.93 20.3 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.174 0.512 . . . . 72.329999999999998 110.551 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -149.63 137.29 20.15 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.1 -0.5 . . . . 65.530000000000001 110.936 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.513 ' HB ' HG11 ' A' ' 258' ' ' VAL . 12.2 tt -143.58 135.82 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.026 0.441 . . . . 71.109999999999999 111.628 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -146.98 139.68 8.1 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.241 -0.504 . . . . 65.540000000000006 112.939 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 49.3 mm -75.41 115.76 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.278 -0.542 . . . . 74.129999999999995 110.821 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 240' ' ' ILE . 61.8 mt -59.94 -50.08 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 120.953 0.406 . . . . 72.299999999999997 111.806 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -130.98 98.78 4.69 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.474 -0.33 . . . . 63.109999999999999 110.972 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -55.3 117.99 4.01 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.475 0.546 . . . . 74.409999999999997 112.475 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 50.2 m -85.61 113.16 21.62 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.946 0.403 . . . . 52.009999999999998 110.0 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 4.9 mp -71.1 -26.28 62.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.234 0.54 . . . . 73.230000000000004 110.93 -176.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 C--O 1.25 1.129 0 CA-C-N 115.362 -0.836 . . . . 71.129999999999995 110.949 177.248 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.59 0.233 . . . . 74.150000000000006 111.28 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -72.87 109.2 6.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.086 0.469 . . . . 71.230000000000004 110.449 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.42 ' CE2' ' HA3' ' A' ' 185' ' ' GLY . 96.5 m-85 -83.3 141.0 32.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.38 0.61 . . . . 72.099999999999994 112.411 -172.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.577 ' HD2' ' HG1' ' A' ' 219' ' ' THR . 18.2 tppt? -81.54 137.76 35.52 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.473 -0.785 . . . . 72.400000000000006 109.956 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.439 HD13 HG22 ' A' ' 222' ' ' ILE . 36.7 mt -52.79 -36.7 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 112.705 0.632 . . . . 74.030000000000001 112.705 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.406 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 35.4 t -64.51 -27.12 68.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.849 0.357 . . . . 71.310000000000002 111.549 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -95.05 6.1 50.04 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.32 0.489 . . . . 62.329999999999998 112.32 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 81.9 mt -68.64 131.05 44.56 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.133 0.492 . . . . 74.430000000000007 111.527 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.7 mtt -121.07 155.28 58.12 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.135 -0.484 . . . . 73.540000000000006 111.506 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.419 ' HG3' HD22 ' A' ' 254' ' ' LEU . 31.2 Cg_exo -61.03 133.29 46.41 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.31 2.007 . . . . 73.439999999999998 112.186 173.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 66.35 37.62 4.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.872 0.469 . . . . 72.430000000000007 111.568 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.8 119.47 39.22 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.452 -0.34 . . . . 63.140000000000001 111.4 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 86.9 p -99.18 126.29 44.94 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.949 0.404 . . . . 63.0 111.181 176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.42 ' HA3' ' CE2' ' A' ' 174' ' ' TYR . . . -171.58 -160.55 20.37 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.613 -0.803 . . . . 73.430000000000007 113.88 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 28.7 m -135.89 136.93 40.92 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.749 -0.266 . . . . 74.420000000000002 111.299 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.39 147.15 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.842 0.353 . . . . 71.25 111.735 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -108.16 112.31 24.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.579 -0.282 . . . . 55.310000000000002 110.647 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -147.95 174.59 11.73 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.316 0.488 . . . . 74.409999999999997 112.316 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -103.72 144.89 30.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.31 -0.404 . . . . 71.329999999999998 111.108 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.445 ' HA ' HD21 ' A' ' 215' ' ' LEU . 43.0 t -77.32 105.26 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.12 0.486 . . . . 75.409999999999997 111.556 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.31 -36.31 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.887 -0.597 . . . . 71.349999999999994 111.391 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.51 158.74 37.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.845 -0.616 . . . . 73.299999999999997 111.369 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.72 122.55 14.42 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.35 -0.386 . . . . 64.239999999999995 111.342 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.42 148.41 35.15 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 120.629 0.252 . . . . 72.329999999999998 111.463 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.81 168.08 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.809 2.34 . . . . 63.229999999999997 113.045 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -74.36 147.72 41.91 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.376 0.607 . . . . 74.409999999999997 112.26 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -111.4 157.25 20.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.863 -0.608 . . . . 75.200000000000003 110.145 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -110.03 157.58 19.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.2 0.524 . . . . 73.120000000000005 110.969 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.481 ' O ' ' HD3' ' A' ' 202' ' ' ARG . 33.0 p90 -156.7 172.47 18.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.734 -0.667 . . . . 72.409999999999997 110.071 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 48.0 t -83.01 108.25 16.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.719 0.295 . . . . 70.120000000000005 110.965 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.481 ' HD3' ' O ' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -82.71 117.04 22.35 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.326 0.584 . . . . 74.439999999999998 111.887 -176.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -52.01 -30.97 27.63 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.481 -0.782 . . . . 75.099999999999994 112.636 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -86.73 -2.86 58.88 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.55 0.574 . . . . 63.149999999999999 112.55 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 72.35 16.78 77.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.091 -0.575 . . . . 63.509999999999998 113.56 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 80.3 p -98.45 166.3 11.43 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.707 -0.29 . . . . 71.329999999999998 110.725 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -87.89 81.76 7.45 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.389 0.614 . . . . 74.019999999999996 111.094 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.85 147.99 19.02 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.533 -0.758 . . . . 71.430000000000007 113.026 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.477 ' NE2' ' HB2' ' A' ' 231' ' ' ALA . 9.0 pt20 -139.38 144.88 38.36 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.116 0.484 . . . . 64.409999999999997 111.717 -176.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 22.0 tp -111.8 105.96 14.59 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.741 -0.663 . . . . 72.519999999999996 112.388 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.446 ' HE3' HD23 ' A' ' 213' ' ' LEU . 4.0 tmtm? -113.02 126.35 55.39 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.141 -0.349 . . . . 74.310000000000002 110.258 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 25.1 p -110.24 142.74 41.41 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.433 0.635 . . . . 73.530000000000001 112.665 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.446 HD23 ' HE3' ' A' ' 211' ' ' LYS . 85.0 mt -125.18 159.92 30.4 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.604 -0.725 . . . . 74.5 110.886 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -125.41 119.71 29.06 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.733 0.301 . . . . 73.409999999999997 110.944 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.533 HD11 HG21 ' A' ' 243' ' ' VAL . 75.7 mt -114.68 162.26 17.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.726 0.41 . . . . 74.239999999999995 111.025 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 216' ' ' LYS . 18.5 ptmt -151.76 168.64 24.42 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.677 0.751 . . . . 75.319999999999993 112.643 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -146.33 174.84 11.0 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.66 -1.155 . . . . 72.109999999999999 109.113 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.14 -14.37 60.38 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.832 -0.543 . . . . 73.549999999999997 112.231 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.577 ' HG1' ' HD2' ' A' ' 175' ' ' LYS . 68.8 p -102.25 -18.86 15.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.289 0.848 . . . . 62.219999999999999 113.289 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 167.7 -179.82 40.86 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.386 -0.912 . . . . 60.119999999999997 113.684 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 44.8 m -127.64 144.41 51.08 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.807 0.337 . . . . 73.510000000000005 111.789 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.439 HG22 HD13 ' A' ' 176' ' ' ILE . 9.7 tp -150.65 150.17 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 116.508 -0.314 . . . . 73.450000000000003 110.849 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.4 ' HD3' ' H ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -107.75 142.66 37.42 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.944 -0.472 . . . . 75.129999999999995 111.699 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.477 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -110.57 155.67 15.98 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 116.063 -0.517 . . . . 72.439999999999998 113.271 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.4 m -116.39 114.01 23.68 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.408 0.522 . . . . 74.430000000000007 112.408 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.462 HD23 ' HB ' ' A' ' 258' ' ' VAL . 85.5 mt -96.71 133.95 40.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.815 0.446 . . . . 74.219999999999999 111.403 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -115.4 156.97 24.6 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.745 0.307 . . . . 75.340000000000003 111.52 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 58.87 -141.16 0.7 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 112.102 0.408 . . . . 71.450000000000003 112.102 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -48.26 -32.27 7.03 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.919 0.711 . . . . 73.439999999999998 112.919 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.411 ' HB3' HD21 ' A' ' 226' ' ' LEU . 85.8 mt -59.71 -19.45 49.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.745 0.307 . . . . 74.219999999999999 111.538 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.477 ' HB2' ' NE2' ' A' ' 209' ' ' GLN . . . -67.22 -32.3 73.26 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.181 0.438 . . . . 75.019999999999996 112.181 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -94.89 -6.62 42.21 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.023 0.379 . . . . 74.530000000000001 112.023 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -54.98 125.61 21.08 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.457 -0.338 . . . . 75.340000000000003 110.365 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.426 ' O ' ' HE3' ' A' ' 266' ' ' LYS . 37.2 tt0 -68.94 111.38 4.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.351 0.595 . . . . 73.140000000000001 111.652 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.437 HG12 HD13 ' A' ' 213' ' ' LEU . 7.3 p -144.42 135.27 20.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.559 -0.746 . . . . 74.439999999999998 109.678 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -139.51 165.92 25.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.525 0.679 . . . . 75.010000000000005 112.133 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -64.36 101.02 0.39 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.917 -0.583 . . . . 74.209999999999994 111.075 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 147.87 -31.37 1.34 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.615 -0.802 . . . . 63.140000000000001 114.583 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.09 154.41 25.6 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.769 0.785 . . . . 73.140000000000001 112.699 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 38.9 mm -94.57 106.05 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.485 -0.78 . . . . 75.349999999999994 110.833 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -100.04 131.12 46.19 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.985 0.735 . . . . 62.350000000000001 112.985 -174.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -97.04 97.63 9.39 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.364 -0.606 . . . . 72.140000000000001 109.364 171.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.533 HG21 HD11 ' A' ' 215' ' ' LEU . 99.3 t -99.01 124.16 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.973 0.731 . . . . 75.129999999999995 112.973 -169.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 37.0 t -98.59 116.55 31.08 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.826 -0.625 . . . . 74.129999999999995 110.348 172.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.03 174.58 33.93 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.317 -0.944 . . . . 71.099999999999994 114.484 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -108.71 109.29 20.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.292 0.637 . . . . 72.510000000000005 110.788 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.438 HG21 ' HB ' ' A' ' 256' ' ' ILE . 40.5 t -78.29 116.04 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.58 0.229 . . . . 64.209999999999994 111.109 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -128.46 161.19 30.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.671 0.272 . . . . 74.200000000000003 111.326 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -110.52 143.91 40.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.798 0.332 . . . . 73.310000000000002 111.521 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -167.32 -131.5 1.28 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 120.91 -0.662 . . . . 64.310000000000002 113.592 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -52.65 -64.66 0.74 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.607 0.595 . . . . 75.099999999999994 112.607 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 68.7 m -89.68 21.07 3.66 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.519 0.563 . . . . 64.109999999999999 112.519 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 93.77 -136.7 13.2 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.065 -0.588 . . . . 73.150000000000006 113.703 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.419 HD22 ' HG3' ' A' ' 181' ' ' PRO . 94.8 mt -86.4 117.56 25.28 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.845 0.355 . . . . 74.430000000000007 111.516 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -134.74 132.58 38.95 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.974 0.416 . . . . 74.420000000000002 110.505 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.477 HG22 ' HA2' ' A' ' 224' ' ' GLY . 7.4 tt -101.13 111.55 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.399 0.619 . . . . 73.25 112.195 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 50.9 m -78.89 111.57 15.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.998 -0.546 . . . . 64.120000000000005 110.462 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.462 ' HB ' HD23 ' A' ' 226' ' ' LEU . 43.1 t -75.74 127.97 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 112.425 0.528 . . . . 75.120000000000005 112.425 -173.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -97.99 -22.49 16.25 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.917 0.389 . . . . 64.209999999999994 111.291 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 47.9 t-20 -156.94 132.68 9.43 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 75.510000000000005 110.377 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.3 tt -126.64 122.23 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.075 0.464 . . . . 74.420000000000002 111.533 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -133.11 117.9 2.03 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.376 -0.44 . . . . 74.510000000000005 112.245 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.568 HD11 ' HD2' ' A' ' 266' ' ' LYS . 63.6 mt -85.4 127.21 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 122.53 -0.394 . . . . 64.219999999999999 111.258 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.1 -46.03 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.084 0.469 . . . . 75.549999999999997 111.282 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -153.02 139.22 18.36 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.86 -0.609 . . . . 72.129999999999995 110.612 176.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.568 ' HD2' HD11 ' A' ' 263' ' ' ILE . 13.9 ptmm? -151.59 125.7 9.25 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.014 0.435 . . . . 75.239999999999995 110.927 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 42.9 t -79.94 177.47 8.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.459 0.647 . . . . 64.0 112.125 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.35 21.17 13.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.825 -0.625 . . . . 72.209999999999994 111.579 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 . . . . . 0 C--O 1.255 1.376 0 CA-C-N 116.124 -0.489 . . . . 72.209999999999994 111.841 -179.78 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 74.6 mtm . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.793 0.33 . . . . 74.340000000000003 111.16 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.426 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 13.2 t-20 -82.52 104.14 12.57 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.496 -0.32 . . . . 74.310000000000002 110.205 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -84.6 137.02 33.53 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.616 0.598 . . . . 74.319999999999993 112.616 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.426 ' NZ ' ' O ' ' A' ' 173' ' ' ASN . 2.8 mppt? -100.86 158.68 15.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.812 -0.631 . . . . 72.439999999999998 110.22 171.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.533 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 89.1 mt -60.93 -32.25 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 113.018 0.747 . . . . 74.109999999999999 113.018 -173.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.495 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 34.1 t -58.2 -31.82 67.69 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 122.103 -0.373 . . . . 71.219999999999999 111.954 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.16 -12.52 54.79 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.503 0.557 . . . . 72.140000000000001 112.503 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.533 ' HG ' ' HA ' ' A' ' 176' ' ' ILE . 65.7 mt -64.66 116.05 5.85 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.526 0.679 . . . . 72.040000000000006 111.934 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.6 ptp -125.74 160.97 53.65 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 115.648 -0.705 . . . . 74.420000000000002 110.55 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.523 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 43.4 Cg_exo -54.99 133.42 57.99 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.331 2.021 . . . . 65.230000000000004 112.876 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 16.4 m120 68.75 20.29 8.17 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.389 0.515 . . . . 72.019999999999996 112.389 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.11 139.48 31.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.951 0.405 . . . . 75.200000000000003 111.498 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.8 p -110.25 127.42 54.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.495 -0.32 . . . . 72.329999999999998 110.342 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.15 -169.78 38.76 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.422 -0.894 . . . . 61.439999999999998 113.987 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 79.1 m -132.63 120.86 22.33 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.706 -0.291 . . . . 74.329999999999998 111.179 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 41.1 pt -108.09 140.61 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.981 0.42 . . . . 74.010000000000005 111.585 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -115.99 112.11 21.33 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.454 -0.339 . . . . 73.310000000000002 110.219 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -142.52 169.34 17.76 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.105 0.479 . . . . 71.019999999999996 112.099 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.82 139.27 30.75 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.05 -0.523 . . . . 74.219999999999999 110.952 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 35.8 t -82.89 116.84 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.127 0.489 . . . . 74.409999999999997 111.534 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 35.7 t -90.41 -64.77 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.189 0.518 . . . . 75.519999999999996 111.553 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -126.84 132.59 50.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.32 -0.4 . . . . 74.530000000000001 111.518 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -103.57 128.03 50.89 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.334 -0.394 . . . . 71.299999999999997 111.011 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -92.2 119.62 68.09 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.744 -0.207 . . . . 72.310000000000002 110.953 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.49 153.81 7.09 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.782 2.321 . . . . 71.109999999999999 113.094 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -64.36 130.49 44.0 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.084 0.772 . . . . 74.140000000000001 113.084 -173.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 3.0 mptp? -101.57 157.09 17.07 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.912 -0.586 . . . . 72.430000000000007 109.499 170.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -130.58 139.12 50.43 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.315 0.579 . . . . 73.409999999999997 111.91 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.407 ' O ' ' HA3' ' A' ' 208' ' ' GLY . 26.2 p90 -151.87 174.52 13.49 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.933 -0.576 . . . . 74.140000000000001 110.893 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 49.2 m -97.47 136.07 38.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.748 0.308 . . . . 74.239999999999995 110.744 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -100.09 -167.73 1.49 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.271 0.558 . . . . 75.019999999999996 112.061 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -59.99 -42.88 95.18 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.74 -0.663 . . . . 65.230000000000004 110.573 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -79.1 -39.6 33.29 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.169 0.509 . . . . 64.340000000000003 110.933 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 121.59 -35.33 3.62 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.859 -0.61 . . . . 71.519999999999996 113.052 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.7 p -102.8 177.18 4.92 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 111.865 0.321 . . . . 73.430000000000007 111.865 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.504 ' HZ3' ' HB3' ' A' ' 207' ' ' LYS . 6.5 mtpm? 60.38 18.42 8.08 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.409 0.522 . . . . 75.219999999999999 112.409 175.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 200' ' ' PHE . . . -76.54 70.32 2.22 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.352 -0.452 . . . . 73.010000000000005 113.608 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -108.4 141.03 40.86 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.788 0.328 . . . . 73.450000000000003 110.893 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 51.5 tp -135.37 142.84 45.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.448 0.299 . . . . 74.010000000000005 111.02 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.496 ' HE2' HD22 ' A' ' 213' ' ' LEU . 0.7 OUTLIER -162.05 119.45 2.15 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.867 0.365 . . . . 64.450000000000003 110.868 -179.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.0 t -104.26 161.65 13.87 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.162 0.506 . . . . 72.209999999999994 112.218 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.496 HD22 ' HE2' ' A' ' 211' ' ' LYS . 95.5 mt -138.16 138.98 39.15 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.023 -0.535 . . . . 73.340000000000003 111.764 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -97.2 106.23 18.52 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.906 0.384 . . . . 74.140000000000001 110.39 175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.422 HD11 HG22 ' A' ' 243' ' ' VAL . 80.0 mt -109.95 156.88 19.88 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.325 -0.398 . . . . 75.239999999999995 111.529 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -160.99 148.52 15.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.956 0.407 . . . . 75.120000000000005 112.062 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -132.21 -162.92 1.28 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.365 -0.606 . . . . 75.530000000000001 109.365 169.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -77.79 -1.7 32.71 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.778 0.659 . . . . 74.349999999999994 112.778 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 30.0 p -114.2 3.21 15.09 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.018 0.748 . . . . 75.319999999999993 113.018 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 149.22 -178.35 26.82 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.37 -0.919 . . . . 60.130000000000003 113.953 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 96.9 p -124.86 145.36 49.83 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.615 0.366 . . . . 72.540000000000006 111.021 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.9 tp -139.42 154.54 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-O 120.912 0.387 . . . . 74.319999999999993 111.263 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -108.02 112.45 25.02 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.891 0.377 . . . . 75.310000000000002 111.107 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -85.14 151.24 25.62 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.363 -0.38 . . . . 74.120000000000005 113.013 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 87.2 m -124.01 112.42 17.15 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.459 -0.436 . . . . 71.5 111.941 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.439 HD11 ' HD2' ' A' ' 211' ' ' LYS . 89.8 mt -94.97 121.95 37.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.342 -0.39 . . . . 73.319999999999993 110.717 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -101.52 157.0 17.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.027 0.441 . . . . 75.310000000000002 111.875 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 54.95 -134.29 1.56 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.795 -0.639 . . . . 75.530000000000001 112.437 170.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 229' ' ' GLU . 4.1 mp0 -48.13 -34.18 9.44 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.704 0.802 . . . . 73.230000000000004 112.625 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 70.5 mt -69.52 -6.62 31.93 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.398 0.518 . . . . 74.239999999999995 112.398 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.43 ' HA ' ' HB3' ' A' ' 211' ' ' LYS . . . -63.86 -45.92 87.31 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.841 0.353 . . . . 73.019999999999996 111.776 177.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.47 6.34 23.88 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.324 0.49 . . . . 71.530000000000001 112.324 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -61.27 123.33 17.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.824 -0.171 . . . . 75.439999999999998 110.664 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -73.7 96.01 2.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.719 0.771 . . . . 75.439999999999998 112.564 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.7 p -121.7 134.97 63.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.258 -0.883 . . . . 64.439999999999998 108.934 168.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -119.71 172.37 7.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.164 0.983 . . . . 74.140000000000001 113.246 -168.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -72.56 99.67 2.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.257 -0.883 . . . . 75.129999999999995 111.58 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.09 20.98 6.09 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.119 0.808 . . . . 62.140000000000001 115.119 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -103.23 167.46 9.81 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.38 1.09 . . . . 71.120000000000005 111.169 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 47.8 mm -101.42 104.74 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.128 -0.487 . . . . 72.010000000000005 110.845 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -104.72 125.55 50.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.077 0.465 . . . . 70.349999999999994 112.204 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -84.71 102.43 12.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.084 0.468 . . . . 71.230000000000004 109.838 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.422 HG22 HD11 ' A' ' 215' ' ' LEU . 98.6 t -99.8 105.9 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.325 0.583 . . . . 73.310000000000002 111.935 -175.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 36.7 t -97.11 125.92 41.92 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.035 -0.529 . . . . 73.010000000000005 110.383 174.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.83 -169.08 34.22 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.022 -1.085 . . . . 73.340000000000003 114.4 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -109.39 121.09 44.43 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.784 0.433 . . . . 74.319999999999993 110.854 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.497 HG22 HD21 ' A' ' 179' ' ' LEU . 38.6 t -83.79 139.19 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.275 -0.42 . . . . 73.439999999999998 111.847 -177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.635 ' HB3' ' HZ2' ' A' ' 248' ' ' LYS . 8.4 mtpm? -134.25 168.39 18.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.183 0.516 . . . . 73.5 111.443 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.523 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 25.8 tt0 -120.78 142.29 49.71 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.09 -0.504 . . . . 64.209999999999994 110.305 172.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 151.38 -77.76 0.22 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.725 -0.75 . . . . 52.130000000000003 112.957 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -86.35 133.3 33.81 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.526 -0.397 . . . . 72.409999999999997 110.451 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 31.7 t 62.31 26.15 15.64 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.285 0.564 . . . . 75.019999999999996 111.0 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 72.62 -77.51 0.77 Allowed Glycine 0 CA--C 1.522 0.504 0 C-N-CA 121.214 -0.517 . . . . 74.120000000000005 111.812 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.0 mt -111.89 130.54 55.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.131 0.491 . . . . 71.219999999999999 110.795 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.63 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 8.6 pt-20 -128.56 169.26 14.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.882 -0.599 . . . . 73.0 110.787 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.464 HG22 ' HA2' ' A' ' 224' ' ' GLY . 11.2 tt -148.79 117.22 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.461 0.648 . . . . 73.409999999999997 111.98 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 77.8 p -85.12 119.69 25.79 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.079 -0.51 . . . . 71.310000000000002 110.318 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.417 ' HB ' HD22 ' A' ' 226' ' ' LEU . 41.8 t -77.02 132.42 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.685 0.624 . . . . 74.420000000000002 112.685 -173.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -95.73 -54.74 3.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.829 -0.623 . . . . 72.420000000000002 110.276 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -139.78 126.81 20.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.056 -0.52 . . . . 73.030000000000001 110.785 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.7 tt -116.38 127.43 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.043 0.449 . . . . 72.129999999999995 111.284 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -125.28 118.78 3.36 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.142 -0.551 . . . . 73.530000000000001 112.955 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.495 HG22 ' HB3' ' A' ' 266' ' ' LYS . 41.3 mm -76.45 111.37 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.931 0.396 . . . . 64.409999999999997 110.889 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.8 mt -69.2 -42.99 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.844 0.354 . . . . 75.120000000000005 111.587 -177.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -140.83 109.56 6.01 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.558 -0.292 . . . . 74.209999999999994 111.309 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.595 ' HE2' HD21 ' A' ' 268' ' ' LEU . 25.1 pttm -113.3 179.26 4.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.896 0.379 . . . . 74.239999999999995 111.018 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 67.4 p -132.09 109.25 9.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.292 0.479 . . . . 65.549999999999997 112.292 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.595 HD21 ' HE2' ' A' ' 266' ' ' LYS . 0.4 OUTLIER -138.12 106.4 5.78 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.559 0.695 . . . . 73.540000000000006 111.249 175.227 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 118.469 -0.777 . . . . 63.409999999999997 111.71 -175.406 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.467 0.175 . . . . 74.200000000000003 111.111 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 186' ' ' THR . 5.8 m-20 -95.58 105.85 17.88 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.103 0.478 . . . . 63.310000000000002 111.045 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -85.67 168.06 14.74 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.477 0.656 . . . . 74.439999999999998 112.091 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -96.72 156.8 16.19 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.511 -0.768 . . . . 75.150000000000006 109.868 169.218 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 51.0 mt -61.43 -32.67 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.105 0.409 . . . . 74.329999999999998 112.105 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.1 t -63.82 -22.73 67.05 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.882 0.373 . . . . 73.430000000000007 111.468 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -87.91 -12.02 45.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.38 -0.373 . . . . 65.329999999999998 111.85 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.459 HD22 HG22 ' A' ' 187' ' ' ILE . 84.1 mt -71.54 103.07 2.87 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.389 0.614 . . . . 73.109999999999999 111.413 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.428 ' HG2' HD11 ' A' ' 183' ' ' LEU . 23.1 ptp -112.56 157.24 40.82 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.844 -0.616 . . . . 61.439999999999998 110.956 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.427 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 52.0 Cg_exo -53.05 135.27 58.64 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.487 2.125 . . . . 74.239999999999995 113.271 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 69.8 26.89 4.71 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.208 0.603 . . . . 70.400000000000006 112.28 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.428 HD11 ' HG2' ' A' ' 180' ' ' MET . 9.1 tt -115.85 144.72 43.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.767 0.318 . . . . 74.109999999999999 110.715 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.427 ' HB2' ' CD2' ' A' ' 246' ' ' TYR . 47.3 t -126.45 157.32 38.94 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.934 0.397 . . . . 74.109999999999999 111.79 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.2 -168.6 33.08 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.043 -0.599 . . . . 62.039999999999999 113.214 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 65.1 m -106.39 152.48 23.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.366 0.266 . . . . 74.209999999999994 110.534 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.459 HG22 HD22 ' A' ' 179' ' ' LEU . 37.4 pt -139.22 161.15 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.117 0.484 . . . . 70.439999999999998 111.584 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -118.38 110.94 18.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.087 -0.506 . . . . 62.450000000000003 110.137 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.67 157.89 44.51 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.346 0.593 . . . . 73.409999999999997 112.085 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -93.65 134.39 36.0 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.702 -0.681 . . . . 75.340000000000003 110.816 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.89 125.48 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.003 0.43 . . . . 73.540000000000006 111.978 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.28 -42.6 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.179 0.514 . . . . 72.219999999999999 111.146 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -146.11 130.55 17.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.992 -0.549 . . . . 71.209999999999994 111.205 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.91 104.55 8.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.019 0.438 . . . . 75.439999999999998 111.602 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.479 ' HB3' ' HD2' ' A' ' 196' ' ' PRO . 97.2 m-85 -86.0 163.33 43.64 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 116.542 -0.299 . . . . 74.140000000000001 111.721 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 195' ' ' TYR . 60.7 Cg_endo -70.28 -164.65 0.14 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.798 2.332 . . . . 72.420000000000002 113.155 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.658 ' HD3' ' HB2' ' A' ' 232' ' ' ASP . 22.1 pttp -100.05 111.49 23.78 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.608 0.718 . . . . 73.519999999999996 111.841 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -92.45 176.55 6.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 64.239999999999995 110.697 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.3 150.12 48.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.091 0.472 . . . . 75.420000000000002 111.334 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -151.33 178.71 8.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.113 0.483 . . . . 74.439999999999998 111.265 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 82.0 p -110.5 134.96 51.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.017 0.437 . . . . 72.340000000000003 110.829 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -84.58 170.62 13.21 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.133 -0.485 . . . . 74.549999999999997 111.045 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -55.05 -30.46 59.62 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.255 0.465 . . . . 73.340000000000003 112.255 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.68 -3.52 56.47 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.48 0.548 . . . . 73.099999999999994 112.48 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 86.57 5.89 81.24 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.331 -0.461 . . . . 64.430000000000007 113.153 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.9 p -86.73 163.19 17.45 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.787 0.327 . . . . 75.340000000000003 111.841 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -76.97 159.98 29.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.613 0.721 . . . . 73.329999999999998 112.67 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -166.61 147.56 12.2 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.448 -0.796 . . . . 55.299999999999997 112.377 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -104.32 147.81 27.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.353 0.577 . . . . 75.510000000000005 111.982 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.5 tp -129.63 123.5 31.41 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.611 -0.722 . . . . 74.109999999999999 111.634 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.51 ' HD3' HD13 ' A' ' 226' ' ' LEU . 44.6 tttp -122.52 108.6 13.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.786 0.327 . . . . 72.319999999999993 111.309 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.6 m -74.32 125.85 29.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.476 -0.329 . . . . 71.0 111.178 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 97.8 mt -132.51 150.56 52.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.092 0.472 . . . . 75.409999999999997 111.67 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -135.01 124.25 24.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.469 -0.332 . . . . 75.25 110.32 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 86.7 mt -118.05 150.0 40.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.713 0.292 . . . . 74.319999999999993 111.688 -174.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -132.8 129.09 38.1 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.778 0.799 . . . . 73.319999999999993 112.095 175.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -115.11 165.68 12.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.113 -0.949 . . . . 71.340000000000003 109.042 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.72 -25.87 66.74 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 111.874 0.324 . . . . 70.430000000000007 111.874 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 69.6 p -91.86 0.34 57.48 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.697 0.628 . . . . 73.439999999999998 112.697 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 146.25 177.09 20.64 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.936 -0.65 . . . . 51.119999999999997 113.469 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 54.0 p -118.31 160.08 22.27 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 122.405 -0.467 . . . . 71.310000000000002 111.596 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.1 tp -146.47 152.67 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.011 0.434 . . . . 74.329999999999998 111.894 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -90.82 121.82 33.01 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.214 -0.448 . . . . 73.439999999999998 110.902 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -120.62 165.9 13.86 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.207 -0.52 . . . . 71.329999999999998 113.313 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 98.8 m -152.82 137.08 16.55 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.268 -0.548 . . . . 72.25 112.395 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.51 HD13 ' HD3' ' A' ' 211' ' ' LYS . 65.9 mt -106.1 141.31 37.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.84 -0.618 . . . . 70.109999999999999 110.47 172.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -114.84 160.88 18.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.1 0.476 . . . . 72.319999999999993 111.601 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 56.08 -134.13 1.41 Allowed 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.925 -0.579 . . . . 71.019999999999996 111.705 172.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.95 -34.65 68.23 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.468 0.544 . . . . 74.400000000000006 112.468 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.41 -15.39 62.55 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.119 0.414 . . . . 74.430000000000007 112.119 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.441 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -61.55 -27.68 68.79 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 120.965 0.412 . . . . 63.109999999999999 111.779 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.658 ' HB2' ' HD3' ' A' ' 197' ' ' LYS . 36.8 t70 -95.18 9.01 41.25 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 120.823 0.344 . . . . 73.140000000000001 111.481 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -56.9 128.52 37.21 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.905 0.383 . . . . 74.010000000000005 111.725 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.4 115.63 16.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.066 0.46 . . . . 71.200000000000003 110.609 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.27 150.02 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.918 -0.583 . . . . 74.530000000000001 110.946 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 267' ' ' SER . 9.5 mmmm -117.66 146.91 43.37 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.087 0.47 . . . . 75.030000000000001 112.242 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.27 95.82 0.32 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.109 -0.496 . . . . 73.329999999999998 110.406 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 129.56 -16.78 5.61 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.916 -0.659 . . . . 63.439999999999998 113.348 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.42 ' CG ' ' HB2' ' A' ' 236' ' ' LYS . 66.2 m-20 -68.37 132.14 46.54 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.051 0.453 . . . . 72.040000000000006 111.086 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.455 HG22 HD12 ' A' ' 264' ' ' ILE . 46.5 mm -77.79 107.99 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.912 0.387 . . . . 74.420000000000002 110.385 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -104.01 139.39 39.2 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.04 0.755 . . . . 61.409999999999997 113.04 -173.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -95.17 99.71 11.64 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.178 -0.675 . . . . 75.200000000000003 109.178 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.27 123.87 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.506 0.558 . . . . 74.200000000000003 112.506 -170.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 45.5 t -112.09 123.19 49.72 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.861 0.363 . . . . 73.0 111.211 176.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -164.6 -167.25 24.86 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.562 -0.827 . . . . 65.420000000000002 113.997 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.427 ' CD2' ' HB2' ' A' ' 184' ' ' SER . 39.3 t80 -121.89 129.34 52.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.736 0.303 . . . . 75.129999999999995 110.966 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 47.0 t -96.22 125.68 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.005 0.431 . . . . 72.420000000000002 112.129 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -122.18 166.21 14.94 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.015 0.436 . . . . 73.140000000000001 110.736 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.427 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 25.2 tt0 -120.65 141.88 49.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.712 0.292 . . . . 74.239999999999995 110.899 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -162.54 -148.33 5.31 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.492 -0.861 . . . . 73.310000000000002 113.382 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -70.17 -33.35 71.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 122.575 0.35 . . . . 72.519999999999996 111.709 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 32.1 t -90.05 19.81 4.7 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.995 0.426 . . . . 70.040000000000006 111.354 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 85.14 -139.31 17.49 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.401 -0.428 . . . . 41.119999999999997 112.832 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.1 mt -91.36 119.68 31.59 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.762 0.315 . . . . 73.519999999999996 110.861 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -113.96 126.13 54.8 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.82 0.343 . . . . 75.329999999999998 111.167 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.04 106.44 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.627 0.727 . . . . 55.340000000000003 111.47 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.2 t -83.62 114.38 21.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.905 -0.589 . . . . 75.230000000000004 110.456 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.492 ' HB ' HD22 ' A' ' 226' ' ' LEU . 39.0 t -91.06 121.28 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.186 0.439 . . . . 73.530000000000001 112.186 -173.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -101.99 -14.24 17.25 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.786 0.327 . . . . 72.400000000000006 111.668 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -149.49 127.37 11.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.684 0.278 . . . . 71.409999999999997 110.668 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.7 tt -137.13 135.36 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.206 0.527 . . . . 72.439999999999998 112.278 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -147.69 122.69 1.59 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 115.826 -0.625 . . . . 74.420000000000002 112.074 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 58.0 mt -82.74 136.88 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 O-C-N 121.992 -0.711 . . . . 71.049999999999997 112.015 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.455 HD12 HG22 ' A' ' 240' ' ' ILE . 66.5 mt -70.6 -45.62 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.932 -0.576 . . . . 73.239999999999995 111.583 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.19 129.89 21.57 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.876 0.369 . . . . 54.399999999999999 111.585 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 266' ' ' LYS . 2.5 mmmp? -103.08 143.35 32.71 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.735 0.303 . . . . 74.420000000000002 111.713 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' SER . . . . . 0.502 ' O ' ' HG3' ' A' ' 236' ' ' LYS . 81.4 p -128.83 140.54 51.65 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.508 -0.315 . . . . 75.239999999999995 110.9 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.98 107.84 7.54 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.971 0.415 . . . . 75.430000000000007 111.774 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.45 ' CD ' ' HZ2' ' A' ' 236' ' ' LYS . 3.1 mp0 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 119.121 -0.466 . . . . 70.129999999999995 110.775 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 84.8 mmm . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 112.258 0.466 . . . . 75.129999999999995 112.258 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.427 ' H ' HD21 ' A' ' 173' ' ' ASN . 0.1 OUTLIER -87.35 130.97 34.43 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.755 -0.461 . . . . 71.430000000000007 109.755 169.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.444 ' HB2' HG23 ' A' ' 187' ' ' ILE . 95.1 m-85 -98.94 135.61 40.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.373 0.606 . . . . 75.420000000000002 112.338 -176.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -91.52 153.37 19.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.012 -0.54 . . . . 75.219999999999999 110.063 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.407 HD11 ' O ' ' A' ' 220' ' ' GLY . 64.2 mt -54.23 -36.65 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 113.492 0.923 . . . . 63.130000000000003 113.492 -172.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.7 t -75.48 -10.14 59.19 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.828 -0.545 . . . . 74.150000000000006 112.348 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.74 -7.57 52.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.678 0.275 . . . . 71.540000000000006 111.388 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.85 159.47 33.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.641 0.734 . . . . 71.120000000000005 112.655 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.534 ' HG2' HD22 ' A' ' 183' ' ' LEU . 25.4 ptp -157.41 155.07 26.9 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.418 -0.81 . . . . 52.539999999999999 110.154 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.42 ' HB3' ' CB ' ' A' ' 249' ' ' GLN . 12.3 Cg_endo -57.35 150.75 56.94 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.995 1.796 . . . . 72.219999999999999 112.38 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 63.8 t30 65.09 32.15 10.51 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.387 0.613 . . . . 73.209999999999994 111.021 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.534 HD22 ' HG2' ' A' ' 180' ' ' MET . 30.1 tp -119.85 128.48 53.72 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.412 -0.358 . . . . 72.140000000000001 111.75 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 88.8 p -111.48 114.79 28.14 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.115 -0.366 . . . . 73.030000000000001 110.325 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.46 176.22 36.26 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.441 -0.885 . . . . 71.439999999999998 114.181 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 88.6 m -108.76 119.74 40.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.932 0.396 . . . . 73.129999999999995 111.328 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.444 HG23 ' HB2' ' A' ' 174' ' ' TYR . 34.4 pt -110.54 155.79 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.127 0.489 . . . . 63.229999999999997 111.886 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -118.58 113.01 20.61 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.226 -0.443 . . . . 75.5 110.483 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -145.65 163.05 36.05 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.294 0.569 . . . . 73.219999999999999 111.935 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -94.89 139.2 31.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.936 -0.574 . . . . 74.010000000000005 111.594 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.9 t -77.19 106.82 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.884 0.374 . . . . 74.299999999999997 111.563 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.7 t -79.93 -45.93 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.228 0.537 . . . . 75.140000000000001 111.229 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -145.05 115.82 7.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.116 -0.493 . . . . 74.230000000000004 111.438 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -100.79 108.81 20.71 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.376 -0.375 . . . . 75.540000000000006 110.852 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -70.78 159.99 83.47 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.505 -0.316 . . . . 75.329999999999998 111.45 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.16 159.45 49.79 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.261 1.974 . . . . 75.310000000000002 112.864 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.412 ' O ' ' HG3' ' A' ' 197' ' ' LYS . 21.0 ptmt -75.39 102.29 5.08 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.475 0.655 . . . . 74.430000000000007 112.075 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -67.08 163.55 19.83 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.66 -0.7 . . . . 75.420000000000002 112.048 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.56 131.11 53.68 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.711 -0.677 . . . . 71.230000000000004 111.485 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -164.51 177.11 8.39 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.706 0.288 . . . . 75.420000000000002 110.969 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.1 m -116.2 128.25 55.46 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.975 -0.453 . . . . 73.450000000000003 111.955 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.476 ' NH1' HD22 ' A' ' 228' ' ' ASN . 47.3 mtp180 -92.23 158.74 15.98 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.124 -0.489 . . . . 75.230000000000004 110.832 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -67.38 -21.84 65.59 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.06 0.457 . . . . 74.439999999999998 110.402 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -106.17 70.98 0.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.26 -0.427 . . . . 74.25 111.838 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 118.89 -15.37 11.21 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 114.683 0.633 . . . . 63.240000000000002 114.683 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 31.1 p 52.23 -175.85 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 117.414 0.607 . . . . 74.129999999999995 112.281 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 52.25 32.06 10.23 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.31 0.485 . . . . 73.239999999999995 112.31 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -82.39 170.8 51.03 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 121.4 0.444 . . . . 74.420000000000002 113.553 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -128.41 154.53 45.93 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.548 -0.383 . . . . 75.439999999999998 110.648 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 38.3 tp -141.5 117.99 10.89 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.089 0.403 . . . . 74.409999999999997 112.089 -176.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -134.9 114.56 12.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.948 0.404 . . . . 72.219999999999999 111.412 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 47.2 t -93.8 149.41 21.26 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.931 0.396 . . . . 74.0 111.396 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.493 HD23 HG12 ' A' ' 235' ' ' VAL . 74.0 mt -128.66 125.36 37.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.601 -0.272 . . . . 71.540000000000006 111.229 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -89.9 111.91 23.11 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.792 0.329 . . . . 73.310000000000002 110.243 175.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 48.1 mt -109.92 156.77 20.0 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.388 -0.369 . . . . 74.030000000000001 111.006 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 221' ' ' SER . 18.1 ptmt -148.79 165.46 31.39 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.494 0.664 . . . . 70.109999999999999 112.155 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -147.5 170.11 18.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.066 -0.97 . . . . 50.299999999999997 109.877 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -48.78 -31.76 7.53 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.561 0.578 . . . . 74.209999999999994 112.561 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 13.1 t -102.48 -8.92 20.67 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.194 1.183 . . . . 73.349999999999994 114.194 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.407 ' O ' HD11 ' A' ' 176' ' ' ILE . . . 168.32 -179.55 41.32 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 119.82 -1.181 . . . . 70.219999999999999 114.453 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 216' ' ' LYS . 36.4 m -122.92 157.96 31.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.541 0.336 . . . . 73.420000000000002 111.325 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.6 tp -151.83 156.46 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.828 0.347 . . . . 72.140000000000001 111.32 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -113.37 112.07 23.04 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.277 0.561 . . . . 71.219999999999999 111.532 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.518 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -94.42 164.78 25.84 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.299 -0.41 . . . . 62.409999999999997 113.065 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 86.0 m -137.51 127.22 25.36 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.483 0.549 . . . . 71.109999999999999 112.483 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.439 HD22 ' HB ' ' A' ' 258' ' ' VAL . 96.1 mt -107.28 124.02 49.17 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.969 -0.56 . . . . 72.239999999999995 110.875 174.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -103.24 152.51 21.41 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.075 0.464 . . . . 73.310000000000002 111.995 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.476 HD22 ' NH1' ' A' ' 202' ' ' ARG . 47.0 m-20 51.01 -132.52 1.9 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.566 0.58 . . . . 75.420000000000002 112.566 171.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -42.72 -39.53 2.46 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.433 0.901 . . . . 73.129999999999995 113.433 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.2 -19.77 63.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.975 0.417 . . . . 75.109999999999999 112.049 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.66 -21.98 66.86 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.091 0.404 . . . . 70.409999999999997 112.091 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.57 3.38 55.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.222 0.453 . . . . 75.400000000000006 112.222 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -64.33 124.31 21.41 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 110.289 -0.263 . . . . 74.340000000000003 110.289 174.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.418 ' OE2' ' HE2' ' A' ' 236' ' ' LYS . 28.9 tt0 -66.86 99.4 0.62 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.17 0.509 . . . . 73.010000000000005 112.043 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.493 HG12 HD23 ' A' ' 213' ' ' LEU . 4.0 p -116.85 111.19 34.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.466 0.65 . . . . 65.340000000000003 110.699 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.418 ' HE2' ' OE2' ' A' ' 234' ' ' GLU . 66.8 mttm -98.36 147.73 24.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.08 0.466 . . . . 75.329999999999998 111.506 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -65.1 112.85 3.56 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 75.439999999999998 110.597 177.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.63 -16.66 23.74 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.463 -0.399 . . . . 37.030000000000001 113.172 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.51 141.54 51.93 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.011 0.434 . . . . 74.420000000000002 111.482 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 37.2 mm -89.09 117.91 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.476 -0.329 . . . . 73.140000000000001 110.522 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -109.01 127.1 53.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.11 0.782 . . . . 72.129999999999995 113.11 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.2 97.54 6.96 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.228 -0.656 . . . . 73.540000000000006 109.228 167.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.7 t -100.79 106.02 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.251 0.548 . . . . 74.540000000000006 112.24 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.9 m -96.65 109.19 21.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.937 -0.574 . . . . 72.409999999999997 110.055 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.67 -172.98 22.33 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.199 -1.0 . . . . 37.030000000000001 114.343 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 74.0 t80 -115.38 115.66 26.96 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.39 -0.405 . . . . 74.329999999999998 110.856 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.83 126.66 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.16 0.505 . . . . 75.450000000000003 111.717 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.4 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 52.4 mtpt -123.04 146.49 47.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.067 -0.515 . . . . 71.349999999999994 111.504 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.42 ' CB ' ' HB3' ' A' ' 181' ' ' PRO . 25.3 tt0 -120.39 135.76 54.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 75.219999999999999 110.648 172.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -160.08 -148.0 5.1 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.434 -0.889 . . . . 55.210000000000001 113.329 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -65.85 -29.57 70.05 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.061 0.458 . . . . 73.129999999999995 111.312 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 75.7 p -75.38 -10.76 59.74 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.329 -0.396 . . . . 74.420000000000002 111.635 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.06 -121.16 7.1 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.804 -0.519 . . . . 72.349999999999994 111.804 -173.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.1 mt -107.4 133.56 51.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.96 0.409 . . . . 74.310000000000002 111.385 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 10.5 pt-20 -144.24 174.03 11.25 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.154 -0.475 . . . . 70.329999999999998 111.007 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.518 HG22 ' HA2' ' A' ' 224' ' ' GLY . 8.5 tt -154.05 116.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.477 0.656 . . . . 75.420000000000002 111.976 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.8 t -87.49 124.37 33.38 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.951 -0.568 . . . . 74.430000000000007 110.098 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.449 HG11 ' HB ' ' A' ' 261' ' ' ILE . 33.3 t -84.08 132.84 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 112.366 0.506 . . . . 74.420000000000002 112.366 -173.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -95.36 -42.48 8.48 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.311 0.577 . . . . 72.230000000000004 110.723 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -145.42 135.41 23.71 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.917 -0.583 . . . . 74.129999999999995 110.702 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.449 ' HB ' HG11 ' A' ' 258' ' ' VAL . 12.6 tt -137.92 140.12 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.935 0.398 . . . . 72.230000000000004 111.596 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -149.98 136.42 5.69 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 116.24 -0.436 . . . . 73.230000000000004 112.159 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.494 ' CG2' ' HG2' ' A' ' 266' ' ' LYS . 25.6 mm -84.8 132.84 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.324 -0.515 . . . . 75.340000000000003 111.287 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 46.6 mt -77.1 -74.52 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 116.713 -0.221 . . . . 71.430000000000007 111.191 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -108.28 126.43 52.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.201 0.524 . . . . 75.420000000000002 110.443 170.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.571 ' NZ ' ' HB3' ' A' ' 266' ' ' LYS . 4.6 mtpm? -106.07 159.91 15.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.095 -0.502 . . . . 74.519999999999996 112.287 -173.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 62.2 p -80.18 105.12 11.21 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.179 0.514 . . . . 74.519999999999996 109.756 168.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.78 74.25 2.74 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.221 0.534 . . . . 74.140000000000001 111.395 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.464 -0.779 . . . . 75.510000000000005 111.915 178.063 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.905 0.383 . . . . 75.129999999999995 111.393 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 186' ' ' THR . 78.0 m-20 -84.59 125.89 32.84 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.34 -0.391 . . . . 74.519999999999996 110.868 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -83.92 171.45 13.02 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.518 0.675 . . . . 64.310000000000002 112.09 -174.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -93.39 156.68 16.64 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.568 -0.742 . . . . 70.530000000000001 109.683 167.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.497 HD13 HG22 ' A' ' 222' ' ' ILE . 40.0 mt -59.12 -31.87 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.114 0.412 . . . . 74.549999999999997 112.114 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.421 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 34.8 t -62.11 -29.26 70.2 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.93 0.395 . . . . 74.409999999999997 111.598 174.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -83.5 -18.22 39.24 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.405 -0.361 . . . . 72.310000000000002 111.695 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.652 HD11 HD13 ' A' ' 187' ' ' ILE . 87.6 mt -64.45 98.86 0.27 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.232 0.539 . . . . 73.030000000000001 110.998 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.441 ' HG2' HD23 ' A' ' 183' ' ' LEU . 23.9 ptp -96.64 152.2 38.4 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.099 -0.5 . . . . 73.310000000000002 111.163 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.18 138.34 78.92 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.169 1.913 . . . . 72.140000000000001 112.769 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 72.54 18.91 4.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.263 0.625 . . . . 71.200000000000003 111.794 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.441 HD23 ' HG2' ' A' ' 180' ' ' MET . 44.1 tp -94.7 154.82 17.13 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 74.120000000000005 111.599 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.4 t -131.31 123.17 27.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.53 -0.305 . . . . 51.200000000000003 110.67 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.54 -164.45 26.28 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.89 -0.671 . . . . 73.299999999999997 113.527 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.408 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 43.8 m -133.76 147.36 51.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.433 0.293 . . . . 74.120000000000005 111.177 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.652 HD13 HD11 ' A' ' 179' ' ' LEU . 39.9 pt -142.51 165.53 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.01 0.433 . . . . 65.400000000000006 111.577 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -122.29 118.31 28.21 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.692 -0.485 . . . . 73.549999999999997 109.692 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.29 170.75 16.14 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.532 0.567 . . . . 73.329999999999998 112.532 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 215' ' ' LEU . 40.1 mt-10 -84.86 134.2 34.29 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.802 -0.635 . . . . 74.450000000000003 111.514 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.26 95.75 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.039 0.447 . . . . 73.120000000000005 110.63 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.25 -29.94 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.127 0.489 . . . . 71.319999999999993 112.001 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.97 145.02 28.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 75.140000000000001 111.694 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -140.84 116.31 10.11 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.216 -0.447 . . . . 74.519999999999996 111.384 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.476 ' O ' ' HE2' ' A' ' 211' ' ' LYS . 97.0 m-85 -87.4 153.93 53.75 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-N 116.627 -0.26 . . . . 75.109999999999999 110.956 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.25 162.43 23.43 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.663 2.242 . . . . 65.109999999999999 112.942 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.465 ' HZ3' ' CG ' ' A' ' 232' ' ' ASP . 20.3 ptmt -72.48 115.3 11.58 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.618 0.723 . . . . 74.329999999999998 111.744 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -102.27 148.74 25.08 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.0 -0.546 . . . . 74.299999999999997 111.19 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.41 144.37 45.05 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.895 0.378 . . . . 74.310000000000002 111.243 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -152.97 173.76 15.0 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.012 0.434 . . . . 63.32 111.315 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 87.9 p -95.83 126.59 41.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.193 0.52 . . . . 62.32 112.266 -175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 16.2 mtp180 -118.66 114.52 22.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.082 -0.508 . . . . 73.030000000000001 110.097 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -52.17 -42.96 63.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.939 0.399 . . . . 75.25 111.719 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -111.48 22.09 15.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.079 0.466 . . . . 73.430000000000007 111.378 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 202' ' ' ARG . . . -160.21 45.98 0.41 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.215 -0.517 . . . . 73.129999999999995 112.567 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 207' ' ' LYS . 60.3 p -51.83 149.03 5.11 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.44 0.533 . . . . 70.319999999999993 112.44 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 206' ' ' THR . 60.2 mttp 72.55 5.7 5.3 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.533 -0.758 . . . . 73.450000000000003 112.599 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -70.71 129.18 18.71 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.081 -0.58 . . . . 73.239999999999995 111.853 172.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -105.77 173.57 6.25 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.424 0.631 . . . . 73.219999999999999 112.695 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.4 tp -138.37 116.5 11.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.431 -0.804 . . . . 75.549999999999997 111.221 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.512 ' HZ1' HD21 ' A' ' 213' ' ' LEU . 59.5 tttm -145.79 107.31 4.24 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.035 -0.416 . . . . 74.120000000000005 111.264 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 225' ' ' THR . 57.9 m -86.49 142.36 28.41 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.525 0.678 . . . . 73.129999999999995 112.65 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.512 HD21 ' HZ1' ' A' ' 211' ' ' LYS . 59.8 mt -123.74 163.01 22.01 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.27 -0.877 . . . . 73.340000000000003 109.619 173.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -119.92 117.12 27.26 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.956 -0.465 . . . . 71.040000000000006 110.686 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 78.3 mt -107.7 133.98 51.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.726 0.298 . . . . 75.140000000000001 111.224 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -124.03 153.64 41.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.426 0.631 . . . . 75.329999999999998 111.877 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -151.15 160.43 43.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.964 -1.016 . . . . 74.109999999999999 109.302 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.31 -25.78 49.84 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.107 0.41 . . . . 72.299999999999997 112.107 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 48.6 p -89.23 -14.09 36.72 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.061 0.763 . . . . 74.140000000000001 113.061 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.02 -179.76 41.55 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.341 -0.933 . . . . 61.299999999999997 114.218 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.5 p -135.41 132.48 37.55 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.659 -0.318 . . . . 54.32 111.216 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.497 HG22 HD13 ' A' ' 176' ' ' ILE . 15.5 tt -144.81 145.74 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.058 0.456 . . . . 73.310000000000002 111.75 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.638 ' H ' ' HD2' ' A' ' 223' ' ' ARG . 0.5 OUTLIER -89.93 130.33 36.16 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.985 -0.447 . . . . 74.439999999999998 111.313 177.217 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -112.32 114.43 3.52 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.459 -0.401 . . . . 74.349999999999994 112.906 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 212' ' ' SER . 87.9 m -95.47 120.14 35.19 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.477 0.547 . . . . 72.409999999999997 112.477 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.483 HD22 ' HB ' ' A' ' 258' ' ' VAL . 91.3 mt -78.74 123.84 27.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.948 -0.569 . . . . 74.099999999999994 110.857 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -107.74 172.72 6.67 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.988 0.423 . . . . 75.230000000000004 111.362 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 57.7 t30 55.72 -141.11 0.86 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 111.525 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -74.85 -5.73 45.18 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.57 -0.706 . . . . 70.430000000000007 112.465 -177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.464 ' HB3' HD23 ' A' ' 226' ' ' LEU . 83.2 mt -68.3 -12.77 61.59 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 122.137 -0.352 . . . . 63.340000000000003 111.656 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.79 67.11 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.153 0.502 . . . . 73.219999999999999 111.595 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.465 ' CG ' ' HZ3' ' A' ' 197' ' ' LYS . 4.1 m-20 -87.0 -3.07 59.06 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.012 0.375 . . . . 73.439999999999998 112.012 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -62.96 118.26 7.56 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.146 0.498 . . . . 74.420000000000002 110.999 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.26 99.42 4.04 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.402 0.62 . . . . 72.329999999999998 112.086 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.77 141.64 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 115.733 -0.667 . . . . 75.540000000000006 110.731 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -116.92 171.03 8.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.037 0.446 . . . . 73.219999999999999 110.835 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -72.99 119.24 16.97 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.852 0.358 . . . . 73.409999999999997 110.633 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 118.16 -24.13 8.9 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.157 -0.544 . . . . 44.25 113.751 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -64.78 134.32 53.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 117.159 0.479 . . . . 72.420000000000002 111.962 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 49.8 mm -84.03 102.33 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.005 0.431 . . . . 72.25 110.112 173.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -108.74 141.61 40.49 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.661 0.615 . . . . 71.239999999999995 112.661 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -89.35 108.45 19.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.802 -0.636 . . . . 73.310000000000002 109.728 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.442 HG12 HG12 ' A' ' 258' ' ' VAL . 75.8 t -111.51 130.24 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.158 0.429 . . . . 72.230000000000004 112.158 -172.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 28.5 t -123.9 137.3 54.66 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.294 -0.412 . . . . 64.040000000000006 110.701 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.98 -164.16 32.29 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.194 -1.003 . . . . 72.439999999999998 114.169 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -105.47 123.19 47.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.827 0.451 . . . . 74.120000000000005 111.189 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.9 t -89.93 134.44 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.229 0.538 . . . . 73.109999999999999 112.271 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.549 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 7.9 mtpm? -128.03 157.2 41.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.94 -0.573 . . . . 70.510000000000005 110.441 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -121.22 126.74 50.36 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.173 -0.329 . . . . 74.400000000000006 110.326 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -175.65 -83.63 0.06 OUTLIER Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.167 -1.016 . . . . 73.120000000000005 113.623 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -73.77 102.15 3.92 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.066 0.46 . . . . 73.239999999999995 111.865 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 50.8 m 56.93 61.58 2.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.751 -0.658 . . . . 72.150000000000006 111.872 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 88.41 -127.44 8.59 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.103 -0.57 . . . . 53.119999999999997 113.338 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 98.2 mt -96.09 147.88 23.26 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.42 0.629 . . . . 54.119999999999997 112.649 -176.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 8.0 pt-20 -143.62 125.85 15.56 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.563 -0.744 . . . . 73.109999999999999 110.038 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.409 HG22 ' HA2' ' A' ' 224' ' ' GLY . 12.2 tt -116.72 135.12 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.438 0.637 . . . . 72.400000000000006 112.443 -176.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 69.8 m -95.66 115.06 26.89 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.771 -0.649 . . . . 74.109999999999999 110.343 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.483 ' HB ' HD22 ' A' ' 226' ' ' LEU . 38.5 t -75.54 120.32 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.302 0.573 . . . . 73.310000000000002 112.158 -174.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.36 -36.41 11.39 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.941 -0.572 . . . . 75.230000000000004 110.654 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 15.7 t-20 -139.93 140.14 36.31 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.804 -0.634 . . . . 74.109999999999999 110.334 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 14.2 tt -148.35 135.2 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.345 0.593 . . . . 74.219999999999999 112.288 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -148.49 125.18 2.01 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.104 -0.498 . . . . 74.340000000000003 112.304 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 54.0 mt -79.85 131.9 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 122.217 -0.578 . . . . 72.140000000000001 111.773 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.1 mt -73.33 -52.75 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.122 0.487 . . . . 73.530000000000001 111.332 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -96.84 111.65 23.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.075 -0.511 . . . . 75.430000000000007 111.792 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -133.93 137.21 44.74 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.528 0.68 . . . . 75.530000000000001 112.312 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 29.3 t -161.76 133.47 5.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.34 -0.845 . . . . 63.310000000000002 110.201 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 268' ' ' LEU . 1.4 pt? -145.08 166.61 24.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.867 0.365 . . . . 74.129999999999995 111.69 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 . . . . . 0 C--O 1.254 1.331 0 CA-C-O 118.739 -0.648 . . . . 71.420000000000002 111.434 178.763 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 111.84 0.311 . . . . 75.040000000000006 111.84 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.26 117.7 15.32 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.726 -0.472 . . . . 72.140000000000001 109.726 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.408 ' O ' HG22 ' A' ' 187' ' ' ILE . 88.8 m-85 -84.35 145.36 28.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.326 0.584 . . . . 74.209999999999994 112.463 -173.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.465 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 46.4 mmtm -79.42 154.34 29.03 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.047 -0.723 . . . . 74.140000000000001 109.047 167.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.428 HG21 ' HB ' ' A' ' 222' ' ' ILE . 58.7 mt -51.94 -36.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 112.591 0.589 . . . . 75.120000000000005 112.591 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.4 t -67.76 -29.14 68.28 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 122.057 -0.402 . . . . 75.329999999999998 111.845 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.465 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 12.3 mm-40 -76.26 -8.04 56.21 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.851 0.315 . . . . 74.519999999999996 111.851 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.411 HD22 HG22 ' A' ' 247' ' ' VAL . 88.1 mt -73.41 145.29 45.92 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.314 0.578 . . . . 74.409999999999997 111.901 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.458 ' HG2' HD21 ' A' ' 183' ' ' LEU . 24.2 ptp -143.97 159.16 54.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.029 -0.532 . . . . 75.209999999999994 110.7 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.22 132.38 38.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.451 2.101 . . . . 75.430000000000007 113.192 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 65.05 46.08 2.89 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.065 0.459 . . . . 70.329999999999998 111.589 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.458 HD21 ' HG2' ' A' ' 180' ' ' MET . 42.8 tp -119.19 120.88 38.37 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.304 -0.407 . . . . 72.439999999999998 111.73 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.5 t -99.14 120.46 39.53 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.556 0.217 . . . . 74.540000000000006 110.639 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.82 -176.17 38.79 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.52 -0.848 . . . . 70.329999999999998 114.402 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 90.6 m -114.57 136.58 52.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.0 0.52 . . . . 74.349999999999994 111.698 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 174' ' ' TYR . 34.6 pt -126.8 157.8 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 122.63 0.372 . . . . 72.200000000000003 110.741 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -129.96 103.15 6.61 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.177 -0.327 . . . . 73.329999999999998 110.174 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -139.31 172.32 12.99 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 113.373 0.879 . . . . 73.010000000000005 113.373 -171.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.92 140.8 29.07 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.052 -0.976 . . . . 75.430000000000007 111.425 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.33 95.05 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.069 0.461 . . . . 75.540000000000006 110.761 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 16.2 t -72.26 -42.6 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.223 -0.444 . . . . 74.140000000000001 111.936 -176.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -140.32 127.7 21.29 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.99 0.424 . . . . 74.150000000000006 111.63 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -104.18 104.41 14.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.342 -0.39 . . . . 54.020000000000003 111.542 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -79.67 150.07 72.25 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.543 -0.299 . . . . 74.349999999999994 111.775 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.6 168.38 16.73 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.981 2.454 . . . . 74.530000000000001 113.801 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.2 156.39 33.65 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.102 -0.499 . . . . 73.430000000000007 111.675 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -141.88 159.08 42.95 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.112 -0.495 . . . . 74.129999999999995 111.056 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -129.08 153.45 47.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.991 0.424 . . . . 61.299999999999997 111.47 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.561 ' HE2' ' HB2' ' A' ' 210' ' ' LEU . 52.4 p90 -161.39 176.4 11.17 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.032 0.444 . . . . 72.340000000000003 111.08 175.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.7 t -107.97 154.68 21.27 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.948 0.404 . . . . 73.519999999999996 111.263 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -99.63 149.86 22.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.756 0.312 . . . . 72.129999999999995 111.229 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -58.97 -26.82 64.79 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.518 0.675 . . . . 74.420000000000002 110.248 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.86 -35.41 79.89 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.34 -0.845 . . . . 74.409999999999997 111.482 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 125.9 -27.9 5.03 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.299 -0.477 . . . . 63.530000000000001 113.261 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 79.5 p -82.89 173.64 11.64 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.481 -0.423 . . . . 54.439999999999998 111.914 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -91.27 143.74 26.33 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.186 0.517 . . . . 74.439999999999998 112.07 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -125.88 134.93 8.9 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.882 -0.599 . . . . 53.210000000000001 112.285 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -100.77 152.77 20.1 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.299 0.55 . . . . 75.120000000000005 111.981 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.561 ' HB2' ' HE2' ' A' ' 200' ' ' PHE . 51.7 tp -135.12 141.01 45.9 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.95 0.5 . . . . 74.409999999999997 111.321 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 231' ' ' ALA . 7.6 tmtm? -167.38 115.2 0.78 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.796 0.332 . . . . 71.329999999999998 111.034 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 69.8 m -99.83 167.26 10.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.741 0.782 . . . . 62.25 113.025 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.41 HD12 HG11 ' A' ' 235' ' ' VAL . 75.9 mt -142.66 157.33 44.79 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.179 -0.919 . . . . 75.530000000000001 110.752 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -117.13 122.52 44.32 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.133 -0.354 . . . . 75.530000000000001 110.851 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.512 HD11 HG21 ' A' ' 243' ' ' VAL . 44.3 mt -118.4 154.63 32.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.655 0.382 . . . . 72.420000000000002 111.004 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -153.25 132.81 12.97 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.764 0.654 . . . . 63.439999999999998 112.764 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -99.81 -171.17 2.0 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.977 -0.556 . . . . 60.530000000000001 110.315 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.94 -15.15 62.58 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.195 0.522 . . . . 73.25 110.587 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 54.1 p -94.47 -20.52 19.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.819 0.674 . . . . 65.25 112.819 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 158.12 -179.53 33.76 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.755 -0.736 . . . . 72.129999999999995 113.361 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 83.9 p -123.67 146.78 47.98 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.056 0.455 . . . . 74.040000000000006 112.047 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.428 ' HB ' HG21 ' A' ' 176' ' ' ILE . 11.4 tp -144.1 157.22 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.251 -0.432 . . . . 73.5 110.966 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 223' ' ' ARG . 29.1 mtm-85 -102.54 117.61 35.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.695 0.284 . . . . 74.019999999999996 111.455 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.525 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -97.7 119.76 6.52 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.419 -0.42 . . . . 62.149999999999999 112.84 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.0 m -99.25 118.41 35.87 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.355 0.502 . . . . 75.439999999999998 112.355 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.538 HD22 ' HB ' ' A' ' 258' ' ' VAL . 91.4 mt -91.9 133.82 35.33 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.974 -0.557 . . . . 71.109999999999999 111.046 175.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -115.46 159.4 21.22 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.08 0.467 . . . . 74.540000000000006 111.886 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.48 -133.54 1.06 Allowed 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 115.921 -0.581 . . . . 73.420000000000002 111.676 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.76 -31.58 39.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.242 0.46 . . . . 72.319999999999993 112.242 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 90.3 mt -64.27 -14.91 58.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.983 0.364 . . . . 74.349999999999994 111.983 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.424 ' HA ' ' HB3' ' A' ' 211' ' ' LYS . . . -73.98 -1.96 22.09 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.968 0.413 . . . . 73.129999999999995 112.063 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.03 14.22 9.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.895 0.478 . . . . 75.420000000000002 110.961 173.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -72.69 126.22 29.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.042 -0.526 . . . . 75.299999999999997 111.139 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -62.86 97.36 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.169 0.509 . . . . 74.120000000000005 111.828 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.41 HG11 HD12 ' A' ' 213' ' ' LEU . 4.0 p -135.72 114.38 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.934 -0.576 . . . . 70.120000000000005 110.541 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -100.35 157.94 16.25 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.169 0.509 . . . . 73.450000000000003 111.507 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -69.35 94.77 0.74 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.994 -0.548 . . . . 74.329999999999998 111.664 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 137.27 -19.35 3.42 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.171 -0.538 . . . . 71.140000000000001 113.793 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -70.0 146.13 51.28 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.139 0.495 . . . . 63.509999999999998 112.083 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.545 HG22 HD12 ' A' ' 264' ' ' ILE . 45.8 mm -86.93 129.31 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.191 -0.458 . . . . 73.430000000000007 110.22 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.558 ' HB1' HD11 ' A' ' 263' ' ' ILE . . . -140.91 152.35 44.96 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.028 0.751 . . . . 74.239999999999995 113.028 -175.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.28 125.52 38.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.787 -0.642 . . . . 74.519999999999996 110.221 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.512 HG21 HD11 ' A' ' 215' ' ' LEU . 92.9 t -122.11 117.58 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.133 0.492 . . . . 71.019999999999996 111.786 -175.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 260' ' ' ASN . 69.7 m -118.0 133.18 56.16 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.321 -0.4 . . . . 73.129999999999995 110.955 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.26 -156.12 13.23 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.438 -0.887 . . . . 44.25 113.84 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -122.75 115.32 21.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.966 0.412 . . . . 73.120000000000005 111.339 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.527 HG21 ' HB ' ' A' ' 256' ' ' ILE . 38.3 t -86.89 125.69 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.249 -0.432 . . . . 75.230000000000004 111.614 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -154.08 154.45 33.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.804 0.335 . . . . 73.430000000000007 111.365 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -75.05 136.83 41.17 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.677 -0.238 . . . . 75.340000000000003 110.472 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -151.04 -70.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.504 -0.855 . . . . 72.129999999999995 112.973 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -138.91 135.51 34.51 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.598 -0.354 . . . . 74.439999999999998 110.535 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 29.7 t 65.5 18.18 11.19 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.048 0.452 . . . . 74.010000000000005 111.933 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 118.7 -143.78 17.64 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.388 -0.434 . . . . 73.439999999999998 113.399 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 88.8 mt -87.81 131.17 34.62 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.017 0.437 . . . . 73.230000000000004 111.278 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -122.27 133.81 54.68 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.437 -0.347 . . . . 73.230000000000004 111.293 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.527 ' HB ' HG21 ' A' ' 247' ' ' VAL . 8.5 tt -103.86 109.09 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.329 0.585 . . . . 74.109999999999999 111.104 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.7 t -78.28 115.47 18.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.212 -0.449 . . . . 74.010000000000005 110.024 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.538 ' HB ' HD22 ' A' ' 226' ' ' LEU . 38.8 t -88.45 116.9 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 112.607 0.595 . . . . 73.239999999999995 112.607 -170.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.76 -24.15 17.92 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.327 -0.397 . . . . 75.319999999999993 111.6 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 244' ' ' SER . 27.3 t-20 -139.79 131.78 27.81 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.678 0.275 . . . . 64.109999999999999 111.163 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.1 tt -149.04 139.33 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.877 0.37 . . . . 72.140000000000001 111.163 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -149.47 129.11 2.92 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.15 -0.548 . . . . 65.049999999999997 112.826 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.558 HD11 ' HB1' ' A' ' 241' ' ' ALA . 46.4 mm -73.36 115.16 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 122.678 -0.307 . . . . 74.120000000000005 110.749 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.545 HD12 HG22 ' A' ' 240' ' ' ILE . 72.2 mt -66.01 -53.62 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.008 0.432 . . . . 71.540000000000006 111.469 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -111.26 120.93 43.91 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.297 -0.41 . . . . 64.340000000000003 111.027 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -89.81 130.24 36.08 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.645 0.609 . . . . 75.209999999999994 112.645 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 34.6 t -109.2 126.57 53.41 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.282 -0.417 . . . . 63.219999999999999 110.0 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 1.2 pp -150.27 175.0 12.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.952 0.723 . . . . 73.310000000000002 112.952 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.749 -0.66 . . . . 74.409999999999997 110.894 175.889 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 112.357 0.503 . . . . 74.010000000000005 112.357 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.53 119.12 36.42 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.622 -0.51 . . . . 64.0 109.622 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -96.8 155.24 16.86 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.154 0.798 . . . . 74.129999999999995 113.154 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -100.04 155.59 17.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.345 -0.843 . . . . 74.340000000000003 109.945 169.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 220' ' ' GLY . 44.2 mt -66.06 -30.09 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 112.551 0.574 . . . . 73.340000000000003 112.551 -172.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 219' ' ' THR . 93.5 p -71.09 -28.52 64.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.237 0.542 . . . . 64.510000000000005 110.664 173.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -77.99 -31.47 50.73 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.959 -0.564 . . . . 74.200000000000003 111.262 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 247' ' ' VAL . 78.0 mt -52.9 134.07 37.55 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.228 0.537 . . . . 73.430000000000007 111.475 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.445 ' HB2' ' HD2' ' A' ' 181' ' ' PRO . 22.9 ptp -140.57 164.65 35.32 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.925 -0.58 . . . . 72.120000000000005 111.077 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.483 ' HB3' ' HB3' ' A' ' 249' ' ' GLN . 9.4 Cg_endo -54.53 144.0 65.05 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.405 2.07 . . . . 75.329999999999998 112.879 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.1 t30 67.6 13.9 9.4 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.034 0.445 . . . . 75.510000000000005 111.909 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 40.2 tp -91.12 150.86 21.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.133 0.492 . . . . 72.150000000000006 111.993 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.8 t -131.78 133.67 45.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.339 -0.392 . . . . 73.329999999999998 110.492 173.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 173.82 -176.61 46.32 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.418 -0.896 . . . . 74.109999999999999 113.864 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 90.5 m -117.23 136.43 53.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.868 0.366 . . . . 71.430000000000007 111.325 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.411 HD12 HD11 ' A' ' 179' ' ' LEU . 33.8 pt -129.25 163.48 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 122.885 0.474 . . . . 75.239999999999995 111.485 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.58 114.25 17.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.47 -0.332 . . . . 75.219999999999999 110.503 175.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.28 168.58 19.44 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.848 0.356 . . . . 62.530000000000001 111.945 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 14.7 pt-20 -89.44 143.51 26.77 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.009 0.433 . . . . 64.450000000000003 111.353 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.439 ' HA ' HD21 ' A' ' 215' ' ' LEU . 39.8 t -79.49 105.01 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.226 0.536 . . . . 74.310000000000002 111.608 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.48 -37.63 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.207 0.527 . . . . 72.5 111.116 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.2 134.05 11.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.041 -0.527 . . . . 74.540000000000006 111.409 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -115.1 101.52 9.06 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.897 0.38 . . . . 72.140000000000001 111.246 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -72.11 143.96 86.82 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.483 -0.326 . . . . 75.25 111.27 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.63 168.75 2.87 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.955 2.437 . . . . 64.310000000000002 113.956 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -83.31 118.28 23.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.319 0.581 . . . . 73.010000000000005 111.785 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.643 ' HE2' ' HG ' ' A' ' 210' ' ' LEU . 2.6 mppt? -96.92 162.82 13.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.117 -0.492 . . . . 74.109999999999999 111.408 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -111.09 146.86 36.04 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.196 -0.457 . . . . 71.099999999999994 111.393 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -156.3 175.26 14.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.175 0.512 . . . . 75.120000000000005 111.125 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 94.8 p -125.17 141.68 51.96 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.242 -0.435 . . . . 74.219999999999999 111.245 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.472 ' HB2' ' OG1' ' A' ' 206' ' ' THR . 36.6 mmt180 -80.02 167.95 19.79 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.068 0.461 . . . . 73.209999999999994 111.601 178.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -60.63 -23.74 64.98 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.007 -0.542 . . . . 75.25 111.561 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.82 -5.11 46.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.19 -0.459 . . . . 75.239999999999995 112.149 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 81.74 21.71 61.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.711 -0.757 . . . . 74.209999999999994 112.051 -172.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 202' ' ' ARG . 76.2 p -101.29 171.16 7.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.889 0.476 . . . . 74.400000000000006 111.336 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -96.54 149.35 21.85 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.156 0.503 . . . . 72.230000000000004 112.239 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -149.22 148.56 20.05 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 116.121 -0.491 . . . . 63.299999999999997 113.286 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -105.99 143.45 34.12 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.411 0.284 . . . . 75.230000000000004 110.882 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.643 ' HG ' ' HE2' ' A' ' 198' ' ' LYS . 14.9 tp -137.33 116.72 12.76 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.391 0.515 . . . . 62.530000000000001 112.391 -175.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 59.8 tttp -122.15 147.79 45.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.762 0.315 . . . . 72.340000000000003 110.736 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.44 ' OG ' ' NZ ' ' A' ' 198' ' ' LYS . 49.0 m -123.74 147.15 47.75 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.022 0.439 . . . . 64.030000000000001 111.342 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.3 mt -135.14 157.45 46.88 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.217 -0.447 . . . . 72.219999999999999 110.92 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -127.87 115.89 19.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.905 -0.406 . . . . 64.409999999999997 109.905 173.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.439 HD21 ' HA ' ' A' ' 191' ' ' VAL . 64.9 mt -117.64 153.49 33.21 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.403 -0.362 . . . . 73.319999999999993 111.316 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 22.0 pttp -147.24 145.2 29.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.782 0.801 . . . . 65.040000000000006 112.35 174.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -122.15 170.94 9.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.657 -1.156 . . . . 74.329999999999998 108.635 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -49.93 -29.91 9.27 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.138 0.494 . . . . 74.109999999999999 111.364 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' A' ' 177' ' ' SER . 77.2 p -88.17 -2.15 58.43 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.755 1.02 . . . . 73.519999999999996 113.755 -175.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.424 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 143.09 -178.95 21.0 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 120.412 -0.899 . . . . 74.129999999999995 113.801 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.9 p -120.33 155.37 33.48 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 120.911 0.386 . . . . 70.310000000000002 111.78 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 14.9 tt -148.84 157.43 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.937 0.399 . . . . 72.049999999999997 111.768 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.414 ' HD2' ' N ' ' A' ' 223' ' ' ARG . 7.6 mpt_? -92.37 128.64 38.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.295 -0.411 . . . . 65.420000000000002 110.903 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -107.97 140.56 15.5 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.343 -0.456 . . . . 44.140000000000001 112.781 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 32.9 m -125.44 116.33 21.68 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.209 -0.583 . . . . 75.299999999999997 112.176 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.542 HD22 ' HB ' ' A' ' 258' ' ' VAL . 74.8 mt -99.02 132.25 44.47 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.479 -0.328 . . . . 75.239999999999995 111.038 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -113.14 154.93 25.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.157 0.503 . . . . 75.430000000000007 112.122 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.1 t30 62.18 -152.25 0.36 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.751 -0.659 . . . . 52.109999999999999 111.201 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.62 -7.29 0.91 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.671 0.989 . . . . 73.049999999999997 113.671 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.68 -13.68 55.23 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.167 0.508 . . . . 73.519999999999996 110.85 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.41 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -64.99 -28.89 69.82 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.106 -0.497 . . . . 62.149999999999999 112.151 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.01 0.19 53.97 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.108 0.41 . . . . 71.209999999999994 112.108 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -66.45 101.77 0.8 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.045 0.45 . . . . 72.010000000000005 110.658 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.51 100.55 1.43 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.12 0.415 . . . . 74.340000000000003 112.12 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.6 150.42 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.098 -0.501 . . . . 73.109999999999999 110.216 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -113.44 163.15 15.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.453 0.645 . . . . 71.219999999999999 112.08 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -81.11 94.76 6.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.136 -0.484 . . . . 65.25 110.688 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 141.57 -11.74 2.7 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.448 -0.882 . . . . 72.120000000000005 114.868 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -88.48 172.82 9.07 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.209 1.005 . . . . 70.439999999999998 111.456 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 48.1 mm -105.04 113.81 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.073 -0.512 . . . . 74.010000000000005 110.94 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -100.04 122.94 43.7 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.809 0.67 . . . . 72.510000000000005 112.809 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -80.24 104.86 11.08 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.818 -0.628 . . . . 73.200000000000003 109.55 170.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.407 HG23 HD11 ' A' ' 215' ' ' LEU . 93.1 t -115.83 128.77 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.543 0.571 . . . . 73.340000000000003 112.543 -172.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 39.2 t -120.85 132.52 55.04 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.16 -0.473 . . . . 73.349999999999994 110.405 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.33 -163.27 29.03 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.274 -0.965 . . . . 74.409999999999997 114.436 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -117.95 115.73 25.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.769 0.428 . . . . 75.109999999999999 111.264 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.498 HG21 HD23 ' A' ' 179' ' ' LEU . 48.5 t -85.44 133.16 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.666 0.617 . . . . 74.340000000000003 112.666 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -128.39 138.51 52.38 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.208 -0.451 . . . . 74.510000000000005 111.207 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.483 ' HB3' ' HB3' ' A' ' 181' ' ' PRO . 29.2 tt0 -100.65 143.07 31.25 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.715 0.293 . . . . 75.430000000000007 110.827 177.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 176.87 -127.29 1.2 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.141 -1.028 . . . . 62.200000000000003 114.185 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -59.68 108.46 0.74 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.739 0.644 . . . . 73.099999999999994 112.739 -173.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 65.1 m 69.51 15.87 8.23 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.337 0.866 . . . . 72.329999999999998 113.337 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 140.96 -167.58 25.61 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.546 -0.835 . . . . 71.219999999999999 113.804 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 4.5 mp -107.48 142.05 37.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.053 0.454 . . . . 74.439999999999998 111.97 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.75 167.18 11.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.14 -0.482 . . . . 64.129999999999995 110.386 175.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tt -136.04 103.86 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.556 0.693 . . . . 71.230000000000004 111.129 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.9 t -66.28 106.72 1.76 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.986 -0.552 . . . . 71.230000000000004 109.873 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.542 ' HB ' HD22 ' A' ' 226' ' ' LEU . 38.9 t -75.5 124.48 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.571 0.582 . . . . 52.350000000000001 112.571 -171.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -81.63 -40.94 22.17 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.85 -0.613 . . . . 75.129999999999995 110.675 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -153.49 148.78 27.01 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.132 -0.486 . . . . 63.420000000000002 111.127 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.8 tt -140.85 142.64 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.062 0.458 . . . . 73.310000000000002 111.567 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -150.51 145.02 12.58 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.171 -0.538 . . . . 74.400000000000006 112.823 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.0 mt -81.79 127.94 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 122.443 -0.445 . . . . 73.209999999999994 110.903 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 34.8 mm -56.41 -43.76 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.718 0.636 . . . . 65.219999999999999 112.718 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.74 124.57 26.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.353 0.597 . . . . 73.329999999999998 112.105 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.03 -15.9 25.62 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.007 -0.542 . . . . 64.319999999999993 111.649 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 38.1 t -111.61 130.32 55.79 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.873 0.368 . . . . 71.109999999999999 111.141 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.97 79.99 1.53 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.724 0.773 . . . . 73.340000000000003 111.815 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.16 -0.924 . . . . 74.340000000000003 111.88 178.998 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.657 ' N ' ' SD ' ' A' ' 172' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.016 0.436 . . . . 64.209999999999994 111.088 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -77.88 136.61 38.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.274 -0.421 . . . . 71.439999999999998 111.896 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . 0.486 ' HB2' HG22 ' A' ' 187' ' ' ILE . 95.5 m-85 -120.78 143.28 48.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.339 0.59 . . . . 73.140000000000001 112.152 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -99.69 159.86 14.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 70.299999999999997 109.798 169.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.469 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 68.6 mt -64.06 -34.88 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 112.609 0.596 . . . . 72.049999999999997 112.609 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.4 t -69.03 -20.56 64.13 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.069 0.461 . . . . 63.039999999999999 111.144 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -84.26 -11.08 57.06 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.026 -0.534 . . . . 73.329999999999998 111.379 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.502 HD21 HG22 ' A' ' 247' ' ' VAL . 77.5 mt -68.44 162.03 26.37 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.888 0.852 . . . . 73.109999999999999 113.248 -174.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.0 ptp -162.7 153.75 14.66 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 114.877 -1.056 . . . . 62.240000000000002 110.031 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.74 144.2 87.63 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.251 1.967 . . . . 74.519999999999996 112.756 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 67.88 24.44 8.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.848 0.459 . . . . 74.230000000000004 111.978 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 49.5 tp -95.83 121.27 37.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.118 0.414 . . . . 65.549999999999997 112.118 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 60.6 m -104.65 115.96 31.23 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.455 -0.339 . . . . 54.140000000000001 110.41 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.08 -168.49 36.38 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.266 -0.969 . . . . 65.040000000000006 114.111 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 52.8 m -119.89 119.25 32.97 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.71 0.29 . . . . 74.420000000000002 111.44 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.486 HG22 ' HB2' ' A' ' 174' ' ' TYR . 31.9 pt -101.36 154.3 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.232 0.539 . . . . 73.540000000000006 111.945 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -122.23 109.08 14.04 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.158 0.504 . . . . 72.409999999999997 110.834 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 216' ' ' LYS . . . -148.4 -177.59 5.85 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.925 -0.58 . . . . 71.400000000000006 111.452 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 10.7 pt-20 -107.89 148.43 29.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.229 0.538 . . . . 74.120000000000005 111.355 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.14 114.29 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.058 -0.519 . . . . 74.140000000000001 111.909 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.1 -49.42 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.205 0.526 . . . . 74.420000000000002 110.988 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -139.2 135.52 34.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 63.039999999999999 111.138 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -131.05 102.89 6.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.333 -0.394 . . . . 63.210000000000001 111.265 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.515 ' HB2' ' HB2' ' A' ' 212' ' ' SER . 74.7 m-85 -95.04 126.3 47.23 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.381 -0.372 . . . . 74.420000000000002 110.607 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 195' ' ' TYR . 48.6 Cg_exo -57.67 -174.83 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.335 2.69 . . . . 74.120000000000005 114.521 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.631 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 20.7 pttm -67.79 141.22 56.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.505 0.928 . . . . 72.010000000000005 113.505 -174.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.713 ' HE2' ' HG ' ' A' ' 210' ' ' LEU . 32.0 mtmm -120.31 157.37 29.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.083 -0.962 . . . . 72.129999999999995 110.368 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -102.82 137.33 41.17 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.139 0.495 . . . . 75.129999999999995 111.952 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -156.88 -176.64 6.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.985 -0.552 . . . . 74.25 110.325 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 78.4 p -122.25 119.8 32.25 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.185 0.517 . . . . 45.0 111.947 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 48.8 mtp85 -76.96 129.29 35.95 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.109 -0.496 . . . . 72.439999999999998 110.804 174.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -64.9 -8.97 17.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.964 0.411 . . . . 73.430000000000007 111.812 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.19 -35.9 55.36 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.293 0.568 . . . . 74.340000000000003 110.706 173.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 106.57 -8.11 40.04 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.925 -0.58 . . . . 70.049999999999997 113.035 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 81.4 p -81.07 157.43 25.4 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.067 0.461 . . . . 72.310000000000002 112.089 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -76.26 115.41 15.96 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.394 -0.366 . . . . 65.510000000000005 111.57 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -135.62 125.15 3.52 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.33 -0.462 . . . . 75.319999999999993 112.803 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.82 150.8 20.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.783 0.325 . . . . 64.5 111.276 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.713 ' HG ' ' HE2' ' A' ' 198' ' ' LYS . 18.4 tp -112.52 108.78 18.01 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.292 0.478 . . . . 70.540000000000006 112.292 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.578 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 82.6 tttt -117.62 139.53 50.87 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.807 0.336 . . . . 72.400000000000006 110.957 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.515 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 15.0 m -109.93 134.25 52.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.066 0.395 . . . . 71.030000000000001 112.066 -172.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 72.1 mt -129.88 145.53 51.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.254 0.549 . . . . 73.450000000000003 112.005 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -126.7 118.83 25.53 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.982 -0.554 . . . . 73.299999999999997 109.68 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.71 154.86 28.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.345 -0.389 . . . . 72.310000000000002 111.476 -174.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.45 ' O ' ' HB3' ' A' ' 189' ' ' ALA . 19.6 ptmt -153.74 170.01 21.96 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.899 0.381 . . . . 75.420000000000002 111.091 174.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.89 -174.73 4.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.852 -0.425 . . . . 74.120000000000005 109.852 171.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.64 -16.03 59.85 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.248 0.462 . . . . 74.150000000000006 112.248 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.4 p -98.76 -21.86 16.16 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.169 0.803 . . . . 73.239999999999995 113.169 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.98 -178.35 42.89 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 120.514 -0.851 . . . . 71.310000000000002 113.825 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 60.9 m -129.59 136.12 49.4 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 120.983 0.42 . . . . 74.430000000000007 111.892 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.0 tp -133.06 153.78 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.098 0.475 . . . . 74.439999999999998 111.76 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.427 ' NH1' ' O ' ' A' ' 252' ' ' SER . 10.8 ptp180 -111.42 135.4 52.03 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.768 0.318 . . . . 74.420000000000002 110.885 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -138.43 178.5 19.26 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.831 -0.699 . . . . 74.430000000000007 114.05 -174.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 88.0 m -148.37 137.4 21.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.568 -0.372 . . . . 61.240000000000002 111.933 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.578 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 83.5 mt -101.92 134.57 44.92 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.143 -0.481 . . . . 73.310000000000002 110.864 175.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -113.48 152.83 29.64 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.901 0.381 . . . . 75.019999999999996 111.666 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 14.4 m120 64.08 -143.36 0.29 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.191 -0.459 . . . . 72.519999999999996 112.001 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -48.33 -29.82 4.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.99 0.737 . . . . 72.109999999999999 112.99 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 92.4 mt -55.9 -18.89 10.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.003 0.43 . . . . 74.430000000000007 111.596 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.631 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -63.19 -44.05 96.45 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.994 0.426 . . . . 64.129999999999995 111.56 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -87.31 -5.33 58.95 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.961 0.356 . . . . 74.129999999999995 111.961 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -63.1 116.98 5.87 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.903 -0.406 . . . . 75.150000000000006 109.903 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.43 126.08 26.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.511 0.672 . . . . 74.329999999999998 112.383 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.08 127.23 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.606 -0.725 . . . . 74.239999999999995 110.039 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -100.34 141.99 32.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.142 0.496 . . . . 74.109999999999999 111.896 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.473 ' HB3' ' HE3' ' A' ' 237' ' ' LYS . 1.1 tmmt? -73.0 125.89 28.67 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.873 -0.603 . . . . 75.140000000000001 110.74 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.37 14.25 51.47 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.234 -0.508 . . . . 55.229999999999997 113.175 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.59 158.65 18.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.96 0.41 . . . . 64.439999999999998 112.071 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 32.7 mm -92.33 127.71 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 116.275 -0.42 . . . . 72.510000000000005 110.898 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -130.25 143.22 50.65 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.088 0.773 . . . . 75.400000000000006 113.088 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.55 117.36 29.87 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.656 -0.702 . . . . 74.400000000000006 109.513 171.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.4 t -117.82 111.47 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.57 0.581 . . . . 75.400000000000006 112.57 -173.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 52.0 m -96.58 112.55 24.25 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.422 -0.353 . . . . 74.540000000000006 110.382 174.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.59 -167.79 17.0 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.418 -0.896 . . . . 63.219999999999999 114.132 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.486 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 93.4 t80 -122.8 113.95 19.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.683 0.393 . . . . 75.319999999999993 111.124 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.502 HG22 HD21 ' A' ' 179' ' ' LEU . 45.5 t -86.11 120.07 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.408 -0.36 . . . . 73.129999999999995 111.13 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 61.0 pttt -134.59 164.3 27.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.265 0.555 . . . . 75.099999999999994 112.06 -176.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -112.12 115.35 28.73 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.596 -0.729 . . . . 75.129999999999995 109.776 173.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -162.69 -50.08 0.02 OUTLIER Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.76 -1.209 . . . . 72.349999999999994 113.53 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.24 -160.4 0.67 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.64 -0.329 . . . . 70.439999999999998 110.743 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.427 ' O ' ' NH1' ' A' ' 223' ' ' ARG . 33.5 m -59.81 85.66 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.109 0.48 . . . . 72.530000000000001 111.45 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 105.58 -111.73 3.76 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.914 -0.585 . . . . 64.109999999999999 113.699 175.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 95.9 mt -143.83 112.33 6.47 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.991 0.916 . . . . 72.230000000000004 109.322 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -111.54 132.91 54.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.291 0.567 . . . . 72.430000000000007 111.897 -176.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.1 tt -101.78 106.13 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.607 0.718 . . . . 75.239999999999995 111.108 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 35.9 t -77.35 110.25 11.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 53.210000000000001 109.959 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.554 ' HB ' HD22 ' A' ' 226' ' ' LEU . 37.9 t -81.27 124.18 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.043 0.449 . . . . 71.530000000000001 112.107 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.85 -43.95 14.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.977 -0.556 . . . . 65.219999999999999 110.797 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -147.16 139.12 24.37 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.142 -0.481 . . . . 71.319999999999993 110.443 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.2 tt -133.36 146.63 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.799 0.333 . . . . 74.019999999999996 111.216 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -147.74 131.97 4.07 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.17 -0.538 . . . . 73.420000000000002 113.047 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.519 HG22 ' HB3' ' A' ' 266' ' ' LYS . 43.9 mm -80.85 130.93 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 122.269 -0.548 . . . . 75.150000000000006 110.678 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 54.8 mt -63.26 -64.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.825 0.345 . . . . 73.099999999999994 111.233 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.11 107.93 3.53 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.339 0.59 . . . . 74.430000000000007 111.225 175.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.519 ' HB3' HG22 ' A' ' 263' ' ' ILE . 22.6 pttm -98.68 170.56 8.7 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.181 -0.463 . . . . 74.510000000000005 110.842 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 83.5 p -129.53 130.84 46.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.324 0.583 . . . . 74.140000000000001 111.426 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 269' ' ' GLU . 2.3 pp -137.59 -32.59 0.75 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.862 -0.608 . . . . 64.109999999999999 111.341 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.592 ' N ' HD12 ' A' ' 268' ' ' LEU . 45.4 mt-10 . . . . . 0 C--O 1.253 1.288 0 CA-C-O 118.228 -0.892 . . . . 74.219999999999999 110.61 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 19.0 mmt . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.829 0.347 . . . . 74.129999999999995 111.574 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 186' ' ' THR . 2.8 p-10 -90.36 111.87 23.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.101 0.476 . . . . 70.420000000000002 110.819 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -104.23 155.84 18.4 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.346 0.593 . . . . 74.239999999999995 111.96 -176.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -74.6 147.07 41.97 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.617 -0.883 . . . . 74.319999999999993 108.617 167.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.73 -32.79 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 112.785 0.661 . . . . 74.209999999999994 112.785 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.5 m -68.94 -7.94 39.79 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.261 0.467 . . . . 74.420000000000002 112.261 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -95.21 -6.19 42.14 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.664 0.385 . . . . 75.129999999999995 111.789 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.566 HD11 HG23 ' A' ' 187' ' ' ILE . 79.9 mt -73.39 106.75 5.33 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.559 0.695 . . . . 71.519999999999996 112.449 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.9 ptp -114.86 156.2 45.35 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.447 -0.797 . . . . 73.450000000000003 110.351 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.01 144.27 69.23 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.17 1.913 . . . . 74.219999999999999 112.757 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 70.45 15.34 7.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.158 0.583 . . . . 75.25 112.151 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.7 tp -93.12 135.96 33.83 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.808 0.337 . . . . 74.040000000000006 111.361 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.6 t -113.01 118.33 34.51 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.766 0.317 . . . . 72.510000000000005 111.081 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.02 -166.15 33.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.657 -0.782 . . . . 74.150000000000006 113.822 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 48.4 m -128.12 146.31 50.74 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.7 0.4 . . . . 75.439999999999998 110.815 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.566 HG23 HD11 ' A' ' 179' ' ' LEU . 30.4 pt -130.46 149.6 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.57 0.582 . . . . 64.209999999999994 112.57 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -108.61 127.34 53.87 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.73 -0.668 . . . . 54.130000000000003 110.089 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -159.66 175.56 13.04 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.319 0.581 . . . . 75.030000000000001 112.497 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -103.61 151.67 22.66 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.756 -0.656 . . . . 64.219999999999999 110.747 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.2 t -88.72 117.55 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.879 0.371 . . . . 71.329999999999998 111.798 -178.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.9 t -95.44 -48.2 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.077 0.465 . . . . 65.239999999999995 111.99 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -139.45 138.87 36.81 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.972 0.415 . . . . 75.409999999999997 112.082 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.77 105.35 8.9 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.017 -0.538 . . . . 71.519999999999996 110.759 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -87.03 142.19 33.71 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 111.873 0.324 . . . . 70.230000000000004 111.873 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -44.79 147.09 1.99 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.056 2.504 . . . . 72.239999999999995 113.485 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.565 ' HB2' ' HB2' ' A' ' 231' ' ' ALA . 23.0 pttp -74.47 134.93 42.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.611 0.719 . . . . 71.25 112.865 -172.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.451 ' N ' ' HD2' ' A' ' 198' ' ' LYS . 2.4 mptp? -90.69 144.21 25.96 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.4 -0.818 . . . . 75.400000000000006 110.038 174.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -130.03 115.86 17.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.963 0.411 . . . . 73.349999999999994 110.728 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -140.37 166.13 25.52 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.301 0.572 . . . . 75.329999999999998 111.872 -173.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 78.9 p -90.09 123.9 34.34 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.267 -0.424 . . . . 62.299999999999997 110.219 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -56.94 164.38 1.6 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.601 0.239 . . . . 75.219999999999999 111.378 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -51.58 -33.17 31.48 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.253 0.835 . . . . 75.349999999999994 113.253 -172.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -102.56 18.29 21.6 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.863 -0.523 . . . . 74.140000000000001 111.966 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 77.36 38.27 29.43 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.36 -0.447 . . . . 75.510000000000005 114.096 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 71.2 p -114.59 166.83 11.3 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 122.408 -0.466 . . . . 74.510000000000005 111.364 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 133.33 45.87 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.038 0.384 . . . . 72.420000000000002 112.038 -176.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -163.56 136.17 4.15 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.953 -0.641 . . . . 51.049999999999997 113.377 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -117.46 173.94 6.43 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 122.531 -0.394 . . . . 74.010000000000005 111.017 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 226' ' ' LEU . 58.6 tp -153.72 144.18 22.38 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.176 -0.466 . . . . 74.430000000000007 111.782 -176.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 230' ' ' LEU . 8.3 ttpm? -144.3 124.38 13.63 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.053 0.454 . . . . 73.019999999999996 111.127 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.5 m -88.32 130.74 35.05 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.087 -0.506 . . . . 72.400000000000006 111.355 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 81.3 mt -122.25 150.84 41.74 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.054 0.454 . . . . 73.239999999999995 111.408 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -114.62 115.41 27.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.326 -0.397 . . . . 75.519999999999996 110.111 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.03 153.62 32.37 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.183 0.193 . . . . 72.230000000000004 111.076 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 221' ' ' SER . 0.0 OUTLIER -146.38 142.92 28.69 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.011 0.91 . . . . 73.140000000000001 112.863 176.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.87 -178.48 3.73 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.791 -1.188 . . . . 64.230000000000004 107.791 165.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.29 -20.13 59.29 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.705 -0.622 . . . . 73.200000000000003 111.08 172.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -82.13 -28.05 32.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.231 0.456 . . . . 73.420000000000002 112.231 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.68 179.53 41.49 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.009 -0.615 . . . . 62.25 113.619 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 216' ' ' LYS . 79.1 p -114.22 163.93 14.57 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.346 0.498 . . . . 72.109999999999999 112.346 -176.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.5 tp -151.33 152.4 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 116.285 -0.416 . . . . 65.140000000000001 111.263 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -95.5 122.3 38.09 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.869 0.366 . . . . 74.010000000000005 111.834 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -93.72 135.5 12.59 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.403 -0.427 . . . . 53.340000000000003 112.957 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 63.2 m -118.26 103.79 10.17 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.524 -0.398 . . . . 74.450000000000003 111.388 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 210' ' ' LEU . 75.4 mt -94.46 117.1 29.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 111.828 0.307 . . . . 74.540000000000006 111.828 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . 0.458 ' O ' ' HB2' ' A' ' 230' ' ' LEU . 84.4 m95 -98.86 166.06 11.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.977 0.418 . . . . 71.230000000000004 111.466 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 61.94 -150.97 0.37 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.527 -0.306 . . . . 72.430000000000007 111.666 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.59 -15.06 6.3 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.612 0.597 . . . . 74.200000000000003 112.612 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.459 ' O ' ' NZ ' ' A' ' 211' ' ' LYS . 96.5 mt -59.13 -16.15 18.23 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.015 0.436 . . . . 74.219999999999999 110.812 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.565 ' HB2' ' HB2' ' A' ' 197' ' ' LYS . . . -65.15 -47.13 78.12 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.315 -0.402 . . . . 70.450000000000003 110.733 170.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.96 -29.31 67.51 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.387 -0.37 . . . . 73.409999999999997 111.425 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -50.87 103.03 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.885 0.374 . . . . 73.019999999999996 110.502 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -81.63 120.89 25.66 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.192 0.52 . . . . 75.530000000000001 111.792 -174.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 13.3 p -116.07 143.93 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.828 -0.624 . . . . 74.299999999999997 110.623 177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.482 ' NZ ' ' O ' ' A' ' 268' ' ' LEU . 5.7 mtpm? -104.97 154.36 20.21 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.979 0.363 . . . . 75.0 111.979 -173.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -81.19 133.66 35.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.808 0.337 . . . . 72.109999999999999 111.277 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.73 -34.45 5.46 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.524 -0.37 . . . . 72.319999999999993 113.06 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.2 144.86 56.56 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.057 0.456 . . . . 74.510000000000005 111.615 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.535 ' HB ' ' HG2' ' A' ' 265' ' ' GLU . 41.4 mm -92.39 136.38 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.75 0.309 . . . . 62.100000000000001 111.027 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -141.05 157.87 44.72 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.139 0.495 . . . . 71.349999999999994 112.122 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.47 120.19 40.78 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.002 -0.545 . . . . 71.329999999999998 110.098 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 85.9 t -110.56 123.89 66.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 111.897 0.332 . . . . 70.040000000000006 111.897 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.9 t -113.67 128.68 56.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.848 0.356 . . . . 75.019999999999996 111.435 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.91 -150.37 7.56 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.477 -0.868 . . . . 63.100000000000001 113.856 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -129.13 117.25 20.5 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.642 0.377 . . . . 72.530000000000001 111.056 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.507 HG22 HD21 ' A' ' 179' ' ' LEU . 46.3 t -86.79 125.88 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.624 0.249 . . . . 63.32 111.325 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.94 164.82 33.43 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.212 0.53 . . . . 74.340000000000003 112.01 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -91.85 115.48 28.1 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.046 -0.525 . . . . 74.230000000000004 110.626 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -138.47 -142.86 4.38 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.401 -0.904 . . . . 70.030000000000001 113.865 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -82.75 -27.94 30.75 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.04 0.448 . . . . 74.239999999999995 111.48 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 32.4 t -79.13 -1.44 36.04 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.088 0.471 . . . . 74.230000000000004 110.923 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 104.02 -126.96 8.95 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.785 -0.526 . . . . 74.409999999999997 111.785 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.3 mt -96.65 93.37 6.7 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.331 -0.618 . . . . 74.420000000000002 109.331 169.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.86 148.46 39.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.582 -0.736 . . . . 73.349999999999994 112.28 -168.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.442 ' HB ' HG21 ' A' ' 247' ' ' VAL . 7.8 tt -105.67 107.93 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.277 0.561 . . . . 74.310000000000002 110.881 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.4 t -70.46 104.84 2.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.976 0.417 . . . . 63.240000000000002 110.241 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.447 ' HB ' HD22 ' A' ' 226' ' ' LEU . 33.4 t -80.25 127.56 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.711 0.634 . . . . 75.129999999999995 112.711 -171.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -92.49 -49.16 6.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.89 -0.596 . . . . 74.120000000000005 110.405 174.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -139.23 132.74 30.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.002 -0.545 . . . . 72.519999999999996 110.586 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.1 tt -125.69 133.81 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.951 0.405 . . . . 73.109999999999999 111.222 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -130.6 131.34 6.47 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.21 -0.519 . . . . 70.329999999999998 112.992 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.6 mm -79.43 131.78 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 122.618 -0.342 . . . . 73.209999999999994 111.275 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 240' ' ' ILE . 66.2 mt -83.59 -48.88 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.25 0.548 . . . . 75.530000000000001 110.335 176.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.535 ' HG2' ' HB ' ' A' ' 240' ' ' ILE . 24.2 mm-40 -87.25 70.71 10.09 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.168 0.509 . . . . 74.5 110.236 175.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -66.74 113.29 4.74 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.938 0.718 . . . . 73.340000000000003 112.938 -173.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 64.3 m 66.87 63.18 0.48 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.481 0.919 . . . . 71.439999999999998 113.481 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.482 ' O ' ' NZ ' ' A' ' 236' ' ' LYS . 81.3 mt -108.49 110.17 21.6 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.253 -0.43 . . . . 71.129999999999995 110.03 170.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 C--O 1.25 1.108 0 N-CA-C 113.715 1.006 . . . . 75.430000000000007 113.715 -172.659 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 172' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.819 0.342 . . . . 64.540000000000006 111.095 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -83.84 119.32 24.7 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.193 0.521 . . . . 72.349999999999994 111.917 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -85.25 169.27 13.95 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.547 0.689 . . . . 75.120000000000005 112.105 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.468 ' N ' ' HD2' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -101.25 167.75 10.0 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.575 -0.739 . . . . 71.409999999999997 109.389 174.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 220' ' ' GLY . 25.9 mt -76.73 -41.27 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 121.866 -0.521 . . . . 75.25 111.055 175.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.8 t -68.55 -8.1 38.49 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.191 0.52 . . . . 74.430000000000007 111.113 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 175' ' ' LYS . 6.8 tp10 -82.6 -21.37 35.19 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 61.039999999999999 110.672 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.714 HD12 HD11 ' A' ' 187' ' ' ILE . 78.3 mt -73.44 117.67 15.48 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.451 0.643 . . . . 75.140000000000001 112.16 -174.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 22.5 ptp -130.15 157.07 78.23 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.708 -0.678 . . . . 72.420000000000002 110.262 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 182' ' ' ASN . 11.3 Cg_endo -54.4 138.37 73.4 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.06 1.84 . . . . 65.230000000000004 112.39 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 181' ' ' PRO . 2.5 m-20 74.63 11.05 3.97 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.29 0.636 . . . . 70.340000000000003 112.443 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.9 tp -90.94 149.11 22.01 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.305 -0.247 . . . . 75.420000000000002 110.855 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 73.3 p -135.8 118.31 15.85 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.184 -0.323 . . . . 70.200000000000003 110.76 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.75 -177.45 40.2 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.354 -0.927 . . . . 74.510000000000005 113.986 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 38.2 m -114.21 122.64 47.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.659 0.266 . . . . 74.519999999999996 111.535 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.714 HD11 HD12 ' A' ' 179' ' ' LEU . 47.7 pt -115.67 138.18 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.058 0.456 . . . . 73.219999999999999 111.41 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -108.73 103.16 12.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.98 -0.378 . . . . 74.019999999999996 109.98 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.78 176.11 8.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.132 0.492 . . . . 64.409999999999997 111.985 -173.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -96.75 130.76 43.94 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.895 -0.593 . . . . 74.329999999999998 111.669 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.96 102.25 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.918 0.39 . . . . 73.400000000000006 111.265 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.86 -48.32 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.096 0.474 . . . . 61.520000000000003 111.583 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -134.3 122.41 22.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.948 0.404 . . . . 72.420000000000002 112.081 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -97.14 103.16 15.07 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.138 -0.483 . . . . 75.430000000000007 110.863 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.414 ' HB3' ' HD2' ' A' ' 196' ' ' PRO . 88.9 m-85 -79.3 160.0 71.42 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 116.6 -0.273 . . . . 74.109999999999999 111.536 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 195' ' ' TYR . 48.4 Cg_endo -67.69 153.66 75.42 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.296 1.997 . . . . 72.109999999999999 113.017 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -85.72 134.79 33.94 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.436 0.636 . . . . 75.040000000000006 112.058 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -104.92 169.71 8.29 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.692 -0.685 . . . . 75.340000000000003 111.105 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.23 152.9 52.06 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.573 -0.285 . . . . 72.230000000000004 110.602 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -162.69 165.55 25.52 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.489 0.662 . . . . 75.219999999999999 112.205 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 88.0 p -104.85 137.38 42.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.658 -0.701 . . . . 74.099999999999994 109.928 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.553 ' HD2' ' OG1' ' A' ' 206' ' ' THR . 49.2 mtt180 -89.87 124.98 35.16 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.257 -0.277 . . . . 74.219999999999999 111.231 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.04 -20.23 16.05 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.893 0.378 . . . . 74.439999999999998 111.258 175.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.44 -34.26 68.78 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.113 -0.494 . . . . 75.439999999999998 111.265 173.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 129.65 -19.18 5.33 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 116.12 -0.491 . . . . 72.319999999999993 112.871 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.553 ' OG1' ' HD2' ' A' ' 202' ' ' ARG . 74.5 p -98.91 -166.11 1.32 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.092 0.405 . . . . 73.319999999999993 112.092 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -132.42 -174.46 3.45 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.815 0.34 . . . . 72.310000000000002 111.391 -177.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 155.76 161.01 10.33 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.689 -0.767 . . . . 65.209999999999994 113.908 176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -98.36 175.67 5.97 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.675 0.39 . . . . 73.329999999999998 111.668 177.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.0 tp -155.23 110.89 3.09 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.168 0.432 . . . . 74.540000000000006 112.168 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.96 140.51 52.26 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.056 -0.403 . . . . 73.209999999999994 111.447 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 37.7 t -106.8 152.61 23.62 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.946 0.403 . . . . 71.450000000000003 111.449 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.3 mt -136.27 143.76 44.42 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.651 0.38 . . . . 74.319999999999993 110.677 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -97.95 112.67 24.51 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.068 -0.395 . . . . 72.420000000000002 110.835 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 79.6 mt -107.74 135.93 48.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.415 0.286 . . . . 75.430000000000007 111.166 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -132.44 154.81 49.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.604 0.716 . . . . 73.340000000000003 111.923 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -155.45 167.21 31.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.971 -1.013 . . . . 72.120000000000005 109.068 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -60.03 -18.41 46.15 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.069 -0.394 . . . . 64.120000000000005 111.821 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 80.5 p -98.23 18.57 15.98 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.332 0.494 . . . . 72.540000000000006 112.332 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 125.83 -179.0 16.43 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.746 -0.74 . . . . 64.409999999999997 113.764 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 47.8 p -136.85 131.63 33.49 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.535 -0.391 . . . . 72.430000000000007 111.196 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 15.3 tt -138.04 156.73 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.005 0.431 . . . . 74.430000000000007 111.22 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -101.03 116.32 32.57 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.968 0.413 . . . . 75.340000000000003 111.29 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.41 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -83.01 157.62 35.57 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.235 -0.439 . . . . 72.329999999999998 113.521 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.1 m -128.97 114.23 16.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.882 0.372 . . . . 73.140000000000001 111.985 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.519 HD22 ' HB ' ' A' ' 258' ' ' VAL . 87.2 mt -99.21 112.13 24.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.235 -0.439 . . . . 75.120000000000005 111.217 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -91.6 157.07 17.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.893 0.378 . . . . 74.540000000000006 111.57 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 63.76 -155.39 0.32 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.325 -0.398 . . . . 75.120000000000005 111.791 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -53.44 -20.12 4.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.964 0.727 . . . . 71.010000000000005 112.964 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 95.6 mt -57.44 -23.5 49.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.29 0.567 . . . . 75.120000000000005 111.276 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.12 -27.97 69.3 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.888 0.375 . . . . 55.310000000000002 111.679 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.48 -0.22 54.85 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.976 0.417 . . . . 72.209999999999994 111.012 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -57.79 135.1 56.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.18 -0.464 . . . . 75.230000000000004 111.87 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.67 118.01 7.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.637 -0.711 . . . . 72.549999999999997 111.979 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.583 ' HA ' HD12 ' A' ' 263' ' ' ILE . 9.7 p -134.53 142.94 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.906 0.384 . . . . 75.450000000000003 111.18 176.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -118.42 151.45 37.76 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.394 -0.366 . . . . 73.239999999999995 111.384 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -75.97 142.21 42.01 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.931 0.396 . . . . 73.200000000000003 111.388 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.77 28.55 73.5 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.124 -0.489 . . . . 75.420000000000002 113.351 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.17 158.1 21.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.784 0.326 . . . . 75.340000000000003 110.958 -178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.518 HG22 HD12 ' A' ' 264' ' ' ILE . 48.0 mm -96.67 117.04 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.214 0.53 . . . . 75.219999999999999 111.209 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -118.38 135.63 54.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.432 0.53 . . . . 74.109999999999999 112.432 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -82.66 103.91 12.52 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.862 -0.608 . . . . 71.439999999999998 109.855 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 72.9 t -113.5 111.84 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 112.219 0.452 . . . . 74.349999999999994 112.219 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.408 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 21.3 t -113.33 129.48 56.52 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.349 -0.22 . . . . 63.329999999999998 110.958 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.0 -173.02 37.08 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.388 -0.91 . . . . 71.420000000000002 114.274 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -104.87 119.41 38.94 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.969 0.508 . . . . 74.209999999999994 110.591 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.455 HG22 HD21 ' A' ' 179' ' ' LEU . 30.6 t -85.83 135.46 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.258 0.551 . . . . 70.340000000000003 112.211 -176.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.47 163.93 29.91 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.98 -0.554 . . . . 75.549999999999997 110.794 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -112.31 133.51 54.38 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.833 0.349 . . . . 74.140000000000001 111.057 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 172.74 -92.06 0.09 OUTLIER Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.937 -0.649 . . . . 70.230000000000004 113.03 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -75.17 132.94 41.52 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.779 0.323 . . . . 72.019999999999996 111.046 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 33.4 t 59.11 25.16 13.59 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.138 0.494 . . . . 74.129999999999995 111.274 -176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 84.44 -84.13 1.6 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.246 -0.502 . . . . 73.400000000000006 112.873 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 93.3 mt -112.16 118.37 35.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.945 0.402 . . . . 73.409999999999997 111.423 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.5 125.5 49.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.217 -0.447 . . . . 73.230000000000004 111.321 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.41 HG22 ' HA2' ' A' ' 224' ' ' GLY . 7.9 tt -105.51 112.79 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.343 0.592 . . . . 75.439999999999998 111.545 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.5 t -77.49 105.29 8.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.198 -0.455 . . . . 71.5 110.591 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.519 ' HB ' HD22 ' A' ' 226' ' ' LEU . 40.3 t -78.51 135.49 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.245 0.545 . . . . 75.340000000000003 112.459 -172.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -106.79 -43.21 4.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.918 -0.583 . . . . 73.129999999999995 110.818 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.408 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 25.6 t-20 -124.13 132.56 53.65 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.967 -0.561 . . . . 73.200000000000003 110.541 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.6 tt -144.02 123.93 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.219 0.533 . . . . 74.129999999999995 111.436 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -139.15 124.84 2.9 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 121.095 -0.574 . . . . 72.219999999999999 113.165 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 235' ' ' VAL . 46.4 mt -69.24 123.13 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.845 0.355 . . . . 70.310000000000002 111.213 176.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.518 HD12 HG22 ' A' ' 240' ' ' ILE . 68.0 mt -76.43 -43.79 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.248 -0.433 . . . . 73.510000000000005 111.631 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -91.67 80.93 5.3 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.55 0.691 . . . . 73.239999999999995 111.424 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -92.59 101.08 13.5 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.169 -0.469 . . . . 75.409999999999997 111.579 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 40.0 t -113.7 136.48 52.79 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.829 0.347 . . . . 71.400000000000006 110.863 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 2.5 pp -101.6 11.53 38.79 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.758 0.314 . . . . 74.329999999999998 111.562 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 C--O 1.254 1.294 0 CA-C-O 118.654 -0.689 . . . . 53.200000000000003 112.058 -177.478 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.528 ' N ' ' SD ' ' A' ' 172' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.538 0.209 . . . . 75.299999999999997 111.457 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -115.68 103.31 10.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.851 -0.426 . . . . 73.430000000000007 109.851 176.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -94.26 146.14 24.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.311 0.577 . . . . 74.129999999999995 112.17 -175.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.89 160.08 16.03 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.904 -0.589 . . . . 75.209999999999994 110.573 169.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 63.6 mt -59.09 -31.86 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.914 0.709 . . . . 74.340000000000003 112.914 -171.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.459 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 70.6 p -62.67 -31.02 71.83 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.946 0.35 . . . . 72.319999999999993 111.946 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -88.33 -19.93 26.04 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 111.816 0.302 . . . . 75.140000000000001 111.816 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.518 HD21 HG22 ' A' ' 247' ' ' VAL . 78.4 mt -56.25 117.37 3.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.5 0.556 . . . . 71.209999999999994 112.5 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 24.1 ptp -114.44 157.42 42.67 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.741 -0.663 . . . . 71.219999999999999 110.465 178.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.83 142.64 99.14 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.054 1.836 . . . . 73.140000000000001 112.52 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 72.7 14.89 4.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.129 0.572 . . . . 64.209999999999994 112.029 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 40.9 tp -93.28 132.89 37.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.959 0.355 . . . . 72.209999999999994 111.959 -177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.0 p -110.83 125.56 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.374 -0.204 . . . . 74.010000000000005 111.104 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -178.69 -165.56 33.39 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.628 -0.796 . . . . 73.0 113.848 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.9 m -126.09 140.48 52.55 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.45 0.3 . . . . 54.409999999999997 111.581 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 33.7 pt -127.12 156.78 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.18 0.515 . . . . 70.219999999999999 111.992 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -118.69 112.04 19.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.046 -0.524 . . . . 73.209999999999994 110.648 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -150.87 163.43 38.68 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.445 0.535 . . . . 75.040000000000006 112.445 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -82.44 135.52 35.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.201 -0.454 . . . . 72.439999999999998 111.494 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.04 100.59 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.929 0.395 . . . . 72.540000000000006 110.743 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.8 -59.04 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.117 0.484 . . . . 73.129999999999995 111.473 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -130.28 143.99 51.11 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.986 -0.552 . . . . 74.230000000000004 111.411 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -126.63 107.01 9.81 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.933 -0.576 . . . . 73.120000000000005 110.849 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.556 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 92.2 m-85 -96.13 135.16 22.84 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.681 -0.236 . . . . 73.430000000000007 111.338 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.46 162.07 0.63 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.222 2.615 . . . . 74.120000000000005 113.899 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -73.4 119.56 17.8 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.059 0.763 . . . . 75.439999999999998 113.059 -173.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -67.81 151.19 47.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.33 -0.85 . . . . 75.340000000000003 111.276 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -115.61 129.61 56.57 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.323 -0.399 . . . . 73.230000000000004 110.693 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -147.27 154.4 40.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.173 0.511 . . . . 74.25 111.654 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 89.5 p -104.84 135.24 46.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.193 -0.458 . . . . 71.420000000000002 110.94 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -71.33 134.75 46.97 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.992 -0.373 . . . . 73.540000000000006 109.992 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -25.16 40.44 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.003 0.43 . . . . 65.219999999999999 111.401 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -55.19 -46.18 75.83 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.903 -0.59 . . . . 73.010000000000005 111.519 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 142.23 -22.81 2.41 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.218 -0.446 . . . . 73.430000000000007 112.147 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 80.5 p -81.61 -174.41 4.97 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.89 0.376 . . . . 73.140000000000001 111.471 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -140.72 166.31 25.1 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.955 0.354 . . . . 74.209999999999994 111.955 -178.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.95 179.63 35.37 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.176 -0.535 . . . . 70.049999999999997 113.012 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -128.07 156.14 43.26 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.632 -0.334 . . . . 72.519999999999996 110.72 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.462 HD13 HG22 ' A' ' 225' ' ' THR . 17.6 tp -144.54 125.14 14.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.181 0.438 . . . . 73.420000000000002 112.181 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.556 ' HG3' ' O ' ' A' ' 195' ' ' TYR . 7.2 ttpm? -112.63 131.92 55.4 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.729 -0.607 . . . . 74.140000000000001 111.111 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 51.2 m -98.86 121.39 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.115 -0.493 . . . . 75.030000000000001 111.686 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 226' ' ' LEU . 80.9 mt -119.8 157.43 28.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.352 -0.385 . . . . 74.549999999999997 111.16 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -128.3 120.81 27.82 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.645 0.26 . . . . 74.530000000000001 110.395 173.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.534 HD13 HG22 ' A' ' 243' ' ' VAL . 66.6 mt -105.2 153.09 22.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.808 0.337 . . . . 74.340000000000003 111.616 -176.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -141.67 152.32 43.81 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.278 0.561 . . . . 73.310000000000002 111.753 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -155.1 168.38 27.22 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.601 -0.727 . . . . 72.319999999999993 109.781 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -61.28 -20.14 62.53 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.928 -0.483 . . . . 74.200000000000003 111.947 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 80.2 p -91.2 -6.22 53.76 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.782 0.66 . . . . 71.319999999999993 112.782 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 150.03 -178.43 27.52 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.669 -0.777 . . . . 75.430000000000007 113.624 -178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 61.5 p -127.28 143.12 51.3 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.671 -0.311 . . . . 60.439999999999998 111.102 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.1 164.48 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 122.318 -0.239 . . . . 73.310000000000002 111.031 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.666 ' H ' ' HD2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -111.52 137.42 49.37 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.851 -0.53 . . . . 75.209999999999994 110.808 176.635 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -108.24 131.49 10.62 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.46 -0.4 . . . . 75.109999999999999 113.205 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.462 HG22 HD13 ' A' ' 210' ' ' LEU . 85.4 m -107.21 111.88 24.49 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.693 -0.298 . . . . 74.140000000000001 111.762 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.507 HD22 ' HB ' ' A' ' 258' ' ' VAL . 70.9 mt -99.04 109.48 22.22 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.035 0.383 . . . . 71.140000000000001 112.035 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -93.44 161.86 14.21 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.11 0.481 . . . . 75.099999999999994 112.104 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.443 ' CG ' ' H ' ' A' ' 229' ' ' GLU . 62.9 t30 57.69 -133.93 1.17 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.178 -0.465 . . . . 74.510000000000005 111.615 170.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.443 ' H ' ' CG ' ' A' ' 228' ' ' ASN . 11.4 pt-20 -60.06 -29.02 68.27 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.912 -0.493 . . . . 74.239999999999995 111.76 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.481 ' HB3' HD23 ' A' ' 226' ' ' LEU . 72.1 mt -61.06 -16.98 49.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.92 0.391 . . . . 75.099999999999994 111.231 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.58 88.11 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.663 0.268 . . . . 73.109999999999999 111.178 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -94.28 -15.62 24.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.842 0.353 . . . . 75.549999999999997 110.96 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -47.34 128.07 11.61 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.706 0.402 . . . . 74.329999999999998 111.524 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -70.23 120.23 15.6 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.658 0.614 . . . . 74.120000000000005 112.658 -175.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.25 134.23 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.698 -0.683 . . . . 73.519999999999996 110.053 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.491 ' HB2' ' HB2' ' A' ' 239' ' ' ASP . 58.6 mttm -99.9 150.71 22.11 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.156 0.503 . . . . 74.140000000000001 112.241 -173.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -66.61 108.7 2.54 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.385 -0.37 . . . . 71.400000000000006 110.419 174.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.39 17.17 29.86 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.408 -0.425 . . . . 53.530000000000001 112.798 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 25.2 t0 -90.88 157.0 17.59 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.699 0.285 . . . . 64.099999999999994 111.181 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 42.3 mm -95.18 105.28 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.146 0.498 . . . . 73.439999999999998 110.805 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -113.8 127.07 55.86 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.821 0.675 . . . . 72.409999999999997 112.821 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -86.75 104.17 15.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.228 0.537 . . . . 72.219999999999999 109.827 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.534 HG22 HD13 ' A' ' 215' ' ' LEU . 89.0 t -102.47 120.24 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.61 0.596 . . . . 70.319999999999993 112.61 -171.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.1 t -113.64 133.14 55.48 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.24 -0.436 . . . . 61.100000000000001 111.176 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.03 -155.78 17.93 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.205 -0.998 . . . . 73.400000000000006 113.983 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 85.8 t80 -116.31 112.12 21.09 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.779 0.432 . . . . 71.25 111.467 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.518 HG22 HD21 ' A' ' 179' ' ' LEU . 48.1 t -83.34 118.18 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 120.965 0.412 . . . . 61.340000000000003 111.177 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.431 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 58.8 pttt -135.42 157.17 47.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.228 0.537 . . . . 73.319999999999993 111.437 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -93.77 133.32 37.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.046 0.45 . . . . 72.0 111.289 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 166.14 -82.61 0.1 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.973 -0.632 . . . . 74.310000000000002 112.823 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -73.95 122.73 23.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.745 0.307 . . . . 73.329999999999998 111.382 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 34.1 t 55.54 43.35 28.56 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.024 0.44 . . . . 71.209999999999994 111.885 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 82.92 -112.92 3.59 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.881 -0.676 . . . . 54.509999999999998 112.616 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.52 121.66 43.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.59 0.356 . . . . 73.120000000000005 110.252 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 160.84 25.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.021 0.439 . . . . 74.239999999999995 111.118 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 7.9 tt -120.36 104.43 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.631 0.729 . . . . 72.439999999999998 111.421 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.6 t -68.93 102.52 1.6 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.647 -0.706 . . . . 75.540000000000006 110.296 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.507 ' HB ' HD22 ' A' ' 226' ' ' LEU . 21.7 t -74.43 117.72 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.264 -0.425 . . . . 72.340000000000003 112.122 -173.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -94.97 -21.7 18.44 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.879 0.371 . . . . 71.230000000000004 111.1 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -156.61 120.76 4.4 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.798 0.332 . . . . 73.219999999999999 110.944 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.487 ' HB ' HG12 ' A' ' 258' ' ' VAL . 11.4 tt -125.3 135.37 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.034 0.445 . . . . 73.230000000000004 111.582 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -133.59 125.29 3.92 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.15 -0.548 . . . . 75.420000000000002 112.763 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.538 ' HB ' ' HD3' ' A' ' 266' ' ' LYS . 49.4 mm -76.02 139.9 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.942 0.401 . . . . 75.340000000000003 110.737 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.521 HG23 ' HG3' ' A' ' 265' ' ' GLU . 48.1 mm -70.37 -46.4 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.776 0.322 . . . . 73.420000000000002 111.717 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.521 ' HG3' HG23 ' A' ' 264' ' ' ILE . 41.1 mt-10 -136.68 106.42 6.21 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.741 0.305 . . . . 75.5 111.317 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.538 ' HD3' ' HB ' ' A' ' 263' ' ' ILE . 2.8 mmmp? -77.25 103.66 7.31 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.018 0.437 . . . . 72.510000000000005 111.057 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 40.7 t -83.04 125.89 31.94 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.261 -0.427 . . . . 75.109999999999999 111.524 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 86.7 mt -99.55 -43.17 6.61 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.038 0.447 . . . . 74.349999999999994 110.915 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 118.633 -0.698 . . . . 55.439999999999998 111.092 179.282 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 16.4 tpt . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.795 0.331 . . . . 72.420000000000002 111.556 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -85.15 138.65 32.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.131 0.491 . . . . 73.329999999999998 111.066 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -106.52 153.93 21.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.298 0.571 . . . . 64.109999999999999 111.603 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -93.21 155.68 17.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.318 -0.623 . . . . 73.239999999999995 109.318 167.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 49.4 mt -61.33 -24.59 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.076 0.465 . . . . 74.019999999999996 111.599 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.44 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 39.2 t -70.75 -12.9 61.83 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.131 0.419 . . . . 74.239999999999995 112.131 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -97.3 -1.94 43.61 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.603 0.594 . . . . 72.420000000000002 112.603 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.51 HD21 HG22 ' A' ' 247' ' ' VAL . 88.4 mt -68.08 150.68 48.11 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.176 0.806 . . . . 75.319999999999993 113.176 -172.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -162.23 156.4 18.51 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.289 -0.869 . . . . 75.120000000000005 110.213 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.62 138.16 83.74 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.307 2.004 . . . . 74.319999999999993 113.295 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.406 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 65.3 m-20 65.42 33.4 8.9 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.161 0.585 . . . . 72.209999999999994 111.562 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 52.8 tp -96.03 145.51 25.39 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.119 -0.491 . . . . 71.230000000000004 111.739 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 75.4 p -120.98 129.36 53.39 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.245 -0.434 . . . . 65.219999999999999 110.693 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.67 179.53 47.87 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.714 -0.755 . . . . 71.540000000000006 113.761 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 77.2 m -121.55 128.14 51.7 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.735 0.302 . . . . 71.450000000000003 111.343 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 34.7 pt -120.5 152.79 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.171 0.51 . . . . 73.439999999999998 111.888 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -114.55 105.88 13.61 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.127 -0.488 . . . . 72.299999999999997 110.243 176.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.07 164.97 25.07 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.862 0.69 . . . . 61.140000000000001 112.862 -173.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.2 136.84 40.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.606 -0.725 . . . . 72.230000000000004 111.44 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.14 102.52 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.912 0.386 . . . . 72.150000000000006 111.519 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.7 t -82.62 -34.1 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.004 0.43 . . . . 72.25 111.872 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -141.17 117.74 10.9 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.757 0.313 . . . . 61.030000000000001 111.31 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -95.35 98.96 10.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.973 0.416 . . . . 63.340000000000003 110.981 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -78.5 143.96 64.75 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.463 -0.335 . . . . 74.430000000000007 111.078 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.12 151.6 83.32 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.775 2.317 . . . . 74.340000000000003 112.863 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 231' ' ' ALA . 20.5 ptmt -67.74 125.24 25.6 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.579 0.585 . . . . 72.409999999999997 112.579 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -94.1 153.16 18.27 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.044 -0.525 . . . . 75.409999999999997 110.94 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.49 143.96 49.37 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.448 -0.342 . . . . 75.409999999999997 110.743 176.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -162.36 163.21 28.0 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.296 0.569 . . . . 75.109999999999999 111.695 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 37.6 t -91.51 133.03 35.86 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.984 -0.553 . . . . 74.310000000000002 110.505 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -72.83 164.05 27.18 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.815 0.34 . . . . 64.310000000000002 111.664 177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -64.24 -20.46 66.06 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.21 0.529 . . . . 75.109999999999999 110.457 174.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.26 -8.8 59.32 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.79 -0.641 . . . . 62.240000000000002 111.453 176.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 77.97 14.66 82.09 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.049 -0.596 . . . . 71.140000000000001 112.714 -174.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 67.8 p -107.11 172.11 7.01 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.954 0.353 . . . . 61.32 111.954 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . 0.688 ' HZ3' ' HB3' ' A' ' 207' ' ' LYS . 8.0 mtpm? -59.16 136.99 58.13 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.517 0.562 . . . . 73.549999999999997 112.517 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.57 131.92 3.95 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.273 -0.489 . . . . 40.32 112.887 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 228' ' ' ASN . 37.5 mt-30 -128.75 155.44 45.12 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.343 -0.504 . . . . 73.230000000000004 110.301 175.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 48.3 tp -142.48 112.75 7.13 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.766 0.317 . . . . 73.439999999999998 111.64 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 49.3 tttm -126.62 108.09 10.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.704 0.288 . . . . 62.109999999999999 110.834 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 66.9 m -86.27 150.07 24.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.932 0.396 . . . . 63.340000000000003 111.566 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.417 HD22 ' HZ2' ' A' ' 211' ' ' LYS . 91.7 mt -137.24 134.94 36.75 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.422 -0.354 . . . . 75.400000000000006 110.915 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -89.59 106.46 18.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.73 0.3 . . . . 75.25 110.224 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.67 141.96 34.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.503 0.321 . . . . 74.450000000000003 110.999 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -127.96 155.06 44.85 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.593 0.711 . . . . 74.409999999999997 112.443 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -148.24 160.9 42.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.06 -0.973 . . . . 74.150000000000006 109.347 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.18 -21.08 64.79 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.992 0.425 . . . . 75.129999999999995 111.553 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 72.3 p -92.49 -1.27 57.09 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.212 0.449 . . . . 73.420000000000002 112.212 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 148.06 176.75 21.84 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.071 -0.585 . . . . 75.530000000000001 113.612 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.7 p -120.48 158.8 26.46 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.503 -0.41 . . . . 72.329999999999998 111.341 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -157.95 145.28 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.92 0.39 . . . . 74.409999999999997 111.265 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -96.71 112.08 23.98 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.918 0.39 . . . . 71.030000000000001 111.197 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.4 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -81.91 159.08 39.43 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 116.101 -0.5 . . . . 38.810000000000002 113.366 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 84.9 m -129.08 114.63 16.6 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.357 0.503 . . . . 63.100000000000001 112.357 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 92.3 mt -95.6 117.28 30.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.437 -0.347 . . . . 71.420000000000002 110.993 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -99.07 156.35 16.98 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.086 0.47 . . . . 74.310000000000002 111.754 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 209' ' ' GLN . 61.2 t30 61.51 -146.84 0.42 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.968 -0.56 . . . . 72.040000000000006 111.482 174.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.407 ' H ' ' CG ' ' A' ' 228' ' ' ASN . 12.3 pt-20 -64.43 -4.9 4.38 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.661 0.615 . . . . 72.510000000000005 112.661 -174.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 93.1 mt -65.29 -15.63 62.72 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.101 0.477 . . . . 74.400000000000006 110.707 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 197' ' ' LYS . . . -65.88 -23.07 66.57 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.201 -0.454 . . . . 52.329999999999998 111.499 175.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.21 4.09 53.17 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.286 -0.415 . . . . 74.209999999999994 111.557 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -69.3 113.8 6.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.044 0.45 . . . . 74.109999999999999 110.488 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.85 90.61 0.43 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.38 0.61 . . . . 63.240000000000002 111.838 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.0 p -128.44 122.83 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.509 -0.769 . . . . 65.010000000000005 110.794 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -113.63 172.36 7.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.098 0.475 . . . . 74.25 111.428 -175.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -65.4 122.1 16.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.361 -0.381 . . . . 73.239999999999995 110.848 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.14 -26.58 9.71 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.157 -0.544 . . . . 74.420000000000002 113.596 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -65.87 130.81 44.54 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 117.188 0.494 . . . . 64.319999999999993 111.618 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 42.0 mm -77.71 108.36 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.078 -0.51 . . . . 72.219999999999999 110.08 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -113.78 130.12 56.49 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.318 0.58 . . . . 71.230000000000004 112.555 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . 0.53 ' HB2' HD12 ' A' ' 264' ' ' ILE . 40.3 tt0 -92.72 112.7 24.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.905 -0.589 . . . . 73.430000000000007 109.597 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.1 t -115.34 127.04 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.269 0.557 . . . . 74.219999999999999 112.423 -172.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.7 t -124.24 132.9 53.62 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.091 -0.504 . . . . 71.340000000000003 109.79 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.02 -164.9 29.83 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.121 -1.038 . . . . 71.230000000000004 114.196 -177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -106.95 115.36 30.05 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.077 0.465 . . . . 73.219999999999999 111.172 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.51 HG22 HD21 ' A' ' 179' ' ' LEU . 47.5 t -89.09 123.87 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.294 -0.412 . . . . 74.099999999999994 111.052 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.406 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 26.6 pttm -142.37 158.23 43.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.094 0.473 . . . . 75.319999999999993 112.005 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -100.38 155.22 17.93 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.176 -0.465 . . . . 71.5 111.317 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 178.48 -152.79 11.81 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.9 -0.667 . . . . 62.409999999999997 113.161 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -61.14 -28.67 69.28 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.057 0.456 . . . . 74.430000000000007 111.731 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.6 t -86.88 10.9 14.7 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.918 0.39 . . . . 70.219999999999999 111.32 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 79.52 -131.51 10.66 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.081 -0.58 . . . . 63.509999999999998 112.191 -176.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 97.2 mt -95.56 115.67 27.76 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 117.017 0.409 . . . . 74.349999999999994 110.827 174.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -120.93 161.24 21.91 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.078 0.466 . . . . 63.329999999999998 111.481 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.418 ' HB ' HG21 ' A' ' 247' ' ' VAL . 6.9 tt -128.17 105.14 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.419 0.628 . . . . 72.150000000000006 110.83 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 72.4 m -73.59 106.95 5.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.114 -0.494 . . . . 74.430000000000007 110.049 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.521 HG11 ' HB ' ' A' ' 261' ' ' ILE . 46.5 t -66.6 129.67 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 113.17 0.804 . . . . 62.32 113.17 -171.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.64 -47.18 6.32 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.695 -0.684 . . . . 73.299999999999997 110.267 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -135.74 128.2 30.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.975 -0.557 . . . . 72.519999999999996 110.452 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.521 ' HB ' HG11 ' A' ' 258' ' ' VAL . 10.7 tt -134.25 135.02 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.777 0.322 . . . . 75.310000000000002 111.217 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -144.59 136.89 6.92 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.844 -0.693 . . . . 70.219999999999999 113.362 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.84 106.75 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.87 0.367 . . . . 75.0 110.964 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.53 HD12 ' HB2' ' A' ' 242' ' ' GLU . 63.4 mt -66.37 -61.4 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.079 0.466 . . . . 71.049999999999997 111.125 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -102.79 97.2 7.39 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.031 -0.531 . . . . 75.129999999999995 110.73 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -102.77 161.19 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.977 0.418 . . . . 74.219999999999999 111.368 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 68.7 p -121.64 115.64 23.12 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.981 0.419 . . . . 64.120000000000005 111.814 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . 0.571 HD11 ' N ' ' A' ' 269' ' ' GLU . 2.0 pp -154.33 -29.85 0.12 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.043 -0.526 . . . . 72.319999999999993 111.471 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.571 ' N ' HD11 ' A' ' 268' ' ' LEU . 65.9 mm-40 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.75 -0.643 . . . . 74.409999999999997 111.094 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.448 ' SD ' ' N ' ' A' ' 172' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.186 0.517 . . . . 65.349999999999994 112.202 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 186' ' ' THR . 12.3 m120 -98.89 110.83 23.38 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.153 -0.476 . . . . 72.450000000000003 110.53 172.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -99.19 156.66 16.85 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.157 0.503 . . . . 53.140000000000001 111.377 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -98.72 168.17 10.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.507 -0.553 . . . . 74.209999999999994 109.507 169.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' A' ' 222' ' ' ILE . 56.8 mt -64.49 -18.5 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.359 0.503 . . . . 74.439999999999998 112.359 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 40.9 t -71.55 -36.46 70.97 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.001 0.371 . . . . 75.450000000000003 112.001 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -79.05 -10.22 59.76 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.511 0.56 . . . . 71.340000000000003 112.511 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.54 HD22 HG22 ' A' ' 247' ' ' VAL . 69.1 mt -62.52 121.73 14.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.315 0.579 . . . . 75.099999999999994 111.998 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.0 ptp -140.88 160.82 57.0 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.69 -0.686 . . . . 71.040000000000006 110.348 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' A' ' 248' ' ' LYS . 18.4 Cg_endo -58.63 133.94 57.6 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.941 1.761 . . . . 74.040000000000006 112.367 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 71.68 29.78 2.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.979 0.512 . . . . 74.239999999999995 111.726 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.62 138.37 40.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.033 0.444 . . . . 75.439999999999998 111.402 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.2 p -116.51 128.37 55.38 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.574 -0.284 . . . . 54.439999999999998 110.537 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.5 178.0 45.93 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.083 -1.055 . . . . 61.530000000000001 114.164 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 61.8 m -113.12 121.84 45.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.393 0.277 . . . . 74.530000000000001 111.627 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 23.6 pt -102.87 152.77 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.073 0.463 . . . . 74.400000000000006 112.029 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.96 110.98 17.34 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.191 -0.459 . . . . 73.340000000000003 111.607 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -161.39 167.12 26.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.835 0.35 . . . . 73.150000000000006 111.668 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.471 ' HB3' HD12 ' A' ' 240' ' ' ILE . 12.5 pt-20 -95.63 149.55 21.33 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.052 0.453 . . . . 74.409999999999997 111.493 176.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 23.5 t -81.81 114.17 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.352 0.596 . . . . 75.120000000000005 111.939 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.433 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 25.4 t -82.23 -52.39 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.945 -0.57 . . . . 73.209999999999994 111.451 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -127.58 128.65 45.94 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.254 -0.43 . . . . 72.430000000000007 111.388 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -114.45 119.08 35.64 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.26 -0.427 . . . . 54.119999999999997 111.17 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.428 ' O ' ' HG2' ' A' ' 211' ' ' LYS . 25.7 m-85 -89.13 140.15 28.86 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.445 -0.343 . . . . 72.140000000000001 111.337 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.73 172.9 14.31 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.56 2.173 . . . . 70.530000000000001 113.186 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . 0.471 ' HZ1' ' HB3' ' A' ' 197' ' ' LYS . 0.1 OUTLIER -53.85 134.98 42.61 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.482 0.919 . . . . 73.430000000000007 113.482 -177.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -111.4 134.83 52.69 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.165 -0.68 . . . . 74.239999999999995 109.165 166.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.94 134.6 44.9 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.976 0.732 . . . . 74.319999999999993 112.976 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -150.81 166.89 29.14 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.111 -0.495 . . . . 73.230000000000004 110.843 172.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 59.3 p -115.44 151.91 33.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.798 0.332 . . . . 62.219999999999999 111.238 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -107.95 149.4 28.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.032 0.444 . . . . 73.400000000000006 111.913 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -52.66 -30.66 33.05 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.763 0.653 . . . . 71.109999999999999 112.763 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.34 -2.39 21.93 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.27 0.47 . . . . 75.120000000000005 112.27 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 83.74 8.53 84.35 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.407 -0.425 . . . . 65.5 112.94 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 52.9 p -92.3 162.94 14.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.016 0.436 . . . . 71.340000000000003 111.595 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -67.86 162.21 24.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.38 0.609 . . . . 74.540000000000006 111.869 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.44 142.79 9.05 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.541 -0.754 . . . . 75.129999999999995 112.316 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -152.68 145.29 24.21 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.154 0.502 . . . . 73.099999999999994 111.659 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.7 tp -125.16 145.31 50.02 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.558 -0.746 . . . . 74.239999999999995 110.957 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.43 ' HE2' HD23 ' A' ' 213' ' ' LEU . 1.6 tmtp? -146.97 136.16 22.57 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.174 -0.328 . . . . 75.439999999999998 110.979 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 51.5 m -111.89 153.97 25.88 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.293 0.479 . . . . 75.310000000000002 112.293 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.43 HD23 ' HE2' ' A' ' 211' ' ' LYS . 95.5 mt -136.68 161.82 34.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.919 -0.582 . . . . 74.129999999999995 110.921 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -128.23 120.04 26.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.621 0.248 . . . . 71.540000000000006 110.869 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.581 HD11 HG21 ' A' ' 243' ' ' VAL . 78.8 mt -114.74 142.93 45.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.554 0.342 . . . . 75.510000000000005 110.653 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -134.92 147.94 49.93 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.346 0.593 . . . . 74.439999999999998 111.994 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -152.32 168.58 24.96 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.55 -0.75 . . . . 73.120000000000005 109.864 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -62.33 -25.23 67.77 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.99 0.424 . . . . 71.329999999999998 111.465 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 80.6 p -79.93 -14.75 58.38 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.403 0.52 . . . . 73.129999999999995 112.403 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 154.54 -179.03 30.98 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.939 -0.648 . . . . 75.129999999999995 113.351 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 84.8 p -127.89 125.75 40.22 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.496 -0.414 . . . . 73.329999999999998 110.976 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.413 ' HB ' HG23 ' A' ' 176' ' ' ILE . 10.1 tp -126.82 148.13 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.122 0.487 . . . . 74.519999999999996 111.93 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 73.9 mtm-85 -100.16 138.7 36.87 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.056 0.455 . . . . 74.150000000000006 110.953 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -114.63 152.25 18.16 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.303 -0.475 . . . . 73.439999999999998 113.197 -176.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 59.5 m -124.45 125.55 44.44 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.151 0.426 . . . . 72.519999999999996 112.151 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.534 HD22 ' HB ' ' A' ' 258' ' ' VAL . 83.4 mt -109.92 134.56 51.95 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.017 0.527 . . . . 72.439999999999998 111.246 176.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -114.58 172.13 7.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.926 0.393 . . . . 74.200000000000003 111.094 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 54.1 t30 57.89 -153.6 0.37 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 116.148 -0.478 . . . . 64.010000000000005 111.207 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.98 -27.11 61.15 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.822 -0.549 . . . . 72.230000000000004 112.46 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 73.7 mt -60.59 -18.83 55.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.906 0.384 . . . . 75.310000000000002 111.633 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.407 ' HB3' ' HB2' ' A' ' 211' ' ' LYS . . . -59.47 -44.05 93.12 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.847 0.356 . . . . 64.230000000000004 111.494 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -90.67 13.39 16.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.903 0.334 . . . . 74.200000000000003 111.903 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -55.35 130.02 40.84 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.37 0.268 . . . . 75.340000000000003 110.722 175.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -70.71 77.44 0.61 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.524 0.678 . . . . 74.540000000000006 112.222 -174.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.66 139.75 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.927 -0.579 . . . . 74.099999999999994 110.23 174.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.406 ' HB3' ' NZ ' ' A' ' 236' ' ' LYS . 0.1 OUTLIER -126.75 115.8 19.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.363 0.601 . . . . 73.519999999999996 111.784 -173.106 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.632 ' HB2' ' HZ1' ' A' ' 237' ' ' LYS . 4.8 ttmp? -42.99 109.24 0.13 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.533 -0.758 . . . . 75.310000000000002 112.894 -172.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.48 4.53 23.38 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.095 -0.502 . . . . 52.450000000000003 113.685 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -86.21 156.67 20.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.148 0.499 . . . . 64.319999999999993 111.872 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.471 HD12 ' HB3' ' A' ' 190' ' ' GLU . 38.1 mm -92.09 103.71 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.267 -0.424 . . . . 74.010000000000005 110.909 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -107.25 119.65 39.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.321 0.489 . . . . 74.430000000000007 112.321 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -87.15 103.49 15.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.24 0.543 . . . . 72.200000000000003 109.77 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.581 HG21 HD11 ' A' ' 215' ' ' LEU . 78.7 t -100.0 124.3 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 112.799 0.666 . . . . 75.519999999999996 112.799 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 42.4 t -118.02 123.53 45.92 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.32 -0.4 . . . . 62.420000000000002 110.781 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 258' ' ' VAL . . . -167.22 -161.48 16.61 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.415 -0.897 . . . . 73.120000000000005 114.202 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -112.9 114.36 26.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.465 0.306 . . . . 74.329999999999998 110.991 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.54 HG22 HD22 ' A' ' 179' ' ' LEU . 25.8 t -90.52 128.14 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.657 0.265 . . . . 71.209999999999994 110.977 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 181' ' ' PRO . 14.6 ptmm? -154.16 170.86 20.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.269 0.557 . . . . 71.219999999999999 112.016 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -101.36 150.4 23.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.882 -0.599 . . . . 74.209999999999994 110.83 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 168.16 -108.33 0.3 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.531 -0.842 . . . . 62.109999999999999 113.144 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -73.11 137.67 45.36 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.803 -0.234 . . . . 75.239999999999995 110.854 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 50.4 m 73.81 -51.99 0.69 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.192 0.597 . . . . 73.230000000000004 111.775 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 161.43 -114.29 0.6 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.269 -0.491 . . . . 72.230000000000004 113.004 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 96.5 mt -110.68 106.34 15.53 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.664 -0.315 . . . . 71.25 111.196 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -136.43 170.27 16.31 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.12 0.486 . . . . 74.120000000000005 111.705 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.483 ' HB ' HG21 ' A' ' 247' ' ' VAL . 7.3 tt -116.65 121.7 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.471 0.545 . . . . 74.540000000000006 112.471 -176.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.5 t -85.72 103.79 14.83 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.009 0.433 . . . . 72.430000000000007 109.917 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.534 ' HB ' HD22 ' A' ' 226' ' ' LEU . 27.0 t -74.56 136.49 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 112.544 0.572 . . . . 74.340000000000003 112.544 -171.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -105.13 -39.95 6.04 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.314 -0.403 . . . . 65.349999999999994 110.612 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -134.61 138.68 44.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.156 -0.474 . . . . 64.030000000000001 110.952 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.7 tt -141.45 123.66 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.05 0.452 . . . . 73.439999999999998 111.242 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -128.33 131.51 6.98 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.029 -0.605 . . . . 62.439999999999998 113.375 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.77 116.1 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 O-C-N 122.681 -0.306 . . . . 61.100000000000001 110.369 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 50.6 mt -56.79 -43.29 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.716 0.293 . . . . 74.409999999999997 111.681 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -95.76 90.06 5.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.065 0.459 . . . . 74.299999999999997 111.203 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -69.04 80.94 0.32 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.521 0.677 . . . . 64.230000000000004 110.827 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 45.9 m -96.91 107.43 19.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.644 -0.707 . . . . 75.340000000000003 111.36 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 88.0 mt -74.61 102.54 4.59 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.943 0.401 . . . . 72.430000000000007 111.238 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 C--O 1.254 1.331 0 CA-C-O 118.615 -0.707 . . . . 73.109999999999999 112.342 179.69 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.81 0.338 . . . . 73.450000000000003 111.242 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -102.67 146.24 28.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.88 0.372 . . . . 75.200000000000003 111.52 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -131.78 158.17 41.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.077 0.465 . . . . 75.219999999999999 111.299 176.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -90.75 155.6 18.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.149 -0.478 . . . . 74.409999999999997 110.267 169.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 65.1 mt -54.49 -35.61 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 112.522 0.564 . . . . 72.439999999999998 112.522 -174.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.527 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 68.2 p -57.96 -41.23 82.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.233 0.457 . . . . 72.120000000000005 112.233 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -73.42 -22.18 60.28 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.274 0.472 . . . . 73.310000000000002 112.274 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.572 HD11 HG21 ' A' ' 187' ' ' ILE . 81.7 mt -55.74 111.7 0.98 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.282 0.563 . . . . 74.340000000000003 112.386 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' MET . . . . . 0.443 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.1 ptp -106.64 157.63 34.67 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.545 -0.752 . . . . 65.25 110.997 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.17 130.6 40.42 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.336 2.024 . . . . 71.549999999999997 113.196 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 70.52 33.68 2.36 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.357 0.663 . . . . 74.120000000000005 111.854 177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.443 HD22 ' HG2' ' A' ' 180' ' ' MET . 46.9 tp -102.09 134.41 45.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.216 -0.447 . . . . 63.200000000000003 111.318 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 81.4 p -110.31 118.35 36.09 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.27 -0.269 . . . . 64.329999999999998 111.077 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -173.79 -172.21 38.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.862 -0.685 . . . . 65.5 113.681 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.1 m -114.08 136.7 52.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.712 0.264 . . . . 75.510000000000005 111.712 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.572 HG21 HD11 ' A' ' 179' ' ' LEU . 33.2 pt -125.57 141.31 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.941 0.401 . . . . 75.519999999999996 111.227 175.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -115.21 116.27 28.07 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 73.120000000000005 111.608 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -158.66 178.33 10.23 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.31 -0.405 . . . . 74.409999999999997 111.362 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . 0.51 ' HB3' HD11 ' A' ' 240' ' ' ILE . 12.3 pt-20 -99.79 146.24 26.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.052 0.453 . . . . 74.120000000000005 111.493 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.48 HG21 HG21 ' A' ' 235' ' ' VAL . 58.1 t -76.15 108.73 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.11 -0.496 . . . . 75.510000000000005 111.831 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 216' ' ' LYS . 14.6 t -76.18 -27.62 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.046 0.451 . . . . 74.400000000000006 111.902 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -155.14 130.97 10.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.135 0.493 . . . . 73.340000000000003 112.016 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -113.53 102.65 10.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 63.350000000000001 110.031 174.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -84.33 155.37 63.16 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 111.962 0.356 . . . . 73.319999999999993 111.962 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.21 140.38 94.03 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.662 2.241 . . . . 71.140000000000001 112.787 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -75.41 126.33 30.81 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.521 0.677 . . . . 75.140000000000001 112.654 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.455 ' N ' ' HD2' ' A' ' 198' ' ' LYS . 2.9 mptp? -86.31 169.49 12.92 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.529 -0.759 . . . . 71.420000000000002 111.331 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -138.21 143.81 40.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.111 -0.495 . . . . 75.439999999999998 110.935 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.67 144.69 24.54 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.349 0.595 . . . . 74.219999999999999 112.316 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 81.2 p -94.59 117.47 30.18 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.709 -0.678 . . . . 73.239999999999995 110.243 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -77.86 146.98 35.35 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.667 0.27 . . . . 74.099999999999994 111.635 -175.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -70.63 -12.98 61.9 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.569 0.699 . . . . 75.340000000000003 109.74 171.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -56.3 -29.92 61.83 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.268 -0.878 . . . . 53.409999999999997 110.729 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 112.85 -29.61 8.0 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.882 -0.599 . . . . 55.310000000000002 112.487 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 67.8 p -89.7 159.21 17.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.314 0.578 . . . . 72.109999999999999 112.212 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -74.91 156.5 36.3 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.158 -0.474 . . . . 73.209999999999994 111.481 176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -147.26 144.32 12.39 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.898 -0.668 . . . . 71.109999999999999 113.451 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -113.47 162.65 15.87 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.74 -0.271 . . . . 75.310000000000002 110.439 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 49.4 tp -153.69 113.72 3.91 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.17 0.433 . . . . 72.340000000000003 112.17 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.416 ' HB3' ' HZ3' ' A' ' 211' ' ' LYS . 6.4 ttpm? -127.04 118.23 24.03 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.669 -0.645 . . . . 72.25 111.734 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.6 p -84.06 147.75 27.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.976 0.417 . . . . 73.409999999999997 111.711 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.402 HD23 ' HE2' ' A' ' 211' ' ' LYS . 97.0 mt -132.41 178.17 7.04 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.05 -0.523 . . . . 72.209999999999994 110.44 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.444 ' CE2' ' HB3' ' A' ' 221' ' ' SER . 21.0 t80 -141.84 138.31 32.08 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.184 -0.323 . . . . 74.140000000000001 110.635 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.477 HD11 HG22 ' A' ' 243' ' ' VAL . 91.2 mt -126.49 151.79 47.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.503 0.321 . . . . 74.239999999999995 111.344 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . 0.742 ' HB2' ' HZ2' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -135.76 149.3 49.12 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.496 0.554 . . . . 74.420000000000002 112.496 -178.655 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -154.68 167.33 30.52 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.486 -0.779 . . . . 71.120000000000005 109.9 174.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.52 -18.57 62.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.209 0.528 . . . . 75.349999999999994 111.601 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 75.0 p -91.05 -0.22 57.68 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.572 0.582 . . . . 61.420000000000002 112.572 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 138.92 -178.97 19.03 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.866 -0.683 . . . . 75.400000000000006 113.261 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.444 ' HB3' ' CE2' ' A' ' 214' ' ' PHE . 67.9 m -130.83 138.9 50.09 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.583 -0.363 . . . . 74.519999999999996 111.16 177.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 13.4 tt -141.95 153.84 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 120.779 0.323 . . . . 73.120000000000005 111.612 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -92.6 147.39 22.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.08 0.467 . . . . 71.129999999999995 111.745 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -112.96 157.33 15.01 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.286 -0.416 . . . . 72.530000000000001 112.531 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 63.4 m -133.15 116.09 15.85 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.197 0.498 . . . . 64.200000000000003 111.988 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.537 HD22 ' HB ' ' A' ' 258' ' ' VAL . 74.2 mt -98.9 116.27 30.77 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.422 -0.354 . . . . 74.329999999999998 111.608 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -102.22 165.77 10.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.995 0.426 . . . . 75.120000000000005 111.764 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 62.5 t30 58.6 -141.88 0.68 Allowed 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.977 -0.556 . . . . 73.0 111.735 171.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.43 -34.61 75.68 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.912 -0.493 . . . . 75.409999999999997 112.27 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.98 -7.64 30.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.964 0.411 . . . . 74.409999999999997 111.911 -176.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -66.11 -34.26 77.65 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 122.133 -0.354 . . . . 73.030000000000001 111.951 177.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -84.74 1.0 48.57 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.947 -0.471 . . . . 75.129999999999995 111.861 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -52.09 116.19 2.08 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.825 0.345 . . . . 75.340000000000003 111.052 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -81.7 121.7 26.71 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.909 -0.587 . . . . 74.219999999999999 111.62 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.48 HG21 HG21 ' A' ' 191' ' ' VAL . 13.1 p -136.12 159.69 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.379 -0.373 . . . . 73.120000000000005 111.339 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.448 ' HZ1' ' HB3' ' A' ' 236' ' ' LYS . 8.8 mtpm? -110.67 163.87 13.31 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.126 0.489 . . . . 72.319999999999993 111.403 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 237' ' ' LYS . 13.2 tmtt? -90.01 123.2 33.7 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.17 -0.468 . . . . 75.099999999999994 110.794 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.99 0.61 56.13 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.241 -0.436 . . . . 61.409999999999997 113.679 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.81 150.2 21.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.934 0.397 . . . . 74.319999999999993 111.772 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 190' ' ' GLU . 32.5 mm -85.31 119.74 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 116.288 -0.415 . . . . 73.439999999999998 111.737 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -130.36 144.92 51.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.725 0.639 . . . . 75.409999999999997 112.725 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -100.5 115.11 29.32 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.841 -0.618 . . . . 75.099999999999994 110.197 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 215' ' ' LEU . 57.5 t -111.02 123.32 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.441 0.534 . . . . 72.430000000000007 112.441 -172.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 67.4 m -107.9 122.21 46.34 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.57 -0.287 . . . . 72.549999999999997 110.821 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -165.9 -164.47 21.46 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.99 -1.1 . . . . 51.439999999999998 114.858 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.403 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 75.4 t80 -122.47 106.01 10.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.123 0.569 . . . . 73.120000000000005 110.938 -177.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.524 HG21 ' HB ' ' A' ' 256' ' ' ILE . 40.6 t -76.57 114.28 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.422 -0.353 . . . . 73.340000000000003 110.998 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.403 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 20.8 ptmt -129.63 153.29 48.25 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.473 0.654 . . . . 71.0 112.197 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -91.62 140.29 29.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.906 -0.588 . . . . 73.519999999999996 111.814 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 140.02 -67.78 0.49 Allowed Glycine 0 CA--C 1.522 0.492 0 CA-C-N 116.051 -0.522 . . . . 75.340000000000003 112.899 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -63.27 97.3 0.12 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.851 0.358 . . . . 72.230000000000004 110.962 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.1 t 61.49 27.22 16.81 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.344 -0.389 . . . . 72.329999999999998 111.93 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.76 -106.43 2.91 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 121.283 -0.484 . . . . 72.120000000000005 112.785 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.99 122.84 44.27 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.597 -0.355 . . . . 75.540000000000006 111.446 176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -139.81 162.75 34.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.93 0.395 . . . . 73.239999999999995 111.029 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.524 ' HB ' HG21 ' A' ' 247' ' ' VAL . 9.3 tt -108.97 104.93 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 121.388 0.613 . . . . 75.150000000000006 111.735 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.4 t -64.77 93.81 0.12 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.978 -0.556 . . . . 73.040000000000006 110.154 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.537 ' HB ' HD22 ' A' ' 226' ' ' LEU . 39.9 t -66.77 125.36 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.053 0.454 . . . . 70.409999999999997 112.143 -174.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -96.11 -28.44 14.59 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.167 -0.469 . . . . 74.430000000000007 110.976 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -160.02 141.71 12.79 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.92 -0.582 . . . . 73.420000000000002 110.5 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.4 tt -138.1 138.65 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.246 0.461 . . . . 75.310000000000002 112.246 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -140.83 119.63 1.58 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.36 -0.448 . . . . 60.439999999999998 112.399 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.413 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 63.8 mt -74.13 126.79 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 122.467 -0.431 . . . . 74.400000000000006 111.318 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 240' ' ' ILE . 69.0 mt -69.91 -50.18 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.998 0.428 . . . . 75.329999999999998 111.138 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -152.11 113.75 4.36 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.276 0.56 . . . . 72.310000000000002 112.017 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.413 ' HG3' HG22 ' A' ' 263' ' ' ILE . 56.7 mtmt -84.49 115.71 22.72 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.157 0.503 . . . . 74.200000000000003 110.69 171.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 41.3 t -98.63 158.18 15.78 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.724 -0.671 . . . . 72.329999999999998 111.116 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 1.2 pp -161.17 173.6 14.86 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.89 0.376 . . . . 70.230000000000004 111.996 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.921 -0.562 . . . . 74.129999999999995 111.595 177.391 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 110.026 -0.361 . . . . 72.299999999999997 110.026 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -85.12 129.36 34.81 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.561 0.578 . . . . 63.25 112.561 -172.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.17 153.64 50.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.182 -0.463 . . . . 74.519999999999996 111.002 177.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.553 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 32.2 mmtp -82.07 162.92 22.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.364 -0.606 . . . . 74.200000000000003 109.364 170.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 35.6 mm -52.7 -45.36 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.638 0.733 . . . . 71.120000000000005 110.441 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.2 t -57.12 -28.7 62.93 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.34 -0.846 . . . . 72.430000000000007 112.607 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.553 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 15.6 mm-40 -92.98 2.77 56.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.913 0.338 . . . . 73.120000000000005 111.913 -174.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.499 HD21 HG22 ' A' ' 247' ' ' VAL . 90.6 mt -81.93 139.0 34.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.992 0.425 . . . . 75.420000000000002 111.331 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 55.8 mtt -132.78 155.18 81.47 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.39 -0.368 . . . . 74.230000000000004 111.255 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.468 ' HG3' HD23 ' A' ' 254' ' ' LEU . 44.3 Cg_exo -58.08 130.69 39.27 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.33 2.02 . . . . 64.340000000000003 112.454 174.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 70.34 22.55 5.32 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.947 0.499 . . . . 64.129999999999995 111.738 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.9 tt -111.18 131.36 55.17 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.0 0.429 . . . . 74.430000000000007 111.263 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.4 m -93.85 136.61 33.95 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.526 -0.306 . . . . 65.319999999999993 110.964 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.71 -174.47 36.72 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.393 -0.908 . . . . 63.450000000000003 113.954 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 53.1 m -131.65 131.68 43.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.666 0.386 . . . . 75.310000000000002 110.777 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.444 HG21 HD11 ' A' ' 179' ' ' LEU . 33.6 pt -124.53 150.35 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.562 0.696 . . . . 75.439999999999998 112.554 -176.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -112.74 103.38 11.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.768 -0.651 . . . . 75.420000000000002 110.093 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -144.01 168.61 19.58 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.793 0.33 . . . . 63.409999999999997 111.648 -175.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.01 155.85 16.6 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.126 0.488 . . . . 62.5 111.29 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.526 ' HB ' ' HA ' ' A' ' 237' ' ' LYS . 61.1 t -83.83 114.1 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 116.151 -0.477 . . . . 74.340000000000003 111.553 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.3 t -77.47 -36.68 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.015 0.436 . . . . 63.329999999999998 111.272 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -154.59 143.14 20.66 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.702 -0.681 . . . . 70.200000000000003 111.533 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -133.34 108.39 8.68 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.42 -0.355 . . . . 72.010000000000005 110.987 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -89.62 147.91 38.91 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.306 0.484 . . . . 72.439999999999998 112.306 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.38 159.85 15.09 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.925 2.416 . . . . 74.209999999999994 113.364 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -65.28 160.5 21.48 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.925 0.713 . . . . 74.109999999999999 112.925 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -141.38 173.28 11.64 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.601 -0.727 . . . . 74.409999999999997 111.73 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -130.34 138.73 50.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.715 -0.675 . . . . 73.430000000000007 110.021 172.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . 0.403 ' CE2' ' HD2' ' A' ' 202' ' ' ARG . 11.7 p90 -145.28 173.24 12.13 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.399 0.619 . . . . 75.230000000000004 111.695 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.0 p -99.3 123.96 44.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.563 -0.744 . . . . 73.200000000000003 110.298 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . 0.403 ' HD2' ' CE2' ' A' ' 200' ' ' PHE . 11.1 mmm180 -58.89 130.92 49.28 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.666 0.247 . . . . 74.310000000000002 111.666 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -61.6 -17.45 55.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.487 0.66 . . . . 75.109999999999999 109.911 169.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.6 -28.37 56.14 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.316 -0.856 . . . . 74.129999999999995 111.103 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 147.9 -59.46 0.46 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 120.738 -0.744 . . . . 73.340000000000003 114.562 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.1 p -86.06 -144.16 0.1 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.204 0.816 . . . . 74.230000000000004 113.204 -170.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -113.43 -178.55 3.4 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.471 0.545 . . . . 74.239999999999995 112.471 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.8 168.0 28.33 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.113 -0.565 . . . . 74.019999999999996 113.157 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -96.25 161.38 13.97 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.036 0.446 . . . . 74.420000000000002 111.246 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 45.2 tp -142.17 140.24 32.33 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.331 -0.395 . . . . 75.310000000000002 111.464 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.512 ' HD3' HD11 ' A' ' 226' ' ' LEU . 60.8 tttp -140.67 128.67 22.02 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.752 0.31 . . . . 75.450000000000003 110.745 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.6 t -96.55 134.18 40.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.189 0.518 . . . . 74.25 111.94 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.453 HD13 HD12 ' A' ' 226' ' ' LEU . 95.0 mt -130.83 174.31 10.09 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.919 -0.582 . . . . 74.200000000000003 111.02 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -148.86 121.46 8.58 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.239 -0.437 . . . . 72.219999999999999 110.013 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.8 mt -113.81 161.64 17.31 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.354 0.262 . . . . 61.409999999999997 110.991 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -159.17 154.19 25.04 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.27 0.841 . . . . 72.430000000000007 113.27 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -125.51 -175.48 3.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.448 -1.251 . . . . 75.150000000000006 108.973 163.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.07 -18.06 61.96 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.16 0.505 . . . . 74.329999999999998 110.796 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 77.6 p -81.83 -18.74 42.87 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.045 -0.525 . . . . 75.120000000000005 112.275 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 159.0 178.75 33.3 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.888 -0.672 . . . . 64.129999999999995 113.282 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 50.0 m -115.91 161.87 18.17 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.887 0.375 . . . . 71.430000000000007 111.651 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.6 tp -150.53 149.09 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 120.974 0.416 . . . . 64.140000000000001 111.363 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -89.7 122.77 33.12 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.293 -0.254 . . . . 72.340000000000003 110.934 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.5 120.3 6.83 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.89 -0.671 . . . . 64.310000000000002 112.901 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 62.3 m -111.51 118.94 37.14 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 122.126 -0.632 . . . . 75.140000000000001 111.845 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.512 HD11 ' HD3' ' A' ' 211' ' ' LYS . 94.0 mt -98.09 124.78 42.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.812 0.339 . . . . 75.200000000000003 111.286 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -107.17 150.82 26.19 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.775 0.321 . . . . 73.400000000000006 111.745 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 59.9 t30 56.75 -132.57 1.47 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 116.428 -0.351 . . . . 74.319999999999993 111.824 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.23 -14.16 46.16 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.666 0.617 . . . . 74.299999999999997 112.666 -174.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.49 ' HB3' HD23 ' A' ' 226' ' ' LEU . 86.9 mt -70.8 -18.49 62.74 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.938 -0.476 . . . . 75.010000000000005 111.142 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.16 78.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.741 0.645 . . . . 74.319999999999993 112.741 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -78.15 -3.9 44.82 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.072 0.397 . . . . 74.430000000000007 112.072 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.09 113.94 10.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.928 0.394 . . . . 71.400000000000006 110.766 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -75.83 105.06 6.66 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.198 0.523 . . . . 74.200000000000003 111.827 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.9 p -129.03 126.81 65.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.499 -0.773 . . . . 71.5 110.252 174.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -131.04 172.22 12.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.137 0.494 . . . . 74.329999999999998 111.9 -174.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.526 ' HA ' ' HB ' ' A' ' 191' ' ' VAL . 55.4 tttp -61.81 128.31 35.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.084 0.469 . . . . 74.439999999999998 111.423 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.65 -17.22 30.78 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.252 -0.431 . . . . 65.5 113.016 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -88.73 112.71 23.48 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.968 0.414 . . . . 73.409999999999997 110.79 178.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 51.6 mm -77.29 103.73 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-O 120.995 0.426 . . . . 75.439999999999998 110.933 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.63 ' HB3' HD12 ' A' ' 263' ' ' ILE . . . -110.67 140.9 44.61 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.536 0.569 . . . . 73.340000000000003 112.536 -175.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.1 106.39 18.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.095 0.474 . . . . 75.319999999999993 109.872 171.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.49 HG21 HG13 ' A' ' 261' ' ' ILE . 59.2 t -106.94 117.73 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.371 0.508 . . . . 72.420000000000002 112.371 -171.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 260' ' ' ASN . 82.4 p -106.9 133.52 51.42 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.411 -0.359 . . . . 62.119999999999997 110.557 173.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.6 -171.46 35.99 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.382 -0.913 . . . . 40.210000000000001 113.966 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -103.16 110.11 21.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.64 0.376 . . . . 75.310000000000002 110.877 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.499 HG22 HD21 ' A' ' 179' ' ' LEU . 50.6 t -81.03 122.18 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.874 0.368 . . . . 64.319999999999993 110.819 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -135.28 169.6 17.21 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.975 0.417 . . . . 73.400000000000006 111.328 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -106.74 144.21 33.73 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.887 0.375 . . . . 75.340000000000003 110.791 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -153.75 -106.77 0.29 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.808 -0.71 . . . . 61.109999999999999 113.056 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -76.91 104.36 7.36 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.43 -0.453 . . . . 74.530000000000001 111.898 -176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 52.6 m 68.66 -27.42 0.15 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.829 1.048 . . . . 73.219999999999999 113.829 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -159.48 -152.69 6.57 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.75 -0.738 . . . . 73.25 113.761 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.468 HD23 ' HG3' ' A' ' 181' ' ' PRO . 90.5 mt -101.4 150.96 22.48 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.38 0.609 . . . . 75.430000000000007 112.381 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.63 159.8 41.4 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.634 -0.712 . . . . 74.209999999999994 110.146 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 9.7 tt -118.65 109.04 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.403 0.621 . . . . 63.020000000000003 111.265 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 74.8 m -76.21 106.56 7.89 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.68 -0.489 . . . . 71.450000000000003 109.68 175.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.403 HG11 ' HB ' ' A' ' 261' ' ' ILE . 55.1 t -68.23 137.08 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.048 0.759 . . . . 71.439999999999998 113.048 -170.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -104.73 -37.15 7.18 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.753 -0.658 . . . . 75.209999999999994 110.528 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . 0.417 ' HB3' ' OG ' ' A' ' 244' ' ' SER . 64.0 t30 -149.76 118.43 6.58 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.163 -0.471 . . . . 73.409999999999997 110.849 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.49 HG13 HG21 ' A' ' 243' ' ' VAL . 9.7 tt -123.22 121.23 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.511 0.672 . . . . 75.120000000000005 111.669 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -132.56 125.76 4.28 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.1 -0.571 . . . . 72.209999999999994 113.136 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.63 HD12 ' HB3' ' A' ' 241' ' ' ALA . 32.6 mm -70.06 113.71 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.595 -0.356 . . . . 70.400000000000006 110.535 176.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.04 -66.47 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.963 0.411 . . . . 71.329999999999998 111.366 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -89.5 110.52 21.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.849 0.357 . . . . 71.140000000000001 111.004 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -118.67 97.33 5.68 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.841 0.353 . . . . 72.129999999999995 111.76 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 70.9 m -71.36 94.04 1.19 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.939 -0.393 . . . . 70.319999999999993 109.939 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.63 119.18 16.5 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.213 -0.449 . . . . 75.400000000000006 111.846 -174.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 . . . . . 0 C--O 1.254 1.32 0 CA-C-O 118.783 -0.627 . . . . 75.209999999999994 112.315 -177.156 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.781 0.324 . . . . 70.099999999999994 110.906 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 186' ' ' THR . 23.8 p-10 -89.94 116.38 27.95 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.283 0.563 . . . . 55.420000000000002 111.702 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -108.11 161.97 14.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.105 0.479 . . . . 75.319999999999993 112.138 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -75.88 151.03 37.47 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.264 -0.643 . . . . 73.530000000000001 109.264 163.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.408 HD13 HG23 ' A' ' 222' ' ' ILE . 28.4 mt -58.26 -39.03 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 121.832 -0.543 . . . . 74.219999999999999 111.835 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.0 t -73.81 -20.03 60.58 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.069 0.461 . . . . 72.400000000000006 111.379 175.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -78.94 -19.53 51.51 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.206 0.527 . . . . 71.5 110.711 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 187' ' ' ILE . 95.1 mt -67.12 146.78 53.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.135 0.493 . . . . 74.329999999999998 111.608 177.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.7 ptp -146.67 152.75 45.77 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.205 -0.452 . . . . 70.319999999999993 110.949 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 51.3 Cg_exo -54.63 147.63 48.2 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.983 2.455 . . . . 74.010000000000005 113.655 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.46 29.1 13.47 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.018 -0.537 . . . . 74.329999999999998 112.352 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.9 tt -133.61 136.75 45.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.343 -0.39 . . . . 73.439999999999998 110.886 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.0 p -97.88 133.92 41.72 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.768 0.318 . . . . 72.150000000000006 111.291 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.2 174.55 34.75 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.659 -0.781 . . . . 73.329999999999998 113.743 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.577 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 44.2 m -122.56 138.48 54.56 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.508 0.323 . . . . 71.510000000000005 110.345 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 179' ' ' LEU . 32.9 pt -134.73 146.12 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.262 0.553 . . . . 73.409999999999997 111.909 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -109.87 103.76 12.59 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.821 -0.437 . . . . 73.120000000000005 109.821 171.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.6 168.19 18.7 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.302 0.573 . . . . 71.109999999999999 112.187 -173.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -82.75 126.73 32.72 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.552 -0.749 . . . . 73.319999999999993 111.024 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.512 HG21 HG21 ' A' ' 235' ' ' VAL . 61.8 t -76.57 95.35 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.204 0.526 . . . . 71.549999999999997 110.195 174.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.477 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 13.7 t -75.76 -35.13 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.963 -0.562 . . . . 64.109999999999999 111.548 -176.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.06 113.4 5.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 74.519999999999996 111.743 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.85 103.97 15.61 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.207 -0.451 . . . . 71.340000000000003 110.479 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -79.31 147.55 68.92 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.23 -0.441 . . . . 75.239999999999995 111.776 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.83 155.01 40.19 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.596 2.197 . . . . 74.400000000000006 112.687 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -72.94 156.05 39.24 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.396 0.617 . . . . 75.239999999999995 112.563 -173.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . 0.569 ' HB2' ' HB3' ' A' ' 210' ' ' LEU . 68.6 mttm -122.92 159.13 28.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.721 -0.672 . . . . 74.420000000000002 109.866 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -141.7 132.16 25.27 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.097 0.475 . . . . 70.140000000000001 111.408 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -140.92 -175.56 4.35 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.089 -0.505 . . . . 73.099999999999994 111.372 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 89.0 p -107.9 144.43 35.15 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.023 0.44 . . . . 75.099999999999994 111.755 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -96.17 123.27 39.73 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.505 -0.316 . . . . 73.219999999999999 111.038 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LYS . . . . . 0.439 ' HZ3' ' CG ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -53.95 -17.78 2.86 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.164 0.431 . . . . 74.019999999999996 112.164 174.345 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.439 ' CG ' ' HZ3' ' A' ' 203' ' ' LYS . 3.0 m-20 -65.5 -29.56 70.22 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.784 0.434 . . . . 64.519999999999996 111.658 177.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 134.0 -29.11 3.12 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.288 -0.415 . . . . 71.040000000000006 112.494 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 71.6 p -90.1 -167.79 1.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.132 0.491 . . . . 75.450000000000003 111.953 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -111.0 174.69 5.74 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.848 0.356 . . . . 63.340000000000003 111.191 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -147.02 158.74 27.83 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.004 -0.617 . . . . 72.510000000000005 113.409 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.406 ' HB2' ' HA ' ' A' ' 228' ' ' ASN . 47.8 mt-30 -134.03 144.47 48.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.591 0.357 . . . . 74.230000000000004 110.655 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 198' ' ' LYS . 56.8 tp -125.78 145.91 50.01 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.662 0.385 . . . . 75.209999999999994 111.571 -174.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.608 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 22.3 tptm -150.59 121.92 7.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.45 -0.341 . . . . 75.030000000000001 110.939 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 47.2 t -101.45 144.03 30.74 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.993 0.425 . . . . 74.409999999999997 111.821 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 97.3 mt -136.34 134.58 38.05 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.153 -0.476 . . . . 74.209999999999994 111.119 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -103.83 109.93 21.85 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.141 -0.349 . . . . 74.230000000000004 110.731 174.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.517 HD11 HG21 ' A' ' 243' ' ' VAL . 67.0 mt -107.55 145.09 33.65 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.346 -0.388 . . . . 74.219999999999999 110.674 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -137.52 150.46 47.54 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.539 0.685 . . . . 71.430000000000007 112.04 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -139.28 170.59 15.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.85 -1.068 . . . . 73.439999999999998 109.69 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -52.48 -41.24 63.2 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.792 0.33 . . . . 73.25 111.846 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 81.5 p -83.83 -6.26 59.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.487 0.921 . . . . 73.209999999999994 113.487 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 148.97 -179.8 25.49 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.721 -0.752 . . . . 70.299999999999997 113.149 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 84.9 p -121.83 159.4 26.84 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 122.258 -0.554 . . . . 74.329999999999998 111.893 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . 0.408 HG23 HD13 ' A' ' 176' ' ' ILE . 14.6 tt -151.8 150.33 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.073 0.463 . . . . 72.329999999999998 110.861 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ARG . . . . . 0.423 ' NH2' ' O ' ' A' ' 252' ' ' SER . 32.0 mtm-85 -100.93 123.27 44.87 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.021 0.439 . . . . 75.540000000000006 111.855 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.459 ' HA2' HG22 ' A' ' 256' ' ' ILE . . . -97.26 161.7 21.58 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 116.033 -0.531 . . . . 70.340000000000003 113.233 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 94.5 m -136.5 121.76 19.22 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.269 0.47 . . . . 74.049999999999997 112.269 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.608 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 92.3 mt -105.49 137.19 43.73 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.958 -0.565 . . . . 74.409999999999997 110.905 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -115.79 150.35 37.07 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.759 0.314 . . . . 74.230000000000004 111.656 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ASN . . . . . 0.41 ' HB3' ' OE2' ' A' ' 229' ' ' GLU . 65.4 t30 53.0 -128.3 2.42 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.552 0.575 . . . . 75.310000000000002 112.552 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLU . . . . . 0.41 ' OE2' ' HB3' ' A' ' 228' ' ' ASN . 0.9 OUTLIER -55.83 -16.69 4.84 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.276 0.843 . . . . 75.530000000000001 113.276 -175.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.42 ' HB3' HD23 ' A' ' 226' ' ' LEU . 91.7 mt -88.16 -17.75 30.25 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.956 0.407 . . . . 71.530000000000001 111.653 176.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.07 98.16 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.67 0.618 . . . . 74.549999999999997 112.67 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -77.7 3.2 14.6 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.668 0.618 . . . . 73.019999999999996 112.668 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -52.65 121.21 6.73 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.838 0.351 . . . . 73.200000000000003 111.74 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.6 116.31 22.54 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.241 -0.436 . . . . 73.430000000000007 111.549 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.512 HG21 HG21 ' A' ' 191' ' ' VAL . 7.9 p -142.57 142.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 116.091 -0.504 . . . . 65.430000000000007 110.382 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -95.55 160.42 14.52 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.04 0.448 . . . . 75.0 111.334 -176.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 192' ' ' VAL . 40.4 ttmt -67.91 93.91 0.44 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.982 0.42 . . . . 73.319999999999993 110.939 174.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 136.11 -21.71 3.48 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.092 -0.575 . . . . 54.32 113.683 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -57.77 137.12 56.88 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.216 0.532 . . . . 74.040000000000006 111.941 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.523 HG22 HD12 ' A' ' 264' ' ' ILE . 32.7 mm -84.85 103.17 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.18 -0.464 . . . . 75.510000000000005 110.03 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -103.07 136.01 43.68 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.886 0.698 . . . . 74.439999999999998 112.886 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.8 98.8 7.2 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.582 -0.736 . . . . 75.219999999999999 110.088 171.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.517 HG21 HD11 ' A' ' 215' ' ' LEU . 57.9 t -105.69 115.97 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.054 0.454 . . . . 71.140000000000001 111.793 -177.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 84.0 p -116.43 136.08 53.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.013 -0.539 . . . . 63.240000000000002 110.418 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -178.91 -166.84 35.58 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.13 -1.033 . . . . 62.329999999999998 114.839 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -106.74 122.07 45.64 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.085 0.554 . . . . 72.439999999999998 110.917 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 56.7 t -86.0 125.79 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.364 0.602 . . . . 73.209999999999994 112.364 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -121.16 169.23 10.74 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.624 -0.716 . . . . 74.329999999999998 110.348 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLN . . . . . 0.518 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 24.8 tt0 -120.99 140.81 51.38 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.704 0.288 . . . . 71.409999999999997 110.731 174.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -168.31 -108.64 0.21 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.281 -0.962 . . . . 62.409999999999997 113.723 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -84.32 122.86 29.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.975 0.417 . . . . 74.319999999999993 112.002 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' SER . . . . . 0.423 ' O ' ' NH2' ' A' ' 223' ' ' ARG . 61.4 m 53.53 62.27 2.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.562 -0.745 . . . . 70.239999999999995 111.95 177.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 93.16 -135.61 12.72 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.129 -0.557 . . . . 70.439999999999998 113.772 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.18 151.15 21.76 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.644 0.609 . . . . 72.200000000000003 112.644 -175.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.44 125.07 39.9 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.618 -0.719 . . . . 74.209999999999994 109.357 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ILE . . . . . 0.459 HG22 ' HA2' ' A' ' 224' ' ' GLY . 10.1 tt -113.83 121.21 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.488 0.661 . . . . 72.439999999999998 112.592 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 18.0 m -82.94 111.71 19.07 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.803 -0.635 . . . . 53.219999999999999 110.024 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . 0.526 ' HB ' HD22 ' A' ' 226' ' ' LEU . 44.7 t -76.99 128.72 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.366 0.603 . . . . 74.120000000000005 112.542 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.8 -44.52 14.28 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.597 -0.729 . . . . 73.040000000000006 110.537 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -152.07 143.18 23.19 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.287 -0.415 . . . . 74.140000000000001 111.21 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 6.2 tt -134.52 134.1 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.285 -0.416 . . . . 75.129999999999995 111.412 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.23 139.01 6.9 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.204 -0.522 . . . . 61.030000000000001 112.146 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.9 mt -69.16 131.96 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 117.333 0.566 . . . . 75.040000000000006 110.642 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.523 HD12 HG22 ' A' ' 240' ' ' ILE . 60.9 mt -70.31 -46.32 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.287 0.477 . . . . 64.439999999999998 112.287 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -112.69 95.73 5.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.961 0.41 . . . . 74.519999999999996 111.205 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.553 ' HB2' ' HZ2' ' A' ' 266' ' ' LYS . 10.7 mtmp? -104.05 -30.55 10.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.069 0.396 . . . . 74.219999999999999 112.069 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 40.8 t -89.59 98.45 11.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.024 0.44 . . . . 72.219999999999999 111.445 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 83.8 mt -68.06 -47.66 67.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.26 -0.427 . . . . 75.310000000000002 111.415 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.68 -0.676 . . . . 73.219999999999999 111.408 179.258 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 120.754 0.312 . . . . 75.1 110.365 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -87.16 152.41 22.36 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.484 0.659 . . . . 64.33 112.261 -174.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.474 ' HG2' ' OE1' ' A' ' 178' ' ' GLU . 27.5 mmtm -100.77 164.47 11.84 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.58 -0.896 . . . . 74.33 108.58 168.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 54.2 mt -58.31 -31.11 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 O-C-N 122.059 -0.401 . . . . 73.21 111.816 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 48.4 t -71.89 -24.14 61.61 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.147 0.425 . . . . 73.32 112.147 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.474 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 45.2 mt-10 -81.63 -5.95 58.54 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.126 -0.359 . . . . 70.43 111.824 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.509 HD22 HG21 ' A' ' 247' ' ' VAL . 82.6 mt -75.86 125.58 29.36 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.293 0.568 . . . . 52.1 111.882 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.539 ' HG2' HD22 ' A' ' 183' ' ' LEU . 22.6 ptp -124.12 159.03 58.62 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 115.859 -0.61 . . . . 74.22 110.3 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 248' ' ' LYS . 14.8 Cg_endo -57.37 133.18 55.49 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.963 1.775 . . . . 64.44 112.904 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 76.4 m-20 69.57 29.89 4.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.397 0.679 . . . . 74.41 111.8 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.539 HD22 ' HG2' ' A' ' 180' ' ' MET . 27.0 tp -106.13 118.26 36.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.124 -0.489 . . . . 75.44 111.578 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.5 t -92.63 108.98 20.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.779 0.323 . . . . 60.32 110.201 173.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -153.29 172.56 32.19 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.585 -0.817 . . . . 73.14 113.911 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 244' ' ' SER . 34.8 m -114.17 129.77 56.62 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.78 0.324 . . . . 71.41 111.726 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.484 HD13 HD11 ' A' ' 179' ' ' LEU . 37.3 pt -122.16 163.68 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.301 0.572 . . . . 72.43 112.298 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -121.76 118.52 29.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.948 -0.569 . . . . 54.23 110.264 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -151.33 171.73 17.01 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.527 0.566 . . . . 53.03 112.527 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -96.01 141.66 29.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.066 -0.515 . . . . 64.23 111.589 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.9 t -78.95 103.49 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.972 0.415 . . . . 74.13 111.136 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' A' ' 216' ' ' LYS . 21.5 t -81.36 -28.61 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.0 0.429 . . . . 73.31 111.728 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -151.33 136.42 17.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.978 0.418 . . . . 71.33 111.572 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -124.05 114.36 19.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.885 -0.598 . . . . 62.23 110.818 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 212' ' ' SER . 94.9 m-85 -109.37 148.69 38.55 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 120.655 0.264 . . . . 52.33 111.632 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.41 156.65 16.79 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.984 2.456 . . . . 71.02 113.841 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -73.44 169.23 17.62 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.53 0.681 . . . . 63.42 111.989 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -138.65 149.47 45.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.455 -0.793 . . . . 64.33 109.361 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 209' ' ' GLN . 44.0 mt-10 -130.82 112.6 13.18 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.912 -0.492 . . . . 70.13 112.248 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.8 p90 . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 121.261 0.553 . . . . 62.55 111.421 -178.019 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.482 ' HG2' ' HG2' ' A' ' 199' ' ' GLU . 75.9 mt-30 . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 120.943 0.401 . . . . 73.4 111.591 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 32.8 tp -145.17 126.4 14.77 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.059 -0.519 . . . . 74.53 111.39 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.601 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 84.7 tttt -126.87 135.08 50.49 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.948 0.404 . . . . 74.21 111.194 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.537 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 5.0 m -98.24 128.37 44.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.016 -0.538 . . . . 61.4 111.81 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.415 HD11 HG11 ' A' ' 235' ' ' VAL . 93.8 mt -137.1 163.72 30.13 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.085 0.469 . . . . 64.31 112.115 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -135.15 129.91 34.57 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.257 -0.429 . . . . 64.41 110.367 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.7 mt -120.7 148.59 43.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.256 0.222 . . . . 71.45 111.376 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.404 ' HB3' HG21 ' A' ' 192' ' ' VAL . 21.4 pttm -136.86 151.97 49.71 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.401 0.62 . . . . 71.15 112.095 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -148.78 165.59 30.97 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.304 -0.862 . . . . 74.34 109.848 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -57.26 -30.65 64.83 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 111.942 0.349 . . . . 61.13 111.942 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 63.0 p -84.07 -11.49 56.62 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.584 0.587 . . . . 53.54 112.584 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 152.25 179.77 28.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.936 -0.65 . . . . 44.15 113.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.4 p -124.2 155.42 38.57 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 122.554 -0.38 . . . . 52.1 111.498 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -147.05 156.75 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.979 0.418 . . . . 72.31 111.716 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 223' ' ' ARG . 8.3 mpt_? -95.08 123.97 38.87 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.69 0.281 . . . . 64.21 110.733 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.43 152.85 20.53 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.26 -0.495 . . . . 60.34 113.617 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 70.2 m -144.4 115.45 7.89 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.091 0.404 . . . . 72.43 112.091 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.601 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 88.8 mt -98.6 137.48 37.18 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.453 -0.34 . . . . 42.32 111.307 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -114.62 151.02 34.2 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.14 0.495 . . . . 74.51 112.233 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 64.2 t30 52.93 -134.24 1.7 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.828 -0.624 . . . . 64.12 111.856 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.42 -26.15 52.57 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.595 0.591 . . . . 74.33 112.595 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.42 -27.19 69.13 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.036 0.446 . . . . 64.14 111.225 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.48 ' O ' ' HD2' ' A' ' 211' ' ' LYS . . . -67.38 -14.24 62.74 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.115 0.413 . . . . 73.23 112.115 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -92.03 -12.98 31.69 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.992 0.425 . . . . 70.55 110.974 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -61.87 134.32 56.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.988 0.423 . . . . 73.33 111.605 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.92 118.24 15.62 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.009 0.433 . . . . 73.43 111.436 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 213' ' ' LEU . 4.2 p -139.07 117.51 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.137 0.494 . . . . 74.13 110.492 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -106.99 152.09 24.45 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.119 0.485 . . . . 74.54 111.885 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -70.15 117.85 12.24 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.187 -0.46 . . . . 72.41 111.478 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.57 -13.18 32.89 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.478 -0.391 . . . . 75.25 113.097 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.56 145.82 36.65 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.055 0.455 . . . . 72.22 111.93 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.584 HG22 HD12 ' A' ' 264' ' ' ILE . 38.9 mm -87.71 118.57 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.037 -0.529 . . . . 53.24 110.566 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.421 ' HB2' HD13 ' A' ' 263' ' ' ILE . . . -128.59 145.55 51.1 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.653 0.612 . . . . 71.21 112.653 -175.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -103.92 110.42 22.56 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.916 -0.584 . . . . 64.11 109.927 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.6 t -108.62 115.29 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.733 0.642 . . . . 73.43 112.733 -171.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 186' ' ' THR . 35.8 t -95.72 122.41 38.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.039 -0.528 . . . . 63.02 110.124 173.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -158.5 167.11 34.51 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.235 -0.983 . . . . 62.44 114.529 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -92.89 104.54 16.77 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.128 0.571 . . . . 74.23 110.596 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 179' ' ' LEU . 44.6 t -86.02 138.86 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.675 0.274 . . . . 64.35 111.438 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 181' ' ' PRO . 10.6 ptmm? -151.06 176.35 11.23 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.066 0.46 . . . . 73.43 111.821 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.485 ' HA ' HD23 ' A' ' 254' ' ' LEU . 23.5 tt0 . . . . . 0 CA--C 1.54 0.561 0 CA-C-N 115.947 -0.569 . . . . 64.0 111.144 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 249' ' ' GLN . 92.3 mt . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 110.406 -0.22 . . . . 72.14 110.406 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -109.66 143.12 39.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.985 0.421 . . . . 74.32 111.482 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.6 tt -108.72 104.35 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.339 0.59 . . . . 73.41 111.202 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.9 t -77.44 98.92 5.45 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.123 -0.49 . . . . 53.12 110.409 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.86 131.26 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.929 0.714 . . . . 53.31 112.929 -171.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -99.64 -44.6 6.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.567 -0.742 . . . . 75.42 110.357 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 244' ' ' SER . 21.7 m-80 -135.93 137.13 41.05 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.344 -0.389 . . . . 63.52 110.536 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.4 tt -137.75 136.19 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.841 0.353 . . . . 74.0 111.571 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.06 140.52 7.93 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.197 -0.525 . . . . 64.13 113.163 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 241' ' ' ALA . 47.2 mm -85.54 115.07 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.062 0.458 . . . . 73.51 110.853 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.584 HD12 HG22 ' A' ' 240' ' ' ILE . 63.0 mt -59.41 -35.95 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.476 0.547 . . . . 72.03 112.476 -174.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 113.396 0.888 . . . . 73.35 113.396 -174.662 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.027 0.441 . . . . 63.52 110.164 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -83.38 141.05 32.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.187 0.518 . . . . 75.04 111.942 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.527 ' N ' ' HD2' ' A' ' 175' ' ' LYS . 12.1 mptt -96.54 155.79 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.61 . . . . 74.45 109.545 173.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.424 HD13 HG22 ' A' ' 222' ' ' ILE . 55.9 mt -59.15 -33.09 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.064 0.394 . . . . 75.24 112.064 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 56.2 p -70.79 -15.45 62.67 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.073 0.398 . . . . 43.04 112.073 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -104.55 -5.97 21.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.975 0.417 . . . . 55.34 111.594 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.548 HD22 HG21 ' A' ' 247' ' ' VAL . 81.6 mt -71.49 148.36 46.87 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.184 0.516 . . . . 72.34 111.987 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.5 ptp -148.18 153.27 41.07 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.945 -0.571 . . . . 73.21 110.801 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.29 128.05 24.18 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.905 2.403 . . . . 73.0 114.358 -177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.483 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 2.1 m-20 66.04 50.77 1.4 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.594 0.711 . . . . 62.32 112.156 173.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.7 tt -131.46 134.03 45.77 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.514 -0.766 . . . . 65.34 110.355 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 89.8 p -100.5 148.13 25.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.129 0.49 . . . . 60.15 111.508 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.67 -169.77 41.39 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.088 -0.577 . . . . 63.41 113.152 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 94.6 m -118.41 124.77 48.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.843 0.354 . . . . 75.23 111.712 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 179' ' ' LEU . 37.2 pt -109.02 154.17 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.068 -0.515 . . . . 75.24 110.285 173.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -135.4 108.51 7.69 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.042 -0.411 . . . . 75.04 110.872 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.29 172.15 13.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.065 0.46 . . . . 64.25 112.099 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -93.61 139.04 31.24 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.911 -0.586 . . . . 71.3 110.635 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.477 ' HA ' HD23 ' A' ' 215' ' ' LEU . 38.2 t -79.16 100.98 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.308 0.484 . . . . 45.31 112.308 -174.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.796 ' HA ' ' HZ3' ' A' ' 237' ' ' LYS . 48.6 t -59.62 -52.56 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.941 0.401 . . . . 74.31 111.723 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -132.71 124.66 28.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.189 -0.46 . . . . 64.53 111.27 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -106.16 102.82 12.21 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.925 0.393 . . . . 40.52 111.351 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -81.99 155.93 69.91 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.187 0.439 . . . . 75.34 112.187 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.96 175.84 10.79 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.61 2.207 . . . . 73.5 112.188 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.579 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 64.1 pttt -93.76 124.06 37.51 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.517 0.675 . . . . 70.41 112.754 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -87.42 146.13 25.99 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.307 -0.86 . . . . 60.43 110.818 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -99.16 136.79 38.61 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.87 0.367 . . . . 75.24 111.685 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.6 p90 . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.992 0.425 . . . . 71.44 111.153 175.442 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 . . . . . 0 CA--C 1.542 0.651 0 CA-C-O 120.703 0.287 . . . . 75.51 110.573 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 28.2 tp -121.64 125.35 46.47 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.441 0.296 . . . . 71.02 111.768 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -141.6 113.58 7.95 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.01 0.433 . . . . 73.23 111.625 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 64.4 m -93.93 139.48 30.86 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.114 0.483 . . . . 74.24 111.721 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.517 HD11 HG11 ' A' ' 235' ' ' VAL . 85.9 mt -123.4 126.34 46.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.476 -0.329 . . . . 65.1 110.603 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -92.12 115.95 28.52 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.988 -0.445 . . . . 63.14 110.759 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.522 HD11 HG21 ' A' ' 243' ' ' VAL . 58.6 mt -112.52 152.87 28.31 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.538 0.335 . . . . 74.04 111.288 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.461 ' HG2' ' CG2' ' A' ' 192' ' ' VAL . 12.9 ptmm? -162.14 150.3 14.72 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.206 0.526 . . . . 73.41 112.067 172.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -116.44 -164.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.714 -0.847 . . . . 73.42 108.714 167.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.53 -6.15 58.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.639 0.733 . . . . 75.35 109.606 166.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.5 p -81.51 -33.81 31.62 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.284 -0.871 . . . . 75.54 111.744 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 167.46 -178.69 41.37 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.396 -0.431 . . . . 72.32 112.811 -176.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 81.0 p -130.3 133.73 46.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 117.35 0.575 . . . . 51.04 112.25 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.424 HG22 HD13 ' A' ' 176' ' ' ILE . 11.6 tt -148.51 153.16 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.653 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -101.2 132.66 46.59 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.704 -0.623 . . . . 72.11 111.675 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.432 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -96.92 117.58 5.8 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.643 -0.583 . . . . 65.3 111.643 173.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 30.8 m -95.95 115.99 28.26 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.438 -0.448 . . . . 73.41 112.107 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.499 HD23 ' HB ' ' A' ' 258' ' ' VAL . 92.8 mt -91.64 128.39 37.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.07 -0.514 . . . . 71.34 111.17 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -113.47 153.85 28.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.231 0.539 . . . . 73.04 111.777 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.8 -134.27 0.69 Allowed 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 115.647 -0.706 . . . . 71.14 112.006 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -63.6 -18.34 63.79 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.097 0.777 . . . . 63.45 113.097 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.0 -14.93 63.38 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.755 0.312 . . . . 74.33 111.593 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.579 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -61.24 -43.69 98.47 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.214 0.45 . . . . 63.31 112.214 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -76.08 1.31 15.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.54 0.57 . . . . 74.52 112.54 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -67.25 123.07 19.29 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.167 -0.333 . . . . 74.23 110.53 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.84 92.98 0.37 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.205 0.526 . . . . 70.25 112.068 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.517 HG11 HD11 ' A' ' 213' ' ' LEU . 3.7 p -120.42 107.64 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.743 -0.662 . . . . 70.14 110.24 173.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -95.34 163.58 13.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.0 -0.545 . . . . 75.11 111.002 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.796 ' HZ3' ' HA ' ' A' ' 192' ' ' VAL . 8.1 tmtm? -71.12 113.12 7.84 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.481 -0.563 . . . . 74.31 109.481 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 121.95 -23.12 7.45 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 116.175 -0.466 . . . . 65.2 112.231 -172.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.4 ' HB3' HD12 ' A' ' 263' ' ' ILE . 24.4 m-20 -65.5 125.58 25.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.137 0.494 . . . . 75.42 112.067 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 49.8 mm -77.85 97.97 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.514 -0.55 . . . . 63.11 109.514 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -97.04 129.96 44.41 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.179 0.807 . . . . 63.14 113.179 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.9 96.57 8.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.685 -0.689 . . . . 71.21 109.417 170.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.522 HG21 HD11 ' A' ' 215' ' ' LEU . 88.6 t -97.61 111.62 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.113 0.483 . . . . 72.21 111.471 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.7 t -118.35 135.51 54.28 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.757 0.313 . . . . 73.34 111.056 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 172.81 -152.91 17.36 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.448 -0.882 . . . . 64.5 113.803 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -111.59 115.18 28.72 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.753 0.311 . . . . 70.33 111.325 -175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.548 HG21 HD22 ' A' ' 179' ' ' LEU . 47.7 t -86.27 120.54 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.776 0.322 . . . . 61.0 111.092 178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.483 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 19.4 ptpt -135.09 -179.82 5.86 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.817 0.341 . . . . 73.31 111.043 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 . . . . . 0 CA--C 1.536 0.438 0 CA-C-N 116.703 -0.226 . . . . 60.15 110.405 171.966 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 121.263 0.554 . . . . 60.54 109.87 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -119.19 137.07 53.88 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.982 -0.554 . . . . 75.53 111.724 -172.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.482 ' HB ' HG22 ' A' ' 247' ' ' VAL . 9.5 tt -104.79 121.05 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.294 0.569 . . . . 41.44 111.98 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 94.5 p -81.75 112.07 18.58 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.491 -0.559 . . . . 71.43 109.491 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.499 ' HB ' HD23 ' A' ' 226' ' ' LEU . 21.7 t -77.64 106.16 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.864 0.364 . . . . 64.21 111.963 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -84.07 -24.06 30.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.01 0.433 . . . . 73.12 111.299 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -146.4 125.78 13.14 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.926 -0.579 . . . . 54.22 111.101 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.452 ' HB ' HG11 ' A' ' 258' ' ' VAL . 13.1 tt -135.67 137.06 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.158 0.504 . . . . 71.33 111.769 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.43 140.27 7.71 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.892 -0.595 . . . . 54.33 111.826 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' A' ' 239' ' ' ASP . 40.5 mm -92.26 128.66 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 117.682 0.741 . . . . 63.12 111.705 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 27.1 mt -83.65 -45.88 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 121.368 0.604 . . . . 75.24 110.758 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.469 0.506 0 CA-C-N 116.052 -0.522 . . . . 73.35 111.35 -178.529 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 120.995 0.426 . . . . 73.21 111.477 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -94.96 151.36 19.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.292 0.568 . . . . 74.33 111.9 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -89.34 153.69 20.67 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.701 -0.851 . . . . 75.15 108.701 169.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.405 HD13 HG22 ' A' ' 222' ' ' ILE . 36.0 mt -55.72 -36.25 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.328 0.492 . . . . 74.14 112.328 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.491 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 47.1 t -69.85 -24.09 63.39 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.138 0.421 . . . . 62.22 112.138 176.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.85 -5.78 59.14 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.288 0.477 . . . . 73.3 112.288 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.447 HD22 HG21 ' A' ' 247' ' ' VAL . 89.2 mt -70.84 155.71 40.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.504 0.669 . . . . 73.22 112.625 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.468 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.2 ptp -154.23 152.04 25.58 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.437 -0.801 . . . . 74.24 109.756 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.0 150.33 79.12 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 121.684 1.589 . . . . 51.43 112.492 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 246' ' ' TYR . 2.3 m-20 64.72 30.91 12.25 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.057 0.456 . . . . 53.41 111.445 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.468 HD22 ' HG2' ' A' ' 180' ' ' MET . 22.8 tp -114.58 115.88 27.88 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.353 -0.385 . . . . 72.13 111.372 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 90.2 p -103.83 109.52 21.28 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.66 0.267 . . . . 64.03 110.765 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.83 -161.56 11.44 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.778 -0.725 . . . . 60.21 113.508 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 25.1 m -122.81 142.98 50.16 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.65 -0.324 . . . . 71.32 111.418 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 34.8 pt -135.31 155.46 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.233 0.54 . . . . 74.11 112.431 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -111.19 124.48 52.28 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.15 -0.477 . . . . 63.12 110.531 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.8 164.94 38.09 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.339 0.59 . . . . 55.05 112.41 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -103.21 138.05 40.53 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.615 -0.721 . . . . 63.21 110.089 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.9 99.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.58 0.585 . . . . 50.12 112.58 -172.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.3 t -70.87 -44.75 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.074 0.464 . . . . 75.41 111.774 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -143.4 132.72 23.3 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.176 -0.465 . . . . 62.43 111.832 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -124.1 99.48 6.26 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.148 -0.478 . . . . 65.33 110.855 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 196' ' ' PRO . 72.3 m-85 -77.49 149.78 78.81 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.55 0.574 . . . . 64.42 112.55 -174.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 195' ' ' TYR . 38.6 Cg_exo -62.19 172.62 3.95 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.299 2.666 . . . . 65.15 114.054 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.405 ' HA ' ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -61.07 109.99 1.24 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.373 -0.83 . . . . 73.23 112.868 -176.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 210' ' ' LEU . 66.7 mttm -83.88 148.96 26.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.185 -0.461 . . . . 62.41 109.929 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -131.86 136.58 47.56 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.986 0.735 . . . . 64.14 112.986 -171.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.43 ' HE1' ' HB2' ' A' ' 210' ' ' LEU . 54.8 p90 . . . . . 0 CA--C 1.541 0.634 0 CA-C-N 115.587 -0.733 . . . . 64.05 110.456 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.645 0.26 . . . . 75.05 111.016 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 198' ' ' LYS . 65.8 tp -144.81 149.38 35.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.992 0.425 . . . . 72.02 111.458 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.614 ' HB2' ' HA ' ' A' ' 231' ' ' ALA . 45.6 tttp -149.85 121.1 7.82 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.937 0.399 . . . . 75.22 111.263 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 41.2 m -95.38 118.26 31.8 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.969 0.414 . . . . 73.41 111.663 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 74.4 mt -109.57 130.45 55.51 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.442 -0.345 . . . . 54.51 110.773 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -97.79 103.75 15.71 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.002 -0.436 . . . . 71.45 110.669 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.17 136.34 35.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.141 -0.481 . . . . 65.51 111.291 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -122.62 147.72 46.09 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 112.718 0.636 . . . . 63.12 112.718 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -148.21 163.05 38.17 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.133 -0.94 . . . . 62.22 109.298 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -77.52 10.05 2.88 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.908 -0.495 . . . . 60.15 112.263 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 69.8 p -115.24 2.81 14.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.947 0.403 . . . . 62.22 111.072 169.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 147.1 170.08 15.11 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.332 -0.461 . . . . 73.14 113.25 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 80.3 p -128.64 126.5 40.32 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.442 -0.446 . . . . 72.54 111.061 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 176' ' ' ILE . 9.6 tp -129.76 151.75 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.946 0.403 . . . . 72.01 111.263 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.627 ' HD3' ' H ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -99.29 125.26 44.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.2 0.524 . . . . 64.43 111.441 178.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.565 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -91.83 138.31 14.19 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.705 -0.68 . . . . 64.11 112.489 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.439 HG23 HD11 ' A' ' 210' ' ' LEU . 28.4 m -106.43 105.5 15.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.903 0.334 . . . . 74.2 111.903 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.595 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 56.4 mt -90.42 138.71 31.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.831 0.348 . . . . 63.43 111.186 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -115.55 157.12 24.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.272 0.558 . . . . 74.1 112.101 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 55.4 t30 57.83 -141.68 0.74 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.559 -0.746 . . . . 54.41 112.468 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.42 -24.21 19.03 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.989 0.737 . . . . 74.01 112.989 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.57 -8.35 4.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.92 0.39 . . . . 74.14 112.006 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -66.06 -30.02 70.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.922 0.391 . . . . 64.54 111.82 175.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.4 5.84 50.18 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.336 -0.393 . . . . 61.21 111.847 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -59.77 126.46 27.66 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.944 0.402 . . . . 75.24 111.856 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -68.39 87.82 0.31 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.245 0.545 . . . . 50.43 111.796 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.5 p -116.89 128.78 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.112 -0.495 . . . . 74.22 110.735 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 239' ' ' ASP . 50.5 mtpt -93.28 150.86 20.17 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.3 0.572 . . . . 72.44 112.281 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -80.16 117.23 20.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.898 -0.592 . . . . 71.22 110.068 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.58 23.6 13.72 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.938 -0.648 . . . . 74.24 112.659 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 3.0 t0 -113.72 162.77 15.87 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.702 0.287 . . . . 61.01 110.564 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 264' ' ' ILE . 47.0 mm -98.94 114.12 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.738 0.304 . . . . 73.31 111.218 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -114.15 142.43 46.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.023 0.749 . . . . 73.43 113.023 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' A' ' 264' ' ' ILE . 30.5 tt0 -112.05 108.73 18.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.971 -0.559 . . . . 73.3 109.655 172.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.1 t -107.04 133.86 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 112.676 0.621 . . . . 72.04 112.676 -170.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 42.8 t -111.94 112.1 23.5 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.356 -0.384 . . . . 73.4 110.375 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.49 -176.88 26.42 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.174 -1.012 . . . . 63.32 114.369 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 182' ' ' ASN . 86.2 t80 -112.92 105.98 14.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.134 0.574 . . . . 73.43 111.084 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 256' ' ' ILE . 24.9 t -74.04 142.35 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.477 -0.329 . . . . 73.14 110.718 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -156.5 178.25 10.54 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.46 0.648 . . . . 75.44 112.677 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 CA--C 1.541 0.599 0 CA-C-N 115.343 -0.844 . . . . 71.03 110.242 172.904 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 98.0 mt . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 109.846 -0.427 . . . . 73.34 109.846 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.92 172.57 7.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.066 0.46 . . . . 71.21 111.83 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.565 HG23 ' HA2' ' A' ' 224' ' ' GLY . 7.8 tt -127.55 112.84 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.339 0.59 . . . . 64.44 111.469 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' SER . . . . . 0.415 ' HA ' ' HB ' ' A' ' 225' ' ' THR . 37.2 t -82.75 110.94 18.23 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.282 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.526 ' HB ' HD23 ' A' ' 226' ' ' LEU . 46.6 t -74.76 137.49 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.219 0.533 . . . . 73.3 111.936 -175.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -106.35 -43.86 4.67 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.993 -0.549 . . . . 61.34 110.583 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -139.41 145.2 38.61 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.093 -0.503 . . . . 75.24 110.479 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.1 tt -140.24 135.97 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.283 0.563 . . . . 71.11 111.983 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -140.68 121.82 2.01 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 116.081 -0.509 . . . . 64.54 112.385 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 14.0 mm -78.48 138.02 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 122.47 -0.429 . . . . 62.2 110.764 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.438 HD11 ' HB2' ' A' ' 242' ' ' GLU . 60.0 mt -84.58 -41.9 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 112.515 0.561 . . . . 64.51 112.515 -174.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 113.073 0.768 . . . . 71.33 113.073 -171.997 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 186' ' ' THR . 8.1 t30 . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.453 0.644 . . . . 74.12 112.725 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.444 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 57.6 m-85 -130.69 167.67 18.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.405 -0.816 . . . . 72.14 110.308 173.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.466 ' HB3' ' OG1' ' A' ' 219' ' ' THR . 22.7 mmtp -97.66 164.64 12.33 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.972 -0.381 . . . . 75.21 109.972 167.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 220' ' ' GLY . 56.8 mt -64.08 -30.34 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 111.946 0.35 . . . . 73.54 111.946 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.474 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 83.7 p -64.7 -24.86 67.71 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.046 0.451 . . . . 72.43 111.157 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 174' ' ' TYR . 26.3 mm-40 -86.79 -12.25 48.59 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.052 -0.522 . . . . 71.44 111.596 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.524 HD11 HD13 ' A' ' 187' ' ' ILE . 71.1 mt -70.16 141.75 52.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.384 0.611 . . . . 72.13 111.714 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.439 ' HG2' HD22 ' A' ' 183' ' ' LEU . 21.5 ptp -154.12 156.36 31.83 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.553 -0.748 . . . . 74.13 110.641 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.97 142.22 76.66 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.141 1.894 . . . . 53.33 112.484 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 66.16 26.21 10.61 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.903 0.382 . . . . 74.41 111.697 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.439 HD22 ' HG2' ' A' ' 180' ' ' MET . 46.5 tp -98.09 135.09 40.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.802 0.334 . . . . 64.2 111.55 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 72.0 p -114.08 118.92 35.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.522 -0.308 . . . . 64.31 110.869 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.76 -160.85 27.63 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 120.888 -0.672 . . . . 61.41 113.685 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 58.0 m -129.69 148.85 51.62 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.83 0.452 . . . . 73.53 111.0 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.524 HD13 HD11 ' A' ' 179' ' ' LEU . 32.3 pt -131.95 144.61 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.244 0.545 . . . . 71.4 111.291 173.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -113.27 107.19 15.55 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.056 -0.52 . . . . 72.54 110.483 175.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.8 176.8 9.6 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.006 0.432 . . . . 41.42 111.819 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -94.0 145.17 24.85 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.149 0.499 . . . . 74.4 111.807 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.8 t -86.01 108.96 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.214 -0.448 . . . . 43.53 111.665 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.84 -35.67 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.161 -0.472 . . . . 71.44 111.449 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.09 124.26 5.74 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.313 -0.403 . . . . 63.32 111.607 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -108.17 100.93 10.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.221 -0.445 . . . . 62.03 110.749 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.503 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 99.0 m-85 -72.41 139.61 81.54 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 111.957 0.354 . . . . 60.23 111.957 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -53.8 148.99 34.9 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.666 2.244 . . . . 70.01 112.851 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.436 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 21.3 pttm -71.72 125.84 28.17 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.474 0.654 . . . . 74.01 112.375 -175.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.02 166.47 11.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.78 -0.646 . . . . 73.0 110.731 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.44 112.17 18.63 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.681 0.277 . . . . 73.14 110.806 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 54.3 p90 . . . . . 0 CA--C 1.536 0.437 0 CA-C-O 121.317 0.579 . . . . 71.14 111.982 -177.096 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 120.825 0.345 . . . . 74.44 111.105 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 18.9 tp -127.65 111.13 13.37 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.225 0.454 . . . . 64.12 112.225 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 195' ' ' TYR . 81.5 tttt -122.21 109.6 14.68 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.191 -0.318 . . . . 65.23 111.282 175.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.9 t -86.07 145.94 26.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.927 0.394 . . . . 75.24 111.387 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.79 124.47 33.47 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.511 -0.313 . . . . 73.34 111.253 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -94.58 115.39 27.52 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 110.132 -0.321 . . . . 75.34 110.132 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.63 HD11 HG21 ' A' ' 243' ' ' VAL . 52.8 mt -112.54 150.75 30.87 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.556 0.217 . . . . 65.44 111.51 -176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -140.47 152.65 45.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.652 0.739 . . . . 72.1 111.934 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -148.19 166.09 28.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.802 -1.09 . . . . 71.24 108.739 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -56.69 -25.82 55.12 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.756 0.312 . . . . 64.43 111.772 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 71.6 p -89.88 1.95 55.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.826 0.676 . . . . 60.45 112.826 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 137.41 -179.25 18.32 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.803 -0.713 . . . . 73.13 113.312 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 57.2 p -127.81 152.23 48.05 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 122.418 -0.46 . . . . 61.23 111.52 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.0 tp -151.77 160.06 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.72 -0.218 . . . . 75.11 111.291 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -107.36 128.08 54.14 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.193 0.52 . . . . 72.31 112.118 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -103.15 167.21 16.77 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.08 -0.509 . . . . 65.22 111.948 172.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 99.8 m -142.79 122.33 13.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.747 0.773 . . . . 65.01 112.379 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.408 HD23 ' HB ' ' A' ' 258' ' ' VAL . 91.4 mt -93.69 120.15 33.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.744 -0.662 . . . . 74.33 110.972 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -100.0 142.95 30.8 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.686 0.279 . . . . 71.12 111.713 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 60.8 t30 66.83 -138.03 0.14 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.099 0.559 . . . . 73.14 111.968 174.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -25.79 64.4 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.305 0.483 . . . . 74.51 112.305 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 91.0 mt -56.59 -21.81 29.36 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.799 0.333 . . . . 65.44 111.786 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -64.64 -20.15 66.11 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 111.978 0.362 . . . . 64.22 111.978 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -99.47 8.4 44.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.693 0.282 . . . . 75.14 111.703 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -65.58 143.7 57.45 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.093 0.473 . . . . 74.04 112.006 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -63.29 96.57 0.11 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.823 -0.626 . . . . 73.01 111.301 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 p -147.08 113.69 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.032 0.444 . . . . 74.31 111.008 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -105.58 160.45 15.17 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.438 0.637 . . . . 75.34 111.758 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.02 99.96 0.93 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.733 -0.667 . . . . 75.22 111.069 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 130.4 -10.61 5.84 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.187 -0.53 . . . . 61.12 114.036 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.78 157.07 20.34 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.782 0.66 . . . . 74.32 112.782 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.444 HG22 HD12 ' A' ' 264' ' ' ILE . 40.9 mm -92.97 110.18 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.708 -0.678 . . . . 63.41 110.495 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -110.1 139.11 45.58 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.794 0.664 . . . . 53.24 112.794 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 31.9 tt0 -84.41 104.63 14.59 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.68 -0.691 . . . . 73.02 110.165 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.63 HG21 HD11 ' A' ' 215' ' ' LEU . 87.1 t -103.99 106.46 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.928 0.394 . . . . 63.23 111.505 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 39.1 p -116.53 130.49 56.78 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.461 -0.336 . . . . 54.15 111.439 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.97 -141.04 4.7 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.656 -0.783 . . . . 71.42 113.771 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -129.11 124.89 35.91 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.696 -0.296 . . . . 70.3 111.198 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.436 HG22 ' HB ' ' A' ' 256' ' ' ILE . 35.0 t -90.84 133.96 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.812 0.339 . . . . 75.11 111.821 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -126.39 -179.61 4.84 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.964 0.412 . . . . 74.14 111.204 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 N--CA 1.467 0.42 0 CA-C-N 116.421 -0.354 . . . . 74.32 111.516 178.401 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.913 0.387 . . . . 72.31 111.726 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.31 156.31 43.26 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.161 -0.472 . . . . 61.5 111.078 173.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.436 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.5 tt -122.99 119.38 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.292 0.567 . . . . 74.33 112.227 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.3 m -72.23 113.8 9.66 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.195 -0.457 . . . . 54.4 110.075 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.527 HG11 ' HB ' ' A' ' 261' ' ' ILE . 23.1 t -82.22 117.43 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.985 0.421 . . . . 75.42 111.731 -175.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -89.81 -26.93 20.3 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.174 0.512 . . . . 72.33 110.551 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -149.63 137.29 20.15 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.1 -0.5 . . . . 65.53 110.936 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.527 ' HB ' HG11 ' A' ' 258' ' ' VAL . 12.2 tt -143.58 135.82 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.026 0.441 . . . . 64.22 111.628 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -146.98 139.68 8.1 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.241 -0.504 . . . . 53.34 112.939 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 49.3 mm -75.41 115.76 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.278 -0.542 . . . . 74.13 110.821 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.444 HD12 HG22 ' A' ' 240' ' ' ILE . 61.8 mt -59.94 -50.08 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 120.953 0.406 . . . . 72.3 111.806 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.468 0.445 0 CA-C-N 116.474 -0.33 . . . . 63.11 110.972 177.416 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.713 ' N ' HD21 ' A' ' 173' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.086 0.469 . . . . 71.23 110.449 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.434 ' CE2' ' HA3' ' A' ' 185' ' ' GLY . 96.5 m-85 -83.3 141.0 32.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.38 0.61 . . . . 72.1 112.411 -172.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.418 ' HD2' ' OG1' ' A' ' 219' ' ' THR . 18.2 tppt? -81.54 137.76 35.52 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.473 -0.785 . . . . 72.4 109.956 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 222' ' ' ILE . 36.7 mt -52.79 -36.7 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 112.705 0.632 . . . . 74.03 112.705 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.418 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 35.4 t -64.51 -27.12 68.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.849 0.357 . . . . 71.31 111.549 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -95.05 6.1 50.04 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.32 0.489 . . . . 45.33 112.32 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.407 HD22 HG21 ' A' ' 247' ' ' VAL . 81.9 mt -68.64 131.05 44.56 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.133 0.492 . . . . 72.13 111.527 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.7 mtt -121.07 155.28 58.12 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.135 -0.484 . . . . 73.54 111.506 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HG3' HD21 ' A' ' 254' ' ' LEU . 31.2 Cg_exo -61.03 133.29 46.41 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.31 2.007 . . . . 73.44 112.186 173.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 66.35 37.62 4.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.872 0.469 . . . . 72.43 111.568 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.8 119.47 39.22 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.452 -0.34 . . . . 63.14 111.4 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.406 ' HB3' ' HD1' ' A' ' 246' ' ' TYR . 86.9 p -99.18 126.29 44.94 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.949 0.404 . . . . 52.51 111.181 176.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 174' ' ' TYR . . . -171.58 -160.55 20.37 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.613 -0.803 . . . . 73.43 113.88 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 28.7 m -135.89 136.93 40.92 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.749 -0.266 . . . . 74.42 111.299 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.39 147.15 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.842 0.353 . . . . 64.02 111.735 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -108.16 112.31 24.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.579 -0.282 . . . . 55.31 110.647 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -147.95 174.59 11.73 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.316 0.488 . . . . 74.41 112.316 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -103.72 144.89 30.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.31 -0.404 . . . . 63.33 111.108 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.46 ' HA ' HD23 ' A' ' 215' ' ' LEU . 43.0 t -77.32 105.26 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.12 0.486 . . . . 75.41 111.556 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.31 -36.31 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.887 -0.597 . . . . 62.0 111.391 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.51 158.74 37.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.845 -0.616 . . . . 73.3 111.369 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.72 122.55 14.42 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.35 -0.386 . . . . 51.1 111.342 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.42 148.41 35.15 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 120.629 0.252 . . . . 72.33 111.463 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.81 168.08 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.809 2.34 . . . . 60.42 113.045 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -74.36 147.72 41.91 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.376 0.607 . . . . 73.32 112.26 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -111.4 157.25 20.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.863 -0.608 . . . . 64.34 110.145 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -110.03 157.58 19.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.2 0.524 . . . . 73.12 110.969 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 33.0 p90 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.734 -0.667 . . . . 72.41 110.071 177.347 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.488 ' NE2' ' HB3' ' A' ' 231' ' ' ALA . 9.0 pt20 . . . . . 0 CA--C 1.541 0.596 0 CA-C-O 121.116 0.484 . . . . 64.41 111.717 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 22.0 tp -111.8 105.96 14.59 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.741 -0.663 . . . . 72.52 112.388 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.478 ' HE3' HD21 ' A' ' 213' ' ' LEU . 4.0 tmtm? -113.02 126.35 55.39 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.141 -0.349 . . . . 74.31 110.258 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 25.1 p -110.24 142.74 41.41 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.433 0.635 . . . . 73.53 112.665 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.478 HD21 ' HE3' ' A' ' 211' ' ' LYS . 85.0 mt -125.18 159.92 30.4 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.604 -0.725 . . . . 55.22 110.886 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -125.41 119.71 29.06 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.733 0.301 . . . . 73.41 110.944 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.568 HD11 HG21 ' A' ' 243' ' ' VAL . 75.7 mt -114.68 162.26 17.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.726 0.41 . . . . 74.24 111.025 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 216' ' ' LYS . 18.5 ptmt -151.76 168.64 24.42 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.677 0.751 . . . . 74.35 112.643 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -146.33 174.84 11.0 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.66 -1.155 . . . . 72.11 109.113 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.14 -14.37 60.38 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.832 -0.543 . . . . 73.55 112.231 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 68.8 p -102.25 -18.86 15.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.289 0.848 . . . . 62.22 113.289 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 167.7 -179.82 40.86 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.386 -0.912 . . . . 60.12 113.684 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 44.8 m -127.64 144.41 51.08 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.807 0.337 . . . . 73.31 111.789 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 176' ' ' ILE . 9.7 tp -150.65 150.17 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 116.508 -0.314 . . . . 70.52 110.849 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.503 ' HD3' ' H ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -107.75 142.66 37.42 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.944 -0.472 . . . . 75.13 111.699 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.519 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -110.57 155.67 15.98 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 116.063 -0.517 . . . . 72.44 113.271 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.4 m -116.39 114.01 23.68 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.408 0.522 . . . . 74.43 112.408 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.475 HD23 ' HB ' ' A' ' 258' ' ' VAL . 85.5 mt -96.71 133.95 40.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.815 0.446 . . . . 72.04 111.403 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -115.4 156.97 24.6 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.745 0.307 . . . . 73.44 111.52 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 58.87 -141.16 0.7 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 112.102 0.408 . . . . 62.22 112.102 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -48.26 -32.27 7.03 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.919 0.711 . . . . 72.51 112.919 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.431 ' HB3' HD22 ' A' ' 226' ' ' LEU . 85.8 mt -59.71 -19.45 49.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.745 0.307 . . . . 74.22 111.538 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.488 ' HB3' ' NE2' ' A' ' 209' ' ' GLN . . . -67.22 -32.3 73.26 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.181 0.438 . . . . 75.02 112.181 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -94.89 -6.62 42.21 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.023 0.379 . . . . 74.53 112.023 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -54.98 125.61 21.08 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.457 -0.338 . . . . 75.34 110.365 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -68.94 111.38 4.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.351 0.595 . . . . 53.32 111.652 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.47 HG11 HD11 ' A' ' 213' ' ' LEU . 7.3 p -144.42 135.27 20.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.559 -0.746 . . . . 74.44 109.678 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -139.51 165.92 25.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.525 0.679 . . . . 62.31 112.133 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -64.36 101.02 0.39 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.917 -0.583 . . . . 72.41 111.075 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 147.87 -31.37 1.34 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.615 -0.802 . . . . 63.14 114.583 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.09 154.41 25.6 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.769 0.785 . . . . 73.14 112.699 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 38.9 mm -94.57 106.05 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.485 -0.78 . . . . 73.41 110.833 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -100.04 131.12 46.19 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.985 0.735 . . . . 51.52 112.985 -174.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -97.04 97.63 9.39 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.364 -0.606 . . . . 72.14 109.364 171.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.568 HG21 HD11 ' A' ' 215' ' ' LEU . 99.3 t -99.01 124.16 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.973 0.731 . . . . 75.13 112.973 -169.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 37.0 t -98.59 116.55 31.08 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.826 -0.625 . . . . 73.33 110.348 172.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.03 174.58 33.93 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.317 -0.944 . . . . 71.1 114.484 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.406 ' HD1' ' HB3' ' A' ' 184' ' ' SER . 59.2 t80 -108.71 109.29 20.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.292 0.637 . . . . 72.51 110.788 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.462 HG22 ' HB ' ' A' ' 256' ' ' ILE . 40.5 t -78.29 116.04 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.58 0.229 . . . . 64.21 111.109 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -128.46 161.19 30.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.671 0.272 . . . . 71.43 111.326 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.798 0.332 . . . . 73.31 111.521 179.376 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.432 HD21 ' HG3' ' A' ' 181' ' ' PRO . 94.8 mt . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 120.845 0.355 . . . . 63.43 111.516 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -134.74 132.58 38.95 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.974 0.416 . . . . 74.42 110.505 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.519 HG23 ' HA2' ' A' ' 224' ' ' GLY . 7.4 tt -101.13 111.55 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.399 0.619 . . . . 73.25 112.195 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 50.9 m -78.89 111.57 15.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.998 -0.546 . . . . 54.4 110.462 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.475 ' HB ' HD23 ' A' ' 226' ' ' LEU . 43.1 t -75.74 127.97 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 112.425 0.528 . . . . 75.12 112.425 -173.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -97.99 -22.49 16.25 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.917 0.389 . . . . 64.21 111.291 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 47.9 t-20 -156.94 132.68 9.43 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 73.04 110.377 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.3 tt -126.64 122.23 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.075 0.464 . . . . 74.31 111.533 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -133.11 117.9 2.03 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.376 -0.44 . . . . 65.54 112.245 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 63.6 mt -85.4 127.21 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 122.53 -0.394 . . . . 54.33 111.258 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.1 -46.03 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.084 0.469 . . . . 75.55 111.282 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 CA--C 1.535 0.403 0 CA-C-N 115.86 -0.609 . . . . 72.13 110.612 176.464 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 4.3 t30 . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 110.205 -0.294 . . . . 73.35 110.205 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -84.6 137.02 33.53 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.616 0.598 . . . . 74.32 112.616 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -100.86 158.68 15.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.812 -0.631 . . . . 71.31 110.22 171.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.561 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 89.1 mt -60.93 -32.25 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 113.018 0.747 . . . . 51.11 113.018 -173.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.53 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 34.1 t -58.2 -31.82 67.69 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 122.103 -0.373 . . . . 63.34 111.954 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.16 -12.52 54.79 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.503 0.557 . . . . 72.14 112.503 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.561 ' HG ' ' HA ' ' A' ' 176' ' ' ILE . 65.7 mt -64.66 116.05 5.85 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.526 0.679 . . . . 71.03 111.934 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.6 ptp -125.74 160.97 53.65 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 115.648 -0.705 . . . . 74.03 110.55 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.524 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 43.4 Cg_exo -54.99 133.42 57.99 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.331 2.021 . . . . 65.23 112.876 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 16.4 m120 68.75 20.29 8.17 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.389 0.515 . . . . 72.02 112.389 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.11 139.48 31.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.951 0.405 . . . . 65.54 111.498 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.8 p -110.25 127.42 54.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.495 -0.32 . . . . 72.33 110.342 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.15 -169.78 38.76 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.422 -0.894 . . . . 54.33 113.987 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 79.1 m -132.63 120.86 22.33 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.706 -0.291 . . . . 72.31 111.179 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 41.1 pt -108.09 140.61 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.981 0.42 . . . . 74.01 111.585 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -115.99 112.11 21.33 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.454 -0.339 . . . . 73.31 110.219 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -142.52 169.34 17.76 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.105 0.479 . . . . 63.43 112.099 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.82 139.27 30.75 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.05 -0.523 . . . . 73.31 110.952 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.405 HG21 ' CG2' ' A' ' 235' ' ' VAL . 35.8 t -82.89 116.84 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.127 0.489 . . . . 74.41 111.534 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 35.7 t -90.41 -64.77 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.189 0.518 . . . . 75.52 111.553 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.452 ' H ' ' HB3' ' A' ' 214' ' ' PHE . . . -126.84 132.59 50.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.32 -0.4 . . . . 74.53 111.518 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -103.57 128.03 50.89 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.334 -0.394 . . . . 71.3 111.011 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -92.2 119.62 68.09 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.744 -0.207 . . . . 63.13 110.953 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.49 153.81 7.09 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.782 2.321 . . . . 71.1 113.094 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -64.36 130.49 44.0 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.084 0.772 . . . . 74.14 113.084 -173.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 3.0 mptp? -101.57 157.09 17.07 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.912 -0.586 . . . . 72.43 109.499 170.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -130.58 139.12 50.43 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.315 0.579 . . . . 73.41 111.91 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 26.2 p90 . . . . . 0 CA--C 1.536 0.412 0 CA-C-N 115.933 -0.576 . . . . 74.14 110.893 -178.967 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 120.788 0.328 . . . . 73.45 110.893 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.408 HD13 ' CZ3' ' A' ' 227' ' ' TRP . 51.5 tp -135.37 142.84 45.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.448 0.299 . . . . 65.44 111.02 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.518 ' HE2' HD21 ' A' ' 213' ' ' LEU . 0.7 OUTLIER -162.05 119.45 2.15 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.867 0.365 . . . . 64.14 110.868 -179.41 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.0 t -104.26 161.65 13.87 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.162 0.506 . . . . 72.12 112.218 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.518 HD21 ' HE2' ' A' ' 211' ' ' LYS . 95.5 mt -138.16 138.98 39.15 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.023 -0.535 . . . . 63.43 111.764 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.452 ' HB3' ' H ' ' A' ' 193' ' ' ALA . 21.8 t80 -97.2 106.23 18.52 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.906 0.384 . . . . 74.14 110.39 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 243' ' ' VAL . 80.0 mt -109.95 156.88 19.88 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.325 -0.398 . . . . 75.24 111.529 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -160.99 148.52 15.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.956 0.407 . . . . 70.11 112.062 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -132.21 -162.92 1.28 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.365 -0.606 . . . . 75.53 109.365 169.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -77.79 -1.7 32.71 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.778 0.659 . . . . 74.35 112.778 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 30.0 p -114.2 3.21 15.09 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.018 0.748 . . . . 55.32 113.018 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.406 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 149.22 -178.35 26.82 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.37 -0.919 . . . . 44.03 113.953 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 96.9 p -124.86 145.36 49.83 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.615 0.366 . . . . 65.15 111.021 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.9 tp -139.42 154.54 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-O 120.912 0.387 . . . . 72.32 111.263 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -108.02 112.45 25.02 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.891 0.377 . . . . 75.31 111.107 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.495 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -85.14 151.24 25.62 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.363 -0.38 . . . . 72.31 113.013 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 87.2 m -124.01 112.42 17.15 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.459 -0.436 . . . . 71.5 111.941 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.452 HD12 ' HD2' ' A' ' 211' ' ' LYS . 89.8 mt -94.97 121.95 37.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.342 -0.39 . . . . 73.14 110.717 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.408 ' CZ3' HD13 ' A' ' 210' ' ' LEU . 97.5 m95 -101.52 157.0 17.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.027 0.441 . . . . 74.45 111.875 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 54.95 -134.29 1.56 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.795 -0.639 . . . . 75.53 112.437 170.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 229' ' ' GLU . 4.1 mp0 -48.13 -34.18 9.44 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.704 0.802 . . . . 73.23 112.625 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 70.5 mt -69.52 -6.62 31.93 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.398 0.518 . . . . 54.25 112.398 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 211' ' ' LYS . . . -63.86 -45.92 87.31 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.841 0.353 . . . . 63.11 111.776 177.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.47 6.34 23.88 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.324 0.49 . . . . 71.53 112.324 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -61.27 123.33 17.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.824 -0.171 . . . . 71.24 110.664 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -73.7 96.01 2.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.719 0.771 . . . . 73.33 112.564 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.405 ' CG2' HG21 ' A' ' 191' ' ' VAL . 7.7 p -121.7 134.97 63.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.258 -0.883 . . . . 64.44 108.934 168.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -119.71 172.37 7.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.164 0.983 . . . . 73.2 113.246 -168.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -72.56 99.67 2.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.257 -0.883 . . . . 52.32 111.58 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.09 20.98 6.09 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.119 0.808 . . . . 62.14 115.119 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -103.23 167.46 9.81 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.38 1.09 . . . . 55.15 111.169 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 47.8 mm -101.42 104.74 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.128 -0.487 . . . . 72.01 110.845 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -104.72 125.55 50.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.077 0.465 . . . . 44.2 112.204 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -84.71 102.43 12.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.084 0.468 . . . . 71.03 109.838 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.457 HG21 HD11 ' A' ' 215' ' ' LEU . 98.6 t -99.8 105.9 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.325 0.583 . . . . 73.31 111.935 -175.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 36.7 t -97.11 125.92 41.92 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.035 -0.529 . . . . 73.01 110.383 174.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.83 -169.08 34.22 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.022 -1.085 . . . . 73.34 114.4 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -109.39 121.09 44.43 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.784 0.433 . . . . 63.34 110.854 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.524 HG21 HD22 ' A' ' 179' ' ' LEU . 38.6 t -83.79 139.19 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.275 -0.42 . . . . 73.44 111.847 -177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.656 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 8.4 mtpm? -134.25 168.39 18.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.183 0.516 . . . . 64.3 111.443 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 25.8 tt0 . . . . . 0 N--CA 1.467 0.416 0 CA-C-N 116.09 -0.504 . . . . 64.21 110.305 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.131 0.491 . . . . 71.15 110.795 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.656 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 8.6 pt-20 -128.56 169.26 14.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.882 -0.599 . . . . 73.0 110.787 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.495 HG23 ' HA2' ' A' ' 224' ' ' GLY . 11.2 tt -148.79 117.22 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.461 0.648 . . . . 53.24 111.98 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 77.8 p -85.12 119.69 25.79 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.079 -0.51 . . . . 71.31 110.318 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.448 ' HB ' HD23 ' A' ' 226' ' ' LEU . 41.8 t -77.02 132.42 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.685 0.624 . . . . 73.13 112.685 -173.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -95.73 -54.74 3.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.829 -0.623 . . . . 72.42 110.276 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -139.78 126.81 20.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.056 -0.52 . . . . 73.03 110.785 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.7 tt -116.38 127.43 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.043 0.449 . . . . 72.13 111.284 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -125.28 118.78 3.36 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.142 -0.551 . . . . 73.53 112.955 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.3 mm -76.45 111.37 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.931 0.396 . . . . 64.41 110.889 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.402 HG22 ' HG3' ' A' ' 265' ' ' GLU . 61.8 mt -69.2 -42.99 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.844 0.354 . . . . 75.12 111.587 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 264' ' ' ILE . 44.5 mt-10 . . . . . 0 N--CA 1.47 0.549 0 CA-C-N 116.558 -0.292 . . . . 63.43 111.309 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 186' ' ' THR . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 121.103 0.478 . . . . 63.31 111.045 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -85.67 168.06 14.74 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.477 0.656 . . . . 63.43 112.091 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -96.72 156.8 16.19 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.511 -0.768 . . . . 64.41 109.868 169.218 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 51.0 mt -61.43 -32.67 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.105 0.409 . . . . 71.51 112.105 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.1 t -63.82 -22.73 67.05 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.882 0.373 . . . . 71.52 111.468 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -87.91 -12.02 45.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.38 -0.373 . . . . 65.33 111.85 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 187' ' ' ILE . 84.1 mt -71.54 103.07 2.87 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.389 0.614 . . . . 73.11 111.413 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.447 ' HG2' HD13 ' A' ' 183' ' ' LEU . 23.1 ptp -112.56 157.24 40.82 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.844 -0.616 . . . . 61.44 110.956 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.437 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 52.0 Cg_exo -53.05 135.27 58.64 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.487 2.125 . . . . 74.24 113.271 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 69.8 26.89 4.71 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.208 0.603 . . . . 70.4 112.28 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.447 HD13 ' HG2' ' A' ' 180' ' ' MET . 9.1 tt -115.85 144.72 43.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.767 0.318 . . . . 71.13 110.715 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.437 ' HB2' ' CD2' ' A' ' 246' ' ' TYR . 47.3 t -126.45 157.32 38.94 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.934 0.397 . . . . 74.11 111.79 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.2 -168.6 33.08 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.043 -0.599 . . . . 62.04 113.214 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 65.1 m -106.39 152.48 23.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.366 0.266 . . . . 71.33 110.534 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.472 HG21 HD21 ' A' ' 179' ' ' LEU . 37.4 pt -139.22 161.15 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.117 0.484 . . . . 61.33 111.584 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -118.38 110.94 18.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.087 -0.506 . . . . 62.45 110.137 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.67 157.89 44.51 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.346 0.593 . . . . 73.41 112.085 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -93.65 134.39 36.0 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.702 -0.681 . . . . 75.34 110.816 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.89 125.48 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.003 0.43 . . . . 51.2 111.978 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.28 -42.6 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.179 0.514 . . . . 72.22 111.146 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -146.11 130.55 17.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.992 -0.549 . . . . 71.21 111.205 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.91 104.55 8.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.019 0.438 . . . . 62.42 111.602 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.473 ' HB3' ' HD2' ' A' ' 196' ' ' PRO . 97.2 m-85 -86.0 163.33 43.64 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 116.542 -0.299 . . . . 73.02 111.721 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 195' ' ' TYR . 60.7 Cg_endo -70.28 -164.65 0.14 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.798 2.332 . . . . 72.42 113.155 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.662 ' HD3' ' HB2' ' A' ' 232' ' ' ASP . 22.1 pttp -100.05 111.49 23.78 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.608 0.718 . . . . 72.21 111.841 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -92.45 176.55 6.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 64.24 110.697 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.3 150.12 48.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.091 0.472 . . . . 74.52 111.334 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 43.5 p90 . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 121.113 0.483 . . . . 64.42 111.265 -179.514 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 121.107 0.479 . . . . 61.24 111.982 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.5 tp -129.63 123.5 31.41 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.611 -0.722 . . . . 74.1 111.634 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.541 ' HD3' HD12 ' A' ' 226' ' ' LEU . 44.6 tttp -122.52 108.6 13.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.786 0.327 . . . . 61.13 111.309 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.6 m -74.32 125.85 29.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.476 -0.329 . . . . 71.0 111.178 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.405 HD21 ' HE3' ' A' ' 211' ' ' LYS . 97.8 mt -132.51 150.56 52.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.092 0.472 . . . . 75.41 111.67 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -135.01 124.25 24.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.469 -0.332 . . . . 73.43 110.32 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 86.7 mt -118.05 150.0 40.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.713 0.292 . . . . 74.32 111.688 -174.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -132.8 129.09 38.1 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.778 0.799 . . . . 73.32 112.095 175.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -115.11 165.68 12.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.113 -0.949 . . . . 71.34 109.042 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.72 -25.87 66.74 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 111.874 0.324 . . . . 62.44 111.874 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 69.6 p -91.86 0.34 57.48 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.697 0.628 . . . . 51.4 112.697 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 146.25 177.09 20.64 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.936 -0.65 . . . . 23.43 113.469 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 54.0 p -118.31 160.08 22.27 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 122.405 -0.467 . . . . 71.31 111.596 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.1 tp -146.47 152.67 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.011 0.434 . . . . 74.33 111.894 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -90.82 121.82 33.01 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.214 -0.448 . . . . 73.1 110.902 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -120.62 165.9 13.86 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.207 -0.52 . . . . 61.43 113.313 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 98.8 m -152.82 137.08 16.55 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.268 -0.548 . . . . 71.14 112.395 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.555 HD23 ' HB ' ' A' ' 258' ' ' VAL . 65.9 mt -106.1 141.31 37.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.84 -0.618 . . . . 64.3 110.47 172.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -114.84 160.88 18.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.1 0.476 . . . . 71.54 111.601 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 56.08 -134.13 1.41 Allowed 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.925 -0.579 . . . . 65.45 111.705 172.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.95 -34.65 68.23 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.468 0.544 . . . . 64.12 112.468 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.41 -15.39 62.55 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.119 0.414 . . . . 74.43 112.119 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -61.55 -27.68 68.79 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 120.965 0.412 . . . . 60.34 111.779 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.662 ' HB2' ' HD3' ' A' ' 197' ' ' LYS . 36.8 t70 -95.18 9.01 41.25 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 120.823 0.344 . . . . 73.14 111.481 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -56.9 128.52 37.21 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.905 0.383 . . . . 72.43 111.725 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.4 115.63 16.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.066 0.46 . . . . 55.51 110.609 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.27 150.02 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.918 -0.583 . . . . 74.53 110.946 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.432 ' HB2' ' CG ' ' A' ' 239' ' ' ASP . 9.5 mmmm -117.66 146.91 43.37 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.087 0.47 . . . . 75.03 112.242 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.27 95.82 0.32 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.109 -0.496 . . . . 73.33 110.406 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 129.56 -16.78 5.61 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.916 -0.659 . . . . 45.51 113.348 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.432 ' CG ' ' HB2' ' A' ' 236' ' ' LYS . 66.2 m-20 -68.37 132.14 46.54 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.051 0.453 . . . . 64.04 111.086 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 264' ' ' ILE . 46.5 mm -77.79 107.99 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.912 0.387 . . . . 74.42 110.385 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -104.01 139.39 39.2 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.04 0.755 . . . . 52.43 113.04 -173.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -95.17 99.71 11.64 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.178 -0.675 . . . . 75.2 109.178 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.27 123.87 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.506 0.558 . . . . 71.14 112.506 -170.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 186' ' ' THR . 45.5 t -112.09 123.19 49.72 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.861 0.363 . . . . 62.34 111.211 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -164.6 -167.25 24.86 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.562 -0.827 . . . . 33.43 113.997 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 184' ' ' SER . 39.3 t80 -121.89 129.34 52.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.736 0.303 . . . . 64.35 110.966 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 47.0 t -96.22 125.68 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.005 0.431 . . . . 72.42 112.129 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -122.18 166.21 14.94 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.015 0.436 . . . . 62.15 110.736 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.437 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 25.2 tt0 . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 120.712 0.292 . . . . 74.24 110.899 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 120.762 0.315 . . . . 62.45 110.861 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -113.96 126.13 54.8 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.82 0.343 . . . . 63.25 111.167 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.04 106.44 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.627 0.727 . . . . 44.41 111.47 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.2 t -83.62 114.38 21.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.905 -0.589 . . . . 73.0 110.456 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.555 ' HB ' HD23 ' A' ' 226' ' ' LEU . 39.0 t -91.06 121.28 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.186 0.439 . . . . 71.14 112.186 -173.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -101.99 -14.24 17.25 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.786 0.327 . . . . 72.4 111.668 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -149.49 127.37 11.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.684 0.278 . . . . 71.41 110.668 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.7 tt -137.13 135.36 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.206 0.527 . . . . 72.44 112.278 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -147.69 122.69 1.59 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 115.826 -0.625 . . . . 64.42 112.074 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 58.0 mt -82.74 136.88 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 O-C-N 121.992 -0.711 . . . . 54.54 112.015 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 240' ' ' ILE . 66.5 mt -70.6 -45.62 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.932 -0.576 . . . . 73.24 111.583 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.876 0.369 . . . . 54.4 111.585 -178.391 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 109.755 -0.461 . . . . 63.21 109.755 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.48 ' HB2' HG22 ' A' ' 187' ' ' ILE . 95.1 m-85 -98.94 135.61 40.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.373 0.606 . . . . 75.24 112.338 -176.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -91.52 153.37 19.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.012 -0.54 . . . . 55.02 110.063 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 220' ' ' GLY . 64.2 mt -54.23 -36.65 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 113.492 0.923 . . . . 62.32 113.492 -172.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.7 t -75.48 -10.14 59.19 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.828 -0.545 . . . . 74.15 112.348 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.74 -7.57 52.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.678 0.275 . . . . 71.54 111.388 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.85 159.47 33.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.641 0.734 . . . . 70.21 112.655 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.568 ' HG2' HD22 ' A' ' 183' ' ' LEU . 25.4 ptp -157.41 155.07 26.9 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.418 -0.81 . . . . 52.54 110.154 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.438 ' HB3' ' CB ' ' A' ' 249' ' ' GLN . 12.3 Cg_endo -57.35 150.75 56.94 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.995 1.796 . . . . 72.22 112.38 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.415 ' HA ' ' OH ' ' A' ' 246' ' ' TYR . 63.8 t30 65.09 32.15 10.51 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.387 0.613 . . . . 73.21 111.021 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.568 HD22 ' HG2' ' A' ' 180' ' ' MET . 30.1 tp -119.85 128.48 53.72 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.412 -0.358 . . . . 62.44 111.75 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 88.8 p -111.48 114.79 28.14 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.115 -0.366 . . . . 73.03 110.325 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.46 176.22 36.26 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.441 -0.885 . . . . 71.44 114.181 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 88.6 m -108.76 119.74 40.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.932 0.396 . . . . 62.55 111.328 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.48 HG22 ' HB2' ' A' ' 174' ' ' TYR . 34.4 pt -110.54 155.79 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.127 0.489 . . . . 60.24 111.886 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -118.58 113.01 20.61 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.226 -0.443 . . . . 75.5 110.483 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -145.65 163.05 36.05 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.294 0.569 . . . . 73.22 111.935 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -94.89 139.2 31.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.936 -0.574 . . . . 74.01 111.594 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' A' ' 215' ' ' LEU . 46.9 t -77.19 106.82 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.884 0.374 . . . . 74.3 111.563 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.401 ' HB ' ' HD2' ' A' ' 214' ' ' PHE . 14.7 t -79.93 -45.93 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.228 0.537 . . . . 75.14 111.229 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -145.05 115.82 7.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.116 -0.493 . . . . 74.23 111.438 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -100.79 108.81 20.71 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.376 -0.375 . . . . 63.22 110.852 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -70.78 159.99 83.47 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.505 -0.316 . . . . 75.33 111.45 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.16 159.45 49.79 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.261 1.974 . . . . 72.0 112.864 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 197' ' ' LYS . 21.0 ptmt -75.39 102.29 5.08 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.475 0.655 . . . . 54.34 112.075 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -67.08 163.55 19.83 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.66 -0.7 . . . . 72.54 112.048 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.56 131.11 53.68 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.711 -0.677 . . . . 71.11 111.485 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 210' ' ' LEU . 8.0 p90 . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 120.706 0.288 . . . . 75.24 110.969 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.564 0.221 . . . . 73.42 110.648 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 200' ' ' PHE . 38.3 tp -141.5 117.99 10.89 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.089 0.403 . . . . 74.2 112.089 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -134.9 114.56 12.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.948 0.404 . . . . 52.22 111.412 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 47.2 t -93.8 149.41 21.26 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.931 0.396 . . . . 74.0 111.396 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.57 HD21 HG11 ' A' ' 235' ' ' VAL . 74.0 mt -128.66 125.36 37.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.601 -0.272 . . . . 71.54 111.229 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.401 ' HD2' ' HB ' ' A' ' 192' ' ' VAL . 34.0 t80 -89.9 111.91 23.11 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.792 0.329 . . . . 64.32 110.243 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 191' ' ' VAL . 48.1 mt -109.92 156.77 20.0 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.388 -0.369 . . . . 74.03 111.006 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 221' ' ' SER . 18.1 ptmt -148.79 165.46 31.39 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.494 0.664 . . . . 61.4 112.155 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.404 ' OD2' HG22 ' A' ' 219' ' ' THR . 25.7 t70 -147.5 170.11 18.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.066 -0.97 . . . . 44.44 109.877 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -48.78 -31.76 7.53 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.561 0.578 . . . . 74.21 112.561 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.404 HG22 ' OD2' ' A' ' 217' ' ' ASP . 13.1 t -102.48 -8.92 20.67 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.194 1.183 . . . . 73.35 114.194 -173.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.436 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 168.32 -179.55 41.32 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 119.82 -1.181 . . . . 70.22 114.453 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 216' ' ' LYS . 36.4 m -122.92 157.96 31.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.541 0.336 . . . . 72.51 111.325 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.6 tp -151.83 156.46 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.828 0.347 . . . . 70.32 111.32 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -113.37 112.07 23.04 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.277 0.561 . . . . 71.15 111.532 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.556 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -94.42 164.78 25.84 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.299 -0.41 . . . . 61.24 113.065 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 86.0 m -137.51 127.22 25.36 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.483 0.549 . . . . 71.11 112.483 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.465 HD23 ' HB ' ' A' ' 258' ' ' VAL . 96.1 mt -107.28 124.02 49.17 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.969 -0.56 . . . . 72.24 110.875 174.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -103.24 152.51 21.41 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.075 0.464 . . . . 73.31 111.995 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 51.01 -132.52 1.9 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.566 0.58 . . . . 75.42 112.566 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -42.72 -39.53 2.46 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.433 0.901 . . . . 73.13 113.433 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.2 -19.77 63.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.975 0.417 . . . . 75.11 112.049 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.66 -21.98 66.86 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.091 0.404 . . . . 54.31 112.091 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.57 3.38 55.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.222 0.453 . . . . 75.4 112.222 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -64.33 124.31 21.41 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 110.289 -0.263 . . . . 74.34 110.289 174.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.434 ' OE2' ' HE2' ' A' ' 236' ' ' LYS . 28.9 tt0 -66.86 99.4 0.62 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.17 0.509 . . . . 73.01 112.043 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 213' ' ' LEU . 4.0 p -116.85 111.19 34.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.466 0.65 . . . . 41.53 110.699 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.434 ' HE2' ' OE2' ' A' ' 234' ' ' GLU . 66.8 mttm -98.36 147.73 24.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.08 0.466 . . . . 74.04 111.506 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -65.1 112.85 3.56 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 75.44 110.597 177.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.63 -16.66 23.74 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.463 -0.399 . . . . 11.1 113.172 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.51 141.54 51.93 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.011 0.434 . . . . 73.44 111.482 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 37.2 mm -89.09 117.91 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.476 -0.329 . . . . 73.14 110.522 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -109.01 127.1 53.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.11 0.782 . . . . 65.52 113.11 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.2 97.54 6.96 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.228 -0.656 . . . . 53.31 109.228 167.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.7 t -100.79 106.02 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.251 0.548 . . . . 74.54 112.24 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.9 m -96.65 109.19 21.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.937 -0.574 . . . . 72.41 110.055 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.67 -172.98 22.33 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.199 -1.0 . . . . 34.11 114.343 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.415 ' OH ' ' HA ' ' A' ' 182' ' ' ASN . 74.0 t80 -115.38 115.66 26.96 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.39 -0.405 . . . . 74.33 110.856 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.83 126.66 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.16 0.505 . . . . 53.32 111.717 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 52.4 mtpt -123.04 146.49 47.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.067 -0.515 . . . . 53.33 111.504 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.438 ' CB ' ' HB3' ' A' ' 181' ' ' PRO . 25.3 tt0 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 75.22 110.648 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 120.96 0.409 . . . . 54.44 111.385 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.418 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 10.5 pt-20 -144.24 174.03 11.25 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.154 -0.475 . . . . 70.33 111.007 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.556 HG23 ' HA2' ' A' ' 224' ' ' GLY . 8.5 tt -154.05 116.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.477 0.656 . . . . 75.42 111.976 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.8 t -87.49 124.37 33.38 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.951 -0.568 . . . . 74.43 110.098 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 226' ' ' LEU . 33.3 t -84.08 132.84 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 112.366 0.506 . . . . 74.42 112.366 -173.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -95.36 -42.48 8.48 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.311 0.577 . . . . 72.23 110.723 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -145.42 135.41 23.71 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.917 -0.583 . . . . 65.41 110.702 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.459 ' HB ' HG11 ' A' ' 258' ' ' VAL . 12.6 tt -137.92 140.12 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.935 0.398 . . . . 62.34 111.596 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -149.98 136.42 5.69 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 116.24 -0.436 . . . . 73.23 112.159 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.6 mm -84.8 132.84 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.324 -0.515 . . . . 72.11 111.287 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 46.6 mt -77.1 -74.52 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 116.713 -0.221 . . . . 71.43 111.191 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 121.201 0.524 . . . . 63.0 110.443 170.182 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 186' ' ' THR . 10.9 m120 . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.912 0.387 . . . . 74.52 110.868 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 33.2 m-85 -83.92 171.45 13.02 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.518 0.675 . . . . 64.31 112.09 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 74.3 mmtt -93.39 156.68 16.64 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.568 -0.742 . . . . 70.53 109.683 167.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.503 HD13 HG22 ' A' ' 222' ' ' ILE . 40.0 mt -59.12 -31.87 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.114 0.412 . . . . 74.55 112.114 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.452 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 34.8 t -62.11 -29.26 70.2 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.93 0.395 . . . . 50.13 111.598 174.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 11.5 mm-40 -83.5 -18.22 39.24 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.405 -0.361 . . . . 72.31 111.695 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.676 HD11 HD13 ' A' ' 187' ' ' ILE . 87.6 mt -64.45 98.86 0.27 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.232 0.539 . . . . 73.03 110.998 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.463 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.9 ptp -96.64 152.2 38.4 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.099 -0.5 . . . . 73.31 111.163 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.18 138.34 78.92 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.169 1.913 . . . . 72.14 112.769 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 72.54 18.91 4.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.263 0.625 . . . . 62.31 111.794 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 180' ' ' MET . 44.1 tp -94.7 154.82 17.13 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 61.14 111.599 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.4 t -131.31 123.17 27.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.53 -0.305 . . . . 44.11 110.67 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.54 -164.45 26.28 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.89 -0.671 . . . . 61.13 113.527 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 43.8 m -133.76 147.36 51.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.433 0.293 . . . . 63.01 111.177 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.676 HD13 HD11 ' A' ' 179' ' ' LEU . 39.9 pt -142.51 165.53 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.01 0.433 . . . . 65.4 111.577 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -122.29 118.31 28.21 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.692 -0.485 . . . . 73.55 109.692 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.29 170.75 16.14 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.532 0.567 . . . . 73.33 112.532 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 215' ' ' LEU . 40.1 mt-10 -84.86 134.2 34.29 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.802 -0.635 . . . . 74.45 111.514 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.26 95.75 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.039 0.447 . . . . 73.12 110.63 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.25 -29.94 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.127 0.489 . . . . 54.22 112.001 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.97 145.02 28.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 75.14 111.694 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -140.84 116.31 10.11 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.216 -0.447 . . . . 33.41 111.384 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.481 ' O ' ' HE2' ' A' ' 211' ' ' LYS . 97.0 m-85 -87.4 153.93 53.75 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-N 116.627 -0.26 . . . . 75.11 110.956 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.25 162.43 23.43 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.663 2.242 . . . . 65.11 112.942 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 197' ' ' LYS . 20.3 ptmt -72.48 115.3 11.58 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.618 0.723 . . . . 71.25 111.744 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -102.27 148.74 25.08 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.0 -0.546 . . . . 74.3 111.19 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.41 144.37 45.05 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.895 0.378 . . . . 74.31 111.243 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 12.4 p90 . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 121.012 0.434 . . . . 62.54 111.315 177.379 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.45 HE21 ' HA ' ' A' ' 229' ' ' GLU . 37.5 mt-30 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 121.424 0.631 . . . . 62.23 112.695 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.4 tp -138.37 116.5 11.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.431 -0.804 . . . . 75.55 111.221 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.481 ' HE2' ' O ' ' A' ' 195' ' ' TYR . 59.5 tttm -145.79 107.31 4.24 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.035 -0.416 . . . . 74.12 111.264 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 225' ' ' THR . 57.9 m -86.49 142.36 28.41 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.525 0.678 . . . . 73.13 112.65 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 59.8 mt -123.74 163.01 22.01 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.27 -0.877 . . . . 63.33 109.619 173.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -119.92 117.12 27.26 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.956 -0.465 . . . . 71.04 110.686 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 78.3 mt -107.7 133.98 51.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.726 0.298 . . . . 75.14 111.224 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -124.03 153.64 41.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.426 0.631 . . . . 71.33 111.877 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -151.15 160.43 43.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.964 -1.016 . . . . 74.11 109.302 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.31 -25.78 49.84 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.107 0.41 . . . . 61.15 112.107 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 48.6 p -89.23 -14.09 36.72 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.061 0.763 . . . . 62.14 113.061 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.02 -179.76 41.55 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.341 -0.933 . . . . 52.32 114.218 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.5 p -135.41 132.48 37.55 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.659 -0.318 . . . . 54.32 111.216 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.503 HG22 HD13 ' A' ' 176' ' ' ILE . 15.5 tt -144.81 145.74 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.058 0.456 . . . . 73.31 111.75 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.708 ' H ' ' HD2' ' A' ' 223' ' ' ARG . 0.5 OUTLIER -89.93 130.33 36.16 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.985 -0.447 . . . . 74.44 111.313 177.217 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.466 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -112.32 114.43 3.52 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.459 -0.401 . . . . 64.32 112.906 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 212' ' ' SER . 87.9 m -95.47 120.14 35.19 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.477 0.547 . . . . 55.1 112.477 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.494 HD23 ' HB ' ' A' ' 258' ' ' VAL . 91.3 mt -78.74 123.84 27.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.948 -0.569 . . . . 74.1 110.857 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -107.74 172.72 6.67 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.988 0.423 . . . . 75.23 111.362 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 57.7 t30 55.72 -141.11 0.86 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 116.217 -0.447 . . . . 74.2 111.525 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.45 ' HA ' HE21 ' A' ' 209' ' ' GLN . 11.5 pt-20 -74.85 -5.73 45.18 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.57 -0.706 . . . . 70.43 112.465 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.487 ' HB3' HD22 ' A' ' 226' ' ' LEU . 83.2 mt -68.3 -12.77 61.59 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 122.137 -0.352 . . . . 51.21 111.656 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.79 67.11 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.153 0.502 . . . . 71.33 111.595 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.0 -3.07 59.06 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.012 0.375 . . . . 73.44 112.012 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -62.96 118.26 7.56 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.146 0.498 . . . . 74.42 110.999 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.26 99.42 4.04 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.402 0.62 . . . . 72.33 112.086 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.77 141.64 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 115.733 -0.667 . . . . 75.54 110.731 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -116.92 171.03 8.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.037 0.446 . . . . 73.22 110.835 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -72.99 119.24 16.97 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.852 0.358 . . . . 71.24 110.633 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 118.16 -24.13 8.9 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.157 -0.544 . . . . 44.25 113.751 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -64.78 134.32 53.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 117.159 0.479 . . . . 72.42 111.962 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 49.8 mm -84.03 102.33 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.005 0.431 . . . . 72.25 110.112 173.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -108.74 141.61 40.49 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.661 0.615 . . . . 71.24 112.661 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -89.35 108.45 19.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.802 -0.636 . . . . 73.31 109.728 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 258' ' ' VAL . 75.8 t -111.51 130.24 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.158 0.429 . . . . 72.23 112.158 -172.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 28.5 t -123.9 137.3 54.66 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.294 -0.412 . . . . 61.42 110.701 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.98 -164.16 32.29 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.194 -1.003 . . . . 51.54 114.169 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -105.47 123.19 47.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.827 0.451 . . . . 74.12 111.189 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.9 t -89.93 134.44 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.229 0.538 . . . . 73.11 112.271 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.57 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 7.9 mtpm? -128.03 157.2 41.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.94 -0.573 . . . . 70.51 110.441 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.469 0.517 0 O-C-N 122.173 -0.329 . . . . 74.4 110.326 173.979 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 CA--C 1.54 0.596 0 CA-C-O 121.42 0.629 . . . . 51.14 112.649 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 255' ' ' GLU . . . . . 0.57 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 8.0 pt-20 -143.62 125.85 15.56 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.563 -0.744 . . . . 51.1 110.038 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.466 HG23 ' HA2' ' A' ' 224' ' ' GLY . 12.2 tt -116.72 135.12 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.438 0.637 . . . . 72.4 112.443 -176.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 69.8 m -95.66 115.06 26.89 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.771 -0.649 . . . . 74.11 110.343 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.494 ' HB ' HD23 ' A' ' 226' ' ' LEU . 38.5 t -75.54 120.32 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.302 0.573 . . . . 63.42 112.158 -174.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.36 -36.41 11.39 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.941 -0.572 . . . . 75.23 110.654 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 15.7 t-20 -139.93 140.14 36.31 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.804 -0.634 . . . . 74.11 110.334 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 14.2 tt -148.35 135.2 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.345 0.593 . . . . 70.54 112.288 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -148.49 125.18 2.01 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.104 -0.498 . . . . 74.34 112.304 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 54.0 mt -79.85 131.9 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 122.217 -0.578 . . . . 51.23 111.773 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.1 mt -73.33 -52.75 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.122 0.487 . . . . 65.41 111.332 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 . . . . . 0 N--CA 1.469 0.511 0 CA-C-N 116.075 -0.511 . . . . 75.43 111.792 179.812 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.578 HD21 ' N ' ' A' ' 173' ' ' ASN . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.726 -0.472 . . . . 72.14 109.726 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.423 ' O ' HG22 ' A' ' 187' ' ' ILE . 88.8 m-85 -84.35 145.36 28.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.326 0.584 . . . . 74.21 112.463 -173.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 46.4 mmtm -79.42 154.34 29.03 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.047 -0.723 . . . . 74.14 109.047 167.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.438 HG23 ' HB ' ' A' ' 222' ' ' ILE . 58.7 mt -51.94 -36.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 112.591 0.589 . . . . 74.24 112.591 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.4 t -67.76 -29.14 68.28 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 122.057 -0.402 . . . . 55.04 111.845 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.482 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 12.3 mm-40 -76.26 -8.04 56.21 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.851 0.315 . . . . 74.52 111.851 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.424 HD22 HG21 ' A' ' 247' ' ' VAL . 88.1 mt -73.41 145.29 45.92 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.314 0.578 . . . . 74.41 111.901 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.478 ' HG2' HD22 ' A' ' 183' ' ' LEU . 24.2 ptp -143.97 159.16 54.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.029 -0.532 . . . . 75.21 110.7 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.22 132.38 38.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.451 2.101 . . . . 63.1 113.192 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 65.05 46.08 2.89 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.065 0.459 . . . . 70.33 111.589 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.478 HD22 ' HG2' ' A' ' 180' ' ' MET . 42.8 tp -119.19 120.88 38.37 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.304 -0.407 . . . . 63.22 111.73 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.5 t -99.14 120.46 39.53 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.556 0.217 . . . . 64.21 110.639 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.82 -176.17 38.79 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.52 -0.848 . . . . 55.13 114.402 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 90.6 m -114.57 136.58 52.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.0 0.52 . . . . 74.35 111.698 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 174' ' ' TYR . 34.6 pt -126.8 157.8 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 122.63 0.372 . . . . 72.2 110.741 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -129.96 103.15 6.61 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.177 -0.327 . . . . 65.23 110.174 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -139.31 172.32 12.99 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 113.373 0.879 . . . . 73.01 113.373 -171.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.92 140.8 29.07 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.052 -0.976 . . . . 75.43 111.425 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.33 95.05 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.069 0.461 . . . . 63.21 110.761 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.405 ' HB ' ' HD2' ' A' ' 214' ' ' PHE . 16.2 t -72.26 -42.6 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.223 -0.444 . . . . 72.01 111.936 -176.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -140.32 127.7 21.29 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.99 0.424 . . . . 74.15 111.63 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -104.18 104.41 14.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.342 -0.39 . . . . 54.02 111.542 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -79.67 150.07 72.25 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.543 -0.299 . . . . 74.35 111.775 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.6 168.38 16.73 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.981 2.454 . . . . 74.53 113.801 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.2 156.39 33.65 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.102 -0.499 . . . . 73.43 111.675 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -141.88 159.08 42.95 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.112 -0.495 . . . . 63.42 111.056 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -129.08 153.45 47.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.991 0.424 . . . . 61.04 111.47 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.574 ' HE2' ' HB2' ' A' ' 210' ' ' LEU . 52.4 p90 . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 121.032 0.444 . . . . 63.23 111.08 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 120.965 0.412 . . . . 64.33 111.981 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.574 ' HB2' ' HE2' ' A' ' 200' ' ' PHE . 51.7 tp -135.12 141.01 45.9 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.95 0.5 . . . . 74.41 111.321 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 231' ' ' ALA . 7.6 tmtm? -167.38 115.2 0.78 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.796 0.332 . . . . 71.33 111.034 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 69.8 m -99.83 167.26 10.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.741 0.782 . . . . 62.25 113.025 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.424 HD11 HG11 ' A' ' 235' ' ' VAL . 75.9 mt -142.66 157.33 44.79 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.179 -0.919 . . . . 54.44 110.752 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.405 ' HD2' ' HB ' ' A' ' 192' ' ' VAL . 35.6 t80 -117.13 122.52 44.32 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.133 -0.354 . . . . 74.54 110.851 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.529 HD11 HG21 ' A' ' 243' ' ' VAL . 44.3 mt -118.4 154.63 32.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.655 0.382 . . . . 71.23 111.004 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -153.25 132.81 12.97 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.764 0.654 . . . . 61.53 112.764 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -99.81 -171.17 2.0 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.977 -0.556 . . . . 43.24 110.315 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.94 -15.15 62.58 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.195 0.522 . . . . 73.25 110.587 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 54.1 p -94.47 -20.52 19.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.819 0.674 . . . . 61.34 112.819 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 158.12 -179.53 33.76 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.755 -0.736 . . . . 72.13 113.361 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 83.9 p -123.67 146.78 47.98 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.056 0.455 . . . . 74.04 112.047 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 176' ' ' ILE . 11.4 tp -144.1 157.22 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.251 -0.432 . . . . 73.5 110.966 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 223' ' ' ARG . 29.1 mtm-85 -102.54 117.61 35.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.695 0.284 . . . . 74.02 111.455 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.556 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -97.7 119.76 6.52 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.419 -0.42 . . . . 62.15 112.84 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.0 m -99.25 118.41 35.87 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.355 0.502 . . . . 75.44 112.355 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.559 HD23 ' HB ' ' A' ' 258' ' ' VAL . 91.4 mt -91.9 133.82 35.33 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.974 -0.557 . . . . 71.11 111.046 175.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -115.46 159.4 21.22 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.08 0.467 . . . . 74.42 111.886 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.48 -133.54 1.06 Allowed 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 115.921 -0.581 . . . . 73.42 111.676 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.76 -31.58 39.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.242 0.46 . . . . 72.32 112.242 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 90.3 mt -64.27 -14.91 58.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.983 0.364 . . . . 63.45 111.983 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 211' ' ' LYS . . . -73.98 -1.96 22.09 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.968 0.413 . . . . 63.21 112.063 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.03 14.22 9.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.895 0.478 . . . . 75.42 110.961 173.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -72.69 126.22 29.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.042 -0.526 . . . . 75.3 111.139 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -62.86 97.36 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.169 0.509 . . . . 55.43 111.828 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.424 HG11 HD11 ' A' ' 213' ' ' LEU . 4.0 p -135.72 114.38 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.934 -0.576 . . . . 70.12 110.541 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -100.35 157.94 16.25 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.169 0.509 . . . . 73.45 111.507 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -69.35 94.77 0.74 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.994 -0.548 . . . . 74.33 111.664 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 137.27 -19.35 3.42 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.171 -0.538 . . . . 71.14 113.793 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -70.0 146.13 51.28 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.139 0.495 . . . . 55.33 112.083 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.537 HG22 HD12 ' A' ' 264' ' ' ILE . 45.8 mm -86.93 129.31 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.191 -0.458 . . . . 73.43 110.22 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.622 ' HB2' HD13 ' A' ' 263' ' ' ILE . . . -140.91 152.35 44.96 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.028 0.751 . . . . 74.24 113.028 -175.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.28 125.52 38.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.787 -0.642 . . . . 74.52 110.221 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 215' ' ' LEU . 92.9 t -122.11 117.58 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.133 0.492 . . . . 52.05 111.786 -175.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 260' ' ' ASN . 69.7 m -118.0 133.18 56.16 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.321 -0.4 . . . . 73.13 110.955 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.26 -156.12 13.23 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.438 -0.887 . . . . 44.25 113.84 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -122.75 115.32 21.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.966 0.412 . . . . 72.35 111.339 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.543 HG22 ' HB ' ' A' ' 256' ' ' ILE . 38.3 t -86.89 125.69 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.249 -0.432 . . . . 64.45 111.614 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -154.08 154.45 33.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.804 0.335 . . . . 53.54 111.365 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 CA--C 1.536 0.428 0 CA-C-N 116.677 -0.238 . . . . 64.42 110.472 176.311 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.017 0.437 . . . . 73.23 111.278 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -122.27 133.81 54.68 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.437 -0.347 . . . . 72.32 111.293 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.556 HG23 ' HA2' ' A' ' 224' ' ' GLY . 8.5 tt -103.86 109.09 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.329 0.585 . . . . 65.5 111.104 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.7 t -78.28 115.47 18.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.212 -0.449 . . . . 74.01 110.024 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.559 ' HB ' HD23 ' A' ' 226' ' ' LEU . 38.8 t -88.45 116.9 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 112.607 0.595 . . . . 73.24 112.607 -170.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.76 -24.15 17.92 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.327 -0.397 . . . . 75.32 111.6 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 244' ' ' SER . 27.3 t-20 -139.79 131.78 27.81 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.678 0.275 . . . . 64.11 111.163 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.1 tt -149.04 139.33 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.877 0.37 . . . . 65.2 111.163 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -149.47 129.11 2.92 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.15 -0.548 . . . . 65.05 112.826 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.622 HD13 ' HB2' ' A' ' 241' ' ' ALA . 46.4 mm -73.36 115.16 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 122.678 -0.307 . . . . 63.14 110.749 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.537 HD12 HG22 ' A' ' 240' ' ' ILE . 72.2 mt -66.01 -53.62 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.008 0.432 . . . . 71.54 111.469 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 . . . . . 0 N--CA 1.47 0.536 0 CA-C-N 116.297 -0.41 . . . . 64.34 111.027 178.627 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 109.622 -0.51 . . . . 51.32 109.622 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -96.8 155.24 16.86 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.154 0.798 . . . . 73.34 113.154 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -100.04 155.59 17.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.345 -0.843 . . . . 74.11 109.945 169.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 220' ' ' GLY . 44.2 mt -66.06 -30.09 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 112.551 0.574 . . . . 73.34 112.551 -172.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 219' ' ' THR . 93.5 p -71.09 -28.52 64.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.237 0.542 . . . . 64.51 110.664 173.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -77.99 -31.47 50.73 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.959 -0.564 . . . . 73.42 111.262 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 247' ' ' VAL . 78.0 mt -52.9 134.07 37.55 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.228 0.537 . . . . 64.12 111.475 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.446 ' HB2' ' HD2' ' A' ' 181' ' ' PRO . 22.9 ptp -140.57 164.65 35.32 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.925 -0.58 . . . . 72.12 111.077 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.514 ' HB3' ' HB3' ' A' ' 249' ' ' GLN . 9.4 Cg_endo -54.53 144.0 65.05 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.405 2.07 . . . . 75.21 112.879 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.1 t30 67.6 13.9 9.4 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.034 0.445 . . . . 61.43 111.909 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 40.2 tp -91.12 150.86 21.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.133 0.492 . . . . 72.15 111.993 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.8 t -131.78 133.67 45.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.339 -0.392 . . . . 73.33 110.492 173.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 173.82 -176.61 46.32 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.418 -0.896 . . . . 74.11 113.864 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 90.5 m -117.23 136.43 53.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.868 0.366 . . . . 60.13 111.325 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.437 HD13 HD11 ' A' ' 179' ' ' LEU . 33.8 pt -129.25 163.48 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 122.885 0.474 . . . . 62.43 111.485 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -127.58 114.25 17.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.47 -0.332 . . . . 75.22 110.503 175.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.28 168.58 19.44 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.848 0.356 . . . . 62.53 111.945 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 14.7 pt-20 -89.44 143.51 26.77 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.009 0.433 . . . . 64.45 111.353 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.444 ' HA ' HD23 ' A' ' 215' ' ' LEU . 39.8 t -79.49 105.01 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.226 0.536 . . . . 74.31 111.608 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.48 -37.63 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.207 0.527 . . . . 71.32 111.116 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.2 134.05 11.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.041 -0.527 . . . . 74.54 111.409 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -115.1 101.52 9.06 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.897 0.38 . . . . 71.14 111.246 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -72.11 143.96 86.82 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.483 -0.326 . . . . 75.25 111.27 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.63 168.75 2.87 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.955 2.437 . . . . 64.31 113.956 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -83.31 118.28 23.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.319 0.581 . . . . 73.01 111.785 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.637 ' HE2' ' HG ' ' A' ' 210' ' ' LEU . 2.6 mppt? -96.92 162.82 13.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.117 -0.492 . . . . 55.34 111.408 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -111.09 146.86 36.04 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.196 -0.457 . . . . 71.1 111.393 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 36.2 p90 . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 121.175 0.512 . . . . 75.12 111.125 173.174 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 . . . . . 0 CA--C 1.542 0.659 0 CA-C-O 120.654 0.264 . . . . 75.23 110.882 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.637 ' HG ' ' HE2' ' A' ' 198' ' ' LYS . 14.9 tp -137.33 116.72 12.76 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.391 0.515 . . . . 62.53 112.391 -175.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.542 ' HD3' HD12 ' A' ' 226' ' ' LEU . 59.8 tttp -122.15 147.79 45.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.762 0.315 . . . . 55.05 110.736 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.44 ' OG ' ' NZ ' ' A' ' 198' ' ' LYS . 49.0 m -123.74 147.15 47.75 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.022 0.439 . . . . 63.21 111.342 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.3 mt -135.14 157.45 46.88 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.217 -0.447 . . . . 72.22 110.92 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -127.87 115.89 19.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.905 -0.406 . . . . 44.21 109.905 173.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 191' ' ' VAL . 64.9 mt -117.64 153.49 33.21 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.403 -0.362 . . . . 70.22 111.316 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 22.0 pttp -147.24 145.2 29.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.782 0.801 . . . . 64.43 112.35 174.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -122.15 170.94 9.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.657 -1.156 . . . . 74.22 108.635 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -49.93 -29.91 9.27 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.138 0.494 . . . . 74.11 111.364 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 177' ' ' SER . 77.2 p -88.17 -2.15 58.43 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.755 1.02 . . . . 73.42 113.755 -175.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 143.09 -178.95 21.0 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 120.412 -0.899 . . . . 74.13 113.801 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.9 p -120.33 155.37 33.48 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 120.911 0.386 . . . . 70.31 111.78 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.409 HG12 ' N ' ' A' ' 223' ' ' ARG . 14.9 tt -148.84 157.43 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.937 0.399 . . . . 72.05 111.768 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 223' ' ' ARG . 7.6 mpt_? -92.37 128.64 38.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.295 -0.411 . . . . 64.42 110.903 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -107.97 140.56 15.5 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.343 -0.456 . . . . 44.14 112.781 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 32.9 m -125.44 116.33 21.68 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.209 -0.583 . . . . 75.3 112.176 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.56 HD23 ' HB ' ' A' ' 258' ' ' VAL . 74.8 mt -99.02 132.25 44.47 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.479 -0.328 . . . . 65.04 111.038 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -113.14 154.93 25.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.157 0.503 . . . . 74.04 112.122 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.1 t30 62.18 -152.25 0.36 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.751 -0.659 . . . . 52.11 111.201 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.62 -7.29 0.91 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.671 0.989 . . . . 73.05 113.671 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.68 -13.68 55.23 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.167 0.508 . . . . 70.44 110.85 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -64.99 -28.89 69.82 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.106 -0.497 . . . . 62.15 112.151 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.01 0.19 53.97 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.108 0.41 . . . . 61.33 112.108 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -66.45 101.77 0.8 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.045 0.45 . . . . 72.01 110.658 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.51 100.55 1.43 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.12 0.415 . . . . 55.23 112.12 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.6 150.42 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.098 -0.501 . . . . 70.44 110.216 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -113.44 163.15 15.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.453 0.645 . . . . 70.11 112.08 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -81.11 94.76 6.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.136 -0.484 . . . . 65.25 110.688 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 141.57 -11.74 2.7 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.448 -0.882 . . . . 65.34 114.868 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -88.48 172.82 9.07 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.209 1.005 . . . . 70.44 111.456 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 48.1 mm -105.04 113.81 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.073 -0.512 . . . . 64.21 110.94 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -100.04 122.94 43.7 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.809 0.67 . . . . 44.13 112.809 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -80.24 104.86 11.08 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.818 -0.628 . . . . 45.44 109.55 170.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 215' ' ' LEU . 93.1 t -115.83 128.77 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.543 0.571 . . . . 71.31 112.543 -172.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 39.2 t -120.85 132.52 55.04 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.16 -0.473 . . . . 51.32 110.405 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.33 -163.27 29.03 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.274 -0.965 . . . . 63.1 114.436 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -117.95 115.73 25.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.769 0.428 . . . . 74.23 111.264 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.516 HG21 HD22 ' A' ' 179' ' ' LEU . 48.5 t -85.44 133.16 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.666 0.617 . . . . 74.34 112.666 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -128.39 138.51 52.38 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.207 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 181' ' ' PRO . 29.2 tt0 . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 120.715 0.293 . . . . 73.31 110.827 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.413 ' O ' ' HD3' ' A' ' 223' ' ' ARG . 4.5 mp . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 121.053 0.454 . . . . 70.42 111.97 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.75 167.18 11.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.14 -0.482 . . . . 64.13 110.386 175.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tt -136.04 103.86 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.556 0.693 . . . . 71.23 111.129 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.9 t -66.28 106.72 1.76 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.986 -0.552 . . . . 52.32 109.873 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.56 ' HB ' HD23 ' A' ' 226' ' ' LEU . 38.9 t -75.5 124.48 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.571 0.582 . . . . 52.35 112.571 -171.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -81.63 -40.94 22.17 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.85 -0.613 . . . . 65.25 110.675 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -153.49 148.78 27.01 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.132 -0.486 . . . . 63.42 111.127 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.8 tt -140.85 142.64 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.062 0.458 . . . . 73.31 111.567 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -150.51 145.02 12.58 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.171 -0.538 . . . . 74.4 112.823 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.0 mt -81.79 127.94 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 122.443 -0.445 . . . . 71.1 110.903 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 34.8 mm -56.41 -43.76 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.718 0.636 . . . . 65.22 112.718 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 121.353 0.597 . . . . 55.32 112.105 -179.742 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 111.896 0.332 . . . . 61.03 111.896 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.534 ' HB2' HG22 ' A' ' 187' ' ' ILE . 95.5 m-85 -120.78 143.28 48.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.339 0.59 . . . . 73.14 112.152 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -99.69 159.86 14.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 70.3 109.798 169.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.49 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 68.6 mt -64.06 -34.88 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 112.609 0.596 . . . . 72.05 112.609 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.4 t -69.03 -20.56 64.13 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.069 0.461 . . . . 63.04 111.144 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -84.26 -11.08 57.06 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.026 -0.534 . . . . 73.33 111.379 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 247' ' ' VAL . 77.5 mt -68.44 162.03 26.37 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.888 0.852 . . . . 52.31 113.248 -174.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.0 ptp -162.7 153.75 14.66 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 114.877 -1.056 . . . . 61.52 110.031 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.74 144.2 87.63 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.251 1.967 . . . . 74.52 112.756 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 67.88 24.44 8.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.848 0.459 . . . . 63.15 111.978 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 49.5 tp -95.83 121.27 37.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.118 0.414 . . . . 65.55 112.118 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 60.6 m -104.65 115.96 31.23 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.455 -0.339 . . . . 40.11 110.41 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.08 -168.49 36.38 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.266 -0.969 . . . . 65.04 114.111 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 52.8 m -119.89 119.25 32.97 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.71 0.29 . . . . 73.53 111.44 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.534 HG22 ' HB2' ' A' ' 174' ' ' TYR . 31.9 pt -101.36 154.3 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.232 0.539 . . . . 51.24 111.945 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -122.23 109.08 14.04 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.158 0.504 . . . . 72.41 110.834 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 216' ' ' LYS . . . -148.4 -177.59 5.85 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.925 -0.58 . . . . 71.03 111.452 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 10.7 pt-20 -107.89 148.43 29.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.229 0.538 . . . . 73.32 111.355 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.14 114.29 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.058 -0.519 . . . . 74.14 111.909 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.1 -49.42 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.205 0.526 . . . . 71.4 110.988 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -139.2 135.52 34.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 61.43 111.138 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -131.05 102.89 6.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.333 -0.394 . . . . 63.21 111.265 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 212' ' ' SER . 74.7 m-85 -95.04 126.3 47.23 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.381 -0.372 . . . . 74.42 110.607 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 195' ' ' TYR . 48.6 Cg_exo -57.67 -174.83 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.335 2.69 . . . . 62.14 114.521 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.666 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 20.7 pttm -67.79 141.22 56.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.505 0.928 . . . . 52.22 113.505 -174.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.734 ' HE2' ' HG ' ' A' ' 210' ' ' LEU . 32.0 mtmm -120.31 157.37 29.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.083 -0.962 . . . . 62.41 110.368 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -102.82 137.33 41.17 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.139 0.495 . . . . 75.13 111.952 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 24.6 p90 . . . . . 0 N--CA 1.47 0.572 0 CA-C-N 115.985 -0.552 . . . . 74.25 110.325 174.025 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 120.783 0.325 . . . . 64.5 111.276 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.734 ' HG ' ' HE2' ' A' ' 198' ' ' LYS . 18.4 tp -112.52 108.78 18.01 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.292 0.478 . . . . 70.54 112.292 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 82.6 tttt -117.62 139.53 50.87 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.807 0.336 . . . . 44.44 110.957 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 15.0 m -109.93 134.25 52.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.066 0.395 . . . . 71.03 112.066 -172.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 72.1 mt -129.88 145.53 51.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.254 0.549 . . . . 71.23 112.005 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -126.7 118.83 25.53 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.982 -0.554 . . . . 71.1 109.68 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.71 154.86 28.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.345 -0.389 . . . . 72.31 111.476 -174.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 19.6 ptmt -153.74 170.01 21.96 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.899 0.381 . . . . 75.42 111.091 174.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.89 -174.73 4.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.852 -0.425 . . . . 63.41 109.852 171.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.64 -16.03 59.85 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.248 0.462 . . . . 64.24 112.248 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.4 p -98.76 -21.86 16.16 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.169 0.803 . . . . 73.24 113.169 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.98 -178.35 42.89 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 120.514 -0.851 . . . . 71.31 113.825 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 60.9 m -129.59 136.12 49.4 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 120.983 0.42 . . . . 74.43 111.892 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.0 tp -133.06 153.78 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.098 0.475 . . . . 65.11 111.76 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -111.42 135.4 52.03 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.768 0.318 . . . . 74.42 110.885 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -138.43 178.5 19.26 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.831 -0.699 . . . . 74.43 114.05 -174.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 88.0 m -148.37 137.4 21.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.568 -0.372 . . . . 44.11 111.933 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.596 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 83.5 mt -101.92 134.57 44.92 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.143 -0.481 . . . . 73.31 110.864 175.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -113.48 152.83 29.64 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.901 0.381 . . . . 75.02 111.666 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 14.4 m120 64.08 -143.36 0.29 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.191 -0.459 . . . . 71.42 112.001 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -48.33 -29.82 4.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.99 0.737 . . . . 72.11 112.99 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 92.4 mt -55.9 -18.89 10.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.003 0.43 . . . . 74.43 111.596 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.666 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -63.19 -44.05 96.45 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.994 0.426 . . . . 52.42 111.56 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -87.31 -5.33 58.95 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.961 0.356 . . . . 74.13 111.961 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -63.1 116.98 5.87 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.903 -0.406 . . . . 75.15 109.903 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.43 126.08 26.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.511 0.672 . . . . 72.32 112.383 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.08 127.23 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.606 -0.725 . . . . 74.01 110.039 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -100.34 141.99 32.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.142 0.496 . . . . 74.11 111.896 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 237' ' ' LYS . 1.1 tmmt? -73.0 125.89 28.67 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.873 -0.603 . . . . 75.14 110.74 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.37 14.25 51.47 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.234 -0.508 . . . . 55.23 113.175 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.59 158.65 18.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.96 0.41 . . . . 64.44 112.071 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 32.7 mm -92.33 127.71 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 116.275 -0.42 . . . . 71.32 110.898 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -130.25 143.22 50.65 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.088 0.773 . . . . 75.4 113.088 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.55 117.36 29.87 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.656 -0.702 . . . . 74.4 109.513 171.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.4 t -117.82 111.47 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.57 0.581 . . . . 71.4 112.57 -173.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 52.0 m -96.58 112.55 24.25 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.422 -0.353 . . . . 74.54 110.382 174.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.59 -167.79 17.0 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.418 -0.896 . . . . 63.22 114.132 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.497 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 93.4 t80 -122.8 113.95 19.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.683 0.393 . . . . 75.32 111.124 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.541 HG21 HD22 ' A' ' 179' ' ' LEU . 45.5 t -86.11 120.07 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.408 -0.36 . . . . 62.11 111.13 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 61.0 pttt -134.59 164.3 27.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.265 0.555 . . . . 75.1 112.06 -176.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 . . . . . 0 C--O 1.237 0.404 0 CA-C-N 115.596 -0.729 . . . . 75.13 109.776 173.823 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 109.322 -0.621 . . . . 53.51 109.322 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -111.54 132.91 54.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.291 0.567 . . . . 71.04 111.897 -176.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.1 tt -101.78 106.13 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.607 0.718 . . . . 62.51 111.108 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 35.9 t -77.35 110.25 11.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 53.21 109.959 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.59 ' HB ' HD23 ' A' ' 226' ' ' LEU . 37.9 t -81.27 124.18 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.043 0.449 . . . . 71.53 112.107 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.85 -43.95 14.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.977 -0.556 . . . . 65.22 110.797 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -147.16 139.12 24.37 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.142 -0.481 . . . . 70.2 110.443 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.2 tt -133.36 146.63 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.799 0.333 . . . . 72.24 111.216 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -147.74 131.97 4.07 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.17 -0.538 . . . . 73.42 113.047 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -80.85 130.93 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 122.269 -0.548 . . . . 70.51 110.678 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 54.8 mt -63.26 -64.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.825 0.345 . . . . 73.1 111.233 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 121.339 0.59 . . . . 72.21 111.225 175.705 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 186' ' ' THR . 2.8 p-10 . . . . . 0 CA--C 1.539 0.552 0 CA-C-O 121.101 0.476 . . . . 70.42 110.819 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 78.5 m-85 -104.23 155.84 18.4 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.346 0.593 . . . . 74.24 111.96 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -74.6 147.07 41.97 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.617 -0.883 . . . . 73.4 108.617 167.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.73 -32.79 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 112.785 0.661 . . . . 72.25 112.785 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.5 m -68.94 -7.94 39.79 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.261 0.467 . . . . 64.31 112.261 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 174' ' ' TYR . 10.9 mm-40 -95.21 -6.19 42.14 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.664 0.385 . . . . 70.12 111.789 178.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 187' ' ' ILE . 79.9 mt -73.39 106.75 5.33 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.559 0.695 . . . . 71.52 112.449 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.9 ptp -114.86 156.2 45.35 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.447 -0.797 . . . . 73.45 110.351 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.01 144.27 69.23 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.17 1.913 . . . . 74.22 112.757 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 70.45 15.34 7.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.158 0.583 . . . . 73.22 112.151 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.7 tp -93.12 135.96 33.83 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.808 0.337 . . . . 71.44 111.361 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.6 t -113.01 118.33 34.51 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.766 0.317 . . . . 53.23 111.081 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.02 -166.15 33.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.657 -0.782 . . . . 74.15 113.822 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 48.4 m -128.12 146.31 50.74 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.7 0.4 . . . . 73.22 110.815 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.582 HG21 HD11 ' A' ' 179' ' ' LEU . 30.4 pt -130.46 149.6 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.57 0.582 . . . . 62.42 112.57 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -108.61 127.34 53.87 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.73 -0.668 . . . . 54.13 110.089 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -159.66 175.56 13.04 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.319 0.581 . . . . 75.03 112.497 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 12.9 pt-20 -103.61 151.67 22.66 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.756 -0.656 . . . . 64.22 110.747 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.427 HG21 ' CG2' ' A' ' 235' ' ' VAL . 38.2 t -88.72 117.55 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.879 0.371 . . . . 50.31 111.798 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.9 t -95.44 -48.2 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.077 0.465 . . . . 61.44 111.99 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -139.45 138.87 36.81 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.972 0.415 . . . . 72.44 112.082 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.77 105.35 8.9 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.017 -0.538 . . . . 71.52 110.759 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 95.0 m-85 -87.03 142.19 33.71 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 111.873 0.324 . . . . 70.23 111.873 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -44.79 147.09 1.99 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.056 2.504 . . . . 72.24 113.485 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.582 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 23.0 pttp -74.47 134.93 42.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.611 0.719 . . . . 60.31 112.865 -172.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 2.4 mptp? -90.69 144.21 25.96 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.4 -0.818 . . . . 70.4 110.038 174.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -130.03 115.86 17.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.963 0.411 . . . . 73.35 110.728 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 37.0 p90 . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 121.301 0.572 . . . . 75.33 111.872 -173.407 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 N--CA 1.47 0.525 0 CA-C-O 120.839 0.352 . . . . 74.01 111.017 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 226' ' ' LEU . 58.6 tp -153.72 144.18 22.38 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.176 -0.466 . . . . 74.43 111.782 -176.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 230' ' ' LEU . 8.3 ttpm? -144.3 124.38 13.63 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.053 0.454 . . . . 72.32 111.127 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.5 m -88.32 130.74 35.05 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.087 -0.506 . . . . 70.25 111.355 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.429 HD11 HD11 ' A' ' 226' ' ' LEU . 81.3 mt -122.25 150.84 41.74 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.054 0.454 . . . . 73.24 111.408 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -114.62 115.41 27.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.326 -0.397 . . . . 75.52 110.111 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.03 153.62 32.37 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.183 0.193 . . . . 71.32 111.076 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 221' ' ' SER . 0.0 OUTLIER -146.38 142.92 28.69 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.011 0.91 . . . . 72.11 112.863 176.566 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.87 -178.48 3.73 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.791 -1.188 . . . . 64.23 107.791 165.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.29 -20.13 59.29 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.705 -0.622 . . . . 73.2 111.08 172.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -82.13 -28.05 32.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.231 0.456 . . . . 70.22 112.231 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.68 179.53 41.49 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.009 -0.615 . . . . 54.31 113.619 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 216' ' ' LYS . 79.1 p -114.22 163.93 14.57 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.346 0.498 . . . . 71.21 112.346 -176.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.5 tp -151.33 152.4 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 116.285 -0.416 . . . . 63.23 111.263 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -95.5 122.3 38.09 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.869 0.366 . . . . 74.01 111.834 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -93.72 135.5 12.59 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.403 -0.427 . . . . 53.34 112.957 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 63.2 m -118.26 103.79 10.17 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.524 -0.398 . . . . 64.22 111.388 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 210' ' ' LEU . 75.4 mt -94.46 117.1 29.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 111.828 0.307 . . . . 63.24 111.828 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' TRP . . . . . 0.454 ' O ' ' HB2' ' A' ' 230' ' ' LEU . 84.4 m95 -98.86 166.06 11.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.977 0.418 . . . . 55.41 111.466 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 61.94 -150.97 0.37 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.527 -0.306 . . . . 64.31 111.666 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.59 -15.06 6.3 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.612 0.597 . . . . 62.33 112.612 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.459 ' O ' ' NZ ' ' A' ' 211' ' ' LYS . 96.5 mt -59.13 -16.15 18.23 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.015 0.436 . . . . 72.52 110.812 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' A' ' 197' ' ' LYS . . . -65.15 -47.13 78.12 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.315 -0.402 . . . . 60.01 110.733 170.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.96 -29.31 67.51 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.387 -0.37 . . . . 73.41 111.425 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -50.87 103.03 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.885 0.374 . . . . 73.02 110.502 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -81.63 120.89 25.66 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.192 0.52 . . . . 75.53 111.792 -174.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.427 ' CG2' HG21 ' A' ' 191' ' ' VAL . 13.3 p -116.07 143.93 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.828 -0.624 . . . . 74.3 110.623 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -104.97 154.36 20.21 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.979 0.363 . . . . 74.01 111.979 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -81.19 133.66 35.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.808 0.337 . . . . 63.05 111.277 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.73 -34.45 5.46 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.524 -0.37 . . . . 72.32 113.06 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.2 144.86 56.56 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.057 0.456 . . . . 74.51 111.615 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.566 ' HB ' ' HG2' ' A' ' 265' ' ' GLU . 41.4 mm -92.39 136.38 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.75 0.309 . . . . 62.1 111.027 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -141.05 157.87 44.72 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.139 0.495 . . . . 64.35 112.122 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.47 120.19 40.78 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.002 -0.545 . . . . 71.33 110.098 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 85.9 t -110.56 123.89 66.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 111.897 0.332 . . . . 70.04 111.897 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.9 t -113.67 128.68 56.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.848 0.356 . . . . 75.02 111.435 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.91 -150.37 7.56 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.477 -0.868 . . . . 63.1 113.856 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -129.13 117.25 20.5 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.642 0.377 . . . . 72.53 111.056 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.53 HG21 HD22 ' A' ' 179' ' ' LEU . 46.3 t -86.79 125.88 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.624 0.249 . . . . 63.32 111.325 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.94 164.82 33.43 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.212 0.53 . . . . 71.02 112.01 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 CA--C 1.538 0.517 0 CA-C-N 116.046 -0.525 . . . . 74.23 110.626 178.024 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 109.331 -0.618 . . . . 61.5 109.331 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.86 148.46 39.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.582 -0.736 . . . . 65.32 112.28 -168.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.458 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.8 tt -105.67 107.93 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.277 0.561 . . . . 63.33 110.881 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.4 t -70.46 104.84 2.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.976 0.417 . . . . 54.54 110.241 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.461 ' HB ' HD23 ' A' ' 226' ' ' LEU . 33.4 t -80.25 127.56 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.711 0.634 . . . . 61.44 112.711 -171.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -92.49 -49.16 6.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.89 -0.596 . . . . 73.51 110.405 174.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -139.23 132.74 30.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.002 -0.545 . . . . 72.52 110.586 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.1 tt -125.69 133.81 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.951 0.405 . . . . 73.11 111.222 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -130.6 131.34 6.47 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.21 -0.519 . . . . 34.32 112.992 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.6 mm -79.43 131.78 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 122.618 -0.342 . . . . 73.21 111.275 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.507 HD12 HG22 ' A' ' 240' ' ' ILE . 66.2 mt -83.59 -48.88 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.25 0.548 . . . . 74.42 110.335 176.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.566 ' HG2' ' HB ' ' A' ' 240' ' ' ILE . 24.2 mm-40 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.168 0.509 . . . . 74.5 110.236 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 121.193 0.521 . . . . 72.32 111.917 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -85.25 169.27 13.95 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.547 0.689 . . . . 75.12 112.105 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -101.25 167.75 10.0 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.575 -0.739 . . . . 71.33 109.389 174.53 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 220' ' ' GLY . 25.9 mt -76.73 -41.27 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 121.866 -0.521 . . . . 75.25 111.055 175.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.8 t -68.55 -8.1 38.49 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.191 0.52 . . . . 72.54 111.113 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 175' ' ' LYS . 6.8 tp10 -82.6 -21.37 35.19 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 61.04 110.672 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.739 HD11 HD13 ' A' ' 187' ' ' ILE . 78.3 mt -73.44 117.67 15.48 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.451 0.643 . . . . 70.35 112.16 -174.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 22.5 ptp -130.15 157.07 78.23 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.708 -0.678 . . . . 72.42 110.262 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 182' ' ' ASN . 11.3 Cg_endo -54.4 138.37 73.4 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.06 1.84 . . . . 65.23 112.39 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 181' ' ' PRO . 2.5 m-20 74.63 11.05 3.97 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.29 0.636 . . . . 70.34 112.443 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.9 tp -90.94 149.11 22.01 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.305 -0.247 . . . . 70.13 110.855 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 73.3 p -135.8 118.31 15.85 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.184 -0.323 . . . . 61.34 110.76 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.75 -177.45 40.2 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.354 -0.927 . . . . 74.51 113.986 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 244' ' ' SER . 38.2 m -114.21 122.64 47.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.659 0.266 . . . . 61.51 111.535 -177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.739 HD13 HD11 ' A' ' 179' ' ' LEU . 47.7 pt -115.67 138.18 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.058 0.456 . . . . 55.55 111.41 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -108.73 103.16 12.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.98 -0.378 . . . . 74.02 109.98 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.78 176.11 8.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.132 0.492 . . . . 63.34 111.985 -173.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -96.75 130.76 43.94 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.895 -0.593 . . . . 74.33 111.669 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.96 102.25 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.918 0.39 . . . . 73.34 111.265 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.86 -48.32 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.096 0.474 . . . . 61.52 111.583 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -134.3 122.41 22.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.948 0.404 . . . . 72.25 112.081 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -97.14 103.16 15.07 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.863 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.43 ' HB3' ' HD2' ' A' ' 196' ' ' PRO . 88.9 m-85 -79.3 160.0 71.42 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 116.6 -0.273 . . . . 65.04 111.536 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 195' ' ' TYR . 48.4 Cg_endo -67.69 153.66 75.42 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.296 1.997 . . . . 44.34 113.017 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -85.72 134.79 33.94 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.436 0.636 . . . . 73.15 112.058 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -104.92 169.71 8.29 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.692 -0.685 . . . . 62.31 111.105 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.23 152.9 52.06 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.573 -0.285 . . . . 72.23 110.602 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 38.4 p90 . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 121.489 0.662 . . . . 72.35 112.205 179.61 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 120.875 0.369 . . . . 63.43 111.668 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.0 tp -155.23 110.89 3.09 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.168 0.432 . . . . 72.04 112.168 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.96 140.51 52.26 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.056 -0.403 . . . . 63.14 111.447 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 37.7 t -106.8 152.61 23.62 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.946 0.403 . . . . 71.45 111.449 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.3 mt -136.27 143.76 44.42 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.651 0.38 . . . . 74.32 110.677 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -97.95 112.67 24.51 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.068 -0.395 . . . . 72.42 110.835 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 79.6 mt -107.74 135.93 48.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.415 0.286 . . . . 54.41 111.166 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -132.44 154.81 49.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.604 0.716 . . . . 73.34 111.923 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -155.45 167.21 31.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.971 -1.013 . . . . 72.12 109.068 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -60.03 -18.41 46.15 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.069 -0.394 . . . . 64.12 111.821 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 80.5 p -98.23 18.57 15.98 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.332 0.494 . . . . 72.54 112.332 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.409 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 125.83 -179.0 16.43 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.746 -0.74 . . . . 64.41 113.764 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 47.8 p -136.85 131.63 33.49 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.535 -0.391 . . . . 72.43 111.196 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 15.3 tt -138.04 156.73 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.005 0.431 . . . . 74.43 111.22 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -101.03 116.32 32.57 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.968 0.413 . . . . 75.31 111.29 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.453 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -83.01 157.62 35.57 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.235 -0.439 . . . . 72.33 113.521 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.1 m -128.97 114.23 16.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.882 0.372 . . . . 73.14 111.985 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.53 HD23 ' HB ' ' A' ' 258' ' ' VAL . 87.2 mt -99.21 112.13 24.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.235 -0.439 . . . . 75.12 111.217 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -91.6 157.07 17.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.893 0.378 . . . . 74.11 111.57 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 63.76 -155.39 0.32 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.325 -0.398 . . . . 75.12 111.791 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -53.44 -20.12 4.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.964 0.727 . . . . 71.01 112.964 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 95.6 mt -57.44 -23.5 49.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.29 0.567 . . . . 70.22 111.276 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.12 -27.97 69.3 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.888 0.375 . . . . 41.03 111.679 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.48 -0.22 54.85 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.976 0.417 . . . . 72.21 111.012 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -57.79 135.1 56.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.18 -0.464 . . . . 53.3 111.87 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.67 118.01 7.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.637 -0.711 . . . . 72.55 111.979 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.614 ' HA ' HD11 ' A' ' 263' ' ' ILE . 9.7 p -134.53 142.94 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.906 0.384 . . . . 75.45 111.18 176.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -118.42 151.45 37.76 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.394 -0.366 . . . . 61.14 111.384 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -75.97 142.21 42.01 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.931 0.396 . . . . 73.2 111.388 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.77 28.55 73.5 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.124 -0.489 . . . . 41.15 113.351 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.17 158.1 21.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.784 0.326 . . . . 75.34 110.958 -178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.548 HG22 HD12 ' A' ' 264' ' ' ILE . 48.0 mm -96.67 117.04 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.214 0.53 . . . . 75.22 111.209 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -118.38 135.63 54.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.432 0.53 . . . . 74.11 112.432 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -82.66 103.91 12.52 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.862 -0.608 . . . . 71.44 109.855 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 72.9 t -113.5 111.84 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 112.219 0.452 . . . . 55.32 112.219 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 21.3 t -113.33 129.48 56.52 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.349 -0.22 . . . . 52.4 110.958 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.0 -173.02 37.08 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.388 -0.91 . . . . 41.34 114.274 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -104.87 119.41 38.94 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.969 0.508 . . . . 74.21 110.591 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.468 HG21 HD22 ' A' ' 179' ' ' LEU . 30.6 t -85.83 135.46 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.258 0.551 . . . . 70.34 112.211 -176.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.47 163.93 29.91 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.98 -0.554 . . . . 75.55 110.794 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 CA--C 1.535 0.374 0 CA-C-O 120.833 0.349 . . . . 53.41 111.057 175.908 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 120.945 0.402 . . . . 61.41 111.423 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.5 125.5 49.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.217 -0.447 . . . . 73.23 111.321 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.453 HG23 ' HA2' ' A' ' 224' ' ' GLY . 7.9 tt -105.51 112.79 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.343 0.592 . . . . 75.44 111.545 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.5 t -77.49 105.29 8.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.198 -0.455 . . . . 71.5 110.591 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.53 ' HB ' HD23 ' A' ' 226' ' ' LEU . 40.3 t -78.51 135.49 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.245 0.545 . . . . 75.34 112.459 -172.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -106.79 -43.21 4.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.918 -0.583 . . . . 73.13 110.818 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 25.6 t-20 -124.13 132.56 53.65 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.967 -0.561 . . . . 73.2 110.541 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.6 tt -144.02 123.93 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.219 0.533 . . . . 74.13 111.436 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -139.15 124.84 2.9 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 121.095 -0.574 . . . . 61.04 113.165 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' A' ' 235' ' ' VAL . 46.4 mt -69.24 123.13 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.845 0.355 . . . . 65.35 111.213 176.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.548 HD12 HG22 ' A' ' 240' ' ' ILE . 68.0 mt -76.43 -43.79 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.631 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.55 0.691 . . . . 63.53 111.424 179.786 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 109.851 -0.426 . . . . 73.43 109.851 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -94.26 146.14 24.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.311 0.577 . . . . 74.13 112.17 -175.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.89 160.08 16.03 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.904 -0.589 . . . . 74.12 110.573 169.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 220' ' ' GLY . 63.6 mt -59.09 -31.86 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.914 0.709 . . . . 72.24 112.914 -171.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.464 ' CB ' ' HB ' ' A' ' 219' ' ' THR . 70.6 p -62.67 -31.02 71.83 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.946 0.35 . . . . 72.32 111.946 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -88.33 -19.93 26.04 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 111.816 0.302 . . . . 75.14 111.816 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.535 HD22 HG21 ' A' ' 247' ' ' VAL . 78.4 mt -56.25 117.37 3.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.5 0.556 . . . . 55.1 112.5 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.416 ' HG2' HD22 ' A' ' 183' ' ' LEU . 24.1 ptp -114.44 157.42 42.67 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.741 -0.663 . . . . 71.22 110.465 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.83 142.64 99.14 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.054 1.836 . . . . 50.21 112.52 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 72.7 14.89 4.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.129 0.572 . . . . 64.21 112.029 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.416 HD22 ' HG2' ' A' ' 180' ' ' MET . 40.9 tp -93.28 132.89 37.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.959 0.355 . . . . 54.41 111.959 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.0 p -110.83 125.56 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.374 -0.204 . . . . 53.03 111.104 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -178.69 -165.56 33.39 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.628 -0.796 . . . . 54.03 113.848 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.9 m -126.09 140.48 52.55 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.45 0.3 . . . . 53.25 111.581 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 33.7 pt -127.12 156.78 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.18 0.515 . . . . 65.12 111.992 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -118.69 112.04 19.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.046 -0.524 . . . . 63.11 110.648 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -150.87 163.43 38.68 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.445 0.535 . . . . 75.04 112.445 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -82.44 135.52 35.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.201 -0.454 . . . . 60.45 111.494 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.04 100.59 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.929 0.395 . . . . 72.44 110.743 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.8 -59.04 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.117 0.484 . . . . 70.34 111.473 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -130.28 143.99 51.11 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.986 -0.552 . . . . 74.23 111.411 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -126.63 107.01 9.81 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.933 -0.576 . . . . 43.51 110.849 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.568 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 92.2 m-85 -96.13 135.16 22.84 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.681 -0.236 . . . . 73.43 111.338 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.46 162.07 0.63 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.222 2.615 . . . . 74.12 113.899 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -73.4 119.56 17.8 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.059 0.763 . . . . 74.12 113.059 -173.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -67.81 151.19 47.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.33 -0.85 . . . . 75.32 111.276 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -115.61 129.61 56.57 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.323 -0.399 . . . . 73.23 110.693 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.9 p90 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 121.173 0.511 . . . . 55.41 111.654 -178.351 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 120.688 0.28 . . . . 63.43 110.72 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 225' ' ' THR . 17.6 tp -144.54 125.14 14.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.181 0.438 . . . . 64.41 112.181 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 195' ' ' TYR . 7.2 ttpm? -112.63 131.92 55.4 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.729 -0.607 . . . . 74.14 111.111 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 51.2 m -98.86 121.39 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.115 -0.493 . . . . 75.03 111.686 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 226' ' ' LEU . 80.9 mt -119.8 157.43 28.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.352 -0.385 . . . . 74.55 111.16 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -128.3 120.81 27.82 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.645 0.26 . . . . 73.34 110.395 173.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.573 HD11 HG21 ' A' ' 243' ' ' VAL . 66.6 mt -105.2 153.09 22.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.808 0.337 . . . . 74.34 111.616 -176.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -141.67 152.32 43.81 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.278 0.561 . . . . 63.14 111.753 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -155.1 168.38 27.22 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.601 -0.727 . . . . 71.12 109.781 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -61.28 -20.14 62.53 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.928 -0.483 . . . . 73.4 111.947 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.464 ' HB ' ' CB ' ' A' ' 177' ' ' SER . 80.2 p -91.2 -6.22 53.76 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.782 0.66 . . . . 70.44 112.782 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 150.03 -178.43 27.52 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.669 -0.777 . . . . 75.43 113.624 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 61.5 p -127.28 143.12 51.3 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.671 -0.311 . . . . 60.44 111.102 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.1 164.48 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 122.318 -0.239 . . . . 73.31 111.031 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.75 ' H ' ' HD2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -111.52 137.42 49.37 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.851 -0.53 . . . . 75.21 110.808 176.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -108.24 131.49 10.62 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.46 -0.4 . . . . 75.11 113.205 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.504 HG23 HD11 ' A' ' 210' ' ' LEU . 85.4 m -107.21 111.88 24.49 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.693 -0.298 . . . . 74.14 111.762 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.519 HD23 ' HB ' ' A' ' 258' ' ' VAL . 70.9 mt -99.04 109.48 22.22 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.035 0.383 . . . . 31.54 112.035 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -93.44 161.86 14.21 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.11 0.481 . . . . 75.1 112.104 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.422 ' CG ' ' H ' ' A' ' 229' ' ' GLU . 62.9 t30 57.69 -133.93 1.17 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.178 -0.465 . . . . 74.51 111.615 170.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.422 ' H ' ' CG ' ' A' ' 228' ' ' ASN . 11.4 pt-20 -60.06 -29.02 68.27 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.912 -0.493 . . . . 74.24 111.76 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.498 ' HB3' HD22 ' A' ' 226' ' ' LEU . 72.1 mt -61.06 -16.98 49.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.92 0.391 . . . . 75.1 111.231 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.58 88.11 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.663 0.268 . . . . 73.11 111.178 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -94.28 -15.62 24.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.842 0.353 . . . . 73.52 110.96 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -47.34 128.07 11.61 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.706 0.402 . . . . 61.11 111.524 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -70.23 120.23 15.6 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.658 0.614 . . . . 74.12 112.658 -175.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.25 134.23 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.698 -0.683 . . . . 73.52 110.053 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 239' ' ' ASP . 58.6 mttm -99.9 150.71 22.11 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.156 0.503 . . . . 73.35 112.241 -173.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -66.61 108.7 2.54 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.385 -0.37 . . . . 44.02 110.419 174.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.39 17.17 29.86 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.408 -0.425 . . . . 53.53 112.798 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 25.2 t0 -90.88 157.0 17.59 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.699 0.285 . . . . 64.1 111.181 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 42.3 mm -95.18 105.28 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.146 0.498 . . . . 72.25 110.805 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -113.8 127.07 55.86 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.821 0.675 . . . . 72.41 112.821 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -86.75 104.17 15.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.228 0.537 . . . . 72.22 109.827 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.573 HG21 HD11 ' A' ' 215' ' ' LEU . 89.0 t -102.47 120.24 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.61 0.596 . . . . 61.35 112.61 -171.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.1 t -113.64 133.14 55.48 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.24 -0.436 . . . . 53.1 111.176 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.03 -155.78 17.93 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.205 -0.998 . . . . 73.4 113.983 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 85.8 t80 -116.31 112.12 21.09 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.779 0.432 . . . . 62.53 111.467 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.535 HG21 HD22 ' A' ' 179' ' ' LEU . 48.1 t -83.34 118.18 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 120.965 0.412 . . . . 61.34 111.177 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 58.8 pttt -135.42 157.17 47.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.228 0.537 . . . . 73.32 111.437 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 121.046 0.45 . . . . 72.0 111.289 178.65 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 110.252 -0.277 . . . . 73.12 110.252 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 160.84 25.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.021 0.439 . . . . 74.24 111.118 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 7.9 tt -120.36 104.43 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.631 0.729 . . . . 71.03 111.421 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.6 t -68.93 102.52 1.6 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.647 -0.706 . . . . 75.54 110.296 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.519 ' HB ' HD23 ' A' ' 226' ' ' LEU . 21.7 t -74.43 117.72 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.264 -0.425 . . . . 72.34 112.122 -173.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -94.97 -21.7 18.44 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.879 0.371 . . . . 71.23 111.1 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -156.61 120.76 4.4 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.798 0.332 . . . . 73.22 110.944 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.5 ' HB ' HG11 ' A' ' 258' ' ' VAL . 11.4 tt -125.3 135.37 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.034 0.445 . . . . 63.21 111.582 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -133.59 125.29 3.92 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.15 -0.548 . . . . 75.42 112.763 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 49.4 mm -76.02 139.9 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.942 0.401 . . . . 75.34 110.737 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.531 HG22 ' HG3' ' A' ' 265' ' ' GLU . 48.1 mm -70.37 -46.4 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.776 0.322 . . . . 64.33 111.717 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.531 ' HG3' HG22 ' A' ' 264' ' ' ILE . 41.1 mt-10 . . . . . 0 N--CA 1.472 0.662 0 CA-C-O 120.741 0.305 . . . . 75.5 111.317 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 121.131 0.491 . . . . 71.12 111.066 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 174' ' ' TYR . . . . . 0.4 ' O ' HG22 ' A' ' 187' ' ' ILE . 47.4 m-85 -106.52 153.93 21.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.298 0.571 . . . . 63.35 111.603 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -93.21 155.68 17.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.318 -0.623 . . . . 71.35 109.318 167.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 49.4 mt -61.33 -24.59 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.076 0.465 . . . . 74.02 111.599 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.477 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 39.2 t -70.75 -12.9 61.83 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.131 0.419 . . . . 74.24 112.131 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -97.3 -1.94 43.61 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.603 0.594 . . . . 72.42 112.603 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.536 HD22 HG21 ' A' ' 247' ' ' VAL . 88.4 mt -68.08 150.68 48.11 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.176 0.806 . . . . 75.32 113.176 -172.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -162.23 156.4 18.51 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.289 -0.869 . . . . 74.1 110.213 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.62 138.16 83.74 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.307 2.004 . . . . 74.11 113.295 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.425 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 65.3 m-20 65.42 33.4 8.9 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.161 0.585 . . . . 70.15 111.562 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 52.8 tp -96.03 145.51 25.39 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.119 -0.491 . . . . 71.23 111.739 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 75.4 p -120.98 129.36 53.39 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.245 -0.434 . . . . 41.24 110.693 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.67 179.53 47.87 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.714 -0.755 . . . . 71.54 113.761 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 77.2 m -121.55 128.14 51.7 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.735 0.302 . . . . 71.45 111.343 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 174' ' ' TYR . 34.7 pt -120.5 152.79 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.171 0.51 . . . . 65.22 111.888 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -114.55 105.88 13.61 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.127 -0.488 . . . . 65.45 110.243 176.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.07 164.97 25.07 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.862 0.69 . . . . 61.14 112.862 -173.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.2 136.84 40.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.606 -0.725 . . . . 72.23 111.44 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.14 102.52 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.912 0.386 . . . . 63.22 111.519 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.7 t -82.62 -34.1 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.004 0.43 . . . . 60.11 111.872 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -141.17 117.74 10.9 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.757 0.313 . . . . 61.03 111.31 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -95.35 98.96 10.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.973 0.416 . . . . 61.45 110.981 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -78.5 143.96 64.75 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.463 -0.335 . . . . 74.43 111.078 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.12 151.6 83.32 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.775 2.317 . . . . 74.34 112.863 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LYS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 20.5 ptmt -67.74 125.24 25.6 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.579 0.585 . . . . 72.04 112.579 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -94.1 153.16 18.27 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.044 -0.525 . . . . 75.41 110.94 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.49 143.96 49.37 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.448 -0.342 . . . . 73.44 110.743 176.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 39.7 p90 . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 121.296 0.569 . . . . 64.01 111.695 179.513 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 228' ' ' ASN . 37.5 mt-30 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 110.301 -0.259 . . . . 73.23 110.301 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 48.3 tp -142.48 112.75 7.13 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.766 0.317 . . . . 53.21 111.64 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 49.3 tttm -126.62 108.09 10.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.704 0.288 . . . . 62.11 110.834 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 66.9 m -86.27 150.07 24.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.932 0.396 . . . . 50.43 111.566 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.422 HD11 HG11 ' A' ' 235' ' ' VAL . 91.7 mt -137.24 134.94 36.75 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.422 -0.354 . . . . 75.34 110.915 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -89.59 106.46 18.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.73 0.3 . . . . 75.25 110.224 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.67 141.96 34.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.503 0.321 . . . . 74.45 110.999 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -127.96 155.06 44.85 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.593 0.711 . . . . 74.41 112.443 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -148.24 160.9 42.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.06 -0.973 . . . . 74.15 109.347 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.18 -21.08 64.79 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.992 0.425 . . . . 75.13 111.553 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 72.3 p -92.49 -1.27 57.09 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.212 0.449 . . . . 70.33 112.212 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 148.06 176.75 21.84 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.071 -0.585 . . . . 75.53 113.612 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.7 p -120.48 158.8 26.46 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.503 -0.41 . . . . 64.44 111.341 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -157.95 145.28 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.92 0.39 . . . . 74.15 111.265 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -96.71 112.08 23.98 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.918 0.39 . . . . 61.41 111.197 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.436 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -81.91 159.08 39.43 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 116.101 -0.5 . . . . 32.34 113.366 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 84.9 m -129.08 114.63 16.6 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.357 0.503 . . . . 63.1 112.357 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 92.3 mt -95.6 117.28 30.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.437 -0.347 . . . . 63.34 110.993 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -99.07 156.35 16.98 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.086 0.47 . . . . 74.11 111.754 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 209' ' ' GLN . 61.2 t30 61.51 -146.84 0.42 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.968 -0.56 . . . . 72.04 111.482 174.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.43 -4.9 4.38 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.661 0.615 . . . . 72.51 112.661 -174.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 93.1 mt -65.29 -15.63 62.72 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.101 0.477 . . . . 73.33 110.707 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 197' ' ' LYS . . . -65.88 -23.07 66.57 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.201 -0.454 . . . . 51.41 111.499 175.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.21 4.09 53.17 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.286 -0.415 . . . . 74.21 111.557 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -69.3 113.8 6.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.044 0.45 . . . . 74.11 110.488 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.85 90.61 0.43 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.38 0.61 . . . . 63.24 111.838 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 213' ' ' LEU . 5.0 p -128.44 122.83 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.509 -0.769 . . . . 65.01 110.794 177.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -113.63 172.36 7.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.098 0.475 . . . . 73.33 111.428 -175.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -65.4 122.1 16.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.361 -0.381 . . . . 73.04 110.848 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.14 -26.58 9.71 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.157 -0.544 . . . . 74.42 113.596 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -65.87 130.81 44.54 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 117.188 0.494 . . . . 64.32 111.618 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 42.0 mm -77.71 108.36 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.078 -0.51 . . . . 64.1 110.08 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -113.78 130.12 56.49 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.318 0.58 . . . . 71.23 112.555 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLU . . . . . 0.532 ' HB2' HD11 ' A' ' 264' ' ' ILE . 40.3 tt0 -92.72 112.7 24.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.905 -0.589 . . . . 73.43 109.597 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.1 t -115.34 127.04 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.269 0.557 . . . . 71.02 112.423 -172.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.7 t -124.24 132.9 53.62 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.091 -0.504 . . . . 71.34 109.79 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.02 -164.9 29.83 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.121 -1.038 . . . . 71.23 114.196 -177.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -106.95 115.36 30.05 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.077 0.465 . . . . 73.22 111.172 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.536 HG21 HD22 ' A' ' 179' ' ' LEU . 47.5 t -89.09 123.87 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.294 -0.412 . . . . 74.1 111.052 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.425 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 26.6 pttm -142.37 158.23 43.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.094 0.473 . . . . 62.55 112.005 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 CA--C 1.541 0.611 0 CA-C-N 116.176 -0.465 . . . . 64.14 111.317 -179.546 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 120.869 0.366 . . . . 65.15 110.827 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -120.93 161.24 21.91 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.078 0.466 . . . . 63.33 111.481 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.436 HG23 ' HA2' ' A' ' 224' ' ' GLY . 6.9 tt -128.17 105.14 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.419 0.628 . . . . 72.15 110.83 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 72.4 m -73.59 106.95 5.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.114 -0.494 . . . . 74.43 110.049 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.529 HG11 ' HB ' ' A' ' 261' ' ' ILE . 46.5 t -66.6 129.67 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 113.17 0.804 . . . . 61.22 113.17 -171.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.64 -47.18 6.32 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.695 -0.684 . . . . 73.3 110.267 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -135.74 128.2 30.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.975 -0.557 . . . . 72.52 110.452 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.529 ' HB ' HG11 ' A' ' 258' ' ' VAL . 10.7 tt -134.25 135.02 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.777 0.322 . . . . 74.44 111.217 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -144.59 136.89 6.92 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.844 -0.693 . . . . 70.22 113.362 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.84 106.75 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.87 0.367 . . . . 62.23 110.964 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 242' ' ' GLU . 63.4 mt -66.37 -61.4 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.079 0.466 . . . . 71.05 111.125 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 CA--C 1.536 0.44 0 CA-C-N 116.031 -0.531 . . . . 74.1 110.73 179.749 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 186' ' ' THR . 12.3 m120 . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 120.931 0.396 . . . . 45.3 110.53 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -99.19 156.66 16.85 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.157 0.503 . . . . 53.14 111.377 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -98.72 168.17 10.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.507 -0.553 . . . . 62.15 109.507 169.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.406 HG23 ' HB ' ' A' ' 222' ' ' ILE . 56.8 mt -64.49 -18.5 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.359 0.503 . . . . 73.25 112.359 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 40.9 t -71.55 -36.46 70.97 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.001 0.371 . . . . 75.45 112.001 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -79.05 -10.22 59.76 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.511 0.56 . . . . 71.34 112.511 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.583 HD22 HG21 ' A' ' 247' ' ' VAL . 69.1 mt -62.52 121.73 14.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.315 0.579 . . . . 71.4 111.998 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.0 ptp -140.88 160.82 57.0 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.69 -0.686 . . . . 55.51 110.348 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 248' ' ' LYS . 18.4 Cg_endo -58.63 133.94 57.6 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.941 1.761 . . . . 74.04 112.367 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 71.68 29.78 2.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.979 0.512 . . . . 74.24 111.726 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.62 138.37 40.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.033 0.444 . . . . 75.44 111.402 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.2 p -116.51 128.37 55.38 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.574 -0.284 . . . . 44.43 110.537 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.5 178.0 45.93 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.083 -1.055 . . . . 31.34 114.164 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 61.8 m -113.12 121.84 45.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.393 0.277 . . . . 74.53 111.627 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.412 ' CG2' HD21 ' A' ' 179' ' ' LEU . 23.6 pt -102.87 152.77 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.073 0.463 . . . . 63.54 112.029 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.96 110.98 17.34 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.191 -0.459 . . . . 73.34 111.607 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -161.39 167.12 26.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.835 0.35 . . . . 73.15 111.668 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.494 ' HB3' HD13 ' A' ' 240' ' ' ILE . 12.5 pt-20 -95.63 149.55 21.33 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.052 0.453 . . . . 74.41 111.493 176.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 23.5 t -81.81 114.17 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.352 0.596 . . . . 71.53 111.939 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 25.4 t -82.23 -52.39 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.945 -0.57 . . . . 63.21 111.451 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -127.58 128.65 45.94 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.254 -0.43 . . . . 72.43 111.388 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -114.45 119.08 35.64 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.26 -0.427 . . . . 54.12 111.17 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.439 ' O ' ' HG2' ' A' ' 211' ' ' LYS . 25.7 m-85 -89.13 140.15 28.86 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.445 -0.343 . . . . 65.43 111.337 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.73 172.9 14.31 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.56 2.173 . . . . 34.13 113.186 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.85 134.98 42.61 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.482 0.919 . . . . 73.43 113.482 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -111.4 134.83 52.69 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.165 -0.68 . . . . 74.2 109.165 166.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.94 134.6 44.9 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.976 0.732 . . . . 73.32 112.976 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.7 p90 . . . . . 0 CA--C 1.538 0.516 0 CA-C-N 116.111 -0.495 . . . . 73.23 110.843 172.848 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 121.154 0.502 . . . . 63.52 111.659 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.7 tp -125.16 145.31 50.02 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.558 -0.746 . . . . 74.24 110.957 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.473 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 1.6 tmtp? -146.97 136.16 22.57 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.174 -0.328 . . . . 74.3 110.979 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 51.5 m -111.89 153.97 25.88 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.293 0.479 . . . . 75.31 112.293 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.47 HD21 ' HE2' ' A' ' 211' ' ' LYS . 95.5 mt -136.68 161.82 34.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.919 -0.582 . . . . 74.13 110.921 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -128.23 120.04 26.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.621 0.248 . . . . 32.51 110.869 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 243' ' ' VAL . 78.8 mt -114.74 142.93 45.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.554 0.342 . . . . 75.51 110.653 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -134.92 147.94 49.93 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.346 0.593 . . . . 74.22 111.994 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -152.32 168.58 24.96 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.55 -0.75 . . . . 73.12 109.864 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -62.33 -25.23 67.77 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.99 0.424 . . . . 71.33 111.465 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 80.6 p -79.93 -14.75 58.38 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.403 0.52 . . . . 63.43 112.403 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 154.54 -179.03 30.98 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.939 -0.648 . . . . 75.13 113.351 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 84.8 p -127.89 125.75 40.22 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.496 -0.414 . . . . 73.33 110.976 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 176' ' ' ILE . 10.1 tp -126.82 148.13 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.122 0.487 . . . . 64.25 111.93 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 73.9 mtm-85 -100.16 138.7 36.87 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.056 0.455 . . . . 74.15 110.953 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -114.63 152.25 18.16 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.303 -0.475 . . . . 73.4 113.197 -176.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 59.5 m -124.45 125.55 44.44 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.151 0.426 . . . . 72.52 112.151 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.582 HD23 ' HB ' ' A' ' 258' ' ' VAL . 83.4 mt -109.92 134.56 51.95 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.017 0.527 . . . . 72.25 111.246 176.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -114.58 172.13 7.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.926 0.393 . . . . 74.2 111.094 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 54.1 t30 57.89 -153.6 0.37 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 116.148 -0.478 . . . . 64.01 111.207 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.98 -27.11 61.15 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.822 -0.549 . . . . 72.23 112.46 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 73.7 mt -60.59 -18.83 55.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.906 0.384 . . . . 74.43 111.633 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 211' ' ' LYS . . . -59.47 -44.05 93.12 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.847 0.356 . . . . 64.23 111.494 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -90.67 13.39 16.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.903 0.334 . . . . 74.2 111.903 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -55.35 130.02 40.84 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.37 0.268 . . . . 72.04 110.722 175.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -70.71 77.44 0.61 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.524 0.678 . . . . 74.54 112.222 -174.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.66 139.75 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.927 -0.579 . . . . 65.42 110.23 174.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.403 ' HB3' ' NZ ' ' A' ' 236' ' ' LYS . 0.1 OUTLIER -126.75 115.8 19.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.363 0.601 . . . . 70.32 111.784 -173.106 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 192' ' ' VAL . 4.8 ttmp? -42.99 109.24 0.13 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.533 -0.758 . . . . 63.42 112.894 -172.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.48 4.53 23.38 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.095 -0.502 . . . . 52.45 113.685 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -86.21 156.67 20.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.148 0.499 . . . . 64.32 111.872 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 190' ' ' GLU . 38.1 mm -92.09 103.71 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.267 -0.424 . . . . 74.01 110.909 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -107.25 119.65 39.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.321 0.489 . . . . 74.43 112.321 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -87.15 103.49 15.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.24 0.543 . . . . 72.2 109.77 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.597 HG21 HD11 ' A' ' 215' ' ' LEU . 78.7 t -100.0 124.3 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 112.799 0.666 . . . . 75.52 112.799 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 42.4 t -118.02 123.53 45.92 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.32 -0.4 . . . . 62.42 110.781 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 258' ' ' VAL . . . -167.22 -161.48 16.61 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.415 -0.897 . . . . 73.12 114.202 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -112.9 114.36 26.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.465 0.306 . . . . 74.33 110.991 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.583 HG21 HD22 ' A' ' 179' ' ' LEU . 25.8 t -90.52 128.14 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.657 0.265 . . . . 71.21 110.977 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 181' ' ' PRO . 14.6 ptmm? -154.16 170.86 20.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.269 0.557 . . . . 63.05 112.016 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.882 -0.599 . . . . 74.21 110.83 178.775 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.54 0.577 0 CA-C-O 120.35 0.119 . . . . 71.25 111.196 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -136.43 170.27 16.31 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.12 0.486 . . . . 74.12 111.705 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.3 tt -116.65 121.7 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.471 0.545 . . . . 74.54 112.471 -176.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.5 t -85.72 103.79 14.83 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.009 0.433 . . . . 72.43 109.917 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.582 ' HB ' HD23 ' A' ' 226' ' ' LEU . 27.0 t -74.56 136.49 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 112.544 0.572 . . . . 73.44 112.544 -171.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -105.13 -39.95 6.04 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.314 -0.403 . . . . 65.35 110.612 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -134.61 138.68 44.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.156 -0.474 . . . . 64.03 110.952 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.7 tt -141.45 123.66 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.05 0.452 . . . . 60.35 111.242 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -128.33 131.51 6.98 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.029 -0.605 . . . . 62.44 113.375 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.77 116.1 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 O-C-N 122.681 -0.306 . . . . 55.22 110.369 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 50.6 mt -56.79 -43.29 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.716 0.293 . . . . 72.42 111.681 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 121.065 0.459 . . . . 71.14 111.203 175.855 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 120.88 0.372 . . . . 75.2 111.52 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -131.78 158.17 41.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.077 0.465 . . . . 75.22 111.299 176.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -90.75 155.6 18.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.149 -0.478 . . . . 74.41 110.267 169.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 220' ' ' GLY . 65.1 mt -54.49 -35.61 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 112.522 0.564 . . . . 72.44 112.522 -174.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' SER . . . . . 0.524 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 68.2 p -57.96 -41.23 82.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.233 0.457 . . . . 64.34 112.233 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -73.42 -22.18 60.28 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.274 0.472 . . . . 73.31 112.274 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 187' ' ' ILE . 81.7 mt -55.74 111.7 0.98 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.282 0.563 . . . . 74.11 112.386 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' MET . . . . . 0.466 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.1 ptp -106.64 157.63 34.67 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.545 -0.752 . . . . 65.25 110.997 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.17 130.6 40.42 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.336 2.024 . . . . 44.11 113.196 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.469 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 70.9 m-20 70.52 33.68 2.36 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.357 0.663 . . . . 60.42 111.854 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.466 HD22 ' HG2' ' A' ' 180' ' ' MET . 46.9 tp -102.09 134.41 45.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.216 -0.447 . . . . 63.2 111.318 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 81.4 p -110.31 118.35 36.09 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.27 -0.269 . . . . 60.54 111.077 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -173.79 -172.21 38.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.862 -0.685 . . . . 45.43 113.681 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.1 m -114.08 136.7 52.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.712 0.264 . . . . 75.51 111.712 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.595 HG21 HD11 ' A' ' 179' ' ' LEU . 33.2 pt -125.57 141.31 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.941 0.401 . . . . 75.52 111.227 175.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -115.21 116.27 28.07 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 64.31 111.608 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -158.66 178.33 10.23 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.31 -0.405 . . . . 74.41 111.362 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLU . . . . . 0.531 ' HB3' HD13 ' A' ' 240' ' ' ILE . 12.3 pt-20 -99.79 146.24 26.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.052 0.453 . . . . 72.44 111.493 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.51 HG21 HG21 ' A' ' 235' ' ' VAL . 58.1 t -76.15 108.73 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.11 -0.496 . . . . 75.22 111.831 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 216' ' ' LYS . 14.6 t -76.18 -27.62 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.046 0.451 . . . . 72.11 111.902 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -155.14 130.97 10.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.135 0.493 . . . . 72.34 112.016 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -113.53 102.65 10.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 63.35 110.031 174.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -84.33 155.37 63.16 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 111.962 0.356 . . . . 73.24 111.962 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.21 140.38 94.03 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.662 2.241 . . . . 60.13 112.787 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -75.41 126.33 30.81 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.521 0.677 . . . . 75.14 112.654 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 2.9 mptp? -86.31 169.49 12.92 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.529 -0.759 . . . . 70.52 111.331 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -138.21 143.81 40.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.111 -0.495 . . . . 75.44 110.935 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 53.2 p90 . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 121.349 0.595 . . . . 73.13 112.316 178.461 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 36.2 mt-30 . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 110.439 -0.208 . . . . 75.1 110.439 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 49.4 tp -153.69 113.72 3.91 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.17 0.433 . . . . 71.41 112.17 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.436 ' HE2' HD21 ' A' ' 213' ' ' LEU . 6.4 ttpm? -127.04 118.23 24.03 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.669 -0.645 . . . . 72.25 111.734 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.6 p -84.06 147.75 27.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.976 0.417 . . . . 73.41 111.711 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.436 HD21 ' HE2' ' A' ' 211' ' ' LYS . 97.0 mt -132.41 178.17 7.04 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.05 -0.523 . . . . 64.34 110.44 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 221' ' ' SER . 21.0 t80 -141.84 138.31 32.08 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.184 -0.323 . . . . 64.15 110.635 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.467 HD11 HG21 ' A' ' 243' ' ' VAL . 91.2 mt -126.49 151.79 47.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.503 0.321 . . . . 74.24 111.344 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LYS . . . . . 0.423 ' HB2' ' NZ ' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -135.76 149.3 49.12 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.496 0.554 . . . . 74.42 112.496 -178.655 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -154.68 167.33 30.52 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.486 -0.779 . . . . 62.53 109.9 174.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.52 -18.57 62.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.209 0.528 . . . . 75.35 111.601 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 75.0 p -91.05 -0.22 57.68 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.572 0.582 . . . . 61.42 112.572 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 138.92 -178.97 19.03 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.866 -0.683 . . . . 72.13 113.261 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.458 ' HB3' ' CE2' ' A' ' 214' ' ' PHE . 67.9 m -130.83 138.9 50.09 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.583 -0.363 . . . . 74.52 111.16 177.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 13.4 tt -141.95 153.84 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 120.779 0.323 . . . . 71.41 111.612 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -92.6 147.39 22.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.08 0.467 . . . . 71.13 111.745 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -112.96 157.33 15.01 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.286 -0.416 . . . . 72.53 112.531 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 63.4 m -133.15 116.09 15.85 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.197 0.498 . . . . 45.23 111.988 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.564 HD23 ' HB ' ' A' ' 258' ' ' VAL . 74.2 mt -98.9 116.27 30.77 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.422 -0.354 . . . . 71.43 111.608 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -102.22 165.77 10.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.995 0.426 . . . . 71.25 111.764 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 62.5 t30 58.6 -141.88 0.68 Allowed 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.977 -0.556 . . . . 73.0 111.735 171.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.43 -34.61 75.68 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.912 -0.493 . . . . 75.41 112.27 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.98 -7.64 30.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.964 0.411 . . . . 74.41 111.911 -176.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 209' ' ' GLN . . . -66.11 -34.26 77.65 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 122.133 -0.354 . . . . 73.03 111.951 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -84.74 1.0 48.57 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.947 -0.471 . . . . 75.13 111.861 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -52.09 116.19 2.08 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.825 0.345 . . . . 73.42 111.052 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -81.7 121.7 26.71 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.909 -0.587 . . . . 74.22 111.62 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.51 HG21 HG21 ' A' ' 191' ' ' VAL . 13.1 p -136.12 159.69 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.379 -0.373 . . . . 65.13 111.339 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.468 ' HB3' ' HZ3' ' A' ' 236' ' ' LYS . 8.8 mtpm? -110.67 163.87 13.31 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.126 0.489 . . . . 72.15 111.403 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 237' ' ' LYS . 13.2 tmtt? -90.01 123.2 33.7 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.794 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.99 0.61 56.13 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.241 -0.436 . . . . 54.54 113.679 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.81 150.2 21.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.934 0.397 . . . . 43.25 111.772 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 190' ' ' GLU . 32.5 mm -85.31 119.74 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 116.288 -0.415 . . . . 43.11 111.737 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -130.36 144.92 51.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.725 0.639 . . . . 75.41 112.725 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -100.5 115.11 29.32 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.841 -0.618 . . . . 64.12 110.197 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.467 HG21 HD11 ' A' ' 215' ' ' LEU . 57.5 t -111.02 123.32 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.441 0.534 . . . . 72.43 112.441 -172.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 67.4 m -107.9 122.21 46.34 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.57 -0.287 . . . . 72.55 110.821 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -165.9 -164.47 21.46 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.99 -1.1 . . . . 43.42 114.858 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 75.4 t80 -122.47 106.01 10.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.123 0.569 . . . . 73.12 110.938 -177.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.542 HG22 ' HB ' ' A' ' 256' ' ' ILE . 40.6 t -76.57 114.28 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.422 -0.353 . . . . 73.34 110.998 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.469 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 20.8 ptmt -129.63 153.29 48.25 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.473 0.654 . . . . 64.13 112.197 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 N--CA 1.469 0.494 0 CA-C-N 115.906 -0.588 . . . . 73.52 111.814 -177.113 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.766 0.317 . . . . 75.54 111.446 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -139.81 162.75 34.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.93 0.395 . . . . 73.24 111.029 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.542 ' HB ' HG22 ' A' ' 247' ' ' VAL . 9.3 tt -108.97 104.93 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 121.388 0.613 . . . . 75.15 111.735 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.4 t -64.77 93.81 0.12 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.978 -0.556 . . . . 73.04 110.154 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.564 ' HB ' HD23 ' A' ' 226' ' ' LEU . 39.9 t -66.77 125.36 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.053 0.454 . . . . 65.44 112.143 -174.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -96.11 -28.44 14.59 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.167 -0.469 . . . . 74.43 110.976 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -160.02 141.71 12.79 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.92 -0.582 . . . . 73.42 110.5 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.4 tt -138.1 138.65 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.246 0.461 . . . . 65.15 112.246 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -140.83 119.63 1.58 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.36 -0.448 . . . . 60.44 112.399 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.8 mt -74.13 126.79 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 122.467 -0.431 . . . . 60.21 111.318 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.484 HD12 HG22 ' A' ' 240' ' ' ILE . 69.0 mt -69.91 -50.18 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.998 0.428 . . . . 75.33 111.138 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.276 0.56 . . . . 72.31 112.017 179.312 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.637 HD21 ' N ' ' A' ' 173' ' ' ASN . 0.6 OUTLIER . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 112.561 0.578 . . . . 61.3 112.561 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.17 153.64 50.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.182 -0.463 . . . . 74.52 111.002 177.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.568 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 32.2 mmtp -82.07 162.92 22.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.364 -0.606 . . . . 72.25 109.364 170.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 35.6 mm -52.7 -45.36 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.638 0.733 . . . . 42.31 110.441 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.2 t -57.12 -28.7 62.93 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.34 -0.846 . . . . 72.43 112.607 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.568 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 15.6 mm-40 -92.98 2.77 56.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.913 0.338 . . . . 73.12 111.913 -174.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.513 HD22 HG21 ' A' ' 247' ' ' VAL . 90.6 mt -81.93 139.0 34.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.992 0.425 . . . . 64.1 111.331 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 55.8 mtt -132.78 155.18 81.47 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.39 -0.368 . . . . 60.22 111.255 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.478 ' HG3' HD21 ' A' ' 254' ' ' LEU . 44.3 Cg_exo -58.08 130.69 39.27 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.33 2.02 . . . . 64.34 112.454 174.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 70.34 22.55 5.32 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.947 0.499 . . . . 64.13 111.738 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.9 tt -111.18 131.36 55.17 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.0 0.429 . . . . 64.44 111.263 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.4 m -93.85 136.61 33.95 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.526 -0.306 . . . . 65.32 110.964 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.71 -174.47 36.72 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.393 -0.908 . . . . 63.45 113.954 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 53.1 m -131.65 131.68 43.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.666 0.386 . . . . 74.31 110.777 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 179' ' ' LEU . 33.6 pt -124.53 150.35 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.562 0.696 . . . . 75.32 112.554 -176.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -112.74 103.38 11.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.768 -0.651 . . . . 75.42 110.093 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -144.01 168.61 19.58 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.793 0.33 . . . . 62.14 111.648 -175.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.01 155.85 16.6 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.126 0.488 . . . . 62.42 111.29 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 237' ' ' LYS . 61.1 t -83.83 114.1 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 116.151 -0.477 . . . . 73.31 111.553 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.3 t -77.47 -36.68 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.015 0.436 . . . . 63.33 111.272 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -154.59 143.14 20.66 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.702 -0.681 . . . . 70.2 111.533 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -133.34 108.39 8.68 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.42 -0.355 . . . . 72.01 110.987 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -89.62 147.91 38.91 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.306 0.484 . . . . 72.24 112.306 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.38 159.85 15.09 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.925 2.416 . . . . 74.21 113.364 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -65.28 160.5 21.48 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.925 0.713 . . . . 53.22 112.925 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -141.38 173.28 11.64 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.601 -0.727 . . . . 74.41 111.73 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -130.34 138.73 50.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.715 -0.675 . . . . 73.43 110.021 172.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 11.7 p90 . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 121.399 0.619 . . . . 73.12 111.695 -177.932 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 121.036 0.446 . . . . 74.42 111.246 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 45.2 tp -142.17 140.24 32.33 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.331 -0.395 . . . . 75.31 111.464 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.517 ' HD3' HD12 ' A' ' 226' ' ' LEU . 60.8 tttp -140.67 128.67 22.02 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.752 0.31 . . . . 75.45 110.745 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.6 t -96.55 134.18 40.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.189 0.518 . . . . 71.3 111.94 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 226' ' ' LEU . 95.0 mt -130.83 174.31 10.09 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.919 -0.582 . . . . 65.21 111.02 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -148.86 121.46 8.58 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.239 -0.437 . . . . 72.22 110.013 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.8 mt -113.81 161.64 17.31 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.354 0.262 . . . . 61.41 110.991 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -159.17 154.19 25.04 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.27 0.841 . . . . 72.41 113.27 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -125.51 -175.48 3.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.448 -1.251 . . . . 75.15 108.973 163.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.07 -18.06 61.96 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.16 0.505 . . . . 74.33 110.796 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 77.6 p -81.83 -18.74 42.87 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.045 -0.525 . . . . 75.12 112.275 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 159.0 178.75 33.3 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.888 -0.672 . . . . 64.13 113.282 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 50.0 m -115.91 161.87 18.17 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.887 0.375 . . . . 52.32 111.651 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.6 tp -150.53 149.09 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 120.974 0.416 . . . . 62.13 111.363 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -89.7 122.77 33.12 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.293 -0.254 . . . . 64.33 110.934 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.5 120.3 6.83 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.89 -0.671 . . . . 64.31 112.901 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 62.3 m -111.51 118.94 37.14 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 122.126 -0.632 . . . . 74.32 111.845 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.517 HD12 ' HD3' ' A' ' 211' ' ' LYS . 94.0 mt -98.09 124.78 42.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.812 0.339 . . . . 51.21 111.286 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -107.17 150.82 26.19 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.775 0.321 . . . . 73.4 111.745 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 59.9 t30 56.75 -132.57 1.47 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 116.428 -0.351 . . . . 74.32 111.824 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.23 -14.16 46.16 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.666 0.617 . . . . 74.3 112.666 -174.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.515 ' HB3' HD22 ' A' ' 226' ' ' LEU . 86.9 mt -70.8 -18.49 62.74 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.938 -0.476 . . . . 44.22 111.142 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.16 78.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.741 0.645 . . . . 74.32 112.741 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -78.15 -3.9 44.82 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.072 0.397 . . . . 60.14 112.072 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.09 113.94 10.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.928 0.394 . . . . 71.4 110.766 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -75.83 105.06 6.66 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.198 0.523 . . . . 74.2 111.827 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.9 p -129.03 126.81 65.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.499 -0.773 . . . . 50.04 110.252 174.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -131.04 172.22 12.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.137 0.494 . . . . 65.42 111.9 -174.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.542 ' HA ' ' HB ' ' A' ' 191' ' ' VAL . 55.4 tttp -61.81 128.31 35.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.084 0.469 . . . . 74.44 111.423 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.65 -17.22 30.78 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.252 -0.431 . . . . 65.5 113.016 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.43 ' HB3' HD12 ' A' ' 263' ' ' ILE . 39.9 m-20 -88.73 112.71 23.48 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.968 0.414 . . . . 73.41 110.79 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 51.6 mm -77.29 103.73 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-O 120.995 0.426 . . . . 71.42 110.933 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 263' ' ' ILE . . . -110.67 140.9 44.61 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.536 0.569 . . . . 73.34 112.536 -175.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.1 106.39 18.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.095 0.474 . . . . 75.32 109.872 171.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.498 HG22 HG13 ' A' ' 261' ' ' ILE . 59.2 t -106.94 117.73 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.371 0.508 . . . . 51.4 112.371 -171.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 260' ' ' ASN . 82.4 p -106.9 133.52 51.42 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.411 -0.359 . . . . 52.2 110.557 173.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.6 -171.46 35.99 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.382 -0.913 . . . . 24.14 113.966 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -103.16 110.11 21.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.64 0.376 . . . . 74.33 110.877 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.513 HG21 HD22 ' A' ' 179' ' ' LEU . 50.6 t -81.03 122.18 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.874 0.368 . . . . 43.52 110.819 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -135.28 169.6 17.21 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.975 0.417 . . . . 73.4 111.328 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 120.887 0.375 . . . . 75.34 110.791 176.556 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.478 HD21 ' HG3' ' A' ' 181' ' ' PRO . 90.5 mt . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.38 0.609 . . . . 75.43 112.381 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.63 159.8 41.4 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.634 -0.712 . . . . 74.21 110.146 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 9.7 tt -118.65 109.04 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.403 0.621 . . . . 61.15 111.265 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 74.8 m -76.21 106.56 7.89 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.68 -0.489 . . . . 71.45 109.68 175.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.413 HG11 ' HB ' ' A' ' 261' ' ' ILE . 55.1 t -68.23 137.08 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.048 0.759 . . . . 71.44 113.048 -170.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -104.73 -37.15 7.18 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.753 -0.658 . . . . 75.21 110.528 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' ASN . . . . . 0.432 ' HB3' ' OG ' ' A' ' 244' ' ' SER . 64.0 t30 -149.76 118.43 6.58 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.163 -0.471 . . . . 73.41 110.849 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.498 HG13 HG22 ' A' ' 243' ' ' VAL . 9.7 tt -123.22 121.23 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.511 0.672 . . . . 75.12 111.669 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -132.56 125.76 4.28 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.1 -0.571 . . . . 72.21 113.136 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 241' ' ' ALA . 32.6 mm -70.06 113.71 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.595 -0.356 . . . . 70.4 110.535 176.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.04 -66.47 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.963 0.411 . . . . 71.33 111.366 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 120.849 0.357 . . . . 71.14 111.004 178.738 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASN . . . . . 0.622 HD21 ' N ' ' A' ' 173' ' ' ASN . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 121.283 0.563 . . . . 55.42 111.702 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -108.11 161.97 14.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.105 0.479 . . . . 75.32 112.138 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -75.88 151.03 37.47 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.264 -0.643 . . . . 53.22 109.264 163.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 222' ' ' ILE . 28.4 mt -58.26 -39.03 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 121.832 -0.543 . . . . 73.45 111.835 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.0 t -73.81 -20.03 60.58 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.069 0.461 . . . . 72.4 111.379 175.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -78.94 -19.53 51.51 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.206 0.527 . . . . 71.5 110.711 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.435 HD11 HG21 ' A' ' 187' ' ' ILE . 95.1 mt -67.12 146.78 53.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.135 0.493 . . . . 74.24 111.608 177.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.7 ptp -146.67 152.75 45.77 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.205 -0.452 . . . . 41.23 110.949 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.54 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 51.3 Cg_exo -54.63 147.63 48.2 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.983 2.455 . . . . 72.32 113.655 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.46 29.1 13.47 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.018 -0.537 . . . . 74.33 112.352 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.9 tt -133.61 136.75 45.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.343 -0.39 . . . . 51.33 110.886 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.0 p -97.88 133.92 41.72 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.768 0.318 . . . . 72.15 111.291 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.2 174.55 34.75 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.659 -0.781 . . . . 73.33 113.743 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 44.2 m -122.56 138.48 54.56 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.508 0.323 . . . . 52.02 110.345 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 179' ' ' LEU . 32.9 pt -134.73 146.12 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.262 0.553 . . . . 73.41 111.909 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -109.87 103.76 12.59 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.821 -0.437 . . . . 73.12 109.821 171.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.6 168.19 18.7 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.302 0.573 . . . . 61.4 112.187 -173.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -82.75 126.73 32.72 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.552 -0.749 . . . . 73.32 111.024 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 235' ' ' VAL . 61.8 t -76.57 95.35 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.204 0.526 . . . . 71.55 110.195 174.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.483 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 13.7 t -75.76 -35.13 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.963 -0.562 . . . . 44.22 111.548 -176.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.06 113.4 5.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 74.52 111.743 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.85 103.97 15.61 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.207 -0.451 . . . . 71.34 110.479 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -79.31 147.55 68.92 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.23 -0.441 . . . . 75.24 111.776 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.83 155.01 40.19 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.596 2.197 . . . . 62.3 112.687 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -72.94 156.05 39.24 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.396 0.617 . . . . 71.13 112.563 -173.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 210' ' ' LEU . 68.6 mttm -122.92 159.13 28.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.721 -0.672 . . . . 72.52 109.866 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -141.7 132.16 25.27 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.097 0.475 . . . . 70.14 111.408 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.0 p90 . . . . . 0 CA--C 1.54 0.594 0 CA-C-N 116.089 -0.505 . . . . 73.1 111.372 -176.163 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 228' ' ' ASN . 47.8 mt-30 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 120.705 0.288 . . . . 63.2 110.655 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 198' ' ' LYS . 56.8 tp -125.78 145.91 50.01 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.662 0.385 . . . . 72.05 111.571 -174.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 22.3 tptm -150.59 121.92 7.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.45 -0.341 . . . . 54.53 110.939 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 47.2 t -101.45 144.03 30.74 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.993 0.425 . . . . 74.41 111.821 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 97.3 mt -136.34 134.58 38.05 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.153 -0.476 . . . . 73.51 111.119 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -103.83 109.93 21.85 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.141 -0.349 . . . . 74.23 110.731 174.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 243' ' ' VAL . 67.0 mt -107.55 145.09 33.65 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.346 -0.388 . . . . 72.1 110.674 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -137.52 150.46 47.54 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.539 0.685 . . . . 71.43 112.04 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -139.28 170.59 15.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.85 -1.068 . . . . 73.44 109.69 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -52.48 -41.24 63.2 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.792 0.33 . . . . 73.25 111.846 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 81.5 p -83.83 -6.26 59.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.487 0.921 . . . . 60.41 113.487 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 148.97 -179.8 25.49 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.721 -0.752 . . . . 70.3 113.149 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 84.9 p -121.83 159.4 26.84 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 122.258 -0.554 . . . . 63.54 111.893 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 176' ' ' ILE . 14.6 tt -151.8 150.33 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.073 0.463 . . . . 72.33 110.861 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 223' ' ' ARG . 32.0 mtm-85 -100.93 123.27 44.87 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.021 0.439 . . . . 75.54 111.855 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -97.26 161.7 21.58 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 116.033 -0.531 . . . . 70.34 113.233 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 94.5 m -136.5 121.76 19.22 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.269 0.47 . . . . 41.35 112.269 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.624 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 92.3 mt -105.49 137.19 43.73 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.958 -0.565 . . . . 74.41 110.905 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -115.79 150.35 37.07 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.759 0.314 . . . . 74.23 111.656 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ASN . . . . . 0.406 ' HB3' ' OE2' ' A' ' 229' ' ' GLU . 65.4 t30 53.0 -128.3 2.42 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.552 0.575 . . . . 75.31 112.552 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' GLU . . . . . 0.406 ' OE2' ' HB3' ' A' ' 228' ' ' ASN . 0.9 OUTLIER -55.83 -16.69 4.84 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.276 0.843 . . . . 75.53 113.276 -175.805 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.437 ' HB3' HD22 ' A' ' 226' ' ' LEU . 91.7 mt -88.16 -17.75 30.25 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.956 0.407 . . . . 71.53 111.653 176.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.07 98.16 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.67 0.618 . . . . 72.34 112.67 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -77.7 3.2 14.6 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.668 0.618 . . . . 73.02 112.668 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -52.65 121.21 6.73 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.838 0.351 . . . . 62.13 111.74 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.6 116.31 22.54 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.241 -0.436 . . . . 73.43 111.549 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 191' ' ' VAL . 7.9 p -142.57 142.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 116.091 -0.504 . . . . 53.22 110.382 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -95.55 160.42 14.52 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.04 0.448 . . . . 75.0 111.334 -176.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 192' ' ' VAL . 40.4 ttmt -67.91 93.91 0.44 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.982 0.42 . . . . 73.32 110.939 174.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 136.11 -21.71 3.48 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.092 -0.575 . . . . 54.32 113.683 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -57.77 137.12 56.88 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.216 0.532 . . . . 74.04 111.941 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.529 HG22 HD12 ' A' ' 264' ' ' ILE . 32.7 mm -84.85 103.17 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.03 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -103.07 136.01 43.68 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.886 0.698 . . . . 50.13 112.886 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.8 98.8 7.2 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.582 -0.736 . . . . 74.43 110.088 171.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 215' ' ' LEU . 57.9 t -105.69 115.97 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.054 0.454 . . . . 35.41 111.793 -177.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 84.0 p -116.43 136.08 53.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.013 -0.539 . . . . 63.24 110.418 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -178.91 -166.84 35.58 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.13 -1.033 . . . . 62.33 114.839 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -106.74 122.07 45.64 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.085 0.554 . . . . 70.33 110.917 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 56.7 t -86.0 125.79 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.364 0.602 . . . . 53.53 112.364 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -121.16 169.23 10.74 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.624 -0.716 . . . . 74.33 110.348 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLN . . . . . 0.54 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 24.8 tt0 . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 120.704 0.288 . . . . 71.41 110.731 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 112.644 0.609 . . . . 72.2 112.644 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.44 125.07 39.9 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.618 -0.719 . . . . 72.41 109.357 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ILE . . . . . 0.488 HG23 ' HA2' ' A' ' 224' ' ' GLY . 10.1 tt -113.83 121.21 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.488 0.661 . . . . 72.44 112.592 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 18.0 m -82.94 111.71 19.07 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.803 -0.635 . . . . 53.22 110.024 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' VAL . . . . . 0.542 ' HB ' HD23 ' A' ' 226' ' ' LEU . 44.7 t -76.99 128.72 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.366 0.603 . . . . 64.54 112.542 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.8 -44.52 14.28 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.597 -0.729 . . . . 73.04 110.537 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -152.07 143.18 23.19 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.287 -0.415 . . . . 74.14 111.21 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 6.2 tt -134.52 134.1 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.285 -0.416 . . . . 75.13 111.412 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.23 139.01 6.9 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.204 -0.522 . . . . 54.31 112.146 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.9 mt -69.16 131.96 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 117.333 0.566 . . . . 75.04 110.642 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.529 HD12 HG22 ' A' ' 240' ' ' ILE . 60.9 mt -70.31 -46.32 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.287 0.477 . . . . 64.44 112.287 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.961 0.41 . . . . 74.52 111.205 -178.755 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 13.0 ptt? . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.151 0.5 . . . . 74.42 111.569 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -79.8 117.46 20.7 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.424 -0.353 . . . . 75.1 110.365 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -87.16 152.41 22.36 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.484 0.659 . . . . 64.33 112.261 -174.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.474 ' HG2' ' OE1' ' A' ' 178' ' ' GLU . 27.5 mmtm -100.77 164.47 11.84 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.58 -0.896 . . . . 74.33 108.58 168.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 54.2 mt -58.31 -31.11 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 O-C-N 122.059 -0.401 . . . . 73.21 111.816 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 48.4 t -71.89 -24.14 61.61 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.147 0.425 . . . . 73.32 112.147 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.474 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 45.2 mt-10 -81.63 -5.95 58.54 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.126 -0.359 . . . . 70.43 111.824 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.509 HD22 HG21 ' A' ' 247' ' ' VAL . 82.6 mt -75.86 125.58 29.36 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.293 0.568 . . . . 52.1 111.882 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.539 ' HG2' HD22 ' A' ' 183' ' ' LEU . 22.6 ptp -124.12 159.03 58.62 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 115.859 -0.61 . . . . 74.22 110.3 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 248' ' ' LYS . 14.8 Cg_endo -57.37 133.18 55.49 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.963 1.775 . . . . 64.44 112.904 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 76.4 m-20 69.57 29.89 4.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.397 0.679 . . . . 74.41 111.8 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.539 HD22 ' HG2' ' A' ' 180' ' ' MET . 27.0 tp -106.13 118.26 36.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.124 -0.489 . . . . 75.44 111.578 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.5 t -92.63 108.98 20.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.779 0.323 . . . . 60.32 110.201 173.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -153.29 172.56 32.19 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.585 -0.817 . . . . 73.14 113.911 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 244' ' ' SER . 34.8 m -114.17 129.77 56.62 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.78 0.324 . . . . 71.41 111.726 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.484 HD13 HD11 ' A' ' 179' ' ' LEU . 37.3 pt -122.16 163.68 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.301 0.572 . . . . 72.43 112.298 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -121.76 118.52 29.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.948 -0.569 . . . . 54.23 110.264 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -151.33 171.73 17.01 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.527 0.566 . . . . 53.03 112.527 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -96.01 141.66 29.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.066 -0.515 . . . . 64.23 111.589 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.9 t -78.95 103.49 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.972 0.415 . . . . 74.13 111.136 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' A' ' 216' ' ' LYS . 21.5 t -81.36 -28.61 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.0 0.429 . . . . 73.31 111.728 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -151.33 136.42 17.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.978 0.418 . . . . 71.33 111.572 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -124.05 114.36 19.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.885 -0.598 . . . . 62.23 110.818 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 212' ' ' SER . 94.9 m-85 -109.37 148.69 38.55 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 120.655 0.264 . . . . 52.33 111.632 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.41 156.65 16.79 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.984 2.456 . . . . 71.02 113.841 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -73.44 169.23 17.62 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.53 0.681 . . . . 63.42 111.989 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -138.65 149.47 45.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.455 -0.793 . . . . 64.33 109.361 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 209' ' ' GLN . 44.0 mt-10 -130.82 112.6 13.18 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.912 -0.492 . . . . 70.13 112.248 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -127.72 -178.73 4.6 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.261 0.553 . . . . 62.55 111.421 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 69.6 m -111.19 126.58 55.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.384 -0.371 . . . . 71.44 111.008 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.56 151.27 41.94 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.668 -0.242 . . . . 65.44 110.559 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -53.34 -29.56 34.62 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.174 0.511 . . . . 75.42 111.516 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.72 -4.85 48.34 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.99 -0.55 . . . . 61.15 112.281 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 107.63 -37.66 3.71 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.198 -0.525 . . . . 63.34 113.62 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 43.8 p -68.68 145.99 53.39 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.993 0.425 . . . . 75.51 111.992 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -71.92 145.67 48.32 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.173 0.511 . . . . 64.03 112.125 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -143.93 136.7 6.99 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 116.245 -0.434 . . . . 53.31 112.689 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.482 ' HG2' ' HG2' ' A' ' 199' ' ' GLU . 75.9 mt-30 -102.53 161.24 13.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.943 0.401 . . . . 73.4 111.591 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 32.8 tp -145.17 126.4 14.77 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.059 -0.519 . . . . 74.53 111.39 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.601 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 84.7 tttt -126.87 135.08 50.49 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.948 0.404 . . . . 74.21 111.194 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.537 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 5.0 m -98.24 128.37 44.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.016 -0.538 . . . . 61.4 111.81 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.415 HD11 HG11 ' A' ' 235' ' ' VAL . 93.8 mt -137.1 163.72 30.13 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.085 0.469 . . . . 64.31 112.115 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -135.15 129.91 34.57 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.257 -0.429 . . . . 64.41 110.367 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.7 mt -120.7 148.59 43.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.256 0.222 . . . . 71.45 111.376 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.404 ' HB3' HG21 ' A' ' 192' ' ' VAL . 21.4 pttm -136.86 151.97 49.71 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.401 0.62 . . . . 71.15 112.095 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -148.78 165.59 30.97 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.304 -0.862 . . . . 74.34 109.848 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -57.26 -30.65 64.83 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 111.942 0.349 . . . . 61.13 111.942 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 63.0 p -84.07 -11.49 56.62 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.584 0.587 . . . . 53.54 112.584 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 152.25 179.77 28.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.936 -0.65 . . . . 44.15 113.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.4 p -124.2 155.42 38.57 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 122.554 -0.38 . . . . 52.1 111.498 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -147.05 156.75 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.979 0.418 . . . . 72.31 111.716 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 223' ' ' ARG . 8.3 mpt_? -95.08 123.97 38.87 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.69 0.281 . . . . 64.21 110.733 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.43 152.85 20.53 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.26 -0.495 . . . . 60.34 113.617 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 70.2 m -144.4 115.45 7.89 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.091 0.404 . . . . 72.43 112.091 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.601 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 88.8 mt -98.6 137.48 37.18 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.453 -0.34 . . . . 42.32 111.307 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -114.62 151.02 34.2 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.14 0.495 . . . . 74.51 112.233 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.4 ' HA ' ' H ' ' A' ' 209' ' ' GLN . 64.2 t30 52.93 -134.24 1.7 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.828 -0.624 . . . . 64.12 111.856 173.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.42 -26.15 52.57 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.595 0.591 . . . . 74.33 112.595 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.42 -27.19 69.13 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.036 0.446 . . . . 64.14 111.225 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.48 ' O ' ' HD2' ' A' ' 211' ' ' LYS . . . -67.38 -14.24 62.74 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.115 0.413 . . . . 73.23 112.115 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -92.03 -12.98 31.69 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.992 0.425 . . . . 70.55 110.974 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -61.87 134.32 56.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.988 0.423 . . . . 73.33 111.605 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.92 118.24 15.62 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.009 0.433 . . . . 73.43 111.436 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 213' ' ' LEU . 4.2 p -139.07 117.51 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.137 0.494 . . . . 74.13 110.492 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -106.99 152.09 24.45 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.119 0.485 . . . . 74.54 111.885 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -70.15 117.85 12.24 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.187 -0.46 . . . . 72.41 111.478 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.57 -13.18 32.89 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.478 -0.391 . . . . 75.25 113.097 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.56 145.82 36.65 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.055 0.455 . . . . 72.22 111.93 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.584 HG22 HD12 ' A' ' 264' ' ' ILE . 38.9 mm -87.71 118.57 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.037 -0.529 . . . . 53.24 110.566 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.421 ' HB2' HD13 ' A' ' 263' ' ' ILE . . . -128.59 145.55 51.1 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.653 0.612 . . . . 71.21 112.653 -175.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -103.92 110.42 22.56 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.916 -0.584 . . . . 64.11 109.927 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.6 t -108.62 115.29 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.733 0.642 . . . . 73.43 112.733 -171.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 186' ' ' THR . 35.8 t -95.72 122.41 38.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.039 -0.528 . . . . 63.02 110.124 173.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -158.5 167.11 34.51 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.235 -0.983 . . . . 62.44 114.529 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -92.89 104.54 16.77 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.128 0.571 . . . . 74.23 110.596 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 179' ' ' LEU . 44.6 t -86.02 138.86 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.675 0.274 . . . . 64.35 111.438 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 181' ' ' PRO . 10.6 ptmm? -151.06 176.35 11.23 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.066 0.46 . . . . 73.43 111.821 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.485 ' HA ' HD23 ' A' ' 254' ' ' LEU . 23.5 tt0 -100.36 129.73 46.37 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.947 -0.569 . . . . 64.0 111.144 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 163.29 -75.77 0.17 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.808 -0.711 . . . . 72.43 113.409 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.628 ' HB3' ' HB3' ' A' ' 255' ' ' GLU . 57.9 t80 -75.74 122.77 24.52 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.63 -0.335 . . . . 74.51 110.891 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.3 t 55.16 28.96 11.79 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.236 0.541 . . . . 62.33 111.511 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 91.72 -66.04 2.3 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.248 -0.501 . . . . 45.13 112.264 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 249' ' ' GLN . 92.3 mt -134.36 116.5 15.29 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.873 0.469 . . . . 72.14 110.406 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 251' ' ' TYR . 2.5 pm0 -109.66 143.12 39.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.985 0.421 . . . . 74.32 111.482 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.6 tt -108.72 104.35 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.339 0.59 . . . . 73.41 111.202 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.9 t -77.44 98.92 5.45 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.123 -0.49 . . . . 53.12 110.409 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.86 131.26 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.929 0.714 . . . . 53.31 112.929 -171.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -99.64 -44.6 6.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.567 -0.742 . . . . 75.42 110.357 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 244' ' ' SER . 21.7 m-80 -135.93 137.13 41.05 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.344 -0.389 . . . . 63.52 110.536 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.4 tt -137.75 136.19 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.841 0.353 . . . . 74.0 111.571 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.06 140.52 7.93 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.197 -0.525 . . . . 64.13 113.163 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.626 ' HB ' ' HG2' ' A' ' 266' ' ' LYS . 47.2 mm -85.54 115.07 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.062 0.458 . . . . 73.51 110.853 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.584 HD12 HG22 ' A' ' 240' ' ' ILE . 63.0 mt -59.41 -35.95 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.476 0.547 . . . . 72.03 112.476 -174.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.13 0.18 22.6 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.396 0.888 . . . . 73.35 113.396 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.626 ' HG2' ' HB ' ' A' ' 263' ' ' ILE . 69.8 mmtt -69.26 157.02 37.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.0 0.741 . . . . 72.35 113.0 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 88.9 p -158.37 179.31 9.26 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.272 -0.876 . . . . 73.33 110.356 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 2.5 pp -153.09 -176.96 6.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.907 0.336 . . . . 51.23 111.907 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.536 -0.745 . . . . 72.22 111.826 179.255 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 11.9 tpt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.873 0.368 . . . . 75.23 111.665 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -82.3 121.87 27.22 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.027 0.441 . . . . 63.52 110.164 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -83.38 141.05 32.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.187 0.518 . . . . 75.04 111.942 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 175' ' ' LYS . 12.1 mptt -96.54 155.79 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.61 . . . . 74.45 109.545 173.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.424 HD13 HG22 ' A' ' 222' ' ' ILE . 55.9 mt -59.15 -33.09 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.064 0.394 . . . . 75.24 112.064 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 56.2 p -70.79 -15.45 62.67 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.073 0.398 . . . . 43.04 112.073 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -104.55 -5.97 21.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.975 0.417 . . . . 55.34 111.594 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.548 HD22 HG21 ' A' ' 247' ' ' VAL . 81.6 mt -71.49 148.36 46.87 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.184 0.516 . . . . 72.34 111.987 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.5 ptp -148.18 153.27 41.07 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.945 -0.571 . . . . 73.21 110.801 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.29 128.05 24.18 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.905 2.403 . . . . 73.0 114.358 -177.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.483 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 2.1 m-20 66.04 50.77 1.4 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.594 0.711 . . . . 62.32 112.156 173.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.7 tt -131.46 134.03 45.77 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.514 -0.766 . . . . 65.34 110.355 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 89.8 p -100.5 148.13 25.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.129 0.49 . . . . 60.15 111.508 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.67 -169.77 41.39 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.088 -0.577 . . . . 63.41 113.152 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 94.6 m -118.41 124.77 48.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.843 0.354 . . . . 75.23 111.712 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 179' ' ' LEU . 37.2 pt -109.02 154.17 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.068 -0.515 . . . . 75.24 110.285 173.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -135.4 108.51 7.69 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.042 -0.411 . . . . 75.04 110.872 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.29 172.15 13.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.065 0.46 . . . . 64.25 112.099 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -93.61 139.04 31.24 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.911 -0.586 . . . . 71.3 110.635 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.477 ' HA ' HD23 ' A' ' 215' ' ' LEU . 38.2 t -79.16 100.98 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.308 0.484 . . . . 45.31 112.308 -174.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.796 ' HA ' ' HZ3' ' A' ' 237' ' ' LYS . 48.6 t -59.62 -52.56 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.941 0.401 . . . . 74.31 111.723 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -132.71 124.66 28.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.189 -0.46 . . . . 64.53 111.27 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -106.16 102.82 12.21 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.925 0.393 . . . . 40.52 111.351 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -81.99 155.93 69.91 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.187 0.439 . . . . 75.34 112.187 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.96 175.84 10.79 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.61 2.207 . . . . 73.5 112.188 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.579 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 64.1 pttt -93.76 124.06 37.51 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.517 0.675 . . . . 70.41 112.754 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -87.42 146.13 25.99 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.307 -0.86 . . . . 60.43 110.818 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -99.16 136.79 38.61 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.87 0.367 . . . . 75.24 111.685 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.26 177.21 11.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.992 0.425 . . . . 71.44 111.153 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 55.7 m -111.4 140.25 46.14 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.057 0.456 . . . . 33.24 111.67 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -83.79 148.09 27.22 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.878 -0.601 . . . . 75.32 111.862 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -60.61 -28.85 68.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.276 0.56 . . . . 71.14 110.412 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.71 -19.9 66.03 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.357 -0.838 . . . . 63.33 111.776 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 101.77 8.01 46.57 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.408 -0.425 . . . . 71.32 113.384 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 75.0 p -106.17 171.89 7.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.253 0.549 . . . . 70.14 112.152 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -72.22 144.25 48.54 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.059 -0.519 . . . . 51.05 111.044 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -130.81 134.4 7.74 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.773 -0.727 . . . . 72.03 113.361 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -118.76 137.31 53.46 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.703 0.287 . . . . 75.51 110.573 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 28.2 tp -121.64 125.35 46.47 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.441 0.296 . . . . 71.02 111.768 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -141.6 113.58 7.95 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.01 0.433 . . . . 73.23 111.625 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 64.4 m -93.93 139.48 30.86 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.114 0.483 . . . . 74.24 111.721 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.517 HD11 HG11 ' A' ' 235' ' ' VAL . 85.9 mt -123.4 126.34 46.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.476 -0.329 . . . . 65.1 110.603 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -92.12 115.95 28.52 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.988 -0.445 . . . . 63.14 110.759 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.522 HD11 HG21 ' A' ' 243' ' ' VAL . 58.6 mt -112.52 152.87 28.31 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.538 0.335 . . . . 74.04 111.288 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.461 ' HG2' ' CG2' ' A' ' 192' ' ' VAL . 12.9 ptmm? -162.14 150.3 14.72 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.206 0.526 . . . . 73.41 112.067 172.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -116.44 -164.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.714 -0.847 . . . . 73.42 108.714 167.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.53 -6.15 58.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.639 0.733 . . . . 75.35 109.606 166.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.5 p -81.51 -33.81 31.62 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.284 -0.871 . . . . 75.54 111.744 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 167.46 -178.69 41.37 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.396 -0.431 . . . . 72.32 112.811 -176.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 81.0 p -130.3 133.73 46.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 117.35 0.575 . . . . 51.04 112.25 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.424 HG22 HD13 ' A' ' 176' ' ' ILE . 11.6 tt -148.51 153.16 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.653 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -101.2 132.66 46.59 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.704 -0.623 . . . . 72.11 111.675 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.432 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -96.92 117.58 5.8 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.643 -0.583 . . . . 65.3 111.643 173.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 30.8 m -95.95 115.99 28.26 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.438 -0.448 . . . . 73.41 112.107 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.499 HD23 ' HB ' ' A' ' 258' ' ' VAL . 92.8 mt -91.64 128.39 37.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.07 -0.514 . . . . 71.34 111.17 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -113.47 153.85 28.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.231 0.539 . . . . 73.04 111.777 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.8 -134.27 0.69 Allowed 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 115.647 -0.706 . . . . 71.14 112.006 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -63.6 -18.34 63.79 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.097 0.777 . . . . 63.45 113.097 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.0 -14.93 63.38 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.755 0.312 . . . . 74.33 111.593 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.579 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -61.24 -43.69 98.47 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.214 0.45 . . . . 63.31 112.214 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -76.08 1.31 15.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.54 0.57 . . . . 74.52 112.54 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -67.25 123.07 19.29 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.167 -0.333 . . . . 74.23 110.53 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.84 92.98 0.37 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.205 0.526 . . . . 70.25 112.068 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.517 HG11 HD11 ' A' ' 213' ' ' LEU . 3.7 p -120.42 107.64 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.743 -0.662 . . . . 70.14 110.24 173.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -95.34 163.58 13.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.0 -0.545 . . . . 75.11 111.002 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.796 ' HZ3' ' HA ' ' A' ' 192' ' ' VAL . 8.1 tmtm? -71.12 113.12 7.84 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.481 -0.563 . . . . 74.31 109.481 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 121.95 -23.12 7.45 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 116.175 -0.466 . . . . 65.2 112.231 -172.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.4 ' HB3' HD12 ' A' ' 263' ' ' ILE . 24.4 m-20 -65.5 125.58 25.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.137 0.494 . . . . 75.42 112.067 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 49.8 mm -77.85 97.97 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.514 -0.55 . . . . 63.11 109.514 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -97.04 129.96 44.41 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.179 0.807 . . . . 63.14 113.179 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.9 96.57 8.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.685 -0.689 . . . . 71.21 109.417 170.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.522 HG21 HD11 ' A' ' 215' ' ' LEU . 88.6 t -97.61 111.62 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.113 0.483 . . . . 72.21 111.471 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.7 t -118.35 135.51 54.28 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.757 0.313 . . . . 73.34 111.056 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 172.81 -152.91 17.36 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.448 -0.882 . . . . 64.5 113.803 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -111.59 115.18 28.72 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.753 0.311 . . . . 70.33 111.325 -175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.548 HG21 HD22 ' A' ' 179' ' ' LEU . 47.7 t -86.27 120.54 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.776 0.322 . . . . 61.0 111.092 178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.483 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 19.4 ptpt -135.09 -179.82 5.86 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.817 0.341 . . . . 73.31 111.043 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -107.93 129.56 55.09 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.703 -0.226 . . . . 60.15 110.405 171.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -129.99 -132.91 3.51 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.917 -0.659 . . . . 21.42 113.624 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -88.98 -28.87 19.93 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.392 0.515 . . . . 74.33 112.392 -174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 37.8 t -89.54 -35.22 16.04 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.081 0.467 . . . . 74.22 111.033 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 155.76 -135.54 4.63 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.95 -0.568 . . . . 64.15 112.041 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 67.7 mt -79.2 102.71 8.67 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.263 0.554 . . . . 60.54 109.87 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -119.19 137.07 53.88 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.982 -0.554 . . . . 75.53 111.724 -172.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.482 ' HB ' HG22 ' A' ' 247' ' ' VAL . 9.5 tt -104.79 121.05 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.294 0.569 . . . . 41.44 111.98 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 94.5 p -81.75 112.07 18.58 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.491 -0.559 . . . . 71.43 109.491 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.499 ' HB ' HD23 ' A' ' 226' ' ' LEU . 21.7 t -77.64 106.16 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.864 0.364 . . . . 64.21 111.963 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -84.07 -24.06 30.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.01 0.433 . . . . 73.12 111.299 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -146.4 125.78 13.14 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.926 -0.579 . . . . 54.22 111.101 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.452 ' HB ' HG11 ' A' ' 258' ' ' VAL . 13.1 tt -135.67 137.06 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.158 0.504 . . . . 71.33 111.769 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.43 140.27 7.71 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.892 -0.595 . . . . 54.33 111.826 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.642 HG21 ' HE3' ' A' ' 266' ' ' LYS . 40.5 mm -92.26 128.66 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 117.682 0.741 . . . . 63.12 111.705 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 27.1 mt -83.65 -45.88 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 121.368 0.604 . . . . 75.24 110.758 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -124.79 126.45 45.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.052 -0.522 . . . . 73.35 111.35 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.642 ' HE3' HG21 ' A' ' 263' ' ' ILE . 6.8 mmpt? -90.26 145.0 25.33 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.591 0.589 . . . . 62.21 112.591 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 46.0 m -121.31 25.05 9.69 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.917 -0.583 . . . . 73.31 111.087 173.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.57 HD12 ' HG2' ' A' ' 269' ' ' GLU . 3.1 pp -66.55 -20.95 66.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.674 0.274 . . . . 71.44 111.391 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.57 ' HG2' HD12 ' A' ' 268' ' ' LEU . 13.2 pt-20 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.68 -0.676 . . . . 54.23 111.026 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.738 0.304 . . . . 72.43 111.32 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -92.46 107.2 19.04 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.995 0.426 . . . . 73.21 111.477 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -94.96 151.36 19.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.292 0.568 . . . . 74.33 111.9 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -89.34 153.69 20.67 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.701 -0.851 . . . . 75.15 108.701 169.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.405 HD13 HG22 ' A' ' 222' ' ' ILE . 36.0 mt -55.72 -36.25 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.328 0.492 . . . . 74.14 112.328 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.491 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 47.1 t -69.85 -24.09 63.39 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.138 0.421 . . . . 62.22 112.138 176.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.85 -5.78 59.14 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.288 0.477 . . . . 73.3 112.288 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.447 HD22 HG21 ' A' ' 247' ' ' VAL . 89.2 mt -70.84 155.71 40.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.504 0.669 . . . . 73.22 112.625 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.468 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.2 ptp -154.23 152.04 25.58 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.437 -0.801 . . . . 74.24 109.756 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.0 150.33 79.12 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 121.684 1.589 . . . . 51.43 112.492 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 246' ' ' TYR . 2.3 m-20 64.72 30.91 12.25 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.057 0.456 . . . . 53.41 111.445 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.468 HD22 ' HG2' ' A' ' 180' ' ' MET . 22.8 tp -114.58 115.88 27.88 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.353 -0.385 . . . . 72.13 111.372 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 90.2 p -103.83 109.52 21.28 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.66 0.267 . . . . 64.03 110.765 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.83 -161.56 11.44 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.778 -0.725 . . . . 60.21 113.508 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 25.1 m -122.81 142.98 50.16 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.65 -0.324 . . . . 71.32 111.418 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 34.8 pt -135.31 155.46 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.233 0.54 . . . . 74.11 112.431 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -111.19 124.48 52.28 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.15 -0.477 . . . . 63.12 110.531 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.8 164.94 38.09 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.339 0.59 . . . . 55.05 112.41 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -103.21 138.05 40.53 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.615 -0.721 . . . . 63.21 110.089 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.9 99.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.58 0.585 . . . . 50.12 112.58 -172.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.3 t -70.87 -44.75 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.074 0.464 . . . . 75.41 111.774 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -143.4 132.72 23.3 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.176 -0.465 . . . . 62.43 111.832 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -124.1 99.48 6.26 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.148 -0.478 . . . . 65.33 110.855 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 196' ' ' PRO . 72.3 m-85 -77.49 149.78 78.81 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.55 0.574 . . . . 64.42 112.55 -174.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 195' ' ' TYR . 38.6 Cg_exo -62.19 172.62 3.95 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.299 2.666 . . . . 65.15 114.054 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.405 ' HA ' ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -61.07 109.99 1.24 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.373 -0.83 . . . . 73.23 112.868 -176.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 210' ' ' LEU . 66.7 mttm -83.88 148.96 26.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.185 -0.461 . . . . 62.41 109.929 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -131.86 136.58 47.56 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.986 0.735 . . . . 64.14 112.986 -171.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.43 ' HE1' ' HB2' ' A' ' 210' ' ' LEU . 54.8 p90 -156.37 -175.34 5.38 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.587 -0.733 . . . . 64.05 110.456 173.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 70.6 p -122.24 143.94 49.28 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.208 -0.307 . . . . 72.52 110.705 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 -90.45 141.01 29.18 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.874 0.369 . . . . 75.45 111.294 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -49.85 -30.31 9.65 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.212 0.53 . . . . 64.23 111.496 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -54.39 -44.09 72.0 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.725 -0.67 . . . . 74.21 112.141 175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 126.52 -20.81 6.1 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.156 -0.545 . . . . 60.04 112.422 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.0 p -85.26 176.53 8.27 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.03 0.443 . . . . 71.04 111.947 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -72.83 163.38 28.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.52 0.676 . . . . 71.4 112.534 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.05 110.84 0.46 Allowed Glycine 0 CA--C 1.523 0.547 0 CA-C-N 115.675 -0.693 . . . . 73.22 112.442 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -110.78 168.02 9.79 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.383 -0.48 . . . . 75.05 111.016 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 198' ' ' LYS . 65.8 tp -144.81 149.38 35.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.992 0.425 . . . . 72.02 111.458 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.614 ' HB2' ' HA ' ' A' ' 231' ' ' ALA . 45.6 tttp -149.85 121.1 7.82 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.937 0.399 . . . . 75.22 111.263 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 41.2 m -95.38 118.26 31.8 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.969 0.414 . . . . 73.41 111.663 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 74.4 mt -109.57 130.45 55.51 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.442 -0.345 . . . . 54.51 110.773 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -97.79 103.75 15.71 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.002 -0.436 . . . . 71.45 110.669 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.17 136.34 35.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.141 -0.481 . . . . 65.51 111.291 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -122.62 147.72 46.09 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 112.718 0.636 . . . . 63.12 112.718 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -148.21 163.05 38.17 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.133 -0.94 . . . . 62.22 109.298 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -77.52 10.05 2.88 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.908 -0.495 . . . . 60.15 112.263 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 69.8 p -115.24 2.81 14.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.947 0.403 . . . . 62.22 111.072 169.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 147.1 170.08 15.11 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.332 -0.461 . . . . 73.14 113.25 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 80.3 p -128.64 126.5 40.32 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.442 -0.446 . . . . 72.54 111.061 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 176' ' ' ILE . 9.6 tp -129.76 151.75 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.946 0.403 . . . . 72.01 111.263 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.627 ' HD3' ' H ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -99.29 125.26 44.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.2 0.524 . . . . 64.43 111.441 178.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.565 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -91.83 138.31 14.19 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.705 -0.68 . . . . 64.11 112.489 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.439 HG23 HD11 ' A' ' 210' ' ' LEU . 28.4 m -106.43 105.5 15.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.903 0.334 . . . . 74.2 111.903 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.595 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 56.4 mt -90.42 138.71 31.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.831 0.348 . . . . 63.43 111.186 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -115.55 157.12 24.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.272 0.558 . . . . 74.1 112.101 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 55.4 t30 57.83 -141.68 0.74 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.559 -0.746 . . . . 54.41 112.468 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.42 -24.21 19.03 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.989 0.737 . . . . 74.01 112.989 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.57 -8.35 4.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.92 0.39 . . . . 74.14 112.006 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -66.06 -30.02 70.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.922 0.391 . . . . 64.54 111.82 175.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.4 5.84 50.18 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.336 -0.393 . . . . 61.21 111.847 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -59.77 126.46 27.66 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.944 0.402 . . . . 75.24 111.856 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -68.39 87.82 0.31 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.245 0.545 . . . . 50.43 111.796 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.5 p -116.89 128.78 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.112 -0.495 . . . . 74.22 110.735 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 239' ' ' ASP . 50.5 mtpt -93.28 150.86 20.17 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.3 0.572 . . . . 72.44 112.281 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -80.16 117.23 20.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.898 -0.592 . . . . 71.22 110.068 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.58 23.6 13.72 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.938 -0.648 . . . . 74.24 112.659 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 3.0 t0 -113.72 162.77 15.87 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.702 0.287 . . . . 61.01 110.564 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 264' ' ' ILE . 47.0 mm -98.94 114.12 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.738 0.304 . . . . 73.31 111.218 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -114.15 142.43 46.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.023 0.749 . . . . 73.43 113.023 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' A' ' 264' ' ' ILE . 30.5 tt0 -112.05 108.73 18.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.971 -0.559 . . . . 73.3 109.655 172.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.1 t -107.04 133.86 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 112.676 0.621 . . . . 72.04 112.676 -170.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 42.8 t -111.94 112.1 23.5 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.356 -0.384 . . . . 73.4 110.375 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.49 -176.88 26.42 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.174 -1.012 . . . . 63.32 114.369 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 182' ' ' ASN . 86.2 t80 -112.92 105.98 14.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.134 0.574 . . . . 73.43 111.084 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 256' ' ' ILE . 24.9 t -74.04 142.35 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.477 -0.329 . . . . 73.14 110.718 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -156.5 178.25 10.54 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.46 0.648 . . . . 75.44 112.677 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -107.36 145.27 33.08 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.343 -0.844 . . . . 71.03 110.242 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 156.51 -129.53 2.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.186 -1.007 . . . . 73.3 114.902 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -71.5 74.29 0.76 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.161 0.584 . . . . 72.22 111.222 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.5 t 155.75 -17.65 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.843 0.857 . . . . 75.14 110.315 -172.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 98.5 -84.29 0.67 Allowed Glycine 0 CA--C 1.519 0.313 0 N-CA-C 110.482 -1.047 . . . . 62.02 110.482 -170.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 98.0 mt -129.99 104.54 7.41 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.791 0.437 . . . . 73.34 109.846 170.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.92 172.57 7.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.066 0.46 . . . . 71.21 111.83 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.565 HG23 ' HA2' ' A' ' 224' ' ' GLY . 7.8 tt -127.55 112.84 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.339 0.59 . . . . 64.44 111.469 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . 0.415 ' HA ' ' HB ' ' A' ' 225' ' ' THR . 37.2 t -82.75 110.94 18.23 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.282 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.526 ' HB ' HD23 ' A' ' 226' ' ' LEU . 46.6 t -74.76 137.49 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.219 0.533 . . . . 73.3 111.936 -175.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -106.35 -43.86 4.67 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.993 -0.549 . . . . 61.34 110.583 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -139.41 145.2 38.61 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.093 -0.503 . . . . 75.24 110.479 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.1 tt -140.24 135.97 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.283 0.563 . . . . 71.11 111.983 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -140.68 121.82 2.01 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 116.081 -0.509 . . . . 64.54 112.385 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.415 ' HB ' ' HG3' ' A' ' 266' ' ' LYS . 14.0 mm -78.48 138.02 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 122.47 -0.429 . . . . 62.2 110.764 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.438 HD11 ' HB2' ' A' ' 242' ' ' GLU . 60.0 mt -84.58 -41.9 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 112.515 0.561 . . . . 64.51 112.515 -174.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -126.45 68.55 1.23 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.073 0.768 . . . . 71.33 113.073 -171.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.505 ' NZ ' ' HB3' ' A' ' 266' ' ' LYS . 8.8 mtpm? -89.81 142.82 27.34 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.66 0.743 . . . . 74.12 112.909 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 43.4 t -128.52 144.75 51.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.102 -0.953 . . . . 62.55 109.831 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 92.8 mt -56.89 -26.49 59.04 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.176 0.512 . . . . 71.24 111.163 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.25 1.126 0 CA-C-N 115.722 -0.672 . . . . 75.04 111.347 178.935 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 20.8 ptp . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 120.651 0.262 . . . . 73.13 111.209 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 186' ' ' THR . 8.1 t30 -97.49 143.42 28.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.453 0.644 . . . . 74.12 112.725 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.444 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 57.6 m-85 -130.69 167.67 18.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.405 -0.816 . . . . 72.14 110.308 173.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.466 ' HB3' ' OG1' ' A' ' 219' ' ' THR . 22.7 mmtp -97.66 164.64 12.33 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.972 -0.381 . . . . 75.21 109.972 167.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 220' ' ' GLY . 56.8 mt -64.08 -30.34 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 111.946 0.35 . . . . 73.54 111.946 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.474 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 83.7 p -64.7 -24.86 67.71 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.046 0.451 . . . . 72.43 111.157 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 174' ' ' TYR . 26.3 mm-40 -86.79 -12.25 48.59 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.052 -0.522 . . . . 71.44 111.596 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.524 HD11 HD13 ' A' ' 187' ' ' ILE . 71.1 mt -70.16 141.75 52.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.384 0.611 . . . . 72.13 111.714 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.439 ' HG2' HD22 ' A' ' 183' ' ' LEU . 21.5 ptp -154.12 156.36 31.83 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.553 -0.748 . . . . 74.13 110.641 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.97 142.22 76.66 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.141 1.894 . . . . 53.33 112.484 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 66.16 26.21 10.61 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.903 0.382 . . . . 74.41 111.697 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.439 HD22 ' HG2' ' A' ' 180' ' ' MET . 46.5 tp -98.09 135.09 40.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.802 0.334 . . . . 64.2 111.55 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 72.0 p -114.08 118.92 35.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.522 -0.308 . . . . 64.31 110.869 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.76 -160.85 27.63 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 120.888 -0.672 . . . . 61.41 113.685 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 58.0 m -129.69 148.85 51.62 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.83 0.452 . . . . 73.53 111.0 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.524 HD13 HD11 ' A' ' 179' ' ' LEU . 32.3 pt -131.95 144.61 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.244 0.545 . . . . 71.4 111.291 173.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -113.27 107.19 15.55 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.056 -0.52 . . . . 72.54 110.483 175.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.8 176.8 9.6 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.006 0.432 . . . . 41.42 111.819 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -94.0 145.17 24.85 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.149 0.499 . . . . 74.4 111.807 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.8 t -86.01 108.96 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.214 -0.448 . . . . 43.53 111.665 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.84 -35.67 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.161 -0.472 . . . . 71.44 111.449 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.09 124.26 5.74 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.313 -0.403 . . . . 63.32 111.607 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -108.17 100.93 10.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.221 -0.445 . . . . 62.03 110.749 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.503 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 99.0 m-85 -72.41 139.61 81.54 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 111.957 0.354 . . . . 60.23 111.957 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -53.8 148.99 34.9 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.666 2.244 . . . . 70.01 112.851 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.436 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 21.3 pttm -71.72 125.84 28.17 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.474 0.654 . . . . 74.01 112.375 -175.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.02 166.47 11.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.78 -0.646 . . . . 73.0 110.731 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.44 112.17 18.63 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.681 0.277 . . . . 73.14 110.806 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -106.92 151.28 25.47 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.317 0.579 . . . . 71.14 111.982 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.8 p -99.36 126.89 45.32 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.955 -0.566 . . . . 53.53 111.169 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -85.89 140.45 30.37 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.512 -0.313 . . . . 75.43 111.175 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -57.69 -26.28 61.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.769 0.795 . . . . 74.24 110.148 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.77 -36.28 69.64 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.896 -1.047 . . . . 72.41 111.933 173.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 125.49 -30.45 4.48 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.356 -0.384 . . . . 64.12 112.986 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.0 p -77.95 163.22 26.17 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.734 0.642 . . . . 70.01 112.734 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -92.83 -173.69 3.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.978 -0.555 . . . . 74.13 110.735 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.36 149.24 10.93 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.813 -0.708 . . . . 71.01 113.308 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -96.67 136.22 37.5 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.825 0.345 . . . . 74.44 111.105 177.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 18.9 tp -127.65 111.13 13.37 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.225 0.454 . . . . 64.12 112.225 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 195' ' ' TYR . 81.5 tttt -122.21 109.6 14.68 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.191 -0.318 . . . . 65.23 111.282 175.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.9 t -86.07 145.94 26.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.927 0.394 . . . . 75.24 111.387 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.79 124.47 33.47 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.511 -0.313 . . . . 73.34 111.253 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -94.58 115.39 27.52 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 110.132 -0.321 . . . . 75.34 110.132 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.63 HD11 HG21 ' A' ' 243' ' ' VAL . 52.8 mt -112.54 150.75 30.87 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.556 0.217 . . . . 65.44 111.51 -176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -140.47 152.65 45.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.652 0.739 . . . . 72.1 111.934 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -148.19 166.09 28.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.802 -1.09 . . . . 71.24 108.739 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -56.69 -25.82 55.12 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.756 0.312 . . . . 64.43 111.772 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 71.6 p -89.88 1.95 55.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.826 0.676 . . . . 60.45 112.826 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 137.41 -179.25 18.32 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.803 -0.713 . . . . 73.13 113.312 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 57.2 p -127.81 152.23 48.05 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 122.418 -0.46 . . . . 61.23 111.52 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.0 tp -151.77 160.06 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.72 -0.218 . . . . 75.11 111.291 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -107.36 128.08 54.14 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.193 0.52 . . . . 72.31 112.118 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -103.15 167.21 16.77 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.08 -0.509 . . . . 65.22 111.948 172.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 99.8 m -142.79 122.33 13.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.747 0.773 . . . . 65.01 112.379 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.408 HD23 ' HB ' ' A' ' 258' ' ' VAL . 91.4 mt -93.69 120.15 33.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.744 -0.662 . . . . 74.33 110.972 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -100.0 142.95 30.8 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.686 0.279 . . . . 71.12 111.713 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 60.8 t30 66.83 -138.03 0.14 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.099 0.559 . . . . 73.14 111.968 174.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -25.79 64.4 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.305 0.483 . . . . 74.51 112.305 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 91.0 mt -56.59 -21.81 29.36 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.799 0.333 . . . . 65.44 111.786 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -64.64 -20.15 66.11 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 111.978 0.362 . . . . 64.22 111.978 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -99.47 8.4 44.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.693 0.282 . . . . 75.14 111.703 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -65.58 143.7 57.45 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.093 0.473 . . . . 74.04 112.006 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -63.29 96.57 0.11 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.823 -0.626 . . . . 73.01 111.301 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 p -147.08 113.69 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.032 0.444 . . . . 74.31 111.008 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -105.58 160.45 15.17 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.438 0.637 . . . . 75.34 111.758 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.02 99.96 0.93 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.733 -0.667 . . . . 75.22 111.069 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 130.4 -10.61 5.84 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.187 -0.53 . . . . 61.12 114.036 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.78 157.07 20.34 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.782 0.66 . . . . 74.32 112.782 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.444 HG22 HD12 ' A' ' 264' ' ' ILE . 40.9 mm -92.97 110.18 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.708 -0.678 . . . . 63.41 110.495 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -110.1 139.11 45.58 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.794 0.664 . . . . 53.24 112.794 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 31.9 tt0 -84.41 104.63 14.59 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.68 -0.691 . . . . 73.02 110.165 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.63 HG21 HD11 ' A' ' 215' ' ' LEU . 87.1 t -103.99 106.46 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.928 0.394 . . . . 63.23 111.505 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 39.1 p -116.53 130.49 56.78 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.461 -0.336 . . . . 54.15 111.439 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.97 -141.04 4.7 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.656 -0.783 . . . . 71.42 113.771 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -129.11 124.89 35.91 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.696 -0.296 . . . . 70.3 111.198 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.436 HG22 ' HB ' ' A' ' 256' ' ' ILE . 35.0 t -90.84 133.96 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.812 0.339 . . . . 75.11 111.821 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -126.39 -179.61 4.84 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.964 0.412 . . . . 74.14 111.204 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -119.37 125.56 49.29 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.421 -0.354 . . . . 74.32 111.516 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -88.59 -131.09 3.79 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.201 -0.999 . . . . 72.41 111.545 168.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -109.67 110.12 21.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.215 0.507 . . . . 71.45 110.385 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 44.2 t 65.33 5.4 3.11 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.32 0.489 . . . . 75.53 112.32 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -146.41 161.9 28.39 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.55 -0.357 . . . . 74.43 112.797 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.33 152.4 37.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.913 0.387 . . . . 72.31 111.726 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.31 156.31 43.26 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.161 -0.472 . . . . 61.5 111.078 173.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.436 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.5 tt -122.99 119.38 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.292 0.567 . . . . 74.33 112.227 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.3 m -72.23 113.8 9.66 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.195 -0.457 . . . . 54.4 110.075 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.527 HG11 ' HB ' ' A' ' 261' ' ' ILE . 23.1 t -82.22 117.43 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.985 0.421 . . . . 75.42 111.731 -175.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -89.81 -26.93 20.3 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.174 0.512 . . . . 72.33 110.551 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -149.63 137.29 20.15 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.1 -0.5 . . . . 65.53 110.936 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.527 ' HB ' HG11 ' A' ' 258' ' ' VAL . 12.2 tt -143.58 135.82 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.026 0.441 . . . . 64.22 111.628 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -146.98 139.68 8.1 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.241 -0.504 . . . . 53.34 112.939 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 49.3 mm -75.41 115.76 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.278 -0.542 . . . . 74.13 110.821 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.444 HD12 HG22 ' A' ' 240' ' ' ILE . 61.8 mt -59.94 -50.08 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 120.953 0.406 . . . . 72.3 111.806 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -130.98 98.78 4.69 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.474 -0.33 . . . . 63.11 110.972 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -55.3 117.99 4.01 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.475 0.546 . . . . 74.41 112.475 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 50.2 m -85.61 113.16 21.62 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.946 0.403 . . . . 52.01 110.0 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.523 ' H ' HD12 ' A' ' 268' ' ' LEU . 4.9 mp -71.1 -26.28 62.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.234 0.54 . . . . 73.23 110.93 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 269' ' ' GLU . 1.4 pm0 . . . . . 0 C--O 1.25 1.129 0 CA-C-N 115.362 -0.836 . . . . 70.41 110.949 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.59 0.233 . . . . 74.15 111.28 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -72.87 109.2 6.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.086 0.469 . . . . 71.23 110.449 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.434 ' CE2' ' HA3' ' A' ' 185' ' ' GLY . 96.5 m-85 -83.3 141.0 32.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.38 0.61 . . . . 72.1 112.411 -172.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.418 ' HD2' ' OG1' ' A' ' 219' ' ' THR . 18.2 tppt? -81.54 137.76 35.52 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.473 -0.785 . . . . 72.4 109.956 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 222' ' ' ILE . 36.7 mt -52.79 -36.7 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 112.705 0.632 . . . . 74.03 112.705 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.418 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 35.4 t -64.51 -27.12 68.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.849 0.357 . . . . 71.31 111.549 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -95.05 6.1 50.04 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.32 0.489 . . . . 45.33 112.32 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.407 HD22 HG21 ' A' ' 247' ' ' VAL . 81.9 mt -68.64 131.05 44.56 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.133 0.492 . . . . 72.13 111.527 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.7 mtt -121.07 155.28 58.12 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.135 -0.484 . . . . 73.54 111.506 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HG3' HD21 ' A' ' 254' ' ' LEU . 31.2 Cg_exo -61.03 133.29 46.41 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.31 2.007 . . . . 73.44 112.186 173.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 66.35 37.62 4.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.872 0.469 . . . . 72.43 111.568 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.8 119.47 39.22 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.452 -0.34 . . . . 63.14 111.4 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.406 ' HB3' ' HD1' ' A' ' 246' ' ' TYR . 86.9 p -99.18 126.29 44.94 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.949 0.404 . . . . 52.51 111.181 176.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 174' ' ' TYR . . . -171.58 -160.55 20.37 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.613 -0.803 . . . . 73.43 113.88 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 28.7 m -135.89 136.93 40.92 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.749 -0.266 . . . . 74.42 111.299 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.39 147.15 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.842 0.353 . . . . 64.02 111.735 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -108.16 112.31 24.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.579 -0.282 . . . . 55.31 110.647 176.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -147.95 174.59 11.73 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.316 0.488 . . . . 74.41 112.316 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -103.72 144.89 30.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.31 -0.404 . . . . 63.33 111.108 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.46 ' HA ' HD23 ' A' ' 215' ' ' LEU . 43.0 t -77.32 105.26 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.12 0.486 . . . . 75.41 111.556 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.31 -36.31 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.887 -0.597 . . . . 62.0 111.391 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.51 158.74 37.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.845 -0.616 . . . . 73.3 111.369 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.72 122.55 14.42 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.35 -0.386 . . . . 51.1 111.342 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.42 148.41 35.15 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 120.629 0.252 . . . . 72.33 111.463 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.81 168.08 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.809 2.34 . . . . 60.42 113.045 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -74.36 147.72 41.91 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.376 0.607 . . . . 73.32 112.26 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -111.4 157.25 20.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.863 -0.608 . . . . 64.34 110.145 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -110.03 157.58 19.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.2 0.524 . . . . 73.12 110.969 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.5 ' O ' ' HD3' ' A' ' 202' ' ' ARG . 33.0 p90 -156.7 172.47 18.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.734 -0.667 . . . . 72.41 110.071 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 48.0 t -83.01 108.25 16.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.719 0.295 . . . . 70.1 110.965 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -82.71 117.04 22.35 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.326 0.584 . . . . 74.44 111.887 -176.017 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -52.01 -30.97 27.63 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.481 -0.782 . . . . 73.51 112.636 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -86.73 -2.86 58.88 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.55 0.574 . . . . 63.15 112.55 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 72.35 16.78 77.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.091 -0.575 . . . . 63.51 113.56 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 80.3 p -98.45 166.3 11.43 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.707 -0.29 . . . . 64.15 110.725 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -87.89 81.76 7.45 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.389 0.614 . . . . 64.12 111.094 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.85 147.99 19.02 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.533 -0.758 . . . . 62.03 113.026 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.488 ' NE2' ' HB3' ' A' ' 231' ' ' ALA . 9.0 pt20 -139.38 144.88 38.36 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.116 0.484 . . . . 64.41 111.717 -176.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 22.0 tp -111.8 105.96 14.59 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.741 -0.663 . . . . 72.52 112.388 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.478 ' HE3' HD21 ' A' ' 213' ' ' LEU . 4.0 tmtm? -113.02 126.35 55.39 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.141 -0.349 . . . . 74.31 110.258 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 25.1 p -110.24 142.74 41.41 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.433 0.635 . . . . 73.53 112.665 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.478 HD21 ' HE3' ' A' ' 211' ' ' LYS . 85.0 mt -125.18 159.92 30.4 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.604 -0.725 . . . . 55.22 110.886 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -125.41 119.71 29.06 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.733 0.301 . . . . 73.41 110.944 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.568 HD11 HG21 ' A' ' 243' ' ' VAL . 75.7 mt -114.68 162.26 17.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.726 0.41 . . . . 74.24 111.025 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 216' ' ' LYS . 18.5 ptmt -151.76 168.64 24.42 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.677 0.751 . . . . 74.35 112.643 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -146.33 174.84 11.0 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.66 -1.155 . . . . 72.11 109.113 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.14 -14.37 60.38 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.832 -0.543 . . . . 73.55 112.231 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 68.8 p -102.25 -18.86 15.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.289 0.848 . . . . 62.22 113.289 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 167.7 -179.82 40.86 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.386 -0.912 . . . . 60.12 113.684 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 44.8 m -127.64 144.41 51.08 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.807 0.337 . . . . 73.31 111.789 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 176' ' ' ILE . 9.7 tp -150.65 150.17 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 116.508 -0.314 . . . . 70.52 110.849 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.503 ' HD3' ' H ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -107.75 142.66 37.42 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.944 -0.472 . . . . 75.13 111.699 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.519 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -110.57 155.67 15.98 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 116.063 -0.517 . . . . 72.44 113.271 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.4 m -116.39 114.01 23.68 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.408 0.522 . . . . 74.43 112.408 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.475 HD23 ' HB ' ' A' ' 258' ' ' VAL . 85.5 mt -96.71 133.95 40.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.815 0.446 . . . . 72.04 111.403 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -115.4 156.97 24.6 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.745 0.307 . . . . 73.44 111.52 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 58.87 -141.16 0.7 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 112.102 0.408 . . . . 62.22 112.102 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -48.26 -32.27 7.03 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.919 0.711 . . . . 72.51 112.919 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.431 ' HB3' HD22 ' A' ' 226' ' ' LEU . 85.8 mt -59.71 -19.45 49.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.745 0.307 . . . . 74.22 111.538 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.488 ' HB3' ' NE2' ' A' ' 209' ' ' GLN . . . -67.22 -32.3 73.26 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.181 0.438 . . . . 75.02 112.181 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -94.89 -6.62 42.21 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.023 0.379 . . . . 74.53 112.023 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -54.98 125.61 21.08 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.457 -0.338 . . . . 75.34 110.365 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.447 ' O ' ' HE3' ' A' ' 266' ' ' LYS . 37.2 tt0 -68.94 111.38 4.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.351 0.595 . . . . 53.32 111.652 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.47 HG11 HD11 ' A' ' 213' ' ' LEU . 7.3 p -144.42 135.27 20.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.559 -0.746 . . . . 74.44 109.678 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -139.51 165.92 25.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.525 0.679 . . . . 62.31 112.133 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -64.36 101.02 0.39 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.917 -0.583 . . . . 72.41 111.075 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 147.87 -31.37 1.34 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.615 -0.802 . . . . 63.14 114.583 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.09 154.41 25.6 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.769 0.785 . . . . 73.14 112.699 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 38.9 mm -94.57 106.05 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.485 -0.78 . . . . 73.41 110.833 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -100.04 131.12 46.19 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.985 0.735 . . . . 51.52 112.985 -174.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -97.04 97.63 9.39 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.364 -0.606 . . . . 72.14 109.364 171.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.568 HG21 HD11 ' A' ' 215' ' ' LEU . 99.3 t -99.01 124.16 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.973 0.731 . . . . 75.13 112.973 -169.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 37.0 t -98.59 116.55 31.08 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.826 -0.625 . . . . 73.33 110.348 172.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.03 174.58 33.93 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.317 -0.944 . . . . 71.1 114.484 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.406 ' HD1' ' HB3' ' A' ' 184' ' ' SER . 59.2 t80 -108.71 109.29 20.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.292 0.637 . . . . 72.51 110.788 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.462 HG22 ' HB ' ' A' ' 256' ' ' ILE . 40.5 t -78.29 116.04 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.58 0.229 . . . . 64.21 111.109 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -128.46 161.19 30.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.671 0.272 . . . . 71.43 111.326 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -110.52 143.91 40.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.798 0.332 . . . . 73.31 111.521 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -167.32 -131.5 1.28 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 120.91 -0.662 . . . . 53.12 113.592 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -52.65 -64.66 0.74 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.607 0.595 . . . . 75.1 112.607 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 68.7 m -89.68 21.07 3.66 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.519 0.563 . . . . 61.53 112.519 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 93.77 -136.7 13.2 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.065 -0.588 . . . . 73.15 113.703 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.432 HD21 ' HG3' ' A' ' 181' ' ' PRO . 94.8 mt -86.4 117.56 25.28 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.845 0.355 . . . . 63.43 111.516 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -134.74 132.58 38.95 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.974 0.416 . . . . 74.42 110.505 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.519 HG23 ' HA2' ' A' ' 224' ' ' GLY . 7.4 tt -101.13 111.55 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.399 0.619 . . . . 73.25 112.195 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 50.9 m -78.89 111.57 15.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.998 -0.546 . . . . 54.4 110.462 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.475 ' HB ' HD23 ' A' ' 226' ' ' LEU . 43.1 t -75.74 127.97 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 112.425 0.528 . . . . 75.12 112.425 -173.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -97.99 -22.49 16.25 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.917 0.389 . . . . 64.21 111.291 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 47.9 t-20 -156.94 132.68 9.43 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 73.04 110.377 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.3 tt -126.64 122.23 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.075 0.464 . . . . 74.31 111.533 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -133.11 117.9 2.03 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.376 -0.44 . . . . 65.54 112.245 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.57 HD12 ' HD2' ' A' ' 266' ' ' LYS . 63.6 mt -85.4 127.21 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 122.53 -0.394 . . . . 54.33 111.258 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.1 -46.03 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.084 0.469 . . . . 75.55 111.282 -177.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -153.02 139.22 18.36 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.86 -0.609 . . . . 72.13 110.612 176.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.57 ' HD2' HD12 ' A' ' 263' ' ' ILE . 13.9 ptmm? -151.59 125.7 9.25 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.014 0.435 . . . . 75.24 110.927 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 42.9 t -79.94 177.47 8.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.459 0.647 . . . . 53.22 112.125 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.35 21.17 13.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.825 -0.625 . . . . 60.34 111.579 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 . . . . . 0 C--O 1.255 1.376 0 CA-C-N 116.124 -0.489 . . . . 70.45 111.841 -179.78 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 74.6 mtm . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.793 0.33 . . . . 74.34 111.16 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -82.52 104.14 12.57 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.496 -0.32 . . . . 73.35 110.205 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -84.6 137.02 33.53 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.616 0.598 . . . . 74.32 112.616 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -100.86 158.68 15.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.812 -0.631 . . . . 71.31 110.22 171.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.561 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 89.1 mt -60.93 -32.25 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 113.018 0.747 . . . . 51.11 113.018 -173.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.53 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 34.1 t -58.2 -31.82 67.69 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 122.103 -0.373 . . . . 63.34 111.954 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.16 -12.52 54.79 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.503 0.557 . . . . 72.14 112.503 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.561 ' HG ' ' HA ' ' A' ' 176' ' ' ILE . 65.7 mt -64.66 116.05 5.85 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.526 0.679 . . . . 71.03 111.934 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.6 ptp -125.74 160.97 53.65 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 115.648 -0.705 . . . . 74.03 110.55 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.524 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 43.4 Cg_exo -54.99 133.42 57.99 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.331 2.021 . . . . 65.23 112.876 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 16.4 m120 68.75 20.29 8.17 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.389 0.515 . . . . 72.02 112.389 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.11 139.48 31.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.951 0.405 . . . . 65.54 111.498 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.8 p -110.25 127.42 54.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.495 -0.32 . . . . 72.33 110.342 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.15 -169.78 38.76 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.422 -0.894 . . . . 54.33 113.987 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 79.1 m -132.63 120.86 22.33 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.706 -0.291 . . . . 72.31 111.179 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 41.1 pt -108.09 140.61 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.981 0.42 . . . . 74.01 111.585 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -115.99 112.11 21.33 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.454 -0.339 . . . . 73.31 110.219 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -142.52 169.34 17.76 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.105 0.479 . . . . 63.43 112.099 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.82 139.27 30.75 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.05 -0.523 . . . . 73.31 110.952 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.405 HG21 ' CG2' ' A' ' 235' ' ' VAL . 35.8 t -82.89 116.84 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.127 0.489 . . . . 74.41 111.534 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 35.7 t -90.41 -64.77 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.189 0.518 . . . . 75.52 111.553 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.452 ' H ' ' HB3' ' A' ' 214' ' ' PHE . . . -126.84 132.59 50.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.32 -0.4 . . . . 74.53 111.518 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -103.57 128.03 50.89 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.334 -0.394 . . . . 71.3 111.011 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -92.2 119.62 68.09 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.744 -0.207 . . . . 63.13 110.953 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.49 153.81 7.09 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.782 2.321 . . . . 71.1 113.094 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -64.36 130.49 44.0 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.084 0.772 . . . . 74.14 113.084 -173.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 3.0 mptp? -101.57 157.09 17.07 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.912 -0.586 . . . . 72.43 109.499 170.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -130.58 139.12 50.43 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.315 0.579 . . . . 73.41 111.91 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.413 ' O ' ' HA3' ' A' ' 208' ' ' GLY . 26.2 p90 -151.87 174.52 13.49 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.933 -0.576 . . . . 74.14 110.893 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 49.2 m -97.47 136.07 38.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.748 0.308 . . . . 74.24 110.744 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -100.09 -167.73 1.49 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.271 0.558 . . . . 71.13 112.061 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -59.99 -42.88 95.18 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.74 -0.663 . . . . 60.11 110.573 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -79.1 -39.6 33.29 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.169 0.509 . . . . 64.34 110.933 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 121.59 -35.33 3.62 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.859 -0.61 . . . . 71.52 113.052 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.7 p -102.8 177.18 4.92 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 111.865 0.321 . . . . 73.34 111.865 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? 60.38 18.42 8.08 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.409 0.522 . . . . 75.14 112.409 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 200' ' ' PHE . . . -76.54 70.32 2.22 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.352 -0.452 . . . . 73.01 113.608 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -108.4 141.03 40.86 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.788 0.328 . . . . 73.45 110.893 178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.408 HD13 ' CZ3' ' A' ' 227' ' ' TRP . 51.5 tp -135.37 142.84 45.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.448 0.299 . . . . 65.44 111.02 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.518 ' HE2' HD21 ' A' ' 213' ' ' LEU . 0.7 OUTLIER -162.05 119.45 2.15 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.867 0.365 . . . . 64.14 110.868 -179.41 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.0 t -104.26 161.65 13.87 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.162 0.506 . . . . 72.12 112.218 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.518 HD21 ' HE2' ' A' ' 211' ' ' LYS . 95.5 mt -138.16 138.98 39.15 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.023 -0.535 . . . . 63.43 111.764 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.452 ' HB3' ' H ' ' A' ' 193' ' ' ALA . 21.8 t80 -97.2 106.23 18.52 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.906 0.384 . . . . 74.14 110.39 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 243' ' ' VAL . 80.0 mt -109.95 156.88 19.88 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.325 -0.398 . . . . 75.24 111.529 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -160.99 148.52 15.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.956 0.407 . . . . 70.11 112.062 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -132.21 -162.92 1.28 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.365 -0.606 . . . . 75.53 109.365 169.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -77.79 -1.7 32.71 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.778 0.659 . . . . 74.35 112.778 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 30.0 p -114.2 3.21 15.09 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.018 0.748 . . . . 55.32 113.018 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.406 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 149.22 -178.35 26.82 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.37 -0.919 . . . . 44.03 113.953 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 96.9 p -124.86 145.36 49.83 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.615 0.366 . . . . 65.15 111.021 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.9 tp -139.42 154.54 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-O 120.912 0.387 . . . . 72.32 111.263 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -108.02 112.45 25.02 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.891 0.377 . . . . 75.31 111.107 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.495 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -85.14 151.24 25.62 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.363 -0.38 . . . . 72.31 113.013 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 87.2 m -124.01 112.42 17.15 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.459 -0.436 . . . . 71.5 111.941 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.452 HD12 ' HD2' ' A' ' 211' ' ' LYS . 89.8 mt -94.97 121.95 37.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.342 -0.39 . . . . 73.14 110.717 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.408 ' CZ3' HD13 ' A' ' 210' ' ' LEU . 97.5 m95 -101.52 157.0 17.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.027 0.441 . . . . 74.45 111.875 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 54.95 -134.29 1.56 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.795 -0.639 . . . . 75.53 112.437 170.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 229' ' ' GLU . 4.1 mp0 -48.13 -34.18 9.44 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.704 0.802 . . . . 73.23 112.625 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 70.5 mt -69.52 -6.62 31.93 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.398 0.518 . . . . 54.25 112.398 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' A' ' 211' ' ' LYS . . . -63.86 -45.92 87.31 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.841 0.353 . . . . 63.11 111.776 177.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.47 6.34 23.88 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.324 0.49 . . . . 71.53 112.324 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -61.27 123.33 17.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.824 -0.171 . . . . 71.24 110.664 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -73.7 96.01 2.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.719 0.771 . . . . 73.33 112.564 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.405 ' CG2' HG21 ' A' ' 191' ' ' VAL . 7.7 p -121.7 134.97 63.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.258 -0.883 . . . . 64.44 108.934 168.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -119.71 172.37 7.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.164 0.983 . . . . 73.2 113.246 -168.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -72.56 99.67 2.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.257 -0.883 . . . . 52.32 111.58 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.09 20.98 6.09 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.119 0.808 . . . . 62.14 115.119 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -103.23 167.46 9.81 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.38 1.09 . . . . 55.15 111.169 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 47.8 mm -101.42 104.74 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.128 -0.487 . . . . 72.01 110.845 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -104.72 125.55 50.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.077 0.465 . . . . 44.2 112.204 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -84.71 102.43 12.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.084 0.468 . . . . 71.03 109.838 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.457 HG21 HD11 ' A' ' 215' ' ' LEU . 98.6 t -99.8 105.9 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.325 0.583 . . . . 73.31 111.935 -175.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 36.7 t -97.11 125.92 41.92 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.035 -0.529 . . . . 73.01 110.383 174.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.83 -169.08 34.22 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.022 -1.085 . . . . 73.34 114.4 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -109.39 121.09 44.43 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.784 0.433 . . . . 63.34 110.854 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.524 HG21 HD22 ' A' ' 179' ' ' LEU . 38.6 t -83.79 139.19 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.275 -0.42 . . . . 73.44 111.847 -177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.656 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 8.4 mtpm? -134.25 168.39 18.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.183 0.516 . . . . 64.3 111.443 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 25.8 tt0 -120.78 142.29 49.71 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.09 -0.504 . . . . 64.21 110.305 172.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 151.38 -77.76 0.22 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.725 -0.75 . . . . 43.13 112.957 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -86.35 133.3 33.81 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.526 -0.397 . . . . 42.15 110.451 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 31.7 t 62.31 26.15 15.64 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.285 0.564 . . . . 74.33 111.0 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 72.62 -77.51 0.77 Allowed Glycine 0 CA--C 1.522 0.504 0 C-N-CA 121.214 -0.517 . . . . 72.42 111.812 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.0 mt -111.89 130.54 55.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.131 0.491 . . . . 71.15 110.795 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.656 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 8.6 pt-20 -128.56 169.26 14.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.882 -0.599 . . . . 73.0 110.787 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.495 HG23 ' HA2' ' A' ' 224' ' ' GLY . 11.2 tt -148.79 117.22 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.461 0.648 . . . . 53.24 111.98 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 77.8 p -85.12 119.69 25.79 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.079 -0.51 . . . . 71.31 110.318 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.448 ' HB ' HD23 ' A' ' 226' ' ' LEU . 41.8 t -77.02 132.42 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.685 0.624 . . . . 73.13 112.685 -173.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -95.73 -54.74 3.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.829 -0.623 . . . . 72.42 110.276 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -139.78 126.81 20.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.056 -0.52 . . . . 73.03 110.785 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.7 tt -116.38 127.43 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.043 0.449 . . . . 72.13 111.284 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -125.28 118.78 3.36 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.142 -0.551 . . . . 73.53 112.955 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.554 HG21 ' HB3' ' A' ' 266' ' ' LYS . 41.3 mm -76.45 111.37 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.931 0.396 . . . . 64.41 110.889 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.402 HG22 ' HG3' ' A' ' 265' ' ' GLU . 61.8 mt -69.2 -42.99 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.844 0.354 . . . . 75.12 111.587 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 264' ' ' ILE . 44.5 mt-10 -140.83 109.56 6.01 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.558 -0.292 . . . . 63.43 111.309 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.583 ' HE2' HD21 ' A' ' 268' ' ' LEU . 25.1 pttm -113.3 179.26 4.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.896 0.379 . . . . 72.24 111.018 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 67.4 p -132.09 109.25 9.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.292 0.479 . . . . 65.55 112.292 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.583 HD21 ' HE2' ' A' ' 266' ' ' LYS . 0.4 OUTLIER -138.12 106.4 5.78 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.559 0.695 . . . . 64.2 111.249 175.227 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 118.469 -0.777 . . . . 62.35 111.71 -175.406 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.467 0.175 . . . . 74.2 111.111 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 186' ' ' THR . 5.8 m-20 -95.58 105.85 17.88 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.103 0.478 . . . . 63.31 111.045 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -85.67 168.06 14.74 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.477 0.656 . . . . 63.43 112.091 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.477 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -96.72 156.8 16.19 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.511 -0.768 . . . . 64.41 109.868 169.218 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 51.0 mt -61.43 -32.67 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.105 0.409 . . . . 71.51 112.105 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.1 t -63.82 -22.73 67.05 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.882 0.373 . . . . 71.52 111.468 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -87.91 -12.02 45.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.38 -0.373 . . . . 65.33 111.85 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 187' ' ' ILE . 84.1 mt -71.54 103.07 2.87 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.389 0.614 . . . . 73.11 111.413 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.447 ' HG2' HD13 ' A' ' 183' ' ' LEU . 23.1 ptp -112.56 157.24 40.82 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.844 -0.616 . . . . 61.44 110.956 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.437 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 52.0 Cg_exo -53.05 135.27 58.64 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.487 2.125 . . . . 74.24 113.271 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 69.8 26.89 4.71 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.208 0.603 . . . . 70.4 112.28 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.447 HD13 ' HG2' ' A' ' 180' ' ' MET . 9.1 tt -115.85 144.72 43.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.767 0.318 . . . . 71.13 110.715 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.437 ' HB2' ' CD2' ' A' ' 246' ' ' TYR . 47.3 t -126.45 157.32 38.94 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.934 0.397 . . . . 74.11 111.79 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.2 -168.6 33.08 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.043 -0.599 . . . . 62.04 113.214 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 65.1 m -106.39 152.48 23.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.366 0.266 . . . . 71.33 110.534 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.472 HG21 HD21 ' A' ' 179' ' ' LEU . 37.4 pt -139.22 161.15 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.117 0.484 . . . . 61.33 111.584 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -118.38 110.94 18.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.087 -0.506 . . . . 62.45 110.137 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.67 157.89 44.51 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.346 0.593 . . . . 73.41 112.085 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -93.65 134.39 36.0 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.702 -0.681 . . . . 75.34 110.816 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.89 125.48 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.003 0.43 . . . . 51.2 111.978 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.28 -42.6 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.179 0.514 . . . . 72.22 111.146 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -146.11 130.55 17.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.992 -0.549 . . . . 71.21 111.205 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.91 104.55 8.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.019 0.438 . . . . 62.42 111.602 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.473 ' HB3' ' HD2' ' A' ' 196' ' ' PRO . 97.2 m-85 -86.0 163.33 43.64 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 116.542 -0.299 . . . . 73.02 111.721 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 195' ' ' TYR . 60.7 Cg_endo -70.28 -164.65 0.14 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.798 2.332 . . . . 72.42 113.155 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.662 ' HD3' ' HB2' ' A' ' 232' ' ' ASP . 22.1 pttp -100.05 111.49 23.78 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.608 0.718 . . . . 72.21 111.841 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -92.45 176.55 6.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 64.24 110.697 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.3 150.12 48.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.091 0.472 . . . . 74.52 111.334 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -151.33 178.71 8.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.113 0.483 . . . . 64.42 111.265 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 82.0 p -110.5 134.96 51.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.017 0.437 . . . . 51.24 110.829 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -84.58 170.62 13.21 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.133 -0.485 . . . . 73.03 111.045 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -55.05 -30.46 59.62 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.255 0.465 . . . . 63.44 112.255 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.68 -3.52 56.47 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.48 0.548 . . . . 73.1 112.48 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 86.57 5.89 81.24 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.331 -0.461 . . . . 64.12 113.153 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.9 p -86.73 163.19 17.45 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.787 0.327 . . . . 73.14 111.841 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -76.97 159.98 29.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.613 0.721 . . . . 61.04 112.67 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -166.61 147.56 12.2 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.448 -0.796 . . . . 55.3 112.377 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -104.32 147.81 27.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.353 0.577 . . . . 61.24 111.982 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.5 tp -129.63 123.5 31.41 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.611 -0.722 . . . . 74.1 111.634 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.541 ' HD3' HD12 ' A' ' 226' ' ' LEU . 44.6 tttp -122.52 108.6 13.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.786 0.327 . . . . 61.13 111.309 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.6 m -74.32 125.85 29.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.476 -0.329 . . . . 71.0 111.178 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.405 HD21 ' HE3' ' A' ' 211' ' ' LYS . 97.8 mt -132.51 150.56 52.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.092 0.472 . . . . 75.41 111.67 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -135.01 124.25 24.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.469 -0.332 . . . . 73.43 110.32 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 86.7 mt -118.05 150.0 40.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.713 0.292 . . . . 74.32 111.688 -174.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.467 ' HB2' ' NZ ' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -132.8 129.09 38.1 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.778 0.799 . . . . 73.32 112.095 175.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -115.11 165.68 12.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.113 -0.949 . . . . 71.34 109.042 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.72 -25.87 66.74 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 111.874 0.324 . . . . 62.44 111.874 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 69.6 p -91.86 0.34 57.48 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.697 0.628 . . . . 51.4 112.697 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 146.25 177.09 20.64 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.936 -0.65 . . . . 23.43 113.469 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 54.0 p -118.31 160.08 22.27 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 122.405 -0.467 . . . . 71.31 111.596 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.1 tp -146.47 152.67 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.011 0.434 . . . . 74.33 111.894 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -90.82 121.82 33.01 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.214 -0.448 . . . . 73.1 110.902 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -120.62 165.9 13.86 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.207 -0.52 . . . . 61.43 113.313 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 98.8 m -152.82 137.08 16.55 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.268 -0.548 . . . . 71.14 112.395 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.555 HD23 ' HB ' ' A' ' 258' ' ' VAL . 65.9 mt -106.1 141.31 37.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.84 -0.618 . . . . 64.3 110.47 172.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -114.84 160.88 18.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.1 0.476 . . . . 71.54 111.601 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 56.08 -134.13 1.41 Allowed 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.925 -0.579 . . . . 65.45 111.705 172.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.95 -34.65 68.23 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.468 0.544 . . . . 64.12 112.468 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.41 -15.39 62.55 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.119 0.414 . . . . 74.43 112.119 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -61.55 -27.68 68.79 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 120.965 0.412 . . . . 60.34 111.779 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.662 ' HB2' ' HD3' ' A' ' 197' ' ' LYS . 36.8 t70 -95.18 9.01 41.25 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 120.823 0.344 . . . . 73.14 111.481 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -56.9 128.52 37.21 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.905 0.383 . . . . 72.43 111.725 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.4 115.63 16.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.066 0.46 . . . . 55.51 110.609 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.27 150.02 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.918 -0.583 . . . . 74.53 110.946 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 267' ' ' SER . 9.5 mmmm -117.66 146.91 43.37 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.087 0.47 . . . . 75.03 112.242 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.27 95.82 0.32 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.109 -0.496 . . . . 73.33 110.406 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 129.56 -16.78 5.61 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.916 -0.659 . . . . 45.51 113.348 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.432 ' CG ' ' HB2' ' A' ' 236' ' ' LYS . 66.2 m-20 -68.37 132.14 46.54 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.051 0.453 . . . . 64.04 111.086 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 264' ' ' ILE . 46.5 mm -77.79 107.99 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.912 0.387 . . . . 74.42 110.385 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -104.01 139.39 39.2 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.04 0.755 . . . . 52.43 113.04 -173.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -95.17 99.71 11.64 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.178 -0.675 . . . . 75.2 109.178 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.27 123.87 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.506 0.558 . . . . 71.14 112.506 -170.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 186' ' ' THR . 45.5 t -112.09 123.19 49.72 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.861 0.363 . . . . 62.34 111.211 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -164.6 -167.25 24.86 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.562 -0.827 . . . . 33.43 113.997 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 184' ' ' SER . 39.3 t80 -121.89 129.34 52.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.736 0.303 . . . . 64.35 110.966 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 47.0 t -96.22 125.68 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.005 0.431 . . . . 72.42 112.129 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -122.18 166.21 14.94 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.015 0.436 . . . . 62.15 110.736 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.437 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 25.2 tt0 -120.65 141.88 49.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.712 0.292 . . . . 74.24 110.899 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -162.54 -148.33 5.31 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.492 -0.861 . . . . 73.31 113.382 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -70.17 -33.35 71.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 122.575 0.35 . . . . 72.52 111.709 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 32.1 t -90.05 19.81 4.7 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.995 0.426 . . . . 70.04 111.354 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 85.14 -139.31 17.49 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.401 -0.428 . . . . 34.23 112.832 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.1 mt -91.36 119.68 31.59 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.762 0.315 . . . . 62.45 110.861 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -113.96 126.13 54.8 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.82 0.343 . . . . 63.25 111.167 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.04 106.44 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.627 0.727 . . . . 44.41 111.47 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.2 t -83.62 114.38 21.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.905 -0.589 . . . . 73.0 110.456 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.555 ' HB ' HD23 ' A' ' 226' ' ' LEU . 39.0 t -91.06 121.28 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.186 0.439 . . . . 71.14 112.186 -173.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -101.99 -14.24 17.25 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.786 0.327 . . . . 72.4 111.668 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -149.49 127.37 11.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.684 0.278 . . . . 71.41 110.668 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.7 tt -137.13 135.36 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.206 0.527 . . . . 72.44 112.278 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -147.69 122.69 1.59 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 115.826 -0.625 . . . . 64.42 112.074 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.528 HD12 ' HE2' ' A' ' 266' ' ' LYS . 58.0 mt -82.74 136.88 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 O-C-N 121.992 -0.711 . . . . 54.54 112.015 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 240' ' ' ILE . 66.5 mt -70.6 -45.62 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.932 -0.576 . . . . 73.24 111.583 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.19 129.89 21.57 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.876 0.369 . . . . 54.4 111.585 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.528 ' HE2' HD12 ' A' ' 263' ' ' ILE . 2.5 mmmp? -103.08 143.35 32.71 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.735 0.303 . . . . 74.14 111.713 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 236' ' ' LYS . 81.4 p -128.83 140.54 51.65 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.508 -0.315 . . . . 72.24 110.9 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.98 107.84 7.54 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.971 0.415 . . . . 75.43 111.774 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 119.121 -0.466 . . . . 61.44 110.775 176.222 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 84.8 mmm . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 112.258 0.466 . . . . 74.2 112.258 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.536 ' H ' HD22 ' A' ' 173' ' ' ASN . 0.1 OUTLIER -87.35 130.97 34.43 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.755 -0.461 . . . . 63.21 109.755 169.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.48 ' HB2' HG22 ' A' ' 187' ' ' ILE . 95.1 m-85 -98.94 135.61 40.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.373 0.606 . . . . 75.24 112.338 -176.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -91.52 153.37 19.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.012 -0.54 . . . . 55.02 110.063 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 220' ' ' GLY . 64.2 mt -54.23 -36.65 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 113.492 0.923 . . . . 62.32 113.492 -172.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.7 t -75.48 -10.14 59.19 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.828 -0.545 . . . . 74.15 112.348 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.74 -7.57 52.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.678 0.275 . . . . 71.54 111.388 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.85 159.47 33.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.641 0.734 . . . . 70.21 112.655 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.568 ' HG2' HD22 ' A' ' 183' ' ' LEU . 25.4 ptp -157.41 155.07 26.9 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.418 -0.81 . . . . 52.54 110.154 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.438 ' HB3' ' CB ' ' A' ' 249' ' ' GLN . 12.3 Cg_endo -57.35 150.75 56.94 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.995 1.796 . . . . 72.22 112.38 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.415 ' HA ' ' OH ' ' A' ' 246' ' ' TYR . 63.8 t30 65.09 32.15 10.51 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.387 0.613 . . . . 73.21 111.021 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.568 HD22 ' HG2' ' A' ' 180' ' ' MET . 30.1 tp -119.85 128.48 53.72 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.412 -0.358 . . . . 62.44 111.75 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 88.8 p -111.48 114.79 28.14 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.115 -0.366 . . . . 73.03 110.325 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.46 176.22 36.26 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.441 -0.885 . . . . 71.44 114.181 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 88.6 m -108.76 119.74 40.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.932 0.396 . . . . 62.55 111.328 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.48 HG22 ' HB2' ' A' ' 174' ' ' TYR . 34.4 pt -110.54 155.79 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.127 0.489 . . . . 60.24 111.886 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -118.58 113.01 20.61 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.226 -0.443 . . . . 75.5 110.483 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -145.65 163.05 36.05 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.294 0.569 . . . . 73.22 111.935 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -94.89 139.2 31.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.936 -0.574 . . . . 74.01 111.594 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' A' ' 215' ' ' LEU . 46.9 t -77.19 106.82 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.884 0.374 . . . . 74.3 111.563 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.401 ' HB ' ' HD2' ' A' ' 214' ' ' PHE . 14.7 t -79.93 -45.93 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.228 0.537 . . . . 75.14 111.229 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -145.05 115.82 7.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.116 -0.493 . . . . 74.23 111.438 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -100.79 108.81 20.71 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.376 -0.375 . . . . 63.22 110.852 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -70.78 159.99 83.47 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.505 -0.316 . . . . 75.33 111.45 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.16 159.45 49.79 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.261 1.974 . . . . 72.0 112.864 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 197' ' ' LYS . 21.0 ptmt -75.39 102.29 5.08 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.475 0.655 . . . . 54.34 112.075 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -67.08 163.55 19.83 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.66 -0.7 . . . . 72.54 112.048 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.56 131.11 53.68 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.711 -0.677 . . . . 71.11 111.485 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 210' ' ' LEU . 8.0 p90 -164.51 177.11 8.39 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.706 0.288 . . . . 75.24 110.969 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.1 m -116.2 128.25 55.46 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.975 -0.453 . . . . 73.45 111.955 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.528 ' NH1' HD21 ' A' ' 228' ' ' ASN . 47.3 mtp180 -92.23 158.74 15.98 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.124 -0.489 . . . . 75.23 110.832 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -67.38 -21.84 65.59 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.06 0.457 . . . . 63.32 110.402 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -106.17 70.98 0.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.26 -0.427 . . . . 74.25 111.838 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 118.89 -15.37 11.21 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 114.683 0.633 . . . . 63.24 114.683 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 31.1 p 52.23 -175.85 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 117.414 0.607 . . . . 35.43 112.281 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 52.25 32.06 10.23 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.31 0.485 . . . . 72.51 112.31 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -82.39 170.8 51.03 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 121.4 0.444 . . . . 74.42 113.553 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -128.41 154.53 45.93 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.548 -0.383 . . . . 73.42 110.648 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 200' ' ' PHE . 38.3 tp -141.5 117.99 10.89 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.089 0.403 . . . . 74.2 112.089 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -134.9 114.56 12.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.948 0.404 . . . . 52.22 111.412 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 47.2 t -93.8 149.41 21.26 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.931 0.396 . . . . 74.0 111.396 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.57 HD21 HG11 ' A' ' 235' ' ' VAL . 74.0 mt -128.66 125.36 37.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.601 -0.272 . . . . 71.54 111.229 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.401 ' HD2' ' HB ' ' A' ' 192' ' ' VAL . 34.0 t80 -89.9 111.91 23.11 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.792 0.329 . . . . 64.32 110.243 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 191' ' ' VAL . 48.1 mt -109.92 156.77 20.0 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.388 -0.369 . . . . 74.03 111.006 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 221' ' ' SER . 18.1 ptmt -148.79 165.46 31.39 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.494 0.664 . . . . 61.4 112.155 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.404 ' OD2' HG22 ' A' ' 219' ' ' THR . 25.7 t70 -147.5 170.11 18.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.066 -0.97 . . . . 44.44 109.877 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -48.78 -31.76 7.53 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.561 0.578 . . . . 74.21 112.561 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.404 HG22 ' OD2' ' A' ' 217' ' ' ASP . 13.1 t -102.48 -8.92 20.67 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.194 1.183 . . . . 73.35 114.194 -173.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.436 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 168.32 -179.55 41.32 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 119.82 -1.181 . . . . 70.22 114.453 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 216' ' ' LYS . 36.4 m -122.92 157.96 31.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.541 0.336 . . . . 72.51 111.325 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.6 tp -151.83 156.46 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.828 0.347 . . . . 70.32 111.32 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -113.37 112.07 23.04 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.277 0.561 . . . . 71.15 111.532 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.556 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -94.42 164.78 25.84 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.299 -0.41 . . . . 61.24 113.065 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 86.0 m -137.51 127.22 25.36 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.483 0.549 . . . . 71.11 112.483 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.465 HD23 ' HB ' ' A' ' 258' ' ' VAL . 96.1 mt -107.28 124.02 49.17 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.969 -0.56 . . . . 72.24 110.875 174.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -103.24 152.51 21.41 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.075 0.464 . . . . 73.31 111.995 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.528 HD21 ' NH1' ' A' ' 202' ' ' ARG . 47.0 m-20 51.01 -132.52 1.9 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.566 0.58 . . . . 75.42 112.566 171.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -42.72 -39.53 2.46 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.433 0.901 . . . . 73.13 113.433 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.2 -19.77 63.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.975 0.417 . . . . 75.11 112.049 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.66 -21.98 66.86 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.091 0.404 . . . . 54.31 112.091 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.57 3.38 55.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.222 0.453 . . . . 75.4 112.222 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -64.33 124.31 21.41 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 110.289 -0.263 . . . . 74.34 110.289 174.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.434 ' OE2' ' HE2' ' A' ' 236' ' ' LYS . 28.9 tt0 -66.86 99.4 0.62 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.17 0.509 . . . . 73.01 112.043 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 213' ' ' LEU . 4.0 p -116.85 111.19 34.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.466 0.65 . . . . 41.53 110.699 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.434 ' HE2' ' OE2' ' A' ' 234' ' ' GLU . 66.8 mttm -98.36 147.73 24.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.08 0.466 . . . . 74.04 111.506 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -65.1 112.85 3.56 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 75.44 110.597 177.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.63 -16.66 23.74 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.463 -0.399 . . . . 11.1 113.172 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.51 141.54 51.93 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.011 0.434 . . . . 73.44 111.482 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 37.2 mm -89.09 117.91 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.476 -0.329 . . . . 73.14 110.522 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -109.01 127.1 53.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.11 0.782 . . . . 65.52 113.11 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.2 97.54 6.96 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.228 -0.656 . . . . 53.31 109.228 167.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.7 t -100.79 106.02 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.251 0.548 . . . . 74.54 112.24 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.9 m -96.65 109.19 21.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.937 -0.574 . . . . 72.41 110.055 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.67 -172.98 22.33 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.199 -1.0 . . . . 34.11 114.343 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.415 ' OH ' ' HA ' ' A' ' 182' ' ' ASN . 74.0 t80 -115.38 115.66 26.96 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.39 -0.405 . . . . 74.33 110.856 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.83 126.66 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.16 0.505 . . . . 53.32 111.717 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 52.4 mtpt -123.04 146.49 47.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.067 -0.515 . . . . 53.33 111.504 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.438 ' CB ' ' HB3' ' A' ' 181' ' ' PRO . 25.3 tt0 -120.39 135.76 54.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 75.22 110.648 172.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -160.08 -148.0 5.1 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.434 -0.889 . . . . 55.21 113.329 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -65.85 -29.57 70.05 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.061 0.458 . . . . 71.05 111.312 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 75.7 p -75.38 -10.76 59.74 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.329 -0.396 . . . . 74.42 111.635 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.06 -121.16 7.1 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.804 -0.519 . . . . 72.35 111.804 -173.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.1 mt -107.4 133.56 51.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.96 0.409 . . . . 54.44 111.385 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.418 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 10.5 pt-20 -144.24 174.03 11.25 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.154 -0.475 . . . . 70.33 111.007 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.556 HG23 ' HA2' ' A' ' 224' ' ' GLY . 8.5 tt -154.05 116.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.477 0.656 . . . . 75.42 111.976 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.8 t -87.49 124.37 33.38 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.951 -0.568 . . . . 74.43 110.098 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 226' ' ' LEU . 33.3 t -84.08 132.84 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 112.366 0.506 . . . . 74.42 112.366 -173.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -95.36 -42.48 8.48 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.311 0.577 . . . . 72.23 110.723 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -145.42 135.41 23.71 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.917 -0.583 . . . . 65.41 110.702 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.459 ' HB ' HG11 ' A' ' 258' ' ' VAL . 12.6 tt -137.92 140.12 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.935 0.398 . . . . 62.34 111.596 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -149.98 136.42 5.69 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 116.24 -0.436 . . . . 73.23 112.159 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.507 ' CG2' ' HG2' ' A' ' 266' ' ' LYS . 25.6 mm -84.8 132.84 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.324 -0.515 . . . . 72.11 111.287 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 46.6 mt -77.1 -74.52 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 116.713 -0.221 . . . . 71.43 111.191 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -108.28 126.43 52.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.201 0.524 . . . . 63.0 110.443 170.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.575 ' NZ ' ' HB3' ' A' ' 266' ' ' LYS . 4.6 mtpm? -106.07 159.91 15.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.095 -0.502 . . . . 71.31 112.287 -173.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 62.2 p -80.18 105.12 11.21 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.179 0.514 . . . . 62.42 109.756 168.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.78 74.25 2.74 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.221 0.534 . . . . 62.41 111.395 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.464 -0.779 . . . . 75.51 111.915 178.063 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.905 0.383 . . . . 63.32 111.393 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 186' ' ' THR . 10.9 m120 -84.59 125.89 32.84 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.34 -0.391 . . . . 74.52 110.868 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 33.2 m-85 -83.92 171.45 13.02 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.518 0.675 . . . . 64.31 112.09 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 74.3 mmtt -93.39 156.68 16.64 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.568 -0.742 . . . . 70.53 109.683 167.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.503 HD13 HG22 ' A' ' 222' ' ' ILE . 40.0 mt -59.12 -31.87 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.114 0.412 . . . . 74.55 112.114 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.452 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 34.8 t -62.11 -29.26 70.2 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.93 0.395 . . . . 50.13 111.598 174.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 11.5 mm-40 -83.5 -18.22 39.24 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.405 -0.361 . . . . 72.31 111.695 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.676 HD11 HD13 ' A' ' 187' ' ' ILE . 87.6 mt -64.45 98.86 0.27 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.232 0.539 . . . . 73.03 110.998 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.463 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.9 ptp -96.64 152.2 38.4 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.099 -0.5 . . . . 73.31 111.163 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.18 138.34 78.92 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.169 1.913 . . . . 72.14 112.769 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 72.54 18.91 4.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.263 0.625 . . . . 62.31 111.794 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 180' ' ' MET . 44.1 tp -94.7 154.82 17.13 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 61.14 111.599 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.4 t -131.31 123.17 27.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.53 -0.305 . . . . 44.11 110.67 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.54 -164.45 26.28 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.89 -0.671 . . . . 61.13 113.527 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 43.8 m -133.76 147.36 51.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.433 0.293 . . . . 63.01 111.177 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.676 HD13 HD11 ' A' ' 179' ' ' LEU . 39.9 pt -142.51 165.53 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.01 0.433 . . . . 65.4 111.577 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -122.29 118.31 28.21 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.692 -0.485 . . . . 73.55 109.692 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.29 170.75 16.14 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.532 0.567 . . . . 73.33 112.532 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 215' ' ' LEU . 40.1 mt-10 -84.86 134.2 34.29 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.802 -0.635 . . . . 74.45 111.514 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.26 95.75 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.039 0.447 . . . . 73.12 110.63 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.25 -29.94 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.127 0.489 . . . . 54.22 112.001 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.97 145.02 28.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 75.14 111.694 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -140.84 116.31 10.11 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.216 -0.447 . . . . 33.41 111.384 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.481 ' O ' ' HE2' ' A' ' 211' ' ' LYS . 97.0 m-85 -87.4 153.93 53.75 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-N 116.627 -0.26 . . . . 75.11 110.956 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.25 162.43 23.43 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.663 2.242 . . . . 65.11 112.942 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 197' ' ' LYS . 20.3 ptmt -72.48 115.3 11.58 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.618 0.723 . . . . 71.25 111.744 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -102.27 148.74 25.08 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.0 -0.546 . . . . 74.3 111.19 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.41 144.37 45.05 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.895 0.378 . . . . 74.31 111.243 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -152.97 173.76 15.0 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.012 0.434 . . . . 62.54 111.315 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 87.9 p -95.83 126.59 41.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.193 0.52 . . . . 62.32 112.266 -175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 16.2 mtp180 -118.66 114.52 22.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.082 -0.508 . . . . 71.5 110.097 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -52.17 -42.96 63.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.939 0.399 . . . . 73.02 111.719 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -111.48 22.09 15.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.079 0.466 . . . . 73.43 111.378 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 202' ' ' ARG . . . -160.21 45.98 0.41 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.215 -0.517 . . . . 73.13 112.567 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 207' ' ' LYS . 60.3 p -51.83 149.03 5.11 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.44 0.533 . . . . 63.53 112.44 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 206' ' ' THR . 60.2 mttp 72.55 5.7 5.3 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.533 -0.758 . . . . 73.45 112.599 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -70.71 129.18 18.71 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.081 -0.58 . . . . 73.24 111.853 172.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.45 HE21 ' HA ' ' A' ' 229' ' ' GLU . 37.5 mt-30 -105.77 173.57 6.25 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.424 0.631 . . . . 62.23 112.695 -174.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.4 tp -138.37 116.5 11.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.431 -0.804 . . . . 75.55 111.221 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.481 ' HE2' ' O ' ' A' ' 195' ' ' TYR . 59.5 tttm -145.79 107.31 4.24 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.035 -0.416 . . . . 74.12 111.264 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 225' ' ' THR . 57.9 m -86.49 142.36 28.41 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.525 0.678 . . . . 73.13 112.65 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 59.8 mt -123.74 163.01 22.01 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.27 -0.877 . . . . 63.33 109.619 173.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -119.92 117.12 27.26 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.956 -0.465 . . . . 71.04 110.686 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 78.3 mt -107.7 133.98 51.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.726 0.298 . . . . 75.14 111.224 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -124.03 153.64 41.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.426 0.631 . . . . 71.33 111.877 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -151.15 160.43 43.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.964 -1.016 . . . . 74.11 109.302 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.31 -25.78 49.84 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.107 0.41 . . . . 61.15 112.107 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 48.6 p -89.23 -14.09 36.72 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.061 0.763 . . . . 62.14 113.061 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.02 -179.76 41.55 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.341 -0.933 . . . . 52.32 114.218 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.5 p -135.41 132.48 37.55 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.659 -0.318 . . . . 54.32 111.216 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.503 HG22 HD13 ' A' ' 176' ' ' ILE . 15.5 tt -144.81 145.74 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.058 0.456 . . . . 73.31 111.75 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.708 ' H ' ' HD2' ' A' ' 223' ' ' ARG . 0.5 OUTLIER -89.93 130.33 36.16 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.985 -0.447 . . . . 74.44 111.313 177.217 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.466 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -112.32 114.43 3.52 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.459 -0.401 . . . . 64.32 112.906 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 212' ' ' SER . 87.9 m -95.47 120.14 35.19 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.477 0.547 . . . . 55.1 112.477 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.494 HD23 ' HB ' ' A' ' 258' ' ' VAL . 91.3 mt -78.74 123.84 27.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.948 -0.569 . . . . 74.1 110.857 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -107.74 172.72 6.67 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.988 0.423 . . . . 75.23 111.362 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 57.7 t30 55.72 -141.11 0.86 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 116.217 -0.447 . . . . 74.2 111.525 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.45 ' HA ' HE21 ' A' ' 209' ' ' GLN . 11.5 pt-20 -74.85 -5.73 45.18 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.57 -0.706 . . . . 70.43 112.465 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.487 ' HB3' HD22 ' A' ' 226' ' ' LEU . 83.2 mt -68.3 -12.77 61.59 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 122.137 -0.352 . . . . 51.21 111.656 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.79 67.11 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.153 0.502 . . . . 71.33 111.595 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.0 -3.07 59.06 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.012 0.375 . . . . 73.44 112.012 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -62.96 118.26 7.56 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.146 0.498 . . . . 74.42 110.999 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.26 99.42 4.04 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.402 0.62 . . . . 72.33 112.086 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.77 141.64 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 115.733 -0.667 . . . . 75.54 110.731 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -116.92 171.03 8.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.037 0.446 . . . . 73.22 110.835 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -72.99 119.24 16.97 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.852 0.358 . . . . 71.24 110.633 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 118.16 -24.13 8.9 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.157 -0.544 . . . . 44.25 113.751 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -64.78 134.32 53.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 117.159 0.479 . . . . 72.42 111.962 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 49.8 mm -84.03 102.33 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.005 0.431 . . . . 72.25 110.112 173.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -108.74 141.61 40.49 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.661 0.615 . . . . 71.24 112.661 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -89.35 108.45 19.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.802 -0.636 . . . . 73.31 109.728 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 258' ' ' VAL . 75.8 t -111.51 130.24 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.158 0.429 . . . . 72.23 112.158 -172.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 28.5 t -123.9 137.3 54.66 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.294 -0.412 . . . . 61.42 110.701 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.98 -164.16 32.29 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.194 -1.003 . . . . 51.54 114.169 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -105.47 123.19 47.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.827 0.451 . . . . 74.12 111.189 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.9 t -89.93 134.44 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.229 0.538 . . . . 73.11 112.271 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.57 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 7.9 mtpm? -128.03 157.2 41.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.94 -0.573 . . . . 70.51 110.441 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -121.22 126.74 50.36 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.173 -0.329 . . . . 74.4 110.326 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -175.65 -83.63 0.06 OUTLIER Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.167 -1.016 . . . . 73.12 113.623 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -73.77 102.15 3.92 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.066 0.46 . . . . 73.24 111.865 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 50.8 m 56.93 61.58 2.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.751 -0.658 . . . . 34.31 111.872 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 88.41 -127.44 8.59 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.103 -0.57 . . . . 53.12 113.338 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 98.2 mt -96.09 147.88 23.26 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.42 0.629 . . . . 51.14 112.649 -176.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLU . . . . . 0.57 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 8.0 pt-20 -143.62 125.85 15.56 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.563 -0.744 . . . . 51.1 110.038 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.466 HG23 ' HA2' ' A' ' 224' ' ' GLY . 12.2 tt -116.72 135.12 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.438 0.637 . . . . 72.4 112.443 -176.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 69.8 m -95.66 115.06 26.89 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.771 -0.649 . . . . 74.11 110.343 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.494 ' HB ' HD23 ' A' ' 226' ' ' LEU . 38.5 t -75.54 120.32 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.302 0.573 . . . . 63.42 112.158 -174.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.36 -36.41 11.39 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.941 -0.572 . . . . 75.23 110.654 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 15.7 t-20 -139.93 140.14 36.31 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.804 -0.634 . . . . 74.11 110.334 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 14.2 tt -148.35 135.2 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.345 0.593 . . . . 70.54 112.288 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -148.49 125.18 2.01 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.104 -0.498 . . . . 74.34 112.304 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 54.0 mt -79.85 131.9 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 122.217 -0.578 . . . . 51.23 111.773 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.1 mt -73.33 -52.75 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.122 0.487 . . . . 65.41 111.332 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -96.84 111.65 23.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.075 -0.511 . . . . 75.43 111.792 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -133.93 137.21 44.74 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.528 0.68 . . . . 74.42 112.312 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 29.3 t -161.76 133.47 5.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.34 -0.845 . . . . 63.31 110.201 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 268' ' ' LEU . 1.4 pt? -145.08 166.61 24.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.867 0.365 . . . . 72.43 111.69 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 . . . . . 0 C--O 1.254 1.331 0 CA-C-O 118.739 -0.648 . . . . 71.42 111.434 178.763 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 111.84 0.311 . . . . 61.12 111.84 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.26 117.7 15.32 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.726 -0.472 . . . . 72.14 109.726 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.423 ' O ' HG22 ' A' ' 187' ' ' ILE . 88.8 m-85 -84.35 145.36 28.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.326 0.584 . . . . 74.21 112.463 -173.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 46.4 mmtm -79.42 154.34 29.03 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.047 -0.723 . . . . 74.14 109.047 167.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.438 HG23 ' HB ' ' A' ' 222' ' ' ILE . 58.7 mt -51.94 -36.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 112.591 0.589 . . . . 74.24 112.591 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.4 t -67.76 -29.14 68.28 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 122.057 -0.402 . . . . 55.04 111.845 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.482 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 12.3 mm-40 -76.26 -8.04 56.21 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.851 0.315 . . . . 74.52 111.851 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.424 HD22 HG21 ' A' ' 247' ' ' VAL . 88.1 mt -73.41 145.29 45.92 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.314 0.578 . . . . 74.41 111.901 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.478 ' HG2' HD22 ' A' ' 183' ' ' LEU . 24.2 ptp -143.97 159.16 54.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.029 -0.532 . . . . 75.21 110.7 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.22 132.38 38.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.451 2.101 . . . . 63.1 113.192 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 65.05 46.08 2.89 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.065 0.459 . . . . 70.33 111.589 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.478 HD22 ' HG2' ' A' ' 180' ' ' MET . 42.8 tp -119.19 120.88 38.37 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.304 -0.407 . . . . 63.22 111.73 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.5 t -99.14 120.46 39.53 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.556 0.217 . . . . 64.21 110.639 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.82 -176.17 38.79 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.52 -0.848 . . . . 55.13 114.402 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 90.6 m -114.57 136.58 52.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.0 0.52 . . . . 74.35 111.698 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 174' ' ' TYR . 34.6 pt -126.8 157.8 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 122.63 0.372 . . . . 72.2 110.741 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -129.96 103.15 6.61 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.177 -0.327 . . . . 65.23 110.174 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -139.31 172.32 12.99 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 113.373 0.879 . . . . 73.01 113.373 -171.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.92 140.8 29.07 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.052 -0.976 . . . . 75.43 111.425 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.33 95.05 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.069 0.461 . . . . 63.21 110.761 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.405 ' HB ' ' HD2' ' A' ' 214' ' ' PHE . 16.2 t -72.26 -42.6 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.223 -0.444 . . . . 72.01 111.936 -176.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -140.32 127.7 21.29 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.99 0.424 . . . . 74.15 111.63 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -104.18 104.41 14.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.342 -0.39 . . . . 54.02 111.542 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -79.67 150.07 72.25 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.543 -0.299 . . . . 74.35 111.775 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.6 168.38 16.73 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.981 2.454 . . . . 74.53 113.801 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.2 156.39 33.65 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.102 -0.499 . . . . 73.43 111.675 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -141.88 159.08 42.95 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.112 -0.495 . . . . 63.42 111.056 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -129.08 153.45 47.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.991 0.424 . . . . 61.04 111.47 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.574 ' HE2' ' HB2' ' A' ' 210' ' ' LEU . 52.4 p90 -161.39 176.4 11.17 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.032 0.444 . . . . 63.23 111.08 175.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.7 t -107.97 154.68 21.27 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.948 0.404 . . . . 52.53 111.263 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -99.63 149.86 22.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.756 0.312 . . . . 61.33 111.229 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -58.97 -26.82 64.79 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.518 0.675 . . . . 73.43 110.248 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.86 -35.41 79.89 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.34 -0.845 . . . . 74.41 111.482 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 125.9 -27.9 5.03 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.299 -0.477 . . . . 63.53 113.261 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 79.5 p -82.89 173.64 11.64 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.481 -0.423 . . . . 52.45 111.914 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -91.27 143.74 26.33 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.186 0.517 . . . . 71.45 112.07 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -125.88 134.93 8.9 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.882 -0.599 . . . . 53.21 112.285 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -100.77 152.77 20.1 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.299 0.55 . . . . 64.33 111.981 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.574 ' HB2' ' HE2' ' A' ' 200' ' ' PHE . 51.7 tp -135.12 141.01 45.9 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.95 0.5 . . . . 74.41 111.321 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 231' ' ' ALA . 7.6 tmtm? -167.38 115.2 0.78 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.796 0.332 . . . . 71.33 111.034 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 69.8 m -99.83 167.26 10.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.741 0.782 . . . . 62.25 113.025 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.424 HD11 HG11 ' A' ' 235' ' ' VAL . 75.9 mt -142.66 157.33 44.79 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.179 -0.919 . . . . 54.44 110.752 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.405 ' HD2' ' HB ' ' A' ' 192' ' ' VAL . 35.6 t80 -117.13 122.52 44.32 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.133 -0.354 . . . . 74.54 110.851 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.529 HD11 HG21 ' A' ' 243' ' ' VAL . 44.3 mt -118.4 154.63 32.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.655 0.382 . . . . 71.23 111.004 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -153.25 132.81 12.97 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.764 0.654 . . . . 61.53 112.764 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -99.81 -171.17 2.0 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.977 -0.556 . . . . 43.24 110.315 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.94 -15.15 62.58 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.195 0.522 . . . . 73.25 110.587 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 54.1 p -94.47 -20.52 19.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.819 0.674 . . . . 61.34 112.819 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 158.12 -179.53 33.76 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.755 -0.736 . . . . 72.13 113.361 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 83.9 p -123.67 146.78 47.98 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.056 0.455 . . . . 74.04 112.047 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 176' ' ' ILE . 11.4 tp -144.1 157.22 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.251 -0.432 . . . . 73.5 110.966 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 223' ' ' ARG . 29.1 mtm-85 -102.54 117.61 35.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.695 0.284 . . . . 74.02 111.455 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.556 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -97.7 119.76 6.52 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.419 -0.42 . . . . 62.15 112.84 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.0 m -99.25 118.41 35.87 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.355 0.502 . . . . 75.44 112.355 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.559 HD23 ' HB ' ' A' ' 258' ' ' VAL . 91.4 mt -91.9 133.82 35.33 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.974 -0.557 . . . . 71.11 111.046 175.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -115.46 159.4 21.22 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.08 0.467 . . . . 74.42 111.886 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.48 -133.54 1.06 Allowed 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 115.921 -0.581 . . . . 73.42 111.676 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.76 -31.58 39.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.242 0.46 . . . . 72.32 112.242 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 90.3 mt -64.27 -14.91 58.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.983 0.364 . . . . 63.45 111.983 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 211' ' ' LYS . . . -73.98 -1.96 22.09 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.968 0.413 . . . . 63.21 112.063 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.03 14.22 9.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.895 0.478 . . . . 75.42 110.961 173.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -72.69 126.22 29.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.042 -0.526 . . . . 75.3 111.139 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -62.86 97.36 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.169 0.509 . . . . 55.43 111.828 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.424 HG11 HD11 ' A' ' 213' ' ' LEU . 4.0 p -135.72 114.38 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.934 -0.576 . . . . 70.12 110.541 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -100.35 157.94 16.25 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.169 0.509 . . . . 73.45 111.507 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -69.35 94.77 0.74 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.994 -0.548 . . . . 74.33 111.664 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 137.27 -19.35 3.42 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.171 -0.538 . . . . 71.14 113.793 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -70.0 146.13 51.28 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.139 0.495 . . . . 55.33 112.083 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.537 HG22 HD12 ' A' ' 264' ' ' ILE . 45.8 mm -86.93 129.31 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.191 -0.458 . . . . 73.43 110.22 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.622 ' HB2' HD13 ' A' ' 263' ' ' ILE . . . -140.91 152.35 44.96 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.028 0.751 . . . . 74.24 113.028 -175.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.28 125.52 38.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.787 -0.642 . . . . 74.52 110.221 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 215' ' ' LEU . 92.9 t -122.11 117.58 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.133 0.492 . . . . 52.05 111.786 -175.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 260' ' ' ASN . 69.7 m -118.0 133.18 56.16 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.321 -0.4 . . . . 73.13 110.955 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.26 -156.12 13.23 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.438 -0.887 . . . . 44.25 113.84 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -122.75 115.32 21.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.966 0.412 . . . . 72.35 111.339 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.543 HG22 ' HB ' ' A' ' 256' ' ' ILE . 38.3 t -86.89 125.69 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.249 -0.432 . . . . 64.45 111.614 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -154.08 154.45 33.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.804 0.335 . . . . 53.54 111.365 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -75.05 136.83 41.17 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.677 -0.238 . . . . 64.42 110.472 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -151.04 -70.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.504 -0.855 . . . . 65.24 112.973 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -138.91 135.51 34.51 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.598 -0.354 . . . . 73.05 110.535 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 29.7 t 65.5 18.18 11.19 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.048 0.452 . . . . 54.15 111.933 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 118.7 -143.78 17.64 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.388 -0.434 . . . . 61.03 113.399 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 88.8 mt -87.81 131.17 34.62 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.017 0.437 . . . . 73.23 111.278 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -122.27 133.81 54.68 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.437 -0.347 . . . . 72.32 111.293 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.556 HG23 ' HA2' ' A' ' 224' ' ' GLY . 8.5 tt -103.86 109.09 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.329 0.585 . . . . 65.5 111.104 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.7 t -78.28 115.47 18.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.212 -0.449 . . . . 74.01 110.024 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.559 ' HB ' HD23 ' A' ' 226' ' ' LEU . 38.8 t -88.45 116.9 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 112.607 0.595 . . . . 73.24 112.607 -170.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.76 -24.15 17.92 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.327 -0.397 . . . . 75.32 111.6 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 244' ' ' SER . 27.3 t-20 -139.79 131.78 27.81 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.678 0.275 . . . . 64.11 111.163 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.1 tt -149.04 139.33 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.877 0.37 . . . . 65.2 111.163 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -149.47 129.11 2.92 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.15 -0.548 . . . . 65.05 112.826 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.622 HD13 ' HB2' ' A' ' 241' ' ' ALA . 46.4 mm -73.36 115.16 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 122.678 -0.307 . . . . 63.14 110.749 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.537 HD12 HG22 ' A' ' 240' ' ' ILE . 72.2 mt -66.01 -53.62 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.008 0.432 . . . . 71.54 111.469 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -111.26 120.93 43.91 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.297 -0.41 . . . . 64.34 111.027 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -89.81 130.24 36.08 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.645 0.609 . . . . 74.12 112.645 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 34.6 t -109.2 126.57 53.41 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.282 -0.417 . . . . 63.22 110.0 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 1.2 pp -150.27 175.0 12.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.952 0.723 . . . . 73.31 112.952 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.749 -0.66 . . . . 74.41 110.894 175.889 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 112.357 0.503 . . . . 73.25 112.357 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.53 119.12 36.42 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.622 -0.51 . . . . 51.32 109.622 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -96.8 155.24 16.86 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.154 0.798 . . . . 73.34 113.154 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -100.04 155.59 17.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.345 -0.843 . . . . 74.11 109.945 169.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 220' ' ' GLY . 44.2 mt -66.06 -30.09 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 112.551 0.574 . . . . 73.34 112.551 -172.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 219' ' ' THR . 93.5 p -71.09 -28.52 64.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.237 0.542 . . . . 64.51 110.664 173.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -77.99 -31.47 50.73 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.959 -0.564 . . . . 73.42 111.262 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 247' ' ' VAL . 78.0 mt -52.9 134.07 37.55 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.228 0.537 . . . . 64.12 111.475 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.446 ' HB2' ' HD2' ' A' ' 181' ' ' PRO . 22.9 ptp -140.57 164.65 35.32 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.925 -0.58 . . . . 72.12 111.077 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.514 ' HB3' ' HB3' ' A' ' 249' ' ' GLN . 9.4 Cg_endo -54.53 144.0 65.05 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.405 2.07 . . . . 75.21 112.879 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.1 t30 67.6 13.9 9.4 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.034 0.445 . . . . 61.43 111.909 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 40.2 tp -91.12 150.86 21.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.133 0.492 . . . . 72.15 111.993 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.8 t -131.78 133.67 45.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.339 -0.392 . . . . 73.33 110.492 173.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 173.82 -176.61 46.32 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.418 -0.896 . . . . 74.11 113.864 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 90.5 m -117.23 136.43 53.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.868 0.366 . . . . 60.13 111.325 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.437 HD13 HD11 ' A' ' 179' ' ' LEU . 33.8 pt -129.25 163.48 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 122.885 0.474 . . . . 62.43 111.485 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 -127.58 114.25 17.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.47 -0.332 . . . . 75.22 110.503 175.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.28 168.58 19.44 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.848 0.356 . . . . 62.53 111.945 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 14.7 pt-20 -89.44 143.51 26.77 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.009 0.433 . . . . 64.45 111.353 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.444 ' HA ' HD23 ' A' ' 215' ' ' LEU . 39.8 t -79.49 105.01 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.226 0.536 . . . . 74.31 111.608 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.48 -37.63 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.207 0.527 . . . . 71.32 111.116 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.2 134.05 11.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.041 -0.527 . . . . 74.54 111.409 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -115.1 101.52 9.06 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.897 0.38 . . . . 71.14 111.246 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -72.11 143.96 86.82 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.483 -0.326 . . . . 75.25 111.27 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.63 168.75 2.87 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.955 2.437 . . . . 64.31 113.956 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -83.31 118.28 23.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.319 0.581 . . . . 73.01 111.785 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.637 ' HE2' ' HG ' ' A' ' 210' ' ' LEU . 2.6 mppt? -96.92 162.82 13.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.117 -0.492 . . . . 55.34 111.408 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -111.09 146.86 36.04 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.196 -0.457 . . . . 71.1 111.393 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -156.3 175.26 14.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.175 0.512 . . . . 75.12 111.125 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 94.8 p -125.17 141.68 51.96 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.242 -0.435 . . . . 74.22 111.245 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.48 ' HB2' ' OG1' ' A' ' 206' ' ' THR . 36.6 mmt180 -80.02 167.95 19.79 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.068 0.461 . . . . 72.13 111.601 178.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -60.63 -23.74 64.98 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.007 -0.542 . . . . 75.25 111.561 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.82 -5.11 46.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.19 -0.459 . . . . 75.24 112.149 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 81.74 21.71 61.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.711 -0.757 . . . . 74.21 112.051 -172.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 202' ' ' ARG . 76.2 p -101.29 171.16 7.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.889 0.476 . . . . 65.11 111.336 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -96.54 149.35 21.85 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.156 0.503 . . . . 72.23 112.239 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -149.22 148.56 20.05 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 116.121 -0.491 . . . . 63.3 113.286 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -105.99 143.45 34.12 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.411 0.284 . . . . 75.23 110.882 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.637 ' HG ' ' HE2' ' A' ' 198' ' ' LYS . 14.9 tp -137.33 116.72 12.76 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.391 0.515 . . . . 62.53 112.391 -175.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.542 ' HD3' HD12 ' A' ' 226' ' ' LEU . 59.8 tttp -122.15 147.79 45.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.762 0.315 . . . . 55.05 110.736 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.44 ' OG ' ' NZ ' ' A' ' 198' ' ' LYS . 49.0 m -123.74 147.15 47.75 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.022 0.439 . . . . 63.21 111.342 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.3 mt -135.14 157.45 46.88 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.217 -0.447 . . . . 72.22 110.92 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -127.87 115.89 19.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.905 -0.406 . . . . 44.21 109.905 173.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 191' ' ' VAL . 64.9 mt -117.64 153.49 33.21 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.403 -0.362 . . . . 70.22 111.316 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 22.0 pttp -147.24 145.2 29.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.782 0.801 . . . . 64.43 112.35 174.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -122.15 170.94 9.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.657 -1.156 . . . . 74.22 108.635 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -49.93 -29.91 9.27 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.138 0.494 . . . . 74.11 111.364 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 177' ' ' SER . 77.2 p -88.17 -2.15 58.43 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.755 1.02 . . . . 73.42 113.755 -175.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 143.09 -178.95 21.0 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 120.412 -0.899 . . . . 74.13 113.801 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.9 p -120.33 155.37 33.48 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 120.911 0.386 . . . . 70.31 111.78 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.409 HG12 ' N ' ' A' ' 223' ' ' ARG . 14.9 tt -148.84 157.43 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.937 0.399 . . . . 72.05 111.768 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.424 ' N ' ' HD2' ' A' ' 223' ' ' ARG . 7.6 mpt_? -92.37 128.64 38.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.295 -0.411 . . . . 64.42 110.903 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -107.97 140.56 15.5 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.343 -0.456 . . . . 44.14 112.781 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 32.9 m -125.44 116.33 21.68 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.209 -0.583 . . . . 75.3 112.176 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.56 HD23 ' HB ' ' A' ' 258' ' ' VAL . 74.8 mt -99.02 132.25 44.47 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.479 -0.328 . . . . 65.04 111.038 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -113.14 154.93 25.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.157 0.503 . . . . 74.04 112.122 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.1 t30 62.18 -152.25 0.36 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.751 -0.659 . . . . 52.11 111.201 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.62 -7.29 0.91 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.671 0.989 . . . . 73.05 113.671 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.68 -13.68 55.23 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.167 0.508 . . . . 70.44 110.85 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -64.99 -28.89 69.82 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.106 -0.497 . . . . 62.15 112.151 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.01 0.19 53.97 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.108 0.41 . . . . 61.33 112.108 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -66.45 101.77 0.8 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.045 0.45 . . . . 72.01 110.658 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.51 100.55 1.43 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.12 0.415 . . . . 55.23 112.12 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.6 150.42 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.098 -0.501 . . . . 70.44 110.216 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -113.44 163.15 15.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.453 0.645 . . . . 70.11 112.08 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -81.11 94.76 6.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.136 -0.484 . . . . 65.25 110.688 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 141.57 -11.74 2.7 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.448 -0.882 . . . . 65.34 114.868 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -88.48 172.82 9.07 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.209 1.005 . . . . 70.44 111.456 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 48.1 mm -105.04 113.81 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.073 -0.512 . . . . 64.21 110.94 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -100.04 122.94 43.7 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.809 0.67 . . . . 44.13 112.809 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -80.24 104.86 11.08 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.818 -0.628 . . . . 45.44 109.55 170.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 215' ' ' LEU . 93.1 t -115.83 128.77 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.543 0.571 . . . . 71.31 112.543 -172.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 39.2 t -120.85 132.52 55.04 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.16 -0.473 . . . . 51.32 110.405 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.33 -163.27 29.03 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.274 -0.965 . . . . 63.1 114.436 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -117.95 115.73 25.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.769 0.428 . . . . 74.23 111.264 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.516 HG21 HD22 ' A' ' 179' ' ' LEU . 48.5 t -85.44 133.16 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.666 0.617 . . . . 74.34 112.666 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -128.39 138.51 52.38 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.207 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 181' ' ' PRO . 29.2 tt0 -100.65 143.07 31.25 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.715 0.293 . . . . 73.31 110.827 177.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 176.87 -127.29 1.2 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.141 -1.028 . . . . 62.2 114.185 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -59.68 108.46 0.74 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.739 0.644 . . . . 73.1 112.739 -173.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 65.1 m 69.51 15.87 8.23 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.337 0.866 . . . . 62.34 113.337 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 140.96 -167.58 25.61 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.546 -0.835 . . . . 71.22 113.804 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.413 ' O ' ' HD3' ' A' ' 223' ' ' ARG . 4.5 mp -107.48 142.05 37.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.053 0.454 . . . . 70.42 111.97 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.75 167.18 11.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.14 -0.482 . . . . 64.13 110.386 175.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tt -136.04 103.86 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.556 0.693 . . . . 71.23 111.129 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.9 t -66.28 106.72 1.76 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.986 -0.552 . . . . 52.32 109.873 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.56 ' HB ' HD23 ' A' ' 226' ' ' LEU . 38.9 t -75.5 124.48 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.571 0.582 . . . . 52.35 112.571 -171.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -81.63 -40.94 22.17 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.85 -0.613 . . . . 65.25 110.675 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -153.49 148.78 27.01 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.132 -0.486 . . . . 63.42 111.127 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.8 tt -140.85 142.64 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.062 0.458 . . . . 73.31 111.567 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -150.51 145.02 12.58 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.171 -0.538 . . . . 74.4 112.823 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.0 mt -81.79 127.94 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 122.443 -0.445 . . . . 71.1 110.903 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 34.8 mm -56.41 -43.76 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.718 0.636 . . . . 65.22 112.718 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.74 124.57 26.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.353 0.597 . . . . 55.32 112.105 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.03 -15.9 25.62 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.007 -0.542 . . . . 55.51 111.649 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 38.1 t -111.61 130.32 55.79 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.873 0.368 . . . . 62.14 111.141 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.97 79.99 1.53 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.724 0.773 . . . . 63.32 111.815 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.16 -0.924 . . . . 74.34 111.88 178.998 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.666 ' SD ' ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.016 0.436 . . . . 61.22 111.088 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 11.3 m-80 -77.88 136.61 38.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.274 -0.421 . . . . 61.03 111.896 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.534 ' HB2' HG22 ' A' ' 187' ' ' ILE . 95.5 m-85 -120.78 143.28 48.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.339 0.59 . . . . 73.14 112.152 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -99.69 159.86 14.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 70.3 109.798 169.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.49 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 68.6 mt -64.06 -34.88 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 112.609 0.596 . . . . 72.05 112.609 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.4 t -69.03 -20.56 64.13 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.069 0.461 . . . . 63.04 111.144 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -84.26 -11.08 57.06 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.026 -0.534 . . . . 73.33 111.379 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 247' ' ' VAL . 77.5 mt -68.44 162.03 26.37 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.888 0.852 . . . . 52.31 113.248 -174.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.0 ptp -162.7 153.75 14.66 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 114.877 -1.056 . . . . 61.52 110.031 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.74 144.2 87.63 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.251 1.967 . . . . 74.52 112.756 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 67.88 24.44 8.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.848 0.459 . . . . 63.15 111.978 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 49.5 tp -95.83 121.27 37.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.118 0.414 . . . . 65.55 112.118 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 60.6 m -104.65 115.96 31.23 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.455 -0.339 . . . . 40.11 110.41 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.08 -168.49 36.38 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.266 -0.969 . . . . 65.04 114.111 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 52.8 m -119.89 119.25 32.97 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.71 0.29 . . . . 73.53 111.44 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.534 HG22 ' HB2' ' A' ' 174' ' ' TYR . 31.9 pt -101.36 154.3 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.232 0.539 . . . . 51.24 111.945 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -122.23 109.08 14.04 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.158 0.504 . . . . 72.41 110.834 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 216' ' ' LYS . . . -148.4 -177.59 5.85 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.925 -0.58 . . . . 71.03 111.452 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 10.7 pt-20 -107.89 148.43 29.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.229 0.538 . . . . 73.32 111.355 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.14 114.29 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.058 -0.519 . . . . 74.14 111.909 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.1 -49.42 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.205 0.526 . . . . 71.4 110.988 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -139.2 135.52 34.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 61.43 111.138 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -131.05 102.89 6.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.333 -0.394 . . . . 63.21 111.265 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 212' ' ' SER . 74.7 m-85 -95.04 126.3 47.23 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.381 -0.372 . . . . 74.42 110.607 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 195' ' ' TYR . 48.6 Cg_exo -57.67 -174.83 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.335 2.69 . . . . 62.14 114.521 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.666 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 20.7 pttm -67.79 141.22 56.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.505 0.928 . . . . 52.22 113.505 -174.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.734 ' HE2' ' HG ' ' A' ' 210' ' ' LEU . 32.0 mtmm -120.31 157.37 29.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.083 -0.962 . . . . 62.41 110.368 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -102.82 137.33 41.17 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.139 0.495 . . . . 75.13 111.952 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -156.88 -176.64 6.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.985 -0.552 . . . . 74.25 110.325 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 78.4 p -122.25 119.8 32.25 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.185 0.517 . . . . 45.0 111.947 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 48.8 mtp85 -76.96 129.29 35.95 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.109 -0.496 . . . . 72.44 110.804 174.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -64.9 -8.97 17.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.964 0.411 . . . . 73.43 111.812 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.19 -35.9 55.36 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.293 0.568 . . . . 74.34 110.706 173.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 106.57 -8.11 40.04 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.925 -0.58 . . . . 54.44 113.035 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 81.4 p -81.07 157.43 25.4 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.067 0.461 . . . . 63.25 112.089 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -76.26 115.41 15.96 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.394 -0.366 . . . . 65.51 111.57 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -135.62 125.15 3.52 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.33 -0.462 . . . . 75.32 112.803 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.82 150.8 20.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.783 0.325 . . . . 64.5 111.276 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.734 ' HG ' ' HE2' ' A' ' 198' ' ' LYS . 18.4 tp -112.52 108.78 18.01 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.292 0.478 . . . . 70.54 112.292 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 82.6 tttt -117.62 139.53 50.87 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.807 0.336 . . . . 44.44 110.957 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 15.0 m -109.93 134.25 52.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.066 0.395 . . . . 71.03 112.066 -172.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 72.1 mt -129.88 145.53 51.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.254 0.549 . . . . 71.23 112.005 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -126.7 118.83 25.53 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.982 -0.554 . . . . 71.1 109.68 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.71 154.86 28.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.345 -0.389 . . . . 72.31 111.476 -174.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 19.6 ptmt -153.74 170.01 21.96 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.899 0.381 . . . . 75.42 111.091 174.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.89 -174.73 4.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.852 -0.425 . . . . 63.41 109.852 171.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.64 -16.03 59.85 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.248 0.462 . . . . 64.24 112.248 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.4 p -98.76 -21.86 16.16 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.169 0.803 . . . . 73.24 113.169 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.98 -178.35 42.89 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 120.514 -0.851 . . . . 71.31 113.825 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 60.9 m -129.59 136.12 49.4 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 120.983 0.42 . . . . 74.43 111.892 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.0 tp -133.06 153.78 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.098 0.475 . . . . 65.11 111.76 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.427 ' NH1' ' O ' ' A' ' 252' ' ' SER . 10.8 ptp180 -111.42 135.4 52.03 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.768 0.318 . . . . 74.42 110.885 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -138.43 178.5 19.26 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.831 -0.699 . . . . 74.43 114.05 -174.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 88.0 m -148.37 137.4 21.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.568 -0.372 . . . . 44.11 111.933 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.596 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 83.5 mt -101.92 134.57 44.92 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.143 -0.481 . . . . 73.31 110.864 175.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -113.48 152.83 29.64 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.901 0.381 . . . . 75.02 111.666 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 14.4 m120 64.08 -143.36 0.29 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.191 -0.459 . . . . 71.42 112.001 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -48.33 -29.82 4.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.99 0.737 . . . . 72.11 112.99 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 92.4 mt -55.9 -18.89 10.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.003 0.43 . . . . 74.43 111.596 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.666 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -63.19 -44.05 96.45 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.994 0.426 . . . . 52.42 111.56 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -87.31 -5.33 58.95 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.961 0.356 . . . . 74.13 111.961 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -63.1 116.98 5.87 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.903 -0.406 . . . . 75.15 109.903 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.43 126.08 26.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.511 0.672 . . . . 72.32 112.383 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.08 127.23 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.606 -0.725 . . . . 74.01 110.039 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -100.34 141.99 32.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.142 0.496 . . . . 74.11 111.896 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 237' ' ' LYS . 1.1 tmmt? -73.0 125.89 28.67 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.873 -0.603 . . . . 75.14 110.74 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.37 14.25 51.47 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.234 -0.508 . . . . 55.23 113.175 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.59 158.65 18.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.96 0.41 . . . . 64.44 112.071 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 32.7 mm -92.33 127.71 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 116.275 -0.42 . . . . 71.32 110.898 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -130.25 143.22 50.65 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.088 0.773 . . . . 75.4 113.088 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.55 117.36 29.87 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.656 -0.702 . . . . 74.4 109.513 171.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.4 t -117.82 111.47 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.57 0.581 . . . . 71.4 112.57 -173.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 52.0 m -96.58 112.55 24.25 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.422 -0.353 . . . . 74.54 110.382 174.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.59 -167.79 17.0 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.418 -0.896 . . . . 63.22 114.132 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.497 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 93.4 t80 -122.8 113.95 19.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.683 0.393 . . . . 75.32 111.124 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.541 HG21 HD22 ' A' ' 179' ' ' LEU . 45.5 t -86.11 120.07 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.408 -0.36 . . . . 62.11 111.13 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 61.0 pttt -134.59 164.3 27.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.265 0.555 . . . . 75.1 112.06 -176.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -112.12 115.35 28.73 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.596 -0.729 . . . . 75.13 109.776 173.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -162.69 -50.08 0.02 OUTLIER Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.76 -1.209 . . . . 63.12 113.53 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.24 -160.4 0.67 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.64 -0.329 . . . . 70.44 110.743 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.427 ' O ' ' NH1' ' A' ' 223' ' ' ARG . 33.5 m -59.81 85.66 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.109 0.48 . . . . 72.53 111.45 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 105.58 -111.73 3.76 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.914 -0.585 . . . . 64.11 113.699 175.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 95.9 mt -143.83 112.33 6.47 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.991 0.916 . . . . 53.51 109.322 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -111.54 132.91 54.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.291 0.567 . . . . 71.04 111.897 -176.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.1 tt -101.78 106.13 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.607 0.718 . . . . 62.51 111.108 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 35.9 t -77.35 110.25 11.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 53.21 109.959 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.59 ' HB ' HD23 ' A' ' 226' ' ' LEU . 37.9 t -81.27 124.18 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.043 0.449 . . . . 71.53 112.107 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.85 -43.95 14.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.977 -0.556 . . . . 65.22 110.797 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -147.16 139.12 24.37 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.142 -0.481 . . . . 70.2 110.443 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.2 tt -133.36 146.63 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.799 0.333 . . . . 72.24 111.216 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -147.74 131.97 4.07 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.17 -0.538 . . . . 73.42 113.047 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.563 HG21 ' HB3' ' A' ' 266' ' ' LYS . 43.9 mm -80.85 130.93 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 122.269 -0.548 . . . . 70.51 110.678 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 54.8 mt -63.26 -64.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.825 0.345 . . . . 73.1 111.233 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.11 107.93 3.53 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.339 0.59 . . . . 72.21 111.225 175.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.563 ' HB3' HG21 ' A' ' 263' ' ' ILE . 22.6 pttm -98.68 170.56 8.7 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.181 -0.463 . . . . 74.51 110.842 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 83.5 p -129.53 130.84 46.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.324 0.583 . . . . 73.02 111.426 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 269' ' ' GLU . 2.3 pp -137.59 -32.59 0.75 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.862 -0.608 . . . . 60.15 111.341 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.607 ' N ' HD12 ' A' ' 268' ' ' LEU . 45.4 mt-10 . . . . . 0 C--O 1.253 1.288 0 CA-C-O 118.228 -0.892 . . . . 74.22 110.61 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 19.0 mmt . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.829 0.347 . . . . 74.13 111.574 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 186' ' ' THR . 2.8 p-10 -90.36 111.87 23.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.101 0.476 . . . . 70.42 110.819 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 78.5 m-85 -104.23 155.84 18.4 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.346 0.593 . . . . 74.24 111.96 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -74.6 147.07 41.97 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.617 -0.883 . . . . 73.4 108.617 167.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.73 -32.79 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 112.785 0.661 . . . . 72.25 112.785 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.5 m -68.94 -7.94 39.79 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.261 0.467 . . . . 64.31 112.261 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 174' ' ' TYR . 10.9 mm-40 -95.21 -6.19 42.14 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.664 0.385 . . . . 70.12 111.789 178.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 187' ' ' ILE . 79.9 mt -73.39 106.75 5.33 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.559 0.695 . . . . 71.52 112.449 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.9 ptp -114.86 156.2 45.35 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.447 -0.797 . . . . 73.45 110.351 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.01 144.27 69.23 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.17 1.913 . . . . 74.22 112.757 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 70.45 15.34 7.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.158 0.583 . . . . 73.22 112.151 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.7 tp -93.12 135.96 33.83 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.808 0.337 . . . . 71.44 111.361 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.6 t -113.01 118.33 34.51 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.766 0.317 . . . . 53.23 111.081 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.02 -166.15 33.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.657 -0.782 . . . . 74.15 113.822 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 48.4 m -128.12 146.31 50.74 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.7 0.4 . . . . 73.22 110.815 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.582 HG21 HD11 ' A' ' 179' ' ' LEU . 30.4 pt -130.46 149.6 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.57 0.582 . . . . 62.42 112.57 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -108.61 127.34 53.87 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.73 -0.668 . . . . 54.13 110.089 174.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -159.66 175.56 13.04 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.319 0.581 . . . . 75.03 112.497 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 12.9 pt-20 -103.61 151.67 22.66 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.756 -0.656 . . . . 64.22 110.747 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.427 HG21 ' CG2' ' A' ' 235' ' ' VAL . 38.2 t -88.72 117.55 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.879 0.371 . . . . 50.31 111.798 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.9 t -95.44 -48.2 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.077 0.465 . . . . 61.44 111.99 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -139.45 138.87 36.81 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.972 0.415 . . . . 72.44 112.082 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.77 105.35 8.9 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.017 -0.538 . . . . 71.52 110.759 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 95.0 m-85 -87.03 142.19 33.71 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 111.873 0.324 . . . . 70.23 111.873 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -44.79 147.09 1.99 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.056 2.504 . . . . 72.24 113.485 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.582 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 23.0 pttp -74.47 134.93 42.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.611 0.719 . . . . 60.31 112.865 -172.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 2.4 mptp? -90.69 144.21 25.96 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.4 -0.818 . . . . 70.4 110.038 174.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -130.03 115.86 17.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.963 0.411 . . . . 73.35 110.728 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -140.37 166.13 25.52 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.301 0.572 . . . . 75.33 111.872 -173.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 78.9 p -90.09 123.9 34.34 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.267 -0.424 . . . . 62.3 110.219 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.401 ' HD3' ' HA3' ' A' ' 208' ' ' GLY . 24.6 mmm180 -56.94 164.38 1.6 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.601 0.239 . . . . 74.54 111.378 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -51.58 -33.17 31.48 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.253 0.835 . . . . 73.34 113.253 -172.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -102.56 18.29 21.6 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.863 -0.523 . . . . 74.14 111.966 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 77.36 38.27 29.43 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.36 -0.447 . . . . 75.51 114.096 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 71.2 p -114.59 166.83 11.3 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 122.408 -0.466 . . . . 72.35 111.364 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 133.33 45.87 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.038 0.384 . . . . 72.42 112.038 -176.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.401 ' HA3' ' HD3' ' A' ' 202' ' ' ARG . . . -163.56 136.17 4.15 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.953 -0.641 . . . . 51.05 113.377 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -117.46 173.94 6.43 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 122.531 -0.394 . . . . 74.01 111.017 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 226' ' ' LEU . 58.6 tp -153.72 144.18 22.38 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.176 -0.466 . . . . 74.43 111.782 -176.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 230' ' ' LEU . 8.3 ttpm? -144.3 124.38 13.63 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.053 0.454 . . . . 72.32 111.127 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.5 m -88.32 130.74 35.05 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.087 -0.506 . . . . 70.25 111.355 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.429 HD11 HD11 ' A' ' 226' ' ' LEU . 81.3 mt -122.25 150.84 41.74 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.054 0.454 . . . . 73.24 111.408 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -114.62 115.41 27.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.326 -0.397 . . . . 75.52 110.111 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.03 153.62 32.37 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.183 0.193 . . . . 71.32 111.076 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 221' ' ' SER . 0.0 OUTLIER -146.38 142.92 28.69 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.011 0.91 . . . . 72.11 112.863 176.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.87 -178.48 3.73 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.791 -1.188 . . . . 64.23 107.791 165.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.29 -20.13 59.29 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.705 -0.622 . . . . 73.2 111.08 172.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -82.13 -28.05 32.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.231 0.456 . . . . 70.22 112.231 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.68 179.53 41.49 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.009 -0.615 . . . . 54.31 113.619 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 216' ' ' LYS . 79.1 p -114.22 163.93 14.57 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.346 0.498 . . . . 71.21 112.346 -176.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.5 tp -151.33 152.4 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 116.285 -0.416 . . . . 63.23 111.263 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -95.5 122.3 38.09 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.869 0.366 . . . . 74.01 111.834 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -93.72 135.5 12.59 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.403 -0.427 . . . . 53.34 112.957 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 63.2 m -118.26 103.79 10.17 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.524 -0.398 . . . . 64.22 111.388 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 210' ' ' LEU . 75.4 mt -94.46 117.1 29.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 111.828 0.307 . . . . 63.24 111.828 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' TRP . . . . . 0.454 ' O ' ' HB2' ' A' ' 230' ' ' LEU . 84.4 m95 -98.86 166.06 11.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.977 0.418 . . . . 55.41 111.466 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 61.94 -150.97 0.37 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.527 -0.306 . . . . 64.31 111.666 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.59 -15.06 6.3 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.612 0.597 . . . . 62.33 112.612 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.459 ' O ' ' NZ ' ' A' ' 211' ' ' LYS . 96.5 mt -59.13 -16.15 18.23 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.015 0.436 . . . . 72.52 110.812 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' A' ' 197' ' ' LYS . . . -65.15 -47.13 78.12 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.315 -0.402 . . . . 60.01 110.733 170.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.96 -29.31 67.51 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.387 -0.37 . . . . 73.41 111.425 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -50.87 103.03 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.885 0.374 . . . . 73.02 110.502 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -81.63 120.89 25.66 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.192 0.52 . . . . 75.53 111.792 -174.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.427 ' CG2' HG21 ' A' ' 191' ' ' VAL . 13.3 p -116.07 143.93 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.828 -0.624 . . . . 74.3 110.623 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.4 ' NZ ' ' O ' ' A' ' 268' ' ' LEU . 5.7 mtpm? -104.97 154.36 20.21 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.979 0.363 . . . . 74.01 111.979 -173.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -81.19 133.66 35.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.808 0.337 . . . . 63.05 111.277 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.73 -34.45 5.46 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.524 -0.37 . . . . 72.32 113.06 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.2 144.86 56.56 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.057 0.456 . . . . 74.51 111.615 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.566 ' HB ' ' HG2' ' A' ' 265' ' ' GLU . 41.4 mm -92.39 136.38 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.75 0.309 . . . . 62.1 111.027 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -141.05 157.87 44.72 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.139 0.495 . . . . 64.35 112.122 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.47 120.19 40.78 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.002 -0.545 . . . . 71.33 110.098 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 85.9 t -110.56 123.89 66.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 111.897 0.332 . . . . 70.04 111.897 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.9 t -113.67 128.68 56.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.848 0.356 . . . . 75.02 111.435 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.91 -150.37 7.56 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.477 -0.868 . . . . 63.1 113.856 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -129.13 117.25 20.5 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.642 0.377 . . . . 72.53 111.056 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.53 HG21 HD22 ' A' ' 179' ' ' LEU . 46.3 t -86.79 125.88 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.624 0.249 . . . . 63.32 111.325 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.94 164.82 33.43 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.212 0.53 . . . . 71.02 112.01 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -91.85 115.48 28.1 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.046 -0.525 . . . . 74.23 110.626 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -138.47 -142.86 4.38 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.401 -0.904 . . . . 70.03 113.865 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -82.75 -27.94 30.75 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.04 0.448 . . . . 73.54 111.48 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 32.4 t -79.13 -1.44 36.04 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.088 0.471 . . . . 74.23 110.923 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 104.02 -126.96 8.95 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.785 -0.526 . . . . 74.41 111.785 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.3 mt -96.65 93.37 6.7 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.331 -0.618 . . . . 61.5 109.331 169.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.86 148.46 39.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.582 -0.736 . . . . 65.32 112.28 -168.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.458 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.8 tt -105.67 107.93 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.277 0.561 . . . . 63.33 110.881 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.4 t -70.46 104.84 2.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.976 0.417 . . . . 54.54 110.241 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.461 ' HB ' HD23 ' A' ' 226' ' ' LEU . 33.4 t -80.25 127.56 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.711 0.634 . . . . 61.44 112.711 -171.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -92.49 -49.16 6.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.89 -0.596 . . . . 73.51 110.405 174.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -139.23 132.74 30.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.002 -0.545 . . . . 72.52 110.586 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.1 tt -125.69 133.81 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.951 0.405 . . . . 73.11 111.222 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -130.6 131.34 6.47 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.21 -0.519 . . . . 34.32 112.992 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.6 mm -79.43 131.78 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 122.618 -0.342 . . . . 73.21 111.275 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.507 HD12 HG22 ' A' ' 240' ' ' ILE . 66.2 mt -83.59 -48.88 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.25 0.548 . . . . 74.42 110.335 176.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.566 ' HG2' ' HB ' ' A' ' 240' ' ' ILE . 24.2 mm-40 -87.25 70.71 10.09 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.168 0.509 . . . . 74.5 110.236 175.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -66.74 113.29 4.74 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.938 0.718 . . . . 73.34 112.938 -173.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 64.3 m 66.87 63.18 0.48 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.481 0.919 . . . . 71.44 113.481 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' ' 265' ' ' GLU . 81.3 mt -108.49 110.17 21.6 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.253 -0.43 . . . . 71.13 110.03 170.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 C--O 1.25 1.108 0 N-CA-C 113.715 1.006 . . . . 75.43 113.715 -172.659 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 172' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.819 0.342 . . . . 60.23 111.095 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -83.84 119.32 24.7 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.193 0.521 . . . . 72.32 111.917 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -85.25 169.27 13.95 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.547 0.689 . . . . 75.12 112.105 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -101.25 167.75 10.0 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.575 -0.739 . . . . 71.33 109.389 174.53 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 220' ' ' GLY . 25.9 mt -76.73 -41.27 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 121.866 -0.521 . . . . 75.25 111.055 175.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.8 t -68.55 -8.1 38.49 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.191 0.52 . . . . 72.54 111.113 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 175' ' ' LYS . 6.8 tp10 -82.6 -21.37 35.19 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 61.04 110.672 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.739 HD11 HD13 ' A' ' 187' ' ' ILE . 78.3 mt -73.44 117.67 15.48 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.451 0.643 . . . . 70.35 112.16 -174.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 22.5 ptp -130.15 157.07 78.23 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.708 -0.678 . . . . 72.42 110.262 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 182' ' ' ASN . 11.3 Cg_endo -54.4 138.37 73.4 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.06 1.84 . . . . 65.23 112.39 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 181' ' ' PRO . 2.5 m-20 74.63 11.05 3.97 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.29 0.636 . . . . 70.34 112.443 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.9 tp -90.94 149.11 22.01 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.305 -0.247 . . . . 70.13 110.855 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 73.3 p -135.8 118.31 15.85 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.184 -0.323 . . . . 61.34 110.76 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.75 -177.45 40.2 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.354 -0.927 . . . . 74.51 113.986 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 244' ' ' SER . 38.2 m -114.21 122.64 47.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.659 0.266 . . . . 61.51 111.535 -177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.739 HD13 HD11 ' A' ' 179' ' ' LEU . 47.7 pt -115.67 138.18 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.058 0.456 . . . . 55.55 111.41 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -108.73 103.16 12.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.98 -0.378 . . . . 74.02 109.98 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.78 176.11 8.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.132 0.492 . . . . 63.34 111.985 -173.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -96.75 130.76 43.94 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.895 -0.593 . . . . 74.33 111.669 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.96 102.25 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.918 0.39 . . . . 73.34 111.265 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.86 -48.32 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.096 0.474 . . . . 61.52 111.583 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -134.3 122.41 22.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.948 0.404 . . . . 72.25 112.081 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -97.14 103.16 15.07 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.863 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.43 ' HB3' ' HD2' ' A' ' 196' ' ' PRO . 88.9 m-85 -79.3 160.0 71.42 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 116.6 -0.273 . . . . 65.04 111.536 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 195' ' ' TYR . 48.4 Cg_endo -67.69 153.66 75.42 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.296 1.997 . . . . 44.34 113.017 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -85.72 134.79 33.94 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.436 0.636 . . . . 73.15 112.058 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -104.92 169.71 8.29 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.692 -0.685 . . . . 62.31 111.105 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.23 152.9 52.06 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.573 -0.285 . . . . 72.23 110.602 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -162.69 165.55 25.52 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.489 0.662 . . . . 72.35 112.205 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 88.0 p -104.85 137.38 42.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.658 -0.701 . . . . 62.12 109.928 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.568 ' HD2' ' OG1' ' A' ' 206' ' ' THR . 49.2 mtt180 -89.87 124.98 35.16 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.257 -0.277 . . . . 74.22 111.231 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.04 -20.23 16.05 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.893 0.378 . . . . 74.44 111.258 175.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.44 -34.26 68.78 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.113 -0.494 . . . . 75.44 111.265 173.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 129.65 -19.18 5.33 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 116.12 -0.491 . . . . 52.4 112.871 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.568 ' OG1' ' HD2' ' A' ' 202' ' ' ARG . 74.5 p -98.91 -166.11 1.32 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.092 0.405 . . . . 73.32 112.092 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -132.42 -174.46 3.45 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.815 0.34 . . . . 70.23 111.391 -177.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 155.76 161.01 10.33 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.689 -0.767 . . . . 52.32 113.908 176.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.425 ' H ' ' HA ' ' A' ' 228' ' ' ASN . 48.5 mt-30 -98.36 175.67 5.97 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.675 0.39 . . . . 63.43 111.668 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.0 tp -155.23 110.89 3.09 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.168 0.432 . . . . 72.04 112.168 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.96 140.51 52.26 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.056 -0.403 . . . . 63.14 111.447 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 37.7 t -106.8 152.61 23.62 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.946 0.403 . . . . 71.45 111.449 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.3 mt -136.27 143.76 44.42 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.651 0.38 . . . . 74.32 110.677 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -97.95 112.67 24.51 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.068 -0.395 . . . . 72.42 110.835 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 79.6 mt -107.74 135.93 48.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.415 0.286 . . . . 54.41 111.166 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -132.44 154.81 49.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.604 0.716 . . . . 73.34 111.923 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -155.45 167.21 31.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.971 -1.013 . . . . 72.12 109.068 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -60.03 -18.41 46.15 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.069 -0.394 . . . . 64.12 111.821 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 80.5 p -98.23 18.57 15.98 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.332 0.494 . . . . 72.54 112.332 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.409 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 125.83 -179.0 16.43 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.746 -0.74 . . . . 64.41 113.764 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 47.8 p -136.85 131.63 33.49 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.535 -0.391 . . . . 72.43 111.196 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 15.3 tt -138.04 156.73 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.005 0.431 . . . . 74.43 111.22 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -101.03 116.32 32.57 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.968 0.413 . . . . 75.31 111.29 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.453 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -83.01 157.62 35.57 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.235 -0.439 . . . . 72.33 113.521 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.1 m -128.97 114.23 16.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.882 0.372 . . . . 73.14 111.985 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.53 HD23 ' HB ' ' A' ' 258' ' ' VAL . 87.2 mt -99.21 112.13 24.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.235 -0.439 . . . . 75.12 111.217 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -91.6 157.07 17.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.893 0.378 . . . . 74.11 111.57 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.425 ' HA ' ' H ' ' A' ' 209' ' ' GLN . 73.6 m-20 63.76 -155.39 0.32 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.325 -0.398 . . . . 75.12 111.791 175.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -53.44 -20.12 4.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.964 0.727 . . . . 71.01 112.964 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 95.6 mt -57.44 -23.5 49.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.29 0.567 . . . . 70.22 111.276 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.12 -27.97 69.3 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.888 0.375 . . . . 41.03 111.679 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.48 -0.22 54.85 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.976 0.417 . . . . 72.21 111.012 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -57.79 135.1 56.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.18 -0.464 . . . . 53.3 111.87 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.67 118.01 7.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.637 -0.711 . . . . 72.55 111.979 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.614 ' HA ' HD11 ' A' ' 263' ' ' ILE . 9.7 p -134.53 142.94 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.906 0.384 . . . . 75.45 111.18 176.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -118.42 151.45 37.76 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.394 -0.366 . . . . 61.14 111.384 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -75.97 142.21 42.01 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.931 0.396 . . . . 73.2 111.388 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.77 28.55 73.5 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.124 -0.489 . . . . 41.15 113.351 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.17 158.1 21.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.784 0.326 . . . . 75.34 110.958 -178.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.548 HG22 HD12 ' A' ' 264' ' ' ILE . 48.0 mm -96.67 117.04 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.214 0.53 . . . . 75.22 111.209 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -118.38 135.63 54.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.432 0.53 . . . . 74.11 112.432 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -82.66 103.91 12.52 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.862 -0.608 . . . . 71.44 109.855 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 72.9 t -113.5 111.84 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 112.219 0.452 . . . . 55.32 112.219 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 21.3 t -113.33 129.48 56.52 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.349 -0.22 . . . . 52.4 110.958 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.0 -173.02 37.08 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.388 -0.91 . . . . 41.34 114.274 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -104.87 119.41 38.94 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.969 0.508 . . . . 74.21 110.591 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.468 HG21 HD22 ' A' ' 179' ' ' LEU . 30.6 t -85.83 135.46 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.258 0.551 . . . . 70.34 112.211 -176.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.47 163.93 29.91 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.98 -0.554 . . . . 75.55 110.794 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -112.31 133.51 54.38 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.833 0.349 . . . . 53.41 111.057 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 172.74 -92.06 0.09 OUTLIER Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.937 -0.649 . . . . 70.23 113.03 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -75.17 132.94 41.52 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.779 0.323 . . . . 72.02 111.046 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 33.4 t 59.11 25.16 13.59 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.138 0.494 . . . . 74.13 111.274 -176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 84.44 -84.13 1.6 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.246 -0.502 . . . . 73.4 112.873 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 93.3 mt -112.16 118.37 35.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.945 0.402 . . . . 61.41 111.423 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.5 125.5 49.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.217 -0.447 . . . . 73.23 111.321 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.453 HG23 ' HA2' ' A' ' 224' ' ' GLY . 7.9 tt -105.51 112.79 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.343 0.592 . . . . 75.44 111.545 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.5 t -77.49 105.29 8.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.198 -0.455 . . . . 71.5 110.591 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.53 ' HB ' HD23 ' A' ' 226' ' ' LEU . 40.3 t -78.51 135.49 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.245 0.545 . . . . 75.34 112.459 -172.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -106.79 -43.21 4.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.918 -0.583 . . . . 73.13 110.818 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 25.6 t-20 -124.13 132.56 53.65 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.967 -0.561 . . . . 73.2 110.541 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.6 tt -144.02 123.93 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.219 0.533 . . . . 74.13 111.436 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -139.15 124.84 2.9 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 121.095 -0.574 . . . . 61.04 113.165 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' A' ' 235' ' ' VAL . 46.4 mt -69.24 123.13 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.845 0.355 . . . . 65.35 111.213 176.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.548 HD12 HG22 ' A' ' 240' ' ' ILE . 68.0 mt -76.43 -43.79 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.631 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -91.67 80.93 5.3 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.55 0.691 . . . . 63.53 111.424 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -92.59 101.08 13.5 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.169 -0.469 . . . . 75.41 111.579 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 40.0 t -113.7 136.48 52.79 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.829 0.347 . . . . 51.55 110.863 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 2.5 pp -101.6 11.53 38.79 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.758 0.314 . . . . 73.02 111.562 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 C--O 1.254 1.294 0 CA-C-O 118.654 -0.689 . . . . 53.2 112.058 -177.478 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.534 ' SD ' ' N ' ' A' ' 172' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.538 0.209 . . . . 75.3 111.457 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -115.68 103.31 10.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.851 -0.426 . . . . 73.43 109.851 176.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -94.26 146.14 24.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.311 0.577 . . . . 74.13 112.17 -175.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.89 160.08 16.03 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.904 -0.589 . . . . 74.12 110.573 169.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 220' ' ' GLY . 63.6 mt -59.09 -31.86 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.914 0.709 . . . . 72.24 112.914 -171.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.464 ' CB ' ' HB ' ' A' ' 219' ' ' THR . 70.6 p -62.67 -31.02 71.83 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.946 0.35 . . . . 72.32 111.946 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -88.33 -19.93 26.04 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 111.816 0.302 . . . . 75.14 111.816 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.535 HD22 HG21 ' A' ' 247' ' ' VAL . 78.4 mt -56.25 117.37 3.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.5 0.556 . . . . 55.1 112.5 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.416 ' HG2' HD22 ' A' ' 183' ' ' LEU . 24.1 ptp -114.44 157.42 42.67 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.741 -0.663 . . . . 71.22 110.465 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.83 142.64 99.14 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.054 1.836 . . . . 50.21 112.52 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 72.7 14.89 4.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.129 0.572 . . . . 64.21 112.029 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.416 HD22 ' HG2' ' A' ' 180' ' ' MET . 40.9 tp -93.28 132.89 37.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.959 0.355 . . . . 54.41 111.959 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.0 p -110.83 125.56 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.374 -0.204 . . . . 53.03 111.104 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -178.69 -165.56 33.39 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.628 -0.796 . . . . 54.03 113.848 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.9 m -126.09 140.48 52.55 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.45 0.3 . . . . 53.25 111.581 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 33.7 pt -127.12 156.78 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.18 0.515 . . . . 65.12 111.992 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -118.69 112.04 19.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.046 -0.524 . . . . 63.11 110.648 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -150.87 163.43 38.68 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.445 0.535 . . . . 75.04 112.445 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -82.44 135.52 35.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.201 -0.454 . . . . 60.45 111.494 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.04 100.59 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.929 0.395 . . . . 72.44 110.743 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.8 -59.04 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.117 0.484 . . . . 70.34 111.473 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -130.28 143.99 51.11 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.986 -0.552 . . . . 74.23 111.411 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -126.63 107.01 9.81 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.933 -0.576 . . . . 43.51 110.849 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.568 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 92.2 m-85 -96.13 135.16 22.84 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.681 -0.236 . . . . 73.43 111.338 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.46 162.07 0.63 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.222 2.615 . . . . 74.12 113.899 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -73.4 119.56 17.8 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.059 0.763 . . . . 74.12 113.059 -173.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -67.81 151.19 47.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.33 -0.85 . . . . 75.32 111.276 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -115.61 129.61 56.57 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.323 -0.399 . . . . 73.23 110.693 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -147.27 154.4 40.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.173 0.511 . . . . 55.41 111.654 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 89.5 p -104.84 135.24 46.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.94 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -71.33 134.75 46.97 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.992 -0.373 . . . . 73.54 109.992 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -25.16 40.44 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.003 0.43 . . . . 61.12 111.401 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -55.19 -46.18 75.83 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.903 -0.59 . . . . 73.01 111.519 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 142.23 -22.81 2.41 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.218 -0.446 . . . . 73.43 112.147 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 80.5 p -81.61 -174.41 4.97 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.89 0.376 . . . . 73.14 111.471 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 207' ' ' LYS . 16.3 ptpt -140.72 166.31 25.1 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.955 0.354 . . . . 74.21 111.955 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.95 179.63 35.37 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.176 -0.535 . . . . 32.32 113.012 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -128.07 156.14 43.26 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.632 -0.334 . . . . 63.43 110.72 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 225' ' ' THR . 17.6 tp -144.54 125.14 14.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.181 0.438 . . . . 64.41 112.181 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 195' ' ' TYR . 7.2 ttpm? -112.63 131.92 55.4 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.729 -0.607 . . . . 74.14 111.111 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 51.2 m -98.86 121.39 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.115 -0.493 . . . . 75.03 111.686 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 226' ' ' LEU . 80.9 mt -119.8 157.43 28.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.352 -0.385 . . . . 74.55 111.16 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -128.3 120.81 27.82 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.645 0.26 . . . . 73.34 110.395 173.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.573 HD11 HG21 ' A' ' 243' ' ' VAL . 66.6 mt -105.2 153.09 22.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.808 0.337 . . . . 74.34 111.616 -176.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -141.67 152.32 43.81 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.278 0.561 . . . . 63.14 111.753 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -155.1 168.38 27.22 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.601 -0.727 . . . . 71.12 109.781 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -61.28 -20.14 62.53 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.928 -0.483 . . . . 73.4 111.947 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.464 ' HB ' ' CB ' ' A' ' 177' ' ' SER . 80.2 p -91.2 -6.22 53.76 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.782 0.66 . . . . 70.44 112.782 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 150.03 -178.43 27.52 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.669 -0.777 . . . . 75.43 113.624 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 61.5 p -127.28 143.12 51.3 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.671 -0.311 . . . . 60.44 111.102 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.1 164.48 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 122.318 -0.239 . . . . 73.31 111.031 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.75 ' H ' ' HD2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -111.52 137.42 49.37 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.851 -0.53 . . . . 75.21 110.808 176.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -108.24 131.49 10.62 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.46 -0.4 . . . . 75.11 113.205 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.504 HG23 HD11 ' A' ' 210' ' ' LEU . 85.4 m -107.21 111.88 24.49 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.693 -0.298 . . . . 74.14 111.762 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.519 HD23 ' HB ' ' A' ' 258' ' ' VAL . 70.9 mt -99.04 109.48 22.22 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.035 0.383 . . . . 31.54 112.035 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -93.44 161.86 14.21 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.11 0.481 . . . . 75.1 112.104 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.422 ' CG ' ' H ' ' A' ' 229' ' ' GLU . 62.9 t30 57.69 -133.93 1.17 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.178 -0.465 . . . . 74.51 111.615 170.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.422 ' H ' ' CG ' ' A' ' 228' ' ' ASN . 11.4 pt-20 -60.06 -29.02 68.27 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.912 -0.493 . . . . 74.24 111.76 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.498 ' HB3' HD22 ' A' ' 226' ' ' LEU . 72.1 mt -61.06 -16.98 49.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.92 0.391 . . . . 75.1 111.231 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.58 88.11 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.663 0.268 . . . . 73.11 111.178 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -94.28 -15.62 24.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.842 0.353 . . . . 73.52 110.96 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -47.34 128.07 11.61 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.706 0.402 . . . . 61.11 111.524 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -70.23 120.23 15.6 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.658 0.614 . . . . 74.12 112.658 -175.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.25 134.23 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.698 -0.683 . . . . 73.52 110.053 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 239' ' ' ASP . 58.6 mttm -99.9 150.71 22.11 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.156 0.503 . . . . 73.35 112.241 -173.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -66.61 108.7 2.54 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.385 -0.37 . . . . 44.02 110.419 174.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.39 17.17 29.86 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.408 -0.425 . . . . 53.53 112.798 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 25.2 t0 -90.88 157.0 17.59 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.699 0.285 . . . . 64.1 111.181 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 42.3 mm -95.18 105.28 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.146 0.498 . . . . 72.25 110.805 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -113.8 127.07 55.86 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.821 0.675 . . . . 72.41 112.821 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -86.75 104.17 15.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.228 0.537 . . . . 72.22 109.827 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.573 HG21 HD11 ' A' ' 215' ' ' LEU . 89.0 t -102.47 120.24 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.61 0.596 . . . . 61.35 112.61 -171.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.1 t -113.64 133.14 55.48 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.24 -0.436 . . . . 53.1 111.176 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.03 -155.78 17.93 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.205 -0.998 . . . . 73.4 113.983 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 85.8 t80 -116.31 112.12 21.09 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.779 0.432 . . . . 62.53 111.467 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.535 HG21 HD22 ' A' ' 179' ' ' LEU . 48.1 t -83.34 118.18 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 120.965 0.412 . . . . 61.34 111.177 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 58.8 pttt -135.42 157.17 47.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.228 0.537 . . . . 73.32 111.437 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -93.77 133.32 37.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.046 0.45 . . . . 72.0 111.289 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 166.14 -82.61 0.1 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.973 -0.632 . . . . 73.42 112.823 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -73.95 122.73 23.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.745 0.307 . . . . 64.21 111.382 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 34.1 t 55.54 43.35 28.56 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.024 0.44 . . . . 55.03 111.885 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 82.92 -112.92 3.59 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.881 -0.676 . . . . 53.4 112.616 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.52 121.66 43.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.59 0.356 . . . . 73.12 110.252 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 160.84 25.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.021 0.439 . . . . 74.24 111.118 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 7.9 tt -120.36 104.43 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.631 0.729 . . . . 71.03 111.421 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.6 t -68.93 102.52 1.6 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.647 -0.706 . . . . 75.54 110.296 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.519 ' HB ' HD23 ' A' ' 226' ' ' LEU . 21.7 t -74.43 117.72 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.264 -0.425 . . . . 72.34 112.122 -173.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -94.97 -21.7 18.44 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.879 0.371 . . . . 71.23 111.1 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -156.61 120.76 4.4 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.798 0.332 . . . . 73.22 110.944 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.5 ' HB ' HG11 ' A' ' 258' ' ' VAL . 11.4 tt -125.3 135.37 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.034 0.445 . . . . 63.21 111.582 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -133.59 125.29 3.92 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.15 -0.548 . . . . 75.42 112.763 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 266' ' ' LYS . 49.4 mm -76.02 139.9 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.942 0.401 . . . . 75.34 110.737 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.531 HG22 ' HG3' ' A' ' 265' ' ' GLU . 48.1 mm -70.37 -46.4 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.776 0.322 . . . . 64.33 111.717 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.531 ' HG3' HG22 ' A' ' 264' ' ' ILE . 41.1 mt-10 -136.68 106.42 6.21 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.741 0.305 . . . . 75.5 111.317 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.552 ' HD3' ' HB ' ' A' ' 263' ' ' ILE . 2.8 mmmp? -77.25 103.66 7.31 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.018 0.437 . . . . 65.14 111.057 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 40.7 t -83.04 125.89 31.94 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.261 -0.427 . . . . 73.31 111.524 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 86.7 mt -99.55 -43.17 6.61 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.038 0.447 . . . . 74.35 110.915 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 118.633 -0.698 . . . . 53.22 111.092 179.282 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 16.4 tpt . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.795 0.331 . . . . 71.44 111.556 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -85.15 138.65 32.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.131 0.491 . . . . 71.12 111.066 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' TYR . . . . . 0.4 ' O ' HG22 ' A' ' 187' ' ' ILE . 47.4 m-85 -106.52 153.93 21.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.298 0.571 . . . . 63.35 111.603 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -93.21 155.68 17.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.318 -0.623 . . . . 71.35 109.318 167.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 49.4 mt -61.33 -24.59 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.076 0.465 . . . . 74.02 111.599 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.477 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 39.2 t -70.75 -12.9 61.83 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.131 0.419 . . . . 74.24 112.131 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -97.3 -1.94 43.61 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.603 0.594 . . . . 72.42 112.603 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.536 HD22 HG21 ' A' ' 247' ' ' VAL . 88.4 mt -68.08 150.68 48.11 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.176 0.806 . . . . 75.32 113.176 -172.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -162.23 156.4 18.51 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.289 -0.869 . . . . 74.1 110.213 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.62 138.16 83.74 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.307 2.004 . . . . 74.11 113.295 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.425 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 65.3 m-20 65.42 33.4 8.9 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.161 0.585 . . . . 70.15 111.562 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 52.8 tp -96.03 145.51 25.39 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.119 -0.491 . . . . 71.23 111.739 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 75.4 p -120.98 129.36 53.39 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.245 -0.434 . . . . 41.24 110.693 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.67 179.53 47.87 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.714 -0.755 . . . . 71.54 113.761 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 77.2 m -121.55 128.14 51.7 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.735 0.302 . . . . 71.45 111.343 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 174' ' ' TYR . 34.7 pt -120.5 152.79 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.171 0.51 . . . . 65.22 111.888 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -114.55 105.88 13.61 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.127 -0.488 . . . . 65.45 110.243 176.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.07 164.97 25.07 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.862 0.69 . . . . 61.14 112.862 -173.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.2 136.84 40.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.606 -0.725 . . . . 72.23 111.44 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.14 102.52 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.912 0.386 . . . . 63.22 111.519 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.7 t -82.62 -34.1 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.004 0.43 . . . . 60.11 111.872 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -141.17 117.74 10.9 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.757 0.313 . . . . 61.03 111.31 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -95.35 98.96 10.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.973 0.416 . . . . 61.45 110.981 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -78.5 143.96 64.75 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.463 -0.335 . . . . 74.43 111.078 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.12 151.6 83.32 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.775 2.317 . . . . 74.34 112.863 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LYS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 20.5 ptmt -67.74 125.24 25.6 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.579 0.585 . . . . 72.04 112.579 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -94.1 153.16 18.27 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.044 -0.525 . . . . 75.41 110.94 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.49 143.96 49.37 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.448 -0.342 . . . . 73.44 110.743 176.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -162.36 163.21 28.0 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.296 0.569 . . . . 64.01 111.695 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 37.6 t -91.51 133.03 35.86 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.984 -0.553 . . . . 74.14 110.505 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -72.83 164.05 27.18 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.815 0.34 . . . . 64.31 111.664 177.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -64.24 -20.46 66.06 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.21 0.529 . . . . 75.11 110.457 174.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.26 -8.8 59.32 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.79 -0.641 . . . . 45.14 111.453 176.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 77.97 14.66 82.09 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.049 -0.596 . . . . 64.42 112.714 -174.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 67.8 p -107.11 172.11 7.01 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.954 0.353 . . . . 54.23 111.954 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' LYS . . . . . 0.506 ' HB3' ' NZ ' ' A' ' 207' ' ' LYS . 8.0 mtpm? -59.16 136.99 58.13 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.517 0.562 . . . . 72.11 112.517 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.57 131.92 3.95 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.273 -0.489 . . . . 40.32 112.887 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 228' ' ' ASN . 37.5 mt-30 -128.75 155.44 45.12 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.343 -0.504 . . . . 73.23 110.301 175.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 48.3 tp -142.48 112.75 7.13 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.766 0.317 . . . . 53.21 111.64 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 49.3 tttm -126.62 108.09 10.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.704 0.288 . . . . 62.11 110.834 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 66.9 m -86.27 150.07 24.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.932 0.396 . . . . 50.43 111.566 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.422 HD11 HG11 ' A' ' 235' ' ' VAL . 91.7 mt -137.24 134.94 36.75 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.422 -0.354 . . . . 75.34 110.915 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -89.59 106.46 18.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.73 0.3 . . . . 75.25 110.224 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.67 141.96 34.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.503 0.321 . . . . 74.45 110.999 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -127.96 155.06 44.85 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.593 0.711 . . . . 74.41 112.443 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -148.24 160.9 42.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.06 -0.973 . . . . 74.15 109.347 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.18 -21.08 64.79 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.992 0.425 . . . . 75.13 111.553 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 72.3 p -92.49 -1.27 57.09 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.212 0.449 . . . . 70.33 112.212 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 148.06 176.75 21.84 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.071 -0.585 . . . . 75.53 113.612 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.7 p -120.48 158.8 26.46 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.503 -0.41 . . . . 64.44 111.341 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -157.95 145.28 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.92 0.39 . . . . 74.15 111.265 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -96.71 112.08 23.98 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.918 0.39 . . . . 61.41 111.197 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.436 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -81.91 159.08 39.43 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 116.101 -0.5 . . . . 32.34 113.366 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 84.9 m -129.08 114.63 16.6 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.357 0.503 . . . . 63.1 112.357 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 92.3 mt -95.6 117.28 30.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.437 -0.347 . . . . 63.34 110.993 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -99.07 156.35 16.98 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.086 0.47 . . . . 74.11 111.754 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 209' ' ' GLN . 61.2 t30 61.51 -146.84 0.42 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.968 -0.56 . . . . 72.04 111.482 174.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.43 -4.9 4.38 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.661 0.615 . . . . 72.51 112.661 -174.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 93.1 mt -65.29 -15.63 62.72 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.101 0.477 . . . . 73.33 110.707 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 197' ' ' LYS . . . -65.88 -23.07 66.57 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.201 -0.454 . . . . 51.41 111.499 175.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.21 4.09 53.17 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.286 -0.415 . . . . 74.21 111.557 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -69.3 113.8 6.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.044 0.45 . . . . 74.11 110.488 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.85 90.61 0.43 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.38 0.61 . . . . 63.24 111.838 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 213' ' ' LEU . 5.0 p -128.44 122.83 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.509 -0.769 . . . . 65.01 110.794 177.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -113.63 172.36 7.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.098 0.475 . . . . 73.33 111.428 -175.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -65.4 122.1 16.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.361 -0.381 . . . . 73.04 110.848 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.14 -26.58 9.71 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.157 -0.544 . . . . 74.42 113.596 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -65.87 130.81 44.54 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 117.188 0.494 . . . . 64.32 111.618 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 42.0 mm -77.71 108.36 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.078 -0.51 . . . . 64.1 110.08 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -113.78 130.12 56.49 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.318 0.58 . . . . 71.23 112.555 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLU . . . . . 0.532 ' HB2' HD11 ' A' ' 264' ' ' ILE . 40.3 tt0 -92.72 112.7 24.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.905 -0.589 . . . . 73.43 109.597 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.1 t -115.34 127.04 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.269 0.557 . . . . 71.02 112.423 -172.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.7 t -124.24 132.9 53.62 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.091 -0.504 . . . . 71.34 109.79 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.02 -164.9 29.83 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.121 -1.038 . . . . 71.23 114.196 -177.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -106.95 115.36 30.05 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.077 0.465 . . . . 73.22 111.172 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.536 HG21 HD22 ' A' ' 179' ' ' LEU . 47.5 t -89.09 123.87 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.294 -0.412 . . . . 74.1 111.052 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.425 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 26.6 pttm -142.37 158.23 43.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.094 0.473 . . . . 62.55 112.005 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -100.38 155.22 17.93 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.176 -0.465 . . . . 64.14 111.317 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 178.48 -152.79 11.81 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.9 -0.667 . . . . 62.41 113.161 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -61.14 -28.67 69.28 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.057 0.456 . . . . 74.43 111.731 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.6 t -86.88 10.9 14.7 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.918 0.39 . . . . 70.22 111.32 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 79.52 -131.51 10.66 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.081 -0.58 . . . . 63.51 112.191 -176.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 97.2 mt -95.56 115.67 27.76 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 117.017 0.409 . . . . 65.15 110.827 174.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -120.93 161.24 21.91 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.078 0.466 . . . . 63.33 111.481 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.436 HG23 ' HA2' ' A' ' 224' ' ' GLY . 6.9 tt -128.17 105.14 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.419 0.628 . . . . 72.15 110.83 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 72.4 m -73.59 106.95 5.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.114 -0.494 . . . . 74.43 110.049 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.529 HG11 ' HB ' ' A' ' 261' ' ' ILE . 46.5 t -66.6 129.67 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 113.17 0.804 . . . . 61.22 113.17 -171.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.64 -47.18 6.32 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.695 -0.684 . . . . 73.3 110.267 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -135.74 128.2 30.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.975 -0.557 . . . . 72.52 110.452 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.529 ' HB ' HG11 ' A' ' 258' ' ' VAL . 10.7 tt -134.25 135.02 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.777 0.322 . . . . 74.44 111.217 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -144.59 136.89 6.92 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.844 -0.693 . . . . 70.22 113.362 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.84 106.75 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.87 0.367 . . . . 62.23 110.964 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 242' ' ' GLU . 63.4 mt -66.37 -61.4 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.079 0.466 . . . . 71.05 111.125 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -102.79 97.2 7.39 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.031 -0.531 . . . . 74.1 110.73 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -102.77 161.19 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.977 0.418 . . . . 65.32 111.368 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 68.7 p -121.64 115.64 23.12 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.981 0.419 . . . . 64.12 111.814 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 269' ' ' GLU . 2.0 pp -154.33 -29.85 0.12 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.043 -0.526 . . . . 72.32 111.471 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.574 ' N ' HD12 ' A' ' 268' ' ' LEU . 65.9 mm-40 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.75 -0.643 . . . . 55.34 111.094 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 172' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.186 0.517 . . . . 61.41 112.202 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 186' ' ' THR . 12.3 m120 -98.89 110.83 23.38 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.153 -0.476 . . . . 45.3 110.53 172.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -99.19 156.66 16.85 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.157 0.503 . . . . 53.14 111.377 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -98.72 168.17 10.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.507 -0.553 . . . . 62.15 109.507 169.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.406 HG23 ' HB ' ' A' ' 222' ' ' ILE . 56.8 mt -64.49 -18.5 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.359 0.503 . . . . 73.25 112.359 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 40.9 t -71.55 -36.46 70.97 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.001 0.371 . . . . 75.45 112.001 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -79.05 -10.22 59.76 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.511 0.56 . . . . 71.34 112.511 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.583 HD22 HG21 ' A' ' 247' ' ' VAL . 69.1 mt -62.52 121.73 14.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.315 0.579 . . . . 71.4 111.998 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.0 ptp -140.88 160.82 57.0 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.69 -0.686 . . . . 55.51 110.348 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 248' ' ' LYS . 18.4 Cg_endo -58.63 133.94 57.6 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.941 1.761 . . . . 74.04 112.367 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 71.68 29.78 2.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.979 0.512 . . . . 74.24 111.726 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.62 138.37 40.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.033 0.444 . . . . 75.44 111.402 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.2 p -116.51 128.37 55.38 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.574 -0.284 . . . . 44.43 110.537 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.5 178.0 45.93 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.083 -1.055 . . . . 31.34 114.164 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 61.8 m -113.12 121.84 45.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.393 0.277 . . . . 74.53 111.627 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.412 ' CG2' HD21 ' A' ' 179' ' ' LEU . 23.6 pt -102.87 152.77 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.073 0.463 . . . . 63.54 112.029 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.96 110.98 17.34 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.191 -0.459 . . . . 73.34 111.607 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -161.39 167.12 26.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.835 0.35 . . . . 73.15 111.668 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.494 ' HB3' HD13 ' A' ' 240' ' ' ILE . 12.5 pt-20 -95.63 149.55 21.33 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.052 0.453 . . . . 74.41 111.493 176.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 23.5 t -81.81 114.17 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.352 0.596 . . . . 71.53 111.939 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 25.4 t -82.23 -52.39 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.945 -0.57 . . . . 63.21 111.451 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -127.58 128.65 45.94 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.254 -0.43 . . . . 72.43 111.388 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -114.45 119.08 35.64 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.26 -0.427 . . . . 54.12 111.17 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.439 ' O ' ' HG2' ' A' ' 211' ' ' LYS . 25.7 m-85 -89.13 140.15 28.86 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.445 -0.343 . . . . 65.43 111.337 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.73 172.9 14.31 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.56 2.173 . . . . 34.13 113.186 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.85 134.98 42.61 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.482 0.919 . . . . 73.43 113.482 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -111.4 134.83 52.69 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.165 -0.68 . . . . 74.2 109.165 166.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.94 134.6 44.9 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.976 0.732 . . . . 73.32 112.976 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -150.81 166.89 29.14 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.111 -0.495 . . . . 73.23 110.843 172.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 59.3 p -115.44 151.91 33.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.798 0.332 . . . . 62.22 111.238 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -107.95 149.4 28.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.032 0.444 . . . . 73.23 111.913 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -52.66 -30.66 33.05 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.763 0.653 . . . . 71.11 112.763 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.34 -2.39 21.93 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.27 0.47 . . . . 75.12 112.27 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 83.74 8.53 84.35 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.407 -0.425 . . . . 65.5 112.94 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 52.9 p -92.3 162.94 14.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.016 0.436 . . . . 63.53 111.595 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -67.86 162.21 24.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.38 0.609 . . . . 74.54 111.869 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.44 142.79 9.05 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.541 -0.754 . . . . 75.13 112.316 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -152.68 145.29 24.21 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.154 0.502 . . . . 63.52 111.659 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.7 tp -125.16 145.31 50.02 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.558 -0.746 . . . . 74.24 110.957 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.473 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 1.6 tmtp? -146.97 136.16 22.57 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.174 -0.328 . . . . 74.3 110.979 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 51.5 m -111.89 153.97 25.88 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.293 0.479 . . . . 75.31 112.293 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.47 HD21 ' HE2' ' A' ' 211' ' ' LYS . 95.5 mt -136.68 161.82 34.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.919 -0.582 . . . . 74.13 110.921 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -128.23 120.04 26.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.621 0.248 . . . . 32.51 110.869 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 243' ' ' VAL . 78.8 mt -114.74 142.93 45.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.554 0.342 . . . . 75.51 110.653 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -134.92 147.94 49.93 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.346 0.593 . . . . 74.22 111.994 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -152.32 168.58 24.96 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.55 -0.75 . . . . 73.12 109.864 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -62.33 -25.23 67.77 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.99 0.424 . . . . 71.33 111.465 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 80.6 p -79.93 -14.75 58.38 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.403 0.52 . . . . 63.43 112.403 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 154.54 -179.03 30.98 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.939 -0.648 . . . . 75.13 113.351 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 84.8 p -127.89 125.75 40.22 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.496 -0.414 . . . . 73.33 110.976 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 176' ' ' ILE . 10.1 tp -126.82 148.13 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.122 0.487 . . . . 64.25 111.93 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 73.9 mtm-85 -100.16 138.7 36.87 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.056 0.455 . . . . 74.15 110.953 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -114.63 152.25 18.16 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.303 -0.475 . . . . 73.4 113.197 -176.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 59.5 m -124.45 125.55 44.44 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.151 0.426 . . . . 72.52 112.151 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.582 HD23 ' HB ' ' A' ' 258' ' ' VAL . 83.4 mt -109.92 134.56 51.95 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.017 0.527 . . . . 72.25 111.246 176.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -114.58 172.13 7.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.926 0.393 . . . . 74.2 111.094 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 54.1 t30 57.89 -153.6 0.37 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 116.148 -0.478 . . . . 64.01 111.207 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.98 -27.11 61.15 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.822 -0.549 . . . . 72.23 112.46 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 73.7 mt -60.59 -18.83 55.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.906 0.384 . . . . 74.43 111.633 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.473 ' HB1' ' HB2' ' A' ' 211' ' ' LYS . . . -59.47 -44.05 93.12 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.847 0.356 . . . . 64.23 111.494 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -90.67 13.39 16.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.903 0.334 . . . . 74.2 111.903 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -55.35 130.02 40.84 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.37 0.268 . . . . 72.04 110.722 175.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -70.71 77.44 0.61 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.524 0.678 . . . . 74.54 112.222 -174.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.66 139.75 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.927 -0.579 . . . . 65.42 110.23 174.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.403 ' HB3' ' NZ ' ' A' ' 236' ' ' LYS . 0.1 OUTLIER -126.75 115.8 19.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.363 0.601 . . . . 70.32 111.784 -173.106 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 192' ' ' VAL . 4.8 ttmp? -42.99 109.24 0.13 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.533 -0.758 . . . . 63.42 112.894 -172.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.48 4.53 23.38 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.095 -0.502 . . . . 52.45 113.685 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -86.21 156.67 20.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.148 0.499 . . . . 64.32 111.872 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 190' ' ' GLU . 38.1 mm -92.09 103.71 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.267 -0.424 . . . . 74.01 110.909 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -107.25 119.65 39.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.321 0.489 . . . . 74.43 112.321 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -87.15 103.49 15.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.24 0.543 . . . . 72.2 109.77 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.597 HG21 HD11 ' A' ' 215' ' ' LEU . 78.7 t -100.0 124.3 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 112.799 0.666 . . . . 75.52 112.799 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 42.4 t -118.02 123.53 45.92 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.32 -0.4 . . . . 62.42 110.781 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 258' ' ' VAL . . . -167.22 -161.48 16.61 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.415 -0.897 . . . . 73.12 114.202 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -112.9 114.36 26.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.465 0.306 . . . . 74.33 110.991 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.583 HG21 HD22 ' A' ' 179' ' ' LEU . 25.8 t -90.52 128.14 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.657 0.265 . . . . 71.21 110.977 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 181' ' ' PRO . 14.6 ptmm? -154.16 170.86 20.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.269 0.557 . . . . 63.05 112.016 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -101.36 150.4 23.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.882 -0.599 . . . . 74.21 110.83 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 168.16 -108.33 0.3 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.531 -0.842 . . . . 62.11 113.144 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -73.11 137.67 45.36 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.803 -0.234 . . . . 75.24 110.854 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 50.4 m 73.81 -51.99 0.69 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.192 0.597 . . . . 73.23 111.775 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 161.43 -114.29 0.6 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.269 -0.491 . . . . 72.23 113.004 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 96.5 mt -110.68 106.34 15.53 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.664 -0.315 . . . . 71.25 111.196 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -136.43 170.27 16.31 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.12 0.486 . . . . 74.12 111.705 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.3 tt -116.65 121.7 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.471 0.545 . . . . 74.54 112.471 -176.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.5 t -85.72 103.79 14.83 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.009 0.433 . . . . 72.43 109.917 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.582 ' HB ' HD23 ' A' ' 226' ' ' LEU . 27.0 t -74.56 136.49 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 112.544 0.572 . . . . 73.44 112.544 -171.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -105.13 -39.95 6.04 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.314 -0.403 . . . . 65.35 110.612 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -134.61 138.68 44.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.156 -0.474 . . . . 64.03 110.952 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.7 tt -141.45 123.66 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.05 0.452 . . . . 60.35 111.242 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -128.33 131.51 6.98 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.029 -0.605 . . . . 62.44 113.375 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.77 116.1 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 O-C-N 122.681 -0.306 . . . . 55.22 110.369 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 50.6 mt -56.79 -43.29 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.716 0.293 . . . . 72.42 111.681 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -95.76 90.06 5.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.065 0.459 . . . . 71.14 111.203 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -69.04 80.94 0.32 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.521 0.677 . . . . 62.12 110.827 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 45.9 m -96.91 107.43 19.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.644 -0.707 . . . . 75.34 111.36 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 88.0 mt -74.61 102.54 4.59 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.943 0.401 . . . . 72.43 111.238 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 C--O 1.254 1.331 0 CA-C-O 118.615 -0.707 . . . . 73.11 112.342 179.69 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.81 0.338 . . . . 72.43 111.242 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -102.67 146.24 28.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.88 0.372 . . . . 75.2 111.52 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -131.78 158.17 41.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.077 0.465 . . . . 75.22 111.299 176.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -90.75 155.6 18.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.149 -0.478 . . . . 74.41 110.267 169.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 220' ' ' GLY . 65.1 mt -54.49 -35.61 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 112.522 0.564 . . . . 72.44 112.522 -174.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.524 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 68.2 p -57.96 -41.23 82.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.233 0.457 . . . . 64.34 112.233 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -73.42 -22.18 60.28 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.274 0.472 . . . . 73.31 112.274 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 187' ' ' ILE . 81.7 mt -55.74 111.7 0.98 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.282 0.563 . . . . 74.11 112.386 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' MET . . . . . 0.466 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.1 ptp -106.64 157.63 34.67 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.545 -0.752 . . . . 65.25 110.997 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.17 130.6 40.42 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.336 2.024 . . . . 44.11 113.196 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.469 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 70.9 m-20 70.52 33.68 2.36 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.357 0.663 . . . . 60.42 111.854 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.466 HD22 ' HG2' ' A' ' 180' ' ' MET . 46.9 tp -102.09 134.41 45.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.216 -0.447 . . . . 63.2 111.318 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 81.4 p -110.31 118.35 36.09 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.27 -0.269 . . . . 60.54 111.077 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -173.79 -172.21 38.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.862 -0.685 . . . . 45.43 113.681 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.1 m -114.08 136.7 52.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.712 0.264 . . . . 75.51 111.712 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.595 HG21 HD11 ' A' ' 179' ' ' LEU . 33.2 pt -125.57 141.31 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.941 0.401 . . . . 75.52 111.227 175.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -115.21 116.27 28.07 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 64.31 111.608 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -158.66 178.33 10.23 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.31 -0.405 . . . . 74.41 111.362 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLU . . . . . 0.531 ' HB3' HD13 ' A' ' 240' ' ' ILE . 12.3 pt-20 -99.79 146.24 26.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.052 0.453 . . . . 72.44 111.493 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.51 HG21 HG21 ' A' ' 235' ' ' VAL . 58.1 t -76.15 108.73 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.11 -0.496 . . . . 75.22 111.831 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 216' ' ' LYS . 14.6 t -76.18 -27.62 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.046 0.451 . . . . 72.11 111.902 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -155.14 130.97 10.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.135 0.493 . . . . 72.34 112.016 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -113.53 102.65 10.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 63.35 110.031 174.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -84.33 155.37 63.16 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 111.962 0.356 . . . . 73.24 111.962 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.21 140.38 94.03 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.662 2.241 . . . . 60.13 112.787 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -75.41 126.33 30.81 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.521 0.677 . . . . 75.14 112.654 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 2.9 mptp? -86.31 169.49 12.92 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.529 -0.759 . . . . 70.52 111.331 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -138.21 143.81 40.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.111 -0.495 . . . . 75.44 110.935 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.67 144.69 24.54 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.349 0.595 . . . . 73.13 112.316 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 81.2 p -94.59 117.47 30.18 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.709 -0.678 . . . . 64.42 110.243 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -77.86 146.98 35.35 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.667 0.27 . . . . 74.1 111.635 -175.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -70.63 -12.98 61.9 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.569 0.699 . . . . 75.34 109.74 171.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -56.3 -29.92 61.83 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.268 -0.878 . . . . 53.41 110.729 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 112.85 -29.61 8.0 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.882 -0.599 . . . . 55.31 112.487 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 67.8 p -89.7 159.21 17.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.314 0.578 . . . . 72.11 112.212 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -74.91 156.5 36.3 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.158 -0.474 . . . . 64.04 111.481 176.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -147.26 144.32 12.39 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.898 -0.668 . . . . 71.11 113.451 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 36.2 mt-30 -113.47 162.65 15.87 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.74 -0.271 . . . . 75.1 110.439 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 49.4 tp -153.69 113.72 3.91 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.17 0.433 . . . . 71.41 112.17 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.436 ' HE2' HD21 ' A' ' 213' ' ' LEU . 6.4 ttpm? -127.04 118.23 24.03 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.669 -0.645 . . . . 72.25 111.734 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.6 p -84.06 147.75 27.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.976 0.417 . . . . 73.41 111.711 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.436 HD21 ' HE2' ' A' ' 211' ' ' LYS . 97.0 mt -132.41 178.17 7.04 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.05 -0.523 . . . . 64.34 110.44 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 221' ' ' SER . 21.0 t80 -141.84 138.31 32.08 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.184 -0.323 . . . . 64.15 110.635 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.467 HD11 HG21 ' A' ' 243' ' ' VAL . 91.2 mt -126.49 151.79 47.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.503 0.321 . . . . 74.24 111.344 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.423 ' HB2' ' NZ ' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -135.76 149.3 49.12 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.496 0.554 . . . . 74.42 112.496 -178.655 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -154.68 167.33 30.52 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.486 -0.779 . . . . 62.53 109.9 174.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.52 -18.57 62.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.209 0.528 . . . . 75.35 111.601 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 75.0 p -91.05 -0.22 57.68 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.572 0.582 . . . . 61.42 112.572 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 138.92 -178.97 19.03 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.866 -0.683 . . . . 72.13 113.261 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.458 ' HB3' ' CE2' ' A' ' 214' ' ' PHE . 67.9 m -130.83 138.9 50.09 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.583 -0.363 . . . . 74.52 111.16 177.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 13.4 tt -141.95 153.84 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 120.779 0.323 . . . . 71.41 111.612 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -92.6 147.39 22.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.08 0.467 . . . . 71.13 111.745 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -112.96 157.33 15.01 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.286 -0.416 . . . . 72.53 112.531 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 63.4 m -133.15 116.09 15.85 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.197 0.498 . . . . 45.23 111.988 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.564 HD23 ' HB ' ' A' ' 258' ' ' VAL . 74.2 mt -98.9 116.27 30.77 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.422 -0.354 . . . . 71.43 111.608 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -102.22 165.77 10.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.995 0.426 . . . . 71.25 111.764 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 62.5 t30 58.6 -141.88 0.68 Allowed 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.977 -0.556 . . . . 73.0 111.735 171.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.43 -34.61 75.68 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.912 -0.493 . . . . 75.41 112.27 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.98 -7.64 30.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.964 0.411 . . . . 74.41 111.911 -176.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 209' ' ' GLN . . . -66.11 -34.26 77.65 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 122.133 -0.354 . . . . 73.03 111.951 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -84.74 1.0 48.57 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.947 -0.471 . . . . 75.13 111.861 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -52.09 116.19 2.08 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.825 0.345 . . . . 73.42 111.052 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -81.7 121.7 26.71 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.909 -0.587 . . . . 74.22 111.62 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.51 HG21 HG21 ' A' ' 191' ' ' VAL . 13.1 p -136.12 159.69 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.379 -0.373 . . . . 65.13 111.339 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.417 ' HZ2' ' CG ' ' A' ' 239' ' ' ASP . 8.8 mtpm? -110.67 163.87 13.31 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.126 0.489 . . . . 72.15 111.403 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 237' ' ' LYS . 13.2 tmtt? -90.01 123.2 33.7 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.794 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.99 0.61 56.13 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.241 -0.436 . . . . 54.54 113.679 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.417 ' CG ' ' HZ2' ' A' ' 236' ' ' LYS . 1.3 m-20 -91.81 150.2 21.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.934 0.397 . . . . 43.25 111.772 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 190' ' ' GLU . 32.5 mm -85.31 119.74 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 116.288 -0.415 . . . . 43.11 111.737 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -130.36 144.92 51.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.725 0.639 . . . . 75.41 112.725 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -100.5 115.11 29.32 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.841 -0.618 . . . . 64.12 110.197 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.467 HG21 HD11 ' A' ' 215' ' ' LEU . 57.5 t -111.02 123.32 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.441 0.534 . . . . 72.43 112.441 -172.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 67.4 m -107.9 122.21 46.34 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.57 -0.287 . . . . 72.55 110.821 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -165.9 -164.47 21.46 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.99 -1.1 . . . . 43.42 114.858 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 75.4 t80 -122.47 106.01 10.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.123 0.569 . . . . 73.12 110.938 -177.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.542 HG22 ' HB ' ' A' ' 256' ' ' ILE . 40.6 t -76.57 114.28 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.422 -0.353 . . . . 73.34 110.998 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.469 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 20.8 ptmt -129.63 153.29 48.25 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.473 0.654 . . . . 64.13 112.197 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -91.62 140.29 29.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.906 -0.588 . . . . 73.52 111.814 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 140.02 -67.78 0.49 Allowed Glycine 0 CA--C 1.522 0.492 0 CA-C-N 116.051 -0.522 . . . . 75.34 112.899 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -63.27 97.3 0.12 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.851 0.358 . . . . 72.23 110.962 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.1 t 61.49 27.22 16.81 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.344 -0.389 . . . . 72.33 111.93 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.76 -106.43 2.91 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 121.283 -0.484 . . . . 72.12 112.785 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.99 122.84 44.27 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.597 -0.355 . . . . 75.54 111.446 176.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -139.81 162.75 34.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.93 0.395 . . . . 73.24 111.029 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.542 ' HB ' HG22 ' A' ' 247' ' ' VAL . 9.3 tt -108.97 104.93 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 121.388 0.613 . . . . 75.15 111.735 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.4 t -64.77 93.81 0.12 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.978 -0.556 . . . . 73.04 110.154 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.564 ' HB ' HD23 ' A' ' 226' ' ' LEU . 39.9 t -66.77 125.36 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.053 0.454 . . . . 65.44 112.143 -174.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -96.11 -28.44 14.59 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.167 -0.469 . . . . 74.43 110.976 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -160.02 141.71 12.79 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.92 -0.582 . . . . 73.42 110.5 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.4 tt -138.1 138.65 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.246 0.461 . . . . 65.15 112.246 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -140.83 119.63 1.58 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.36 -0.448 . . . . 60.44 112.399 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.461 HG21 ' HG3' ' A' ' 266' ' ' LYS . 63.8 mt -74.13 126.79 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 122.467 -0.431 . . . . 60.21 111.318 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.484 HD12 HG22 ' A' ' 240' ' ' ILE . 69.0 mt -69.91 -50.18 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.998 0.428 . . . . 75.33 111.138 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -152.11 113.75 4.36 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.276 0.56 . . . . 72.31 112.017 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.461 ' HG3' HG21 ' A' ' 263' ' ' ILE . 56.7 mtmt -84.49 115.71 22.72 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.157 0.503 . . . . 74.1 110.69 171.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 41.3 t -98.63 158.18 15.78 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.724 -0.671 . . . . 61.51 111.116 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 1.2 pp -161.17 173.6 14.86 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.89 0.376 . . . . 64.24 111.996 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.921 -0.562 . . . . 74.13 111.595 177.391 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 110.026 -0.361 . . . . 72.3 110.026 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -85.12 129.36 34.81 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.561 0.578 . . . . 61.3 112.561 -172.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.17 153.64 50.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.182 -0.463 . . . . 74.52 111.002 177.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.568 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 32.2 mmtp -82.07 162.92 22.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.364 -0.606 . . . . 72.25 109.364 170.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 35.6 mm -52.7 -45.36 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.638 0.733 . . . . 42.31 110.441 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.2 t -57.12 -28.7 62.93 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.34 -0.846 . . . . 72.43 112.607 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.568 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 15.6 mm-40 -92.98 2.77 56.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.913 0.338 . . . . 73.12 111.913 -174.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.513 HD22 HG21 ' A' ' 247' ' ' VAL . 90.6 mt -81.93 139.0 34.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.992 0.425 . . . . 64.1 111.331 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 55.8 mtt -132.78 155.18 81.47 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.39 -0.368 . . . . 60.22 111.255 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.478 ' HG3' HD21 ' A' ' 254' ' ' LEU . 44.3 Cg_exo -58.08 130.69 39.27 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.33 2.02 . . . . 64.34 112.454 174.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 70.34 22.55 5.32 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.947 0.499 . . . . 64.13 111.738 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.9 tt -111.18 131.36 55.17 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.0 0.429 . . . . 64.44 111.263 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.4 m -93.85 136.61 33.95 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.526 -0.306 . . . . 65.32 110.964 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.71 -174.47 36.72 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.393 -0.908 . . . . 63.45 113.954 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 53.1 m -131.65 131.68 43.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.666 0.386 . . . . 74.31 110.777 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 179' ' ' LEU . 33.6 pt -124.53 150.35 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.562 0.696 . . . . 75.32 112.554 -176.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -112.74 103.38 11.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.768 -0.651 . . . . 75.42 110.093 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -144.01 168.61 19.58 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.793 0.33 . . . . 62.14 111.648 -175.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.01 155.85 16.6 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.126 0.488 . . . . 62.42 111.29 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 237' ' ' LYS . 61.1 t -83.83 114.1 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 116.151 -0.477 . . . . 73.31 111.553 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.3 t -77.47 -36.68 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.015 0.436 . . . . 63.33 111.272 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -154.59 143.14 20.66 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.702 -0.681 . . . . 70.2 111.533 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -133.34 108.39 8.68 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.42 -0.355 . . . . 72.01 110.987 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -89.62 147.91 38.91 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.306 0.484 . . . . 72.24 112.306 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.38 159.85 15.09 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.925 2.416 . . . . 74.21 113.364 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -65.28 160.5 21.48 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.925 0.713 . . . . 53.22 112.925 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -141.38 173.28 11.64 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.601 -0.727 . . . . 74.41 111.73 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -130.34 138.73 50.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.715 -0.675 . . . . 73.43 110.021 172.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.418 ' CE2' ' HD2' ' A' ' 202' ' ' ARG . 11.7 p90 -145.28 173.24 12.13 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.399 0.619 . . . . 73.12 111.695 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.0 p -99.3 123.96 44.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.563 -0.744 . . . . 53.42 110.298 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ARG . . . . . 0.418 ' HD2' ' CE2' ' A' ' 200' ' ' PHE . 11.1 mmm180 -58.89 130.92 49.28 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.666 0.247 . . . . 72.23 111.666 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -61.6 -17.45 55.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.487 0.66 . . . . 63.45 109.911 169.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.6 -28.37 56.14 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.316 -0.856 . . . . 71.33 111.103 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 147.9 -59.46 0.46 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 120.738 -0.744 . . . . 73.34 114.562 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.1 p -86.06 -144.16 0.1 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.204 0.816 . . . . 74.23 113.204 -170.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -113.43 -178.55 3.4 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.471 0.545 . . . . 71.21 112.471 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.8 168.0 28.33 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.113 -0.565 . . . . 74.02 113.157 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -96.25 161.38 13.97 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.036 0.446 . . . . 74.42 111.246 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 45.2 tp -142.17 140.24 32.33 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.331 -0.395 . . . . 75.31 111.464 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.517 ' HD3' HD12 ' A' ' 226' ' ' LEU . 60.8 tttp -140.67 128.67 22.02 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.752 0.31 . . . . 75.45 110.745 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.6 t -96.55 134.18 40.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.189 0.518 . . . . 71.3 111.94 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 226' ' ' LEU . 95.0 mt -130.83 174.31 10.09 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.919 -0.582 . . . . 65.21 111.02 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -148.86 121.46 8.58 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.239 -0.437 . . . . 72.22 110.013 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.8 mt -113.81 161.64 17.31 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.354 0.262 . . . . 61.41 110.991 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -159.17 154.19 25.04 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.27 0.841 . . . . 72.41 113.27 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -125.51 -175.48 3.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.448 -1.251 . . . . 75.15 108.973 163.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.07 -18.06 61.96 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.16 0.505 . . . . 74.33 110.796 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 77.6 p -81.83 -18.74 42.87 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.045 -0.525 . . . . 75.12 112.275 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 159.0 178.75 33.3 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.888 -0.672 . . . . 64.13 113.282 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 50.0 m -115.91 161.87 18.17 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.887 0.375 . . . . 52.32 111.651 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.6 tp -150.53 149.09 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 120.974 0.416 . . . . 62.13 111.363 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -89.7 122.77 33.12 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.293 -0.254 . . . . 64.33 110.934 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.5 120.3 6.83 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.89 -0.671 . . . . 64.31 112.901 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 62.3 m -111.51 118.94 37.14 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 122.126 -0.632 . . . . 74.32 111.845 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.517 HD12 ' HD3' ' A' ' 211' ' ' LYS . 94.0 mt -98.09 124.78 42.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.812 0.339 . . . . 51.21 111.286 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -107.17 150.82 26.19 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.775 0.321 . . . . 73.4 111.745 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 59.9 t30 56.75 -132.57 1.47 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 116.428 -0.351 . . . . 74.32 111.824 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.23 -14.16 46.16 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.666 0.617 . . . . 74.3 112.666 -174.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.515 ' HB3' HD22 ' A' ' 226' ' ' LEU . 86.9 mt -70.8 -18.49 62.74 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.938 -0.476 . . . . 44.22 111.142 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.16 78.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.741 0.645 . . . . 74.32 112.741 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -78.15 -3.9 44.82 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.072 0.397 . . . . 60.14 112.072 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.09 113.94 10.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.928 0.394 . . . . 71.4 110.766 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -75.83 105.06 6.66 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.198 0.523 . . . . 74.2 111.827 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.9 p -129.03 126.81 65.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.499 -0.773 . . . . 50.04 110.252 174.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -131.04 172.22 12.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.137 0.494 . . . . 65.42 111.9 -174.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.542 ' HA ' ' HB ' ' A' ' 191' ' ' VAL . 55.4 tttp -61.81 128.31 35.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.084 0.469 . . . . 74.44 111.423 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.65 -17.22 30.78 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.252 -0.431 . . . . 65.5 113.016 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.43 ' HB3' HD12 ' A' ' 263' ' ' ILE . 39.9 m-20 -88.73 112.71 23.48 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.968 0.414 . . . . 73.41 110.79 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 51.6 mm -77.29 103.73 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-O 120.995 0.426 . . . . 71.42 110.933 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 263' ' ' ILE . . . -110.67 140.9 44.61 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.536 0.569 . . . . 73.34 112.536 -175.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.1 106.39 18.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.095 0.474 . . . . 75.32 109.872 171.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.498 HG22 HG13 ' A' ' 261' ' ' ILE . 59.2 t -106.94 117.73 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.371 0.508 . . . . 51.4 112.371 -171.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 260' ' ' ASN . 82.4 p -106.9 133.52 51.42 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.411 -0.359 . . . . 52.2 110.557 173.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.6 -171.46 35.99 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.382 -0.913 . . . . 24.14 113.966 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -103.16 110.11 21.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.64 0.376 . . . . 74.33 110.877 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.513 HG21 HD22 ' A' ' 179' ' ' LEU . 50.6 t -81.03 122.18 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.874 0.368 . . . . 43.52 110.819 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -135.28 169.6 17.21 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.975 0.417 . . . . 73.4 111.328 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -106.74 144.21 33.73 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.887 0.375 . . . . 75.34 110.791 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -153.75 -106.77 0.29 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.808 -0.71 . . . . 61.11 113.056 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -76.91 104.36 7.36 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.43 -0.453 . . . . 72.11 111.898 -176.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 52.6 m 68.66 -27.42 0.15 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.829 1.048 . . . . 64.11 113.829 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -159.48 -152.69 6.57 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.75 -0.738 . . . . 72.33 113.761 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.478 HD21 ' HG3' ' A' ' 181' ' ' PRO . 90.5 mt -101.4 150.96 22.48 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.38 0.609 . . . . 75.43 112.381 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.63 159.8 41.4 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.634 -0.712 . . . . 74.21 110.146 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 9.7 tt -118.65 109.04 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.403 0.621 . . . . 61.15 111.265 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 74.8 m -76.21 106.56 7.89 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.68 -0.489 . . . . 71.45 109.68 175.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.413 HG11 ' HB ' ' A' ' 261' ' ' ILE . 55.1 t -68.23 137.08 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.048 0.759 . . . . 71.44 113.048 -170.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -104.73 -37.15 7.18 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.753 -0.658 . . . . 75.21 110.528 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ASN . . . . . 0.432 ' HB3' ' OG ' ' A' ' 244' ' ' SER . 64.0 t30 -149.76 118.43 6.58 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.163 -0.471 . . . . 73.41 110.849 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.498 HG13 HG22 ' A' ' 243' ' ' VAL . 9.7 tt -123.22 121.23 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.511 0.672 . . . . 75.12 111.669 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -132.56 125.76 4.28 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.1 -0.571 . . . . 72.21 113.136 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 241' ' ' ALA . 32.6 mm -70.06 113.71 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.595 -0.356 . . . . 70.4 110.535 176.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.04 -66.47 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.963 0.411 . . . . 71.33 111.366 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -89.5 110.52 21.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.849 0.357 . . . . 71.14 111.004 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -118.67 97.33 5.68 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.841 0.353 . . . . 72.13 111.76 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 70.9 m -71.36 94.04 1.19 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.939 -0.393 . . . . 70.32 109.939 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.63 119.18 16.5 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.213 -0.449 . . . . 73.21 111.846 -174.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 . . . . . 0 C--O 1.254 1.32 0 CA-C-O 118.783 -0.627 . . . . 75.21 112.315 -177.156 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.781 0.324 . . . . 70.1 110.906 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 186' ' ' THR . 23.8 p-10 -89.94 116.38 27.95 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.283 0.563 . . . . 55.42 111.702 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -108.11 161.97 14.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.105 0.479 . . . . 75.32 112.138 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -75.88 151.03 37.47 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.264 -0.643 . . . . 53.22 109.264 163.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 222' ' ' ILE . 28.4 mt -58.26 -39.03 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 121.832 -0.543 . . . . 73.45 111.835 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.0 t -73.81 -20.03 60.58 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.069 0.461 . . . . 72.4 111.379 175.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -78.94 -19.53 51.51 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.206 0.527 . . . . 71.5 110.711 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.435 HD11 HG21 ' A' ' 187' ' ' ILE . 95.1 mt -67.12 146.78 53.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.135 0.493 . . . . 74.24 111.608 177.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.7 ptp -146.67 152.75 45.77 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.205 -0.452 . . . . 41.23 110.949 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.54 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 51.3 Cg_exo -54.63 147.63 48.2 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.983 2.455 . . . . 72.32 113.655 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.46 29.1 13.47 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.018 -0.537 . . . . 74.33 112.352 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.9 tt -133.61 136.75 45.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.343 -0.39 . . . . 51.33 110.886 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.0 p -97.88 133.92 41.72 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.768 0.318 . . . . 72.15 111.291 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.2 174.55 34.75 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.659 -0.781 . . . . 73.33 113.743 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 44.2 m -122.56 138.48 54.56 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.508 0.323 . . . . 52.02 110.345 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 179' ' ' LEU . 32.9 pt -134.73 146.12 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.262 0.553 . . . . 73.41 111.909 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -109.87 103.76 12.59 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.821 -0.437 . . . . 73.12 109.821 171.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.6 168.19 18.7 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.302 0.573 . . . . 61.4 112.187 -173.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -82.75 126.73 32.72 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.552 -0.749 . . . . 73.32 111.024 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 235' ' ' VAL . 61.8 t -76.57 95.35 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.204 0.526 . . . . 71.55 110.195 174.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.483 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 13.7 t -75.76 -35.13 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.963 -0.562 . . . . 44.22 111.548 -176.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.06 113.4 5.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 74.52 111.743 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.85 103.97 15.61 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.207 -0.451 . . . . 71.34 110.479 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -79.31 147.55 68.92 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.23 -0.441 . . . . 75.24 111.776 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.83 155.01 40.19 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.596 2.197 . . . . 62.3 112.687 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -72.94 156.05 39.24 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.396 0.617 . . . . 71.13 112.563 -173.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 210' ' ' LEU . 68.6 mttm -122.92 159.13 28.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.721 -0.672 . . . . 72.52 109.866 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -141.7 132.16 25.27 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.097 0.475 . . . . 70.14 111.408 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -140.92 -175.56 4.35 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.089 -0.505 . . . . 73.1 111.372 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 89.0 p -107.9 144.43 35.15 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.023 0.44 . . . . 72.32 111.755 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -96.17 123.27 39.73 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.505 -0.316 . . . . 51.42 111.038 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -17.78 2.86 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.164 0.431 . . . . 74.02 112.164 174.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.5 -29.56 70.22 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.784 0.434 . . . . 64.52 111.658 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 134.0 -29.11 3.12 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.288 -0.415 . . . . 71.04 112.494 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 71.6 p -90.1 -167.79 1.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.132 0.491 . . . . 75.45 111.953 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -111.0 174.69 5.74 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.848 0.356 . . . . 60.24 111.191 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -147.02 158.74 27.83 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.004 -0.617 . . . . 72.51 113.409 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 228' ' ' ASN . 47.8 mt-30 -134.03 144.47 48.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.591 0.357 . . . . 63.2 110.655 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 198' ' ' LYS . 56.8 tp -125.78 145.91 50.01 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.662 0.385 . . . . 72.05 111.571 -174.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 22.3 tptm -150.59 121.92 7.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.45 -0.341 . . . . 54.53 110.939 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 47.2 t -101.45 144.03 30.74 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.993 0.425 . . . . 74.41 111.821 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 97.3 mt -136.34 134.58 38.05 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.153 -0.476 . . . . 73.51 111.119 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -103.83 109.93 21.85 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.141 -0.349 . . . . 74.23 110.731 174.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 243' ' ' VAL . 67.0 mt -107.55 145.09 33.65 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.346 -0.388 . . . . 72.1 110.674 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -137.52 150.46 47.54 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.539 0.685 . . . . 71.43 112.04 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -139.28 170.59 15.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.85 -1.068 . . . . 73.44 109.69 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -52.48 -41.24 63.2 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.792 0.33 . . . . 73.25 111.846 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 81.5 p -83.83 -6.26 59.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.487 0.921 . . . . 60.41 113.487 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 148.97 -179.8 25.49 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.721 -0.752 . . . . 70.3 113.149 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 84.9 p -121.83 159.4 26.84 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 122.258 -0.554 . . . . 63.54 111.893 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 176' ' ' ILE . 14.6 tt -151.8 150.33 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.073 0.463 . . . . 72.33 110.861 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ARG . . . . . 0.423 ' NH2' ' O ' ' A' ' 252' ' ' SER . 32.0 mtm-85 -100.93 123.27 44.87 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.021 0.439 . . . . 75.54 111.855 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -97.26 161.7 21.58 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 116.033 -0.531 . . . . 70.34 113.233 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 94.5 m -136.5 121.76 19.22 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.269 0.47 . . . . 41.35 112.269 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.624 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 92.3 mt -105.49 137.19 43.73 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.958 -0.565 . . . . 74.41 110.905 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -115.79 150.35 37.07 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.759 0.314 . . . . 74.23 111.656 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ASN . . . . . 0.406 ' HB3' ' OE2' ' A' ' 229' ' ' GLU . 65.4 t30 53.0 -128.3 2.42 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.552 0.575 . . . . 75.31 112.552 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLU . . . . . 0.406 ' OE2' ' HB3' ' A' ' 228' ' ' ASN . 0.9 OUTLIER -55.83 -16.69 4.84 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.276 0.843 . . . . 75.53 113.276 -175.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.437 ' HB3' HD22 ' A' ' 226' ' ' LEU . 91.7 mt -88.16 -17.75 30.25 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.956 0.407 . . . . 71.53 111.653 176.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.07 98.16 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.67 0.618 . . . . 72.34 112.67 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -77.7 3.2 14.6 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.668 0.618 . . . . 73.02 112.668 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -52.65 121.21 6.73 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.838 0.351 . . . . 62.13 111.74 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.6 116.31 22.54 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.241 -0.436 . . . . 73.43 111.549 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 191' ' ' VAL . 7.9 p -142.57 142.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 116.091 -0.504 . . . . 53.22 110.382 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -95.55 160.42 14.52 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.04 0.448 . . . . 75.0 111.334 -176.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 192' ' ' VAL . 40.4 ttmt -67.91 93.91 0.44 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.982 0.42 . . . . 73.32 110.939 174.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 136.11 -21.71 3.48 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.092 -0.575 . . . . 54.32 113.683 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -57.77 137.12 56.88 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.216 0.532 . . . . 74.04 111.941 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.529 HG22 HD12 ' A' ' 264' ' ' ILE . 32.7 mm -84.85 103.17 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.03 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -103.07 136.01 43.68 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.886 0.698 . . . . 50.13 112.886 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.8 98.8 7.2 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.582 -0.736 . . . . 74.43 110.088 171.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 215' ' ' LEU . 57.9 t -105.69 115.97 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.054 0.454 . . . . 35.41 111.793 -177.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 84.0 p -116.43 136.08 53.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.013 -0.539 . . . . 63.24 110.418 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -178.91 -166.84 35.58 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.13 -1.033 . . . . 62.33 114.839 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -106.74 122.07 45.64 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.085 0.554 . . . . 70.33 110.917 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 56.7 t -86.0 125.79 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.364 0.602 . . . . 53.53 112.364 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -121.16 169.23 10.74 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.624 -0.716 . . . . 74.33 110.348 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLN . . . . . 0.54 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 24.8 tt0 -120.99 140.81 51.38 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.704 0.288 . . . . 71.41 110.731 174.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -168.31 -108.64 0.21 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.281 -0.962 . . . . 62.41 113.723 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -84.32 122.86 29.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.975 0.417 . . . . 72.43 112.002 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' SER . . . . . 0.423 ' O ' ' NH2' ' A' ' 223' ' ' ARG . 61.4 m 53.53 62.27 2.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.562 -0.745 . . . . 70.24 111.95 177.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 93.16 -135.61 12.72 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.129 -0.557 . . . . 70.44 113.772 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.18 151.15 21.76 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.644 0.609 . . . . 72.2 112.644 -175.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.44 125.07 39.9 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.618 -0.719 . . . . 72.41 109.357 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ILE . . . . . 0.488 HG23 ' HA2' ' A' ' 224' ' ' GLY . 10.1 tt -113.83 121.21 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.488 0.661 . . . . 72.44 112.592 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 18.0 m -82.94 111.71 19.07 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.803 -0.635 . . . . 53.22 110.024 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' VAL . . . . . 0.542 ' HB ' HD23 ' A' ' 226' ' ' LEU . 44.7 t -76.99 128.72 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.366 0.603 . . . . 64.54 112.542 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.8 -44.52 14.28 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.597 -0.729 . . . . 73.04 110.537 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -152.07 143.18 23.19 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.287 -0.415 . . . . 74.14 111.21 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 6.2 tt -134.52 134.1 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.285 -0.416 . . . . 75.13 111.412 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.23 139.01 6.9 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.204 -0.522 . . . . 54.31 112.146 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.9 mt -69.16 131.96 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 117.333 0.566 . . . . 75.04 110.642 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.529 HD12 HG22 ' A' ' 240' ' ' ILE . 60.9 mt -70.31 -46.32 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.287 0.477 . . . . 64.44 112.287 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -112.69 95.73 5.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.961 0.41 . . . . 74.52 111.205 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.465 ' NZ ' ' HB2' ' A' ' 266' ' ' LYS . 10.7 mtmp? -104.05 -30.55 10.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.069 0.396 . . . . 73.02 112.069 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 40.8 t -89.59 98.45 11.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.024 0.44 . . . . 64.22 111.445 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 83.8 mt -68.06 -47.66 67.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.26 -0.427 . . . . 62.54 111.415 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.68 -0.676 . . . . 62.32 111.408 179.258 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 14.9 m120 . . . . . 0 CA--C 1.535 0.401 0 CA-C-O 120.754 0.312 . . . . 75.1 110.365 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -87.16 152.41 22.36 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.484 0.659 . . . . 64.33 112.261 -174.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.474 ' HG2' ' OE1' ' A' ' 178' ' ' GLU . 27.5 mmtm -100.77 164.47 11.84 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.58 -0.896 . . . . 74.33 108.58 168.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 54.2 mt -58.31 -31.11 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 O-C-N 122.059 -0.401 . . . . 73.21 111.816 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 48.4 t -71.89 -24.14 61.61 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.147 0.425 . . . . 73.32 112.147 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.474 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 45.2 mt-10 -81.63 -5.95 58.54 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.126 -0.359 . . . . 70.43 111.824 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.509 HD22 HG21 ' A' ' 247' ' ' VAL . 82.6 mt -75.86 125.58 29.36 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.293 0.568 . . . . 52.1 111.882 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.539 ' HG2' HD22 ' A' ' 183' ' ' LEU . 22.6 ptp -124.12 159.03 58.62 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 115.859 -0.61 . . . . 74.22 110.3 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 248' ' ' LYS . 14.8 Cg_endo -57.37 133.18 55.49 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.963 1.775 . . . . 64.44 112.904 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 76.4 m-20 69.57 29.89 4.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.397 0.679 . . . . 74.41 111.8 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.539 HD22 ' HG2' ' A' ' 180' ' ' MET . 27.0 tp -106.13 118.26 36.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.124 -0.489 . . . . 75.44 111.578 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.5 t -92.63 108.98 20.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.779 0.323 . . . . 60.32 110.201 173.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -153.29 172.56 32.19 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.585 -0.817 . . . . 73.14 113.911 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 244' ' ' SER . 34.8 m -114.17 129.77 56.62 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.78 0.324 . . . . 71.41 111.726 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.484 HD13 HD11 ' A' ' 179' ' ' LEU . 37.3 pt -122.16 163.68 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.301 0.572 . . . . 72.43 112.298 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -121.76 118.52 29.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.948 -0.569 . . . . 54.23 110.264 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -151.33 171.73 17.01 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.527 0.566 . . . . 53.03 112.527 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -96.01 141.66 29.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.066 -0.515 . . . . 64.23 111.589 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.9 t -78.95 103.49 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.972 0.415 . . . . 74.13 111.136 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' A' ' 216' ' ' LYS . 21.5 t -81.36 -28.61 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.0 0.429 . . . . 73.31 111.728 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -151.33 136.42 17.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.978 0.418 . . . . 71.33 111.572 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -124.05 114.36 19.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.885 -0.598 . . . . 62.23 110.818 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 212' ' ' SER . 94.9 m-85 -109.37 148.69 38.55 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 120.655 0.264 . . . . 52.33 111.632 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.41 156.65 16.79 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.984 2.456 . . . . 71.02 113.841 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -73.44 169.23 17.62 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.53 0.681 . . . . 63.42 111.989 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -138.65 149.47 45.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.455 -0.793 . . . . 64.33 109.361 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 209' ' ' GLN . 44.0 mt-10 -130.82 112.6 13.18 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.912 -0.492 . . . . 70.13 112.248 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.8 p90 . . . . . 0 CA--C 1.54 0.584 0 CA-C-O 121.261 0.553 . . . . 62.55 111.421 -178.019 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.482 ' HG2' ' HG2' ' A' ' 199' ' ' GLU . 24.6 mt-30 . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 120.943 0.401 . . . . 73.4 111.591 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 32.8 tp -145.17 126.4 14.77 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.059 -0.519 . . . . 74.53 111.39 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.601 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 84.7 tttt -126.87 135.08 50.49 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.948 0.404 . . . . 74.21 111.194 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.537 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 5.0 m -98.24 128.37 44.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.016 -0.538 . . . . 61.4 111.81 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.415 HD11 HG11 ' A' ' 235' ' ' VAL . 93.8 mt -137.1 163.72 30.13 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.085 0.469 . . . . 64.31 112.115 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -135.15 129.91 34.57 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.257 -0.429 . . . . 64.41 110.367 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.7 mt -120.7 148.59 43.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.256 0.222 . . . . 71.45 111.376 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.404 ' HB3' HG21 ' A' ' 192' ' ' VAL . 21.4 pttm -136.86 151.97 49.71 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.401 0.62 . . . . 71.15 112.095 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -148.78 165.59 30.97 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.304 -0.862 . . . . 74.34 109.848 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -57.26 -30.65 64.83 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 111.942 0.349 . . . . 61.13 111.942 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 63.0 p -84.07 -11.49 56.62 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.584 0.587 . . . . 53.54 112.584 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 152.25 179.77 28.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.936 -0.65 . . . . 44.15 113.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.4 p -124.2 155.42 38.57 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 122.554 -0.38 . . . . 52.1 111.498 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -147.05 156.75 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.979 0.418 . . . . 72.31 111.716 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 223' ' ' ARG . 8.3 mpt_? -95.08 123.97 38.87 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.69 0.281 . . . . 64.21 110.733 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.43 152.85 20.53 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.26 -0.495 . . . . 60.34 113.617 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 70.2 m -144.4 115.45 7.89 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.091 0.404 . . . . 72.43 112.091 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.601 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 88.8 mt -98.6 137.48 37.18 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.453 -0.34 . . . . 42.32 111.307 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -114.62 151.02 34.2 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.14 0.495 . . . . 74.51 112.233 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 64.2 t30 52.93 -134.24 1.7 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.828 -0.624 . . . . 64.12 111.856 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.42 -26.15 52.57 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.595 0.591 . . . . 74.33 112.595 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.42 -27.19 69.13 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.036 0.446 . . . . 64.14 111.225 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.48 ' O ' ' HD2' ' A' ' 211' ' ' LYS . . . -67.38 -14.24 62.74 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.115 0.413 . . . . 73.23 112.115 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -92.03 -12.98 31.69 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.992 0.425 . . . . 70.55 110.974 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -61.87 134.32 56.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.988 0.423 . . . . 73.33 111.605 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.92 118.24 15.62 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.009 0.433 . . . . 73.43 111.436 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 213' ' ' LEU . 4.2 p -139.07 117.51 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.137 0.494 . . . . 74.13 110.492 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -106.99 152.09 24.45 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.119 0.485 . . . . 74.54 111.885 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -70.15 117.85 12.24 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.187 -0.46 . . . . 72.41 111.478 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.57 -13.18 32.89 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.478 -0.391 . . . . 75.25 113.097 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.56 145.82 36.65 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.055 0.455 . . . . 72.22 111.93 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.584 HG22 HD12 ' A' ' 264' ' ' ILE . 38.9 mm -87.71 118.57 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.037 -0.529 . . . . 53.24 110.566 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.421 ' HB2' HD13 ' A' ' 263' ' ' ILE . . . -128.59 145.55 51.1 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.653 0.612 . . . . 71.21 112.653 -175.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -103.92 110.42 22.56 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.916 -0.584 . . . . 64.11 109.927 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.6 t -108.62 115.29 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.733 0.642 . . . . 73.43 112.733 -171.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 186' ' ' THR . 35.8 t -95.72 122.41 38.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.039 -0.528 . . . . 63.02 110.124 173.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -158.5 167.11 34.51 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.235 -0.983 . . . . 62.44 114.529 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -92.89 104.54 16.77 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.128 0.571 . . . . 74.23 110.596 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 179' ' ' LEU . 44.6 t -86.02 138.86 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.675 0.274 . . . . 64.35 111.438 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 181' ' ' PRO . 10.6 ptmm? -151.06 176.35 11.23 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.066 0.46 . . . . 73.43 111.821 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.485 ' HA ' HD23 ' A' ' 254' ' ' LEU . 23.5 tt0 . . . . . 0 CA--C 1.54 0.561 0 CA-C-N 115.947 -0.569 . . . . 64.0 111.144 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 249' ' ' GLN . 92.3 mt . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 110.406 -0.22 . . . . 72.14 110.406 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -109.66 143.12 39.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.985 0.421 . . . . 74.32 111.482 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.6 tt -108.72 104.35 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.339 0.59 . . . . 73.41 111.202 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.9 t -77.44 98.92 5.45 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.123 -0.49 . . . . 53.12 110.409 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.86 131.26 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.929 0.714 . . . . 53.31 112.929 -171.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -99.64 -44.6 6.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.567 -0.742 . . . . 75.42 110.357 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 244' ' ' SER . 21.7 m-80 -135.93 137.13 41.05 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.344 -0.389 . . . . 63.52 110.536 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.4 tt -137.75 136.19 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.841 0.353 . . . . 74.0 111.571 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.06 140.52 7.93 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.197 -0.525 . . . . 64.13 113.163 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 241' ' ' ALA . 47.2 mm -85.54 115.07 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.062 0.458 . . . . 73.51 110.853 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.584 HD12 HG22 ' A' ' 240' ' ' ILE . 63.0 mt -59.41 -35.95 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.476 0.547 . . . . 72.03 112.476 -174.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.475 0.82 0 N-CA-C 113.396 0.888 . . . . 73.35 113.396 -174.662 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.027 0.441 . . . . 63.52 110.164 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -83.38 141.05 32.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.187 0.518 . . . . 75.04 111.942 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.527 ' N ' ' HD2' ' A' ' 175' ' ' LYS . 12.1 mptt -96.54 155.79 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.61 . . . . 74.45 109.545 173.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.424 HD13 HG22 ' A' ' 222' ' ' ILE . 55.9 mt -59.15 -33.09 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.064 0.394 . . . . 75.24 112.064 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 56.2 p -70.79 -15.45 62.67 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.073 0.398 . . . . 43.04 112.073 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -104.55 -5.97 21.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.975 0.417 . . . . 55.34 111.594 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.548 HD22 HG21 ' A' ' 247' ' ' VAL . 81.6 mt -71.49 148.36 46.87 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.184 0.516 . . . . 72.34 111.987 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.5 ptp -148.18 153.27 41.07 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.945 -0.571 . . . . 73.21 110.801 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.29 128.05 24.18 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.905 2.403 . . . . 73.0 114.358 -177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.483 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 2.1 m-20 66.04 50.77 1.4 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.594 0.711 . . . . 62.32 112.156 173.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.7 tt -131.46 134.03 45.77 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.514 -0.766 . . . . 65.34 110.355 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 89.8 p -100.5 148.13 25.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.129 0.49 . . . . 60.15 111.508 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.67 -169.77 41.39 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.088 -0.577 . . . . 63.41 113.152 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 94.6 m -118.41 124.77 48.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.843 0.354 . . . . 75.23 111.712 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 179' ' ' LEU . 37.2 pt -109.02 154.17 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.068 -0.515 . . . . 75.24 110.285 173.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -135.4 108.51 7.69 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.042 -0.411 . . . . 75.04 110.872 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.29 172.15 13.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.065 0.46 . . . . 64.25 112.099 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -93.61 139.04 31.24 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.911 -0.586 . . . . 71.3 110.635 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.477 ' HA ' HD23 ' A' ' 215' ' ' LEU . 38.2 t -79.16 100.98 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.308 0.484 . . . . 45.31 112.308 -174.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.796 ' HA ' ' HZ3' ' A' ' 237' ' ' LYS . 48.6 t -59.62 -52.56 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.941 0.401 . . . . 74.31 111.723 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -132.71 124.66 28.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.189 -0.46 . . . . 64.53 111.27 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -106.16 102.82 12.21 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.925 0.393 . . . . 40.52 111.351 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -81.99 155.93 69.91 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.187 0.439 . . . . 75.34 112.187 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.96 175.84 10.79 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.61 2.207 . . . . 73.5 112.188 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.579 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 64.1 pttt -93.76 124.06 37.51 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.517 0.675 . . . . 70.41 112.754 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -87.42 146.13 25.99 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.307 -0.86 . . . . 60.43 110.818 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -99.16 136.79 38.61 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.87 0.367 . . . . 75.24 111.685 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.6 p90 . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 120.992 0.425 . . . . 71.44 111.153 175.442 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 . . . . . 0 CA--C 1.542 0.651 0 CA-C-O 120.703 0.287 . . . . 75.51 110.573 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 28.2 tp -121.64 125.35 46.47 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.441 0.296 . . . . 71.02 111.768 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -141.6 113.58 7.95 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.01 0.433 . . . . 73.23 111.625 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 64.4 m -93.93 139.48 30.86 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.114 0.483 . . . . 74.24 111.721 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.517 HD11 HG11 ' A' ' 235' ' ' VAL . 85.9 mt -123.4 126.34 46.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.476 -0.329 . . . . 65.1 110.603 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -92.12 115.95 28.52 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.988 -0.445 . . . . 63.14 110.759 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.522 HD11 HG21 ' A' ' 243' ' ' VAL . 58.6 mt -112.52 152.87 28.31 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.538 0.335 . . . . 74.04 111.288 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.461 ' HG2' ' CG2' ' A' ' 192' ' ' VAL . 12.9 ptmm? -162.14 150.3 14.72 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.206 0.526 . . . . 73.41 112.067 172.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -116.44 -164.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.714 -0.847 . . . . 73.42 108.714 167.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.53 -6.15 58.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.639 0.733 . . . . 75.35 109.606 166.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.5 p -81.51 -33.81 31.62 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.284 -0.871 . . . . 75.54 111.744 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 167.46 -178.69 41.37 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.396 -0.431 . . . . 72.32 112.811 -176.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 81.0 p -130.3 133.73 46.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 117.35 0.575 . . . . 51.04 112.25 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.424 HG22 HD13 ' A' ' 176' ' ' ILE . 11.6 tt -148.51 153.16 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.653 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -101.2 132.66 46.59 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.704 -0.623 . . . . 72.11 111.675 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.432 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -96.92 117.58 5.8 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.643 -0.583 . . . . 65.3 111.643 173.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 30.8 m -95.95 115.99 28.26 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.438 -0.448 . . . . 73.41 112.107 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.499 HD23 ' HB ' ' A' ' 258' ' ' VAL . 92.8 mt -91.64 128.39 37.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.07 -0.514 . . . . 71.34 111.17 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -113.47 153.85 28.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.231 0.539 . . . . 73.04 111.777 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.8 -134.27 0.69 Allowed 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 115.647 -0.706 . . . . 71.14 112.006 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -63.6 -18.34 63.79 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.097 0.777 . . . . 63.45 113.097 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.0 -14.93 63.38 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.755 0.312 . . . . 74.33 111.593 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.579 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -61.24 -43.69 98.47 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.214 0.45 . . . . 63.31 112.214 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -76.08 1.31 15.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.54 0.57 . . . . 74.52 112.54 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -67.25 123.07 19.29 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.167 -0.333 . . . . 74.23 110.53 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.84 92.98 0.37 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.205 0.526 . . . . 70.25 112.068 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.517 HG11 HD11 ' A' ' 213' ' ' LEU . 3.7 p -120.42 107.64 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.743 -0.662 . . . . 70.14 110.24 173.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -95.34 163.58 13.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.0 -0.545 . . . . 75.11 111.002 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.796 ' HZ3' ' HA ' ' A' ' 192' ' ' VAL . 8.1 tmtm? -71.12 113.12 7.84 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.481 -0.563 . . . . 74.31 109.481 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 121.95 -23.12 7.45 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 116.175 -0.466 . . . . 65.2 112.231 -172.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.4 ' HB3' HD12 ' A' ' 263' ' ' ILE . 24.4 m-20 -65.5 125.58 25.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.137 0.494 . . . . 75.42 112.067 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 49.8 mm -77.85 97.97 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.514 -0.55 . . . . 63.11 109.514 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -97.04 129.96 44.41 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.179 0.807 . . . . 63.14 113.179 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.9 96.57 8.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.685 -0.689 . . . . 71.21 109.417 170.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.522 HG21 HD11 ' A' ' 215' ' ' LEU . 88.6 t -97.61 111.62 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.113 0.483 . . . . 72.21 111.471 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.7 t -118.35 135.51 54.28 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.757 0.313 . . . . 73.34 111.056 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 172.81 -152.91 17.36 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.448 -0.882 . . . . 64.5 113.803 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -111.59 115.18 28.72 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.753 0.311 . . . . 70.33 111.325 -175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.548 HG21 HD22 ' A' ' 179' ' ' LEU . 47.7 t -86.27 120.54 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.776 0.322 . . . . 61.0 111.092 178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.483 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 19.4 ptpt -135.09 -179.82 5.86 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.817 0.341 . . . . 73.31 111.043 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 . . . . . 0 CA--C 1.536 0.438 0 CA-C-N 116.703 -0.226 . . . . 60.15 110.405 171.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 67.7 mt . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 121.263 0.554 . . . . 60.54 109.87 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -119.19 137.07 53.88 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.982 -0.554 . . . . 75.53 111.724 -172.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.482 ' HB ' HG22 ' A' ' 247' ' ' VAL . 9.5 tt -104.79 121.05 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.294 0.569 . . . . 41.44 111.98 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 94.5 p -81.75 112.07 18.58 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.491 -0.559 . . . . 71.43 109.491 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.499 ' HB ' HD23 ' A' ' 226' ' ' LEU . 21.7 t -77.64 106.16 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.864 0.364 . . . . 64.21 111.963 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -84.07 -24.06 30.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.01 0.433 . . . . 73.12 111.299 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -146.4 125.78 13.14 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.926 -0.579 . . . . 54.22 111.101 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.452 ' HB ' HG11 ' A' ' 258' ' ' VAL . 13.1 tt -135.67 137.06 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.158 0.504 . . . . 71.33 111.769 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.43 140.27 7.71 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.892 -0.595 . . . . 54.33 111.826 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.4 HD12 ' HB3' ' A' ' 239' ' ' ASP . 40.5 mm -92.26 128.66 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 117.682 0.741 . . . . 63.12 111.705 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 27.1 mt -83.65 -45.88 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 121.368 0.604 . . . . 75.24 110.758 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.469 0.506 0 CA-C-N 116.052 -0.522 . . . . 73.35 111.35 -178.529 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 . . . . . 0 N--CA 1.469 0.509 0 CA-C-O 120.995 0.426 . . . . 73.21 111.477 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -94.96 151.36 19.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.292 0.568 . . . . 74.33 111.9 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -89.34 153.69 20.67 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.701 -0.851 . . . . 75.15 108.701 169.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.405 HD13 HG22 ' A' ' 222' ' ' ILE . 36.0 mt -55.72 -36.25 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.328 0.492 . . . . 74.14 112.328 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.491 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 47.1 t -69.85 -24.09 63.39 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.138 0.421 . . . . 62.22 112.138 176.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.85 -5.78 59.14 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.288 0.477 . . . . 73.3 112.288 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.447 HD22 HG21 ' A' ' 247' ' ' VAL . 89.2 mt -70.84 155.71 40.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.504 0.669 . . . . 73.22 112.625 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.468 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.2 ptp -154.23 152.04 25.58 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.437 -0.801 . . . . 74.24 109.756 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.0 150.33 79.12 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 121.684 1.589 . . . . 51.43 112.492 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 246' ' ' TYR . 2.3 m-20 64.72 30.91 12.25 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.057 0.456 . . . . 53.41 111.445 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.468 HD22 ' HG2' ' A' ' 180' ' ' MET . 22.8 tp -114.58 115.88 27.88 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.353 -0.385 . . . . 72.13 111.372 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 90.2 p -103.83 109.52 21.28 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.66 0.267 . . . . 64.03 110.765 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.83 -161.56 11.44 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.778 -0.725 . . . . 60.21 113.508 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 25.1 m -122.81 142.98 50.16 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.65 -0.324 . . . . 71.32 111.418 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 34.8 pt -135.31 155.46 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.233 0.54 . . . . 74.11 112.431 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -111.19 124.48 52.28 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.15 -0.477 . . . . 63.12 110.531 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.8 164.94 38.09 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.339 0.59 . . . . 55.05 112.41 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -103.21 138.05 40.53 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.615 -0.721 . . . . 63.21 110.089 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.9 99.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.58 0.585 . . . . 50.12 112.58 -172.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.3 t -70.87 -44.75 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.074 0.464 . . . . 75.41 111.774 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -143.4 132.72 23.3 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.176 -0.465 . . . . 62.43 111.832 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -124.1 99.48 6.26 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.148 -0.478 . . . . 65.33 110.855 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 196' ' ' PRO . 72.3 m-85 -77.49 149.78 78.81 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.55 0.574 . . . . 64.42 112.55 -174.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 195' ' ' TYR . 38.6 Cg_exo -62.19 172.62 3.95 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.299 2.666 . . . . 65.15 114.054 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.405 ' HA ' ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -61.07 109.99 1.24 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.373 -0.83 . . . . 73.23 112.868 -176.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 210' ' ' LEU . 66.7 mttm -83.88 148.96 26.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.185 -0.461 . . . . 62.41 109.929 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -131.86 136.58 47.56 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.986 0.735 . . . . 64.14 112.986 -171.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.43 ' HE1' ' HB2' ' A' ' 210' ' ' LEU . 54.8 p90 . . . . . 0 CA--C 1.541 0.634 0 CA-C-N 115.587 -0.733 . . . . 64.05 110.456 173.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 CA--C 1.536 0.41 0 CA-C-O 120.645 0.26 . . . . 75.05 111.016 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 198' ' ' LYS . 65.8 tp -144.81 149.38 35.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.992 0.425 . . . . 72.02 111.458 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.614 ' HB2' ' HA ' ' A' ' 231' ' ' ALA . 45.6 tttp -149.85 121.1 7.82 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.937 0.399 . . . . 75.22 111.263 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 41.2 m -95.38 118.26 31.8 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.969 0.414 . . . . 73.41 111.663 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 74.4 mt -109.57 130.45 55.51 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.442 -0.345 . . . . 54.51 110.773 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -97.79 103.75 15.71 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.002 -0.436 . . . . 71.45 110.669 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.17 136.34 35.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.141 -0.481 . . . . 65.51 111.291 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -122.62 147.72 46.09 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 112.718 0.636 . . . . 63.12 112.718 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -148.21 163.05 38.17 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.133 -0.94 . . . . 62.22 109.298 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -77.52 10.05 2.88 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.908 -0.495 . . . . 60.15 112.263 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 69.8 p -115.24 2.81 14.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.947 0.403 . . . . 62.22 111.072 169.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 147.1 170.08 15.11 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.332 -0.461 . . . . 73.14 113.25 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 80.3 p -128.64 126.5 40.32 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.442 -0.446 . . . . 72.54 111.061 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 176' ' ' ILE . 9.6 tp -129.76 151.75 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.946 0.403 . . . . 72.01 111.263 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.627 ' HD3' ' H ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -99.29 125.26 44.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.2 0.524 . . . . 64.43 111.441 178.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.565 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -91.83 138.31 14.19 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.705 -0.68 . . . . 64.11 112.489 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.439 HG23 HD11 ' A' ' 210' ' ' LEU . 28.4 m -106.43 105.5 15.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.903 0.334 . . . . 74.2 111.903 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.595 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 56.4 mt -90.42 138.71 31.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.831 0.348 . . . . 63.43 111.186 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -115.55 157.12 24.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.272 0.558 . . . . 74.1 112.101 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 55.4 t30 57.83 -141.68 0.74 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.559 -0.746 . . . . 54.41 112.468 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.42 -24.21 19.03 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.989 0.737 . . . . 74.01 112.989 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.57 -8.35 4.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.92 0.39 . . . . 74.14 112.006 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -66.06 -30.02 70.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.922 0.391 . . . . 64.54 111.82 175.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.4 5.84 50.18 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.336 -0.393 . . . . 61.21 111.847 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -59.77 126.46 27.66 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.944 0.402 . . . . 75.24 111.856 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -68.39 87.82 0.31 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.245 0.545 . . . . 50.43 111.796 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.5 p -116.89 128.78 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.112 -0.495 . . . . 74.22 110.735 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 239' ' ' ASP . 50.5 mtpt -93.28 150.86 20.17 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.3 0.572 . . . . 72.44 112.281 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -80.16 117.23 20.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.898 -0.592 . . . . 71.22 110.068 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.58 23.6 13.72 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.938 -0.648 . . . . 74.24 112.659 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 3.0 t0 -113.72 162.77 15.87 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.702 0.287 . . . . 61.01 110.564 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 264' ' ' ILE . 47.0 mm -98.94 114.12 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.738 0.304 . . . . 73.31 111.218 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -114.15 142.43 46.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.023 0.749 . . . . 73.43 113.023 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' A' ' 264' ' ' ILE . 30.5 tt0 -112.05 108.73 18.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.971 -0.559 . . . . 73.3 109.655 172.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.1 t -107.04 133.86 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 112.676 0.621 . . . . 72.04 112.676 -170.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 42.8 t -111.94 112.1 23.5 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.356 -0.384 . . . . 73.4 110.375 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.49 -176.88 26.42 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.174 -1.012 . . . . 63.32 114.369 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 182' ' ' ASN . 86.2 t80 -112.92 105.98 14.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.134 0.574 . . . . 73.43 111.084 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 256' ' ' ILE . 24.9 t -74.04 142.35 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.477 -0.329 . . . . 73.14 110.718 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -156.5 178.25 10.54 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.46 0.648 . . . . 75.44 112.677 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 CA--C 1.541 0.599 0 CA-C-N 115.343 -0.844 . . . . 71.03 110.242 172.904 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 98.0 mt . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 109.846 -0.427 . . . . 73.34 109.846 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.92 172.57 7.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.066 0.46 . . . . 71.21 111.83 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.565 HG23 ' HA2' ' A' ' 224' ' ' GLY . 7.8 tt -127.55 112.84 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.339 0.59 . . . . 64.44 111.469 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . 0.415 ' HA ' ' HB ' ' A' ' 225' ' ' THR . 37.2 t -82.75 110.94 18.23 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.282 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.526 ' HB ' HD23 ' A' ' 226' ' ' LEU . 46.6 t -74.76 137.49 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.219 0.533 . . . . 73.3 111.936 -175.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -106.35 -43.86 4.67 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.993 -0.549 . . . . 61.34 110.583 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -139.41 145.2 38.61 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.093 -0.503 . . . . 75.24 110.479 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.1 tt -140.24 135.97 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.283 0.563 . . . . 71.11 111.983 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -140.68 121.82 2.01 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 116.081 -0.509 . . . . 64.54 112.385 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 14.0 mm -78.48 138.02 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 122.47 -0.429 . . . . 62.2 110.764 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.438 HD11 ' HB2' ' A' ' 242' ' ' GLU . 60.0 mt -84.58 -41.9 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 112.515 0.561 . . . . 64.51 112.515 -174.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 CA--C 1.546 0.799 0 N-CA-C 113.073 0.768 . . . . 71.33 113.073 -171.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 186' ' ' THR . 8.1 t30 . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.453 0.644 . . . . 74.12 112.725 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.444 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 57.6 m-85 -130.69 167.67 18.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.405 -0.816 . . . . 72.14 110.308 173.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.466 ' HB3' ' OG1' ' A' ' 219' ' ' THR . 22.7 mmtp -97.66 164.64 12.33 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.972 -0.381 . . . . 75.21 109.972 167.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 220' ' ' GLY . 56.8 mt -64.08 -30.34 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 111.946 0.35 . . . . 73.54 111.946 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.474 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 83.7 p -64.7 -24.86 67.71 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.046 0.451 . . . . 72.43 111.157 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 174' ' ' TYR . 26.3 mm-40 -86.79 -12.25 48.59 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.052 -0.522 . . . . 71.44 111.596 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.524 HD11 HD13 ' A' ' 187' ' ' ILE . 71.1 mt -70.16 141.75 52.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.384 0.611 . . . . 72.13 111.714 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.439 ' HG2' HD22 ' A' ' 183' ' ' LEU . 21.5 ptp -154.12 156.36 31.83 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.553 -0.748 . . . . 74.13 110.641 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.97 142.22 76.66 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.141 1.894 . . . . 53.33 112.484 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 66.16 26.21 10.61 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.903 0.382 . . . . 74.41 111.697 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.439 HD22 ' HG2' ' A' ' 180' ' ' MET . 46.5 tp -98.09 135.09 40.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.802 0.334 . . . . 64.2 111.55 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 72.0 p -114.08 118.92 35.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.522 -0.308 . . . . 64.31 110.869 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.76 -160.85 27.63 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 120.888 -0.672 . . . . 61.41 113.685 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 58.0 m -129.69 148.85 51.62 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.83 0.452 . . . . 73.53 111.0 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.524 HD13 HD11 ' A' ' 179' ' ' LEU . 32.3 pt -131.95 144.61 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.244 0.545 . . . . 71.4 111.291 173.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -113.27 107.19 15.55 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.056 -0.52 . . . . 72.54 110.483 175.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.8 176.8 9.6 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.006 0.432 . . . . 41.42 111.819 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -94.0 145.17 24.85 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.149 0.499 . . . . 74.4 111.807 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.8 t -86.01 108.96 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.214 -0.448 . . . . 43.53 111.665 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.84 -35.67 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.161 -0.472 . . . . 71.44 111.449 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.09 124.26 5.74 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.313 -0.403 . . . . 63.32 111.607 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -108.17 100.93 10.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.221 -0.445 . . . . 62.03 110.749 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.503 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 99.0 m-85 -72.41 139.61 81.54 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 111.957 0.354 . . . . 60.23 111.957 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -53.8 148.99 34.9 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.666 2.244 . . . . 70.01 112.851 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.436 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 21.3 pttm -71.72 125.84 28.17 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.474 0.654 . . . . 74.01 112.375 -175.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.02 166.47 11.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.78 -0.646 . . . . 73.0 110.731 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.44 112.17 18.63 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.681 0.277 . . . . 73.14 110.806 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 54.3 p90 . . . . . 0 CA--C 1.536 0.437 0 CA-C-O 121.317 0.579 . . . . 71.14 111.982 -177.096 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 231' ' ' ALA . 26.7 mt-30 . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 120.825 0.345 . . . . 74.44 111.105 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 18.9 tp -127.65 111.13 13.37 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.225 0.454 . . . . 64.12 112.225 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 195' ' ' TYR . 81.5 tttt -122.21 109.6 14.68 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.191 -0.318 . . . . 65.23 111.282 175.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.9 t -86.07 145.94 26.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.927 0.394 . . . . 75.24 111.387 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.79 124.47 33.47 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.511 -0.313 . . . . 73.34 111.253 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -94.58 115.39 27.52 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 110.132 -0.321 . . . . 75.34 110.132 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.63 HD11 HG21 ' A' ' 243' ' ' VAL . 52.8 mt -112.54 150.75 30.87 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.556 0.217 . . . . 65.44 111.51 -176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -140.47 152.65 45.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.652 0.739 . . . . 72.1 111.934 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -148.19 166.09 28.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.802 -1.09 . . . . 71.24 108.739 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -56.69 -25.82 55.12 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.756 0.312 . . . . 64.43 111.772 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 71.6 p -89.88 1.95 55.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.826 0.676 . . . . 60.45 112.826 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 137.41 -179.25 18.32 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.803 -0.713 . . . . 73.13 113.312 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 57.2 p -127.81 152.23 48.05 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 122.418 -0.46 . . . . 61.23 111.52 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.0 tp -151.77 160.06 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.72 -0.218 . . . . 75.11 111.291 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -107.36 128.08 54.14 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.193 0.52 . . . . 72.31 112.118 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -103.15 167.21 16.77 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.08 -0.509 . . . . 65.22 111.948 172.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 99.8 m -142.79 122.33 13.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.747 0.773 . . . . 65.01 112.379 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.408 HD23 ' HB ' ' A' ' 258' ' ' VAL . 91.4 mt -93.69 120.15 33.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.744 -0.662 . . . . 74.33 110.972 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -100.0 142.95 30.8 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.686 0.279 . . . . 71.12 111.713 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 60.8 t30 66.83 -138.03 0.14 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.099 0.559 . . . . 73.14 111.968 174.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -25.79 64.4 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.305 0.483 . . . . 74.51 112.305 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 91.0 mt -56.59 -21.81 29.36 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.799 0.333 . . . . 65.44 111.786 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -64.64 -20.15 66.11 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 111.978 0.362 . . . . 64.22 111.978 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -99.47 8.4 44.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.693 0.282 . . . . 75.14 111.703 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -65.58 143.7 57.45 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.093 0.473 . . . . 74.04 112.006 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -63.29 96.57 0.11 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.823 -0.626 . . . . 73.01 111.301 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 p -147.08 113.69 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.032 0.444 . . . . 74.31 111.008 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -105.58 160.45 15.17 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.438 0.637 . . . . 75.34 111.758 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.02 99.96 0.93 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.733 -0.667 . . . . 75.22 111.069 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 130.4 -10.61 5.84 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.187 -0.53 . . . . 61.12 114.036 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.78 157.07 20.34 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.782 0.66 . . . . 74.32 112.782 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.444 HG22 HD12 ' A' ' 264' ' ' ILE . 40.9 mm -92.97 110.18 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.708 -0.678 . . . . 63.41 110.495 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -110.1 139.11 45.58 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.794 0.664 . . . . 53.24 112.794 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 31.9 tt0 -84.41 104.63 14.59 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.68 -0.691 . . . . 73.02 110.165 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.63 HG21 HD11 ' A' ' 215' ' ' LEU . 87.1 t -103.99 106.46 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.928 0.394 . . . . 63.23 111.505 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 39.1 p -116.53 130.49 56.78 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.461 -0.336 . . . . 54.15 111.439 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.97 -141.04 4.7 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.656 -0.783 . . . . 71.42 113.771 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -129.11 124.89 35.91 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.696 -0.296 . . . . 70.3 111.198 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.436 HG22 ' HB ' ' A' ' 256' ' ' ILE . 35.0 t -90.84 133.96 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.812 0.339 . . . . 75.11 111.821 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -126.39 -179.61 4.84 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.964 0.412 . . . . 74.14 111.204 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 N--CA 1.467 0.42 0 CA-C-N 116.421 -0.354 . . . . 74.32 111.516 178.401 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.6 mt . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 120.913 0.387 . . . . 72.31 111.726 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.31 156.31 43.26 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.161 -0.472 . . . . 61.5 111.078 173.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.436 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.5 tt -122.99 119.38 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.292 0.567 . . . . 74.33 112.227 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.3 m -72.23 113.8 9.66 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.195 -0.457 . . . . 54.4 110.075 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.527 HG11 ' HB ' ' A' ' 261' ' ' ILE . 23.1 t -82.22 117.43 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.985 0.421 . . . . 75.42 111.731 -175.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -89.81 -26.93 20.3 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.174 0.512 . . . . 72.33 110.551 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -149.63 137.29 20.15 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.1 -0.5 . . . . 65.53 110.936 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.527 ' HB ' HG11 ' A' ' 258' ' ' VAL . 12.2 tt -143.58 135.82 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.026 0.441 . . . . 64.22 111.628 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -146.98 139.68 8.1 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.241 -0.504 . . . . 53.34 112.939 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 49.3 mm -75.41 115.76 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.278 -0.542 . . . . 74.13 110.821 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.444 HD12 HG22 ' A' ' 240' ' ' ILE . 61.8 mt -59.94 -50.08 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 120.953 0.406 . . . . 72.3 111.806 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.468 0.445 0 CA-C-N 116.474 -0.33 . . . . 63.11 110.972 177.416 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 121.086 0.469 . . . . 71.23 110.449 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.434 ' CE2' ' HA3' ' A' ' 185' ' ' GLY . 96.5 m-85 -83.3 141.0 32.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.38 0.61 . . . . 72.1 112.411 -172.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.418 ' HD2' ' OG1' ' A' ' 219' ' ' THR . 18.2 tppt? -81.54 137.76 35.52 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.473 -0.785 . . . . 72.4 109.956 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 222' ' ' ILE . 36.7 mt -52.79 -36.7 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 112.705 0.632 . . . . 74.03 112.705 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.418 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 35.4 t -64.51 -27.12 68.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.849 0.357 . . . . 71.31 111.549 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -95.05 6.1 50.04 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.32 0.489 . . . . 45.33 112.32 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.407 HD22 HG21 ' A' ' 247' ' ' VAL . 81.9 mt -68.64 131.05 44.56 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.133 0.492 . . . . 72.13 111.527 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.7 mtt -121.07 155.28 58.12 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.135 -0.484 . . . . 73.54 111.506 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HG3' HD21 ' A' ' 254' ' ' LEU . 31.2 Cg_exo -61.03 133.29 46.41 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.31 2.007 . . . . 73.44 112.186 173.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 66.35 37.62 4.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.872 0.469 . . . . 72.43 111.568 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.8 119.47 39.22 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.452 -0.34 . . . . 63.14 111.4 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.406 ' HB3' ' HD1' ' A' ' 246' ' ' TYR . 86.9 p -99.18 126.29 44.94 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.949 0.404 . . . . 52.51 111.181 176.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 174' ' ' TYR . . . -171.58 -160.55 20.37 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.613 -0.803 . . . . 73.43 113.88 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 28.7 m -135.89 136.93 40.92 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.749 -0.266 . . . . 74.42 111.299 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.39 147.15 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.842 0.353 . . . . 64.02 111.735 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.428 HD22 HD11 ' A' ' 264' ' ' ILE . 17.8 m120 -108.16 112.31 24.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.579 -0.282 . . . . 55.31 110.647 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -147.95 174.59 11.73 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.316 0.488 . . . . 74.41 112.316 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -103.72 144.89 30.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.31 -0.404 . . . . 63.33 111.108 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.46 ' HA ' HD23 ' A' ' 215' ' ' LEU . 43.0 t -77.32 105.26 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.12 0.486 . . . . 75.41 111.556 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.31 -36.31 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.887 -0.597 . . . . 62.0 111.391 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.51 158.74 37.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.845 -0.616 . . . . 73.3 111.369 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.72 122.55 14.42 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.35 -0.386 . . . . 51.1 111.342 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.42 148.41 35.15 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 120.629 0.252 . . . . 72.33 111.463 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.81 168.08 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.809 2.34 . . . . 60.42 113.045 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -74.36 147.72 41.91 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.376 0.607 . . . . 73.32 112.26 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -111.4 157.25 20.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.863 -0.608 . . . . 64.34 110.145 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -110.03 157.58 19.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.2 0.524 . . . . 73.12 110.969 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 33.0 p90 . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.734 -0.667 . . . . 72.41 110.071 177.347 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.488 ' NE2' ' HB3' ' A' ' 231' ' ' ALA . 9.0 pt20 . . . . . 0 CA--C 1.541 0.596 0 CA-C-O 121.116 0.484 . . . . 64.41 111.717 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 22.0 tp -111.8 105.96 14.59 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.741 -0.663 . . . . 72.52 112.388 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.478 ' HE3' HD21 ' A' ' 213' ' ' LEU . 4.0 tmtm? -113.02 126.35 55.39 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.141 -0.349 . . . . 74.31 110.258 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 25.1 p -110.24 142.74 41.41 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.433 0.635 . . . . 73.53 112.665 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.478 HD21 ' HE3' ' A' ' 211' ' ' LYS . 85.0 mt -125.18 159.92 30.4 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.604 -0.725 . . . . 55.22 110.886 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -125.41 119.71 29.06 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.733 0.301 . . . . 73.41 110.944 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.568 HD11 HG21 ' A' ' 243' ' ' VAL . 75.7 mt -114.68 162.26 17.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.726 0.41 . . . . 74.24 111.025 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 216' ' ' LYS . 18.5 ptmt -151.76 168.64 24.42 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.677 0.751 . . . . 74.35 112.643 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -146.33 174.84 11.0 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.66 -1.155 . . . . 72.11 109.113 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.14 -14.37 60.38 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.832 -0.543 . . . . 73.55 112.231 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 68.8 p -102.25 -18.86 15.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.289 0.848 . . . . 62.22 113.289 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 167.7 -179.82 40.86 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.386 -0.912 . . . . 60.12 113.684 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 44.8 m -127.64 144.41 51.08 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.807 0.337 . . . . 73.31 111.789 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 176' ' ' ILE . 9.7 tp -150.65 150.17 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 116.508 -0.314 . . . . 70.52 110.849 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.503 ' HD3' ' H ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -107.75 142.66 37.42 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.944 -0.472 . . . . 75.13 111.699 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.519 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -110.57 155.67 15.98 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 116.063 -0.517 . . . . 72.44 113.271 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.4 m -116.39 114.01 23.68 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.408 0.522 . . . . 74.43 112.408 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.475 HD23 ' HB ' ' A' ' 258' ' ' VAL . 85.5 mt -96.71 133.95 40.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.815 0.446 . . . . 72.04 111.403 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -115.4 156.97 24.6 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.745 0.307 . . . . 73.44 111.52 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 58.87 -141.16 0.7 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 112.102 0.408 . . . . 62.22 112.102 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -48.26 -32.27 7.03 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.919 0.711 . . . . 72.51 112.919 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.431 ' HB3' HD22 ' A' ' 226' ' ' LEU . 85.8 mt -59.71 -19.45 49.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.745 0.307 . . . . 74.22 111.538 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.488 ' HB3' ' NE2' ' A' ' 209' ' ' GLN . . . -67.22 -32.3 73.26 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.181 0.438 . . . . 75.02 112.181 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -94.89 -6.62 42.21 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.023 0.379 . . . . 74.53 112.023 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -54.98 125.61 21.08 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.457 -0.338 . . . . 75.34 110.365 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -68.94 111.38 4.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.351 0.595 . . . . 53.32 111.652 -176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.47 HG11 HD11 ' A' ' 213' ' ' LEU . 7.3 p -144.42 135.27 20.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.559 -0.746 . . . . 74.44 109.678 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -139.51 165.92 25.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.525 0.679 . . . . 62.31 112.133 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -64.36 101.02 0.39 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.917 -0.583 . . . . 72.41 111.075 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 147.87 -31.37 1.34 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.615 -0.802 . . . . 63.14 114.583 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.09 154.41 25.6 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.769 0.785 . . . . 73.14 112.699 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 38.9 mm -94.57 106.05 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.485 -0.78 . . . . 73.41 110.833 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -100.04 131.12 46.19 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.985 0.735 . . . . 51.52 112.985 -174.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -97.04 97.63 9.39 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.364 -0.606 . . . . 72.14 109.364 171.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.568 HG21 HD11 ' A' ' 215' ' ' LEU . 99.3 t -99.01 124.16 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.973 0.731 . . . . 75.13 112.973 -169.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 37.0 t -98.59 116.55 31.08 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.826 -0.625 . . . . 73.33 110.348 172.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.03 174.58 33.93 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.317 -0.944 . . . . 71.1 114.484 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.406 ' HD1' ' HB3' ' A' ' 184' ' ' SER . 59.2 t80 -108.71 109.29 20.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.292 0.637 . . . . 72.51 110.788 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.462 HG22 ' HB ' ' A' ' 256' ' ' ILE . 40.5 t -78.29 116.04 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.58 0.229 . . . . 64.21 111.109 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -128.46 161.19 30.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.671 0.272 . . . . 71.43 111.326 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 . . . . . 0 N--CA 1.47 0.562 0 CA-C-O 120.798 0.332 . . . . 73.31 111.521 179.376 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.432 HD21 ' HG3' ' A' ' 181' ' ' PRO . 94.8 mt . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 120.845 0.355 . . . . 63.43 111.516 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -134.74 132.58 38.95 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.974 0.416 . . . . 74.42 110.505 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.519 HG23 ' HA2' ' A' ' 224' ' ' GLY . 7.4 tt -101.13 111.55 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.399 0.619 . . . . 73.25 112.195 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 50.9 m -78.89 111.57 15.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.998 -0.546 . . . . 54.4 110.462 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.475 ' HB ' HD23 ' A' ' 226' ' ' LEU . 43.1 t -75.74 127.97 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 112.425 0.528 . . . . 75.12 112.425 -173.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -97.99 -22.49 16.25 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.917 0.389 . . . . 64.21 111.291 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 47.9 t-20 -156.94 132.68 9.43 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 73.04 110.377 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.3 tt -126.64 122.23 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.075 0.464 . . . . 74.31 111.533 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -133.11 117.9 2.03 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.376 -0.44 . . . . 65.54 112.245 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.533 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 63.6 mt -85.4 127.21 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 122.53 -0.394 . . . . 54.33 111.258 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.428 HD11 HD22 ' A' ' 188' ' ' ASN . 49.4 mt -59.1 -46.03 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.084 0.469 . . . . 75.55 111.282 -177.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 CA--C 1.535 0.403 0 CA-C-N 115.86 -0.609 . . . . 72.13 110.612 176.464 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 110.205 -0.294 . . . . 73.35 110.205 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -84.6 137.02 33.53 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.616 0.598 . . . . 74.32 112.616 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -100.86 158.68 15.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.812 -0.631 . . . . 71.31 110.22 171.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.561 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 89.1 mt -60.93 -32.25 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 113.018 0.747 . . . . 51.11 113.018 -173.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.53 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 34.1 t -58.2 -31.82 67.69 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 122.103 -0.373 . . . . 63.34 111.954 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.16 -12.52 54.79 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.503 0.557 . . . . 72.14 112.503 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.561 ' HG ' ' HA ' ' A' ' 176' ' ' ILE . 65.7 mt -64.66 116.05 5.85 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.526 0.679 . . . . 71.03 111.934 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.6 ptp -125.74 160.97 53.65 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 115.648 -0.705 . . . . 74.03 110.55 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.524 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 43.4 Cg_exo -54.99 133.42 57.99 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.331 2.021 . . . . 65.23 112.876 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 16.4 m120 68.75 20.29 8.17 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.389 0.515 . . . . 72.02 112.389 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.11 139.48 31.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.951 0.405 . . . . 65.54 111.498 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.8 p -110.25 127.42 54.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.495 -0.32 . . . . 72.33 110.342 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.15 -169.78 38.76 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.422 -0.894 . . . . 54.33 113.987 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 79.1 m -132.63 120.86 22.33 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.706 -0.291 . . . . 72.31 111.179 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 41.1 pt -108.09 140.61 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.981 0.42 . . . . 74.01 111.585 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -115.99 112.11 21.33 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.454 -0.339 . . . . 73.31 110.219 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -142.52 169.34 17.76 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.105 0.479 . . . . 63.43 112.099 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.82 139.27 30.75 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.05 -0.523 . . . . 73.31 110.952 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.405 HG21 ' CG2' ' A' ' 235' ' ' VAL . 35.8 t -82.89 116.84 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.127 0.489 . . . . 74.41 111.534 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 35.7 t -90.41 -64.77 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.189 0.518 . . . . 75.52 111.553 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.452 ' H ' ' HB3' ' A' ' 214' ' ' PHE . . . -126.84 132.59 50.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.32 -0.4 . . . . 74.53 111.518 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -103.57 128.03 50.89 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.334 -0.394 . . . . 71.3 111.011 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -92.2 119.62 68.09 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.744 -0.207 . . . . 63.13 110.953 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.49 153.81 7.09 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.782 2.321 . . . . 71.1 113.094 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -64.36 130.49 44.0 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.084 0.772 . . . . 74.14 113.084 -173.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 3.0 mptp? -101.57 157.09 17.07 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.912 -0.586 . . . . 72.43 109.499 170.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -130.58 139.12 50.43 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.315 0.579 . . . . 73.41 111.91 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 26.2 p90 . . . . . 0 CA--C 1.536 0.412 0 CA-C-N 115.933 -0.576 . . . . 74.14 110.893 -178.967 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.461 HE21 ' HB3' ' A' ' 231' ' ' ALA . 24.8 mt-30 . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 120.788 0.328 . . . . 73.45 110.893 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.408 HD13 ' CZ3' ' A' ' 227' ' ' TRP . 51.5 tp -135.37 142.84 45.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.448 0.299 . . . . 65.44 111.02 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.518 ' HE2' HD21 ' A' ' 213' ' ' LEU . 0.7 OUTLIER -162.05 119.45 2.15 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.867 0.365 . . . . 64.14 110.868 -179.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.0 t -104.26 161.65 13.87 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.162 0.506 . . . . 72.12 112.218 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.518 HD21 ' HE2' ' A' ' 211' ' ' LYS . 95.5 mt -138.16 138.98 39.15 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.023 -0.535 . . . . 63.43 111.764 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.452 ' HB3' ' H ' ' A' ' 193' ' ' ALA . 21.8 t80 -97.2 106.23 18.52 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.906 0.384 . . . . 74.14 110.39 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 243' ' ' VAL . 80.0 mt -109.95 156.88 19.88 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.325 -0.398 . . . . 75.24 111.529 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -160.99 148.52 15.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.956 0.407 . . . . 70.11 112.062 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -132.21 -162.92 1.28 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.365 -0.606 . . . . 75.53 109.365 169.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -77.79 -1.7 32.71 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.778 0.659 . . . . 74.35 112.778 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 30.0 p -114.2 3.21 15.09 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.018 0.748 . . . . 55.32 113.018 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.406 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 149.22 -178.35 26.82 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.37 -0.919 . . . . 44.03 113.953 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 96.9 p -124.86 145.36 49.83 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.615 0.366 . . . . 65.15 111.021 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.9 tp -139.42 154.54 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-O 120.912 0.387 . . . . 72.32 111.263 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -108.02 112.45 25.02 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.891 0.377 . . . . 75.31 111.107 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.495 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -85.14 151.24 25.62 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.363 -0.38 . . . . 72.31 113.013 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 87.2 m -124.01 112.42 17.15 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.459 -0.436 . . . . 71.5 111.941 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.452 HD12 ' HD2' ' A' ' 211' ' ' LYS . 89.8 mt -94.97 121.95 37.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.342 -0.39 . . . . 73.14 110.717 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.408 ' CZ3' HD13 ' A' ' 210' ' ' LEU . 97.5 m95 -101.52 157.0 17.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.027 0.441 . . . . 74.45 111.875 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 54.95 -134.29 1.56 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.795 -0.639 . . . . 75.53 112.437 170.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 229' ' ' GLU . 4.1 mp0 -48.13 -34.18 9.44 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.704 0.802 . . . . 73.23 112.625 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 70.5 mt -69.52 -6.62 31.93 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.398 0.518 . . . . 54.25 112.398 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.461 ' HB3' HE21 ' A' ' 209' ' ' GLN . . . -63.86 -45.92 87.31 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.841 0.353 . . . . 63.11 111.776 177.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.47 6.34 23.88 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.324 0.49 . . . . 71.53 112.324 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -61.27 123.33 17.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.824 -0.171 . . . . 71.24 110.664 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -73.7 96.01 2.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.719 0.771 . . . . 73.33 112.564 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.405 ' CG2' HG21 ' A' ' 191' ' ' VAL . 7.7 p -121.7 134.97 63.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.258 -0.883 . . . . 64.44 108.934 168.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -119.71 172.37 7.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.164 0.983 . . . . 73.2 113.246 -168.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -72.56 99.67 2.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.257 -0.883 . . . . 52.32 111.58 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.09 20.98 6.09 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.119 0.808 . . . . 62.14 115.119 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -103.23 167.46 9.81 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.38 1.09 . . . . 55.15 111.169 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 47.8 mm -101.42 104.74 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.128 -0.487 . . . . 72.01 110.845 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -104.72 125.55 50.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.077 0.465 . . . . 44.2 112.204 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -84.71 102.43 12.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.084 0.468 . . . . 71.03 109.838 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.457 HG21 HD11 ' A' ' 215' ' ' LEU . 98.6 t -99.8 105.9 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.325 0.583 . . . . 73.31 111.935 -175.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 36.7 t -97.11 125.92 41.92 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.035 -0.529 . . . . 73.01 110.383 174.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.83 -169.08 34.22 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.022 -1.085 . . . . 73.34 114.4 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -109.39 121.09 44.43 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.784 0.433 . . . . 63.34 110.854 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.524 HG21 HD22 ' A' ' 179' ' ' LEU . 38.6 t -83.79 139.19 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.275 -0.42 . . . . 73.44 111.847 -177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.656 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 8.4 mtpm? -134.25 168.39 18.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.183 0.516 . . . . 64.3 111.443 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 25.8 tt0 . . . . . 0 N--CA 1.467 0.416 0 CA-C-N 116.09 -0.504 . . . . 64.21 110.305 172.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.131 0.491 . . . . 71.15 110.795 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.656 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 8.6 pt-20 -128.56 169.26 14.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.882 -0.599 . . . . 73.0 110.787 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.495 HG23 ' HA2' ' A' ' 224' ' ' GLY . 11.2 tt -148.79 117.22 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.461 0.648 . . . . 53.24 111.98 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 77.8 p -85.12 119.69 25.79 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.079 -0.51 . . . . 71.31 110.318 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.448 ' HB ' HD23 ' A' ' 226' ' ' LEU . 41.8 t -77.02 132.42 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.685 0.624 . . . . 73.13 112.685 -173.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -95.73 -54.74 3.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.829 -0.623 . . . . 72.42 110.276 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -139.78 126.81 20.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.056 -0.52 . . . . 73.03 110.785 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.7 tt -116.38 127.43 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.043 0.449 . . . . 72.13 111.284 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -125.28 118.78 3.36 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.142 -0.551 . . . . 73.53 112.955 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 41.3 mm -76.45 111.37 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.931 0.396 . . . . 64.41 110.889 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.402 HG22 ' HG3' ' A' ' 265' ' ' GLU . 61.8 mt -69.2 -42.99 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.844 0.354 . . . . 75.12 111.587 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 264' ' ' ILE . 44.5 mt-10 . . . . . 0 N--CA 1.47 0.549 0 CA-C-N 116.558 -0.292 . . . . 63.43 111.309 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 186' ' ' THR . 5.8 m-20 . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 121.103 0.478 . . . . 63.31 111.045 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -85.67 168.06 14.74 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.477 0.656 . . . . 63.43 112.091 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -96.72 156.8 16.19 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.511 -0.768 . . . . 64.41 109.868 169.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 51.0 mt -61.43 -32.67 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.105 0.409 . . . . 71.51 112.105 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.1 t -63.82 -22.73 67.05 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.882 0.373 . . . . 71.52 111.468 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -87.91 -12.02 45.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.38 -0.373 . . . . 65.33 111.85 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 187' ' ' ILE . 84.1 mt -71.54 103.07 2.87 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.389 0.614 . . . . 73.11 111.413 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.447 ' HG2' HD13 ' A' ' 183' ' ' LEU . 23.1 ptp -112.56 157.24 40.82 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.844 -0.616 . . . . 61.44 110.956 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.437 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 52.0 Cg_exo -53.05 135.27 58.64 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.487 2.125 . . . . 74.24 113.271 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 69.8 26.89 4.71 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.208 0.603 . . . . 70.4 112.28 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.447 HD13 ' HG2' ' A' ' 180' ' ' MET . 9.1 tt -115.85 144.72 43.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.767 0.318 . . . . 71.13 110.715 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.437 ' HB2' ' CD2' ' A' ' 246' ' ' TYR . 47.3 t -126.45 157.32 38.94 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.934 0.397 . . . . 74.11 111.79 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.2 -168.6 33.08 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.043 -0.599 . . . . 62.04 113.214 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 65.1 m -106.39 152.48 23.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.366 0.266 . . . . 71.33 110.534 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.472 HG21 HD21 ' A' ' 179' ' ' LEU . 37.4 pt -139.22 161.15 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.117 0.484 . . . . 61.33 111.584 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -118.38 110.94 18.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.087 -0.506 . . . . 62.45 110.137 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.67 157.89 44.51 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.346 0.593 . . . . 73.41 112.085 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -93.65 134.39 36.0 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.702 -0.681 . . . . 75.34 110.816 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.89 125.48 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.003 0.43 . . . . 51.2 111.978 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.28 -42.6 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.179 0.514 . . . . 72.22 111.146 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -146.11 130.55 17.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.992 -0.549 . . . . 71.21 111.205 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.91 104.55 8.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.019 0.438 . . . . 62.42 111.602 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.473 ' HB3' ' HD2' ' A' ' 196' ' ' PRO . 97.2 m-85 -86.0 163.33 43.64 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 116.542 -0.299 . . . . 73.02 111.721 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 195' ' ' TYR . 60.7 Cg_endo -70.28 -164.65 0.14 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.798 2.332 . . . . 72.42 113.155 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.662 ' HD3' ' HB2' ' A' ' 232' ' ' ASP . 22.1 pttp -100.05 111.49 23.78 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.608 0.718 . . . . 72.21 111.841 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -92.45 176.55 6.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 64.24 110.697 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.3 150.12 48.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.091 0.472 . . . . 74.52 111.334 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 43.5 p90 . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 121.113 0.483 . . . . 64.42 111.265 -179.514 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.472 0.629 0 CA-C-O 121.107 0.479 . . . . 61.24 111.982 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.5 tp -129.63 123.5 31.41 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.611 -0.722 . . . . 74.1 111.634 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.541 ' HD3' HD12 ' A' ' 226' ' ' LEU . 44.6 tttp -122.52 108.6 13.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.786 0.327 . . . . 61.13 111.309 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.6 m -74.32 125.85 29.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.476 -0.329 . . . . 71.0 111.178 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.405 HD21 ' HE3' ' A' ' 211' ' ' LYS . 97.8 mt -132.51 150.56 52.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.092 0.472 . . . . 75.41 111.67 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -135.01 124.25 24.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.469 -0.332 . . . . 73.43 110.32 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 86.7 mt -118.05 150.0 40.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.713 0.292 . . . . 74.32 111.688 -174.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -132.8 129.09 38.1 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.778 0.799 . . . . 73.32 112.095 175.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -115.11 165.68 12.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.113 -0.949 . . . . 71.34 109.042 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.72 -25.87 66.74 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 111.874 0.324 . . . . 62.44 111.874 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 69.6 p -91.86 0.34 57.48 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.697 0.628 . . . . 51.4 112.697 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 146.25 177.09 20.64 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.936 -0.65 . . . . 23.43 113.469 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 54.0 p -118.31 160.08 22.27 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 122.405 -0.467 . . . . 71.31 111.596 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.1 tp -146.47 152.67 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.011 0.434 . . . . 74.33 111.894 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -90.82 121.82 33.01 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.214 -0.448 . . . . 73.1 110.902 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -120.62 165.9 13.86 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.207 -0.52 . . . . 61.43 113.313 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 98.8 m -152.82 137.08 16.55 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.268 -0.548 . . . . 71.14 112.395 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.555 HD23 ' HB ' ' A' ' 258' ' ' VAL . 65.9 mt -106.1 141.31 37.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.84 -0.618 . . . . 64.3 110.47 172.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -114.84 160.88 18.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.1 0.476 . . . . 71.54 111.601 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 56.08 -134.13 1.41 Allowed 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.925 -0.579 . . . . 65.45 111.705 172.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.95 -34.65 68.23 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.468 0.544 . . . . 64.12 112.468 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.41 -15.39 62.55 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.119 0.414 . . . . 74.43 112.119 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -61.55 -27.68 68.79 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 120.965 0.412 . . . . 60.34 111.779 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.662 ' HB2' ' HD3' ' A' ' 197' ' ' LYS . 36.8 t70 -95.18 9.01 41.25 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 120.823 0.344 . . . . 73.14 111.481 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -56.9 128.52 37.21 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.905 0.383 . . . . 72.43 111.725 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.4 115.63 16.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.066 0.46 . . . . 55.51 110.609 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.27 150.02 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.918 -0.583 . . . . 74.53 110.946 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.432 ' HB2' ' CG ' ' A' ' 239' ' ' ASP . 9.5 mmmm -117.66 146.91 43.37 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.087 0.47 . . . . 75.03 112.242 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.27 95.82 0.32 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.109 -0.496 . . . . 73.33 110.406 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 129.56 -16.78 5.61 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.916 -0.659 . . . . 45.51 113.348 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.432 ' CG ' ' HB2' ' A' ' 236' ' ' LYS . 66.2 m-20 -68.37 132.14 46.54 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.051 0.453 . . . . 64.04 111.086 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 264' ' ' ILE . 46.5 mm -77.79 107.99 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.912 0.387 . . . . 74.42 110.385 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -104.01 139.39 39.2 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.04 0.755 . . . . 52.43 113.04 -173.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -95.17 99.71 11.64 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.178 -0.675 . . . . 75.2 109.178 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.27 123.87 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.506 0.558 . . . . 71.14 112.506 -170.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 186' ' ' THR . 45.5 t -112.09 123.19 49.72 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.861 0.363 . . . . 62.34 111.211 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -164.6 -167.25 24.86 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.562 -0.827 . . . . 33.43 113.997 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 184' ' ' SER . 39.3 t80 -121.89 129.34 52.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.736 0.303 . . . . 64.35 110.966 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 47.0 t -96.22 125.68 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.005 0.431 . . . . 72.42 112.129 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -122.18 166.21 14.94 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.015 0.436 . . . . 62.15 110.736 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.437 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 25.2 tt0 . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 120.712 0.292 . . . . 74.24 110.899 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 120.762 0.315 . . . . 62.45 110.861 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -113.96 126.13 54.8 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.82 0.343 . . . . 63.25 111.167 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.04 106.44 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.627 0.727 . . . . 44.41 111.47 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.2 t -83.62 114.38 21.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.905 -0.589 . . . . 73.0 110.456 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.555 ' HB ' HD23 ' A' ' 226' ' ' LEU . 39.0 t -91.06 121.28 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.186 0.439 . . . . 71.14 112.186 -173.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -101.99 -14.24 17.25 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.786 0.327 . . . . 72.4 111.668 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -149.49 127.37 11.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.684 0.278 . . . . 71.41 110.668 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.7 tt -137.13 135.36 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.206 0.527 . . . . 72.44 112.278 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -147.69 122.69 1.59 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 115.826 -0.625 . . . . 64.42 112.074 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 58.0 mt -82.74 136.88 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 O-C-N 121.992 -0.711 . . . . 54.54 112.015 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 240' ' ' ILE . 66.5 mt -70.6 -45.62 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.932 -0.576 . . . . 73.24 111.583 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.876 0.369 . . . . 54.4 111.585 -178.391 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 109.755 -0.461 . . . . 63.21 109.755 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.48 ' HB2' HG22 ' A' ' 187' ' ' ILE . 95.1 m-85 -98.94 135.61 40.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.373 0.606 . . . . 75.24 112.338 -176.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -91.52 153.37 19.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.012 -0.54 . . . . 55.02 110.063 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 220' ' ' GLY . 64.2 mt -54.23 -36.65 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 113.492 0.923 . . . . 62.32 113.492 -172.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.7 t -75.48 -10.14 59.19 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.828 -0.545 . . . . 74.15 112.348 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.74 -7.57 52.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.678 0.275 . . . . 71.54 111.388 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.85 159.47 33.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.641 0.734 . . . . 70.21 112.655 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.568 ' HG2' HD22 ' A' ' 183' ' ' LEU . 25.4 ptp -157.41 155.07 26.9 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.418 -0.81 . . . . 52.54 110.154 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.438 ' HB3' ' CB ' ' A' ' 249' ' ' GLN . 12.3 Cg_endo -57.35 150.75 56.94 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.995 1.796 . . . . 72.22 112.38 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.415 ' HA ' ' OH ' ' A' ' 246' ' ' TYR . 63.8 t30 65.09 32.15 10.51 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.387 0.613 . . . . 73.21 111.021 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.568 HD22 ' HG2' ' A' ' 180' ' ' MET . 30.1 tp -119.85 128.48 53.72 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.412 -0.358 . . . . 62.44 111.75 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 88.8 p -111.48 114.79 28.14 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.115 -0.366 . . . . 73.03 110.325 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.46 176.22 36.26 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.441 -0.885 . . . . 71.44 114.181 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 88.6 m -108.76 119.74 40.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.932 0.396 . . . . 62.55 111.328 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.48 HG22 ' HB2' ' A' ' 174' ' ' TYR . 34.4 pt -110.54 155.79 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.127 0.489 . . . . 60.24 111.886 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -118.58 113.01 20.61 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.226 -0.443 . . . . 75.5 110.483 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -145.65 163.05 36.05 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.294 0.569 . . . . 73.22 111.935 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -94.89 139.2 31.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.936 -0.574 . . . . 74.01 111.594 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' A' ' 215' ' ' LEU . 46.9 t -77.19 106.82 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.884 0.374 . . . . 74.3 111.563 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.401 ' HB ' ' HD2' ' A' ' 214' ' ' PHE . 14.7 t -79.93 -45.93 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.228 0.537 . . . . 75.14 111.229 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -145.05 115.82 7.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.116 -0.493 . . . . 74.23 111.438 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -100.79 108.81 20.71 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.376 -0.375 . . . . 63.22 110.852 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -70.78 159.99 83.47 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.505 -0.316 . . . . 75.33 111.45 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.16 159.45 49.79 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.261 1.974 . . . . 72.0 112.864 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 197' ' ' LYS . 21.0 ptmt -75.39 102.29 5.08 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.475 0.655 . . . . 54.34 112.075 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -67.08 163.55 19.83 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.66 -0.7 . . . . 72.54 112.048 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.56 131.11 53.68 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.711 -0.677 . . . . 71.11 111.485 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 210' ' ' LEU . 8.0 p90 . . . . . 0 N--CA 1.472 0.639 0 CA-C-O 120.706 0.288 . . . . 75.24 110.969 175.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.564 0.221 . . . . 73.42 110.648 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 200' ' ' PHE . 38.3 tp -141.5 117.99 10.89 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.089 0.403 . . . . 74.2 112.089 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -134.9 114.56 12.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.948 0.404 . . . . 52.22 111.412 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 47.2 t -93.8 149.41 21.26 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.931 0.396 . . . . 74.0 111.396 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.57 HD21 HG11 ' A' ' 235' ' ' VAL . 74.0 mt -128.66 125.36 37.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.601 -0.272 . . . . 71.54 111.229 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.401 ' HD2' ' HB ' ' A' ' 192' ' ' VAL . 34.0 t80 -89.9 111.91 23.11 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.792 0.329 . . . . 64.32 110.243 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 191' ' ' VAL . 48.1 mt -109.92 156.77 20.0 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.388 -0.369 . . . . 74.03 111.006 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 221' ' ' SER . 18.1 ptmt -148.79 165.46 31.39 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.494 0.664 . . . . 61.4 112.155 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.404 ' OD2' HG22 ' A' ' 219' ' ' THR . 25.7 t70 -147.5 170.11 18.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.066 -0.97 . . . . 44.44 109.877 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -48.78 -31.76 7.53 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.561 0.578 . . . . 74.21 112.561 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.404 HG22 ' OD2' ' A' ' 217' ' ' ASP . 13.1 t -102.48 -8.92 20.67 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.194 1.183 . . . . 73.35 114.194 -173.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.436 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 168.32 -179.55 41.32 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 119.82 -1.181 . . . . 70.22 114.453 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 216' ' ' LYS . 36.4 m -122.92 157.96 31.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.541 0.336 . . . . 72.51 111.325 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.6 tp -151.83 156.46 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.828 0.347 . . . . 70.32 111.32 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -113.37 112.07 23.04 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.277 0.561 . . . . 71.15 111.532 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.556 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -94.42 164.78 25.84 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.299 -0.41 . . . . 61.24 113.065 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 86.0 m -137.51 127.22 25.36 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.483 0.549 . . . . 71.11 112.483 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.465 HD23 ' HB ' ' A' ' 258' ' ' VAL . 96.1 mt -107.28 124.02 49.17 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.969 -0.56 . . . . 72.24 110.875 174.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -103.24 152.51 21.41 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.075 0.464 . . . . 73.31 111.995 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.0 m-20 51.01 -132.52 1.9 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.566 0.58 . . . . 75.42 112.566 171.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -42.72 -39.53 2.46 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.433 0.901 . . . . 73.13 113.433 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.2 -19.77 63.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.975 0.417 . . . . 75.11 112.049 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.66 -21.98 66.86 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.091 0.404 . . . . 54.31 112.091 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.57 3.38 55.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.222 0.453 . . . . 75.4 112.222 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -64.33 124.31 21.41 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 110.289 -0.263 . . . . 74.34 110.289 174.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.434 ' OE2' ' HE2' ' A' ' 236' ' ' LYS . 28.9 tt0 -66.86 99.4 0.62 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.17 0.509 . . . . 73.01 112.043 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 213' ' ' LEU . 4.0 p -116.85 111.19 34.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.466 0.65 . . . . 41.53 110.699 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.434 ' HE2' ' OE2' ' A' ' 234' ' ' GLU . 66.8 mttm -98.36 147.73 24.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.08 0.466 . . . . 74.04 111.506 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -65.1 112.85 3.56 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 75.44 110.597 177.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.63 -16.66 23.74 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.463 -0.399 . . . . 11.1 113.172 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.51 141.54 51.93 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.011 0.434 . . . . 73.44 111.482 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 37.2 mm -89.09 117.91 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.476 -0.329 . . . . 73.14 110.522 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -109.01 127.1 53.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.11 0.782 . . . . 65.52 113.11 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.2 97.54 6.96 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.228 -0.656 . . . . 53.31 109.228 167.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.7 t -100.79 106.02 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.251 0.548 . . . . 74.54 112.24 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.9 m -96.65 109.19 21.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.937 -0.574 . . . . 72.41 110.055 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.67 -172.98 22.33 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.199 -1.0 . . . . 34.11 114.343 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.415 ' OH ' ' HA ' ' A' ' 182' ' ' ASN . 74.0 t80 -115.38 115.66 26.96 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.39 -0.405 . . . . 74.33 110.856 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.83 126.66 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.16 0.505 . . . . 53.32 111.717 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 52.4 mtpt -123.04 146.49 47.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.067 -0.515 . . . . 53.33 111.504 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.438 ' CB ' ' HB3' ' A' ' 181' ' ' PRO . 25.3 tt0 . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 75.22 110.648 172.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 120.96 0.409 . . . . 54.44 111.385 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.418 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 10.5 pt-20 -144.24 174.03 11.25 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.154 -0.475 . . . . 70.33 111.007 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.556 HG23 ' HA2' ' A' ' 224' ' ' GLY . 8.5 tt -154.05 116.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.477 0.656 . . . . 75.42 111.976 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.8 t -87.49 124.37 33.38 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.951 -0.568 . . . . 74.43 110.098 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 226' ' ' LEU . 33.3 t -84.08 132.84 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 112.366 0.506 . . . . 74.42 112.366 -173.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -95.36 -42.48 8.48 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.311 0.577 . . . . 72.23 110.723 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -145.42 135.41 23.71 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.917 -0.583 . . . . 65.41 110.702 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.459 ' HB ' HG11 ' A' ' 258' ' ' VAL . 12.6 tt -137.92 140.12 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.935 0.398 . . . . 62.34 111.596 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -149.98 136.42 5.69 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 116.24 -0.436 . . . . 73.23 112.159 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.6 mm -84.8 132.84 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.324 -0.515 . . . . 72.11 111.287 -178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 46.6 mt -77.1 -74.52 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 116.713 -0.221 . . . . 71.43 111.191 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.473 0.694 0 CA-C-O 121.201 0.524 . . . . 63.0 110.443 170.182 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 186' ' ' THR . 78.0 m-20 . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.912 0.387 . . . . 74.52 110.868 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 33.2 m-85 -83.92 171.45 13.02 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.518 0.675 . . . . 64.31 112.09 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 74.3 mmtt -93.39 156.68 16.64 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.568 -0.742 . . . . 70.53 109.683 167.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.503 HD13 HG22 ' A' ' 222' ' ' ILE . 40.0 mt -59.12 -31.87 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.114 0.412 . . . . 74.55 112.114 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.452 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 34.8 t -62.11 -29.26 70.2 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.93 0.395 . . . . 50.13 111.598 174.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 11.5 mm-40 -83.5 -18.22 39.24 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.405 -0.361 . . . . 72.31 111.695 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.676 HD11 HD13 ' A' ' 187' ' ' ILE . 87.6 mt -64.45 98.86 0.27 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.232 0.539 . . . . 73.03 110.998 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.463 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.9 ptp -96.64 152.2 38.4 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.099 -0.5 . . . . 73.31 111.163 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.18 138.34 78.92 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.169 1.913 . . . . 72.14 112.769 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 72.54 18.91 4.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.263 0.625 . . . . 62.31 111.794 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 180' ' ' MET . 44.1 tp -94.7 154.82 17.13 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 61.14 111.599 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.4 t -131.31 123.17 27.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.53 -0.305 . . . . 44.11 110.67 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.54 -164.45 26.28 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.89 -0.671 . . . . 61.13 113.527 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 43.8 m -133.76 147.36 51.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.433 0.293 . . . . 63.01 111.177 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.676 HD13 HD11 ' A' ' 179' ' ' LEU . 39.9 pt -142.51 165.53 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.01 0.433 . . . . 65.4 111.577 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -122.29 118.31 28.21 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.692 -0.485 . . . . 73.55 109.692 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.29 170.75 16.14 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.532 0.567 . . . . 73.33 112.532 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 215' ' ' LEU . 40.1 mt-10 -84.86 134.2 34.29 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.802 -0.635 . . . . 74.45 111.514 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.26 95.75 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.039 0.447 . . . . 73.12 110.63 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.25 -29.94 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.127 0.489 . . . . 54.22 112.001 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.97 145.02 28.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 75.14 111.694 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -140.84 116.31 10.11 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.216 -0.447 . . . . 33.41 111.384 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.481 ' O ' ' HE2' ' A' ' 211' ' ' LYS . 97.0 m-85 -87.4 153.93 53.75 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-N 116.627 -0.26 . . . . 75.11 110.956 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.25 162.43 23.43 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.663 2.242 . . . . 65.11 112.942 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 197' ' ' LYS . 20.3 ptmt -72.48 115.3 11.58 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.618 0.723 . . . . 71.25 111.744 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -102.27 148.74 25.08 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.0 -0.546 . . . . 74.3 111.19 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.41 144.37 45.05 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.895 0.378 . . . . 74.31 111.243 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 12.4 p90 . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 121.012 0.434 . . . . 62.54 111.315 177.379 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.45 HE21 ' HA ' ' A' ' 229' ' ' GLU . 37.5 mt-30 . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 121.424 0.631 . . . . 62.23 112.695 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.4 tp -138.37 116.5 11.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.431 -0.804 . . . . 75.55 111.221 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.481 ' HE2' ' O ' ' A' ' 195' ' ' TYR . 59.5 tttm -145.79 107.31 4.24 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.035 -0.416 . . . . 74.12 111.264 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 225' ' ' THR . 57.9 m -86.49 142.36 28.41 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.525 0.678 . . . . 73.13 112.65 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 59.8 mt -123.74 163.01 22.01 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.27 -0.877 . . . . 63.33 109.619 173.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -119.92 117.12 27.26 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.956 -0.465 . . . . 71.04 110.686 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 78.3 mt -107.7 133.98 51.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.726 0.298 . . . . 75.14 111.224 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -124.03 153.64 41.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.426 0.631 . . . . 71.33 111.877 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -151.15 160.43 43.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.964 -1.016 . . . . 74.11 109.302 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.31 -25.78 49.84 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.107 0.41 . . . . 61.15 112.107 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 48.6 p -89.23 -14.09 36.72 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.061 0.763 . . . . 62.14 113.061 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.02 -179.76 41.55 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.341 -0.933 . . . . 52.32 114.218 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.5 p -135.41 132.48 37.55 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.659 -0.318 . . . . 54.32 111.216 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.503 HG22 HD13 ' A' ' 176' ' ' ILE . 15.5 tt -144.81 145.74 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.058 0.456 . . . . 73.31 111.75 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.708 ' H ' ' HD2' ' A' ' 223' ' ' ARG . 0.5 OUTLIER -89.93 130.33 36.16 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.985 -0.447 . . . . 74.44 111.313 177.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.466 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -112.32 114.43 3.52 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.459 -0.401 . . . . 64.32 112.906 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 212' ' ' SER . 87.9 m -95.47 120.14 35.19 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.477 0.547 . . . . 55.1 112.477 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.494 HD23 ' HB ' ' A' ' 258' ' ' VAL . 91.3 mt -78.74 123.84 27.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.948 -0.569 . . . . 74.1 110.857 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -107.74 172.72 6.67 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.988 0.423 . . . . 75.23 111.362 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 57.7 t30 55.72 -141.11 0.86 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 116.217 -0.447 . . . . 74.2 111.525 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.45 ' HA ' HE21 ' A' ' 209' ' ' GLN . 11.5 pt-20 -74.85 -5.73 45.18 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.57 -0.706 . . . . 70.43 112.465 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.487 ' HB3' HD22 ' A' ' 226' ' ' LEU . 83.2 mt -68.3 -12.77 61.59 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 122.137 -0.352 . . . . 51.21 111.656 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.79 67.11 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.153 0.502 . . . . 71.33 111.595 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.0 -3.07 59.06 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.012 0.375 . . . . 73.44 112.012 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -62.96 118.26 7.56 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.146 0.498 . . . . 74.42 110.999 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.26 99.42 4.04 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.402 0.62 . . . . 72.33 112.086 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.77 141.64 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 115.733 -0.667 . . . . 75.54 110.731 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -116.92 171.03 8.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.037 0.446 . . . . 73.22 110.835 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -72.99 119.24 16.97 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.852 0.358 . . . . 71.24 110.633 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 118.16 -24.13 8.9 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.157 -0.544 . . . . 44.25 113.751 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -64.78 134.32 53.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 117.159 0.479 . . . . 72.42 111.962 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 49.8 mm -84.03 102.33 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.005 0.431 . . . . 72.25 110.112 173.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -108.74 141.61 40.49 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.661 0.615 . . . . 71.24 112.661 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -89.35 108.45 19.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.802 -0.636 . . . . 73.31 109.728 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 258' ' ' VAL . 75.8 t -111.51 130.24 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.158 0.429 . . . . 72.23 112.158 -172.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 28.5 t -123.9 137.3 54.66 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.294 -0.412 . . . . 61.42 110.701 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.98 -164.16 32.29 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.194 -1.003 . . . . 51.54 114.169 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -105.47 123.19 47.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.827 0.451 . . . . 74.12 111.189 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.9 t -89.93 134.44 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.229 0.538 . . . . 73.11 112.271 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.57 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 7.9 mtpm? -128.03 157.2 41.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.94 -0.573 . . . . 70.51 110.441 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 . . . . . 0 N--CA 1.469 0.517 0 O-C-N 122.173 -0.329 . . . . 74.4 110.326 173.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 98.2 mt . . . . . 0 CA--C 1.54 0.596 0 CA-C-O 121.42 0.629 . . . . 51.14 112.649 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . 0.57 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 8.0 pt-20 -143.62 125.85 15.56 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.563 -0.744 . . . . 51.1 110.038 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.466 HG23 ' HA2' ' A' ' 224' ' ' GLY . 12.2 tt -116.72 135.12 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.438 0.637 . . . . 72.4 112.443 -176.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 69.8 m -95.66 115.06 26.89 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.771 -0.649 . . . . 74.11 110.343 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.494 ' HB ' HD23 ' A' ' 226' ' ' LEU . 38.5 t -75.54 120.32 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.302 0.573 . . . . 63.42 112.158 -174.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.36 -36.41 11.39 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.941 -0.572 . . . . 75.23 110.654 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 15.7 t-20 -139.93 140.14 36.31 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.804 -0.634 . . . . 74.11 110.334 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 14.2 tt -148.35 135.2 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.345 0.593 . . . . 70.54 112.288 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -148.49 125.18 2.01 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.104 -0.498 . . . . 74.34 112.304 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 54.0 mt -79.85 131.9 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 122.217 -0.578 . . . . 51.23 111.773 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.1 mt -73.33 -52.75 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.122 0.487 . . . . 65.41 111.332 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 . . . . . 0 N--CA 1.469 0.511 0 CA-C-N 116.075 -0.511 . . . . 75.43 111.792 179.812 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.726 -0.472 . . . . 72.14 109.726 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.423 ' O ' HG22 ' A' ' 187' ' ' ILE . 88.8 m-85 -84.35 145.36 28.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.326 0.584 . . . . 74.21 112.463 -173.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 46.4 mmtm -79.42 154.34 29.03 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.047 -0.723 . . . . 74.14 109.047 167.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.438 HG23 ' HB ' ' A' ' 222' ' ' ILE . 58.7 mt -51.94 -36.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 112.591 0.589 . . . . 74.24 112.591 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.4 t -67.76 -29.14 68.28 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 122.057 -0.402 . . . . 55.04 111.845 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.482 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 12.3 mm-40 -76.26 -8.04 56.21 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.851 0.315 . . . . 74.52 111.851 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.424 HD22 HG21 ' A' ' 247' ' ' VAL . 88.1 mt -73.41 145.29 45.92 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.314 0.578 . . . . 74.41 111.901 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.478 ' HG2' HD22 ' A' ' 183' ' ' LEU . 24.2 ptp -143.97 159.16 54.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.029 -0.532 . . . . 75.21 110.7 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.22 132.38 38.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.451 2.101 . . . . 63.1 113.192 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 65.05 46.08 2.89 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.065 0.459 . . . . 70.33 111.589 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.478 HD22 ' HG2' ' A' ' 180' ' ' MET . 42.8 tp -119.19 120.88 38.37 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.304 -0.407 . . . . 63.22 111.73 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.5 t -99.14 120.46 39.53 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.556 0.217 . . . . 64.21 110.639 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.82 -176.17 38.79 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.52 -0.848 . . . . 55.13 114.402 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 90.6 m -114.57 136.58 52.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.0 0.52 . . . . 74.35 111.698 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 174' ' ' TYR . 34.6 pt -126.8 157.8 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 122.63 0.372 . . . . 72.2 110.741 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -129.96 103.15 6.61 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.177 -0.327 . . . . 65.23 110.174 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -139.31 172.32 12.99 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 113.373 0.879 . . . . 73.01 113.373 -171.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.92 140.8 29.07 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.052 -0.976 . . . . 75.43 111.425 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.33 95.05 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.069 0.461 . . . . 63.21 110.761 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.405 ' HB ' ' HD2' ' A' ' 214' ' ' PHE . 16.2 t -72.26 -42.6 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.223 -0.444 . . . . 72.01 111.936 -176.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -140.32 127.7 21.29 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.99 0.424 . . . . 74.15 111.63 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -104.18 104.41 14.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.342 -0.39 . . . . 54.02 111.542 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -79.67 150.07 72.25 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.543 -0.299 . . . . 74.35 111.775 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.6 168.38 16.73 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.981 2.454 . . . . 74.53 113.801 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.2 156.39 33.65 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.102 -0.499 . . . . 73.43 111.675 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -141.88 159.08 42.95 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.112 -0.495 . . . . 63.42 111.056 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -129.08 153.45 47.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.991 0.424 . . . . 61.04 111.47 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.574 ' HE2' ' HB2' ' A' ' 210' ' ' LEU . 52.4 p90 . . . . . 0 N--CA 1.47 0.556 0 CA-C-O 121.032 0.444 . . . . 63.23 111.08 175.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 120.965 0.412 . . . . 64.33 111.981 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.574 ' HB2' ' HE2' ' A' ' 200' ' ' PHE . 51.7 tp -135.12 141.01 45.9 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.95 0.5 . . . . 74.41 111.321 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 231' ' ' ALA . 7.6 tmtm? -167.38 115.2 0.78 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.796 0.332 . . . . 71.33 111.034 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 69.8 m -99.83 167.26 10.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.741 0.782 . . . . 62.25 113.025 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.424 HD11 HG11 ' A' ' 235' ' ' VAL . 75.9 mt -142.66 157.33 44.79 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.179 -0.919 . . . . 54.44 110.752 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.405 ' HD2' ' HB ' ' A' ' 192' ' ' VAL . 35.6 t80 -117.13 122.52 44.32 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.133 -0.354 . . . . 74.54 110.851 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.529 HD11 HG21 ' A' ' 243' ' ' VAL . 44.3 mt -118.4 154.63 32.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.655 0.382 . . . . 71.23 111.004 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -153.25 132.81 12.97 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.764 0.654 . . . . 61.53 112.764 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -99.81 -171.17 2.0 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.977 -0.556 . . . . 43.24 110.315 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.94 -15.15 62.58 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.195 0.522 . . . . 73.25 110.587 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 54.1 p -94.47 -20.52 19.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.819 0.674 . . . . 61.34 112.819 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 158.12 -179.53 33.76 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.755 -0.736 . . . . 72.13 113.361 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 83.9 p -123.67 146.78 47.98 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.056 0.455 . . . . 74.04 112.047 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 176' ' ' ILE . 11.4 tp -144.1 157.22 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.251 -0.432 . . . . 73.5 110.966 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 223' ' ' ARG . 29.1 mtm-85 -102.54 117.61 35.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.695 0.284 . . . . 74.02 111.455 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.556 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -97.7 119.76 6.52 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.419 -0.42 . . . . 62.15 112.84 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.0 m -99.25 118.41 35.87 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.355 0.502 . . . . 75.44 112.355 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.559 HD23 ' HB ' ' A' ' 258' ' ' VAL . 91.4 mt -91.9 133.82 35.33 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.974 -0.557 . . . . 71.11 111.046 175.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -115.46 159.4 21.22 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.08 0.467 . . . . 74.42 111.886 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.48 -133.54 1.06 Allowed 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 115.921 -0.581 . . . . 73.42 111.676 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.76 -31.58 39.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.242 0.46 . . . . 72.32 112.242 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 90.3 mt -64.27 -14.91 58.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.983 0.364 . . . . 63.45 111.983 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 211' ' ' LYS . . . -73.98 -1.96 22.09 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.968 0.413 . . . . 63.21 112.063 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.03 14.22 9.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.895 0.478 . . . . 75.42 110.961 173.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -72.69 126.22 29.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.042 -0.526 . . . . 75.3 111.139 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -62.86 97.36 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.169 0.509 . . . . 55.43 111.828 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.424 HG11 HD11 ' A' ' 213' ' ' LEU . 4.0 p -135.72 114.38 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.934 -0.576 . . . . 70.12 110.541 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -100.35 157.94 16.25 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.169 0.509 . . . . 73.45 111.507 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -69.35 94.77 0.74 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.994 -0.548 . . . . 74.33 111.664 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 137.27 -19.35 3.42 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.171 -0.538 . . . . 71.14 113.793 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -70.0 146.13 51.28 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.139 0.495 . . . . 55.33 112.083 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.537 HG22 HD12 ' A' ' 264' ' ' ILE . 45.8 mm -86.93 129.31 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.191 -0.458 . . . . 73.43 110.22 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.622 ' HB2' HD13 ' A' ' 263' ' ' ILE . . . -140.91 152.35 44.96 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.028 0.751 . . . . 74.24 113.028 -175.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.28 125.52 38.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.787 -0.642 . . . . 74.52 110.221 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 215' ' ' LEU . 92.9 t -122.11 117.58 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.133 0.492 . . . . 52.05 111.786 -175.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 260' ' ' ASN . 69.7 m -118.0 133.18 56.16 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.321 -0.4 . . . . 73.13 110.955 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.26 -156.12 13.23 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.438 -0.887 . . . . 44.25 113.84 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -122.75 115.32 21.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.966 0.412 . . . . 72.35 111.339 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.543 HG22 ' HB ' ' A' ' 256' ' ' ILE . 38.3 t -86.89 125.69 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.249 -0.432 . . . . 64.45 111.614 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -154.08 154.45 33.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.804 0.335 . . . . 53.54 111.365 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 CA--C 1.536 0.428 0 CA-C-N 116.677 -0.238 . . . . 64.42 110.472 176.311 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.017 0.437 . . . . 73.23 111.278 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -122.27 133.81 54.68 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.437 -0.347 . . . . 72.32 111.293 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.556 HG23 ' HA2' ' A' ' 224' ' ' GLY . 8.5 tt -103.86 109.09 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.329 0.585 . . . . 65.5 111.104 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.7 t -78.28 115.47 18.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.212 -0.449 . . . . 74.01 110.024 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.559 ' HB ' HD23 ' A' ' 226' ' ' LEU . 38.8 t -88.45 116.9 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 112.607 0.595 . . . . 73.24 112.607 -170.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.76 -24.15 17.92 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.327 -0.397 . . . . 75.32 111.6 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 244' ' ' SER . 27.3 t-20 -139.79 131.78 27.81 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.678 0.275 . . . . 64.11 111.163 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.1 tt -149.04 139.33 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.877 0.37 . . . . 65.2 111.163 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -149.47 129.11 2.92 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.15 -0.548 . . . . 65.05 112.826 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.622 HD13 ' HB2' ' A' ' 241' ' ' ALA . 46.4 mm -73.36 115.16 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 122.678 -0.307 . . . . 63.14 110.749 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.537 HD12 HG22 ' A' ' 240' ' ' ILE . 72.2 mt -66.01 -53.62 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.008 0.432 . . . . 71.54 111.469 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 . . . . . 0 N--CA 1.47 0.536 0 CA-C-N 116.297 -0.41 . . . . 64.34 111.027 178.627 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 109.622 -0.51 . . . . 51.32 109.622 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -96.8 155.24 16.86 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.154 0.798 . . . . 73.34 113.154 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -100.04 155.59 17.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.345 -0.843 . . . . 74.11 109.945 169.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 220' ' ' GLY . 44.2 mt -66.06 -30.09 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 112.551 0.574 . . . . 73.34 112.551 -172.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 219' ' ' THR . 93.5 p -71.09 -28.52 64.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.237 0.542 . . . . 64.51 110.664 173.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -77.99 -31.47 50.73 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.959 -0.564 . . . . 73.42 111.262 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 247' ' ' VAL . 78.0 mt -52.9 134.07 37.55 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.228 0.537 . . . . 64.12 111.475 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.446 ' HB2' ' HD2' ' A' ' 181' ' ' PRO . 22.9 ptp -140.57 164.65 35.32 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.925 -0.58 . . . . 72.12 111.077 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.514 ' HB3' ' HB3' ' A' ' 249' ' ' GLN . 9.4 Cg_endo -54.53 144.0 65.05 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.405 2.07 . . . . 75.21 112.879 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.1 t30 67.6 13.9 9.4 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.034 0.445 . . . . 61.43 111.909 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 40.2 tp -91.12 150.86 21.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.133 0.492 . . . . 72.15 111.993 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.8 t -131.78 133.67 45.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.339 -0.392 . . . . 73.33 110.492 173.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 173.82 -176.61 46.32 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.418 -0.896 . . . . 74.11 113.864 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 90.5 m -117.23 136.43 53.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.868 0.366 . . . . 60.13 111.325 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.437 HD13 HD11 ' A' ' 179' ' ' LEU . 33.8 pt -129.25 163.48 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 122.885 0.474 . . . . 62.43 111.485 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.58 114.25 17.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.47 -0.332 . . . . 75.22 110.503 175.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.28 168.58 19.44 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.848 0.356 . . . . 62.53 111.945 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 14.7 pt-20 -89.44 143.51 26.77 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.009 0.433 . . . . 64.45 111.353 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.444 ' HA ' HD23 ' A' ' 215' ' ' LEU . 39.8 t -79.49 105.01 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.226 0.536 . . . . 74.31 111.608 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.48 -37.63 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.207 0.527 . . . . 71.32 111.116 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.2 134.05 11.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.041 -0.527 . . . . 74.54 111.409 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -115.1 101.52 9.06 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.897 0.38 . . . . 71.14 111.246 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -72.11 143.96 86.82 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.483 -0.326 . . . . 75.25 111.27 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.63 168.75 2.87 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.955 2.437 . . . . 64.31 113.956 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -83.31 118.28 23.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.319 0.581 . . . . 73.01 111.785 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.637 ' HE2' ' HG ' ' A' ' 210' ' ' LEU . 2.6 mppt? -96.92 162.82 13.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.117 -0.492 . . . . 55.34 111.408 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -111.09 146.86 36.04 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.196 -0.457 . . . . 71.1 111.393 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 36.2 p90 . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 121.175 0.512 . . . . 75.12 111.125 173.174 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 . . . . . 0 CA--C 1.542 0.659 0 CA-C-O 120.654 0.264 . . . . 75.23 110.882 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.637 ' HG ' ' HE2' ' A' ' 198' ' ' LYS . 14.9 tp -137.33 116.72 12.76 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.391 0.515 . . . . 62.53 112.391 -175.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.542 ' HD3' HD12 ' A' ' 226' ' ' LEU . 59.8 tttp -122.15 147.79 45.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.762 0.315 . . . . 55.05 110.736 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.44 ' OG ' ' NZ ' ' A' ' 198' ' ' LYS . 49.0 m -123.74 147.15 47.75 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.022 0.439 . . . . 63.21 111.342 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.3 mt -135.14 157.45 46.88 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.217 -0.447 . . . . 72.22 110.92 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -127.87 115.89 19.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.905 -0.406 . . . . 44.21 109.905 173.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 191' ' ' VAL . 64.9 mt -117.64 153.49 33.21 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.403 -0.362 . . . . 70.22 111.316 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 22.0 pttp -147.24 145.2 29.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.782 0.801 . . . . 64.43 112.35 174.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -122.15 170.94 9.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.657 -1.156 . . . . 74.22 108.635 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -49.93 -29.91 9.27 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.138 0.494 . . . . 74.11 111.364 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 177' ' ' SER . 77.2 p -88.17 -2.15 58.43 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.755 1.02 . . . . 73.42 113.755 -175.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 143.09 -178.95 21.0 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 120.412 -0.899 . . . . 74.13 113.801 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.9 p -120.33 155.37 33.48 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 120.911 0.386 . . . . 70.31 111.78 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.409 HG12 ' N ' ' A' ' 223' ' ' ARG . 14.9 tt -148.84 157.43 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.937 0.399 . . . . 72.05 111.768 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 223' ' ' ARG . 7.6 mpt_? -92.37 128.64 38.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.295 -0.411 . . . . 64.42 110.903 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -107.97 140.56 15.5 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.343 -0.456 . . . . 44.14 112.781 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 32.9 m -125.44 116.33 21.68 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.209 -0.583 . . . . 75.3 112.176 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.56 HD23 ' HB ' ' A' ' 258' ' ' VAL . 74.8 mt -99.02 132.25 44.47 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.479 -0.328 . . . . 65.04 111.038 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -113.14 154.93 25.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.157 0.503 . . . . 74.04 112.122 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.1 t30 62.18 -152.25 0.36 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.751 -0.659 . . . . 52.11 111.201 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.62 -7.29 0.91 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.671 0.989 . . . . 73.05 113.671 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.68 -13.68 55.23 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.167 0.508 . . . . 70.44 110.85 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -64.99 -28.89 69.82 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.106 -0.497 . . . . 62.15 112.151 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.01 0.19 53.97 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.108 0.41 . . . . 61.33 112.108 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -66.45 101.77 0.8 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.045 0.45 . . . . 72.01 110.658 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.51 100.55 1.43 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.12 0.415 . . . . 55.23 112.12 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.6 150.42 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.098 -0.501 . . . . 70.44 110.216 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -113.44 163.15 15.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.453 0.645 . . . . 70.11 112.08 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -81.11 94.76 6.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.136 -0.484 . . . . 65.25 110.688 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 141.57 -11.74 2.7 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.448 -0.882 . . . . 65.34 114.868 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -88.48 172.82 9.07 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.209 1.005 . . . . 70.44 111.456 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 48.1 mm -105.04 113.81 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.073 -0.512 . . . . 64.21 110.94 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -100.04 122.94 43.7 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.809 0.67 . . . . 44.13 112.809 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -80.24 104.86 11.08 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.818 -0.628 . . . . 45.44 109.55 170.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 215' ' ' LEU . 93.1 t -115.83 128.77 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.543 0.571 . . . . 71.31 112.543 -172.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 39.2 t -120.85 132.52 55.04 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.16 -0.473 . . . . 51.32 110.405 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.33 -163.27 29.03 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.274 -0.965 . . . . 63.1 114.436 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -117.95 115.73 25.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.769 0.428 . . . . 74.23 111.264 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.516 HG21 HD22 ' A' ' 179' ' ' LEU . 48.5 t -85.44 133.16 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.666 0.617 . . . . 74.34 112.666 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -128.39 138.51 52.38 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.207 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 181' ' ' PRO . 29.2 tt0 . . . . . 0 N--CA 1.469 0.48 0 CA-C-O 120.715 0.293 . . . . 73.31 110.827 177.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.413 ' O ' ' HD3' ' A' ' 223' ' ' ARG . 4.5 mp . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 121.053 0.454 . . . . 70.42 111.97 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.75 167.18 11.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.14 -0.482 . . . . 64.13 110.386 175.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tt -136.04 103.86 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.556 0.693 . . . . 71.23 111.129 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.9 t -66.28 106.72 1.76 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.986 -0.552 . . . . 52.32 109.873 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.56 ' HB ' HD23 ' A' ' 226' ' ' LEU . 38.9 t -75.5 124.48 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.571 0.582 . . . . 52.35 112.571 -171.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -81.63 -40.94 22.17 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.85 -0.613 . . . . 65.25 110.675 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -153.49 148.78 27.01 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.132 -0.486 . . . . 63.42 111.127 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.8 tt -140.85 142.64 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.062 0.458 . . . . 73.31 111.567 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -150.51 145.02 12.58 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.171 -0.538 . . . . 74.4 112.823 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.0 mt -81.79 127.94 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 122.443 -0.445 . . . . 71.1 110.903 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 34.8 mm -56.41 -43.76 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.718 0.636 . . . . 65.22 112.718 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 121.353 0.597 . . . . 55.32 112.105 -179.742 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.9 m120 . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 111.896 0.332 . . . . 61.03 111.896 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.534 ' HB2' HG22 ' A' ' 187' ' ' ILE . 95.5 m-85 -120.78 143.28 48.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.339 0.59 . . . . 73.14 112.152 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -99.69 159.86 14.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 70.3 109.798 169.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.49 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 68.6 mt -64.06 -34.88 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 112.609 0.596 . . . . 72.05 112.609 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.4 t -69.03 -20.56 64.13 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.069 0.461 . . . . 63.04 111.144 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -84.26 -11.08 57.06 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.026 -0.534 . . . . 73.33 111.379 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 247' ' ' VAL . 77.5 mt -68.44 162.03 26.37 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.888 0.852 . . . . 52.31 113.248 -174.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.0 ptp -162.7 153.75 14.66 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 114.877 -1.056 . . . . 61.52 110.031 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.74 144.2 87.63 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.251 1.967 . . . . 74.52 112.756 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 67.88 24.44 8.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.848 0.459 . . . . 63.15 111.978 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 49.5 tp -95.83 121.27 37.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.118 0.414 . . . . 65.55 112.118 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 60.6 m -104.65 115.96 31.23 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.455 -0.339 . . . . 40.11 110.41 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.08 -168.49 36.38 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.266 -0.969 . . . . 65.04 114.111 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 52.8 m -119.89 119.25 32.97 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.71 0.29 . . . . 73.53 111.44 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.534 HG22 ' HB2' ' A' ' 174' ' ' TYR . 31.9 pt -101.36 154.3 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.232 0.539 . . . . 51.24 111.945 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -122.23 109.08 14.04 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.158 0.504 . . . . 72.41 110.834 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 216' ' ' LYS . . . -148.4 -177.59 5.85 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.925 -0.58 . . . . 71.03 111.452 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 10.7 pt-20 -107.89 148.43 29.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.229 0.538 . . . . 73.32 111.355 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.14 114.29 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.058 -0.519 . . . . 74.14 111.909 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.1 -49.42 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.205 0.526 . . . . 71.4 110.988 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -139.2 135.52 34.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 61.43 111.138 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -131.05 102.89 6.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.333 -0.394 . . . . 63.21 111.265 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 212' ' ' SER . 74.7 m-85 -95.04 126.3 47.23 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.381 -0.372 . . . . 74.42 110.607 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 195' ' ' TYR . 48.6 Cg_exo -57.67 -174.83 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.335 2.69 . . . . 62.14 114.521 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.666 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 20.7 pttm -67.79 141.22 56.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.505 0.928 . . . . 52.22 113.505 -174.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.734 ' HE2' ' HG ' ' A' ' 210' ' ' LEU . 32.0 mtmm -120.31 157.37 29.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.083 -0.962 . . . . 62.41 110.368 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -102.82 137.33 41.17 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.139 0.495 . . . . 75.13 111.952 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 24.6 p90 . . . . . 0 N--CA 1.47 0.572 0 CA-C-N 115.985 -0.552 . . . . 74.25 110.325 174.025 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 . . . . . 0 N--CA 1.471 0.596 0 CA-C-O 120.783 0.325 . . . . 64.5 111.276 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.734 ' HG ' ' HE2' ' A' ' 198' ' ' LYS . 18.4 tp -112.52 108.78 18.01 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.292 0.478 . . . . 70.54 112.292 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 82.6 tttt -117.62 139.53 50.87 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.807 0.336 . . . . 44.44 110.957 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 15.0 m -109.93 134.25 52.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.066 0.395 . . . . 71.03 112.066 -172.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 72.1 mt -129.88 145.53 51.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.254 0.549 . . . . 71.23 112.005 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -126.7 118.83 25.53 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.982 -0.554 . . . . 71.1 109.68 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.71 154.86 28.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.345 -0.389 . . . . 72.31 111.476 -174.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 19.6 ptmt -153.74 170.01 21.96 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.899 0.381 . . . . 75.42 111.091 174.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.89 -174.73 4.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.852 -0.425 . . . . 63.41 109.852 171.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.64 -16.03 59.85 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.248 0.462 . . . . 64.24 112.248 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.4 p -98.76 -21.86 16.16 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.169 0.803 . . . . 73.24 113.169 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.98 -178.35 42.89 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 120.514 -0.851 . . . . 71.31 113.825 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 60.9 m -129.59 136.12 49.4 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 120.983 0.42 . . . . 74.43 111.892 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.0 tp -133.06 153.78 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.098 0.475 . . . . 65.11 111.76 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -111.42 135.4 52.03 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.768 0.318 . . . . 74.42 110.885 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -138.43 178.5 19.26 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.831 -0.699 . . . . 74.43 114.05 -174.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 88.0 m -148.37 137.4 21.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.568 -0.372 . . . . 44.11 111.933 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.596 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 83.5 mt -101.92 134.57 44.92 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.143 -0.481 . . . . 73.31 110.864 175.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -113.48 152.83 29.64 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.901 0.381 . . . . 75.02 111.666 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 14.4 m120 64.08 -143.36 0.29 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.191 -0.459 . . . . 71.42 112.001 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -48.33 -29.82 4.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.99 0.737 . . . . 72.11 112.99 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 92.4 mt -55.9 -18.89 10.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.003 0.43 . . . . 74.43 111.596 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.666 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -63.19 -44.05 96.45 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.994 0.426 . . . . 52.42 111.56 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -87.31 -5.33 58.95 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.961 0.356 . . . . 74.13 111.961 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -63.1 116.98 5.87 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.903 -0.406 . . . . 75.15 109.903 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.43 126.08 26.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.511 0.672 . . . . 72.32 112.383 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.08 127.23 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.606 -0.725 . . . . 74.01 110.039 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -100.34 141.99 32.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.142 0.496 . . . . 74.11 111.896 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 237' ' ' LYS . 1.1 tmmt? -73.0 125.89 28.67 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.873 -0.603 . . . . 75.14 110.74 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.37 14.25 51.47 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.234 -0.508 . . . . 55.23 113.175 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.59 158.65 18.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.96 0.41 . . . . 64.44 112.071 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 32.7 mm -92.33 127.71 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 116.275 -0.42 . . . . 71.32 110.898 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -130.25 143.22 50.65 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.088 0.773 . . . . 75.4 113.088 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.55 117.36 29.87 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.656 -0.702 . . . . 74.4 109.513 171.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.4 t -117.82 111.47 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.57 0.581 . . . . 71.4 112.57 -173.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 52.0 m -96.58 112.55 24.25 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.422 -0.353 . . . . 74.54 110.382 174.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.59 -167.79 17.0 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.418 -0.896 . . . . 63.22 114.132 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.497 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 93.4 t80 -122.8 113.95 19.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.683 0.393 . . . . 75.32 111.124 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.541 HG21 HD22 ' A' ' 179' ' ' LEU . 45.5 t -86.11 120.07 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.408 -0.36 . . . . 62.11 111.13 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 61.0 pttt -134.59 164.3 27.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.265 0.555 . . . . 75.1 112.06 -176.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 . . . . . 0 C--O 1.237 0.404 0 CA-C-N 115.596 -0.729 . . . . 75.13 109.776 173.823 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 109.322 -0.621 . . . . 53.51 109.322 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -111.54 132.91 54.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.291 0.567 . . . . 71.04 111.897 -176.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.1 tt -101.78 106.13 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.607 0.718 . . . . 62.51 111.108 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 35.9 t -77.35 110.25 11.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 53.21 109.959 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.59 ' HB ' HD23 ' A' ' 226' ' ' LEU . 37.9 t -81.27 124.18 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.043 0.449 . . . . 71.53 112.107 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.85 -43.95 14.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.977 -0.556 . . . . 65.22 110.797 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -147.16 139.12 24.37 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.142 -0.481 . . . . 70.2 110.443 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.2 tt -133.36 146.63 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.799 0.333 . . . . 72.24 111.216 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -147.74 131.97 4.07 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.17 -0.538 . . . . 73.42 113.047 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -80.85 130.93 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 122.269 -0.548 . . . . 70.51 110.678 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 54.8 mt -63.26 -64.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.825 0.345 . . . . 73.1 111.233 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 CA--C 1.538 0.498 0 CA-C-O 121.339 0.59 . . . . 72.21 111.225 175.705 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 186' ' ' THR . 2.8 p-10 . . . . . 0 CA--C 1.539 0.552 0 CA-C-O 121.101 0.476 . . . . 70.42 110.819 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 78.5 m-85 -104.23 155.84 18.4 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.346 0.593 . . . . 74.24 111.96 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -74.6 147.07 41.97 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.617 -0.883 . . . . 73.4 108.617 167.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.73 -32.79 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 112.785 0.661 . . . . 72.25 112.785 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.5 m -68.94 -7.94 39.79 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.261 0.467 . . . . 64.31 112.261 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 174' ' ' TYR . 10.9 mm-40 -95.21 -6.19 42.14 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.664 0.385 . . . . 70.12 111.789 178.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 187' ' ' ILE . 79.9 mt -73.39 106.75 5.33 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.559 0.695 . . . . 71.52 112.449 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.9 ptp -114.86 156.2 45.35 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.447 -0.797 . . . . 73.45 110.351 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.01 144.27 69.23 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.17 1.913 . . . . 74.22 112.757 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 70.45 15.34 7.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.158 0.583 . . . . 73.22 112.151 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.7 tp -93.12 135.96 33.83 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.808 0.337 . . . . 71.44 111.361 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.6 t -113.01 118.33 34.51 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.766 0.317 . . . . 53.23 111.081 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.02 -166.15 33.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.657 -0.782 . . . . 74.15 113.822 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 48.4 m -128.12 146.31 50.74 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.7 0.4 . . . . 73.22 110.815 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.582 HG21 HD11 ' A' ' 179' ' ' LEU . 30.4 pt -130.46 149.6 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.57 0.582 . . . . 62.42 112.57 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . 0.408 HD22 HD11 ' A' ' 264' ' ' ILE . 17.0 m120 -108.61 127.34 53.87 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.73 -0.668 . . . . 54.13 110.089 174.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -159.66 175.56 13.04 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.319 0.581 . . . . 75.03 112.497 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 12.9 pt-20 -103.61 151.67 22.66 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.756 -0.656 . . . . 64.22 110.747 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.427 HG21 ' CG2' ' A' ' 235' ' ' VAL . 38.2 t -88.72 117.55 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.879 0.371 . . . . 50.31 111.798 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.9 t -95.44 -48.2 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.077 0.465 . . . . 61.44 111.99 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -139.45 138.87 36.81 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.972 0.415 . . . . 72.44 112.082 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.77 105.35 8.9 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.017 -0.538 . . . . 71.52 110.759 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 95.0 m-85 -87.03 142.19 33.71 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 111.873 0.324 . . . . 70.23 111.873 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -44.79 147.09 1.99 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.056 2.504 . . . . 72.24 113.485 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.582 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 23.0 pttp -74.47 134.93 42.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.611 0.719 . . . . 60.31 112.865 -172.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 2.4 mptp? -90.69 144.21 25.96 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.4 -0.818 . . . . 70.4 110.038 174.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -130.03 115.86 17.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.963 0.411 . . . . 73.35 110.728 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 37.0 p90 . . . . . 0 CA--C 1.537 0.453 0 CA-C-O 121.301 0.572 . . . . 75.33 111.872 -173.407 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 . . . . . 0 N--CA 1.47 0.525 0 CA-C-O 120.839 0.352 . . . . 74.01 111.017 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 226' ' ' LEU . 58.6 tp -153.72 144.18 22.38 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.176 -0.466 . . . . 74.43 111.782 -176.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 230' ' ' LEU . 8.3 ttpm? -144.3 124.38 13.63 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.053 0.454 . . . . 72.32 111.127 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.5 m -88.32 130.74 35.05 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.087 -0.506 . . . . 70.25 111.355 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.429 HD11 HD11 ' A' ' 226' ' ' LEU . 81.3 mt -122.25 150.84 41.74 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.054 0.454 . . . . 73.24 111.408 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -114.62 115.41 27.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.326 -0.397 . . . . 75.52 110.111 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.03 153.62 32.37 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.183 0.193 . . . . 71.32 111.076 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 221' ' ' SER . 0.0 OUTLIER -146.38 142.92 28.69 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.011 0.91 . . . . 72.11 112.863 176.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.87 -178.48 3.73 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.791 -1.188 . . . . 64.23 107.791 165.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.29 -20.13 59.29 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.705 -0.622 . . . . 73.2 111.08 172.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -82.13 -28.05 32.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.231 0.456 . . . . 70.22 112.231 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.68 179.53 41.49 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.009 -0.615 . . . . 54.31 113.619 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 216' ' ' LYS . 79.1 p -114.22 163.93 14.57 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.346 0.498 . . . . 71.21 112.346 -176.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.5 tp -151.33 152.4 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 116.285 -0.416 . . . . 63.23 111.263 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -95.5 122.3 38.09 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.869 0.366 . . . . 74.01 111.834 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -93.72 135.5 12.59 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.403 -0.427 . . . . 53.34 112.957 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 63.2 m -118.26 103.79 10.17 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.524 -0.398 . . . . 64.22 111.388 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 210' ' ' LEU . 75.4 mt -94.46 117.1 29.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 111.828 0.307 . . . . 63.24 111.828 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . 0.454 ' O ' ' HB2' ' A' ' 230' ' ' LEU . 84.4 m95 -98.86 166.06 11.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.977 0.418 . . . . 55.41 111.466 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 61.94 -150.97 0.37 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.527 -0.306 . . . . 64.31 111.666 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.59 -15.06 6.3 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.612 0.597 . . . . 62.33 112.612 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.459 ' O ' ' NZ ' ' A' ' 211' ' ' LYS . 96.5 mt -59.13 -16.15 18.23 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.015 0.436 . . . . 72.52 110.812 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' A' ' 197' ' ' LYS . . . -65.15 -47.13 78.12 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.315 -0.402 . . . . 60.01 110.733 170.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.96 -29.31 67.51 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.387 -0.37 . . . . 73.41 111.425 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -50.87 103.03 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.885 0.374 . . . . 73.02 110.502 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -81.63 120.89 25.66 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.192 0.52 . . . . 75.53 111.792 -174.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.427 ' CG2' HG21 ' A' ' 191' ' ' VAL . 13.3 p -116.07 143.93 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.828 -0.624 . . . . 74.3 110.623 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -104.97 154.36 20.21 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.979 0.363 . . . . 74.01 111.979 -173.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -81.19 133.66 35.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.808 0.337 . . . . 63.05 111.277 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.73 -34.45 5.46 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.524 -0.37 . . . . 72.32 113.06 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.2 144.86 56.56 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.057 0.456 . . . . 74.51 111.615 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.566 ' HB ' ' HG2' ' A' ' 265' ' ' GLU . 41.4 mm -92.39 136.38 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.75 0.309 . . . . 62.1 111.027 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -141.05 157.87 44.72 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.139 0.495 . . . . 64.35 112.122 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.47 120.19 40.78 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.002 -0.545 . . . . 71.33 110.098 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 85.9 t -110.56 123.89 66.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 111.897 0.332 . . . . 70.04 111.897 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.9 t -113.67 128.68 56.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.848 0.356 . . . . 75.02 111.435 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.91 -150.37 7.56 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.477 -0.868 . . . . 63.1 113.856 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -129.13 117.25 20.5 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.642 0.377 . . . . 72.53 111.056 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.53 HG21 HD22 ' A' ' 179' ' ' LEU . 46.3 t -86.79 125.88 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.624 0.249 . . . . 63.32 111.325 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.94 164.82 33.43 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.212 0.53 . . . . 71.02 112.01 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 CA--C 1.538 0.517 0 CA-C-N 116.046 -0.525 . . . . 74.23 110.626 178.024 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 109.331 -0.618 . . . . 61.5 109.331 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.86 148.46 39.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.582 -0.736 . . . . 65.32 112.28 -168.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.458 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.8 tt -105.67 107.93 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.277 0.561 . . . . 63.33 110.881 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.4 t -70.46 104.84 2.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.976 0.417 . . . . 54.54 110.241 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.461 ' HB ' HD23 ' A' ' 226' ' ' LEU . 33.4 t -80.25 127.56 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.711 0.634 . . . . 61.44 112.711 -171.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -92.49 -49.16 6.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.89 -0.596 . . . . 73.51 110.405 174.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -139.23 132.74 30.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.002 -0.545 . . . . 72.52 110.586 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.1 tt -125.69 133.81 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.951 0.405 . . . . 73.11 111.222 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -130.6 131.34 6.47 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.21 -0.519 . . . . 34.32 112.992 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.6 mm -79.43 131.78 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 122.618 -0.342 . . . . 73.21 111.275 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.507 HD12 HG22 ' A' ' 240' ' ' ILE . 66.2 mt -83.59 -48.88 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.25 0.548 . . . . 74.42 110.335 176.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.566 ' HG2' ' HB ' ' A' ' 240' ' ' ILE . 24.2 mm-40 . . . . . 0 CA--C 1.538 0.495 0 CA-C-O 121.168 0.509 . . . . 74.5 110.236 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 121.193 0.521 . . . . 72.32 111.917 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -85.25 169.27 13.95 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.547 0.689 . . . . 75.12 112.105 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -101.25 167.75 10.0 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.575 -0.739 . . . . 71.33 109.389 174.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 220' ' ' GLY . 25.9 mt -76.73 -41.27 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 121.866 -0.521 . . . . 75.25 111.055 175.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.8 t -68.55 -8.1 38.49 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.191 0.52 . . . . 72.54 111.113 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 175' ' ' LYS . 6.8 tp10 -82.6 -21.37 35.19 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 61.04 110.672 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.739 HD11 HD13 ' A' ' 187' ' ' ILE . 78.3 mt -73.44 117.67 15.48 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.451 0.643 . . . . 70.35 112.16 -174.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 22.5 ptp -130.15 157.07 78.23 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.708 -0.678 . . . . 72.42 110.262 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 182' ' ' ASN . 11.3 Cg_endo -54.4 138.37 73.4 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.06 1.84 . . . . 65.23 112.39 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 181' ' ' PRO . 2.5 m-20 74.63 11.05 3.97 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.29 0.636 . . . . 70.34 112.443 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.9 tp -90.94 149.11 22.01 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.305 -0.247 . . . . 70.13 110.855 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 73.3 p -135.8 118.31 15.85 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.184 -0.323 . . . . 61.34 110.76 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.75 -177.45 40.2 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.354 -0.927 . . . . 74.51 113.986 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 244' ' ' SER . 38.2 m -114.21 122.64 47.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.659 0.266 . . . . 61.51 111.535 -177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.739 HD13 HD11 ' A' ' 179' ' ' LEU . 47.7 pt -115.67 138.18 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.058 0.456 . . . . 55.55 111.41 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -108.73 103.16 12.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.98 -0.378 . . . . 74.02 109.98 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.78 176.11 8.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.132 0.492 . . . . 63.34 111.985 -173.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -96.75 130.76 43.94 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.895 -0.593 . . . . 74.33 111.669 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.96 102.25 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.918 0.39 . . . . 73.34 111.265 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.86 -48.32 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.096 0.474 . . . . 61.52 111.583 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -134.3 122.41 22.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.948 0.404 . . . . 72.25 112.081 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -97.14 103.16 15.07 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.863 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.43 ' HB3' ' HD2' ' A' ' 196' ' ' PRO . 88.9 m-85 -79.3 160.0 71.42 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 116.6 -0.273 . . . . 65.04 111.536 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 195' ' ' TYR . 48.4 Cg_endo -67.69 153.66 75.42 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.296 1.997 . . . . 44.34 113.017 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -85.72 134.79 33.94 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.436 0.636 . . . . 73.15 112.058 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -104.92 169.71 8.29 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.692 -0.685 . . . . 62.31 111.105 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.23 152.9 52.06 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.573 -0.285 . . . . 72.23 110.602 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 38.4 p90 . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 121.489 0.662 . . . . 72.35 112.205 179.61 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 120.875 0.369 . . . . 63.43 111.668 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.0 tp -155.23 110.89 3.09 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.168 0.432 . . . . 72.04 112.168 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.96 140.51 52.26 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.056 -0.403 . . . . 63.14 111.447 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 37.7 t -106.8 152.61 23.62 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.946 0.403 . . . . 71.45 111.449 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.3 mt -136.27 143.76 44.42 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.651 0.38 . . . . 74.32 110.677 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -97.95 112.67 24.51 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.068 -0.395 . . . . 72.42 110.835 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 79.6 mt -107.74 135.93 48.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.415 0.286 . . . . 54.41 111.166 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -132.44 154.81 49.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.604 0.716 . . . . 73.34 111.923 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -155.45 167.21 31.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.971 -1.013 . . . . 72.12 109.068 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -60.03 -18.41 46.15 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.069 -0.394 . . . . 64.12 111.821 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 80.5 p -98.23 18.57 15.98 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.332 0.494 . . . . 72.54 112.332 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.409 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 125.83 -179.0 16.43 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.746 -0.74 . . . . 64.41 113.764 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 47.8 p -136.85 131.63 33.49 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.535 -0.391 . . . . 72.43 111.196 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 15.3 tt -138.04 156.73 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.005 0.431 . . . . 74.43 111.22 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -101.03 116.32 32.57 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.968 0.413 . . . . 75.31 111.29 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.453 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -83.01 157.62 35.57 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.235 -0.439 . . . . 72.33 113.521 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.1 m -128.97 114.23 16.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.882 0.372 . . . . 73.14 111.985 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.53 HD23 ' HB ' ' A' ' 258' ' ' VAL . 87.2 mt -99.21 112.13 24.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.235 -0.439 . . . . 75.12 111.217 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -91.6 157.07 17.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.893 0.378 . . . . 74.11 111.57 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 63.76 -155.39 0.32 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.325 -0.398 . . . . 75.12 111.791 175.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -53.44 -20.12 4.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.964 0.727 . . . . 71.01 112.964 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 95.6 mt -57.44 -23.5 49.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.29 0.567 . . . . 70.22 111.276 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.12 -27.97 69.3 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.888 0.375 . . . . 41.03 111.679 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.48 -0.22 54.85 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.976 0.417 . . . . 72.21 111.012 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -57.79 135.1 56.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.18 -0.464 . . . . 53.3 111.87 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.67 118.01 7.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.637 -0.711 . . . . 72.55 111.979 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.614 ' HA ' HD11 ' A' ' 263' ' ' ILE . 9.7 p -134.53 142.94 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.906 0.384 . . . . 75.45 111.18 176.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -118.42 151.45 37.76 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.394 -0.366 . . . . 61.14 111.384 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -75.97 142.21 42.01 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.931 0.396 . . . . 73.2 111.388 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.77 28.55 73.5 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.124 -0.489 . . . . 41.15 113.351 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.17 158.1 21.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.784 0.326 . . . . 75.34 110.958 -178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.548 HG22 HD12 ' A' ' 264' ' ' ILE . 48.0 mm -96.67 117.04 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.214 0.53 . . . . 75.22 111.209 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -118.38 135.63 54.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.432 0.53 . . . . 74.11 112.432 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -82.66 103.91 12.52 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.862 -0.608 . . . . 71.44 109.855 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 72.9 t -113.5 111.84 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 112.219 0.452 . . . . 55.32 112.219 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 21.3 t -113.33 129.48 56.52 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.349 -0.22 . . . . 52.4 110.958 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.0 -173.02 37.08 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.388 -0.91 . . . . 41.34 114.274 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -104.87 119.41 38.94 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.969 0.508 . . . . 74.21 110.591 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.468 HG21 HD22 ' A' ' 179' ' ' LEU . 30.6 t -85.83 135.46 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.258 0.551 . . . . 70.34 112.211 -176.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.47 163.93 29.91 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.98 -0.554 . . . . 75.55 110.794 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 CA--C 1.535 0.374 0 CA-C-O 120.833 0.349 . . . . 53.41 111.057 175.908 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.537 0.468 0 CA-C-O 120.945 0.402 . . . . 61.41 111.423 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.5 125.5 49.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.217 -0.447 . . . . 73.23 111.321 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.453 HG23 ' HA2' ' A' ' 224' ' ' GLY . 7.9 tt -105.51 112.79 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.343 0.592 . . . . 75.44 111.545 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.5 t -77.49 105.29 8.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.198 -0.455 . . . . 71.5 110.591 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.53 ' HB ' HD23 ' A' ' 226' ' ' LEU . 40.3 t -78.51 135.49 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.245 0.545 . . . . 75.34 112.459 -172.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -106.79 -43.21 4.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.918 -0.583 . . . . 73.13 110.818 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 25.6 t-20 -124.13 132.56 53.65 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.967 -0.561 . . . . 73.2 110.541 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.6 tt -144.02 123.93 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.219 0.533 . . . . 74.13 111.436 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -139.15 124.84 2.9 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 121.095 -0.574 . . . . 61.04 113.165 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' A' ' 235' ' ' VAL . 46.4 mt -69.24 123.13 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.845 0.355 . . . . 65.35 111.213 176.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.548 HD12 HG22 ' A' ' 240' ' ' ILE . 68.0 mt -76.43 -43.79 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.631 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 CA--C 1.539 0.532 0 CA-C-O 121.55 0.691 . . . . 63.53 111.424 179.786 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 109.851 -0.426 . . . . 73.43 109.851 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -94.26 146.14 24.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.311 0.577 . . . . 74.13 112.17 -175.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.89 160.08 16.03 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.904 -0.589 . . . . 74.12 110.573 169.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 220' ' ' GLY . 63.6 mt -59.09 -31.86 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.914 0.709 . . . . 72.24 112.914 -171.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.464 ' CB ' ' HB ' ' A' ' 219' ' ' THR . 70.6 p -62.67 -31.02 71.83 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.946 0.35 . . . . 72.32 111.946 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -88.33 -19.93 26.04 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 111.816 0.302 . . . . 75.14 111.816 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.535 HD22 HG21 ' A' ' 247' ' ' VAL . 78.4 mt -56.25 117.37 3.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.5 0.556 . . . . 55.1 112.5 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.416 ' HG2' HD22 ' A' ' 183' ' ' LEU . 24.1 ptp -114.44 157.42 42.67 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.741 -0.663 . . . . 71.22 110.465 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.83 142.64 99.14 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.054 1.836 . . . . 50.21 112.52 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 72.7 14.89 4.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.129 0.572 . . . . 64.21 112.029 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.416 HD22 ' HG2' ' A' ' 180' ' ' MET . 40.9 tp -93.28 132.89 37.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.959 0.355 . . . . 54.41 111.959 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.0 p -110.83 125.56 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.374 -0.204 . . . . 53.03 111.104 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -178.69 -165.56 33.39 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.628 -0.796 . . . . 54.03 113.848 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.9 m -126.09 140.48 52.55 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.45 0.3 . . . . 53.25 111.581 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 33.7 pt -127.12 156.78 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.18 0.515 . . . . 65.12 111.992 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -118.69 112.04 19.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.046 -0.524 . . . . 63.11 110.648 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -150.87 163.43 38.68 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.445 0.535 . . . . 75.04 112.445 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -82.44 135.52 35.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.201 -0.454 . . . . 60.45 111.494 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.04 100.59 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.929 0.395 . . . . 72.44 110.743 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.8 -59.04 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.117 0.484 . . . . 70.34 111.473 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -130.28 143.99 51.11 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.986 -0.552 . . . . 74.23 111.411 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -126.63 107.01 9.81 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.933 -0.576 . . . . 43.51 110.849 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.568 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 92.2 m-85 -96.13 135.16 22.84 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.681 -0.236 . . . . 73.43 111.338 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.46 162.07 0.63 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.222 2.615 . . . . 74.12 113.899 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -73.4 119.56 17.8 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.059 0.763 . . . . 74.12 113.059 -173.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -67.81 151.19 47.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.33 -0.85 . . . . 75.32 111.276 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -115.61 129.61 56.57 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.323 -0.399 . . . . 73.23 110.693 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.9 p90 . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 121.173 0.511 . . . . 55.41 111.654 -178.351 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 120.688 0.28 . . . . 63.43 110.72 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 225' ' ' THR . 17.6 tp -144.54 125.14 14.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.181 0.438 . . . . 64.41 112.181 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 195' ' ' TYR . 7.2 ttpm? -112.63 131.92 55.4 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.729 -0.607 . . . . 74.14 111.111 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 51.2 m -98.86 121.39 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.115 -0.493 . . . . 75.03 111.686 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 226' ' ' LEU . 80.9 mt -119.8 157.43 28.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.352 -0.385 . . . . 74.55 111.16 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -128.3 120.81 27.82 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.645 0.26 . . . . 73.34 110.395 173.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.573 HD11 HG21 ' A' ' 243' ' ' VAL . 66.6 mt -105.2 153.09 22.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.808 0.337 . . . . 74.34 111.616 -176.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -141.67 152.32 43.81 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.278 0.561 . . . . 63.14 111.753 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -155.1 168.38 27.22 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.601 -0.727 . . . . 71.12 109.781 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -61.28 -20.14 62.53 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.928 -0.483 . . . . 73.4 111.947 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.464 ' HB ' ' CB ' ' A' ' 177' ' ' SER . 80.2 p -91.2 -6.22 53.76 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.782 0.66 . . . . 70.44 112.782 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 150.03 -178.43 27.52 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.669 -0.777 . . . . 75.43 113.624 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 61.5 p -127.28 143.12 51.3 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.671 -0.311 . . . . 60.44 111.102 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.1 164.48 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 122.318 -0.239 . . . . 73.31 111.031 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.75 ' H ' ' HD2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -111.52 137.42 49.37 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.851 -0.53 . . . . 75.21 110.808 176.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -108.24 131.49 10.62 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.46 -0.4 . . . . 75.11 113.205 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.504 HG23 HD11 ' A' ' 210' ' ' LEU . 85.4 m -107.21 111.88 24.49 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.693 -0.298 . . . . 74.14 111.762 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.519 HD23 ' HB ' ' A' ' 258' ' ' VAL . 70.9 mt -99.04 109.48 22.22 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.035 0.383 . . . . 31.54 112.035 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -93.44 161.86 14.21 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.11 0.481 . . . . 75.1 112.104 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.422 ' CG ' ' H ' ' A' ' 229' ' ' GLU . 62.9 t30 57.69 -133.93 1.17 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.178 -0.465 . . . . 74.51 111.615 170.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.422 ' H ' ' CG ' ' A' ' 228' ' ' ASN . 11.4 pt-20 -60.06 -29.02 68.27 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.912 -0.493 . . . . 74.24 111.76 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.498 ' HB3' HD22 ' A' ' 226' ' ' LEU . 72.1 mt -61.06 -16.98 49.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.92 0.391 . . . . 75.1 111.231 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.58 88.11 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.663 0.268 . . . . 73.11 111.178 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -94.28 -15.62 24.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.842 0.353 . . . . 73.52 110.96 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -47.34 128.07 11.61 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.706 0.402 . . . . 61.11 111.524 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -70.23 120.23 15.6 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.658 0.614 . . . . 74.12 112.658 -175.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.25 134.23 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.698 -0.683 . . . . 73.52 110.053 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 239' ' ' ASP . 58.6 mttm -99.9 150.71 22.11 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.156 0.503 . . . . 73.35 112.241 -173.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -66.61 108.7 2.54 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.385 -0.37 . . . . 44.02 110.419 174.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.39 17.17 29.86 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.408 -0.425 . . . . 53.53 112.798 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 25.2 t0 -90.88 157.0 17.59 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.699 0.285 . . . . 64.1 111.181 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 42.3 mm -95.18 105.28 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.146 0.498 . . . . 72.25 110.805 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -113.8 127.07 55.86 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.821 0.675 . . . . 72.41 112.821 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -86.75 104.17 15.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.228 0.537 . . . . 72.22 109.827 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.573 HG21 HD11 ' A' ' 215' ' ' LEU . 89.0 t -102.47 120.24 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.61 0.596 . . . . 61.35 112.61 -171.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.1 t -113.64 133.14 55.48 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.24 -0.436 . . . . 53.1 111.176 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.03 -155.78 17.93 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.205 -0.998 . . . . 73.4 113.983 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 85.8 t80 -116.31 112.12 21.09 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.779 0.432 . . . . 62.53 111.467 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.535 HG21 HD22 ' A' ' 179' ' ' LEU . 48.1 t -83.34 118.18 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 120.965 0.412 . . . . 61.34 111.177 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 58.8 pttt -135.42 157.17 47.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.228 0.537 . . . . 73.32 111.437 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 121.046 0.45 . . . . 72.0 111.289 178.65 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 110.252 -0.277 . . . . 73.12 110.252 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 160.84 25.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.021 0.439 . . . . 74.24 111.118 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 7.9 tt -120.36 104.43 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.631 0.729 . . . . 71.03 111.421 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.6 t -68.93 102.52 1.6 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.647 -0.706 . . . . 75.54 110.296 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.519 ' HB ' HD23 ' A' ' 226' ' ' LEU . 21.7 t -74.43 117.72 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.264 -0.425 . . . . 72.34 112.122 -173.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -94.97 -21.7 18.44 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.879 0.371 . . . . 71.23 111.1 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -156.61 120.76 4.4 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.798 0.332 . . . . 73.22 110.944 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.5 ' HB ' HG11 ' A' ' 258' ' ' VAL . 11.4 tt -125.3 135.37 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.034 0.445 . . . . 63.21 111.582 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -133.59 125.29 3.92 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.15 -0.548 . . . . 75.42 112.763 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 49.4 mm -76.02 139.9 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.942 0.401 . . . . 75.34 110.737 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.531 HG22 ' HG3' ' A' ' 265' ' ' GLU . 48.1 mm -70.37 -46.4 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.776 0.322 . . . . 64.33 111.717 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.531 ' HG3' HG22 ' A' ' 264' ' ' ILE . 41.1 mt-10 . . . . . 0 N--CA 1.472 0.662 0 CA-C-O 120.741 0.305 . . . . 75.5 111.317 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 CA--C 1.535 0.393 0 CA-C-O 121.131 0.491 . . . . 71.12 111.066 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . 0.4 ' O ' HG22 ' A' ' 187' ' ' ILE . 47.4 m-85 -106.52 153.93 21.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.298 0.571 . . . . 63.35 111.603 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -93.21 155.68 17.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.318 -0.623 . . . . 71.35 109.318 167.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 49.4 mt -61.33 -24.59 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.076 0.465 . . . . 74.02 111.599 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.477 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 39.2 t -70.75 -12.9 61.83 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.131 0.419 . . . . 74.24 112.131 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -97.3 -1.94 43.61 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.603 0.594 . . . . 72.42 112.603 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.536 HD22 HG21 ' A' ' 247' ' ' VAL . 88.4 mt -68.08 150.68 48.11 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.176 0.806 . . . . 75.32 113.176 -172.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -162.23 156.4 18.51 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.289 -0.869 . . . . 74.1 110.213 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.62 138.16 83.74 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.307 2.004 . . . . 74.11 113.295 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.425 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 65.3 m-20 65.42 33.4 8.9 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.161 0.585 . . . . 70.15 111.562 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 52.8 tp -96.03 145.51 25.39 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.119 -0.491 . . . . 71.23 111.739 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 75.4 p -120.98 129.36 53.39 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.245 -0.434 . . . . 41.24 110.693 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.67 179.53 47.87 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.714 -0.755 . . . . 71.54 113.761 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 77.2 m -121.55 128.14 51.7 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.735 0.302 . . . . 71.45 111.343 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 174' ' ' TYR . 34.7 pt -120.5 152.79 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.171 0.51 . . . . 65.22 111.888 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -114.55 105.88 13.61 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.127 -0.488 . . . . 65.45 110.243 176.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.07 164.97 25.07 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.862 0.69 . . . . 61.14 112.862 -173.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.2 136.84 40.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.606 -0.725 . . . . 72.23 111.44 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.14 102.52 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.912 0.386 . . . . 63.22 111.519 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.7 t -82.62 -34.1 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.004 0.43 . . . . 60.11 111.872 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -141.17 117.74 10.9 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.757 0.313 . . . . 61.03 111.31 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -95.35 98.96 10.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.973 0.416 . . . . 61.45 110.981 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -78.5 143.96 64.75 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.463 -0.335 . . . . 74.43 111.078 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.12 151.6 83.32 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.775 2.317 . . . . 74.34 112.863 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 20.5 ptmt -67.74 125.24 25.6 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.579 0.585 . . . . 72.04 112.579 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -94.1 153.16 18.27 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.044 -0.525 . . . . 75.41 110.94 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.49 143.96 49.37 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.448 -0.342 . . . . 73.44 110.743 176.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 39.7 p90 . . . . . 0 CA--C 1.539 0.546 0 CA-C-O 121.296 0.569 . . . . 64.01 111.695 179.513 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 228' ' ' ASN . 37.5 mt-30 . . . . . 0 N--CA 1.47 0.556 0 N-CA-C 110.301 -0.259 . . . . 73.23 110.301 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 48.3 tp -142.48 112.75 7.13 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.766 0.317 . . . . 53.21 111.64 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 49.3 tttm -126.62 108.09 10.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.704 0.288 . . . . 62.11 110.834 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 66.9 m -86.27 150.07 24.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.932 0.396 . . . . 50.43 111.566 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.422 HD11 HG11 ' A' ' 235' ' ' VAL . 91.7 mt -137.24 134.94 36.75 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.422 -0.354 . . . . 75.34 110.915 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -89.59 106.46 18.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.73 0.3 . . . . 75.25 110.224 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.67 141.96 34.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.503 0.321 . . . . 74.45 110.999 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -127.96 155.06 44.85 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.593 0.711 . . . . 74.41 112.443 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -148.24 160.9 42.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.06 -0.973 . . . . 74.15 109.347 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.18 -21.08 64.79 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.992 0.425 . . . . 75.13 111.553 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 72.3 p -92.49 -1.27 57.09 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.212 0.449 . . . . 70.33 112.212 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 148.06 176.75 21.84 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.071 -0.585 . . . . 75.53 113.612 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.7 p -120.48 158.8 26.46 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.503 -0.41 . . . . 64.44 111.341 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -157.95 145.28 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.92 0.39 . . . . 74.15 111.265 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -96.71 112.08 23.98 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.918 0.39 . . . . 61.41 111.197 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.436 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -81.91 159.08 39.43 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 116.101 -0.5 . . . . 32.34 113.366 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 84.9 m -129.08 114.63 16.6 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.357 0.503 . . . . 63.1 112.357 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 92.3 mt -95.6 117.28 30.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.437 -0.347 . . . . 63.34 110.993 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -99.07 156.35 16.98 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.086 0.47 . . . . 74.11 111.754 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 209' ' ' GLN . 61.2 t30 61.51 -146.84 0.42 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.968 -0.56 . . . . 72.04 111.482 174.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.43 -4.9 4.38 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.661 0.615 . . . . 72.51 112.661 -174.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 93.1 mt -65.29 -15.63 62.72 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.101 0.477 . . . . 73.33 110.707 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 197' ' ' LYS . . . -65.88 -23.07 66.57 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.201 -0.454 . . . . 51.41 111.499 175.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.21 4.09 53.17 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.286 -0.415 . . . . 74.21 111.557 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -69.3 113.8 6.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.044 0.45 . . . . 74.11 110.488 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.85 90.61 0.43 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.38 0.61 . . . . 63.24 111.838 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 213' ' ' LEU . 5.0 p -128.44 122.83 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.509 -0.769 . . . . 65.01 110.794 177.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -113.63 172.36 7.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.098 0.475 . . . . 73.33 111.428 -175.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -65.4 122.1 16.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.361 -0.381 . . . . 73.04 110.848 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.14 -26.58 9.71 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.157 -0.544 . . . . 74.42 113.596 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -65.87 130.81 44.54 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 117.188 0.494 . . . . 64.32 111.618 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 42.0 mm -77.71 108.36 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.078 -0.51 . . . . 64.1 110.08 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -113.78 130.12 56.49 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.318 0.58 . . . . 71.23 112.555 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . 0.532 ' HB2' HD11 ' A' ' 264' ' ' ILE . 40.3 tt0 -92.72 112.7 24.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.905 -0.589 . . . . 73.43 109.597 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.1 t -115.34 127.04 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.269 0.557 . . . . 71.02 112.423 -172.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.7 t -124.24 132.9 53.62 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.091 -0.504 . . . . 71.34 109.79 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.02 -164.9 29.83 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.121 -1.038 . . . . 71.23 114.196 -177.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -106.95 115.36 30.05 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.077 0.465 . . . . 73.22 111.172 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.536 HG21 HD22 ' A' ' 179' ' ' LEU . 47.5 t -89.09 123.87 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.294 -0.412 . . . . 74.1 111.052 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.425 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 26.6 pttm -142.37 158.23 43.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.094 0.473 . . . . 62.55 112.005 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 CA--C 1.541 0.611 0 CA-C-N 116.176 -0.465 . . . . 64.14 111.317 -179.546 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 120.869 0.366 . . . . 65.15 110.827 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -120.93 161.24 21.91 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.078 0.466 . . . . 63.33 111.481 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.436 HG23 ' HA2' ' A' ' 224' ' ' GLY . 6.9 tt -128.17 105.14 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.419 0.628 . . . . 72.15 110.83 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 72.4 m -73.59 106.95 5.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.114 -0.494 . . . . 74.43 110.049 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.529 HG11 ' HB ' ' A' ' 261' ' ' ILE . 46.5 t -66.6 129.67 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 113.17 0.804 . . . . 61.22 113.17 -171.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.64 -47.18 6.32 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.695 -0.684 . . . . 73.3 110.267 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -135.74 128.2 30.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.975 -0.557 . . . . 72.52 110.452 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.529 ' HB ' HG11 ' A' ' 258' ' ' VAL . 10.7 tt -134.25 135.02 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.777 0.322 . . . . 74.44 111.217 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -144.59 136.89 6.92 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.844 -0.693 . . . . 70.22 113.362 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.84 106.75 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.87 0.367 . . . . 62.23 110.964 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 242' ' ' GLU . 63.4 mt -66.37 -61.4 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.079 0.466 . . . . 71.05 111.125 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 CA--C 1.536 0.44 0 CA-C-N 116.031 -0.531 . . . . 74.1 110.73 179.749 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 186' ' ' THR . 12.3 m120 . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 120.931 0.396 . . . . 45.3 110.53 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -99.19 156.66 16.85 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.157 0.503 . . . . 53.14 111.377 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -98.72 168.17 10.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.507 -0.553 . . . . 62.15 109.507 169.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.406 HG23 ' HB ' ' A' ' 222' ' ' ILE . 56.8 mt -64.49 -18.5 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.359 0.503 . . . . 73.25 112.359 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 40.9 t -71.55 -36.46 70.97 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.001 0.371 . . . . 75.45 112.001 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -79.05 -10.22 59.76 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.511 0.56 . . . . 71.34 112.511 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.583 HD22 HG21 ' A' ' 247' ' ' VAL . 69.1 mt -62.52 121.73 14.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.315 0.579 . . . . 71.4 111.998 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.0 ptp -140.88 160.82 57.0 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.69 -0.686 . . . . 55.51 110.348 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 248' ' ' LYS . 18.4 Cg_endo -58.63 133.94 57.6 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.941 1.761 . . . . 74.04 112.367 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 71.68 29.78 2.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.979 0.512 . . . . 74.24 111.726 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.62 138.37 40.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.033 0.444 . . . . 75.44 111.402 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.2 p -116.51 128.37 55.38 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.574 -0.284 . . . . 44.43 110.537 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.5 178.0 45.93 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.083 -1.055 . . . . 31.34 114.164 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 61.8 m -113.12 121.84 45.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.393 0.277 . . . . 74.53 111.627 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.412 ' CG2' HD21 ' A' ' 179' ' ' LEU . 23.6 pt -102.87 152.77 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.073 0.463 . . . . 63.54 112.029 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.96 110.98 17.34 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.191 -0.459 . . . . 73.34 111.607 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -161.39 167.12 26.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.835 0.35 . . . . 73.15 111.668 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.494 ' HB3' HD13 ' A' ' 240' ' ' ILE . 12.5 pt-20 -95.63 149.55 21.33 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.052 0.453 . . . . 74.41 111.493 176.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 23.5 t -81.81 114.17 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.352 0.596 . . . . 71.53 111.939 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 25.4 t -82.23 -52.39 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.945 -0.57 . . . . 63.21 111.451 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -127.58 128.65 45.94 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.254 -0.43 . . . . 72.43 111.388 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -114.45 119.08 35.64 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.26 -0.427 . . . . 54.12 111.17 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.439 ' O ' ' HG2' ' A' ' 211' ' ' LYS . 25.7 m-85 -89.13 140.15 28.86 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.445 -0.343 . . . . 65.43 111.337 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.73 172.9 14.31 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.56 2.173 . . . . 34.13 113.186 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.85 134.98 42.61 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.482 0.919 . . . . 73.43 113.482 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -111.4 134.83 52.69 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.165 -0.68 . . . . 74.2 109.165 166.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.94 134.6 44.9 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.976 0.732 . . . . 73.32 112.976 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.7 p90 . . . . . 0 CA--C 1.538 0.516 0 CA-C-N 116.111 -0.495 . . . . 73.23 110.843 172.848 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.477 HE21 ' HB3' ' A' ' 231' ' ' ALA . 19.2 pt20 . . . . . 0 CA--C 1.537 0.471 0 CA-C-O 121.154 0.502 . . . . 63.52 111.659 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.7 tp -125.16 145.31 50.02 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.558 -0.746 . . . . 74.24 110.957 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.473 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 1.6 tmtp? -146.97 136.16 22.57 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.174 -0.328 . . . . 74.3 110.979 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 51.5 m -111.89 153.97 25.88 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.293 0.479 . . . . 75.31 112.293 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.47 HD21 ' HE2' ' A' ' 211' ' ' LYS . 95.5 mt -136.68 161.82 34.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.919 -0.582 . . . . 74.13 110.921 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -128.23 120.04 26.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.621 0.248 . . . . 32.51 110.869 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 243' ' ' VAL . 78.8 mt -114.74 142.93 45.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.554 0.342 . . . . 75.51 110.653 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -134.92 147.94 49.93 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.346 0.593 . . . . 74.22 111.994 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -152.32 168.58 24.96 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.55 -0.75 . . . . 73.12 109.864 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -62.33 -25.23 67.77 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.99 0.424 . . . . 71.33 111.465 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 80.6 p -79.93 -14.75 58.38 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.403 0.52 . . . . 63.43 112.403 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 154.54 -179.03 30.98 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.939 -0.648 . . . . 75.13 113.351 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 84.8 p -127.89 125.75 40.22 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.496 -0.414 . . . . 73.33 110.976 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 176' ' ' ILE . 10.1 tp -126.82 148.13 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.122 0.487 . . . . 64.25 111.93 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 73.9 mtm-85 -100.16 138.7 36.87 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.056 0.455 . . . . 74.15 110.953 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -114.63 152.25 18.16 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.303 -0.475 . . . . 73.4 113.197 -176.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 59.5 m -124.45 125.55 44.44 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.151 0.426 . . . . 72.52 112.151 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.582 HD23 ' HB ' ' A' ' 258' ' ' VAL . 83.4 mt -109.92 134.56 51.95 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.017 0.527 . . . . 72.25 111.246 176.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -114.58 172.13 7.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.926 0.393 . . . . 74.2 111.094 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 54.1 t30 57.89 -153.6 0.37 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 116.148 -0.478 . . . . 64.01 111.207 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.98 -27.11 61.15 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.822 -0.549 . . . . 72.23 112.46 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 73.7 mt -60.59 -18.83 55.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.906 0.384 . . . . 74.43 111.633 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.477 ' HB3' HE21 ' A' ' 209' ' ' GLN . . . -59.47 -44.05 93.12 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.847 0.356 . . . . 64.23 111.494 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -90.67 13.39 16.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.903 0.334 . . . . 74.2 111.903 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -55.35 130.02 40.84 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.37 0.268 . . . . 72.04 110.722 175.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -70.71 77.44 0.61 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.524 0.678 . . . . 74.54 112.222 -174.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.66 139.75 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.927 -0.579 . . . . 65.42 110.23 174.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.403 ' HB3' ' NZ ' ' A' ' 236' ' ' LYS . 0.1 OUTLIER -126.75 115.8 19.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.363 0.601 . . . . 70.32 111.784 -173.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 192' ' ' VAL . 4.8 ttmp? -42.99 109.24 0.13 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.533 -0.758 . . . . 63.42 112.894 -172.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.48 4.53 23.38 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.095 -0.502 . . . . 52.45 113.685 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -86.21 156.67 20.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.148 0.499 . . . . 64.32 111.872 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 190' ' ' GLU . 38.1 mm -92.09 103.71 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.267 -0.424 . . . . 74.01 110.909 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -107.25 119.65 39.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.321 0.489 . . . . 74.43 112.321 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -87.15 103.49 15.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.24 0.543 . . . . 72.2 109.77 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.597 HG21 HD11 ' A' ' 215' ' ' LEU . 78.7 t -100.0 124.3 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 112.799 0.666 . . . . 75.52 112.799 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 42.4 t -118.02 123.53 45.92 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.32 -0.4 . . . . 62.42 110.781 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 258' ' ' VAL . . . -167.22 -161.48 16.61 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.415 -0.897 . . . . 73.12 114.202 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -112.9 114.36 26.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.465 0.306 . . . . 74.33 110.991 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.583 HG21 HD22 ' A' ' 179' ' ' LEU . 25.8 t -90.52 128.14 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.657 0.265 . . . . 71.21 110.977 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 181' ' ' PRO . 14.6 ptmm? -154.16 170.86 20.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.269 0.557 . . . . 63.05 112.016 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.882 -0.599 . . . . 74.21 110.83 178.775 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.54 0.577 0 CA-C-O 120.35 0.119 . . . . 71.25 111.196 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -136.43 170.27 16.31 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.12 0.486 . . . . 74.12 111.705 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.3 tt -116.65 121.7 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.471 0.545 . . . . 74.54 112.471 -176.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.5 t -85.72 103.79 14.83 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.009 0.433 . . . . 72.43 109.917 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.582 ' HB ' HD23 ' A' ' 226' ' ' LEU . 27.0 t -74.56 136.49 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 112.544 0.572 . . . . 73.44 112.544 -171.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -105.13 -39.95 6.04 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.314 -0.403 . . . . 65.35 110.612 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -134.61 138.68 44.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.156 -0.474 . . . . 64.03 110.952 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.7 tt -141.45 123.66 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.05 0.452 . . . . 60.35 111.242 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -128.33 131.51 6.98 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.029 -0.605 . . . . 62.44 113.375 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.77 116.1 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 O-C-N 122.681 -0.306 . . . . 55.22 110.369 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 50.6 mt -56.79 -43.29 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.716 0.293 . . . . 72.42 111.681 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 121.065 0.459 . . . . 71.14 111.203 175.855 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 CA--C 1.54 0.563 0 CA-C-O 120.88 0.372 . . . . 75.2 111.52 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -131.78 158.17 41.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.077 0.465 . . . . 75.22 111.299 176.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -90.75 155.6 18.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.149 -0.478 . . . . 74.41 110.267 169.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 220' ' ' GLY . 65.1 mt -54.49 -35.61 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 112.522 0.564 . . . . 72.44 112.522 -174.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . 0.524 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 68.2 p -57.96 -41.23 82.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.233 0.457 . . . . 64.34 112.233 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -73.42 -22.18 60.28 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.274 0.472 . . . . 73.31 112.274 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 187' ' ' ILE . 81.7 mt -55.74 111.7 0.98 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.282 0.563 . . . . 74.11 112.386 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . 0.466 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.1 ptp -106.64 157.63 34.67 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.545 -0.752 . . . . 65.25 110.997 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.17 130.6 40.42 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.336 2.024 . . . . 44.11 113.196 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.469 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 70.9 m-20 70.52 33.68 2.36 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.357 0.663 . . . . 60.42 111.854 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.466 HD22 ' HG2' ' A' ' 180' ' ' MET . 46.9 tp -102.09 134.41 45.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.216 -0.447 . . . . 63.2 111.318 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 81.4 p -110.31 118.35 36.09 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.27 -0.269 . . . . 60.54 111.077 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -173.79 -172.21 38.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.862 -0.685 . . . . 45.43 113.681 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.1 m -114.08 136.7 52.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.712 0.264 . . . . 75.51 111.712 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.595 HG21 HD11 ' A' ' 179' ' ' LEU . 33.2 pt -125.57 141.31 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.941 0.401 . . . . 75.52 111.227 175.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -115.21 116.27 28.07 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 64.31 111.608 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -158.66 178.33 10.23 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.31 -0.405 . . . . 74.41 111.362 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . 0.531 ' HB3' HD13 ' A' ' 240' ' ' ILE . 12.3 pt-20 -99.79 146.24 26.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.052 0.453 . . . . 72.44 111.493 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.51 HG21 HG21 ' A' ' 235' ' ' VAL . 58.1 t -76.15 108.73 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.11 -0.496 . . . . 75.22 111.831 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 216' ' ' LYS . 14.6 t -76.18 -27.62 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.046 0.451 . . . . 72.11 111.902 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -155.14 130.97 10.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.135 0.493 . . . . 72.34 112.016 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -113.53 102.65 10.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 63.35 110.031 174.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -84.33 155.37 63.16 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 111.962 0.356 . . . . 73.24 111.962 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.21 140.38 94.03 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.662 2.241 . . . . 60.13 112.787 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -75.41 126.33 30.81 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.521 0.677 . . . . 75.14 112.654 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 2.9 mptp? -86.31 169.49 12.92 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.529 -0.759 . . . . 70.52 111.331 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -138.21 143.81 40.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.111 -0.495 . . . . 75.44 110.935 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 53.2 p90 . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 121.349 0.595 . . . . 73.13 112.316 178.461 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 36.2 mt-30 . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 110.439 -0.208 . . . . 75.1 110.439 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 49.4 tp -153.69 113.72 3.91 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.17 0.433 . . . . 71.41 112.17 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.436 ' HE2' HD21 ' A' ' 213' ' ' LEU . 6.4 ttpm? -127.04 118.23 24.03 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.669 -0.645 . . . . 72.25 111.734 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.6 p -84.06 147.75 27.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.976 0.417 . . . . 73.41 111.711 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.436 HD21 ' HE2' ' A' ' 211' ' ' LYS . 97.0 mt -132.41 178.17 7.04 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.05 -0.523 . . . . 64.34 110.44 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 221' ' ' SER . 21.0 t80 -141.84 138.31 32.08 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.184 -0.323 . . . . 64.15 110.635 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.467 HD11 HG21 ' A' ' 243' ' ' VAL . 91.2 mt -126.49 151.79 47.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.503 0.321 . . . . 74.24 111.344 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . 0.423 ' HB2' ' NZ ' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -135.76 149.3 49.12 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.496 0.554 . . . . 74.42 112.496 -178.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -154.68 167.33 30.52 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.486 -0.779 . . . . 62.53 109.9 174.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.52 -18.57 62.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.209 0.528 . . . . 75.35 111.601 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 75.0 p -91.05 -0.22 57.68 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.572 0.582 . . . . 61.42 112.572 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 138.92 -178.97 19.03 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.866 -0.683 . . . . 72.13 113.261 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.458 ' HB3' ' CE2' ' A' ' 214' ' ' PHE . 67.9 m -130.83 138.9 50.09 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.583 -0.363 . . . . 74.52 111.16 177.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 13.4 tt -141.95 153.84 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 120.779 0.323 . . . . 71.41 111.612 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -92.6 147.39 22.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.08 0.467 . . . . 71.13 111.745 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -112.96 157.33 15.01 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.286 -0.416 . . . . 72.53 112.531 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 63.4 m -133.15 116.09 15.85 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.197 0.498 . . . . 45.23 111.988 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.564 HD23 ' HB ' ' A' ' 258' ' ' VAL . 74.2 mt -98.9 116.27 30.77 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.422 -0.354 . . . . 71.43 111.608 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -102.22 165.77 10.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.995 0.426 . . . . 71.25 111.764 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 62.5 t30 58.6 -141.88 0.68 Allowed 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.977 -0.556 . . . . 73.0 111.735 171.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.43 -34.61 75.68 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.912 -0.493 . . . . 75.41 112.27 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.98 -7.64 30.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.964 0.411 . . . . 74.41 111.911 -176.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 209' ' ' GLN . . . -66.11 -34.26 77.65 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 122.133 -0.354 . . . . 73.03 111.951 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -84.74 1.0 48.57 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.947 -0.471 . . . . 75.13 111.861 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -52.09 116.19 2.08 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.825 0.345 . . . . 73.42 111.052 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -81.7 121.7 26.71 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.909 -0.587 . . . . 74.22 111.62 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.51 HG21 HG21 ' A' ' 191' ' ' VAL . 13.1 p -136.12 159.69 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.379 -0.373 . . . . 65.13 111.339 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.468 ' HB3' ' HZ3' ' A' ' 236' ' ' LYS . 8.8 mtpm? -110.67 163.87 13.31 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.126 0.489 . . . . 72.15 111.403 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 237' ' ' LYS . 13.2 tmtt? -90.01 123.2 33.7 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.794 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.99 0.61 56.13 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.241 -0.436 . . . . 54.54 113.679 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.81 150.2 21.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.934 0.397 . . . . 43.25 111.772 -179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 190' ' ' GLU . 32.5 mm -85.31 119.74 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 116.288 -0.415 . . . . 43.11 111.737 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -130.36 144.92 51.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.725 0.639 . . . . 75.41 112.725 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -100.5 115.11 29.32 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.841 -0.618 . . . . 64.12 110.197 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.467 HG21 HD11 ' A' ' 215' ' ' LEU . 57.5 t -111.02 123.32 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.441 0.534 . . . . 72.43 112.441 -172.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 67.4 m -107.9 122.21 46.34 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.57 -0.287 . . . . 72.55 110.821 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -165.9 -164.47 21.46 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.99 -1.1 . . . . 43.42 114.858 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 75.4 t80 -122.47 106.01 10.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.123 0.569 . . . . 73.12 110.938 -177.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.542 HG22 ' HB ' ' A' ' 256' ' ' ILE . 40.6 t -76.57 114.28 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.422 -0.353 . . . . 73.34 110.998 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.469 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 20.8 ptmt -129.63 153.29 48.25 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.473 0.654 . . . . 64.13 112.197 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 . . . . . 0 N--CA 1.469 0.494 0 CA-C-N 115.906 -0.588 . . . . 73.52 111.814 -177.113 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 120.766 0.317 . . . . 75.54 111.446 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -139.81 162.75 34.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.93 0.395 . . . . 73.24 111.029 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.542 ' HB ' HG22 ' A' ' 247' ' ' VAL . 9.3 tt -108.97 104.93 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 121.388 0.613 . . . . 75.15 111.735 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.4 t -64.77 93.81 0.12 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.978 -0.556 . . . . 73.04 110.154 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.564 ' HB ' HD23 ' A' ' 226' ' ' LEU . 39.9 t -66.77 125.36 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.053 0.454 . . . . 65.44 112.143 -174.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -96.11 -28.44 14.59 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.167 -0.469 . . . . 74.43 110.976 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -160.02 141.71 12.79 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.92 -0.582 . . . . 73.42 110.5 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.4 tt -138.1 138.65 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.246 0.461 . . . . 65.15 112.246 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -140.83 119.63 1.58 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.36 -0.448 . . . . 60.44 112.399 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.8 mt -74.13 126.79 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 122.467 -0.431 . . . . 60.21 111.318 -179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.484 HD12 HG22 ' A' ' 240' ' ' ILE . 69.0 mt -69.91 -50.18 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.998 0.428 . . . . 75.33 111.138 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.276 0.56 . . . . 72.31 112.017 179.312 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 CA--C 1.542 0.651 0 N-CA-C 112.561 0.578 . . . . 61.3 112.561 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.17 153.64 50.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.182 -0.463 . . . . 74.52 111.002 177.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.568 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 32.2 mmtp -82.07 162.92 22.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.364 -0.606 . . . . 72.25 109.364 170.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 35.6 mm -52.7 -45.36 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.638 0.733 . . . . 42.31 110.441 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.2 t -57.12 -28.7 62.93 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.34 -0.846 . . . . 72.43 112.607 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.568 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 15.6 mm-40 -92.98 2.77 56.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.913 0.338 . . . . 73.12 111.913 -174.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.513 HD22 HG21 ' A' ' 247' ' ' VAL . 90.6 mt -81.93 139.0 34.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.992 0.425 . . . . 64.1 111.331 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 55.8 mtt -132.78 155.18 81.47 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.39 -0.368 . . . . 60.22 111.255 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.478 ' HG3' HD21 ' A' ' 254' ' ' LEU . 44.3 Cg_exo -58.08 130.69 39.27 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.33 2.02 . . . . 64.34 112.454 174.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 70.34 22.55 5.32 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.947 0.499 . . . . 64.13 111.738 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.9 tt -111.18 131.36 55.17 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.0 0.429 . . . . 64.44 111.263 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.4 m -93.85 136.61 33.95 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.526 -0.306 . . . . 65.32 110.964 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.71 -174.47 36.72 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.393 -0.908 . . . . 63.45 113.954 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 53.1 m -131.65 131.68 43.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.666 0.386 . . . . 74.31 110.777 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 179' ' ' LEU . 33.6 pt -124.53 150.35 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.562 0.696 . . . . 75.32 112.554 -176.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -112.74 103.38 11.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.768 -0.651 . . . . 75.42 110.093 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -144.01 168.61 19.58 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.793 0.33 . . . . 62.14 111.648 -175.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.01 155.85 16.6 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.126 0.488 . . . . 62.42 111.29 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 237' ' ' LYS . 61.1 t -83.83 114.1 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 116.151 -0.477 . . . . 73.31 111.553 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.3 t -77.47 -36.68 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.015 0.436 . . . . 63.33 111.272 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -154.59 143.14 20.66 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.702 -0.681 . . . . 70.2 111.533 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -133.34 108.39 8.68 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.42 -0.355 . . . . 72.01 110.987 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -89.62 147.91 38.91 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.306 0.484 . . . . 72.24 112.306 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.38 159.85 15.09 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.925 2.416 . . . . 74.21 113.364 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -65.28 160.5 21.48 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.925 0.713 . . . . 53.22 112.925 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -141.38 173.28 11.64 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.601 -0.727 . . . . 74.41 111.73 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -130.34 138.73 50.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.715 -0.675 . . . . 73.43 110.021 172.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 11.7 p90 . . . . . 0 CA--C 1.538 0.486 0 CA-C-O 121.399 0.619 . . . . 73.12 111.695 -177.932 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 121.036 0.446 . . . . 74.42 111.246 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 45.2 tp -142.17 140.24 32.33 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.331 -0.395 . . . . 75.31 111.464 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.517 ' HD3' HD12 ' A' ' 226' ' ' LEU . 60.8 tttp -140.67 128.67 22.02 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.752 0.31 . . . . 75.45 110.745 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.6 t -96.55 134.18 40.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.189 0.518 . . . . 71.3 111.94 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 226' ' ' LEU . 95.0 mt -130.83 174.31 10.09 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.919 -0.582 . . . . 65.21 111.02 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -148.86 121.46 8.58 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.239 -0.437 . . . . 72.22 110.013 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.8 mt -113.81 161.64 17.31 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.354 0.262 . . . . 61.41 110.991 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -159.17 154.19 25.04 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.27 0.841 . . . . 72.41 113.27 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -125.51 -175.48 3.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.448 -1.251 . . . . 75.15 108.973 163.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.07 -18.06 61.96 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.16 0.505 . . . . 74.33 110.796 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 77.6 p -81.83 -18.74 42.87 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.045 -0.525 . . . . 75.12 112.275 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 159.0 178.75 33.3 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.888 -0.672 . . . . 64.13 113.282 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 50.0 m -115.91 161.87 18.17 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.887 0.375 . . . . 52.32 111.651 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.6 tp -150.53 149.09 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 120.974 0.416 . . . . 62.13 111.363 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -89.7 122.77 33.12 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.293 -0.254 . . . . 64.33 110.934 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.5 120.3 6.83 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.89 -0.671 . . . . 64.31 112.901 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 62.3 m -111.51 118.94 37.14 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 122.126 -0.632 . . . . 74.32 111.845 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.517 HD12 ' HD3' ' A' ' 211' ' ' LYS . 94.0 mt -98.09 124.78 42.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.812 0.339 . . . . 51.21 111.286 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -107.17 150.82 26.19 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.775 0.321 . . . . 73.4 111.745 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 59.9 t30 56.75 -132.57 1.47 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 116.428 -0.351 . . . . 74.32 111.824 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.23 -14.16 46.16 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.666 0.617 . . . . 74.3 112.666 -174.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.515 ' HB3' HD22 ' A' ' 226' ' ' LEU . 86.9 mt -70.8 -18.49 62.74 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.938 -0.476 . . . . 44.22 111.142 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.16 78.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.741 0.645 . . . . 74.32 112.741 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -78.15 -3.9 44.82 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.072 0.397 . . . . 60.14 112.072 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.09 113.94 10.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.928 0.394 . . . . 71.4 110.766 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -75.83 105.06 6.66 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.198 0.523 . . . . 74.2 111.827 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.9 p -129.03 126.81 65.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.499 -0.773 . . . . 50.04 110.252 174.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -131.04 172.22 12.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.137 0.494 . . . . 65.42 111.9 -174.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.542 ' HA ' ' HB ' ' A' ' 191' ' ' VAL . 55.4 tttp -61.81 128.31 35.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.084 0.469 . . . . 74.44 111.423 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.65 -17.22 30.78 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.252 -0.431 . . . . 65.5 113.016 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.43 ' HB3' HD12 ' A' ' 263' ' ' ILE . 39.9 m-20 -88.73 112.71 23.48 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.968 0.414 . . . . 73.41 110.79 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 51.6 mm -77.29 103.73 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-O 120.995 0.426 . . . . 71.42 110.933 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 263' ' ' ILE . . . -110.67 140.9 44.61 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.536 0.569 . . . . 73.34 112.536 -175.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.1 106.39 18.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.095 0.474 . . . . 75.32 109.872 171.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.498 HG22 HG13 ' A' ' 261' ' ' ILE . 59.2 t -106.94 117.73 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.371 0.508 . . . . 51.4 112.371 -171.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 260' ' ' ASN . 82.4 p -106.9 133.52 51.42 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.411 -0.359 . . . . 52.2 110.557 173.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.6 -171.46 35.99 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.382 -0.913 . . . . 24.14 113.966 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -103.16 110.11 21.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.64 0.376 . . . . 74.33 110.877 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.513 HG21 HD22 ' A' ' 179' ' ' LEU . 50.6 t -81.03 122.18 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.874 0.368 . . . . 43.52 110.819 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -135.28 169.6 17.21 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.975 0.417 . . . . 73.4 111.328 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 120.887 0.375 . . . . 75.34 110.791 176.556 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.478 HD21 ' HG3' ' A' ' 181' ' ' PRO . 90.5 mt . . . . . 0 CA--C 1.537 0.46 0 CA-C-O 121.38 0.609 . . . . 75.43 112.381 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.63 159.8 41.4 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.634 -0.712 . . . . 74.21 110.146 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 9.7 tt -118.65 109.04 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.403 0.621 . . . . 61.15 111.265 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 74.8 m -76.21 106.56 7.89 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.68 -0.489 . . . . 71.45 109.68 175.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.413 HG11 ' HB ' ' A' ' 261' ' ' ILE . 55.1 t -68.23 137.08 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.048 0.759 . . . . 71.44 113.048 -170.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -104.73 -37.15 7.18 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.753 -0.658 . . . . 75.21 110.528 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . 0.432 ' HB3' ' OG ' ' A' ' 244' ' ' SER . 64.0 t30 -149.76 118.43 6.58 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.163 -0.471 . . . . 73.41 110.849 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.498 HG13 HG22 ' A' ' 243' ' ' VAL . 9.7 tt -123.22 121.23 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.511 0.672 . . . . 75.12 111.669 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -132.56 125.76 4.28 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.1 -0.571 . . . . 72.21 113.136 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 241' ' ' ALA . 32.6 mm -70.06 113.71 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.595 -0.356 . . . . 70.4 110.535 176.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.04 -66.47 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.963 0.411 . . . . 71.33 111.366 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 120.849 0.357 . . . . 71.14 111.004 178.738 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 186' ' ' THR . 23.8 p-10 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 121.283 0.563 . . . . 55.42 111.702 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -108.11 161.97 14.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.105 0.479 . . . . 75.32 112.138 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -75.88 151.03 37.47 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.264 -0.643 . . . . 53.22 109.264 163.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 222' ' ' ILE . 28.4 mt -58.26 -39.03 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 121.832 -0.543 . . . . 73.45 111.835 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.0 t -73.81 -20.03 60.58 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.069 0.461 . . . . 72.4 111.379 175.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -78.94 -19.53 51.51 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.206 0.527 . . . . 71.5 110.711 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.435 HD11 HG21 ' A' ' 187' ' ' ILE . 95.1 mt -67.12 146.78 53.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.135 0.493 . . . . 74.24 111.608 177.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.7 ptp -146.67 152.75 45.77 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.205 -0.452 . . . . 41.23 110.949 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.54 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 51.3 Cg_exo -54.63 147.63 48.2 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.983 2.455 . . . . 72.32 113.655 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.46 29.1 13.47 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.018 -0.537 . . . . 74.33 112.352 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.9 tt -133.61 136.75 45.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.343 -0.39 . . . . 51.33 110.886 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.0 p -97.88 133.92 41.72 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.768 0.318 . . . . 72.15 111.291 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.2 174.55 34.75 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.659 -0.781 . . . . 73.33 113.743 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 44.2 m -122.56 138.48 54.56 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.508 0.323 . . . . 52.02 110.345 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 179' ' ' LEU . 32.9 pt -134.73 146.12 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.262 0.553 . . . . 73.41 111.909 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -109.87 103.76 12.59 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.821 -0.437 . . . . 73.12 109.821 171.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.6 168.19 18.7 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.302 0.573 . . . . 61.4 112.187 -173.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -82.75 126.73 32.72 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.552 -0.749 . . . . 73.32 111.024 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 235' ' ' VAL . 61.8 t -76.57 95.35 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.204 0.526 . . . . 71.55 110.195 174.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.483 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 13.7 t -75.76 -35.13 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.963 -0.562 . . . . 44.22 111.548 -176.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.06 113.4 5.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 74.52 111.743 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.85 103.97 15.61 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.207 -0.451 . . . . 71.34 110.479 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -79.31 147.55 68.92 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.23 -0.441 . . . . 75.24 111.776 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.83 155.01 40.19 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.596 2.197 . . . . 62.3 112.687 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -72.94 156.05 39.24 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.396 0.617 . . . . 71.13 112.563 -173.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 210' ' ' LEU . 68.6 mttm -122.92 159.13 28.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.721 -0.672 . . . . 72.52 109.866 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -141.7 132.16 25.27 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.097 0.475 . . . . 70.14 111.408 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.0 p90 . . . . . 0 CA--C 1.54 0.594 0 CA-C-N 116.089 -0.505 . . . . 73.1 111.372 -176.163 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 228' ' ' ASN . 47.8 mt-30 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 120.705 0.288 . . . . 63.2 110.655 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 198' ' ' LYS . 56.8 tp -125.78 145.91 50.01 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.662 0.385 . . . . 72.05 111.571 -174.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 22.3 tptm -150.59 121.92 7.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.45 -0.341 . . . . 54.53 110.939 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 47.2 t -101.45 144.03 30.74 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.993 0.425 . . . . 74.41 111.821 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 97.3 mt -136.34 134.58 38.05 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.153 -0.476 . . . . 73.51 111.119 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -103.83 109.93 21.85 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.141 -0.349 . . . . 74.23 110.731 174.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 243' ' ' VAL . 67.0 mt -107.55 145.09 33.65 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.346 -0.388 . . . . 72.1 110.674 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -137.52 150.46 47.54 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.539 0.685 . . . . 71.43 112.04 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -139.28 170.59 15.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.85 -1.068 . . . . 73.44 109.69 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -52.48 -41.24 63.2 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.792 0.33 . . . . 73.25 111.846 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 81.5 p -83.83 -6.26 59.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.487 0.921 . . . . 60.41 113.487 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 148.97 -179.8 25.49 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.721 -0.752 . . . . 70.3 113.149 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 84.9 p -121.83 159.4 26.84 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 122.258 -0.554 . . . . 63.54 111.893 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 176' ' ' ILE . 14.6 tt -151.8 150.33 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.073 0.463 . . . . 72.33 110.861 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 223' ' ' ARG . 32.0 mtm-85 -100.93 123.27 44.87 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.021 0.439 . . . . 75.54 111.855 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -97.26 161.7 21.58 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 116.033 -0.531 . . . . 70.34 113.233 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 94.5 m -136.5 121.76 19.22 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.269 0.47 . . . . 41.35 112.269 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.624 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 92.3 mt -105.49 137.19 43.73 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.958 -0.565 . . . . 74.41 110.905 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -115.79 150.35 37.07 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.759 0.314 . . . . 74.23 111.656 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ASN . . . . . 0.406 ' HB3' ' OE2' ' A' ' 229' ' ' GLU . 65.4 t30 53.0 -128.3 2.42 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.552 0.575 . . . . 75.31 112.552 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' GLU . . . . . 0.406 ' OE2' ' HB3' ' A' ' 228' ' ' ASN . 0.9 OUTLIER -55.83 -16.69 4.84 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.276 0.843 . . . . 75.53 113.276 -175.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.437 ' HB3' HD22 ' A' ' 226' ' ' LEU . 91.7 mt -88.16 -17.75 30.25 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.956 0.407 . . . . 71.53 111.653 176.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.07 98.16 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.67 0.618 . . . . 72.34 112.67 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -77.7 3.2 14.6 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.668 0.618 . . . . 73.02 112.668 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -52.65 121.21 6.73 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.838 0.351 . . . . 62.13 111.74 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.6 116.31 22.54 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.241 -0.436 . . . . 73.43 111.549 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 191' ' ' VAL . 7.9 p -142.57 142.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 116.091 -0.504 . . . . 53.22 110.382 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -95.55 160.42 14.52 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.04 0.448 . . . . 75.0 111.334 -176.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 192' ' ' VAL . 40.4 ttmt -67.91 93.91 0.44 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.982 0.42 . . . . 73.32 110.939 174.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 136.11 -21.71 3.48 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.092 -0.575 . . . . 54.32 113.683 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -57.77 137.12 56.88 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.216 0.532 . . . . 74.04 111.941 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.529 HG22 HD12 ' A' ' 264' ' ' ILE . 32.7 mm -84.85 103.17 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.03 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -103.07 136.01 43.68 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.886 0.698 . . . . 50.13 112.886 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.8 98.8 7.2 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.582 -0.736 . . . . 74.43 110.088 171.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 215' ' ' LEU . 57.9 t -105.69 115.97 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.054 0.454 . . . . 35.41 111.793 -177.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 84.0 p -116.43 136.08 53.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.013 -0.539 . . . . 63.24 110.418 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -178.91 -166.84 35.58 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.13 -1.033 . . . . 62.33 114.839 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -106.74 122.07 45.64 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.085 0.554 . . . . 70.33 110.917 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 56.7 t -86.0 125.79 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.364 0.602 . . . . 53.53 112.364 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -121.16 169.23 10.74 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.624 -0.716 . . . . 74.33 110.348 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLN . . . . . 0.54 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 24.8 tt0 . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 120.704 0.288 . . . . 71.41 110.731 174.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 91.5 mt . . . . . 0 CA--C 1.54 0.581 0 N-CA-C 112.644 0.609 . . . . 72.2 112.644 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.44 125.07 39.9 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.618 -0.719 . . . . 72.41 109.357 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ILE . . . . . 0.488 HG23 ' HA2' ' A' ' 224' ' ' GLY . 10.1 tt -113.83 121.21 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.488 0.661 . . . . 72.44 112.592 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 18.0 m -82.94 111.71 19.07 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.803 -0.635 . . . . 53.22 110.024 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . 0.542 ' HB ' HD23 ' A' ' 226' ' ' LEU . 44.7 t -76.99 128.72 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.366 0.603 . . . . 64.54 112.542 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.8 -44.52 14.28 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.597 -0.729 . . . . 73.04 110.537 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -152.07 143.18 23.19 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.287 -0.415 . . . . 74.14 111.21 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 6.2 tt -134.52 134.1 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.285 -0.416 . . . . 75.13 111.412 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.23 139.01 6.9 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.204 -0.522 . . . . 54.31 112.146 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.9 mt -69.16 131.96 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 117.333 0.566 . . . . 75.04 110.642 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.529 HD12 HG22 ' A' ' 240' ' ' ILE . 60.9 mt -70.31 -46.32 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.287 0.477 . . . . 64.44 112.287 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.961 0.41 . . . . 74.52 111.205 -178.755 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 13.0 ptt? . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.151 0.5 . . . . 74.42 111.569 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -79.8 117.46 20.7 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.424 -0.353 . . . . 75.1 110.365 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -87.16 152.41 22.36 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.484 0.659 . . . . 64.33 112.261 -174.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.474 ' HG2' ' OE1' ' A' ' 178' ' ' GLU . 27.5 mmtm -100.77 164.47 11.84 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.58 -0.896 . . . . 74.33 108.58 168.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 54.2 mt -58.31 -31.11 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 O-C-N 122.059 -0.401 . . . . 73.21 111.816 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 48.4 t -71.89 -24.14 61.61 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.147 0.425 . . . . 73.32 112.147 176.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.474 ' OE1' ' HG2' ' A' ' 175' ' ' LYS . 45.2 mt-10 -81.63 -5.95 58.54 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.126 -0.359 . . . . 70.43 111.824 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.509 HD22 HG21 ' A' ' 247' ' ' VAL . 82.6 mt -75.86 125.58 29.36 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.293 0.568 . . . . 52.1 111.882 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.539 ' HG2' HD22 ' A' ' 183' ' ' LEU . 22.6 ptp -124.12 159.03 58.62 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 115.859 -0.61 . . . . 74.22 110.3 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 248' ' ' LYS . 14.8 Cg_endo -57.37 133.18 55.49 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 121.963 1.775 . . . . 64.44 112.904 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.431 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 76.4 m-20 69.57 29.89 4.15 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.397 0.679 . . . . 74.41 111.8 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.539 HD22 ' HG2' ' A' ' 180' ' ' MET . 27.0 tp -106.13 118.26 36.17 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.124 -0.489 . . . . 75.44 111.578 178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 42.5 t -92.63 108.98 20.39 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.779 0.323 . . . . 60.32 110.201 173.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -153.29 172.56 32.19 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.585 -0.817 . . . . 73.14 113.911 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 244' ' ' SER . 34.8 m -114.17 129.77 56.62 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.78 0.324 . . . . 71.41 111.726 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.484 HD13 HD11 ' A' ' 179' ' ' LEU . 37.3 pt -122.16 163.68 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.301 0.572 . . . . 72.43 112.298 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -121.76 118.52 29.27 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.948 -0.569 . . . . 54.23 110.264 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -151.33 171.73 17.01 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.527 0.566 . . . . 53.03 112.527 -176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -96.01 141.66 29.15 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.066 -0.515 . . . . 64.23 111.589 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.9 t -78.95 103.49 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.972 0.415 . . . . 74.13 111.136 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.404 HG21 ' HB3' ' A' ' 216' ' ' LYS . 21.5 t -81.36 -28.61 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 121.0 0.429 . . . . 73.31 111.728 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -151.33 136.42 17.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.978 0.418 . . . . 71.33 111.572 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -124.05 114.36 19.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.885 -0.598 . . . . 62.23 110.818 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 212' ' ' SER . 94.9 m-85 -109.37 148.69 38.55 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 120.655 0.264 . . . . 52.33 111.632 -178.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.41 156.65 16.79 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.984 2.456 . . . . 71.02 113.841 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -73.44 169.23 17.62 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.53 0.681 . . . . 63.42 111.989 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -138.65 149.47 45.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.455 -0.793 . . . . 64.33 109.361 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.482 ' HG2' ' HG2' ' A' ' 209' ' ' GLN . 44.0 mt-10 -130.82 112.6 13.18 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.912 -0.492 . . . . 70.13 112.248 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -127.72 -178.73 4.6 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.261 0.553 . . . . 62.55 111.421 -178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 69.6 m -111.19 126.58 55.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.384 -0.371 . . . . 71.44 111.008 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.56 151.27 41.94 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.668 -0.242 . . . . 65.44 110.559 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -53.34 -29.56 34.62 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.174 0.511 . . . . 75.42 111.516 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -77.72 -4.85 48.34 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.99 -0.55 . . . . 61.15 112.281 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 107.63 -37.66 3.71 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 121.198 -0.525 . . . . 63.34 113.62 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 43.8 p -68.68 145.99 53.39 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.993 0.425 . . . . 75.51 111.992 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -71.92 145.67 48.32 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.173 0.511 . . . . 64.03 112.125 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -143.93 136.7 6.99 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 116.245 -0.434 . . . . 53.31 112.689 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.482 ' HG2' ' HG2' ' A' ' 199' ' ' GLU . 24.6 mt-30 -102.53 161.24 13.87 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.943 0.401 . . . . 73.4 111.591 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 32.8 tp -145.17 126.4 14.77 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.059 -0.519 . . . . 74.53 111.39 -175.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.601 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 84.7 tttt -126.87 135.08 50.49 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.948 0.404 . . . . 74.21 111.194 177.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.537 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 5.0 m -98.24 128.37 44.66 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.016 -0.538 . . . . 61.4 111.81 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.415 HD11 HG11 ' A' ' 235' ' ' VAL . 93.8 mt -137.1 163.72 30.13 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.085 0.469 . . . . 64.31 112.115 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -135.15 129.91 34.57 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.257 -0.429 . . . . 64.41 110.367 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 77.7 mt -120.7 148.59 43.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.256 0.222 . . . . 71.45 111.376 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.404 ' HB3' HG21 ' A' ' 192' ' ' VAL . 21.4 pttm -136.86 151.97 49.71 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.401 0.62 . . . . 71.15 112.095 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -148.78 165.59 30.97 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.304 -0.862 . . . . 74.34 109.848 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -57.26 -30.65 64.83 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 111.942 0.349 . . . . 61.13 111.942 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 63.0 p -84.07 -11.49 56.62 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.584 0.587 . . . . 53.54 112.584 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 152.25 179.77 28.13 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 120.936 -0.65 . . . . 44.15 113.567 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 93.4 p -124.2 155.42 38.57 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 122.554 -0.38 . . . . 52.1 111.498 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -147.05 156.75 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 CA-C-O 120.979 0.418 . . . . 72.31 111.716 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.507 ' N ' ' HD2' ' A' ' 223' ' ' ARG . 8.3 mpt_? -95.08 123.97 38.87 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.69 0.281 . . . . 64.21 110.733 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -95.43 152.85 20.53 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.26 -0.495 . . . . 60.34 113.617 -175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 70.2 m -144.4 115.45 7.89 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.091 0.404 . . . . 72.43 112.091 -178.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.601 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 88.8 mt -98.6 137.48 37.18 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 116.453 -0.34 . . . . 42.32 111.307 178.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 93.4 m95 -114.62 151.02 34.2 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.14 0.495 . . . . 74.51 112.233 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.4 ' HA ' ' H ' ' A' ' 209' ' ' GLN . 64.2 t30 52.93 -134.24 1.7 Allowed 'General case' 0 CA--C 1.553 1.095 0 CA-C-N 115.828 -0.624 . . . . 64.12 111.856 173.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -56.42 -26.15 52.57 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.595 0.591 . . . . 74.33 112.595 -177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.42 -27.19 69.13 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.036 0.446 . . . . 64.14 111.225 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.48 ' O ' ' HD2' ' A' ' 211' ' ' LYS . . . -67.38 -14.24 62.74 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.115 0.413 . . . . 73.23 112.115 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -92.03 -12.98 31.69 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.992 0.425 . . . . 70.55 110.974 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -61.87 134.32 56.54 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.988 0.423 . . . . 73.33 111.605 -177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -72.92 118.24 15.62 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.009 0.433 . . . . 73.43 111.436 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.415 HG11 HD11 ' A' ' 213' ' ' LEU . 4.2 p -139.07 117.51 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.137 0.494 . . . . 74.13 110.492 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -106.99 152.09 24.45 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.119 0.485 . . . . 74.54 111.885 -173.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -70.15 117.85 12.24 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.187 -0.46 . . . . 72.41 111.478 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.57 -13.18 32.89 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.478 -0.391 . . . . 75.25 113.097 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.56 145.82 36.65 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.055 0.455 . . . . 72.22 111.93 -179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.584 HG22 HD12 ' A' ' 264' ' ' ILE . 38.9 mm -87.71 118.57 33.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.037 -0.529 . . . . 53.24 110.566 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.421 ' HB2' HD13 ' A' ' 263' ' ' ILE . . . -128.59 145.55 51.1 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.653 0.612 . . . . 71.21 112.653 -175.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -103.92 110.42 22.56 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.916 -0.584 . . . . 64.11 109.927 173.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.6 t -108.62 115.29 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 112.733 0.642 . . . . 73.43 112.733 -171.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.557 ' HA ' ' HA ' ' A' ' 186' ' ' THR . 35.8 t -95.72 122.41 38.47 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.039 -0.528 . . . . 63.02 110.124 173.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -158.5 167.11 34.51 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 120.235 -0.983 . . . . 62.44 114.529 -177.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -92.89 104.54 16.77 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.128 0.571 . . . . 74.23 110.596 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.509 HG21 HD22 ' A' ' 179' ' ' LEU . 44.6 t -86.02 138.86 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.675 0.274 . . . . 64.35 111.438 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 181' ' ' PRO . 10.6 ptmm? -151.06 176.35 11.23 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.066 0.46 . . . . 73.43 111.821 178.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.485 ' HA ' HD23 ' A' ' 254' ' ' LEU . 23.5 tt0 -100.36 129.73 46.37 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.947 -0.569 . . . . 64.0 111.144 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 163.29 -75.77 0.17 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.808 -0.711 . . . . 72.43 113.409 177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.628 ' HB3' ' HB3' ' A' ' 255' ' ' GLU . 57.9 t80 -75.74 122.77 24.52 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 122.63 -0.335 . . . . 74.51 110.891 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 35.3 t 55.16 28.96 11.79 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.236 0.541 . . . . 62.33 111.511 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 91.72 -66.04 2.3 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.248 -0.501 . . . . 45.13 112.264 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 249' ' ' GLN . 92.3 mt -134.36 116.5 15.29 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 122.873 0.469 . . . . 72.14 110.406 178.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.628 ' HB3' ' HB3' ' A' ' 251' ' ' TYR . 2.5 pm0 -109.66 143.12 39.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.985 0.421 . . . . 74.32 111.482 178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.6 tt -108.72 104.35 16.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.339 0.59 . . . . 73.41 111.202 175.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.9 t -77.44 98.92 5.45 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.123 -0.49 . . . . 53.12 110.409 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.86 131.26 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 112.929 0.714 . . . . 53.31 112.929 -171.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -99.64 -44.6 6.07 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.567 -0.742 . . . . 75.42 110.357 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 244' ' ' SER . 21.7 m-80 -135.93 137.13 41.05 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 116.344 -0.389 . . . . 63.52 110.536 177.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.4 tt -137.75 136.19 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 120.841 0.353 . . . . 74.0 111.571 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.06 140.52 7.93 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 121.197 -0.525 . . . . 64.13 113.163 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.626 ' HB ' ' HG2' ' A' ' 266' ' ' LYS . 47.2 mm -85.54 115.07 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.062 0.458 . . . . 73.51 110.853 178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.584 HD12 HG22 ' A' ' 240' ' ' ILE . 63.0 mt -59.41 -35.95 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 112.476 0.547 . . . . 72.03 112.476 -174.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -77.13 0.18 22.6 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.396 0.888 . . . . 73.35 113.396 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.626 ' HG2' ' HB ' ' A' ' 263' ' ' ILE . 69.8 mmtt -69.26 157.02 37.78 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.0 0.741 . . . . 72.35 113.0 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 88.9 p -158.37 179.31 9.26 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.272 -0.876 . . . . 73.33 110.356 177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 2.5 pp -153.09 -176.96 6.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.907 0.336 . . . . 51.23 111.907 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.536 -0.745 . . . . 72.22 111.826 179.255 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 11.9 tpt . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.873 0.368 . . . . 75.23 111.665 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -82.3 121.87 27.22 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.027 0.441 . . . . 63.52 110.164 173.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -83.38 141.05 32.03 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.187 0.518 . . . . 75.04 111.942 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.527 ' HD2' ' N ' ' A' ' 175' ' ' LYS . 12.1 mptt -96.54 155.79 16.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.61 . . . . 74.45 109.545 173.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.424 HD13 HG22 ' A' ' 222' ' ' ILE . 55.9 mt -59.15 -33.09 49.52 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 112.064 0.394 . . . . 75.24 112.064 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 56.2 p -70.79 -15.45 62.67 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.073 0.398 . . . . 43.04 112.073 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -104.55 -5.97 21.0 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 120.975 0.417 . . . . 55.34 111.594 -176.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.548 HD22 HG21 ' A' ' 247' ' ' VAL . 81.6 mt -71.49 148.36 46.87 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.184 0.516 . . . . 72.34 111.987 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.5 ptp -148.18 153.27 41.07 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.945 -0.571 . . . . 73.21 110.801 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.29 128.05 24.18 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.905 2.403 . . . . 73.0 114.358 -177.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.483 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 2.1 m-20 66.04 50.77 1.4 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.594 0.711 . . . . 62.32 112.156 173.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.7 tt -131.46 134.03 45.77 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.514 -0.766 . . . . 65.34 110.355 176.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 89.8 p -100.5 148.13 25.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.129 0.49 . . . . 60.15 111.508 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.67 -169.77 41.39 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.088 -0.577 . . . . 63.41 113.152 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 94.6 m -118.41 124.77 48.48 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.843 0.354 . . . . 75.23 111.712 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 179' ' ' LEU . 37.2 pt -109.02 154.17 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.068 -0.515 . . . . 75.24 110.285 173.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -135.4 108.51 7.69 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 122.042 -0.411 . . . . 75.04 110.872 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.29 172.15 13.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.065 0.46 . . . . 64.25 112.099 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -93.61 139.04 31.24 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.911 -0.586 . . . . 71.3 110.635 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.477 ' HA ' HD23 ' A' ' 215' ' ' LEU . 38.2 t -79.16 100.98 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 112.308 0.484 . . . . 45.31 112.308 -174.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.796 ' HA ' ' HZ3' ' A' ' 237' ' ' LYS . 48.6 t -59.62 -52.56 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-O 120.941 0.401 . . . . 74.31 111.723 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -132.71 124.66 28.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.189 -0.46 . . . . 64.53 111.27 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -106.16 102.82 12.21 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.925 0.393 . . . . 40.52 111.351 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -81.99 155.93 69.91 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.187 0.439 . . . . 75.34 112.187 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.96 175.84 10.79 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.61 2.207 . . . . 73.5 112.188 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.579 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 64.1 pttt -93.76 124.06 37.51 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.517 0.675 . . . . 70.41 112.754 -177.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -87.42 146.13 25.99 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.307 -0.86 . . . . 60.43 110.818 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -99.16 136.79 38.61 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.87 0.367 . . . . 75.24 111.685 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -154.26 177.21 11.38 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.992 0.425 . . . . 71.44 111.153 175.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 55.7 m -111.4 140.25 46.14 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.057 0.456 . . . . 33.24 111.67 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -83.79 148.09 27.22 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.878 -0.601 . . . . 75.32 111.862 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -60.61 -28.85 68.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.276 0.56 . . . . 71.14 110.412 173.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -64.71 -19.9 66.03 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.357 -0.838 . . . . 63.33 111.776 177.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 101.77 8.01 46.57 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 121.408 -0.425 . . . . 71.32 113.384 -178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 75.0 p -106.17 171.89 7.1 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.253 0.549 . . . . 70.14 112.152 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -72.22 144.25 48.54 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.059 -0.519 . . . . 51.05 111.044 175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -130.81 134.4 7.74 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.773 -0.727 . . . . 72.03 113.361 -179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -118.76 137.31 53.46 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.703 0.287 . . . . 75.51 110.573 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 28.2 tp -121.64 125.35 46.47 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.441 0.296 . . . . 71.02 111.768 -177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -141.6 113.58 7.95 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.01 0.433 . . . . 73.23 111.625 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 64.4 m -93.93 139.48 30.86 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.114 0.483 . . . . 74.24 111.721 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.517 HD11 HG11 ' A' ' 235' ' ' VAL . 85.9 mt -123.4 126.34 46.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.476 -0.329 . . . . 65.1 110.603 175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -92.12 115.95 28.52 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.988 -0.445 . . . . 63.14 110.759 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.522 HD11 HG21 ' A' ' 243' ' ' VAL . 58.6 mt -112.52 152.87 28.31 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 122.538 0.335 . . . . 74.04 111.288 -177.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.461 ' HG2' ' CG2' ' A' ' 192' ' ' VAL . 12.9 ptmm? -162.14 150.3 14.72 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.206 0.526 . . . . 73.41 112.067 172.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -116.44 -164.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.714 -0.847 . . . . 73.42 108.714 167.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -81.53 -6.15 58.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.639 0.733 . . . . 75.35 109.606 166.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 41.5 p -81.51 -33.81 31.62 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.284 -0.871 . . . . 75.54 111.744 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 167.46 -178.69 41.37 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 121.396 -0.431 . . . . 72.32 112.811 -176.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 81.0 p -130.3 133.73 46.68 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 117.35 0.575 . . . . 51.04 112.25 179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.424 HG22 HD13 ' A' ' 176' ' ' ILE . 11.6 tt -148.51 153.16 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 116.173 -0.467 . . . . 73.42 110.653 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -101.2 132.66 46.59 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.704 -0.623 . . . . 72.11 111.675 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.432 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -96.92 117.58 5.8 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.643 -0.583 . . . . 65.3 111.643 173.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 30.8 m -95.95 115.99 28.26 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 122.438 -0.448 . . . . 73.41 112.107 -175.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.499 HD23 ' HB ' ' A' ' 258' ' ' VAL . 92.8 mt -91.64 128.39 37.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.07 -0.514 . . . . 71.34 111.17 175.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 95.8 m95 -113.47 153.85 28.0 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.231 0.539 . . . . 73.04 111.777 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 65.2 t30 60.8 -134.27 0.69 Allowed 'General case' 0 CA--C 1.555 1.147 0 CA-C-N 115.647 -0.706 . . . . 71.14 112.006 172.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -63.6 -18.34 63.79 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 113.097 0.777 . . . . 63.45 113.097 -173.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.0 -14.93 63.38 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.755 0.312 . . . . 74.33 111.593 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.579 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -61.24 -43.69 98.47 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.214 0.45 . . . . 63.31 112.214 178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -76.08 1.31 15.93 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.54 0.57 . . . . 74.52 112.54 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -67.25 123.07 19.29 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 122.167 -0.333 . . . . 74.23 110.53 176.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.84 92.98 0.37 Allowed 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.205 0.526 . . . . 70.25 112.068 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.517 HG11 HD11 ' A' ' 213' ' ' LEU . 3.7 p -120.42 107.64 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 115.743 -0.662 . . . . 70.14 110.24 173.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -95.34 163.58 13.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.0 -0.545 . . . . 75.11 111.002 -175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.796 ' HZ3' ' HA ' ' A' ' 192' ' ' VAL . 8.1 tmtm? -71.12 113.12 7.84 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.481 -0.563 . . . . 74.31 109.481 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 121.95 -23.12 7.45 Favored Glycine 0 CA--C 1.524 0.619 0 CA-C-N 116.175 -0.466 . . . . 65.2 112.231 -172.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.4 ' HB3' HD12 ' A' ' 263' ' ' ILE . 24.4 m-20 -65.5 125.58 25.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.137 0.494 . . . . 75.42 112.067 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 49.8 mm -77.85 97.97 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.514 -0.55 . . . . 63.11 109.514 172.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -97.04 129.96 44.41 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.179 0.807 . . . . 63.14 113.179 -171.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -83.9 96.57 8.85 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.685 -0.689 . . . . 71.21 109.417 170.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.522 HG21 HD11 ' A' ' 215' ' ' LEU . 88.6 t -97.61 111.62 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.113 0.483 . . . . 72.21 111.471 -175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.7 t -118.35 135.51 54.28 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.757 0.313 . . . . 73.34 111.056 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 172.81 -152.91 17.36 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 120.448 -0.882 . . . . 64.5 113.803 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -111.59 115.18 28.72 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.753 0.311 . . . . 70.33 111.325 -175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.548 HG21 HD22 ' A' ' 179' ' ' LEU . 47.7 t -86.27 120.54 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.776 0.322 . . . . 61.0 111.092 178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.483 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 19.4 ptpt -135.09 -179.82 5.86 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.817 0.341 . . . . 73.31 111.043 -178.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -107.93 129.56 55.09 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.703 -0.226 . . . . 60.15 110.405 171.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -129.99 -132.91 3.51 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.917 -0.659 . . . . 21.42 113.624 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -88.98 -28.87 19.93 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.392 0.515 . . . . 74.33 112.392 -174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 37.8 t -89.54 -35.22 16.04 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.081 0.467 . . . . 74.22 111.033 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 155.76 -135.54 4.63 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 115.95 -0.568 . . . . 64.15 112.041 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 67.7 mt -79.2 102.71 8.67 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.263 0.554 . . . . 60.54 109.87 172.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -119.19 137.07 53.88 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.982 -0.554 . . . . 75.53 111.724 -172.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.482 ' HB ' HG22 ' A' ' 247' ' ' VAL . 9.5 tt -104.79 121.05 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.294 0.569 . . . . 41.44 111.98 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 94.5 p -81.75 112.07 18.58 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.491 -0.559 . . . . 71.43 109.491 173.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.499 ' HB ' HD23 ' A' ' 226' ' ' LEU . 21.7 t -77.64 106.16 7.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.864 0.364 . . . . 64.21 111.963 -173.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -84.07 -24.06 30.54 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.01 0.433 . . . . 73.12 111.299 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -146.4 125.78 13.14 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.926 -0.579 . . . . 54.22 111.101 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.452 ' HB ' HG11 ' A' ' 258' ' ' VAL . 13.1 tt -135.67 137.06 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.158 0.504 . . . . 71.33 111.769 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.43 140.27 7.71 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.892 -0.595 . . . . 54.33 111.826 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.642 HG21 ' HE3' ' A' ' 266' ' ' LYS . 40.5 mm -92.26 128.66 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 117.682 0.741 . . . . 63.12 111.705 -177.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 27.1 mt -83.65 -45.88 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 CA-C-O 121.368 0.604 . . . . 75.24 110.758 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -124.79 126.45 45.64 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.052 -0.522 . . . . 73.35 111.35 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.642 ' HE3' HG21 ' A' ' 263' ' ' ILE . 6.8 mmpt? -90.26 145.0 25.33 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.591 0.589 . . . . 62.21 112.591 -174.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 46.0 m -121.31 25.05 9.69 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.917 -0.583 . . . . 73.31 111.087 173.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.57 HD12 ' HG2' ' A' ' 269' ' ' GLU . 3.1 pp -66.55 -20.95 66.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.674 0.274 . . . . 71.44 111.391 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.57 ' HG2' HD12 ' A' ' 268' ' ' LEU . 13.2 pt-20 . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.68 -0.676 . . . . 54.23 111.026 170.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 73.6 mtm . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 120.738 0.304 . . . . 72.43 111.32 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -92.46 107.2 19.04 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.995 0.426 . . . . 73.21 111.477 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -94.96 151.36 19.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.292 0.568 . . . . 74.33 111.9 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -89.34 153.69 20.67 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.701 -0.851 . . . . 75.15 108.701 169.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.405 HD13 HG22 ' A' ' 222' ' ' ILE . 36.0 mt -55.72 -36.25 42.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 N-CA-C 112.328 0.492 . . . . 74.14 112.328 -176.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.491 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 47.1 t -69.85 -24.09 63.39 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 112.138 0.421 . . . . 62.22 112.138 176.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -82.85 -5.78 59.14 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.288 0.477 . . . . 73.3 112.288 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.447 HD22 HG21 ' A' ' 247' ' ' VAL . 89.2 mt -70.84 155.71 40.45 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.504 0.669 . . . . 73.22 112.625 -176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.468 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.2 ptp -154.23 152.04 25.58 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-N 115.437 -0.801 . . . . 74.24 109.756 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.0 150.33 79.12 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 121.684 1.589 . . . . 51.43 112.492 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 246' ' ' TYR . 2.3 m-20 64.72 30.91 12.25 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.057 0.456 . . . . 53.41 111.445 -178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.468 HD22 ' HG2' ' A' ' 180' ' ' MET . 22.8 tp -114.58 115.88 27.88 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.353 -0.385 . . . . 72.13 111.372 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 90.2 p -103.83 109.52 21.28 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.66 0.267 . . . . 64.03 110.765 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.83 -161.56 11.44 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.778 -0.725 . . . . 60.21 113.508 -176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 25.1 m -122.81 142.98 50.16 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.65 -0.324 . . . . 71.32 111.418 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 34.8 pt -135.31 155.46 37.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-O 121.233 0.54 . . . . 74.11 112.431 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -111.19 124.48 52.28 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.15 -0.477 . . . . 63.12 110.531 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -154.8 164.94 38.09 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.339 0.59 . . . . 55.05 112.41 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -103.21 138.05 40.53 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.615 -0.721 . . . . 63.21 110.089 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.9 99.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 N-CA-C 112.58 0.585 . . . . 50.12 112.58 -172.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 27.3 t -70.87 -44.75 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 121.074 0.464 . . . . 75.41 111.774 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -143.4 132.72 23.3 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.176 -0.465 . . . . 62.43 111.832 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -124.1 99.48 6.26 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.148 -0.478 . . . . 65.33 110.855 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 196' ' ' PRO . 72.3 m-85 -77.49 149.78 78.81 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 112.55 0.574 . . . . 64.42 112.55 -174.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 195' ' ' TYR . 38.6 Cg_exo -62.19 172.62 3.95 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 123.299 2.666 . . . . 65.15 114.054 -178.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.405 ' HA ' ' HB1' ' A' ' 231' ' ' ALA . 0.2 OUTLIER -61.07 109.99 1.24 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.373 -0.83 . . . . 73.23 112.868 -176.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 210' ' ' LEU . 66.7 mttm -83.88 148.96 26.67 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.185 -0.461 . . . . 62.41 109.929 171.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -131.86 136.58 47.56 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.986 0.735 . . . . 64.14 112.986 -171.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.43 ' HE1' ' HB2' ' A' ' 210' ' ' LEU . 54.8 p90 -156.37 -175.34 5.38 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.587 -0.733 . . . . 64.05 110.456 173.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 70.6 p -122.24 143.94 49.28 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.208 -0.307 . . . . 72.52 110.705 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 -90.45 141.01 29.18 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.874 0.369 . . . . 75.45 111.294 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -49.85 -30.31 9.65 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.212 0.53 . . . . 64.23 111.496 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -54.39 -44.09 72.0 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.725 -0.67 . . . . 74.21 112.141 175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 126.52 -20.81 6.1 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 121.156 -0.545 . . . . 60.04 112.422 -175.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.0 p -85.26 176.53 8.27 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.03 0.443 . . . . 71.04 111.947 177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -72.83 163.38 28.21 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.52 0.676 . . . . 71.4 112.534 -176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -158.05 110.84 0.46 Allowed Glycine 0 CA--C 1.523 0.547 0 CA-C-N 115.675 -0.693 . . . . 73.22 112.442 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -110.78 168.02 9.79 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.383 -0.48 . . . . 75.05 111.016 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 198' ' ' LYS . 65.8 tp -144.81 149.38 35.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 120.992 0.425 . . . . 72.02 111.458 -176.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.614 ' HB2' ' HA ' ' A' ' 231' ' ' ALA . 45.6 tttp -149.85 121.1 7.82 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.937 0.399 . . . . 75.22 111.263 178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 41.2 m -95.38 118.26 31.8 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.969 0.414 . . . . 73.41 111.663 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 74.4 mt -109.57 130.45 55.51 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.442 -0.345 . . . . 54.51 110.773 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -97.79 103.75 15.71 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.002 -0.436 . . . . 71.45 110.669 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.8 mt -95.17 136.34 35.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.141 -0.481 . . . . 65.51 111.291 -177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -122.62 147.72 46.09 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 112.718 0.636 . . . . 63.12 112.718 -179.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -148.21 163.05 38.17 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.133 -0.94 . . . . 62.22 109.298 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -77.52 10.05 2.88 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.908 -0.495 . . . . 60.15 112.263 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.491 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 69.8 p -115.24 2.81 14.14 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.947 0.403 . . . . 62.22 111.072 169.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 147.1 170.08 15.11 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.332 -0.461 . . . . 73.14 113.25 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 80.3 p -128.64 126.5 40.32 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.442 -0.446 . . . . 72.54 111.061 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 176' ' ' ILE . 9.6 tp -129.76 151.75 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.946 0.403 . . . . 72.01 111.263 -177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.627 ' HD3' ' H ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -99.29 125.26 44.89 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.2 0.524 . . . . 64.43 111.441 178.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.565 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -91.83 138.31 14.19 Favored Glycine 0 CA--C 1.522 0.528 0 CA-C-N 115.705 -0.68 . . . . 64.11 112.489 178.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.439 HG23 HD11 ' A' ' 210' ' ' LEU . 28.4 m -106.43 105.5 15.57 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.903 0.334 . . . . 74.2 111.903 -174.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.595 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 56.4 mt -90.42 138.71 31.33 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.831 0.348 . . . . 63.43 111.186 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -115.55 157.12 24.56 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.272 0.558 . . . . 74.1 112.101 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 55.4 t30 57.83 -141.68 0.74 Allowed 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.559 -0.746 . . . . 54.41 112.468 172.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -54.42 -24.21 19.03 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.989 0.737 . . . . 74.01 112.989 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 99.2 mt -61.57 -8.35 4.28 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 120.92 0.39 . . . . 74.14 112.006 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -66.06 -30.02 70.47 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.922 0.391 . . . . 64.54 111.82 175.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -93.4 5.84 50.18 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.336 -0.393 . . . . 61.21 111.847 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -59.77 126.46 27.66 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 120.944 0.402 . . . . 75.24 111.856 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -68.39 87.82 0.31 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.245 0.545 . . . . 50.43 111.796 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.5 p -116.89 128.78 74.21 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.112 -0.495 . . . . 74.22 110.735 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 239' ' ' ASP . 50.5 mtpt -93.28 150.86 20.17 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.3 0.572 . . . . 72.44 112.281 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -80.16 117.23 20.78 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.898 -0.592 . . . . 71.22 110.068 172.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.58 23.6 13.72 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.938 -0.648 . . . . 74.24 112.659 -175.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 3.0 t0 -113.72 162.77 15.87 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.702 0.287 . . . . 61.01 110.564 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.401 HG22 HD12 ' A' ' 264' ' ' ILE . 47.0 mm -98.94 114.12 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 120.738 0.304 . . . . 73.31 111.218 -177.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -114.15 142.43 46.25 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.023 0.749 . . . . 73.43 113.023 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' A' ' 264' ' ' ILE . 30.5 tt0 -112.05 108.73 18.14 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.971 -0.559 . . . . 73.3 109.655 172.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 91.1 t -107.04 133.86 50.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 112.676 0.621 . . . . 72.04 112.676 -170.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 42.8 t -111.94 112.1 23.5 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.356 -0.384 . . . . 73.4 110.375 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.49 -176.88 26.42 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.174 -1.012 . . . . 63.32 114.369 -174.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 182' ' ' ASN . 86.2 t80 -112.92 105.98 14.17 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.134 0.574 . . . . 73.43 111.084 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 256' ' ' ILE . 24.9 t -74.04 142.35 14.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 116.477 -0.329 . . . . 73.14 110.718 175.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -156.5 178.25 10.54 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 121.46 0.648 . . . . 75.44 112.677 -174.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -107.36 145.27 33.08 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.343 -0.844 . . . . 71.03 110.242 172.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 156.51 -129.53 2.46 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.186 -1.007 . . . . 73.3 114.902 175.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -71.5 74.29 0.76 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.161 0.584 . . . . 72.22 111.222 -174.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.5 t 155.75 -17.65 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.843 0.857 . . . . 75.14 110.315 -172.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 98.5 -84.29 0.67 Allowed Glycine 0 CA--C 1.519 0.313 0 N-CA-C 110.482 -1.047 . . . . 62.02 110.482 -170.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 98.0 mt -129.99 104.54 7.41 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.791 0.437 . . . . 73.34 109.846 170.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.92 172.57 7.17 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.066 0.46 . . . . 71.21 111.83 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.565 HG23 ' HA2' ' A' ' 224' ' ' GLY . 7.8 tt -127.55 112.84 29.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.339 0.59 . . . . 64.44 111.469 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . 0.415 ' HA ' ' HB ' ' A' ' 225' ' ' THR . 37.2 t -82.75 110.94 18.23 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.157 -0.474 . . . . 72.42 110.282 176.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.526 ' HB ' HD23 ' A' ' 226' ' ' LEU . 46.6 t -74.76 137.49 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-O 121.219 0.533 . . . . 73.3 111.936 -175.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -106.35 -43.86 4.67 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.993 -0.549 . . . . 61.34 110.583 176.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -139.41 145.2 38.61 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.093 -0.503 . . . . 75.24 110.479 178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.1 tt -140.24 135.97 36.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-O 121.283 0.563 . . . . 71.11 111.983 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -140.68 121.82 2.01 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-N 116.081 -0.509 . . . . 64.54 112.385 176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.415 ' HB ' ' HG3' ' A' ' 266' ' ' LYS . 14.0 mm -78.48 138.02 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 O-C-N 122.47 -0.429 . . . . 62.2 110.764 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.438 HD11 ' HB2' ' A' ' 242' ' ' GLU . 60.0 mt -84.58 -41.9 16.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 112.515 0.561 . . . . 64.51 112.515 -174.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -126.45 68.55 1.23 Allowed 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.073 0.768 . . . . 71.33 113.073 -171.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.505 ' NZ ' ' HB3' ' A' ' 266' ' ' LYS . 8.8 mtpm? -89.81 142.82 27.34 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.66 0.743 . . . . 74.12 112.909 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 43.4 t -128.52 144.75 51.2 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.102 -0.953 . . . . 62.55 109.831 169.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 92.8 mt -56.89 -26.49 59.04 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.176 0.512 . . . . 71.24 111.163 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 C--O 1.25 1.126 0 CA-C-N 115.722 -0.672 . . . . 75.04 111.347 178.935 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 20.8 ptp . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 120.651 0.262 . . . . 73.13 111.209 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 186' ' ' THR . 8.1 t30 -97.49 143.42 28.23 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.453 0.644 . . . . 74.12 112.725 -175.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.444 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 57.6 m-85 -130.69 167.67 18.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.405 -0.816 . . . . 72.14 110.308 173.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.466 ' HB3' ' OG1' ' A' ' 219' ' ' THR . 22.7 mmtp -97.66 164.64 12.33 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.972 -0.381 . . . . 75.21 109.972 167.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 220' ' ' GLY . 56.8 mt -64.08 -30.34 49.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 111.946 0.35 . . . . 73.54 111.946 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.474 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 83.7 p -64.7 -24.86 67.71 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.046 0.451 . . . . 72.43 111.157 173.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 174' ' ' TYR . 26.3 mm-40 -86.79 -12.25 48.59 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.052 -0.522 . . . . 71.44 111.596 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.524 HD11 HD13 ' A' ' 187' ' ' ILE . 71.1 mt -70.16 141.75 52.59 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.384 0.611 . . . . 72.13 111.714 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.439 ' HG2' HD22 ' A' ' 183' ' ' LEU . 21.5 ptp -154.12 156.36 31.83 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.553 -0.748 . . . . 74.13 110.641 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.97 142.22 76.66 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 122.141 1.894 . . . . 53.33 112.484 176.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 66.16 26.21 10.61 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 120.903 0.382 . . . . 74.41 111.697 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.439 HD22 ' HG2' ' A' ' 180' ' ' MET . 46.5 tp -98.09 135.09 40.26 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.802 0.334 . . . . 64.2 111.55 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 72.0 p -114.08 118.92 35.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.522 -0.308 . . . . 64.31 110.869 176.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.76 -160.85 27.63 Favored Glycine 0 CA--C 1.527 0.844 0 C-N-CA 120.888 -0.672 . . . . 61.41 113.685 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 58.0 m -129.69 148.85 51.62 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.83 0.452 . . . . 73.53 111.0 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.524 HD13 HD11 ' A' ' 179' ' ' LEU . 32.3 pt -131.95 144.61 36.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.244 0.545 . . . . 71.4 111.291 173.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -113.27 107.19 15.55 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.056 -0.52 . . . . 72.54 110.483 175.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.8 176.8 9.6 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.006 0.432 . . . . 41.42 111.819 -177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -94.0 145.17 24.85 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.149 0.499 . . . . 74.4 111.807 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 42.8 t -86.01 108.96 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 116.214 -0.448 . . . . 43.53 111.665 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.84 -35.67 24.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-N 116.161 -0.472 . . . . 71.44 111.449 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.09 124.26 5.74 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.313 -0.403 . . . . 63.32 111.607 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -108.17 100.93 10.2 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.221 -0.445 . . . . 62.03 110.749 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.503 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 99.0 m-85 -72.41 139.61 81.54 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 111.957 0.354 . . . . 60.23 111.957 -176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -53.8 148.99 34.9 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.666 2.244 . . . . 70.01 112.851 174.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.436 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 21.3 pttm -71.72 125.84 28.17 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.474 0.654 . . . . 74.01 112.375 -175.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -98.02 166.47 11.42 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.78 -0.646 . . . . 73.0 110.731 176.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -120.44 112.17 18.63 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 120.681 0.277 . . . . 73.14 110.806 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -106.92 151.28 25.47 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.317 0.579 . . . . 71.14 111.982 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 77.8 p -99.36 126.89 45.32 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.955 -0.566 . . . . 53.53 111.169 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -85.89 140.45 30.37 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.512 -0.313 . . . . 75.43 111.175 176.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -57.69 -26.28 61.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.769 0.795 . . . . 74.24 110.148 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.77 -36.28 69.64 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.896 -1.047 . . . . 72.41 111.933 173.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 125.49 -30.45 4.48 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-N 116.356 -0.384 . . . . 64.12 112.986 -177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.0 p -77.95 163.22 26.17 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.734 0.642 . . . . 70.01 112.734 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -92.83 -173.69 3.39 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.978 -0.555 . . . . 74.13 110.735 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -173.36 149.24 10.93 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 120.813 -0.708 . . . . 71.01 113.308 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.411 HE21 ' HB3' ' A' ' 231' ' ' ALA . 26.7 mt-30 -96.67 136.22 37.5 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.825 0.345 . . . . 74.44 111.105 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 18.9 tp -127.65 111.13 13.37 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.225 0.454 . . . . 64.12 112.225 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 195' ' ' TYR . 81.5 tttt -122.21 109.6 14.68 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.191 -0.318 . . . . 65.23 111.282 175.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.9 t -86.07 145.94 26.84 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.927 0.394 . . . . 75.24 111.387 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 94.8 mt -129.79 124.47 33.47 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.511 -0.313 . . . . 73.34 111.253 -178.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -94.58 115.39 27.52 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 110.132 -0.321 . . . . 75.34 110.132 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.63 HD11 HG21 ' A' ' 243' ' ' VAL . 52.8 mt -112.54 150.75 30.87 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.556 0.217 . . . . 65.44 111.51 -176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -140.47 152.65 45.81 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.652 0.739 . . . . 72.1 111.934 174.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -148.19 166.09 28.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.802 -1.09 . . . . 71.24 108.739 176.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -56.69 -25.82 55.12 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-O 120.756 0.312 . . . . 64.43 111.772 178.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 71.6 p -89.88 1.95 55.59 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.826 0.676 . . . . 60.45 112.826 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.441 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 137.41 -179.25 18.32 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 120.803 -0.713 . . . . 73.13 113.312 -178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 57.2 p -127.81 152.23 48.05 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 122.418 -0.46 . . . . 61.23 111.52 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.0 tp -151.77 160.06 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 116.72 -0.218 . . . . 75.11 111.291 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -107.36 128.08 54.14 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.193 0.52 . . . . 72.31 112.118 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -103.15 167.21 16.77 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 116.08 -0.509 . . . . 65.22 111.948 172.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 99.8 m -142.79 122.33 13.25 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.747 0.773 . . . . 65.01 112.379 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.408 HD23 ' HB ' ' A' ' 258' ' ' VAL . 91.4 mt -93.69 120.15 33.6 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.744 -0.662 . . . . 74.33 110.972 177.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -100.0 142.95 30.8 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.686 0.279 . . . . 71.12 111.713 179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 60.8 t30 66.83 -138.03 0.14 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.099 0.559 . . . . 73.14 111.968 174.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -25.79 64.4 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 112.305 0.483 . . . . 74.51 112.305 -173.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 91.0 mt -56.59 -21.81 29.36 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.799 0.333 . . . . 65.44 111.786 177.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -64.64 -20.15 66.11 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 111.978 0.362 . . . . 64.22 111.978 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -99.47 8.4 44.58 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.693 0.282 . . . . 75.14 111.703 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -65.58 143.7 57.45 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.093 0.473 . . . . 74.04 112.006 -177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -63.29 96.57 0.11 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.823 -0.626 . . . . 73.01 111.301 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 4.6 p -147.08 113.69 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.032 0.444 . . . . 74.31 111.008 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -105.58 160.45 15.17 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.438 0.637 . . . . 75.34 111.758 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -68.02 99.96 0.93 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.733 -0.667 . . . . 75.22 111.069 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 130.4 -10.61 5.84 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 121.187 -0.53 . . . . 61.12 114.036 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -85.78 157.07 20.34 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.782 0.66 . . . . 74.32 112.782 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.444 HG22 HD12 ' A' ' 264' ' ' ILE . 40.9 mm -92.97 110.18 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.708 -0.678 . . . . 63.41 110.495 177.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -110.1 139.11 45.58 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.794 0.664 . . . . 53.24 112.794 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 31.9 tt0 -84.41 104.63 14.59 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.68 -0.691 . . . . 73.02 110.165 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.63 HG21 HD11 ' A' ' 215' ' ' LEU . 87.1 t -103.99 106.46 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 120.928 0.394 . . . . 63.23 111.505 -177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 39.1 p -116.53 130.49 56.78 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.461 -0.336 . . . . 54.15 111.439 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.97 -141.04 4.7 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 120.656 -0.783 . . . . 71.42 113.771 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -129.11 124.89 35.91 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 122.696 -0.296 . . . . 70.3 111.198 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.436 HG22 ' HB ' ' A' ' 256' ' ' ILE . 35.0 t -90.84 133.96 31.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.812 0.339 . . . . 75.11 111.821 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -126.39 -179.61 4.84 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.964 0.412 . . . . 74.14 111.204 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -119.37 125.56 49.29 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.421 -0.354 . . . . 74.32 111.516 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -88.59 -131.09 3.79 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.201 -0.999 . . . . 72.41 111.545 168.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -109.67 110.12 21.06 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 117.215 0.507 . . . . 71.45 110.385 174.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 44.2 t 65.33 5.4 3.11 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.32 0.489 . . . . 75.53 112.32 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -146.41 161.9 28.39 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.55 -0.357 . . . . 74.43 112.797 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.33 152.4 37.9 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.913 0.387 . . . . 72.31 111.726 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -146.31 156.31 43.26 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.161 -0.472 . . . . 61.5 111.078 173.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.436 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.5 tt -122.99 119.38 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.292 0.567 . . . . 74.33 112.227 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 70.3 m -72.23 113.8 9.66 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.195 -0.457 . . . . 54.4 110.075 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.527 HG11 ' HB ' ' A' ' 261' ' ' ILE . 23.1 t -82.22 117.43 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.985 0.421 . . . . 75.42 111.731 -175.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -89.81 -26.93 20.3 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.174 0.512 . . . . 72.33 110.551 177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -149.63 137.29 20.15 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.1 -0.5 . . . . 65.53 110.936 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.527 ' HB ' HG11 ' A' ' 258' ' ' VAL . 12.2 tt -143.58 135.82 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.026 0.441 . . . . 64.22 111.628 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -146.98 139.68 8.1 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.241 -0.504 . . . . 53.34 112.939 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 49.3 mm -75.41 115.76 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 O-C-N 122.278 -0.542 . . . . 74.13 110.821 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.444 HD12 HG22 ' A' ' 240' ' ' ILE . 61.8 mt -59.94 -50.08 81.49 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 120.953 0.406 . . . . 72.3 111.806 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -130.98 98.78 4.69 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.474 -0.33 . . . . 63.11 110.972 177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -55.3 117.99 4.01 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.475 0.546 . . . . 74.41 112.475 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 50.2 m -85.61 113.16 21.62 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.946 0.403 . . . . 52.01 110.0 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.523 ' H ' HD12 ' A' ' 268' ' ' LEU . 4.9 mp -71.1 -26.28 62.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.234 0.54 . . . . 73.23 110.93 -176.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 269' ' ' GLU . 1.4 pm0 . . . . . 0 C--O 1.25 1.129 0 CA-C-N 115.362 -0.836 . . . . 70.41 110.949 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 96.5 mmm . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 120.59 0.233 . . . . 74.15 111.28 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -72.87 109.2 6.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.086 0.469 . . . . 71.23 110.449 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.434 ' CE2' ' HA3' ' A' ' 185' ' ' GLY . 96.5 m-85 -83.3 141.0 32.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.38 0.61 . . . . 72.1 112.411 -172.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.418 ' HD2' ' OG1' ' A' ' 219' ' ' THR . 18.2 tppt? -81.54 137.76 35.52 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.473 -0.785 . . . . 72.4 109.956 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.448 HD13 HG22 ' A' ' 222' ' ' ILE . 36.7 mt -52.79 -36.7 23.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 112.705 0.632 . . . . 74.03 112.705 -176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.418 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 35.4 t -64.51 -27.12 68.75 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.849 0.357 . . . . 71.31 111.549 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -95.05 6.1 50.04 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.32 0.489 . . . . 45.33 112.32 -175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.407 HD22 HG21 ' A' ' 247' ' ' VAL . 81.9 mt -68.64 131.05 44.56 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.133 0.492 . . . . 72.13 111.527 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 52.7 mtt -121.07 155.28 58.12 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.135 -0.484 . . . . 73.54 111.506 -175.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HG3' HD21 ' A' ' 254' ' ' LEU . 31.2 Cg_exo -61.03 133.29 46.41 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.31 2.007 . . . . 73.44 112.186 173.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 66.35 37.62 4.74 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.872 0.469 . . . . 72.43 111.568 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 16.8 tp -110.8 119.47 39.22 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.452 -0.34 . . . . 63.14 111.4 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.406 ' HB3' ' HD1' ' A' ' 246' ' ' TYR . 86.9 p -99.18 126.29 44.94 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 120.949 0.404 . . . . 52.51 111.181 176.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.434 ' HA3' ' CE2' ' A' ' 174' ' ' TYR . . . -171.58 -160.55 20.37 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.613 -0.803 . . . . 73.43 113.88 -178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 28.7 m -135.89 136.93 40.92 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.749 -0.266 . . . . 74.42 111.299 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.39 147.15 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 120.842 0.353 . . . . 64.02 111.735 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.428 HD22 HD11 ' A' ' 264' ' ' ILE . 17.8 m120 -108.16 112.31 24.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.579 -0.282 . . . . 55.31 110.647 176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -147.95 174.59 11.73 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.316 0.488 . . . . 74.41 112.316 -177.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -103.72 144.89 30.86 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.31 -0.404 . . . . 63.33 111.108 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.46 ' HA ' HD23 ' A' ' 215' ' ' LEU . 43.0 t -77.32 105.26 6.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 121.12 0.486 . . . . 75.41 111.556 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 12.6 t -76.31 -36.31 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 115.887 -0.597 . . . . 62.0 111.391 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.51 158.74 37.73 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.845 -0.616 . . . . 73.3 111.369 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.72 122.55 14.42 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.35 -0.386 . . . . 51.1 111.342 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -101.42 148.41 35.15 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 120.629 0.252 . . . . 72.33 111.463 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.81 168.08 14.25 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.809 2.34 . . . . 60.42 113.045 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -74.36 147.72 41.91 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.376 0.607 . . . . 73.32 112.26 -177.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -111.4 157.25 20.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.863 -0.608 . . . . 64.34 110.145 174.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -110.03 157.58 19.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.2 0.524 . . . . 73.12 110.969 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.5 ' O ' ' HD3' ' A' ' 202' ' ' ARG . 33.0 p90 -156.7 172.47 18.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.734 -0.667 . . . . 72.41 110.071 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 48.0 t -83.01 108.25 16.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.719 0.295 . . . . 70.1 110.965 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 200' ' ' PHE . 0.0 OUTLIER -82.71 117.04 22.35 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.326 0.584 . . . . 74.44 111.887 -176.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -52.01 -30.97 27.63 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.481 -0.782 . . . . 73.51 112.636 177.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -86.73 -2.86 58.88 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.55 0.574 . . . . 63.15 112.55 -176.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 72.35 16.78 77.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 121.091 -0.575 . . . . 63.51 113.56 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 80.3 p -98.45 166.3 11.43 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 122.707 -0.29 . . . . 64.15 110.725 178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -87.89 81.76 7.45 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.389 0.614 . . . . 64.12 111.094 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.85 147.99 19.02 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-N 115.533 -0.758 . . . . 62.03 113.026 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.488 ' NE2' ' HB3' ' A' ' 231' ' ' ALA . 9.0 pt20 -139.38 144.88 38.36 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.116 0.484 . . . . 64.41 111.717 -176.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 22.0 tp -111.8 105.96 14.59 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.741 -0.663 . . . . 72.52 112.388 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.478 ' HE3' HD21 ' A' ' 213' ' ' LEU . 4.0 tmtm? -113.02 126.35 55.39 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 122.141 -0.349 . . . . 74.31 110.258 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 25.1 p -110.24 142.74 41.41 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.433 0.635 . . . . 73.53 112.665 -176.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.478 HD21 ' HE3' ' A' ' 211' ' ' LYS . 85.0 mt -125.18 159.92 30.4 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.604 -0.725 . . . . 55.22 110.886 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -125.41 119.71 29.06 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.733 0.301 . . . . 73.41 110.944 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.568 HD11 HG21 ' A' ' 243' ' ' VAL . 75.7 mt -114.68 162.26 17.04 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 122.726 0.41 . . . . 74.24 111.025 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 216' ' ' LYS . 18.5 ptmt -151.76 168.64 24.42 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.677 0.751 . . . . 74.35 112.643 173.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -146.33 174.84 11.0 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 114.66 -1.155 . . . . 72.11 109.113 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.14 -14.37 60.38 Favored 'General case' 0 CA--C 1.546 0.806 0 O-C-N 121.832 -0.543 . . . . 73.55 112.231 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 68.8 p -102.25 -18.86 15.28 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.289 0.848 . . . . 62.22 113.289 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 167.7 -179.82 40.86 Favored Glycine 0 CA--C 1.523 0.54 0 C-N-CA 120.386 -0.912 . . . . 60.12 113.684 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 44.8 m -127.64 144.41 51.08 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.807 0.337 . . . . 73.31 111.789 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.448 HG22 HD13 ' A' ' 176' ' ' ILE . 9.7 tp -150.65 150.17 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-N 116.508 -0.314 . . . . 70.52 110.849 -178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.503 ' HD3' ' H ' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -107.75 142.66 37.42 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.944 -0.472 . . . . 75.13 111.699 -179.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.519 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -110.57 155.67 15.98 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 116.063 -0.517 . . . . 72.44 113.271 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.4 m -116.39 114.01 23.68 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.408 0.522 . . . . 74.43 112.408 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.475 HD23 ' HB ' ' A' ' 258' ' ' VAL . 85.5 mt -96.71 133.95 40.61 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.815 0.446 . . . . 72.04 111.403 175.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -115.4 156.97 24.6 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.745 0.307 . . . . 73.44 111.52 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 58.87 -141.16 0.7 Allowed 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 112.102 0.408 . . . . 62.22 112.102 172.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -48.26 -32.27 7.03 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.919 0.711 . . . . 72.51 112.919 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.431 ' HB3' HD22 ' A' ' 226' ' ' LEU . 85.8 mt -59.71 -19.45 49.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.745 0.307 . . . . 74.22 111.538 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.488 ' HB3' ' NE2' ' A' ' 209' ' ' GLN . . . -67.22 -32.3 73.26 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.181 0.438 . . . . 75.02 112.181 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -94.89 -6.62 42.21 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 112.023 0.379 . . . . 74.53 112.023 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -54.98 125.61 21.08 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.457 -0.338 . . . . 75.34 110.365 175.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.447 ' O ' ' HE3' ' A' ' 266' ' ' LYS . 37.2 tt0 -68.94 111.38 4.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.351 0.595 . . . . 53.32 111.652 -176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.47 HG11 HD11 ' A' ' 213' ' ' LEU . 7.3 p -144.42 135.27 20.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.559 -0.746 . . . . 74.44 109.678 174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -139.51 165.92 25.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.525 0.679 . . . . 62.31 112.133 -172.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -64.36 101.02 0.39 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.917 -0.583 . . . . 72.41 111.075 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 147.87 -31.37 1.34 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.615 -0.802 . . . . 63.14 114.583 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.09 154.41 25.6 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.769 0.785 . . . . 73.14 112.699 -177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 38.9 mm -94.57 106.05 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 115.485 -0.78 . . . . 73.41 110.833 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -100.04 131.12 46.19 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.985 0.735 . . . . 51.52 112.985 -174.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -97.04 97.63 9.39 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.364 -0.606 . . . . 72.14 109.364 171.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.568 HG21 HD11 ' A' ' 215' ' ' LEU . 99.3 t -99.01 124.16 52.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 112.973 0.731 . . . . 75.13 112.973 -169.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.427 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 37.0 t -98.59 116.55 31.08 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.826 -0.625 . . . . 73.33 110.348 172.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -156.03 174.58 33.93 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 120.317 -0.944 . . . . 71.1 114.484 -176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.406 ' HD1' ' HB3' ' A' ' 184' ' ' SER . 59.2 t80 -108.71 109.29 20.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.292 0.637 . . . . 72.51 110.788 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.462 HG22 ' HB ' ' A' ' 256' ' ' ILE . 40.5 t -78.29 116.04 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.58 0.229 . . . . 64.21 111.109 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -128.46 161.19 30.1 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.671 0.272 . . . . 71.43 111.326 178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -110.52 143.91 40.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.798 0.332 . . . . 73.31 111.521 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -167.32 -131.5 1.28 Allowed Glycine 0 CA--C 1.53 1.025 0 C-N-CA 120.91 -0.662 . . . . 53.12 113.592 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -52.65 -64.66 0.74 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 112.607 0.595 . . . . 75.1 112.607 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 68.7 m -89.68 21.07 3.66 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.519 0.563 . . . . 61.53 112.519 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 93.77 -136.7 13.2 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.065 -0.588 . . . . 73.15 113.703 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.432 HD21 ' HG3' ' A' ' 181' ' ' PRO . 94.8 mt -86.4 117.56 25.28 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.845 0.355 . . . . 63.43 111.516 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -134.74 132.58 38.95 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.974 0.416 . . . . 74.42 110.505 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.519 HG23 ' HA2' ' A' ' 224' ' ' GLY . 7.4 tt -101.13 111.55 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-O 121.399 0.619 . . . . 73.25 112.195 -173.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 50.9 m -78.89 111.57 15.18 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.998 -0.546 . . . . 54.4 110.462 177.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.475 ' HB ' HD23 ' A' ' 226' ' ' LEU . 43.1 t -75.74 127.97 37.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 112.425 0.528 . . . . 75.12 112.425 -173.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -97.99 -22.49 16.25 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.917 0.389 . . . . 64.21 111.291 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 47.9 t-20 -156.94 132.68 9.43 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.487 -0.324 . . . . 73.04 110.377 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.3 tt -126.64 122.23 60.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-O 121.075 0.464 . . . . 74.31 111.533 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -133.11 117.9 2.03 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.376 -0.44 . . . . 65.54 112.245 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.57 HD12 ' HD2' ' A' ' 266' ' ' LYS . 63.6 mt -85.4 127.21 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 O-C-N 122.53 -0.394 . . . . 54.33 111.258 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.428 HD11 HD22 ' A' ' 188' ' ' ASN . 49.4 mt -59.1 -46.03 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.084 0.469 . . . . 75.55 111.282 -177.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -153.02 139.22 18.36 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.86 -0.609 . . . . 72.13 110.612 176.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.57 ' HD2' HD12 ' A' ' 263' ' ' ILE . 13.9 ptmm? -151.59 125.7 9.25 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.014 0.435 . . . . 75.24 110.927 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 42.9 t -79.94 177.47 8.9 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.459 0.647 . . . . 53.22 112.125 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.35 21.17 13.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.825 -0.625 . . . . 60.34 111.579 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 . . . . . 0 C--O 1.255 1.376 0 CA-C-N 116.124 -0.489 . . . . 70.45 111.841 -179.78 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 74.6 mtm . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.793 0.33 . . . . 74.34 111.16 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -82.52 104.14 12.57 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.496 -0.32 . . . . 73.35 110.205 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -84.6 137.02 33.53 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.616 0.598 . . . . 74.32 112.616 -175.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -100.86 158.68 15.8 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.812 -0.631 . . . . 71.31 110.22 171.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.561 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 89.1 mt -60.93 -32.25 51.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 113.018 0.747 . . . . 51.11 113.018 -173.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.53 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 34.1 t -58.2 -31.82 67.69 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 122.103 -0.373 . . . . 63.34 111.954 177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -84.16 -12.52 54.79 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.503 0.557 . . . . 72.14 112.503 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.561 ' HG ' ' HA ' ' A' ' 176' ' ' ILE . 65.7 mt -64.66 116.05 5.85 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.526 0.679 . . . . 71.03 111.934 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.6 ptp -125.74 160.97 53.65 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 115.648 -0.705 . . . . 74.03 110.55 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.524 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 43.4 Cg_exo -54.99 133.42 57.99 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.331 2.021 . . . . 65.23 112.876 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 16.4 m120 68.75 20.29 8.17 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.389 0.515 . . . . 72.02 112.389 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 52.3 tp -85.11 139.48 31.68 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.951 0.405 . . . . 65.54 111.498 177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.8 p -110.25 127.42 54.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.495 -0.32 . . . . 72.33 110.342 174.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.15 -169.78 38.76 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.422 -0.894 . . . . 54.33 113.987 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 79.1 m -132.63 120.86 22.33 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 122.706 -0.291 . . . . 72.31 111.179 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 41.1 pt -108.09 140.61 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.981 0.42 . . . . 74.01 111.585 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -115.99 112.11 21.33 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.454 -0.339 . . . . 73.31 110.219 177.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -142.52 169.34 17.76 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.105 0.479 . . . . 63.43 112.099 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -89.82 139.27 30.75 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.05 -0.523 . . . . 73.31 110.952 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.405 HG21 ' CG2' ' A' ' 235' ' ' VAL . 35.8 t -82.89 116.84 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 121.127 0.489 . . . . 74.41 111.534 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 35.7 t -90.41 -64.77 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 121.189 0.518 . . . . 75.52 111.553 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.452 ' H ' ' HB3' ' A' ' 214' ' ' PHE . . . -126.84 132.59 50.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.32 -0.4 . . . . 74.53 111.518 -177.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -103.57 128.03 50.89 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.334 -0.394 . . . . 71.3 111.011 178.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -92.2 119.62 68.09 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.744 -0.207 . . . . 63.13 110.953 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -50.49 153.81 7.09 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 122.782 2.321 . . . . 71.1 113.094 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -64.36 130.49 44.0 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 113.084 0.772 . . . . 74.14 113.084 -173.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 3.0 mptp? -101.57 157.09 17.07 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.912 -0.586 . . . . 72.43 109.499 170.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -130.58 139.12 50.43 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.315 0.579 . . . . 73.41 111.91 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.413 ' O ' ' HA3' ' A' ' 208' ' ' GLY . 26.2 p90 -151.87 174.52 13.49 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.933 -0.576 . . . . 74.14 110.893 -178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 49.2 m -97.47 136.07 38.42 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.748 0.308 . . . . 74.24 110.744 175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -100.09 -167.73 1.49 Allowed 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.271 0.558 . . . . 71.13 112.061 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -59.99 -42.88 95.18 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.74 -0.663 . . . . 60.11 110.573 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -79.1 -39.6 33.29 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.169 0.509 . . . . 64.34 110.933 177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 121.59 -35.33 3.62 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 115.859 -0.61 . . . . 71.52 113.052 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.7 p -102.8 177.18 4.92 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 111.865 0.321 . . . . 73.34 111.865 -175.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? 60.38 18.42 8.08 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.409 0.522 . . . . 75.14 112.409 175.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 200' ' ' PHE . . . -76.54 70.32 2.22 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.352 -0.452 . . . . 73.01 113.608 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.461 HE21 ' HB3' ' A' ' 231' ' ' ALA . 24.8 mt-30 -108.4 141.03 40.86 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.788 0.328 . . . . 73.45 110.893 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.408 HD13 ' CZ3' ' A' ' 227' ' ' TRP . 51.5 tp -135.37 142.84 45.8 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.448 0.299 . . . . 65.44 111.02 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.518 ' HE2' HD21 ' A' ' 213' ' ' LEU . 0.7 OUTLIER -162.05 119.45 2.15 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.867 0.365 . . . . 64.14 110.868 -179.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.0 t -104.26 161.65 13.87 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.162 0.506 . . . . 72.12 112.218 -174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.518 HD21 ' HE2' ' A' ' 211' ' ' LYS . 95.5 mt -138.16 138.98 39.15 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.023 -0.535 . . . . 63.43 111.764 -177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.452 ' HB3' ' H ' ' A' ' 193' ' ' ALA . 21.8 t80 -97.2 106.23 18.52 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.906 0.384 . . . . 74.14 110.39 175.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 243' ' ' VAL . 80.0 mt -109.95 156.88 19.88 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.325 -0.398 . . . . 75.24 111.529 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -160.99 148.52 15.51 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.956 0.407 . . . . 70.11 112.062 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -132.21 -162.92 1.28 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.365 -0.606 . . . . 75.53 109.365 169.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -77.79 -1.7 32.71 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.778 0.659 . . . . 74.35 112.778 -177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.53 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 30.0 p -114.2 3.21 15.09 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.018 0.748 . . . . 55.32 113.018 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.406 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 149.22 -178.35 26.82 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.37 -0.919 . . . . 44.03 113.953 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 96.9 p -124.86 145.36 49.83 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.615 0.366 . . . . 65.15 111.021 176.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.9 tp -139.42 154.54 24.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-O 120.912 0.387 . . . . 72.32 111.263 -178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -108.02 112.45 25.02 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.891 0.377 . . . . 75.31 111.107 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.495 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -85.14 151.24 25.62 Favored Glycine 0 CA--C 1.525 0.674 0 CA-C-N 116.363 -0.38 . . . . 72.31 113.013 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 87.2 m -124.01 112.42 17.15 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 122.459 -0.436 . . . . 71.5 111.941 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.452 HD12 ' HD2' ' A' ' 211' ' ' LYS . 89.8 mt -94.97 121.95 37.1 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.342 -0.39 . . . . 73.14 110.717 174.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.408 ' CZ3' HD13 ' A' ' 210' ' ' LEU . 97.5 m95 -101.52 157.0 17.13 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.027 0.441 . . . . 74.45 111.875 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 38.8 m-20 54.95 -134.29 1.56 Allowed 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.795 -0.639 . . . . 75.53 112.437 170.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 229' ' ' GLU . 4.1 mp0 -48.13 -34.18 9.44 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.704 0.802 . . . . 73.23 112.625 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 70.5 mt -69.52 -6.62 31.93 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.398 0.518 . . . . 54.25 112.398 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.461 ' HB3' HE21 ' A' ' 209' ' ' GLN . . . -63.86 -45.92 87.31 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.841 0.353 . . . . 63.11 111.776 177.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.47 6.34 23.88 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 112.324 0.49 . . . . 71.53 112.324 -179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -61.27 123.33 17.43 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.824 -0.171 . . . . 71.24 110.664 175.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -73.7 96.01 2.44 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.719 0.771 . . . . 73.33 112.564 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.405 ' CG2' HG21 ' A' ' 191' ' ' VAL . 7.7 p -121.7 134.97 63.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.258 -0.883 . . . . 64.44 108.934 168.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -119.71 172.37 7.73 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.164 0.983 . . . . 73.2 113.246 -168.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -72.56 99.67 2.58 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.257 -0.883 . . . . 52.32 111.58 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.09 20.98 6.09 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 115.119 0.808 . . . . 62.14 115.119 172.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -103.23 167.46 9.81 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.38 1.09 . . . . 55.15 111.169 172.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 47.8 mm -101.42 104.74 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.128 -0.487 . . . . 72.01 110.845 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -104.72 125.55 50.91 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.077 0.465 . . . . 44.2 112.204 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -84.71 102.43 12.98 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.084 0.468 . . . . 71.03 109.838 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.457 HG21 HD11 ' A' ' 215' ' ' LEU . 98.6 t -99.8 105.9 18.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.325 0.583 . . . . 73.31 111.935 -175.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 36.7 t -97.11 125.92 41.92 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.035 -0.529 . . . . 73.01 110.383 174.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -171.83 -169.08 34.22 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 120.022 -1.085 . . . . 73.34 114.4 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -109.39 121.09 44.43 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.784 0.433 . . . . 63.34 110.854 -177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.524 HG21 HD22 ' A' ' 179' ' ' LEU . 38.6 t -83.79 139.19 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.275 -0.42 . . . . 73.44 111.847 -177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.656 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 8.4 mtpm? -134.25 168.39 18.96 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.183 0.516 . . . . 64.3 111.443 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.524 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 25.8 tt0 -120.78 142.29 49.71 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.09 -0.504 . . . . 64.21 110.305 172.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 151.38 -77.76 0.22 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.725 -0.75 . . . . 43.13 112.957 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -86.35 133.3 33.81 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.526 -0.397 . . . . 42.15 110.451 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 31.7 t 62.31 26.15 15.64 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 121.285 0.564 . . . . 74.33 111.0 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 72.62 -77.51 0.77 Allowed Glycine 0 CA--C 1.522 0.504 0 C-N-CA 121.214 -0.517 . . . . 72.42 111.812 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.0 mt -111.89 130.54 55.8 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.131 0.491 . . . . 71.15 110.795 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.656 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 8.6 pt-20 -128.56 169.26 14.6 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.882 -0.599 . . . . 73.0 110.787 -178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.495 HG23 ' HA2' ' A' ' 224' ' ' GLY . 11.2 tt -148.79 117.22 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.461 0.648 . . . . 53.24 111.98 177.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 77.8 p -85.12 119.69 25.79 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.079 -0.51 . . . . 71.31 110.318 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.448 ' HB ' HD23 ' A' ' 226' ' ' LEU . 41.8 t -77.02 132.42 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.685 0.624 . . . . 73.13 112.685 -173.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -95.73 -54.74 3.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.829 -0.623 . . . . 72.42 110.276 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -139.78 126.81 20.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.056 -0.52 . . . . 73.03 110.785 175.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.7 tt -116.38 127.43 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.043 0.449 . . . . 72.13 111.284 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -125.28 118.78 3.36 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.142 -0.551 . . . . 73.53 112.955 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.554 HG21 ' HB3' ' A' ' 266' ' ' LYS . 41.3 mm -76.45 111.37 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.931 0.396 . . . . 64.41 110.889 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.402 HG22 ' HG3' ' A' ' 265' ' ' GLU . 61.8 mt -69.2 -42.99 81.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.844 0.354 . . . . 75.12 111.587 -177.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.402 ' HG3' HG22 ' A' ' 264' ' ' ILE . 44.5 mt-10 -140.83 109.56 6.01 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.558 -0.292 . . . . 63.43 111.309 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.583 ' HE2' HD21 ' A' ' 268' ' ' LEU . 25.1 pttm -113.3 179.26 4.01 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.896 0.379 . . . . 72.24 111.018 176.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 67.4 p -132.09 109.25 9.86 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.292 0.479 . . . . 65.55 112.292 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.583 HD21 ' HE2' ' A' ' 266' ' ' LYS . 0.4 OUTLIER -138.12 106.4 5.78 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.559 0.695 . . . . 64.2 111.249 175.227 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 C--O 1.252 1.233 0 CA-C-O 118.469 -0.777 . . . . 62.35 111.71 -175.406 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.467 0.175 . . . . 74.2 111.111 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 186' ' ' THR . 5.8 m-20 -95.58 105.85 17.88 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.103 0.478 . . . . 63.31 111.045 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -85.67 168.06 14.74 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.477 0.656 . . . . 63.43 112.091 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.477 ' HA ' ' HE2' ' A' ' 175' ' ' LYS . 0.1 OUTLIER -96.72 156.8 16.19 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.511 -0.768 . . . . 64.41 109.868 169.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 51.0 mt -61.43 -32.67 53.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.105 0.409 . . . . 71.51 112.105 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 41.1 t -63.82 -22.73 67.05 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 120.882 0.373 . . . . 71.52 111.468 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -87.91 -12.02 45.92 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.38 -0.373 . . . . 65.33 111.85 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 187' ' ' ILE . 84.1 mt -71.54 103.07 2.87 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.389 0.614 . . . . 73.11 111.413 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.447 ' HG2' HD13 ' A' ' 183' ' ' LEU . 23.1 ptp -112.56 157.24 40.82 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 115.844 -0.616 . . . . 61.44 110.956 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.437 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 52.0 Cg_exo -53.05 135.27 58.64 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.487 2.125 . . . . 74.24 113.271 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 69.8 26.89 4.71 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.208 0.603 . . . . 70.4 112.28 176.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.447 HD13 ' HG2' ' A' ' 180' ' ' MET . 9.1 tt -115.85 144.72 43.62 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.767 0.318 . . . . 71.13 110.715 176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.437 ' HB2' ' CD2' ' A' ' 246' ' ' TYR . 47.3 t -126.45 157.32 38.94 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 120.934 0.397 . . . . 74.11 111.79 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.2 -168.6 33.08 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.043 -0.599 . . . . 62.04 113.214 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 65.1 m -106.39 152.48 23.54 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 122.366 0.266 . . . . 71.33 110.534 178.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.472 HG21 HD21 ' A' ' 179' ' ' LEU . 37.4 pt -139.22 161.15 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.117 0.484 . . . . 61.33 111.584 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -118.38 110.94 18.07 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.087 -0.506 . . . . 62.45 110.137 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.67 157.89 44.51 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.346 0.593 . . . . 73.41 112.085 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -93.65 134.39 36.0 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.702 -0.681 . . . . 75.34 110.816 178.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.3 t -73.89 125.48 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 121.003 0.43 . . . . 51.2 111.978 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.28 -42.6 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.179 0.514 . . . . 72.22 111.146 178.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -146.11 130.55 17.72 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.992 -0.549 . . . . 71.21 111.205 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.91 104.55 8.36 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.019 0.438 . . . . 62.42 111.602 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.473 ' HB3' ' HD2' ' A' ' 196' ' ' PRO . 97.2 m-85 -86.0 163.33 43.64 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 116.542 -0.299 . . . . 73.02 111.721 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 195' ' ' TYR . 60.7 Cg_endo -70.28 -164.65 0.14 Allowed 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 122.798 2.332 . . . . 72.42 113.155 178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.662 ' HD3' ' HB2' ' A' ' 232' ' ' ASP . 22.1 pttp -100.05 111.49 23.78 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.608 0.718 . . . . 72.21 111.841 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -92.45 176.55 6.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.654 -0.703 . . . . 64.24 110.697 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -136.3 150.12 48.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.091 0.472 . . . . 74.52 111.334 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -151.33 178.71 8.99 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.113 0.483 . . . . 64.42 111.265 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 82.0 p -110.5 134.96 51.88 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.017 0.437 . . . . 51.24 110.829 177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -84.58 170.62 13.21 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.133 -0.485 . . . . 73.03 111.045 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -55.05 -30.46 59.62 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 112.255 0.465 . . . . 63.44 112.255 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -82.68 -3.52 56.47 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.48 0.548 . . . . 73.1 112.48 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 86.57 5.89 81.24 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.331 -0.461 . . . . 64.12 113.153 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.9 p -86.73 163.19 17.45 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.787 0.327 . . . . 73.14 111.841 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -76.97 159.98 29.52 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.613 0.721 . . . . 61.04 112.67 -177.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -166.61 147.56 12.2 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 115.448 -0.796 . . . . 55.3 112.377 176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -104.32 147.81 27.09 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 117.353 0.577 . . . . 61.24 111.982 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 27.5 tp -129.63 123.5 31.41 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.611 -0.722 . . . . 74.1 111.634 -174.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.541 ' HD3' HD12 ' A' ' 226' ' ' LEU . 44.6 tttp -122.52 108.6 13.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.786 0.327 . . . . 61.13 111.309 177.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 24.6 m -74.32 125.85 29.37 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.476 -0.329 . . . . 71.0 111.178 178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.405 HD21 ' HE3' ' A' ' 211' ' ' LYS . 97.8 mt -132.51 150.56 52.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.092 0.472 . . . . 75.41 111.67 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -135.01 124.25 24.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.469 -0.332 . . . . 73.43 110.32 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 86.7 mt -118.05 150.0 40.05 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.713 0.292 . . . . 74.32 111.688 -174.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.467 ' HB2' ' NZ ' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -132.8 129.09 38.1 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.778 0.799 . . . . 73.32 112.095 175.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -115.11 165.68 12.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.113 -0.949 . . . . 71.34 109.042 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -60.72 -25.87 66.74 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 111.874 0.324 . . . . 62.44 111.874 -177.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 69.6 p -91.86 0.34 57.48 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.697 0.628 . . . . 51.4 112.697 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 146.25 177.09 20.64 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.936 -0.65 . . . . 23.43 113.469 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 54.0 p -118.31 160.08 22.27 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 122.405 -0.467 . . . . 71.31 111.596 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.1 tp -146.47 152.67 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.011 0.434 . . . . 74.33 111.894 -176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 25.2 mtp180 -90.82 121.82 33.01 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 116.214 -0.448 . . . . 73.1 110.902 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -120.62 165.9 13.86 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 121.207 -0.52 . . . . 61.43 113.313 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 98.8 m -152.82 137.08 16.55 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 122.268 -0.548 . . . . 71.14 112.395 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.555 HD23 ' HB ' ' A' ' 258' ' ' VAL . 65.9 mt -106.1 141.31 37.68 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.84 -0.618 . . . . 64.3 110.47 172.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 59.9 m95 -114.84 160.88 18.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.1 0.476 . . . . 71.54 111.601 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 56.08 -134.13 1.41 Allowed 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.925 -0.579 . . . . 65.45 111.705 172.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.95 -34.65 68.23 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.468 0.544 . . . . 64.12 112.468 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 80.2 mt -65.41 -15.39 62.55 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 112.119 0.414 . . . . 74.43 112.119 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -61.55 -27.68 68.79 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 120.965 0.412 . . . . 60.34 111.779 178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.662 ' HB2' ' HD3' ' A' ' 197' ' ' LYS . 36.8 t70 -95.18 9.01 41.25 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 120.823 0.344 . . . . 73.14 111.481 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -56.9 128.52 37.21 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.905 0.383 . . . . 72.43 111.725 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -76.4 115.63 16.32 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.066 0.46 . . . . 55.51 110.609 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.27 150.02 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.918 -0.583 . . . . 74.53 110.946 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.504 ' HG3' ' O ' ' A' ' 267' ' ' SER . 9.5 mmmm -117.66 146.91 43.37 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.087 0.47 . . . . 75.03 112.242 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -66.27 95.82 0.32 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.109 -0.496 . . . . 73.33 110.406 173.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 129.56 -16.78 5.61 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 120.916 -0.659 . . . . 45.51 113.348 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.432 ' CG ' ' HB2' ' A' ' 236' ' ' LYS . 66.2 m-20 -68.37 132.14 46.54 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.051 0.453 . . . . 64.04 111.086 176.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 264' ' ' ILE . 46.5 mm -77.79 107.99 10.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.912 0.387 . . . . 74.42 110.385 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -104.01 139.39 39.2 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.04 0.755 . . . . 52.43 113.04 -173.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -95.17 99.71 11.64 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 109.178 -0.675 . . . . 75.2 109.178 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.27 123.87 58.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 112.506 0.558 . . . . 71.14 112.506 -170.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 186' ' ' THR . 45.5 t -112.09 123.19 49.72 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.861 0.363 . . . . 62.34 111.211 176.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -164.6 -167.25 24.86 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.562 -0.827 . . . . 33.43 113.997 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.437 ' CD2' ' HB2' ' A' ' 184' ' ' SER . 39.3 t80 -121.89 129.34 52.49 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 120.736 0.303 . . . . 64.35 110.966 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 47.0 t -96.22 125.68 49.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-O 121.005 0.431 . . . . 72.42 112.129 -177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -122.18 166.21 14.94 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.015 0.436 . . . . 62.15 110.736 176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.437 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 25.2 tt0 -120.65 141.88 49.97 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.712 0.292 . . . . 74.24 110.899 176.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -162.54 -148.33 5.31 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 120.492 -0.861 . . . . 73.31 113.382 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -70.17 -33.35 71.65 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 122.575 0.35 . . . . 72.52 111.709 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 32.1 t -90.05 19.81 4.7 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 120.995 0.426 . . . . 70.04 111.354 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 85.14 -139.31 17.49 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.401 -0.428 . . . . 34.23 112.832 -179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.1 mt -91.36 119.68 31.59 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.762 0.315 . . . . 62.45 110.861 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -113.96 126.13 54.8 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.82 0.343 . . . . 63.25 111.167 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.7 tt -106.04 106.44 20.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.627 0.727 . . . . 44.41 111.47 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 34.2 t -83.62 114.38 21.51 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.905 -0.589 . . . . 73.0 110.456 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.555 ' HB ' HD23 ' A' ' 226' ' ' LEU . 39.0 t -91.06 121.28 41.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.186 0.439 . . . . 71.14 112.186 -173.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -101.99 -14.24 17.25 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 120.786 0.327 . . . . 72.4 111.668 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -149.49 127.37 11.83 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.684 0.278 . . . . 71.41 110.668 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.7 tt -137.13 135.36 47.63 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.206 0.527 . . . . 72.44 112.278 -177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -147.69 122.69 1.59 Allowed Glycine 0 CA--C 1.523 0.584 0 CA-C-N 115.826 -0.625 . . . . 64.42 112.074 175.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.528 HD12 ' HE2' ' A' ' 266' ' ' LYS . 58.0 mt -82.74 136.88 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 O-C-N 121.992 -0.711 . . . . 54.54 112.015 -175.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.462 HD12 HG22 ' A' ' 240' ' ' ILE . 66.5 mt -70.6 -45.62 73.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-N 115.932 -0.576 . . . . 73.24 111.583 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -142.19 129.89 21.57 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.876 0.369 . . . . 54.4 111.585 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.528 ' HE2' HD12 ' A' ' 263' ' ' ILE . 2.5 mmmp? -103.08 143.35 32.71 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 120.735 0.303 . . . . 74.14 111.713 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . 0.504 ' O ' ' HG3' ' A' ' 236' ' ' LYS . 81.4 p -128.83 140.54 51.65 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 116.508 -0.315 . . . . 72.24 110.9 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 96.3 mt -134.98 107.84 7.54 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 120.971 0.415 . . . . 75.43 111.774 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.251 1.171 0 CA-C-O 119.121 -0.466 . . . . 61.44 110.775 176.222 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 84.8 mmm . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 112.258 0.466 . . . . 74.2 112.258 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.536 ' H ' HD22 ' A' ' 173' ' ' ASN . 0.1 OUTLIER -87.35 130.97 34.43 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.755 -0.461 . . . . 63.21 109.755 169.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.48 ' HB2' HG22 ' A' ' 187' ' ' ILE . 95.1 m-85 -98.94 135.61 40.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.373 0.606 . . . . 75.24 112.338 -176.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -91.52 153.37 19.83 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.012 -0.54 . . . . 55.02 110.063 171.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 220' ' ' GLY . 64.2 mt -54.23 -36.65 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 N-CA-C 113.492 0.923 . . . . 62.32 113.492 -172.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 32.7 t -75.48 -10.14 59.19 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.828 -0.545 . . . . 74.15 112.348 -178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.74 -7.57 52.15 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.678 0.275 . . . . 71.54 111.388 178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 85.2 mt -72.85 159.47 33.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.641 0.734 . . . . 70.21 112.655 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.568 ' HG2' HD22 ' A' ' 183' ' ' LEU . 25.4 ptp -157.41 155.07 26.9 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.418 -0.81 . . . . 52.54 110.154 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.438 ' HB3' ' CB ' ' A' ' 249' ' ' GLN . 12.3 Cg_endo -57.35 150.75 56.94 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 121.995 1.796 . . . . 72.22 112.38 174.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.415 ' HA ' ' OH ' ' A' ' 246' ' ' TYR . 63.8 t30 65.09 32.15 10.51 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.387 0.613 . . . . 73.21 111.021 178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.568 HD22 ' HG2' ' A' ' 180' ' ' MET . 30.1 tp -119.85 128.48 53.72 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.412 -0.358 . . . . 62.44 111.75 -177.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 88.8 p -111.48 114.79 28.14 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 122.115 -0.366 . . . . 73.03 110.325 175.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.46 176.22 36.26 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.441 -0.885 . . . . 71.44 114.181 -176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 88.6 m -108.76 119.74 40.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.932 0.396 . . . . 62.55 111.328 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.48 HG22 ' HB2' ' A' ' 174' ' ' TYR . 34.4 pt -110.54 155.79 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-O 121.127 0.489 . . . . 60.24 111.886 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -118.58 113.01 20.61 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.226 -0.443 . . . . 75.5 110.483 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -145.65 163.05 36.05 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.294 0.569 . . . . 73.22 111.935 -177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -94.89 139.2 31.64 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.936 -0.574 . . . . 74.01 111.594 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.404 ' HA ' HD23 ' A' ' 215' ' ' LEU . 46.9 t -77.19 106.82 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-O 120.884 0.374 . . . . 74.3 111.563 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.401 ' HB ' ' HD2' ' A' ' 214' ' ' PHE . 14.7 t -79.93 -45.93 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.228 0.537 . . . . 75.14 111.229 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -145.05 115.82 7.75 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.116 -0.493 . . . . 74.23 111.438 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -100.79 108.81 20.71 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.376 -0.375 . . . . 63.22 110.852 177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -70.78 159.99 83.47 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.505 -0.316 . . . . 75.33 111.45 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.16 159.45 49.79 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.261 1.974 . . . . 72.0 112.864 176.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 197' ' ' LYS . 21.0 ptmt -75.39 102.29 5.08 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.475 0.655 . . . . 54.34 112.075 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -67.08 163.55 19.83 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.66 -0.7 . . . . 72.54 112.048 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -122.56 131.11 53.68 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.711 -0.677 . . . . 71.11 111.485 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 210' ' ' LEU . 8.0 p90 -164.51 177.11 8.39 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.706 0.288 . . . . 75.24 110.969 175.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 28.1 m -116.2 128.25 55.46 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 121.975 -0.453 . . . . 73.45 111.955 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.528 ' NH1' HD21 ' A' ' 228' ' ' ASN . 47.3 mtp180 -92.23 158.74 15.98 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.124 -0.489 . . . . 75.23 110.832 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -67.38 -21.84 65.59 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.06 0.457 . . . . 63.32 110.402 175.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -106.17 70.98 0.86 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.26 -0.427 . . . . 74.25 111.838 178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 118.89 -15.37 11.21 Favored Glycine 0 CA--C 1.53 0.985 0 N-CA-C 114.683 0.633 . . . . 63.24 114.683 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 31.1 p 52.23 -175.85 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 117.414 0.607 . . . . 35.43 112.281 -176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 52.25 32.06 10.23 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.31 0.485 . . . . 72.51 112.31 175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -82.39 170.8 51.03 Favored Glycine 0 CA--C 1.527 0.816 0 CA-C-O 121.4 0.444 . . . . 74.42 113.553 -175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -128.41 154.53 45.93 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.548 -0.383 . . . . 73.42 110.648 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.41 ' HB2' ' CE1' ' A' ' 200' ' ' PHE . 38.3 tp -141.5 117.99 10.89 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.089 0.403 . . . . 74.2 112.089 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -134.9 114.56 12.67 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.948 0.404 . . . . 52.22 111.412 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 47.2 t -93.8 149.41 21.26 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.931 0.396 . . . . 74.0 111.396 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.57 HD21 HG11 ' A' ' 235' ' ' VAL . 74.0 mt -128.66 125.36 37.9 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.601 -0.272 . . . . 71.54 111.229 -177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.401 ' HD2' ' HB ' ' A' ' 192' ' ' VAL . 34.0 t80 -89.9 111.91 23.11 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.792 0.329 . . . . 64.32 110.243 175.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 191' ' ' VAL . 48.1 mt -109.92 156.77 20.0 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.388 -0.369 . . . . 74.03 111.006 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 221' ' ' SER . 18.1 ptmt -148.79 165.46 31.39 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.494 0.664 . . . . 61.4 112.155 173.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.404 ' OD2' HG22 ' A' ' 219' ' ' THR . 25.7 t70 -147.5 170.11 18.13 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.066 -0.97 . . . . 44.44 109.877 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -48.78 -31.76 7.53 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.561 0.578 . . . . 74.21 112.561 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.404 HG22 ' OD2' ' A' ' 217' ' ' ASP . 13.1 t -102.48 -8.92 20.67 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.194 1.183 . . . . 73.35 114.194 -173.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.436 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 168.32 -179.55 41.32 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 119.82 -1.181 . . . . 70.22 114.453 -177.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 216' ' ' LYS . 36.4 m -122.92 157.96 31.45 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.541 0.336 . . . . 72.51 111.325 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.6 tp -151.83 156.46 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-O 120.828 0.347 . . . . 70.32 111.32 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -113.37 112.07 23.04 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.277 0.561 . . . . 71.15 111.532 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.556 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -94.42 164.78 25.84 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.299 -0.41 . . . . 61.24 113.065 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 86.0 m -137.51 127.22 25.36 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.483 0.549 . . . . 71.11 112.483 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.465 HD23 ' HB ' ' A' ' 258' ' ' VAL . 96.1 mt -107.28 124.02 49.17 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.969 -0.56 . . . . 72.24 110.875 174.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -103.24 152.51 21.41 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.075 0.464 . . . . 73.31 111.995 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.528 HD21 ' NH1' ' A' ' 202' ' ' ARG . 47.0 m-20 51.01 -132.52 1.9 Allowed 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 112.566 0.58 . . . . 75.42 112.566 171.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -42.72 -39.53 2.46 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.433 0.901 . . . . 73.13 113.433 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 82.7 mt -62.2 -19.77 63.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.975 0.417 . . . . 75.11 112.049 -176.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.66 -21.98 66.86 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.091 0.404 . . . . 54.31 112.091 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -94.57 3.38 55.18 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.222 0.453 . . . . 75.4 112.222 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -64.33 124.31 21.41 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 110.289 -0.263 . . . . 74.34 110.289 174.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.434 ' OE2' ' HE2' ' A' ' 236' ' ' LYS . 28.9 tt0 -66.86 99.4 0.62 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.17 0.509 . . . . 73.01 112.043 -178.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.57 HG11 HD21 ' A' ' 213' ' ' LEU . 4.0 p -116.85 111.19 34.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.466 0.65 . . . . 41.53 110.699 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.434 ' HE2' ' OE2' ' A' ' 234' ' ' GLU . 66.8 mttm -98.36 147.73 24.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.08 0.466 . . . . 74.04 111.506 -176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.407 ' HE3' ' HB3' ' A' ' 237' ' ' LYS . 0.8 OUTLIER -65.1 112.85 3.56 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.036 0.446 . . . . 75.44 110.597 177.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 112.63 -16.66 23.74 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.463 -0.399 . . . . 11.1 113.172 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -70.51 141.54 51.93 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 121.011 0.434 . . . . 73.44 111.482 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 37.2 mm -89.09 117.91 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 116.476 -0.329 . . . . 73.14 110.522 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -109.01 127.1 53.8 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 113.11 0.782 . . . . 65.52 113.11 -171.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -80.2 97.54 6.96 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.228 -0.656 . . . . 53.31 109.228 167.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.7 t -100.79 106.02 18.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.251 0.548 . . . . 74.54 112.24 -173.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 35.9 m -96.65 109.19 21.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.937 -0.574 . . . . 72.41 110.055 175.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -153.67 -172.98 22.33 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.199 -1.0 . . . . 34.11 114.343 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.415 ' OH ' ' HA ' ' A' ' 182' ' ' ASN . 74.0 t80 -115.38 115.66 26.96 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.39 -0.405 . . . . 74.33 110.856 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.2 t -78.83 126.66 38.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.16 0.505 . . . . 53.32 111.717 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.418 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 52.4 mtpt -123.04 146.49 47.62 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.067 -0.515 . . . . 53.33 111.504 -177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.438 ' CB ' ' HB3' ' A' ' 181' ' ' PRO . 25.3 tt0 -120.39 135.76 54.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.851 0.358 . . . . 75.22 110.648 172.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -160.08 -148.0 5.1 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.434 -0.889 . . . . 55.21 113.329 177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -65.85 -29.57 70.05 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.061 0.458 . . . . 71.05 111.312 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 75.7 p -75.38 -10.76 59.74 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.329 -0.396 . . . . 74.42 111.635 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.06 -121.16 7.1 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.804 -0.519 . . . . 72.35 111.804 -173.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 89.1 mt -107.4 133.56 51.73 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.96 0.409 . . . . 54.44 111.385 177.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.418 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 10.5 pt-20 -144.24 174.03 11.25 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.154 -0.475 . . . . 70.33 111.007 177.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.556 HG23 ' HA2' ' A' ' 224' ' ' GLY . 8.5 tt -154.05 116.88 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 121.477 0.656 . . . . 75.42 111.976 178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 32.8 t -87.49 124.37 33.38 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.951 -0.568 . . . . 74.43 110.098 177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 226' ' ' LEU . 33.3 t -84.08 132.84 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 112.366 0.506 . . . . 74.42 112.366 -173.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -95.36 -42.48 8.48 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.311 0.577 . . . . 72.23 110.723 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -145.42 135.41 23.71 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.917 -0.583 . . . . 65.41 110.702 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.459 ' HB ' HG11 ' A' ' 258' ' ' VAL . 12.6 tt -137.92 140.12 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.935 0.398 . . . . 62.34 111.596 -178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -149.98 136.42 5.69 Favored Glycine 0 CA--C 1.525 0.675 0 CA-C-N 116.24 -0.436 . . . . 73.23 112.159 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.507 ' CG2' ' HG2' ' A' ' 266' ' ' LYS . 25.6 mm -84.8 132.84 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 O-C-N 122.324 -0.515 . . . . 72.11 111.287 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 46.6 mt -77.1 -74.52 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 116.713 -0.221 . . . . 71.43 111.191 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -108.28 126.43 52.82 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.201 0.524 . . . . 63.0 110.443 170.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.575 ' NZ ' ' HB3' ' A' ' 266' ' ' LYS . 4.6 mtpm? -106.07 159.91 15.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.095 -0.502 . . . . 71.31 112.287 -173.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 62.2 p -80.18 105.12 11.21 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.179 0.514 . . . . 62.42 109.756 168.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.78 74.25 2.74 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.221 0.534 . . . . 62.41 111.395 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.464 -0.779 . . . . 75.51 111.915 178.063 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.905 0.383 . . . . 63.32 111.393 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 186' ' ' THR . 78.0 m-20 -84.59 125.89 32.84 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.34 -0.391 . . . . 74.52 110.868 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 33.2 m-85 -83.92 171.45 13.02 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.518 0.675 . . . . 64.31 112.09 -174.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 74.3 mmtt -93.39 156.68 16.64 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.568 -0.742 . . . . 70.53 109.683 167.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.503 HD13 HG22 ' A' ' 222' ' ' ILE . 40.0 mt -59.12 -31.87 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 112.114 0.412 . . . . 74.55 112.114 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.452 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 34.8 t -62.11 -29.26 70.2 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.93 0.395 . . . . 50.13 111.598 174.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 11.5 mm-40 -83.5 -18.22 39.24 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.405 -0.361 . . . . 72.31 111.695 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.676 HD11 HD13 ' A' ' 187' ' ' ILE . 87.6 mt -64.45 98.86 0.27 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.232 0.539 . . . . 73.03 110.998 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.463 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.9 ptp -96.64 152.2 38.4 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.099 -0.5 . . . . 73.31 111.163 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.18 138.34 78.92 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.169 1.913 . . . . 72.14 112.769 177.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 72.54 18.91 4.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.263 0.625 . . . . 62.31 111.794 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.463 HD22 ' HG2' ' A' ' 180' ' ' MET . 44.1 tp -94.7 154.82 17.13 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.995 0.426 . . . . 61.14 111.599 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.4 t -131.31 123.17 27.75 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.53 -0.305 . . . . 44.11 110.67 172.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -170.54 -164.45 26.28 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 120.89 -0.671 . . . . 61.13 113.527 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 43.8 m -133.76 147.36 51.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.433 0.293 . . . . 63.01 111.177 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.676 HD13 HD11 ' A' ' 179' ' ' LEU . 39.9 pt -142.51 165.53 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.01 0.433 . . . . 65.4 111.577 -179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -122.29 118.31 28.21 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.692 -0.485 . . . . 73.55 109.692 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -146.29 170.75 16.14 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.532 0.567 . . . . 73.33 112.532 -175.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.445 ' O ' ' HA ' ' A' ' 215' ' ' LEU . 40.1 mt-10 -84.86 134.2 34.29 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.802 -0.635 . . . . 74.45 111.514 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.4 t -83.26 95.75 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-O 121.039 0.447 . . . . 73.12 110.63 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 24.1 t -79.25 -29.94 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-O 121.127 0.489 . . . . 54.22 112.001 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -147.97 145.02 28.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.89 0.376 . . . . 75.14 111.694 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -140.84 116.31 10.11 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.216 -0.447 . . . . 33.41 111.384 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.481 ' O ' ' HE2' ' A' ' 211' ' ' LYS . 97.0 m-85 -87.4 153.93 53.75 Favored Pre-proline 0 N--CA 1.472 0.654 0 CA-C-N 116.627 -0.26 . . . . 75.11 110.956 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.25 162.43 23.43 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 122.663 2.242 . . . . 65.11 112.942 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.419 ' HE3' ' HB2' ' A' ' 197' ' ' LYS . 20.3 ptmt -72.48 115.3 11.58 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.618 0.723 . . . . 71.25 111.744 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -102.27 148.74 25.08 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.0 -0.546 . . . . 74.3 111.19 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -117.41 144.37 45.05 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.895 0.378 . . . . 74.31 111.243 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -152.97 173.76 15.0 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.012 0.434 . . . . 62.54 111.315 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 87.9 p -95.83 126.59 41.19 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.193 0.52 . . . . 62.32 112.266 -175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 205' ' ' GLY . 16.2 mtp180 -118.66 114.52 22.87 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.082 -0.508 . . . . 71.5 110.097 170.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -52.17 -42.96 63.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.939 0.399 . . . . 73.02 111.719 -174.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -111.48 22.09 15.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.079 0.466 . . . . 73.43 111.378 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 202' ' ' ARG . . . -160.21 45.98 0.41 Allowed Glycine 0 CA--C 1.525 0.699 0 C-N-CA 121.215 -0.517 . . . . 73.13 112.567 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.44 ' O ' ' HB2' ' A' ' 207' ' ' LYS . 60.3 p -51.83 149.03 5.11 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.44 0.533 . . . . 63.53 112.44 -179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 206' ' ' THR . 60.2 mttp 72.55 5.7 5.3 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.533 -0.758 . . . . 73.45 112.599 -175.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -70.71 129.18 18.71 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.081 -0.58 . . . . 73.24 111.853 172.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.45 HE21 ' HA ' ' A' ' 229' ' ' GLU . 37.5 mt-30 -105.77 173.57 6.25 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.424 0.631 . . . . 62.23 112.695 -174.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.4 tp -138.37 116.5 11.76 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.431 -0.804 . . . . 75.55 111.221 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.481 ' HE2' ' O ' ' A' ' 195' ' ' TYR . 59.5 tttm -145.79 107.31 4.24 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 122.035 -0.416 . . . . 74.12 111.264 177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.462 ' HA ' ' HA ' ' A' ' 225' ' ' THR . 57.9 m -86.49 142.36 28.41 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.525 0.678 . . . . 73.13 112.65 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 59.8 mt -123.74 163.01 22.01 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.27 -0.877 . . . . 63.33 109.619 173.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -119.92 117.12 27.26 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.956 -0.465 . . . . 71.04 110.686 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 190' ' ' GLU . 78.3 mt -107.7 133.98 51.34 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.726 0.298 . . . . 75.14 111.224 -178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -124.03 153.64 41.03 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.426 0.631 . . . . 71.33 111.877 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -151.15 160.43 43.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.964 -1.016 . . . . 74.11 109.302 175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.31 -25.78 49.84 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.107 0.41 . . . . 61.15 112.107 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.452 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 48.6 p -89.23 -14.09 36.72 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 113.061 0.763 . . . . 62.14 113.061 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.02 -179.76 41.55 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 120.341 -0.933 . . . . 52.32 114.218 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 78.5 p -135.41 132.48 37.55 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.659 -0.318 . . . . 54.32 111.216 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.503 HG22 HD13 ' A' ' 176' ' ' ILE . 15.5 tt -144.81 145.74 20.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-O 121.058 0.456 . . . . 73.31 111.75 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.708 ' H ' ' HD2' ' A' ' 223' ' ' ARG . 0.5 OUTLIER -89.93 130.33 36.16 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 121.985 -0.447 . . . . 74.44 111.313 177.217 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.466 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -112.32 114.43 3.52 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.459 -0.401 . . . . 64.32 112.906 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 212' ' ' SER . 87.9 m -95.47 120.14 35.19 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.477 0.547 . . . . 55.1 112.477 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.494 HD23 ' HB ' ' A' ' 258' ' ' VAL . 91.3 mt -78.74 123.84 27.59 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.948 -0.569 . . . . 74.1 110.857 172.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 93.6 m95 -107.74 172.72 6.67 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.988 0.423 . . . . 75.23 111.362 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 57.7 t30 55.72 -141.11 0.86 Allowed 'General case' 0 CA--C 1.553 1.066 0 CA-C-N 116.217 -0.447 . . . . 74.2 111.525 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.45 ' HA ' HE21 ' A' ' 209' ' ' GLN . 11.5 pt-20 -74.85 -5.73 45.18 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.57 -0.706 . . . . 70.43 112.465 -177.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.487 ' HB3' HD22 ' A' ' 226' ' ' LEU . 83.2 mt -68.3 -12.77 61.59 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 122.137 -0.352 . . . . 51.21 111.656 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.48 -23.79 67.11 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.153 0.502 . . . . 71.33 111.595 176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.0 -3.07 59.06 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.012 0.375 . . . . 73.44 112.012 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -62.96 118.26 7.56 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.146 0.498 . . . . 74.42 110.999 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.26 99.42 4.04 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.402 0.62 . . . . 72.33 112.086 -175.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.5 p -129.77 141.64 45.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 115.733 -0.667 . . . . 75.54 110.731 175.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 23.7 mtmm -116.92 171.03 8.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.037 0.446 . . . . 73.22 110.835 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -72.99 119.24 16.97 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.852 0.358 . . . . 71.24 110.633 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 118.16 -24.13 8.9 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 121.157 -0.544 . . . . 44.25 113.751 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -64.78 134.32 53.9 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 117.159 0.479 . . . . 72.42 111.962 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 49.8 mm -84.03 102.33 9.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.005 0.431 . . . . 72.25 110.112 173.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 263' ' ' ILE . . . -108.74 141.61 40.49 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.661 0.615 . . . . 71.24 112.661 -174.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -89.35 108.45 19.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 115.802 -0.636 . . . . 73.31 109.728 172.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.432 HG13 HG13 ' A' ' 258' ' ' VAL . 75.8 t -111.51 130.24 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 112.158 0.429 . . . . 72.23 112.158 -172.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.419 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 28.5 t -123.9 137.3 54.66 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.294 -0.412 . . . . 61.42 110.701 177.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.98 -164.16 32.29 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.194 -1.003 . . . . 51.54 114.169 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -105.47 123.19 47.48 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.827 0.451 . . . . 74.12 111.189 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 43.9 t -89.93 134.44 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 CA-C-O 121.229 0.538 . . . . 73.11 112.271 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.57 ' HB2' ' HG3' ' A' ' 255' ' ' GLU . 7.9 mtpm? -128.03 157.2 41.3 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.94 -0.573 . . . . 70.51 110.441 178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -121.22 126.74 50.36 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 122.173 -0.329 . . . . 74.4 110.326 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -175.65 -83.63 0.06 OUTLIER Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.167 -1.016 . . . . 73.12 113.623 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 19.4 t80 -73.77 102.15 3.92 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.066 0.46 . . . . 73.24 111.865 -176.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 50.8 m 56.93 61.58 2.55 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.751 -0.658 . . . . 34.31 111.872 176.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 88.41 -127.44 8.59 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.103 -0.57 . . . . 53.12 113.338 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 98.2 mt -96.09 147.88 23.26 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.42 0.629 . . . . 51.14 112.649 -176.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . 0.57 ' HG3' ' HB2' ' A' ' 248' ' ' LYS . 8.0 pt-20 -143.62 125.85 15.56 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.563 -0.744 . . . . 51.1 110.038 177.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.466 HG23 ' HA2' ' A' ' 224' ' ' GLY . 12.2 tt -116.72 135.12 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 121.438 0.637 . . . . 72.4 112.443 -176.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 69.8 m -95.66 115.06 26.89 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.771 -0.649 . . . . 74.11 110.343 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.494 ' HB ' HD23 ' A' ' 226' ' ' LEU . 38.5 t -75.54 120.32 25.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.302 0.573 . . . . 63.42 112.158 -174.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -95.36 -36.41 11.39 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.941 -0.572 . . . . 75.23 110.654 177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.419 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 15.7 t-20 -139.93 140.14 36.31 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 115.804 -0.634 . . . . 74.11 110.334 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 14.2 tt -148.35 135.2 13.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.345 0.593 . . . . 70.54 112.288 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -148.49 125.18 2.01 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 116.104 -0.498 . . . . 74.34 112.304 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 241' ' ' ALA . 54.0 mt -79.85 131.9 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 O-C-N 122.217 -0.578 . . . . 51.23 111.773 -176.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 61.1 mt -73.33 -52.75 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 121.122 0.487 . . . . 65.41 111.332 -178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -96.84 111.65 23.75 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.075 -0.511 . . . . 75.43 111.792 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -133.93 137.21 44.74 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.528 0.68 . . . . 74.42 112.312 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 29.3 t -161.76 133.47 5.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.34 -0.845 . . . . 63.31 110.201 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 268' ' ' LEU . 1.4 pt? -145.08 166.61 24.88 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.867 0.365 . . . . 72.43 111.69 -176.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 . . . . . 0 C--O 1.254 1.331 0 CA-C-O 118.739 -0.648 . . . . 71.42 111.434 178.763 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 111.84 0.311 . . . . 61.12 111.84 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -73.26 117.7 15.32 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.726 -0.472 . . . . 72.14 109.726 171.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.423 ' O ' HG22 ' A' ' 187' ' ' ILE . 88.8 m-85 -84.35 145.36 28.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.326 0.584 . . . . 74.21 112.463 -173.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 46.4 mmtm -79.42 154.34 29.03 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.047 -0.723 . . . . 74.14 109.047 167.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.438 HG23 ' HB ' ' A' ' 222' ' ' ILE . 58.7 mt -51.94 -36.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 N-CA-C 112.591 0.589 . . . . 74.24 112.591 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 42.4 t -67.76 -29.14 68.28 Favored 'General case' 0 N--CA 1.479 1.018 0 O-C-N 122.057 -0.402 . . . . 55.04 111.845 177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.482 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 12.3 mm-40 -76.26 -8.04 56.21 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 111.851 0.315 . . . . 74.52 111.851 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.424 HD22 HG21 ' A' ' 247' ' ' VAL . 88.1 mt -73.41 145.29 45.92 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.314 0.578 . . . . 74.41 111.901 -178.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.478 ' HG2' HD22 ' A' ' 183' ' ' LEU . 24.2 ptp -143.97 159.16 54.14 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 116.029 -0.532 . . . . 75.21 110.7 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.22 132.38 38.86 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.451 2.101 . . . . 63.1 113.192 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 65.05 46.08 2.89 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.065 0.459 . . . . 70.33 111.589 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.478 HD22 ' HG2' ' A' ' 180' ' ' MET . 42.8 tp -119.19 120.88 38.37 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.304 -0.407 . . . . 63.22 111.73 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 46.5 t -99.14 120.46 39.53 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.556 0.217 . . . . 64.21 110.639 175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.82 -176.17 38.79 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 120.52 -0.848 . . . . 55.13 114.402 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 90.6 m -114.57 136.58 52.87 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.0 0.52 . . . . 74.35 111.698 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 174' ' ' TYR . 34.6 pt -126.8 157.8 37.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 122.63 0.372 . . . . 72.2 110.741 174.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -129.96 103.15 6.61 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.177 -0.327 . . . . 65.23 110.174 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -139.31 172.32 12.99 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 113.373 0.879 . . . . 73.01 113.373 -171.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -88.92 140.8 29.07 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.052 -0.976 . . . . 75.43 111.425 178.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 54.5 t -81.33 95.05 2.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.069 0.461 . . . . 63.21 110.761 175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.405 ' HB ' ' HD2' ' A' ' 214' ' ' PHE . 16.2 t -72.26 -42.6 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 116.223 -0.444 . . . . 72.01 111.936 -176.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -140.32 127.7 21.29 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 120.99 0.424 . . . . 74.15 111.63 -178.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -104.18 104.41 14.32 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.342 -0.39 . . . . 54.02 111.542 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -79.67 150.07 72.25 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 116.543 -0.299 . . . . 74.35 111.775 178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -66.6 168.38 16.73 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.981 2.454 . . . . 74.53 113.801 -177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.2 156.39 33.65 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.102 -0.499 . . . . 73.43 111.675 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -141.88 159.08 42.95 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.112 -0.495 . . . . 63.42 111.056 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -129.08 153.45 47.63 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.991 0.424 . . . . 61.04 111.47 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.574 ' HE2' ' HB2' ' A' ' 210' ' ' LEU . 52.4 p90 -161.39 176.4 11.17 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.032 0.444 . . . . 63.23 111.08 175.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 39.7 t -107.97 154.68 21.27 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.948 0.404 . . . . 52.53 111.263 178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -99.63 149.86 22.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.756 0.312 . . . . 61.33 111.229 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -58.97 -26.82 64.79 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.518 0.675 . . . . 73.43 110.248 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.86 -35.41 79.89 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.34 -0.845 . . . . 74.41 111.482 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 125.9 -27.9 5.03 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.299 -0.477 . . . . 63.53 113.261 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 79.5 p -82.89 173.64 11.64 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 122.481 -0.423 . . . . 52.45 111.914 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -91.27 143.74 26.33 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.186 0.517 . . . . 71.45 112.07 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -125.88 134.93 8.9 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.882 -0.599 . . . . 53.21 112.285 177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -100.77 152.77 20.1 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 117.299 0.55 . . . . 64.33 111.981 179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.574 ' HB2' ' HE2' ' A' ' 200' ' ' PHE . 51.7 tp -135.12 141.01 45.9 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.95 0.5 . . . . 74.41 111.321 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 231' ' ' ALA . 7.6 tmtm? -167.38 115.2 0.78 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.796 0.332 . . . . 71.33 111.034 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 69.8 m -99.83 167.26 10.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.741 0.782 . . . . 62.25 113.025 -174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.424 HD11 HG11 ' A' ' 235' ' ' VAL . 75.9 mt -142.66 157.33 44.79 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.179 -0.919 . . . . 54.44 110.752 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.405 ' HD2' ' HB ' ' A' ' 192' ' ' VAL . 35.6 t80 -117.13 122.52 44.32 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 122.133 -0.354 . . . . 74.54 110.851 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.529 HD11 HG21 ' A' ' 243' ' ' VAL . 44.3 mt -118.4 154.63 32.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.655 0.382 . . . . 71.23 111.004 -177.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -153.25 132.81 12.97 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.764 0.654 . . . . 61.53 112.764 174.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -99.81 -171.17 2.0 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.977 -0.556 . . . . 43.24 110.315 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.94 -15.15 62.58 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.195 0.522 . . . . 73.25 110.587 168.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 54.1 p -94.47 -20.52 19.6 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.819 0.674 . . . . 61.34 112.819 -175.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 158.12 -179.53 33.76 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.755 -0.736 . . . . 72.13 113.361 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 83.9 p -123.67 146.78 47.98 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.056 0.455 . . . . 74.04 112.047 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.438 ' HB ' HG23 ' A' ' 176' ' ' ILE . 11.4 tp -144.1 157.22 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.251 -0.432 . . . . 73.5 110.966 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 223' ' ' ARG . 29.1 mtm-85 -102.54 117.61 35.07 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.695 0.284 . . . . 74.02 111.455 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.556 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -97.7 119.76 6.52 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.419 -0.42 . . . . 62.15 112.84 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.0 m -99.25 118.41 35.87 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.355 0.502 . . . . 75.44 112.355 -176.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.559 HD23 ' HB ' ' A' ' 258' ' ' VAL . 91.4 mt -91.9 133.82 35.33 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.974 -0.557 . . . . 71.11 111.046 175.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -115.46 159.4 21.22 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 121.08 0.467 . . . . 74.42 111.886 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 62.0 t30 58.48 -133.54 1.06 Allowed 'General case' 0 CA--C 1.551 1.003 0 CA-C-N 115.921 -0.581 . . . . 73.42 111.676 171.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -52.76 -31.58 39.05 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.242 0.46 . . . . 72.32 112.242 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 90.3 mt -64.27 -14.91 58.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 111.983 0.364 . . . . 63.45 111.983 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 211' ' ' LYS . . . -73.98 -1.96 22.09 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.968 0.413 . . . . 63.21 112.063 176.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -124.03 14.22 9.15 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 122.895 0.478 . . . . 75.42 110.961 173.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -72.69 126.22 29.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.042 -0.526 . . . . 75.3 111.139 179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -62.86 97.36 0.1 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.169 0.509 . . . . 55.43 111.828 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.424 HG11 HD11 ' A' ' 213' ' ' LEU . 4.0 p -135.72 114.38 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.934 -0.576 . . . . 70.12 110.541 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -100.35 157.94 16.25 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.169 0.509 . . . . 73.45 111.507 -175.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -69.35 94.77 0.74 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.994 -0.548 . . . . 74.33 111.664 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 137.27 -19.35 3.42 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 121.171 -0.538 . . . . 71.14 113.793 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -70.0 146.13 51.28 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.139 0.495 . . . . 55.33 112.083 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.537 HG22 HD12 ' A' ' 264' ' ' ILE . 45.8 mm -86.93 129.31 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 116.191 -0.458 . . . . 73.43 110.22 173.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.622 ' HB2' HD13 ' A' ' 263' ' ' ILE . . . -140.91 152.35 44.96 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 113.028 0.751 . . . . 74.24 113.028 -175.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -94.28 125.52 38.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.787 -0.642 . . . . 74.52 110.221 172.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 215' ' ' LEU . 92.9 t -122.11 117.58 52.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.133 0.492 . . . . 52.05 111.786 -175.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.55 ' HB2' ' HB3' ' A' ' 260' ' ' ASN . 69.7 m -118.0 133.18 56.16 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.321 -0.4 . . . . 73.13 110.955 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.26 -156.12 13.23 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.438 -0.887 . . . . 44.25 113.84 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -122.75 115.32 21.85 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.966 0.412 . . . . 72.35 111.339 -177.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.543 HG22 ' HB ' ' A' ' 256' ' ' ILE . 38.3 t -86.89 125.69 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 116.249 -0.432 . . . . 64.45 111.614 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -154.08 154.45 33.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.804 0.335 . . . . 53.54 111.365 176.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -75.05 136.83 41.17 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.677 -0.238 . . . . 64.42 110.472 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -151.04 -70.81 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.504 -0.855 . . . . 65.24 112.973 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 65.4 t80 -138.91 135.51 34.51 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.598 -0.354 . . . . 73.05 110.535 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 29.7 t 65.5 18.18 11.19 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.048 0.452 . . . . 54.15 111.933 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 118.7 -143.78 17.64 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.388 -0.434 . . . . 61.03 113.399 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 88.8 mt -87.81 131.17 34.62 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.017 0.437 . . . . 73.23 111.278 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -122.27 133.81 54.68 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.437 -0.347 . . . . 72.32 111.293 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.556 HG23 ' HA2' ' A' ' 224' ' ' GLY . 8.5 tt -103.86 109.09 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.329 0.585 . . . . 65.5 111.104 175.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.7 t -78.28 115.47 18.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.212 -0.449 . . . . 74.01 110.024 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.559 ' HB ' HD23 ' A' ' 226' ' ' LEU . 38.8 t -88.45 116.9 31.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 112.607 0.595 . . . . 73.24 112.607 -170.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -93.76 -24.15 17.92 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.327 -0.397 . . . . 75.32 111.6 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.55 ' HB3' ' HB2' ' A' ' 244' ' ' SER . 27.3 t-20 -139.79 131.78 27.81 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.678 0.275 . . . . 64.11 111.163 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 13.1 tt -149.04 139.33 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.877 0.37 . . . . 65.2 111.163 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -149.47 129.11 2.92 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.15 -0.548 . . . . 65.05 112.826 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.622 HD13 ' HB2' ' A' ' 241' ' ' ALA . 46.4 mm -73.36 115.16 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 O-C-N 122.678 -0.307 . . . . 63.14 110.749 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.537 HD12 HG22 ' A' ' 240' ' ' ILE . 72.2 mt -66.01 -53.62 35.7 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.008 0.432 . . . . 71.54 111.469 -177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -111.26 120.93 43.91 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.297 -0.41 . . . . 64.34 111.027 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -89.81 130.24 36.08 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.645 0.609 . . . . 74.12 112.645 -173.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 34.6 t -109.2 126.57 53.41 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.282 -0.417 . . . . 63.22 110.0 172.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 1.2 pp -150.27 175.0 12.2 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.952 0.723 . . . . 73.31 112.952 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 . . . . . 0 C--O 1.25 1.122 0 CA-C-N 115.749 -0.66 . . . . 74.41 110.894 175.889 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 112.357 0.503 . . . . 73.25 112.357 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -113.53 119.12 36.42 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.622 -0.51 . . . . 51.32 109.622 171.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -96.8 155.24 16.86 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.154 0.798 . . . . 73.34 113.154 -169.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -100.04 155.59 17.63 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.345 -0.843 . . . . 74.11 109.945 169.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.446 HD12 ' O ' ' A' ' 220' ' ' GLY . 44.2 mt -66.06 -30.09 48.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 112.551 0.574 . . . . 73.34 112.551 -172.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 219' ' ' THR . 93.5 p -71.09 -28.52 64.39 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.237 0.542 . . . . 64.51 110.664 173.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -77.99 -31.47 50.73 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.959 -0.564 . . . . 73.42 111.262 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.516 HD22 HG21 ' A' ' 247' ' ' VAL . 78.0 mt -52.9 134.07 37.55 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.228 0.537 . . . . 64.12 111.475 177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.446 ' HB2' ' HD2' ' A' ' 181' ' ' PRO . 22.9 ptp -140.57 164.65 35.32 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 115.925 -0.58 . . . . 72.12 111.077 -174.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.514 ' HB3' ' HB3' ' A' ' 249' ' ' GLN . 9.4 Cg_endo -54.53 144.0 65.05 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.405 2.07 . . . . 75.21 112.879 174.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 6.1 t30 67.6 13.9 9.4 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.034 0.445 . . . . 61.43 111.909 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 40.2 tp -91.12 150.86 21.22 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.133 0.492 . . . . 72.15 111.993 -176.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 40.8 t -131.78 133.67 45.0 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.339 -0.392 . . . . 73.33 110.492 173.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 173.82 -176.61 46.32 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.418 -0.896 . . . . 74.11 113.864 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 90.5 m -117.23 136.43 53.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.868 0.366 . . . . 60.13 111.325 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.437 HD13 HD11 ' A' ' 179' ' ' LEU . 33.8 pt -129.25 163.48 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 122.885 0.474 . . . . 62.43 111.485 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -127.58 114.25 17.16 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.47 -0.332 . . . . 75.22 110.503 175.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -141.28 168.58 19.44 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.848 0.356 . . . . 62.53 111.945 -176.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 14.7 pt-20 -89.44 143.51 26.77 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.009 0.433 . . . . 64.45 111.353 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.444 ' HA ' HD23 ' A' ' 215' ' ' LEU . 39.8 t -79.49 105.01 8.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.226 0.536 . . . . 74.31 111.608 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 8.5 t -80.48 -37.63 17.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.207 0.527 . . . . 71.32 111.116 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -156.2 134.05 11.13 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.041 -0.527 . . . . 74.54 111.409 178.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -115.1 101.52 9.06 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.897 0.38 . . . . 71.14 111.246 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -72.11 143.96 86.82 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 116.483 -0.326 . . . . 75.25 111.27 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.63 168.75 2.87 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.955 2.437 . . . . 64.31 113.956 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -83.31 118.28 23.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.319 0.581 . . . . 73.01 111.785 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.637 ' HE2' ' HG ' ' A' ' 210' ' ' LEU . 2.6 mppt? -96.92 162.82 13.23 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.117 -0.492 . . . . 55.34 111.408 177.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -111.09 146.86 36.04 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.196 -0.457 . . . . 71.1 111.393 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -156.3 175.26 14.23 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.175 0.512 . . . . 75.12 111.125 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 94.8 p -125.17 141.68 51.96 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.242 -0.435 . . . . 74.22 111.245 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.48 ' HB2' ' OG1' ' A' ' 206' ' ' THR . 36.6 mmt180 -80.02 167.95 19.79 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.068 0.461 . . . . 72.13 111.601 178.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -60.63 -23.74 64.98 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.007 -0.542 . . . . 75.25 111.561 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -76.82 -5.11 46.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.19 -0.459 . . . . 75.24 112.149 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 81.74 21.71 61.16 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.711 -0.757 . . . . 74.21 112.051 -172.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.48 ' OG1' ' HB2' ' A' ' 202' ' ' ARG . 76.2 p -101.29 171.16 7.76 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.889 0.476 . . . . 65.11 111.336 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -96.54 149.35 21.85 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.156 0.503 . . . . 72.23 112.239 -176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -149.22 148.56 20.05 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 116.121 -0.491 . . . . 63.3 113.286 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -105.99 143.45 34.12 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 122.411 0.284 . . . . 75.23 110.882 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.637 ' HG ' ' HE2' ' A' ' 198' ' ' LYS . 14.9 tp -137.33 116.72 12.76 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.391 0.515 . . . . 62.53 112.391 -175.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.542 ' HD3' HD12 ' A' ' 226' ' ' LEU . 59.8 tttp -122.15 147.79 45.72 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.762 0.315 . . . . 55.05 110.736 177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.44 ' OG ' ' NZ ' ' A' ' 198' ' ' LYS . 49.0 m -123.74 147.15 47.75 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.022 0.439 . . . . 63.21 111.342 -178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.3 mt -135.14 157.45 46.88 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.217 -0.447 . . . . 72.22 110.92 -178.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -127.87 115.89 19.3 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 109.905 -0.406 . . . . 44.21 109.905 173.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 191' ' ' VAL . 64.9 mt -117.64 153.49 33.21 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.403 -0.362 . . . . 70.22 111.316 -175.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 22.0 pttp -147.24 145.2 29.35 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.782 0.801 . . . . 64.43 112.35 174.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -122.15 170.94 9.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.657 -1.156 . . . . 74.22 108.635 173.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -49.93 -29.91 9.27 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-O 121.138 0.494 . . . . 74.11 111.364 175.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 177' ' ' SER . 77.2 p -88.17 -2.15 58.43 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.755 1.02 . . . . 73.42 113.755 -175.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 143.09 -178.95 21.0 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 120.412 -0.899 . . . . 74.13 113.801 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.9 p -120.33 155.37 33.48 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 120.911 0.386 . . . . 70.31 111.78 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.409 HG12 ' N ' ' A' ' 223' ' ' ARG . 14.9 tt -148.84 157.43 7.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.937 0.399 . . . . 72.05 111.768 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.424 ' N ' ' HD2' ' A' ' 223' ' ' ARG . 7.6 mpt_? -92.37 128.64 38.3 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.295 -0.411 . . . . 64.42 110.903 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -107.97 140.56 15.5 Favored Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.343 -0.456 . . . . 44.14 112.781 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 32.9 m -125.44 116.33 21.68 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 122.209 -0.583 . . . . 75.3 112.176 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.56 HD23 ' HB ' ' A' ' 258' ' ' VAL . 74.8 mt -99.02 132.25 44.47 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.479 -0.328 . . . . 65.04 111.038 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 94.6 m95 -113.14 154.93 25.84 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.157 0.503 . . . . 74.04 112.122 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.1 t30 62.18 -152.25 0.36 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 115.751 -0.659 . . . . 52.11 111.201 175.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -58.62 -7.29 0.91 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 113.671 0.989 . . . . 73.05 113.671 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.68 -13.68 55.23 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.167 0.508 . . . . 70.44 110.85 173.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' A' ' 211' ' ' LYS . . . -64.99 -28.89 69.82 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.106 -0.497 . . . . 62.15 112.151 177.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -86.01 0.19 53.97 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.108 0.41 . . . . 61.33 112.108 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -66.45 101.77 0.8 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.045 0.45 . . . . 72.01 110.658 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -69.51 100.55 1.43 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.12 0.415 . . . . 55.23 112.12 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.6 150.42 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 116.098 -0.501 . . . . 70.44 110.216 174.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -113.44 163.15 15.25 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.453 0.645 . . . . 70.11 112.08 -174.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -81.11 94.76 6.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.136 -0.484 . . . . 65.25 110.688 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 141.57 -11.74 2.7 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 120.448 -0.882 . . . . 65.34 114.868 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -88.48 172.82 9.07 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.209 1.005 . . . . 70.44 111.456 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 48.1 mm -105.04 113.81 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 116.073 -0.512 . . . . 64.21 110.94 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -100.04 122.94 43.7 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.809 0.67 . . . . 44.13 112.809 -175.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -80.24 104.86 11.08 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.818 -0.628 . . . . 45.44 109.55 170.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 215' ' ' LEU . 93.1 t -115.83 128.77 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 N-CA-C 112.543 0.571 . . . . 71.31 112.543 -172.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 39.2 t -120.85 132.52 55.04 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.16 -0.473 . . . . 51.32 110.405 176.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.33 -163.27 29.03 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.274 -0.965 . . . . 63.1 114.436 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -117.95 115.73 25.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.769 0.428 . . . . 74.23 111.264 -176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.516 HG21 HD22 ' A' ' 179' ' ' LEU . 48.5 t -85.44 133.16 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.666 0.617 . . . . 74.34 112.666 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -128.39 138.51 52.38 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.208 -0.451 . . . . 72.43 111.207 178.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 181' ' ' PRO . 29.2 tt0 -100.65 143.07 31.25 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.715 0.293 . . . . 73.31 110.827 177.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 176.87 -127.29 1.2 Allowed Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.141 -1.028 . . . . 62.2 114.185 175.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -59.68 108.46 0.74 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.739 0.644 . . . . 73.1 112.739 -173.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 65.1 m 69.51 15.87 8.23 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.337 0.866 . . . . 62.34 113.337 172.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 140.96 -167.58 25.61 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 120.546 -0.835 . . . . 71.22 113.804 175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.413 ' O ' ' HD3' ' A' ' 223' ' ' ARG . 4.5 mp -107.48 142.05 37.94 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.053 0.454 . . . . 70.42 111.97 178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -115.75 167.18 11.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.14 -0.482 . . . . 64.13 110.386 175.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 10.5 tt -136.04 103.86 3.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.556 0.693 . . . . 71.23 111.129 173.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.9 t -66.28 106.72 1.76 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.986 -0.552 . . . . 52.32 109.873 174.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.56 ' HB ' HD23 ' A' ' 226' ' ' LEU . 38.9 t -75.5 124.48 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.571 0.582 . . . . 52.35 112.571 -171.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -81.63 -40.94 22.17 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.85 -0.613 . . . . 65.25 110.675 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -153.49 148.78 27.01 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.132 -0.486 . . . . 63.42 111.127 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.8 tt -140.85 142.64 29.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.062 0.458 . . . . 73.31 111.567 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -150.51 145.02 12.58 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.171 -0.538 . . . . 74.4 112.823 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.0 mt -81.79 127.94 39.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 122.443 -0.445 . . . . 71.1 110.903 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 34.8 mm -56.41 -43.76 78.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 N-CA-C 112.718 0.636 . . . . 65.22 112.718 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.74 124.57 26.88 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 121.353 0.597 . . . . 55.32 112.105 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.03 -15.9 25.62 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.007 -0.542 . . . . 55.51 111.649 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 38.1 t -111.61 130.32 55.79 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.873 0.368 . . . . 62.14 111.141 178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.97 79.99 1.53 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.724 0.773 . . . . 63.32 111.815 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.16 -0.924 . . . . 74.34 111.88 178.998 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.666 ' SD ' ' N ' ' A' ' 172' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.016 0.436 . . . . 61.22 111.088 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -77.88 136.61 38.08 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.274 -0.421 . . . . 61.03 111.896 -175.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.534 ' HB2' HG22 ' A' ' 187' ' ' ILE . 95.5 m-85 -120.78 143.28 48.91 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.339 0.59 . . . . 73.14 112.152 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -99.69 159.86 14.73 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 70.3 109.798 169.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.49 ' HA ' ' HG ' ' A' ' 179' ' ' LEU . 68.6 mt -64.06 -34.88 71.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 112.609 0.596 . . . . 72.05 112.609 -173.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.4 t -69.03 -20.56 64.13 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.069 0.461 . . . . 63.04 111.144 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -84.26 -11.08 57.06 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.026 -0.534 . . . . 73.33 111.379 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.541 HD22 HG21 ' A' ' 247' ' ' VAL . 77.5 mt -68.44 162.03 26.37 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.888 0.852 . . . . 52.31 113.248 -174.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.0 ptp -162.7 153.75 14.66 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 114.877 -1.056 . . . . 61.52 110.031 -178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.74 144.2 87.63 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.251 1.967 . . . . 74.52 112.756 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 67.88 24.44 8.09 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.848 0.459 . . . . 63.15 111.978 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 49.5 tp -95.83 121.27 37.37 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.118 0.414 . . . . 65.55 112.118 -177.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 60.6 m -104.65 115.96 31.23 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.455 -0.339 . . . . 40.11 110.41 175.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.08 -168.49 36.38 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.266 -0.969 . . . . 65.04 114.111 -178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 52.8 m -119.89 119.25 32.97 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.71 0.29 . . . . 73.53 111.44 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.534 HG22 ' HB2' ' A' ' 174' ' ' TYR . 31.9 pt -101.36 154.3 4.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.232 0.539 . . . . 51.24 111.945 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -122.23 109.08 14.04 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.158 0.504 . . . . 72.41 110.834 176.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.458 ' HB1' ' O ' ' A' ' 216' ' ' LYS . . . -148.4 -177.59 5.85 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.925 -0.58 . . . . 71.03 111.452 -176.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 10.7 pt-20 -107.89 148.43 29.62 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 121.229 0.538 . . . . 73.32 111.355 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 46.3 t -84.14 114.29 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.058 -0.519 . . . . 74.14 111.909 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.1 t -84.1 -49.42 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.205 0.526 . . . . 71.4 110.988 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -139.2 135.52 34.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 61.43 111.138 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -131.05 102.89 6.22 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.333 -0.394 . . . . 63.21 111.265 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 212' ' ' SER . 74.7 m-85 -95.04 126.3 47.23 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.381 -0.372 . . . . 74.42 110.607 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 195' ' ' TYR . 48.6 Cg_exo -57.67 -174.83 0.06 OUTLIER 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 123.335 2.69 . . . . 62.14 114.521 -176.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.666 ' HB3' ' HB1' ' A' ' 231' ' ' ALA . 20.7 pttm -67.79 141.22 56.6 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.505 0.928 . . . . 52.22 113.505 -174.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.734 ' HE2' ' HG ' ' A' ' 210' ' ' LEU . 32.0 mtmm -120.31 157.37 29.34 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.083 -0.962 . . . . 62.41 110.368 174.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -102.82 137.33 41.17 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.139 0.495 . . . . 75.13 111.952 -176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 24.6 p90 -156.88 -176.64 6.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.985 -0.552 . . . . 74.25 110.325 174.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 78.4 p -122.25 119.8 32.25 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.185 0.517 . . . . 45.0 111.947 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 48.8 mtp85 -76.96 129.29 35.95 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.109 -0.496 . . . . 72.44 110.804 174.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -64.9 -8.97 17.71 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.964 0.411 . . . . 73.43 111.812 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.19 -35.9 55.36 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.293 0.568 . . . . 74.34 110.706 173.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 106.57 -8.11 40.04 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 115.925 -0.58 . . . . 54.44 113.035 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 81.4 p -81.07 157.43 25.4 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.067 0.461 . . . . 63.25 112.089 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -76.26 115.41 15.96 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.394 -0.366 . . . . 65.51 111.57 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -135.62 125.15 3.52 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.33 -0.462 . . . . 75.32 112.803 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -96.82 150.8 20.31 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.783 0.325 . . . . 64.5 111.276 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.734 ' HG ' ' HE2' ' A' ' 198' ' ' LYS . 18.4 tp -112.52 108.78 18.01 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.292 0.478 . . . . 70.54 112.292 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 82.6 tttt -117.62 139.53 50.87 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.807 0.336 . . . . 44.44 110.957 178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 195' ' ' TYR . 15.0 m -109.93 134.25 52.3 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 112.066 0.395 . . . . 71.03 112.066 -172.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 72.1 mt -129.88 145.53 51.6 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.254 0.549 . . . . 71.23 112.005 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -126.7 118.83 25.53 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.982 -0.554 . . . . 71.1 109.68 170.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 66.2 mt -115.71 154.86 28.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.345 -0.389 . . . . 72.31 111.476 -174.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 190' ' ' GLU . 19.6 ptmt -153.74 170.01 21.96 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.899 0.381 . . . . 75.42 111.091 174.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -160.89 -174.73 4.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.852 -0.425 . . . . 63.41 109.852 171.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.64 -16.03 59.85 Favored 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 112.248 0.462 . . . . 64.24 112.248 -175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 27.4 p -98.76 -21.86 16.16 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.169 0.803 . . . . 73.24 113.169 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.98 -178.35 42.89 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 120.514 -0.851 . . . . 71.31 113.825 -176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 60.9 m -129.59 136.12 49.4 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 120.983 0.42 . . . . 74.43 111.892 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 11.0 tp -133.06 153.78 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.098 0.475 . . . . 65.11 111.76 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.427 ' NH1' ' O ' ' A' ' 252' ' ' SER . 10.8 ptp180 -111.42 135.4 52.03 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 120.768 0.318 . . . . 74.42 110.885 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -138.43 178.5 19.26 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.831 -0.699 . . . . 74.43 114.05 -174.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 88.0 m -148.37 137.4 21.79 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 122.568 -0.372 . . . . 44.11 111.933 -177.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.596 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 83.5 mt -101.92 134.57 44.92 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.143 -0.481 . . . . 73.31 110.864 175.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 76.4 m95 -113.48 152.83 29.64 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.901 0.381 . . . . 75.02 111.666 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 14.4 m120 64.08 -143.36 0.29 Allowed 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.191 -0.459 . . . . 71.42 112.001 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -48.33 -29.82 4.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 112.99 0.737 . . . . 72.11 112.99 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 92.4 mt -55.9 -18.89 10.07 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.003 0.43 . . . . 74.43 111.596 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.666 ' HB1' ' HB3' ' A' ' 197' ' ' LYS . . . -63.19 -44.05 96.45 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.994 0.426 . . . . 52.42 111.56 175.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -87.31 -5.33 58.95 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 111.961 0.356 . . . . 74.13 111.961 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -63.1 116.98 5.87 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 109.903 -0.406 . . . . 75.15 109.903 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.43 126.08 26.68 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.511 0.672 . . . . 72.32 112.383 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.08 127.23 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 115.606 -0.725 . . . . 74.01 110.039 173.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 49.1 mttp -100.34 141.99 32.43 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.142 0.496 . . . . 74.11 111.896 -177.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 237' ' ' LYS . 1.1 tmmt? -73.0 125.89 28.67 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.873 -0.603 . . . . 75.14 110.74 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.37 14.25 51.47 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.234 -0.508 . . . . 55.23 113.175 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -110.59 158.65 18.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.96 0.41 . . . . 64.44 112.071 179.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 32.7 mm -92.33 127.71 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 116.275 -0.42 . . . . 71.32 110.898 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -130.25 143.22 50.65 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.088 0.773 . . . . 75.4 113.088 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -92.55 117.36 29.87 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.656 -0.702 . . . . 74.4 109.513 171.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 84.4 t -117.82 111.47 34.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 112.57 0.581 . . . . 71.4 112.57 -173.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 52.0 m -96.58 112.55 24.25 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.422 -0.353 . . . . 74.54 110.382 174.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -154.59 -167.79 17.0 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.418 -0.896 . . . . 63.22 114.132 -176.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.497 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 93.4 t80 -122.8 113.95 19.86 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.683 0.393 . . . . 75.32 111.124 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.541 HG21 HD22 ' A' ' 179' ' ' LEU . 45.5 t -86.11 120.07 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.408 -0.36 . . . . 62.11 111.13 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 61.0 pttt -134.59 164.3 27.79 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.265 0.555 . . . . 75.1 112.06 -176.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -112.12 115.35 28.73 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.596 -0.729 . . . . 75.13 109.776 173.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -162.69 -50.08 0.02 OUTLIER Glycine 0 CA--C 1.521 0.436 0 C-N-CA 119.76 -1.209 . . . . 63.12 113.53 -178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -89.24 -160.4 0.67 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.64 -0.329 . . . . 70.44 110.743 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.427 ' O ' ' NH1' ' A' ' 223' ' ' ARG . 33.5 m -59.81 85.66 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.109 0.48 . . . . 72.53 111.45 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 105.58 -111.73 3.76 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 115.914 -0.585 . . . . 64.11 113.699 175.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 95.9 mt -143.83 112.33 6.47 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.991 0.916 . . . . 53.51 109.322 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -111.54 132.91 54.19 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.291 0.567 . . . . 71.04 111.897 -176.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 8.1 tt -101.78 106.13 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 121.607 0.718 . . . . 62.51 111.108 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 35.9 t -77.35 110.25 11.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.134 -0.485 . . . . 53.21 109.959 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.59 ' HB ' HD23 ' A' ' 226' ' ' LEU . 37.9 t -81.27 124.18 38.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.043 0.449 . . . . 71.53 112.107 -172.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.85 -43.95 14.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.977 -0.556 . . . . 65.22 110.797 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -147.16 139.12 24.37 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.142 -0.481 . . . . 70.2 110.443 178.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.2 tt -133.36 146.63 31.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.799 0.333 . . . . 72.24 111.216 -177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -147.74 131.97 4.07 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.17 -0.538 . . . . 73.42 113.047 178.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.563 HG21 ' HB3' ' A' ' 266' ' ' LYS . 43.9 mm -80.85 130.93 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 O-C-N 122.269 -0.548 . . . . 70.51 110.678 178.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 54.8 mt -63.26 -64.69 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 120.825 0.345 . . . . 73.1 111.233 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.11 107.93 3.53 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.339 0.59 . . . . 72.21 111.225 175.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.563 ' HB3' HG21 ' A' ' 263' ' ' ILE . 22.6 pttm -98.68 170.56 8.7 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.181 -0.463 . . . . 74.51 110.842 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 83.5 p -129.53 130.84 46.28 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.324 0.583 . . . . 73.02 111.426 177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 269' ' ' GLU . 2.3 pp -137.59 -32.59 0.75 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.862 -0.608 . . . . 60.15 111.341 178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.607 ' N ' HD12 ' A' ' 268' ' ' LEU . 45.4 mt-10 . . . . . 0 C--O 1.253 1.288 0 CA-C-O 118.228 -0.892 . . . . 74.22 110.61 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 19.0 mmt . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 120.829 0.347 . . . . 74.13 111.574 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 186' ' ' THR . 2.8 p-10 -90.36 111.87 23.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.101 0.476 . . . . 70.42 110.819 176.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.403 ' HB3' ' HB2' ' A' ' 178' ' ' GLU . 78.5 m-85 -104.23 155.84 18.4 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.346 0.593 . . . . 74.24 111.96 -176.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -74.6 147.07 41.97 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.617 -0.883 . . . . 73.4 108.617 167.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.1 mt -53.73 -32.79 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 112.785 0.661 . . . . 72.25 112.785 -176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 47.5 m -68.94 -7.94 39.79 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.261 0.467 . . . . 64.31 112.261 178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 174' ' ' TYR . 10.9 mm-40 -95.21 -6.19 42.14 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.664 0.385 . . . . 70.12 111.789 178.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.582 HD11 HG21 ' A' ' 187' ' ' ILE . 79.9 mt -73.39 106.75 5.33 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.559 0.695 . . . . 71.52 112.449 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.9 ptp -114.86 156.2 45.35 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 115.447 -0.797 . . . . 73.45 110.351 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.01 144.27 69.23 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.17 1.913 . . . . 74.22 112.757 174.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 70.45 15.34 7.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.158 0.583 . . . . 73.22 112.151 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 30.7 tp -93.12 135.96 33.83 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.808 0.337 . . . . 71.44 111.361 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 37.6 t -113.01 118.33 34.51 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.766 0.317 . . . . 53.23 111.081 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -177.02 -166.15 33.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.657 -0.782 . . . . 74.15 113.822 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 48.4 m -128.12 146.31 50.74 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.7 0.4 . . . . 73.22 110.815 -178.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.582 HG21 HD11 ' A' ' 179' ' ' LEU . 30.4 pt -130.46 149.6 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.57 0.582 . . . . 62.42 112.57 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . 0.408 HD22 HD11 ' A' ' 264' ' ' ILE . 17.0 m120 -108.61 127.34 53.87 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.73 -0.668 . . . . 54.13 110.089 174.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -159.66 175.56 13.04 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.319 0.581 . . . . 75.03 112.497 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 216' ' ' LYS . 12.9 pt-20 -103.61 151.67 22.66 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.756 -0.656 . . . . 64.22 110.747 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.427 HG21 ' CG2' ' A' ' 235' ' ' VAL . 38.2 t -88.72 117.55 32.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.879 0.371 . . . . 50.31 111.798 -178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.9 t -95.44 -48.2 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-O 121.077 0.465 . . . . 61.44 111.99 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -139.45 138.87 36.81 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.972 0.415 . . . . 72.44 112.082 -176.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -125.77 105.35 8.9 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.017 -0.538 . . . . 71.52 110.759 176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 95.0 m-85 -87.03 142.19 33.71 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 111.873 0.324 . . . . 70.23 111.873 -177.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -44.79 147.09 1.99 Allowed 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 123.056 2.504 . . . . 72.24 113.485 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.582 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 23.0 pttp -74.47 134.93 42.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.611 0.719 . . . . 60.31 112.865 -172.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.465 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 2.4 mptp? -90.69 144.21 25.96 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.4 -0.818 . . . . 70.4 110.038 174.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -130.03 115.86 17.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.963 0.411 . . . . 73.35 110.728 -178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -140.37 166.13 25.52 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.301 0.572 . . . . 75.33 111.872 -173.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 78.9 p -90.09 123.9 34.34 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.267 -0.424 . . . . 62.3 110.219 174.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.401 ' HD3' ' HA3' ' A' ' 208' ' ' GLY . 24.6 mmm180 -56.94 164.38 1.6 Allowed 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.601 0.239 . . . . 74.54 111.378 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -51.58 -33.17 31.48 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.253 0.835 . . . . 73.34 113.253 -172.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -102.56 18.29 21.6 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.863 -0.523 . . . . 74.14 111.966 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 77.36 38.27 29.43 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.36 -0.447 . . . . 75.51 114.096 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 71.2 p -114.59 166.83 11.3 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 122.408 -0.466 . . . . 72.35 111.364 177.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 133.33 45.87 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.038 0.384 . . . . 72.42 112.038 -176.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.401 ' HA3' ' HD3' ' A' ' 202' ' ' ARG . . . -163.56 136.17 4.15 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.953 -0.641 . . . . 51.05 113.377 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -117.46 173.94 6.43 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 122.531 -0.394 . . . . 74.01 111.017 177.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 226' ' ' LEU . 58.6 tp -153.72 144.18 22.38 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.176 -0.466 . . . . 74.43 111.782 -176.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 230' ' ' LEU . 8.3 ttpm? -144.3 124.38 13.63 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.053 0.454 . . . . 72.32 111.127 169.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.5 m -88.32 130.74 35.05 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.087 -0.506 . . . . 70.25 111.355 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.429 HD11 HD11 ' A' ' 226' ' ' LEU . 81.3 mt -122.25 150.84 41.74 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.054 0.454 . . . . 73.24 111.408 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -114.62 115.41 27.11 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.326 -0.397 . . . . 75.52 110.111 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 72.9 mt -117.03 153.62 32.37 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 122.183 0.193 . . . . 71.32 111.076 -176.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 221' ' ' SER . 0.0 OUTLIER -146.38 142.92 28.69 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 122.011 0.91 . . . . 72.11 112.863 176.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -101.87 -178.48 3.73 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.791 -1.188 . . . . 64.23 107.791 165.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -75.29 -20.13 59.29 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.705 -0.622 . . . . 73.2 111.08 172.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 30.5 p -82.13 -28.05 32.42 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.231 0.456 . . . . 70.22 112.231 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 169.68 179.53 41.49 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.009 -0.615 . . . . 54.31 113.619 -178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 216' ' ' LYS . 79.1 p -114.22 163.93 14.57 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 112.346 0.498 . . . . 71.21 112.346 -176.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.5 tp -151.33 152.4 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 116.285 -0.416 . . . . 63.23 111.263 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 22.6 mtp180 -95.5 122.3 38.09 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.869 0.366 . . . . 74.01 111.834 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -93.72 135.5 12.59 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.403 -0.427 . . . . 53.34 112.957 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 63.2 m -118.26 103.79 10.17 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 122.524 -0.398 . . . . 64.22 111.388 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 210' ' ' LEU . 75.4 mt -94.46 117.1 29.61 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 111.828 0.307 . . . . 63.24 111.828 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . 0.454 ' O ' ' HB2' ' A' ' 230' ' ' LEU . 84.4 m95 -98.86 166.06 11.48 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 120.977 0.418 . . . . 55.41 111.466 177.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 61.94 -150.97 0.37 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 116.527 -0.306 . . . . 64.31 111.666 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -57.59 -15.06 6.3 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.612 0.597 . . . . 62.33 112.612 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.459 ' O ' ' NZ ' ' A' ' 211' ' ' LYS . 96.5 mt -59.13 -16.15 18.23 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.015 0.436 . . . . 72.52 110.812 175.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.582 ' HB1' ' HB2' ' A' ' 197' ' ' LYS . . . -65.15 -47.13 78.12 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.315 -0.402 . . . . 60.01 110.733 170.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -68.96 -29.31 67.51 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.387 -0.37 . . . . 73.41 111.425 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -50.87 103.03 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.885 0.374 . . . . 73.02 110.502 176.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -81.63 120.89 25.66 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.192 0.52 . . . . 75.53 111.792 -174.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.427 ' CG2' HG21 ' A' ' 191' ' ' VAL . 13.3 p -116.07 143.93 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.828 -0.624 . . . . 74.3 110.623 177.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.4 ' NZ ' ' O ' ' A' ' 268' ' ' LEU . 5.7 mtpm? -104.97 154.36 20.21 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 111.979 0.363 . . . . 74.01 111.979 -173.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -81.19 133.66 35.49 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.808 0.337 . . . . 63.05 111.277 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.73 -34.45 5.46 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.524 -0.37 . . . . 72.32 113.06 -178.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -63.2 144.86 56.56 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.057 0.456 . . . . 74.51 111.615 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.566 ' HB ' ' HG2' ' A' ' 265' ' ' GLU . 41.4 mm -92.39 136.38 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.75 0.309 . . . . 62.1 111.027 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -141.05 157.87 44.72 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.139 0.495 . . . . 64.35 112.122 -177.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -112.47 120.19 40.78 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.002 -0.545 . . . . 71.33 110.098 174.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 85.9 t -110.56 123.89 66.85 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 111.897 0.332 . . . . 70.04 111.897 -174.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 26.9 t -113.67 128.68 56.52 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.848 0.356 . . . . 75.02 111.435 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -173.91 -150.37 7.56 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.477 -0.868 . . . . 63.1 113.856 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -129.13 117.25 20.5 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.642 0.377 . . . . 72.53 111.056 -177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.53 HG21 HD22 ' A' ' 179' ' ' LEU . 46.3 t -86.79 125.88 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.624 0.249 . . . . 63.32 111.325 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.94 164.82 33.43 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.212 0.53 . . . . 71.02 112.01 179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -91.85 115.48 28.1 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.046 -0.525 . . . . 74.23 110.626 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -138.47 -142.86 4.38 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.401 -0.904 . . . . 70.03 113.865 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -82.75 -27.94 30.75 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.04 0.448 . . . . 73.54 111.48 -178.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 32.4 t -79.13 -1.44 36.04 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.088 0.471 . . . . 74.23 110.923 177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 104.02 -126.96 8.95 Favored Glycine 0 C--N 1.335 0.499 0 N-CA-C 111.785 -0.526 . . . . 74.41 111.785 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 82.3 mt -96.65 93.37 6.7 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 109.331 -0.618 . . . . 61.5 109.331 169.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -115.86 148.46 39.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.582 -0.736 . . . . 65.32 112.28 -168.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.458 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.8 tt -105.67 107.93 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 121.277 0.561 . . . . 63.33 110.881 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 27.4 t -70.46 104.84 2.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 120.976 0.417 . . . . 54.54 110.241 177.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.461 ' HB ' HD23 ' A' ' 226' ' ' LEU . 33.4 t -80.25 127.56 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 N-CA-C 112.711 0.634 . . . . 61.44 112.711 -171.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -92.49 -49.16 6.27 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.89 -0.596 . . . . 73.51 110.405 174.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -139.23 132.74 30.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.002 -0.545 . . . . 72.52 110.586 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.1 tt -125.69 133.81 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.951 0.405 . . . . 73.11 111.222 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -130.6 131.34 6.47 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 121.21 -0.519 . . . . 34.32 112.992 179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.6 mm -79.43 131.78 33.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 122.618 -0.342 . . . . 73.21 111.275 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.507 HD12 HG22 ' A' ' 240' ' ' ILE . 66.2 mt -83.59 -48.88 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 121.25 0.548 . . . . 74.42 110.335 176.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.566 ' HG2' ' HB ' ' A' ' 240' ' ' ILE . 24.2 mm-40 -87.25 70.71 10.09 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.168 0.509 . . . . 74.5 110.236 175.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -66.74 113.29 4.74 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 112.938 0.718 . . . . 73.34 112.938 -173.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 64.3 m 66.87 63.18 0.48 Allowed 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.481 0.919 . . . . 71.44 113.481 172.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' A' ' 265' ' ' GLU . 81.3 mt -108.49 110.17 21.6 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.253 -0.43 . . . . 71.13 110.03 170.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 C--O 1.25 1.108 0 N-CA-C 113.715 1.006 . . . . 75.43 113.715 -172.659 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.587 ' N ' ' SD ' ' A' ' 172' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 120.819 0.342 . . . . 60.23 111.095 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -83.84 119.32 24.7 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.193 0.521 . . . . 72.32 111.917 -176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -85.25 169.27 13.95 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.547 0.689 . . . . 75.12 112.105 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.483 ' N ' ' HD2' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -101.25 167.75 10.0 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.575 -0.739 . . . . 71.33 109.389 174.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.409 HD12 ' O ' ' A' ' 220' ' ' GLY . 25.9 mt -76.73 -41.27 33.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 O-C-N 121.866 -0.521 . . . . 75.25 111.055 175.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 35.8 t -68.55 -8.1 38.49 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 121.191 0.52 . . . . 72.54 111.113 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 175' ' ' LYS . 6.8 tp10 -82.6 -21.37 35.19 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 61.04 110.672 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.739 HD11 HD13 ' A' ' 187' ' ' ILE . 78.3 mt -73.44 117.67 15.48 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.451 0.643 . . . . 70.35 112.16 -174.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 22.5 ptp -130.15 157.07 78.23 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-N 115.708 -0.678 . . . . 72.42 110.262 178.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 182' ' ' ASN . 11.3 Cg_endo -54.4 138.37 73.4 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.06 1.84 . . . . 65.23 112.39 178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 181' ' ' PRO . 2.5 m-20 74.63 11.05 3.97 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.29 0.636 . . . . 70.34 112.443 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 17.9 tp -90.94 149.11 22.01 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 122.305 -0.247 . . . . 70.13 110.855 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 73.3 p -135.8 118.31 15.85 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.184 -0.323 . . . . 61.34 110.76 176.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -169.75 -177.45 40.2 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.354 -0.927 . . . . 74.51 113.986 -177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 244' ' ' SER . 38.2 m -114.21 122.64 47.4 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.659 0.266 . . . . 61.51 111.535 -177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.739 HD13 HD11 ' A' ' 179' ' ' LEU . 47.7 pt -115.67 138.18 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 121.058 0.456 . . . . 55.55 111.41 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -108.73 103.16 12.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.98 -0.378 . . . . 74.02 109.98 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.78 176.11 8.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.132 0.492 . . . . 63.34 111.985 -173.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -96.75 130.76 43.94 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.895 -0.593 . . . . 74.33 111.669 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 38.3 t -80.96 102.25 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 120.918 0.39 . . . . 73.34 111.265 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 39.3 t -74.86 -48.32 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 121.096 0.474 . . . . 61.52 111.583 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -134.3 122.41 22.64 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.948 0.404 . . . . 72.25 112.081 -176.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -97.14 103.16 15.07 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.138 -0.483 . . . . 75.43 110.863 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.43 ' HB3' ' HD2' ' A' ' 196' ' ' PRO . 88.9 m-85 -79.3 160.0 71.42 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 116.6 -0.273 . . . . 65.04 111.536 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 195' ' ' TYR . 48.4 Cg_endo -67.69 153.66 75.42 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.296 1.997 . . . . 44.34 113.017 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -85.72 134.79 33.94 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.436 0.636 . . . . 73.15 112.058 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -104.92 169.71 8.29 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.692 -0.685 . . . . 62.31 111.105 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.23 152.9 52.06 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.573 -0.285 . . . . 72.23 110.602 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -162.69 165.55 25.52 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.489 0.662 . . . . 72.35 112.205 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 88.0 p -104.85 137.38 42.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.658 -0.701 . . . . 62.12 109.928 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.568 ' HD2' ' OG1' ' A' ' 206' ' ' THR . 49.2 mtt180 -89.87 124.98 35.16 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 122.257 -0.277 . . . . 74.22 111.231 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.04 -20.23 16.05 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.893 0.378 . . . . 74.44 111.258 175.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -57.44 -34.26 68.78 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.113 -0.494 . . . . 75.44 111.265 173.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 129.65 -19.18 5.33 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 116.12 -0.491 . . . . 52.4 112.871 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.568 ' OG1' ' HD2' ' A' ' 202' ' ' ARG . 74.5 p -98.91 -166.11 1.32 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.092 0.405 . . . . 73.32 112.092 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -132.42 -174.46 3.45 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.815 0.34 . . . . 70.23 111.391 -177.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 155.76 161.01 10.33 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.689 -0.767 . . . . 52.32 113.908 176.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.425 ' H ' ' HA ' ' A' ' 228' ' ' ASN . 48.5 mt-30 -98.36 175.67 5.97 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.675 0.39 . . . . 63.43 111.668 177.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 25.0 tp -155.23 110.89 3.09 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.168 0.432 . . . . 72.04 112.168 -175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -126.96 140.51 52.26 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.056 -0.403 . . . . 63.14 111.447 176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 37.7 t -106.8 152.61 23.62 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.946 0.403 . . . . 71.45 111.449 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.3 mt -136.27 143.76 44.42 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.651 0.38 . . . . 74.32 110.677 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -97.95 112.67 24.51 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.068 -0.395 . . . . 72.42 110.835 177.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 79.6 mt -107.74 135.93 48.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.415 0.286 . . . . 54.41 111.166 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -132.44 154.81 49.49 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.604 0.716 . . . . 73.34 111.923 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -155.45 167.21 31.13 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.971 -1.013 . . . . 72.12 109.068 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -60.03 -18.41 46.15 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 122.069 -0.394 . . . . 64.12 111.821 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 80.5 p -98.23 18.57 15.98 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.332 0.494 . . . . 72.54 112.332 179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.409 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 125.83 -179.0 16.43 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 120.746 -0.74 . . . . 64.41 113.764 177.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 47.8 p -136.85 131.63 33.49 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.535 -0.391 . . . . 72.43 111.196 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 15.3 tt -138.04 156.73 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 121.005 0.431 . . . . 74.43 111.22 -177.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 47.8 mtp85 -101.03 116.32 32.57 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.968 0.413 . . . . 75.31 111.29 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.453 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -83.01 157.62 35.57 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-N 116.235 -0.439 . . . . 72.33 113.521 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 91.1 m -128.97 114.23 16.18 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.882 0.372 . . . . 73.14 111.985 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.53 HD23 ' HB ' ' A' ' 258' ' ' VAL . 87.2 mt -99.21 112.13 24.35 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.235 -0.439 . . . . 75.12 111.217 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -91.6 157.07 17.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.893 0.378 . . . . 74.11 111.57 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.425 ' HA ' ' H ' ' A' ' 209' ' ' GLN . 73.6 m-20 63.76 -155.39 0.32 Allowed 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 116.325 -0.398 . . . . 75.12 111.791 175.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -53.44 -20.12 4.34 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.964 0.727 . . . . 71.01 112.964 -178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 95.6 mt -57.44 -23.5 49.98 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 121.29 0.567 . . . . 70.22 111.276 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -62.12 -27.97 69.3 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.888 0.375 . . . . 41.03 111.679 175.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -94.48 -0.22 54.85 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 120.976 0.417 . . . . 72.21 111.012 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -57.79 135.1 56.76 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.18 -0.464 . . . . 53.3 111.87 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -63.67 118.01 7.65 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.637 -0.711 . . . . 72.55 111.979 179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.614 ' HA ' HD11 ' A' ' 263' ' ' ILE . 9.7 p -134.53 142.94 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.906 0.384 . . . . 75.45 111.18 176.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -118.42 151.45 37.76 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.394 -0.366 . . . . 61.14 111.384 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -75.97 142.21 42.01 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.931 0.396 . . . . 73.2 111.388 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 64.77 28.55 73.5 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.124 -0.489 . . . . 41.15 113.351 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.17 158.1 21.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.784 0.326 . . . . 75.34 110.958 -178.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.548 HG22 HD12 ' A' ' 264' ' ' ILE . 48.0 mm -96.67 117.04 40.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.214 0.53 . . . . 75.22 111.209 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -118.38 135.63 54.22 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.432 0.53 . . . . 74.11 112.432 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -82.66 103.91 12.52 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.862 -0.608 . . . . 71.44 109.855 173.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 72.9 t -113.5 111.84 37.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 112.219 0.452 . . . . 55.32 112.219 -173.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 260' ' ' ASN . 21.3 t -113.33 129.48 56.52 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.349 -0.22 . . . . 52.4 110.958 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.0 -173.02 37.08 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 120.388 -0.91 . . . . 41.34 114.274 -178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -104.87 119.41 38.94 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.969 0.508 . . . . 74.21 110.591 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.468 HG21 HD22 ' A' ' 179' ' ' LEU . 30.6 t -85.83 135.46 24.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 121.258 0.551 . . . . 70.34 112.211 -176.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -137.47 163.93 29.91 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.98 -0.554 . . . . 75.55 110.794 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -112.31 133.51 54.38 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.833 0.349 . . . . 53.41 111.057 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 172.74 -92.06 0.09 OUTLIER Glycine 0 CA--C 1.525 0.66 0 C-N-CA 120.937 -0.649 . . . . 70.23 113.03 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -75.17 132.94 41.52 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.779 0.323 . . . . 72.02 111.046 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 33.4 t 59.11 25.16 13.59 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.138 0.494 . . . . 74.13 111.274 -176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 84.44 -84.13 1.6 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.246 -0.502 . . . . 73.4 112.873 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 93.3 mt -112.16 118.37 35.17 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.945 0.402 . . . . 61.41 111.423 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.5 125.5 49.04 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.217 -0.447 . . . . 73.23 111.321 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.453 HG23 ' HA2' ' A' ' 224' ' ' GLY . 7.9 tt -105.51 112.79 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-O 121.343 0.592 . . . . 75.44 111.545 178.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 33.5 t -77.49 105.29 8.54 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.198 -0.455 . . . . 71.5 110.591 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.53 ' HB ' HD23 ' A' ' 226' ' ' LEU . 40.3 t -78.51 135.49 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.245 0.545 . . . . 75.34 112.459 -172.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -106.79 -43.21 4.74 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.918 -0.583 . . . . 73.13 110.818 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 244' ' ' SER . 25.6 t-20 -124.13 132.56 53.65 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.967 -0.561 . . . . 73.2 110.541 178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 12.6 tt -144.02 123.93 8.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.219 0.533 . . . . 74.13 111.436 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -139.15 124.84 2.9 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 121.095 -0.574 . . . . 61.04 113.165 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.614 HD11 ' HA ' ' A' ' 235' ' ' VAL . 46.4 mt -69.24 123.13 22.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.845 0.355 . . . . 65.35 111.213 176.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.548 HD12 HG22 ' A' ' 240' ' ' ILE . 68.0 mt -76.43 -43.79 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 116.248 -0.433 . . . . 73.51 111.631 -177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -91.67 80.93 5.3 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.55 0.691 . . . . 63.53 111.424 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -92.59 101.08 13.5 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.169 -0.469 . . . . 75.41 111.579 178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 40.0 t -113.7 136.48 52.79 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.829 0.347 . . . . 51.55 110.863 175.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 2.5 pp -101.6 11.53 38.79 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 120.758 0.314 . . . . 73.02 111.562 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 . . . . . 0 C--O 1.254 1.294 0 CA-C-O 118.654 -0.689 . . . . 53.2 112.058 -177.478 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.534 ' SD ' ' N ' ' A' ' 172' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 120.538 0.209 . . . . 75.3 111.457 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -115.68 103.31 10.56 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.851 -0.426 . . . . 73.43 109.851 176.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -94.26 146.14 24.23 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.311 0.577 . . . . 74.13 112.17 -175.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -107.89 160.08 16.03 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.904 -0.589 . . . . 74.12 110.573 169.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 220' ' ' GLY . 63.6 mt -59.09 -31.86 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 112.914 0.709 . . . . 72.24 112.914 -171.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.464 ' CB ' ' HB ' ' A' ' 219' ' ' THR . 70.6 p -62.67 -31.02 71.83 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 111.946 0.35 . . . . 72.32 111.946 177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -88.33 -19.93 26.04 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 111.816 0.302 . . . . 75.14 111.816 -175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.535 HD22 HG21 ' A' ' 247' ' ' VAL . 78.4 mt -56.25 117.37 3.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.5 0.556 . . . . 55.1 112.5 -177.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.416 ' HG2' HD22 ' A' ' 183' ' ' LEU . 24.1 ptp -114.44 157.42 42.67 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.741 -0.663 . . . . 71.22 110.465 178.221 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.83 142.64 99.14 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.054 1.836 . . . . 50.21 112.52 176.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 41.8 m-20 72.7 14.89 4.97 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.129 0.572 . . . . 64.21 112.029 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.416 HD22 ' HG2' ' A' ' 180' ' ' MET . 40.9 tp -93.28 132.89 37.05 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 111.959 0.355 . . . . 54.41 111.959 -177.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 49.0 p -110.83 125.56 53.72 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 122.374 -0.204 . . . . 53.03 111.104 175.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -178.69 -165.56 33.39 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 120.628 -0.796 . . . . 54.03 113.848 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.9 m -126.09 140.48 52.55 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.45 0.3 . . . . 53.25 111.581 -178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 33.7 pt -127.12 156.78 38.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.18 0.515 . . . . 65.12 111.992 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -118.69 112.04 19.28 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.046 -0.524 . . . . 63.11 110.648 175.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -150.87 163.43 38.68 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.445 0.535 . . . . 75.04 112.445 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -82.44 135.52 35.12 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.201 -0.454 . . . . 60.45 111.494 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 47.5 t -78.04 100.59 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.929 0.395 . . . . 72.44 110.743 174.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 40.1 t -64.8 -59.04 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.117 0.484 . . . . 70.34 111.473 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -130.28 143.99 51.11 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.986 -0.552 . . . . 74.23 111.411 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -126.63 107.01 9.81 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.933 -0.576 . . . . 43.51 110.849 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.568 ' O ' ' HG3' ' A' ' 211' ' ' LYS . 92.2 m-85 -96.13 135.16 22.84 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.681 -0.236 . . . . 73.43 111.338 -178.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -49.46 162.07 0.63 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.222 2.615 . . . . 74.12 113.899 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -73.4 119.56 17.8 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.059 0.763 . . . . 74.12 113.059 -173.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -67.81 151.19 47.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.33 -0.85 . . . . 75.32 111.276 171.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -115.61 129.61 56.57 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.323 -0.399 . . . . 73.23 110.693 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -147.27 154.4 40.93 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.173 0.511 . . . . 55.41 111.654 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 89.5 p -104.84 135.24 46.58 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.193 -0.458 . . . . 71.42 110.94 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -71.33 134.75 46.97 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 109.992 -0.373 . . . . 73.54 109.992 176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -25.16 40.44 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.003 0.43 . . . . 61.12 111.401 -178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -55.19 -46.18 75.83 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.903 -0.59 . . . . 73.01 111.519 174.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 142.23 -22.81 2.41 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 116.218 -0.446 . . . . 73.43 112.147 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 80.5 p -81.61 -174.41 4.97 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 120.89 0.376 . . . . 73.14 111.471 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 207' ' ' LYS . 16.3 ptpt -140.72 166.31 25.1 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 111.955 0.354 . . . . 74.21 111.955 -178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -159.95 179.63 35.37 Favored Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.176 -0.535 . . . . 32.32 113.012 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -128.07 156.14 43.26 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 122.632 -0.334 . . . . 63.43 110.72 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.504 HD11 HG23 ' A' ' 225' ' ' THR . 17.6 tp -144.54 125.14 14.05 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.181 0.438 . . . . 64.41 112.181 -175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' A' ' 195' ' ' TYR . 7.2 ttpm? -112.63 131.92 55.4 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.729 -0.607 . . . . 74.14 111.111 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 51.2 m -98.86 121.39 40.74 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.115 -0.493 . . . . 75.03 111.686 -176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.427 HD11 HD11 ' A' ' 226' ' ' LEU . 80.9 mt -119.8 157.43 28.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.352 -0.385 . . . . 74.55 111.16 177.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -128.3 120.81 27.82 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.645 0.26 . . . . 73.34 110.395 173.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.573 HD11 HG21 ' A' ' 243' ' ' VAL . 66.6 mt -105.2 153.09 22.03 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.808 0.337 . . . . 74.34 111.616 -176.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -141.67 152.32 43.81 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.278 0.561 . . . . 63.14 111.753 176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -155.1 168.38 27.22 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.601 -0.727 . . . . 71.12 109.781 175.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -61.28 -20.14 62.53 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.928 -0.483 . . . . 73.4 111.947 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.464 ' HB ' ' CB ' ' A' ' 177' ' ' SER . 80.2 p -91.2 -6.22 53.76 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.782 0.66 . . . . 70.44 112.782 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 150.03 -178.43 27.52 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.669 -0.777 . . . . 75.43 113.624 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 61.5 p -127.28 143.12 51.3 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 122.671 -0.311 . . . . 60.44 111.102 177.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.6 tp -144.1 164.48 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 O-C-N 122.318 -0.239 . . . . 73.31 111.031 -175.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.75 ' H ' ' HD2' ' A' ' 223' ' ' ARG . 0.0 OUTLIER -111.52 137.42 49.37 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.851 -0.53 . . . . 75.21 110.808 176.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -108.24 131.49 10.62 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.46 -0.4 . . . . 75.11 113.205 -177.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.504 HG23 HD11 ' A' ' 210' ' ' LEU . 85.4 m -107.21 111.88 24.49 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.693 -0.298 . . . . 74.14 111.762 -177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.519 HD23 ' HB ' ' A' ' 258' ' ' VAL . 70.9 mt -99.04 109.48 22.22 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.035 0.383 . . . . 31.54 112.035 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -93.44 161.86 14.21 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.11 0.481 . . . . 75.1 112.104 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.422 ' CG ' ' H ' ' A' ' 229' ' ' GLU . 62.9 t30 57.69 -133.93 1.17 Allowed 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.178 -0.465 . . . . 74.51 111.615 170.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.422 ' H ' ' CG ' ' A' ' 228' ' ' ASN . 11.4 pt-20 -60.06 -29.02 68.27 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.912 -0.493 . . . . 74.24 111.76 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.498 ' HB3' HD22 ' A' ' 226' ' ' LEU . 72.1 mt -61.06 -16.98 49.76 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.92 0.391 . . . . 75.1 111.231 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.58 88.11 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.663 0.268 . . . . 73.11 111.178 175.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -94.28 -15.62 24.31 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.842 0.353 . . . . 73.52 110.96 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -47.34 128.07 11.61 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.706 0.402 . . . . 61.11 111.524 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -70.23 120.23 15.6 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.658 0.614 . . . . 74.12 112.658 -175.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.25 134.23 22.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.698 -0.683 . . . . 73.52 110.053 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 239' ' ' ASP . 58.6 mttm -99.9 150.71 22.11 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.156 0.503 . . . . 73.35 112.241 -173.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -66.61 108.7 2.54 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.385 -0.37 . . . . 44.02 110.419 174.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.39 17.17 29.86 Favored Glycine 0 CA--C 1.523 0.543 0 C-N-CA 121.408 -0.425 . . . . 53.53 112.798 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 236' ' ' LYS . 25.2 t0 -90.88 157.0 17.59 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.699 0.285 . . . . 64.1 111.181 -178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 42.3 mm -95.18 105.28 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.146 0.498 . . . . 72.25 110.805 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -113.8 127.07 55.86 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.821 0.675 . . . . 72.41 112.821 -174.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -86.75 104.17 15.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.228 0.537 . . . . 72.22 109.827 170.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.573 HG21 HD11 ' A' ' 215' ' ' LEU . 89.0 t -102.47 120.24 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 112.61 0.596 . . . . 61.35 112.61 -171.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.1 t -113.64 133.14 55.48 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.24 -0.436 . . . . 53.1 111.176 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 178.03 -155.78 17.93 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.205 -0.998 . . . . 73.4 113.983 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 85.8 t80 -116.31 112.12 21.09 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.779 0.432 . . . . 62.53 111.467 -176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.535 HG21 HD22 ' A' ' 179' ' ' LEU . 48.1 t -83.34 118.18 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 120.965 0.412 . . . . 61.34 111.177 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.441 ' HB3' ' CE2' ' A' ' 246' ' ' TYR . 58.8 pttt -135.42 157.17 47.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.228 0.537 . . . . 73.32 111.437 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -93.77 133.32 37.27 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.046 0.45 . . . . 72.0 111.289 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 166.14 -82.61 0.1 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.973 -0.632 . . . . 73.42 112.823 176.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -73.95 122.73 23.04 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.745 0.307 . . . . 64.21 111.382 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 34.1 t 55.54 43.35 28.56 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 121.024 0.44 . . . . 55.03 111.885 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 82.92 -112.92 3.59 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.881 -0.676 . . . . 53.4 112.616 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.52 121.66 43.32 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 122.59 0.356 . . . . 73.12 110.252 175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 160.84 25.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.021 0.439 . . . . 74.24 111.118 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 7.9 tt -120.36 104.43 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.631 0.729 . . . . 71.03 111.421 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 42.6 t -68.93 102.52 1.6 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.647 -0.706 . . . . 75.54 110.296 174.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.519 ' HB ' HD23 ' A' ' 226' ' ' LEU . 21.7 t -74.43 117.72 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 116.264 -0.425 . . . . 72.34 112.122 -173.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -94.97 -21.7 18.44 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.879 0.371 . . . . 71.23 111.1 176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -156.61 120.76 4.4 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.798 0.332 . . . . 73.22 110.944 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.5 ' HB ' HG11 ' A' ' 258' ' ' VAL . 11.4 tt -125.3 135.37 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 121.034 0.445 . . . . 63.21 111.582 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -133.59 125.29 3.92 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.15 -0.548 . . . . 75.42 112.763 178.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 266' ' ' LYS . 49.4 mm -76.02 139.9 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 120.942 0.401 . . . . 75.34 110.737 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.531 HG22 ' HG3' ' A' ' 265' ' ' GLU . 48.1 mm -70.37 -46.4 71.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 CA-C-O 120.776 0.322 . . . . 64.33 111.717 -178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.531 ' HG3' HG22 ' A' ' 264' ' ' ILE . 41.1 mt-10 -136.68 106.42 6.21 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.741 0.305 . . . . 75.5 111.317 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.552 ' HD3' ' HB ' ' A' ' 263' ' ' ILE . 2.8 mmmp? -77.25 103.66 7.31 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.018 0.437 . . . . 65.14 111.057 178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 40.7 t -83.04 125.89 31.94 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.261 -0.427 . . . . 73.31 111.524 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 86.7 mt -99.55 -43.17 6.61 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.038 0.447 . . . . 74.35 110.915 177.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 C--O 1.252 1.225 0 CA-C-O 118.633 -0.698 . . . . 53.22 111.092 179.282 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 16.4 tpt . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 120.795 0.331 . . . . 71.44 111.556 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -85.15 138.65 32.25 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.131 0.491 . . . . 71.12 111.066 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . 0.4 ' O ' HG22 ' A' ' 187' ' ' ILE . 47.4 m-85 -106.52 153.93 21.6 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.298 0.571 . . . . 63.35 111.603 -178.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -93.21 155.68 17.3 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.318 -0.623 . . . . 71.35 109.318 167.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 49.4 mt -61.33 -24.59 33.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-O 121.076 0.465 . . . . 74.02 111.599 -178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.477 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 39.2 t -70.75 -12.9 61.83 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.131 0.419 . . . . 74.24 112.131 175.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -97.3 -1.94 43.61 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.603 0.594 . . . . 72.42 112.603 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.536 HD22 HG21 ' A' ' 247' ' ' VAL . 88.4 mt -68.08 150.68 48.11 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 113.176 0.806 . . . . 75.32 113.176 -172.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 20.5 ptt? -162.23 156.4 18.51 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.289 -0.869 . . . . 74.1 110.213 178.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -56.62 138.16 83.74 Favored 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.307 2.004 . . . . 74.11 113.295 -178.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.425 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 65.3 m-20 65.42 33.4 8.9 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.161 0.585 . . . . 70.15 111.562 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 52.8 tp -96.03 145.51 25.39 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.119 -0.491 . . . . 71.23 111.739 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 75.4 p -120.98 129.36 53.39 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.245 -0.434 . . . . 41.24 110.693 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.67 179.53 47.87 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 120.714 -0.755 . . . . 71.54 113.761 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 77.2 m -121.55 128.14 51.7 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.735 0.302 . . . . 71.45 111.343 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 174' ' ' TYR . 34.7 pt -120.5 152.79 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.171 0.51 . . . . 65.22 111.888 -179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -114.55 105.88 13.61 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.127 -0.488 . . . . 65.45 110.243 176.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.07 164.97 25.07 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.862 0.69 . . . . 61.14 112.862 -173.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -101.2 136.84 40.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.606 -0.725 . . . . 72.23 111.44 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 40.6 t -80.14 102.52 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 120.912 0.386 . . . . 63.22 111.519 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 14.7 t -82.62 -34.1 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.004 0.43 . . . . 60.11 111.872 -179.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -141.17 117.74 10.9 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 120.757 0.313 . . . . 61.03 111.31 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -95.35 98.96 10.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.973 0.416 . . . . 61.45 110.981 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -78.5 143.96 64.75 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.463 -0.335 . . . . 74.43 111.078 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -66.12 151.6 83.32 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.775 2.317 . . . . 74.34 112.863 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . 0.523 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 20.5 ptmt -67.74 125.24 25.6 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.579 0.585 . . . . 72.04 112.579 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -94.1 153.16 18.27 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.044 -0.525 . . . . 75.41 110.94 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -122.49 143.96 49.37 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.448 -0.342 . . . . 73.44 110.743 176.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -162.36 163.21 28.0 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.296 0.569 . . . . 64.01 111.695 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 37.6 t -91.51 133.03 35.86 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.984 -0.553 . . . . 74.14 110.505 173.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 20.6 mtp180 -72.83 164.05 27.18 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 120.815 0.34 . . . . 64.31 111.664 177.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -64.24 -20.46 66.06 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.21 0.529 . . . . 75.11 110.457 174.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -79.26 -8.8 59.32 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.79 -0.641 . . . . 45.14 111.453 176.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 77.97 14.66 82.09 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.049 -0.596 . . . . 64.42 112.714 -174.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 67.8 p -107.11 172.11 7.01 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.954 0.353 . . . . 54.23 111.954 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . 0.506 ' HB3' ' NZ ' ' A' ' 207' ' ' LYS . 8.0 mtpm? -59.16 136.99 58.13 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.517 0.562 . . . . 72.11 112.517 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -148.57 131.92 3.95 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.273 -0.489 . . . . 40.32 112.887 177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 228' ' ' ASN . 37.5 mt-30 -128.75 155.44 45.12 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 122.343 -0.504 . . . . 73.23 110.301 175.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 48.3 tp -142.48 112.75 7.13 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.766 0.317 . . . . 53.21 111.64 -173.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 49.3 tttm -126.62 108.09 10.8 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.704 0.288 . . . . 62.11 110.834 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 66.9 m -86.27 150.07 24.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.932 0.396 . . . . 50.43 111.566 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.422 HD11 HG11 ' A' ' 235' ' ' VAL . 91.7 mt -137.24 134.94 36.75 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.422 -0.354 . . . . 75.34 110.915 179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -89.59 106.46 18.47 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.73 0.3 . . . . 75.25 110.224 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.4 mt -102.67 141.96 34.62 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.503 0.321 . . . . 74.45 110.999 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -127.96 155.06 44.85 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-O 121.593 0.711 . . . . 74.41 112.443 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -148.24 160.9 42.48 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.06 -0.973 . . . . 74.15 109.347 171.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -62.18 -21.08 64.79 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.992 0.425 . . . . 75.13 111.553 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.477 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 72.3 p -92.49 -1.27 57.09 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.212 0.449 . . . . 70.33 112.212 178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 148.06 176.75 21.84 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.071 -0.585 . . . . 75.53 113.612 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 89.7 p -120.48 158.8 26.46 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.503 -0.41 . . . . 64.44 111.341 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 10.7 tp -157.95 145.28 9.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.92 0.39 . . . . 74.15 111.265 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -96.71 112.08 23.98 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.918 0.39 . . . . 61.41 111.197 177.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.436 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -81.91 159.08 39.43 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 116.101 -0.5 . . . . 32.34 113.366 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 84.9 m -129.08 114.63 16.6 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.357 0.503 . . . . 63.1 112.357 -176.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 92.3 mt -95.6 117.28 30.16 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.437 -0.347 . . . . 63.34 110.993 175.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -99.07 156.35 16.98 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.086 0.47 . . . . 74.11 111.754 179.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 209' ' ' GLN . 61.2 t30 61.51 -146.84 0.42 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 115.968 -0.56 . . . . 72.04 111.482 174.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.43 -4.9 4.38 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.661 0.615 . . . . 72.51 112.661 -174.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 93.1 mt -65.29 -15.63 62.72 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.101 0.477 . . . . 73.33 110.707 173.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 197' ' ' LYS . . . -65.88 -23.07 66.57 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.201 -0.454 . . . . 51.41 111.499 175.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.21 4.09 53.17 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.286 -0.415 . . . . 74.21 111.557 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -69.3 113.8 6.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.044 0.45 . . . . 74.11 110.488 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -68.85 90.61 0.43 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.38 0.61 . . . . 63.24 111.838 -175.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.422 HG11 HD11 ' A' ' 213' ' ' LEU . 5.0 p -128.44 122.83 58.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 115.509 -0.769 . . . . 65.01 110.794 177.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 70.4 mttt -113.63 172.36 7.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.098 0.475 . . . . 73.33 111.428 -175.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -65.4 122.1 16.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.361 -0.381 . . . . 73.04 110.848 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 114.14 -26.58 9.71 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.157 -0.544 . . . . 74.42 113.596 178.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -65.87 130.81 44.54 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 117.188 0.494 . . . . 64.32 111.618 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 42.0 mm -77.71 108.36 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.078 -0.51 . . . . 64.1 110.08 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -113.78 130.12 56.49 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.318 0.58 . . . . 71.23 112.555 -172.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . 0.532 ' HB2' HD11 ' A' ' 264' ' ' ILE . 40.3 tt0 -92.72 112.7 24.75 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.905 -0.589 . . . . 73.43 109.597 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.1 t -115.34 127.04 73.06 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.269 0.557 . . . . 71.02 112.423 -172.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.7 t -124.24 132.9 53.62 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.091 -0.504 . . . . 71.34 109.79 174.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.02 -164.9 29.83 Favored Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.121 -1.038 . . . . 71.23 114.196 -177.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -106.95 115.36 30.05 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.077 0.465 . . . . 73.22 111.172 -177.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.536 HG21 HD22 ' A' ' 179' ' ' LEU . 47.5 t -89.09 123.87 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.294 -0.412 . . . . 74.1 111.052 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.425 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 26.6 pttm -142.37 158.23 43.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.094 0.473 . . . . 62.55 112.005 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -100.38 155.22 17.93 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.176 -0.465 . . . . 64.14 111.317 -179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 178.48 -152.79 11.81 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.9 -0.667 . . . . 62.41 113.161 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -61.14 -28.67 69.28 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.057 0.456 . . . . 74.43 111.731 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 22.6 t -86.88 10.9 14.7 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.918 0.39 . . . . 70.22 111.32 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 79.52 -131.51 10.66 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.081 -0.58 . . . . 63.51 112.191 -176.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 97.2 mt -95.56 115.67 27.76 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 117.017 0.409 . . . . 65.15 110.827 174.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -120.93 161.24 21.91 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.078 0.466 . . . . 63.33 111.481 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.436 HG23 ' HA2' ' A' ' 224' ' ' GLY . 6.9 tt -128.17 105.14 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.419 0.628 . . . . 72.15 110.83 172.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 72.4 m -73.59 106.95 5.58 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.114 -0.494 . . . . 74.43 110.049 177.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.529 HG11 ' HB ' ' A' ' 261' ' ' ILE . 46.5 t -66.6 129.67 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 N-CA-C 113.17 0.804 . . . . 61.22 113.17 -171.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.64 -47.18 6.32 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.695 -0.684 . . . . 73.3 110.267 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -135.74 128.2 30.46 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.975 -0.557 . . . . 72.52 110.452 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.529 ' HB ' HG11 ' A' ' 258' ' ' VAL . 10.7 tt -134.25 135.02 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 120.777 0.322 . . . . 74.44 111.217 178.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -144.59 136.89 6.92 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.844 -0.693 . . . . 70.22 113.362 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.84 106.75 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.87 0.367 . . . . 62.23 110.964 178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 242' ' ' GLU . 63.4 mt -66.37 -61.4 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.079 0.466 . . . . 71.05 111.125 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -102.79 97.2 7.39 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.031 -0.531 . . . . 74.1 110.73 179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -102.77 161.19 13.94 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.977 0.418 . . . . 65.32 111.368 -178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 68.7 p -121.64 115.64 23.12 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.981 0.419 . . . . 64.12 111.814 -178.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 269' ' ' GLU . 2.0 pp -154.33 -29.85 0.12 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.043 -0.526 . . . . 72.32 111.471 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.574 ' N ' HD12 ' A' ' 268' ' ' LEU . 65.9 mm-40 . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.75 -0.643 . . . . 55.34 111.094 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 172' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.186 0.517 . . . . 61.41 112.202 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 186' ' ' THR . 12.3 m120 -98.89 110.83 23.38 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.153 -0.476 . . . . 45.3 110.53 172.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -99.19 156.66 16.85 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.157 0.503 . . . . 53.14 111.377 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -98.72 168.17 10.31 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.507 -0.553 . . . . 62.15 109.507 169.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.406 HG23 ' HB ' ' A' ' 222' ' ' ILE . 56.8 mt -64.49 -18.5 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 112.359 0.503 . . . . 73.25 112.359 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 219' ' ' THR . 40.9 t -71.55 -36.46 70.97 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.001 0.371 . . . . 75.45 112.001 177.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -79.05 -10.22 59.76 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 112.511 0.56 . . . . 71.34 112.511 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.583 HD22 HG21 ' A' ' 247' ' ' VAL . 69.1 mt -62.52 121.73 14.02 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.315 0.579 . . . . 71.4 111.998 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.0 ptp -140.88 160.82 57.0 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.69 -0.686 . . . . 55.51 110.348 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 248' ' ' LYS . 18.4 Cg_endo -58.63 133.94 57.6 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 121.941 1.761 . . . . 74.04 112.367 176.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 71.68 29.78 2.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.979 0.512 . . . . 74.24 111.726 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 34.1 tp -103.62 138.37 40.38 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.033 0.444 . . . . 75.44 111.402 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.2 p -116.51 128.37 55.38 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.574 -0.284 . . . . 44.43 110.537 176.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 176.5 178.0 45.93 Favored Glycine 0 CA--C 1.523 0.584 0 C-N-CA 120.083 -1.055 . . . . 31.34 114.164 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 61.8 m -113.12 121.84 45.75 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.393 0.277 . . . . 74.53 111.627 -178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.412 ' CG2' HD21 ' A' ' 179' ' ' LEU . 23.6 pt -102.87 152.77 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.073 0.463 . . . . 63.54 112.029 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -119.96 110.98 17.34 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.191 -0.459 . . . . 73.34 111.607 -176.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -161.39 167.12 26.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.835 0.35 . . . . 73.15 111.668 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.494 ' HB3' HD13 ' A' ' 240' ' ' ILE . 12.5 pt-20 -95.63 149.55 21.33 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.052 0.453 . . . . 74.41 111.493 176.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 23.5 t -81.81 114.17 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.352 0.596 . . . . 71.53 111.939 -177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.437 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 25.4 t -82.23 -52.39 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.945 -0.57 . . . . 63.21 111.451 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -127.58 128.65 45.94 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.254 -0.43 . . . . 72.43 111.388 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -114.45 119.08 35.64 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.26 -0.427 . . . . 54.12 111.17 178.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.439 ' O ' ' HG2' ' A' ' 211' ' ' LYS . 25.7 m-85 -89.13 140.15 28.86 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.445 -0.343 . . . . 65.43 111.337 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.73 172.9 14.31 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.56 2.173 . . . . 34.13 113.186 177.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.85 134.98 42.61 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.482 0.919 . . . . 73.43 113.482 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -111.4 134.83 52.69 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.165 -0.68 . . . . 74.2 109.165 166.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -101.94 134.6 44.9 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.976 0.732 . . . . 73.32 112.976 -171.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -150.81 166.89 29.14 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.111 -0.495 . . . . 73.23 110.843 172.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 59.3 p -115.44 151.91 33.89 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 120.798 0.332 . . . . 62.22 111.238 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -107.95 149.4 28.4 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.032 0.444 . . . . 73.23 111.913 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -52.66 -30.66 33.05 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.763 0.653 . . . . 71.11 112.763 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -73.34 -2.39 21.93 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 112.27 0.47 . . . . 75.12 112.27 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 83.74 8.53 84.35 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.407 -0.425 . . . . 65.5 112.94 -178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 52.9 p -92.3 162.94 14.08 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.016 0.436 . . . . 63.53 111.595 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -67.86 162.21 24.62 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.38 0.609 . . . . 74.54 111.869 177.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -156.44 142.79 9.05 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.541 -0.754 . . . . 75.13 112.316 177.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.477 HE21 ' HB3' ' A' ' 231' ' ' ALA . 19.2 pt20 -152.68 145.29 24.21 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.154 0.502 . . . . 63.52 111.659 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.7 tp -125.16 145.31 50.02 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.558 -0.746 . . . . 74.24 110.957 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.473 ' HB2' ' HB1' ' A' ' 231' ' ' ALA . 1.6 tmtp? -146.97 136.16 22.57 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 122.174 -0.328 . . . . 74.3 110.979 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 51.5 m -111.89 153.97 25.88 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.293 0.479 . . . . 75.31 112.293 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.47 HD21 ' HE2' ' A' ' 211' ' ' LYS . 95.5 mt -136.68 161.82 34.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.919 -0.582 . . . . 74.13 110.921 178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -128.23 120.04 26.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.621 0.248 . . . . 32.51 110.869 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.597 HD11 HG21 ' A' ' 243' ' ' VAL . 78.8 mt -114.74 142.93 45.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.554 0.342 . . . . 75.51 110.653 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -134.92 147.94 49.93 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.346 0.593 . . . . 74.22 111.994 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -152.32 168.58 24.96 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.55 -0.75 . . . . 73.12 109.864 177.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -62.33 -25.23 67.77 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.99 0.424 . . . . 71.33 111.465 178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 177' ' ' SER . 80.6 p -79.93 -14.75 58.38 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.403 0.52 . . . . 63.43 112.403 178.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 154.54 -179.03 30.98 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 120.939 -0.648 . . . . 75.13 113.351 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 84.8 p -127.89 125.75 40.22 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 122.496 -0.414 . . . . 73.33 110.976 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.406 ' HB ' HG23 ' A' ' 176' ' ' ILE . 10.1 tp -126.82 148.13 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.122 0.487 . . . . 64.25 111.93 -175.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 73.9 mtm-85 -100.16 138.7 36.87 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.056 0.455 . . . . 74.15 110.953 176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -114.63 152.25 18.16 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.303 -0.475 . . . . 73.4 113.197 -176.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 59.5 m -124.45 125.55 44.44 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.151 0.426 . . . . 72.52 112.151 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.582 HD23 ' HB ' ' A' ' 258' ' ' VAL . 83.4 mt -109.92 134.56 51.95 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.017 0.527 . . . . 72.25 111.246 176.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 68.1 m95 -114.58 172.13 7.21 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.926 0.393 . . . . 74.2 111.094 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 54.1 t30 57.89 -153.6 0.37 Allowed 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 116.148 -0.478 . . . . 64.01 111.207 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.98 -27.11 61.15 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.822 -0.549 . . . . 72.23 112.46 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 73.7 mt -60.59 -18.83 55.43 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.906 0.384 . . . . 74.43 111.633 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.477 ' HB3' HE21 ' A' ' 209' ' ' GLN . . . -59.47 -44.05 93.12 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.847 0.356 . . . . 64.23 111.494 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -90.67 13.39 16.21 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.903 0.334 . . . . 74.2 111.903 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -55.35 130.02 40.84 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.37 0.268 . . . . 72.04 110.722 175.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -70.71 77.44 0.61 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.524 0.678 . . . . 74.54 112.222 -174.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 7.3 p -88.66 139.75 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.927 -0.579 . . . . 65.42 110.23 174.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.403 ' HB3' ' NZ ' ' A' ' 236' ' ' LYS . 0.1 OUTLIER -126.75 115.8 19.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.363 0.601 . . . . 70.32 111.784 -173.106 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 192' ' ' VAL . 4.8 ttmp? -42.99 109.24 0.13 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 115.533 -0.758 . . . . 63.42 112.894 -172.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 113.48 4.53 23.38 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 116.095 -0.502 . . . . 52.45 113.685 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 29.4 p-10 -86.21 156.67 20.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.148 0.499 . . . . 64.32 111.872 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 190' ' ' GLU . 38.1 mm -92.09 103.71 14.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.267 -0.424 . . . . 74.01 110.909 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -107.25 119.65 39.96 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.321 0.489 . . . . 74.43 112.321 -175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -87.15 103.49 15.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.24 0.543 . . . . 72.2 109.77 173.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.597 HG21 HD11 ' A' ' 215' ' ' LEU . 78.7 t -100.0 124.3 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 N-CA-C 112.799 0.666 . . . . 75.52 112.799 -169.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 42.4 t -118.02 123.53 45.92 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.32 -0.4 . . . . 62.42 110.781 177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . 0.471 ' HA3' ' HA ' ' A' ' 258' ' ' VAL . . . -167.22 -161.48 16.61 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.415 -0.897 . . . . 73.12 114.202 -177.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -112.9 114.36 26.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.465 0.306 . . . . 74.33 110.991 -177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.583 HG21 HD22 ' A' ' 179' ' ' LEU . 25.8 t -90.52 128.14 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.657 0.265 . . . . 71.21 110.977 178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.664 ' HA ' ' HA ' ' A' ' 181' ' ' PRO . 14.6 ptmm? -154.16 170.86 20.19 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.269 0.557 . . . . 63.05 112.016 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -101.36 150.4 23.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.882 -0.599 . . . . 74.21 110.83 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 168.16 -108.33 0.3 Allowed Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.531 -0.842 . . . . 62.11 113.144 174.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -73.11 137.67 45.36 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 122.803 -0.234 . . . . 75.24 110.854 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 50.4 m 73.81 -51.99 0.69 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.192 0.597 . . . . 73.23 111.775 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 161.43 -114.29 0.6 Allowed Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.269 -0.491 . . . . 72.23 113.004 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 96.5 mt -110.68 106.34 15.53 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 122.664 -0.315 . . . . 71.25 111.196 178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -136.43 170.27 16.31 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.12 0.486 . . . . 74.12 111.705 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 247' ' ' VAL . 7.3 tt -116.65 121.7 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.471 0.545 . . . . 74.54 112.471 -176.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.5 t -85.72 103.79 14.83 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.009 0.433 . . . . 72.43 109.917 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.582 ' HB ' HD23 ' A' ' 226' ' ' LEU . 27.0 t -74.56 136.49 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 112.544 0.572 . . . . 73.44 112.544 -171.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -105.13 -39.95 6.04 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 116.314 -0.403 . . . . 65.35 110.612 177.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -134.61 138.68 44.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 116.156 -0.474 . . . . 64.03 110.952 173.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 10.7 tt -141.45 123.66 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.05 0.452 . . . . 60.35 111.242 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -128.33 131.51 6.98 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 121.029 -0.605 . . . . 62.44 113.375 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 46.4 mm -79.77 116.1 23.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 O-C-N 122.681 -0.306 . . . . 55.22 110.369 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 50.6 mt -56.79 -43.29 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 120.716 0.293 . . . . 72.42 111.681 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -95.76 90.06 5.52 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.065 0.459 . . . . 71.14 111.203 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -69.04 80.94 0.32 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.521 0.677 . . . . 62.12 110.827 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 45.9 m -96.91 107.43 19.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.644 -0.707 . . . . 75.34 111.36 -177.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 88.0 mt -74.61 102.54 4.59 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.943 0.401 . . . . 72.43 111.238 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 C--O 1.254 1.331 0 CA-C-O 118.615 -0.707 . . . . 73.11 112.342 179.69 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 58.7 ttp . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.81 0.338 . . . . 72.43 111.242 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -102.67 146.24 28.49 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.88 0.372 . . . . 75.2 111.52 -177.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -131.78 158.17 41.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.077 0.465 . . . . 75.22 111.299 176.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -90.75 155.6 18.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.149 -0.478 . . . . 74.41 110.267 169.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 220' ' ' GLY . 65.1 mt -54.49 -35.61 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 112.522 0.564 . . . . 72.44 112.522 -174.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.524 ' HB3' ' HB ' ' A' ' 219' ' ' THR . 68.2 p -57.96 -41.23 82.46 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.233 0.457 . . . . 64.34 112.233 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -73.42 -22.18 60.28 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.274 0.472 . . . . 73.31 112.274 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.595 HD11 HG21 ' A' ' 187' ' ' ILE . 81.7 mt -55.74 111.7 0.98 Allowed 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.282 0.563 . . . . 74.11 112.386 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . 0.466 ' HG2' HD22 ' A' ' 183' ' ' LEU . 23.1 ptp -106.64 157.63 34.67 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.545 -0.752 . . . . 65.25 110.997 179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.17 130.6 40.42 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.336 2.024 . . . . 44.11 113.196 175.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.469 ' H ' ' HA ' ' A' ' 248' ' ' LYS . 70.9 m-20 70.52 33.68 2.36 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.357 0.663 . . . . 60.42 111.854 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.466 HD22 ' HG2' ' A' ' 180' ' ' MET . 46.9 tp -102.09 134.41 45.37 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.216 -0.447 . . . . 63.2 111.318 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 81.4 p -110.31 118.35 36.09 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.27 -0.269 . . . . 60.54 111.077 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -173.79 -172.21 38.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.862 -0.685 . . . . 45.43 113.681 -177.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 62.1 m -114.08 136.7 52.64 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.712 0.264 . . . . 75.51 111.712 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.595 HG21 HD11 ' A' ' 179' ' ' LEU . 33.2 pt -125.57 141.31 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 120.941 0.401 . . . . 75.52 111.227 175.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -115.21 116.27 28.07 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 64.31 111.608 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -158.66 178.33 10.23 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.31 -0.405 . . . . 74.41 111.362 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . 0.531 ' HB3' HD13 ' A' ' 240' ' ' ILE . 12.3 pt-20 -99.79 146.24 26.8 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.052 0.453 . . . . 72.44 111.493 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.51 HG21 HG21 ' A' ' 235' ' ' VAL . 58.1 t -76.15 108.73 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.11 -0.496 . . . . 75.22 111.831 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 216' ' ' LYS . 14.6 t -76.18 -27.62 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-O 121.046 0.451 . . . . 72.11 111.902 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -155.14 130.97 10.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.135 0.493 . . . . 72.34 112.016 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -113.53 102.65 10.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.752 -0.658 . . . . 63.35 110.031 174.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -84.33 155.37 63.16 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 111.962 0.356 . . . . 73.24 111.962 -174.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -58.21 140.38 94.03 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.662 2.241 . . . . 60.13 112.787 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -75.41 126.33 30.81 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.521 0.677 . . . . 75.14 112.654 -176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 198' ' ' LYS . 2.9 mptp? -86.31 169.49 12.92 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.529 -0.759 . . . . 70.52 111.331 176.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -138.21 143.81 40.34 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.111 -0.495 . . . . 75.44 110.935 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -151.67 144.69 24.54 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.349 0.595 . . . . 73.13 112.316 178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 81.2 p -94.59 117.47 30.18 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.709 -0.678 . . . . 64.42 110.243 175.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 20.7 mtt180 -77.86 146.98 35.35 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.667 0.27 . . . . 74.1 111.635 -175.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -70.63 -12.98 61.9 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.569 0.699 . . . . 75.34 109.74 171.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -56.3 -29.92 61.83 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 115.268 -0.878 . . . . 53.41 110.729 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 112.85 -29.61 8.0 Favored Glycine 0 CA--C 1.523 0.568 0 CA-C-N 115.882 -0.599 . . . . 55.31 112.487 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 67.8 p -89.7 159.21 17.21 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.314 0.578 . . . . 72.11 112.212 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -74.91 156.5 36.3 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 116.158 -0.474 . . . . 64.04 111.481 176.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -147.26 144.32 12.39 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 120.898 -0.668 . . . . 71.11 113.451 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 231' ' ' ALA . 36.2 mt-30 -113.47 162.65 15.87 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 122.74 -0.271 . . . . 75.1 110.439 176.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 49.4 tp -153.69 113.72 3.91 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 112.17 0.433 . . . . 71.41 112.17 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.436 ' HE2' HD21 ' A' ' 213' ' ' LEU . 6.4 ttpm? -127.04 118.23 24.03 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 121.669 -0.645 . . . . 72.25 111.734 176.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.6 p -84.06 147.75 27.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.976 0.417 . . . . 73.41 111.711 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.436 HD21 ' HE2' ' A' ' 211' ' ' LYS . 97.0 mt -132.41 178.17 7.04 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.05 -0.523 . . . . 64.34 110.44 177.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.458 ' CE2' ' HB3' ' A' ' 221' ' ' SER . 21.0 t80 -141.84 138.31 32.08 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.184 -0.323 . . . . 64.15 110.635 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.467 HD11 HG21 ' A' ' 243' ' ' VAL . 91.2 mt -126.49 151.79 47.33 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.503 0.321 . . . . 74.24 111.344 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.423 ' HB2' ' NZ ' ' A' ' 216' ' ' LYS . 0.0 OUTLIER -135.76 149.3 49.12 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.496 0.554 . . . . 74.42 112.496 -178.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -154.68 167.33 30.52 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.486 -0.779 . . . . 62.53 109.9 174.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -62.52 -18.57 62.25 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.209 0.528 . . . . 75.35 111.601 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 177' ' ' SER . 75.0 p -91.05 -0.22 57.68 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.572 0.582 . . . . 61.42 112.572 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 176' ' ' ILE . . . 138.92 -178.97 19.03 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.866 -0.683 . . . . 72.13 113.261 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.458 ' HB3' ' CE2' ' A' ' 214' ' ' PHE . 67.9 m -130.83 138.9 50.09 Favored 'General case' 0 N--CA 1.474 0.735 0 O-C-N 122.583 -0.363 . . . . 74.52 111.16 177.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 13.4 tt -141.95 153.84 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 120.779 0.323 . . . . 71.41 111.612 -178.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -92.6 147.39 22.92 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.08 0.467 . . . . 71.13 111.745 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -112.96 157.33 15.01 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-N 116.286 -0.416 . . . . 72.53 112.531 177.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 63.4 m -133.15 116.09 15.85 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 117.197 0.498 . . . . 45.23 111.988 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.564 HD23 ' HB ' ' A' ' 258' ' ' VAL . 74.2 mt -98.9 116.27 30.77 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.422 -0.354 . . . . 71.43 111.608 178.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -102.22 165.77 10.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.995 0.426 . . . . 71.25 111.764 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 62.5 t30 58.6 -141.88 0.68 Allowed 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.977 -0.556 . . . . 73.0 111.735 171.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -61.43 -34.61 75.68 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 121.912 -0.493 . . . . 75.41 112.27 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 86.6 mt -67.98 -7.64 30.52 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.964 0.411 . . . . 74.41 111.911 -176.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 209' ' ' GLN . . . -66.11 -34.26 77.65 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 122.133 -0.354 . . . . 73.03 111.951 177.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -84.74 1.0 48.57 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.947 -0.471 . . . . 75.13 111.861 179.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -52.09 116.19 2.08 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.825 0.345 . . . . 73.42 111.052 176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -81.7 121.7 26.71 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.909 -0.587 . . . . 74.22 111.62 -174.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.51 HG21 HG21 ' A' ' 191' ' ' VAL . 13.1 p -136.12 159.69 38.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 CA-C-N 116.379 -0.373 . . . . 65.13 111.339 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.417 ' HZ2' ' CG ' ' A' ' 239' ' ' ASP . 8.8 mtpm? -110.67 163.87 13.31 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.126 0.489 . . . . 72.15 111.403 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 237' ' ' LYS . 13.2 tmtt? -90.01 123.2 33.7 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.794 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 99.99 0.61 56.13 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 116.241 -0.436 . . . . 54.54 113.679 178.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.417 ' CG ' ' HZ2' ' A' ' 236' ' ' LYS . 1.3 m-20 -91.81 150.2 21.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.934 0.397 . . . . 43.25 111.772 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 190' ' ' GLU . 32.5 mm -85.31 119.74 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 116.288 -0.415 . . . . 43.11 111.737 -175.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -130.36 144.92 51.68 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 112.725 0.639 . . . . 75.41 112.725 -178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -100.5 115.11 29.32 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.841 -0.618 . . . . 64.12 110.197 173.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.467 HG21 HD11 ' A' ' 215' ' ' LEU . 57.5 t -111.02 123.32 66.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.441 0.534 . . . . 72.43 112.441 -172.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 67.4 m -107.9 122.21 46.34 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.57 -0.287 . . . . 72.55 110.821 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -165.9 -164.47 21.46 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 119.99 -1.1 . . . . 43.42 114.858 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 248' ' ' LYS . 75.4 t80 -122.47 106.01 10.65 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.123 0.569 . . . . 73.12 110.938 -177.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.542 HG22 ' HB ' ' A' ' 256' ' ' ILE . 40.6 t -76.57 114.28 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.422 -0.353 . . . . 73.34 110.998 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.469 ' HA ' ' H ' ' A' ' 182' ' ' ASN . 20.8 ptmt -129.63 153.29 48.25 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.473 0.654 . . . . 64.13 112.197 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -91.62 140.29 29.87 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.906 -0.588 . . . . 73.52 111.814 -177.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . 140.02 -67.78 0.49 Allowed Glycine 0 CA--C 1.522 0.492 0 CA-C-N 116.051 -0.522 . . . . 75.34 112.899 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -63.27 97.3 0.12 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.851 0.358 . . . . 72.23 110.962 -178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 23.1 t 61.49 27.22 16.81 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.344 -0.389 . . . . 72.33 111.93 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 102.76 -106.43 2.91 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 121.283 -0.484 . . . . 72.12 112.785 -178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.99 122.84 44.27 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.597 -0.355 . . . . 75.54 111.446 176.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -139.81 162.75 34.41 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.93 0.395 . . . . 73.24 111.029 175.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.542 ' HB ' HG22 ' A' ' 247' ' ' VAL . 9.3 tt -108.97 104.93 17.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 121.388 0.613 . . . . 75.15 111.735 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 41.4 t -64.77 93.81 0.12 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.978 -0.556 . . . . 73.04 110.154 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.564 ' HB ' HD23 ' A' ' 226' ' ' LEU . 39.9 t -66.77 125.36 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 121.053 0.454 . . . . 65.44 112.143 -174.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -96.11 -28.44 14.59 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.167 -0.469 . . . . 74.43 110.976 178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -160.02 141.71 12.79 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.92 -0.582 . . . . 73.42 110.5 178.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 11.4 tt -138.1 138.65 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 112.246 0.461 . . . . 65.15 112.246 -175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -140.83 119.63 1.58 Allowed Glycine 0 CA--C 1.527 0.823 0 C-N-CA 121.36 -0.448 . . . . 60.44 112.399 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.461 HG21 ' HG3' ' A' ' 266' ' ' LYS . 63.8 mt -74.13 126.79 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 122.467 -0.431 . . . . 60.21 111.318 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.484 HD12 HG22 ' A' ' 240' ' ' ILE . 69.0 mt -69.91 -50.18 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 120.998 0.428 . . . . 75.33 111.138 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -152.11 113.75 4.36 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.276 0.56 . . . . 72.31 112.017 179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.461 ' HG3' HG21 ' A' ' 263' ' ' ILE . 56.7 mtmt -84.49 115.71 22.72 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.157 0.503 . . . . 74.1 110.69 171.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 41.3 t -98.63 158.18 15.78 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.724 -0.671 . . . . 61.51 111.116 -178.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 1.2 pp -161.17 173.6 14.86 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.89 0.376 . . . . 64.24 111.996 -178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 . . . . . 0 C--O 1.252 1.236 0 CA-C-O 118.921 -0.562 . . . . 74.13 111.595 177.391 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 110.026 -0.361 . . . . 72.3 110.026 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -85.12 129.36 34.81 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.561 0.578 . . . . 61.3 112.561 -172.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.17 153.64 50.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.182 -0.463 . . . . 74.52 111.002 177.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.568 ' HB2' ' HG2' ' A' ' 178' ' ' GLU . 32.2 mmtp -82.07 162.92 22.38 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.364 -0.606 . . . . 72.25 109.364 170.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 35.6 mm -52.7 -45.36 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-O 121.638 0.733 . . . . 42.31 110.441 173.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 16.2 t -57.12 -28.7 62.93 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.34 -0.846 . . . . 72.43 112.607 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.568 ' HG2' ' HB2' ' A' ' 175' ' ' LYS . 15.6 mm-40 -92.98 2.77 56.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.913 0.338 . . . . 73.12 111.913 -174.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.513 HD22 HG21 ' A' ' 247' ' ' VAL . 90.6 mt -81.93 139.0 34.88 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.992 0.425 . . . . 64.1 111.331 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 55.8 mtt -132.78 155.18 81.47 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.39 -0.368 . . . . 60.22 111.255 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.478 ' HG3' HD21 ' A' ' 254' ' ' LEU . 44.3 Cg_exo -58.08 130.69 39.27 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.33 2.02 . . . . 64.34 112.454 174.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 70.34 22.55 5.32 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.947 0.499 . . . . 64.13 111.738 178.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 8.9 tt -111.18 131.36 55.17 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.0 0.429 . . . . 64.44 111.263 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.4 m -93.85 136.61 33.95 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 116.526 -0.306 . . . . 65.32 110.964 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.71 -174.47 36.72 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.393 -0.908 . . . . 63.45 113.954 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 53.1 m -131.65 131.68 43.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.666 0.386 . . . . 74.31 110.777 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 179' ' ' LEU . 33.6 pt -124.53 150.35 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.562 0.696 . . . . 75.32 112.554 -176.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -112.74 103.38 11.4 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.768 -0.651 . . . . 75.42 110.093 173.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -144.01 168.61 19.58 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.793 0.33 . . . . 62.14 111.648 -175.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -97.01 155.85 16.6 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.126 0.488 . . . . 62.42 111.29 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 237' ' ' LYS . 61.1 t -83.83 114.1 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-N 116.151 -0.477 . . . . 73.31 111.553 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 20.3 t -77.47 -36.68 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 121.015 0.436 . . . . 63.33 111.272 176.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -154.59 143.14 20.66 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.702 -0.681 . . . . 70.2 111.533 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -133.34 108.39 8.68 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.42 -0.355 . . . . 72.01 110.987 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -89.62 147.91 38.91 Favored Pre-proline 0 CA--C 1.543 0.709 0 N-CA-C 112.306 0.484 . . . . 72.24 112.306 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.38 159.85 15.09 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.925 2.416 . . . . 74.21 113.364 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -65.28 160.5 21.48 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.925 0.713 . . . . 53.22 112.925 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -141.38 173.28 11.64 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.601 -0.727 . . . . 74.41 111.73 -178.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -130.34 138.73 50.57 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.715 -0.675 . . . . 73.43 110.021 172.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.418 ' CE2' ' HD2' ' A' ' 202' ' ' ARG . 11.7 p90 -145.28 173.24 12.13 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.399 0.619 . . . . 73.12 111.695 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 84.0 p -99.3 123.96 44.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.563 -0.744 . . . . 53.42 110.298 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . 0.418 ' HD2' ' CE2' ' A' ' 200' ' ' PHE . 11.1 mmm180 -58.89 130.92 49.28 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.666 0.247 . . . . 72.23 111.666 179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -61.6 -17.45 55.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.487 0.66 . . . . 63.45 109.911 169.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -76.6 -28.37 56.14 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.316 -0.856 . . . . 71.33 111.103 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 147.9 -59.46 0.46 Allowed Glycine 0 CA--C 1.532 1.151 0 C-N-CA 120.738 -0.744 . . . . 73.34 114.562 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.1 p -86.06 -144.16 0.1 Allowed 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.204 0.816 . . . . 74.23 113.204 -170.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -113.43 -178.55 3.4 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.471 0.545 . . . . 71.21 112.471 -173.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 166.8 168.0 28.33 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 121.113 -0.565 . . . . 74.02 113.157 176.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -96.25 161.38 13.97 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.036 0.446 . . . . 74.42 111.246 176.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 45.2 tp -142.17 140.24 32.33 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.331 -0.395 . . . . 75.31 111.464 -179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.517 ' HD3' HD12 ' A' ' 226' ' ' LEU . 60.8 tttp -140.67 128.67 22.02 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.752 0.31 . . . . 75.45 110.745 175.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.6 t -96.55 134.18 40.09 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.189 0.518 . . . . 71.3 111.94 -177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.447 HD11 HD11 ' A' ' 226' ' ' LEU . 95.0 mt -130.83 174.31 10.09 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.919 -0.582 . . . . 65.21 111.02 178.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -148.86 121.46 8.58 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.239 -0.437 . . . . 72.22 110.013 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 81.8 mt -113.81 161.64 17.31 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.354 0.262 . . . . 61.41 110.991 -177.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -159.17 154.19 25.04 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.27 0.841 . . . . 72.41 113.27 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -125.51 -175.48 3.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.448 -1.251 . . . . 75.15 108.973 163.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -72.07 -18.06 61.96 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-O 121.16 0.505 . . . . 74.33 110.796 174.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 77.6 p -81.83 -18.74 42.87 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.045 -0.525 . . . . 75.12 112.275 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 159.0 178.75 33.3 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.888 -0.672 . . . . 64.13 113.282 177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 50.0 m -115.91 161.87 18.17 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.887 0.375 . . . . 52.32 111.651 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 9.6 tp -150.53 149.09 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 120.974 0.416 . . . . 62.13 111.363 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -89.7 122.77 33.12 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 122.293 -0.254 . . . . 64.33 110.934 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -100.5 120.3 6.83 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.89 -0.671 . . . . 64.31 112.901 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 62.3 m -111.51 118.94 37.14 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 122.126 -0.632 . . . . 74.32 111.845 -178.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.517 HD12 ' HD3' ' A' ' 211' ' ' LYS . 94.0 mt -98.09 124.78 42.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.812 0.339 . . . . 51.21 111.286 176.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -107.17 150.82 26.19 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 120.775 0.321 . . . . 73.4 111.745 179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . . . . . . . . . 59.9 t30 56.75 -132.57 1.47 Allowed 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 116.428 -0.351 . . . . 74.32 111.824 171.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.23 -14.16 46.16 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.666 0.617 . . . . 74.3 112.666 -174.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.515 ' HB3' HD22 ' A' ' 226' ' ' LEU . 86.9 mt -70.8 -18.49 62.74 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.938 -0.476 . . . . 44.22 111.142 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -69.21 -39.16 78.76 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.741 0.645 . . . . 74.32 112.741 -178.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -78.15 -3.9 44.82 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.072 0.397 . . . . 60.14 112.072 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.09 113.94 10.7 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.928 0.394 . . . . 71.4 110.766 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -75.83 105.06 6.66 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.198 0.523 . . . . 74.2 111.827 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 3.9 p -129.03 126.81 65.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-N 115.499 -0.773 . . . . 50.04 110.252 174.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -131.04 172.22 12.33 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.137 0.494 . . . . 65.42 111.9 -174.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.542 ' HA ' ' HB ' ' A' ' 191' ' ' VAL . 55.4 tttp -61.81 128.31 35.61 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.084 0.469 . . . . 74.44 111.423 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 109.65 -17.22 30.78 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.252 -0.431 . . . . 65.5 113.016 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.43 ' HB3' HD12 ' A' ' 263' ' ' ILE . 39.9 m-20 -88.73 112.71 23.48 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.968 0.414 . . . . 73.41 110.79 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 51.6 mm -77.29 103.73 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-O 120.995 0.426 . . . . 71.42 110.933 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 263' ' ' ILE . . . -110.67 140.9 44.61 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 112.536 0.569 . . . . 73.34 112.536 -175.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -93.1 106.39 18.36 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.095 0.474 . . . . 75.32 109.872 171.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.498 HG22 HG13 ' A' ' 261' ' ' ILE . 59.2 t -106.94 117.73 53.33 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 N-CA-C 112.371 0.508 . . . . 51.4 112.371 -171.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.432 ' OG ' ' HB3' ' A' ' 260' ' ' ASN . 82.4 p -106.9 133.52 51.42 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.411 -0.359 . . . . 52.2 110.557 173.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -170.6 -171.46 35.99 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.382 -0.913 . . . . 24.14 113.966 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -103.16 110.11 21.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.64 0.376 . . . . 74.33 110.877 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.513 HG21 HD22 ' A' ' 179' ' ' LEU . 50.6 t -81.03 122.18 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 120.874 0.368 . . . . 43.52 110.819 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -135.28 169.6 17.21 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.975 0.417 . . . . 73.4 111.328 -177.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -106.74 144.21 33.73 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.887 0.375 . . . . 75.34 110.791 176.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -153.75 -106.77 0.29 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.808 -0.71 . . . . 61.11 113.056 178.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -76.91 104.36 7.36 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.43 -0.453 . . . . 72.11 111.898 -176.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . . . . . . . . . 52.6 m 68.66 -27.42 0.15 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.829 1.048 . . . . 64.11 113.829 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -159.48 -152.69 6.57 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.75 -0.738 . . . . 72.33 113.761 -176.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.478 HD21 ' HG3' ' A' ' 181' ' ' PRO . 90.5 mt -101.4 150.96 22.48 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.38 0.609 . . . . 75.43 112.381 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.63 159.8 41.4 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.634 -0.712 . . . . 74.21 110.146 172.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . . . . . . . . . 9.7 tt -118.65 109.04 25.66 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.403 0.621 . . . . 61.15 111.265 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 74.8 m -76.21 106.56 7.89 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 109.68 -0.489 . . . . 71.45 109.68 175.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.413 HG11 ' HB ' ' A' ' 261' ' ' ILE . 55.1 t -68.23 137.08 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 113.048 0.759 . . . . 71.44 113.048 -170.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -104.73 -37.15 7.18 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.753 -0.658 . . . . 75.21 110.528 175.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . 0.432 ' HB3' ' OG ' ' A' ' 244' ' ' SER . 64.0 t30 -149.76 118.43 6.58 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 116.163 -0.471 . . . . 73.41 110.849 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.498 HG13 HG22 ' A' ' 243' ' ' VAL . 9.7 tt -123.22 121.23 62.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.511 0.672 . . . . 75.12 111.669 -179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -132.56 125.76 4.28 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 121.1 -0.571 . . . . 72.21 113.136 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 241' ' ' ALA . 32.6 mm -70.06 113.71 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 O-C-N 122.595 -0.356 . . . . 70.4 110.535 176.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 56.7 mt -62.04 -66.47 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.963 0.411 . . . . 71.33 111.366 -178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -89.5 110.52 21.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.849 0.357 . . . . 71.14 111.004 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -118.67 97.33 5.68 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.841 0.353 . . . . 72.13 111.76 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 70.9 m -71.36 94.04 1.19 Allowed 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.939 -0.393 . . . . 70.32 109.939 172.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.63 119.18 16.5 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.213 -0.449 . . . . 73.21 111.846 -174.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 . . . . . 0 C--O 1.254 1.32 0 CA-C-O 118.783 -0.627 . . . . 75.21 112.315 -177.156 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.781 0.324 . . . . 70.1 110.906 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 186' ' ' THR . 23.8 p-10 -89.94 116.38 27.95 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.283 0.563 . . . . 55.42 111.702 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -108.11 161.97 14.49 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.105 0.479 . . . . 75.32 112.138 -176.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -75.88 151.03 37.47 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.264 -0.643 . . . . 53.22 109.264 163.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.418 HD13 HG22 ' A' ' 222' ' ' ILE . 28.4 mt -58.26 -39.03 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 O-C-N 121.832 -0.543 . . . . 73.45 111.835 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 23.0 t -73.81 -20.03 60.58 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.069 0.461 . . . . 72.4 111.379 175.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -78.94 -19.53 51.51 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.206 0.527 . . . . 71.5 110.711 177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.435 HD11 HG21 ' A' ' 187' ' ' ILE . 95.1 mt -67.12 146.78 53.91 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.135 0.493 . . . . 74.24 111.608 177.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 21.7 ptp -146.67 152.75 45.77 Favored Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.205 -0.452 . . . . 41.23 110.949 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.54 ' HG3' ' HB2' ' A' ' 249' ' ' GLN . 51.3 Cg_exo -54.63 147.63 48.2 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.983 2.455 . . . . 72.32 113.655 -178.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 64.46 29.1 13.47 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.018 -0.537 . . . . 74.33 112.352 177.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.9 tt -133.61 136.75 45.05 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.343 -0.39 . . . . 51.33 110.886 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 80.0 p -97.88 133.92 41.72 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.768 0.318 . . . . 72.15 111.291 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.2 174.55 34.75 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.659 -0.781 . . . . 73.33 113.743 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 173' ' ' ASN . 44.2 m -122.56 138.48 54.56 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 122.508 0.323 . . . . 52.02 110.345 178.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 179' ' ' LEU . 32.9 pt -134.73 146.12 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.262 0.553 . . . . 73.41 111.909 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -109.87 103.76 12.59 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.821 -0.437 . . . . 73.12 109.821 171.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -132.6 168.19 18.7 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.302 0.573 . . . . 61.4 112.187 -173.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -82.75 126.73 32.72 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.552 -0.749 . . . . 73.32 111.024 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 235' ' ' VAL . 61.8 t -76.57 95.35 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.204 0.526 . . . . 71.55 110.195 174.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.483 ' O ' ' HG3' ' A' ' 237' ' ' LYS . 13.7 t -75.76 -35.13 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 CA-C-N 115.963 -0.562 . . . . 44.22 111.548 -176.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . . . . . . . . . . . -149.06 113.4 5.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 74.52 111.743 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -99.85 103.97 15.61 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.207 -0.451 . . . . 71.34 110.479 174.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -79.31 147.55 68.92 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.23 -0.441 . . . . 75.24 111.776 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -58.83 155.01 40.19 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.596 2.197 . . . . 62.3 112.687 176.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -72.94 156.05 39.24 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.396 0.617 . . . . 71.13 112.563 -173.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 210' ' ' LEU . 68.6 mttm -122.92 159.13 28.89 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.721 -0.672 . . . . 72.52 109.866 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -141.7 132.16 25.27 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.097 0.475 . . . . 70.14 111.408 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -140.92 -175.56 4.35 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.089 -0.505 . . . . 73.1 111.372 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 89.0 p -107.9 144.43 35.15 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.023 0.44 . . . . 72.32 111.755 -179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -96.17 123.27 39.73 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.505 -0.316 . . . . 51.42 111.038 176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -17.78 2.86 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.164 0.431 . . . . 74.02 112.164 174.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.5 -29.56 70.22 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 122.784 0.434 . . . . 64.52 111.658 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLY . . . . . . . . . . . . . . . 134.0 -29.11 3.12 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.288 -0.415 . . . . 71.04 112.494 -177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 71.6 p -90.1 -167.79 1.94 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.132 0.491 . . . . 75.45 111.953 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' LYS . . . . . . . . . . . . . 56.1 mttp -111.0 174.69 5.74 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.848 0.356 . . . . 60.24 111.191 176.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -147.02 158.74 27.83 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 121.004 -0.617 . . . . 72.51 113.409 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.402 ' HB2' ' HA ' ' A' ' 228' ' ' ASN . 47.8 mt-30 -134.03 144.47 48.7 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 122.591 0.357 . . . . 63.2 110.655 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' A' ' 198' ' ' LYS . 56.8 tp -125.78 145.91 50.01 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.662 0.385 . . . . 72.05 111.571 -174.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 226' ' ' LEU . 22.3 tptm -150.59 121.92 7.85 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.45 -0.341 . . . . 54.53 110.939 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 47.2 t -101.45 144.03 30.74 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.993 0.425 . . . . 74.41 111.821 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 97.3 mt -136.34 134.58 38.05 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.153 -0.476 . . . . 73.51 111.119 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -103.83 109.93 21.85 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 122.141 -0.349 . . . . 74.23 110.731 174.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.519 HD11 HG21 ' A' ' 243' ' ' VAL . 67.0 mt -107.55 145.09 33.65 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.346 -0.388 . . . . 72.1 110.674 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -137.52 150.46 47.54 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.539 0.685 . . . . 71.43 112.04 175.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -139.28 170.59 15.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.85 -1.068 . . . . 73.44 109.69 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -52.48 -41.24 63.2 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.792 0.33 . . . . 73.25 111.846 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 81.5 p -83.83 -6.26 59.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.487 0.921 . . . . 60.41 113.487 -174.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 148.97 -179.8 25.49 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 120.721 -0.752 . . . . 70.3 113.149 -178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 84.9 p -121.83 159.4 26.84 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 122.258 -0.554 . . . . 63.54 111.893 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 176' ' ' ILE . 14.6 tt -151.8 150.33 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.073 0.463 . . . . 72.33 110.861 179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ARG . . . . . 0.423 ' NH2' ' O ' ' A' ' 252' ' ' SER . 32.0 mtm-85 -100.93 123.27 44.87 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.021 0.439 . . . . 75.54 111.855 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 256' ' ' ILE . . . -97.26 161.7 21.58 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-N 116.033 -0.531 . . . . 70.34 113.233 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 94.5 m -136.5 121.76 19.22 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.269 0.47 . . . . 41.35 112.269 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.624 ' HB2' ' HB3' ' A' ' 211' ' ' LYS . 92.3 mt -105.49 137.19 43.73 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 115.958 -0.565 . . . . 74.41 110.905 176.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -115.79 150.35 37.07 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.759 0.314 . . . . 74.23 111.656 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ASN . . . . . 0.406 ' HB3' ' OE2' ' A' ' 229' ' ' GLU . 65.4 t30 53.0 -128.3 2.42 Favored 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 112.552 0.575 . . . . 75.31 112.552 170.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLU . . . . . 0.406 ' OE2' ' HB3' ' A' ' 228' ' ' ASN . 0.9 OUTLIER -55.83 -16.69 4.84 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 113.276 0.843 . . . . 75.53 113.276 -175.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.437 ' HB3' HD22 ' A' ' 226' ' ' LEU . 91.7 mt -88.16 -17.75 30.25 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 120.956 0.407 . . . . 71.53 111.653 176.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.07 98.16 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.67 0.618 . . . . 72.34 112.67 -176.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -77.7 3.2 14.6 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.668 0.618 . . . . 73.02 112.668 -176.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -52.65 121.21 6.73 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.838 0.351 . . . . 62.13 111.74 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -83.6 116.31 22.54 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.241 -0.436 . . . . 73.43 111.549 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.539 HG21 HG21 ' A' ' 191' ' ' VAL . 7.9 p -142.57 142.31 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 116.091 -0.504 . . . . 53.22 110.382 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.0 mmtp -95.55 160.42 14.52 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.04 0.448 . . . . 75.0 111.334 -176.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 192' ' ' VAL . 40.4 ttmt -67.91 93.91 0.44 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.982 0.42 . . . . 73.32 110.939 174.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 136.11 -21.71 3.48 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 121.092 -0.575 . . . . 54.32 113.683 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -57.77 137.12 56.88 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.216 0.532 . . . . 74.04 111.941 -178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.529 HG22 HD12 ' A' ' 264' ' ' ILE . 32.7 mm -84.85 103.17 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.03 175.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -103.07 136.01 43.68 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.886 0.698 . . . . 50.13 112.886 -173.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -79.8 98.8 7.2 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.582 -0.736 . . . . 74.43 110.088 171.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 215' ' ' LEU . 57.9 t -105.69 115.97 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 121.054 0.454 . . . . 35.41 111.793 -177.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 84.0 p -116.43 136.08 53.3 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.013 -0.539 . . . . 63.24 110.418 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -178.91 -166.84 35.58 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.13 -1.033 . . . . 62.33 114.839 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -106.74 122.07 45.64 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.085 0.554 . . . . 70.33 110.917 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 56.7 t -86.0 125.79 40.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.364 0.602 . . . . 53.53 112.364 -176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -121.16 169.23 10.74 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.624 -0.716 . . . . 74.33 110.348 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLN . . . . . 0.54 ' HB2' ' HG3' ' A' ' 181' ' ' PRO . 24.8 tt0 -120.99 140.81 51.38 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.704 0.288 . . . . 71.41 110.731 174.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLY . . . . . . . . . . . . . . . -168.31 -108.64 0.21 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.281 -0.962 . . . . 62.41 113.723 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -84.32 122.86 29.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.975 0.417 . . . . 72.43 112.002 -176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' SER . . . . . 0.423 ' O ' ' NH2' ' A' ' 223' ' ' ARG . 61.4 m 53.53 62.27 2.72 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.562 -0.745 . . . . 70.24 111.95 177.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . 93.16 -135.61 12.72 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.129 -0.557 . . . . 70.44 113.772 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.18 151.15 21.76 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.644 0.609 . . . . 72.2 112.644 -175.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -127.44 125.07 39.9 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.618 -0.719 . . . . 72.41 109.357 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ILE . . . . . 0.488 HG23 ' HA2' ' A' ' 224' ' ' GLY . 10.1 tt -113.83 121.21 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-O 121.488 0.661 . . . . 72.44 112.592 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 18.0 m -82.94 111.71 19.07 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.803 -0.635 . . . . 53.22 110.024 175.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . 0.542 ' HB ' HD23 ' A' ' 226' ' ' LEU . 44.7 t -76.99 128.72 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-O 121.366 0.603 . . . . 64.54 112.542 -172.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.8 -44.52 14.28 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.597 -0.729 . . . . 73.04 110.537 175.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -152.07 143.18 23.19 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.287 -0.415 . . . . 74.14 111.21 177.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 6.2 tt -134.52 134.1 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-N 116.285 -0.416 . . . . 75.13 111.412 178.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . . . . . . . . . . . -151.23 139.01 6.9 Favored Glycine 0 CA--C 1.524 0.654 0 C-N-CA 121.204 -0.522 . . . . 54.31 112.146 175.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 63.9 mt -69.16 131.96 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 117.333 0.566 . . . . 75.04 110.642 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.529 HD12 HG22 ' A' ' 240' ' ' ILE . 60.9 mt -70.31 -46.32 71.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 112.287 0.477 . . . . 64.44 112.287 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -112.69 95.73 5.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.961 0.41 . . . . 74.52 111.205 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.465 ' NZ ' ' HB2' ' A' ' 266' ' ' LYS . 10.7 mtmp? -104.05 -30.55 10.19 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.069 0.396 . . . . 73.02 112.069 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' SER . . . . . . . . . . . . . 40.8 t -89.59 98.45 11.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.024 0.44 . . . . 64.22 111.445 -179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' LEU . . . . . . . . . . . . . 83.8 mt -68.06 -47.66 67.74 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.26 -0.427 . . . . 62.54 111.415 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.68 -0.676 . . . . 62.32 111.408 179.258 . . . . . . . . 0 0 . 1 stop_ save_